data_5m1u_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5m1u _Structure_validation_residue.Date_analyzed 2017-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 . . . . . 0 N--CA 1.451 -0.412 0 CA-C-O 120.516 0.198 . . . . 65.32 111.338 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 9.8 m -115.97 86.57 16.85 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 120.725 0.298 . . . . 73.11 110.304 175.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.413 ' HB2' ' HB2' ' A' ' 52' ' ' ASP . 74.3 Cg_endo -77.37 84.57 1.93 Allowed 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.122 1.881 . . . . 73.11 111.896 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.7 m -86.07 -80.15 0.24 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.896 -0.593 . . . . 73.25 111.159 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -93.84 -37.85 11.54 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.807 0.337 . . . . 71.23 111.355 -177.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -66.64 -13.83 61.68 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.01 -0.541 . . . . 73.42 111.273 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.413 ' HB2' ' HB2' ' A' ' 48' ' ' PRO . 12.7 t70 -49.01 -53.46 19.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.674 -0.694 . . . . 72.13 112.509 -175.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.45 -30.96 67.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.826 0.346 . . . . 73.01 111.349 -178.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.477 ' O ' HG13 ' A' ' 58' ' ' ILE . 67.2 t80 -67.23 -44.64 78.96 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.192 -0.458 . . . . 74.25 110.407 -178.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 87.0 m -55.34 -37.2 67.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.425 0.631 . . . . 75.41 111.557 178.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -80.19 -31.7 38.73 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.796 -0.638 . . . . 63.02 110.771 -174.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.81 -25.19 68.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.031 -0.532 . . . . 74.22 110.263 175.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.533 ' O ' HG13 ' A' ' 62' ' ' ILE . 2.5 mt -86.28 -45.37 16.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.974 -0.557 . . . . 75.44 110.968 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.438 ' HA ' HD12 ' A' ' 62' ' ' ILE . 76.1 mt-30 -59.14 -30.45 68.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.769 0.319 . . . . 74.14 111.283 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.5 m -66.58 -37.96 86.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.352 -0.386 . . . . 73.34 111.152 178.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.5 ' HG2' ' O ' ' A' ' 58' ' ' ILE . 11.1 pt20 -83.19 -20.9 33.8 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.794 0.33 . . . . 71.1 110.943 -178.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.533 HG13 ' O ' ' A' ' 58' ' ' ILE . 83.9 mt -66.5 -31.1 52.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.996 0.427 . . . . 75.12 109.894 177.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 91.9 mt -57.65 -32.85 67.69 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.734 -0.666 . . . . 74.53 110.933 178.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -74.51 -40.47 39.05 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.993 -0.623 . . . . 74.2 111.602 176.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -63.71 -25.99 69.49 Favored Glycine 0 C--N 1.33 0.2 0 C-N-CA 120.992 -0.623 . . . . 72.43 112.286 178.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 62' ' ' ILE . 91.8 mt -66.22 -18.34 65.29 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.706 0.289 . . . . 72.23 110.916 178.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 93.7 mt -85.59 5.97 29.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.076 0.465 . . . . 71.34 110.563 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.9 t -126.11 -42.21 1.88 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.947 -0.57 . . . . 75.11 110.587 179.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -75.73 5.36 6.34 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.699 0.629 . . . . 72.41 112.699 -173.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 50.4 mm . . . . . 0 C--N 1.322 -0.595 0 CA-C-O 121.653 0.739 . . . . 73.52 109.664 176.016 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.465 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 27.6 ttt . . . . . 0 N--CA 1.455 -0.207 0 CA-C-O 120.729 0.3 . . . . 73.31 110.472 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 53.1 t -85.5 97.65 5.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.373 0.606 . . . . 64.42 110.696 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.689 ' HB ' ' O ' ' A' ' 83' ' ' TYR . 6.7 m -113.65 148.86 35.53 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.307 -0.86 . . . . 50.13 108.854 177.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -73.52 -59.64 2.62 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.007 0.373 . . . . 72.31 112.007 -170.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -82.82 -14.16 54.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.795 0.331 . . . . 75.51 111.448 -174.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.689 ' O ' ' HB ' ' A' ' 80' ' ' THR . 59.4 m-85 -133.99 121.3 21.41 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.334 -0.394 . . . . 74.53 110.482 -177.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.558 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 2.9 mp -81.91 102.56 7.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.089 -0.708 . . . . 71.04 109.089 175.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.465 ' HB ' ' HB3' ' A' ' 78' ' ' MET . 47.3 t -96.69 94.31 4.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.715 -0.675 . . . . 64.33 110.769 -176.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -98.45 115.62 28.91 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.343 -0.614 . . . . 74.51 109.343 178.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 71.6 mt -82.02 94.66 2.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.939 -0.573 . . . . 73.15 110.673 -176.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.05 74.54 8.08 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.687 -0.688 . . . . 75.04 111.102 -177.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -88.59 92.73 9.31 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.147 -0.686 . . . . 62.25 109.147 173.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.415 ' HA ' ' HD2' ' A' ' 90' ' ' ARG . 13.6 tpt180 -133.68 154.16 51.14 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.818 -0.628 . . . . 75.44 109.726 -178.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.9 t70 69.93 -68.18 0.21 Allowed 'General case' 0 N--CA 1.465 0.317 0 O-C-N 124.082 0.864 . . . . 71.02 111.151 178.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 177.74 23.62 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.736 -0.745 . . . . 75.32 113.433 178.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.436 ' HA ' HE21 ' A' ' 93' ' ' GLN . 0.0 OUTLIER -138.1 152.5 48.83 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 122.265 -0.55 . . . . 73.12 110.264 178.351 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -89.61 94.58 9.91 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.761 -0.459 . . . . 75.0 109.761 176.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.464 ' HG2' ' OD1' ' A' ' 97' ' ' ASN . 7.3 tt0 -97.31 109.29 22.08 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.137 0.494 . . . . 55.53 109.692 -179.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.526 ' HB3' ' HB ' ' A' ' 109' ' ' ILE . 29.0 tp -90.11 98.64 11.89 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.868 -0.605 . . . . 75.11 110.389 -177.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.475 ' OD1' HG21 ' A' ' 108' ' ' THR . 6.5 m-20 -90.61 93.44 9.27 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.283 0.564 . . . . 73.45 110.532 -179.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.443 ' CG1' ' HD1' ' A' ' 83' ' ' TYR . 56.1 t -92.8 114.18 29.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.658 -0.701 . . . . 72.02 110.677 178.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.558 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 30.7 m -103.32 109.23 20.77 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.845 -0.616 . . . . 64.32 110.077 178.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.578 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 25.2 t70 -62.32 141.23 58.4 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.489 -0.323 . . . . 63.4 110.777 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.07 -26.69 19.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.259 -0.428 . . . . 73.23 110.251 -177.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 32.7 mtmm -70.04 -69.58 0.34 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.374 -0.375 . . . . 73.34 111.149 -174.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 12.0 t -99.05 -26.8 14.11 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.243 0.544 . . . . 74.11 109.716 -179.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.578 ' HA2' ' O ' ' A' ' 100' ' ' ASP . . . 83.65 79.45 1.06 Allowed Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.544 -0.753 . . . . 65.24 112.909 176.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.447 ' H ' ' HB3' ' A' ' 100' ' ' ASP . 68.6 mm-40 -124.69 144.16 50.36 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.587 -0.523 . . . . 74.43 109.587 174.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.9 m -89.05 96.11 10.59 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.123 0.487 . . . . 62.24 110.724 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.419 ' HB3' ' HB ' ' A' ' 98' ' ' VAL . 47.4 t -88.17 80.83 7.51 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.454 -0.573 . . . . 71.15 109.454 177.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.475 HG21 ' OD1' ' A' ' 97' ' ' ASN . 28.2 m -82.35 101.49 10.62 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.901 -0.591 . . . . 73.23 110.709 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.526 ' HB ' ' HB3' ' A' ' 96' ' ' LEU . 54.5 mt -99.88 92.34 2.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.052 -0.522 . . . . 75.24 110.514 -178.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -72.56 106.91 4.81 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.723 -0.473 . . . . 61.1 109.723 175.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.2 t . . . . . 0 C--N 1.323 -0.584 0 N-CA-C 109.688 -0.486 . . . . 75.11 109.688 177.435 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 . . . . . 0 N--CA 1.456 -0.157 0 CA-C-O 120.804 0.335 . . . . 65.32 110.923 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 47.0 p -124.75 86.7 55.69 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.492 -0.322 . . . . 73.11 110.943 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.434 ' HA ' ' HG ' ' A' ' 51' ' ' LEU . 32.0 Cg_exo -57.66 98.94 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.81 2.34 . . . . 73.11 112.702 -177.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 14.3 m -104.4 -46.83 4.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.613 -0.721 . . . . 73.25 110.375 176.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.68 -2.65 3.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.466 0.65 . . . . 71.23 110.303 174.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.434 ' HG ' ' HA ' ' A' ' 48' ' ' PRO . 0.7 OUTLIER -95.46 0.55 53.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.672 -0.695 . . . . 73.42 110.394 -178.728 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -68.28 -40.83 81.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.142 -0.481 . . . . 72.13 109.977 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -63.69 -30.73 71.79 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.711 -0.677 . . . . 73.01 110.368 176.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -83.14 -51.57 7.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.819 -0.628 . . . . 74.25 111.322 -177.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.0 t -69.05 -26.43 64.96 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.046 0.387 . . . . 75.41 112.046 -173.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -77.3 -19.87 55.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.86 0.362 . . . . 63.02 110.433 178.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.51 -18.41 48.6 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.477 0.656 . . . . 74.22 109.683 175.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.458 ' O ' HG13 ' A' ' 62' ' ' ILE . 13.3 mt -77.04 -32.22 19.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.636 -0.711 . . . . 75.44 110.182 177.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -61.64 -27.88 68.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 74.14 110.795 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.624 ' O ' HD22 ' A' ' 63' ' ' LEU . 5.9 m -75.87 -43.15 46.95 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.21 -0.45 . . . . 73.34 110.691 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -74.53 -3.81 33.12 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.484 -0.326 . . . . 71.1 111.641 -173.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 58' ' ' ILE . 64.7 mt -66.9 -17.8 23.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.287 0.565 . . . . 75.12 110.0 174.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.624 HD22 ' O ' ' A' ' 60' ' ' SER . 0.5 OUTLIER -63.75 -19.21 64.79 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.857 -0.611 . . . . 74.53 111.199 -179.024 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.606 ' N ' HD21 ' A' ' 63' ' ' LEU . . . -81.68 -30.37 36.25 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 111.101 -0.8 . . . . 74.2 111.101 176.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -69.77 -26.02 74.89 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.081 -0.808 . . . . 72.43 111.081 175.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.428 ' HA ' HD12 ' A' ' 70' ' ' ILE . 86.8 mt -70.49 -5.45 28.86 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.089 0.471 . . . . 72.23 110.647 176.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 87.4 mt -109.41 -66.69 1.04 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.925 -0.579 . . . . 71.34 110.952 178.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 17.8 m -98.51 15.41 25.03 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.865 0.691 . . . . 75.11 112.865 -171.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -129.45 20.73 5.66 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.539 0.685 . . . . 72.41 110.197 178.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.428 HD12 ' HA ' ' A' ' 66' ' ' LEU . 45.2 mm . . . . . 0 C--O 1.235 0.323 0 CA-C-O 121.629 0.728 . . . . 73.52 109.319 178.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 59.6 ttp . . . . . 0 N--CA 1.453 -0.284 0 N-CA-C 109.299 -0.63 . . . . 73.31 109.299 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 58.5 t -67.4 103.52 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.096 0.474 . . . . 64.42 111.202 -178.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -108.19 167.6 9.9 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.686 -0.688 . . . . 50.13 110.987 176.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -64.28 -73.88 0.11 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.499 -0.318 . . . . 72.31 111.809 -174.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -120.6 32.96 5.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.809 0.814 . . . . 75.51 109.873 -178.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -125.85 144.17 50.77 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.174 -0.921 . . . . 74.53 110.243 177.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.545 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 4.4 mp -108.55 100.48 10.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.172 -0.677 . . . . 71.04 109.172 175.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.9 p -125.28 110.72 25.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.579 0.704 . . . . 64.33 110.973 -177.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -110.38 143.95 39.87 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.477 -0.783 . . . . 74.51 109.858 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 59.5 mt -87.13 98.68 7.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 109.641 -0.503 . . . . 73.15 109.641 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -88.26 89.44 7.99 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.888 -0.596 . . . . 75.04 111.146 -176.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.468 ' HA ' ' O ' ' A' ' 93' ' ' GLN . 29.0 t-20 -84.97 77.43 10.11 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.901 -0.778 . . . . 62.25 108.901 172.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.404 ' O ' ' HB3' ' A' ' 91' ' ' ASP . 47.3 ttp180 -102.6 144.45 30.99 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.737 -1.12 . . . . 75.44 109.107 -178.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.404 ' HB3' ' O ' ' A' ' 90' ' ' ARG . 11.4 t70 69.05 -67.78 0.2 Allowed 'General case' 0 N--CA 1.467 0.384 0 O-C-N 123.726 0.641 . . . . 71.02 110.664 -177.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 172.34 31.54 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.297 -0.721 . . . . 75.32 111.297 178.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.468 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 26.2 mm-40 -136.82 150.06 48.1 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.048 -0.353 . . . . 73.12 110.048 -178.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.431 ' HB2' ' HB ' ' A' ' 111' ' ' VAL . 3.6 mm? -88.24 101.92 14.32 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.102 -0.333 . . . . 75.0 110.102 178.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -104.74 121.53 43.81 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.012 0.434 . . . . 55.53 110.245 178.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 15.7 tp -103.94 102.68 12.47 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.16 -0.473 . . . . 75.11 110.169 -177.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -96.46 115.25 27.13 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.42 -0.355 . . . . 73.45 110.723 -177.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 39.7 t -99.61 111.26 28.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.171 -0.468 . . . . 72.02 110.821 178.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.545 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 43.6 m -97.75 110.59 23.13 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.813 -0.63 . . . . 64.32 110.391 177.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.428 ' HB3' ' H ' ' A' ' 105' ' ' GLN . 7.1 t70 -71.34 124.97 25.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.941 -0.572 . . . . 63.4 109.923 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.488 ' O ' ' HD3' ' A' ' 101' ' ' ARG . 3.1 tmt_? -82.84 -28.69 29.96 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.599 0.238 . . . . 73.23 110.639 -176.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -84.77 -58.4 2.73 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.491 0.663 . . . . 73.34 110.804 -175.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.7 m -88.68 -25.34 22.42 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.989 -1.005 . . . . 74.11 110.83 -172.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.97 69.32 1.41 Allowed Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.704 -0.68 . . . . 65.24 113.214 177.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.428 ' H ' ' HB3' ' A' ' 100' ' ' ASP . 44.7 mt-30 -136.82 144.75 43.82 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.993 -0.743 . . . . 74.43 108.993 176.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.2 t -110.77 94.41 4.98 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.982 0.896 . . . . 62.24 110.446 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 27.0 t -87.26 113.23 22.8 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.457 -0.792 . . . . 71.15 109.371 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 41.9 m -103.62 111.39 23.85 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.925 -0.58 . . . . 73.23 111.219 -176.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 4.5 mp -108.34 109.47 28.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.097 -0.501 . . . . 75.24 109.649 178.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -91.61 153.83 19.46 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.017 0.436 . . . . 61.1 111.491 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.431 ' HB ' ' HB2' ' A' ' 94' ' ' LEU . 4.4 p . . . . . 0 C--N 1.325 -0.479 0 CA-C-N 115.177 -0.92 . . . . 75.11 111.683 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 N--CA 1.469 0.504 0 N-CA-C 112.757 0.651 . . . . 65.32 112.757 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 4.7 t -136.6 88.23 19.95 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-O 121.483 0.659 . . . . 73.11 110.989 -177.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -71.82 84.39 1.04 Allowed 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.398 2.066 . . . . 73.11 111.167 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 12.4 p -127.29 -72.6 0.63 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.659 -0.7 . . . . 73.25 110.786 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.95 -14.78 63.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.132 -0.485 . . . . 71.23 111.92 -177.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.405 ' O ' HG21 ' A' ' 55' ' ' THR . 2.9 pp -115.62 1.69 13.6 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.472 -0.331 . . . . 73.42 111.351 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.617 ' O ' ' HB2' ' A' ' 56' ' ' GLN . 28.3 t70 -68.05 -36.81 80.5 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.451 -0.34 . . . . 72.13 111.397 -174.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -84.66 -38.24 20.05 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.781 0.324 . . . . 73.01 110.922 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.455 ' O ' HG13 ' A' ' 58' ' ' ILE . 60.9 t80 -61.23 -57.99 10.13 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.884 -0.598 . . . . 74.25 111.42 -177.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.405 HG21 ' O ' ' A' ' 51' ' ' LEU . 7.2 t -70.01 -16.72 63.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.186 0.517 . . . . 75.41 110.958 -176.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.617 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 1.5 tp-100 -75.16 -29.96 60.59 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.385 0.612 . . . . 63.02 109.752 -178.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.72 -35.76 44.39 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.563 -0.744 . . . . 74.22 109.926 176.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.569 ' O ' HG13 ' A' ' 62' ' ' ILE . 17.3 mt -62.38 -40.07 86.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.648 -0.705 . . . . 75.44 111.055 -178.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -54.48 -32.85 58.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.429 -0.35 . . . . 74.14 111.413 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.3 t -81.51 -18.4 45.21 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.508 -0.314 . . . . 73.34 111.59 -176.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.526 ' HG2' ' O ' ' A' ' 58' ' ' ILE . 3.4 pt20 -96.63 -17.21 20.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.863 0.363 . . . . 71.1 110.687 -178.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.581 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 84.2 mt -65.15 -41.81 92.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.211 -0.45 . . . . 75.12 110.295 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.2 mp -61.59 -31.1 71.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.709 -0.678 . . . . 74.53 110.967 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -73.14 -41.8 45.9 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.658 -0.782 . . . . 74.2 111.833 178.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -71.33 -19.46 77.55 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 121.295 -0.478 . . . . 72.43 112.814 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.581 ' HG ' ' O ' ' A' ' 62' ' ' ILE . 86.2 mt -57.35 -34.43 68.79 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.884 0.373 . . . . 72.23 110.966 178.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.405 HD12 HH11 ' A' ' 90' ' ' ARG . 97.1 mt -65.87 -36.5 83.6 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.199 -0.455 . . . . 71.34 110.851 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.9 m -71.51 -27.6 63.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.025 0.441 . . . . 75.11 110.255 177.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -72.83 -27.3 61.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.118 0.485 . . . . 72.41 109.927 176.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.518 HG12 ' O ' ' A' ' 66' ' ' LEU . 48.8 mm . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 115.888 -0.596 . . . . 73.52 109.634 175.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 45.1 ttm . . . . . 0 N--CA 1.453 -0.283 0 N-CA-C 110.299 -0.26 . . . . 73.31 110.299 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 54.2 t -72.38 124.98 30.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.507 -0.553 . . . . 64.42 109.507 176.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.616 ' HB ' ' O ' ' A' ' 83' ' ' TYR . 2.7 m -127.27 162.35 26.44 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.663 -0.244 . . . . 50.13 110.532 -176.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -72.59 -75.89 0.13 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.954 0.407 . . . . 72.31 111.264 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -88.96 5.98 41.61 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.225 -0.443 . . . . 75.51 111.781 -174.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.616 ' O ' ' HB ' ' A' ' 80' ' ' THR . 60.7 m-85 -143.81 167.65 21.81 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.882 0.372 . . . . 74.53 110.748 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.551 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 40.8 mm -121.88 99.55 7.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 108.762 -0.829 . . . . 71.04 108.762 168.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 37.1 t -85.0 82.38 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.194 0.521 . . . . 64.33 109.977 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -94.81 98.77 10.98 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.754 -0.657 . . . . 74.51 111.226 -177.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.422 HG12 HD11 ' A' ' 96' ' ' LEU . 58.2 mt -86.82 95.4 4.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.574 -0.528 . . . . 73.15 109.574 175.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -88.14 114.33 24.66 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.954 -0.566 . . . . 75.04 110.457 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.497 ' HA ' ' O ' ' A' ' 93' ' ' GLN . 2.8 t-20 -109.89 111.17 22.42 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.906 -0.588 . . . . 62.25 110.211 178.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.405 HH11 HD12 ' A' ' 67' ' ' LEU . 59.0 ttp85 -127.44 133.74 49.91 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.476 -0.564 . . . . 75.44 109.476 175.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 64.43 -86.05 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 O-C-N 123.861 0.725 . . . . 71.02 110.558 -176.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -148.64 15.1 1.22 Allowed Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 110.996 -0.842 . . . . 75.32 110.996 177.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.497 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -98.11 124.31 42.57 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.814 0.34 . . . . 73.12 110.799 -177.588 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -95.7 101.17 12.83 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.65 -0.87 . . . . 75.0 108.65 171.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -117.45 110.7 18.32 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.184 -0.462 . . . . 55.53 110.754 -174.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.483 ' HG ' HG23 ' A' ' 98' ' ' VAL . 61.1 tp -89.21 109.58 20.44 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.896 -0.593 . . . . 75.11 110.971 -176.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -97.44 88.31 4.36 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.848 -0.427 . . . . 73.45 109.848 178.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.515 ' HB ' ' HB3' ' A' ' 107' ' ' SER . 43.1 t -78.95 102.55 5.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.205 0.526 . . . . 72.02 110.516 178.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.551 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 25.1 m -90.64 106.39 18.47 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.456 -0.793 . . . . 64.32 109.371 176.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -63.02 140.23 58.85 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.061 0.458 . . . . 63.4 110.73 -177.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 24.4 tpp180 -76.6 -35.47 58.09 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.672 -0.694 . . . . 73.23 111.785 -174.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -102.35 -47.44 4.49 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 111.876 0.324 . . . . 73.34 111.876 -169.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 42.7 p -89.9 -26.84 20.25 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.156 0.503 . . . . 74.11 110.486 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.03 19.02 68.21 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.855 -0.688 . . . . 65.24 112.861 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -64.8 124.49 22.11 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.242 -0.281 . . . . 74.43 110.242 174.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 36.9 m -92.92 91.64 7.5 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.234 0.54 . . . . 62.24 109.571 175.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.515 ' HB3' ' HB ' ' A' ' 98' ' ' VAL . 17.1 t -88.45 89.39 7.97 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.869 -0.605 . . . . 71.15 109.589 -179.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 32.1 m -86.84 102.86 14.7 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.78 -0.645 . . . . 73.23 110.257 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 61.4 mt -111.39 109.11 27.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.77 -0.65 . . . . 75.24 110.816 -177.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -76.14 147.48 38.5 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.431 -0.35 . . . . 61.1 110.474 174.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 5.7 p . . . . . 0 C--N 1.322 -0.587 0 CA-C-N 115.563 -0.744 . . . . 75.11 110.179 174.374 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 . . . . . 0 CA--C 1.529 0.16 0 N-CA-C 111.864 0.32 . . . . 65.32 111.864 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.7 t -137.63 74.79 45.39 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-O 121.885 0.85 . . . . 73.11 109.673 172.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -89.9 99.54 0.3 Allowed 'Trans proline' 0 N--CA 1.448 -1.2 0 C-N-CA 122.941 2.428 . . . . 73.11 112.775 -175.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 38.3 m -129.39 -62.69 0.97 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.849 -0.614 . . . . 73.25 109.759 174.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.83 -43.78 13.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.12 0.486 . . . . 71.23 110.124 178.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.9 pp -75.58 -11.12 59.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.865 -0.607 . . . . 73.42 110.613 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.553 ' O ' ' HB2' ' A' ' 56' ' ' GLN . 26.9 t70 -62.42 -50.48 71.33 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.991 -0.55 . . . . 72.13 110.439 178.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -63.41 -32.47 73.92 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.049 -0.523 . . . . 73.01 110.908 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.523 ' O ' HG13 ' A' ' 58' ' ' ILE . 57.4 t80 -68.11 -55.33 12.83 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.035 -0.53 . . . . 74.25 110.227 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.3 t -67.85 -19.22 65.02 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.25 0.548 . . . . 75.41 110.524 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.553 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 2.8 tp-100 -67.38 -41.3 85.25 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.795 -0.638 . . . . 63.02 109.4 178.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.94 -29.28 61.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.505 -0.771 . . . . 74.22 110.798 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.523 HG13 ' O ' ' A' ' 54' ' ' PHE . 20.7 mt -63.84 -35.61 73.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.123 0.487 . . . . 75.44 110.552 178.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -66.92 -22.14 65.96 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.132 -0.486 . . . . 74.14 111.263 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.3 m -85.93 -30.07 23.11 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.018 -0.537 . . . . 73.34 111.073 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.466 ' HG2' ' O ' ' A' ' 58' ' ' ILE . 3.9 pt20 -83.14 -3.33 57.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.795 0.331 . . . . 71.1 111.093 -176.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.504 HG12 ' O ' ' A' ' 58' ' ' ILE . 47.5 mm -74.95 -37.61 41.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.891 0.377 . . . . 75.12 110.343 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.483 ' H ' HD21 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -65.5 -41.89 92.72 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.008 -0.542 . . . . 74.53 110.792 -175.778 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -77.79 -22.51 69.12 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.631 -0.795 . . . . 74.2 112.346 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -77.22 -6.83 86.63 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.982 -0.627 . . . . 72.43 112.435 -178.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.603 ' O ' HG12 ' A' ' 70' ' ' ILE . 97.9 mt -70.11 -29.66 66.66 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 122.819 -0.224 . . . . 72.23 111.018 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 91.2 mt -54.28 -46.89 72.81 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.308 -0.405 . . . . 71.34 111.995 -175.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -70.8 -21.95 62.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.222 -0.445 . . . . 75.11 111.255 -178.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -94.1 -7.93 41.07 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.311 -0.404 . . . . 72.41 111.032 -178.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.603 HG12 ' O ' ' A' ' 66' ' ' LEU . 31.9 mm . . . . . 0 C--N 1.325 -0.468 0 CA-C-N 116.413 -0.358 . . . . 73.52 110.368 177.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.4 ' HB3' HG13 ' A' ' 85' ' ' VAL . 27.5 ttt . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.986 0.422 . . . . 73.31 111.043 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 46.1 t -81.87 107.39 13.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.088 -0.505 . . . . 64.42 110.154 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.771 ' HB ' ' O ' ' A' ' 83' ' ' TYR . 1.8 m -107.95 168.39 9.31 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.192 -0.458 . . . . 50.13 110.139 -178.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -89.03 -65.33 1.03 Allowed 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.172 0.434 . . . . 72.31 112.172 -175.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -94.66 -2.72 50.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.205 0.526 . . . . 75.51 111.192 -176.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.771 ' O ' ' HB ' ' A' ' 80' ' ' THR . 31.8 m-85 -130.73 149.95 52.14 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.97 -0.752 . . . . 74.53 108.97 177.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.561 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 4.7 mp -117.5 93.92 2.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 108.914 -0.773 . . . . 71.04 108.914 172.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.4 HG13 ' HB3' ' A' ' 78' ' ' MET . 4.9 p -91.57 101.29 12.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.955 0.883 . . . . 64.33 110.216 178.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -93.81 127.26 39.45 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.339 -0.846 . . . . 74.51 109.967 -177.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 63.5 mt -93.37 109.47 21.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.162 -0.472 . . . . 73.15 110.465 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -120.77 176.24 5.63 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.915 -0.584 . . . . 75.04 110.474 179.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -139.11 123.81 18.54 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.691 -0.485 . . . . 62.25 109.691 176.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.453 ' O ' ' HB3' ' A' ' 91' ' ' ASP . 14.8 ptm180 -106.23 99.62 9.19 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.712 -0.676 . . . . 75.44 110.057 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.453 ' HB3' ' O ' ' A' ' 90' ' ' ARG . 4.8 t70 73.38 -57.97 0.61 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.878 -0.601 . . . . 71.02 111.696 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -172.2 32.07 0.12 Allowed Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 111.076 -0.809 . . . . 75.32 111.076 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.42 ' HA ' HE21 ' A' ' 93' ' ' GLN . 0.0 OUTLIER -135.8 124.52 23.85 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.613 -0.514 . . . . 73.12 109.613 -179.175 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -64.37 120.09 11.58 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.14 0.495 . . . . 75.0 110.405 176.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -102.17 115.77 31.26 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.502 -0.772 . . . . 55.53 109.932 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 12.9 tp -92.62 91.05 7.37 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.303 -0.629 . . . . 75.11 109.303 178.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -83.59 96.24 8.58 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.365 -0.38 . . . . 73.45 110.77 -177.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.1 t -88.93 104.87 15.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.332 0.587 . . . . 72.02 110.623 176.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.561 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 31.0 m -96.69 112.48 24.21 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.109 -0.95 . . . . 64.32 109.867 176.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.466 ' HB3' ' N ' ' A' ' 105' ' ' GLN . 12.6 t70 -71.26 130.93 42.66 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.185 -0.462 . . . . 63.4 111.125 178.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 -94.48 -11.47 29.63 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.188 0.518 . . . . 73.23 110.469 -176.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -86.3 -62.48 1.5 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.113 -0.494 . . . . 73.34 111.509 -176.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 63.6 p -111.35 -27.88 8.46 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.018 0.437 . . . . 74.11 111.393 -176.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 103.04 34.41 4.0 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.786 -0.643 . . . . 65.24 112.54 178.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.466 ' N ' ' HB3' ' A' ' 100' ' ' ASP . 51.3 mt-30 -71.84 115.9 11.59 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.984 -0.376 . . . . 74.43 109.984 174.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 21.1 m -86.55 92.16 8.79 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.059 0.457 . . . . 62.24 110.4 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 22.6 t -97.43 86.78 3.95 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.221 0.534 . . . . 71.15 110.126 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.4 m -91.42 95.54 10.03 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.054 -0.521 . . . . 73.23 110.289 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 57.0 mt -102.89 136.29 36.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.827 -0.624 . . . . 75.24 110.577 -175.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -95.59 163.32 13.26 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.859 0.361 . . . . 61.1 110.553 173.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.6 p . . . . . 0 C--N 1.324 -0.529 0 CA-C-N 116.002 -0.544 . . . . 75.11 110.518 176.167 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 . . . . . 0 N--CA 1.451 -0.412 0 CA-C-O 120.516 0.198 . . . . 65.32 111.338 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 9.8 m -115.97 86.57 16.85 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 120.725 0.298 . . . . 73.11 110.304 175.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.413 ' HB2' ' HB2' ' A' ' 52' ' ' ASP . 74.3 Cg_endo -77.37 84.57 1.93 Allowed 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.122 1.881 . . . . 73.11 111.896 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.7 m -86.07 -80.15 0.24 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.896 -0.593 . . . . 73.25 111.159 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -93.84 -37.85 11.54 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.807 0.337 . . . . 71.23 111.355 -177.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -66.64 -13.83 61.68 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.01 -0.541 . . . . 73.42 111.273 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.413 ' HB2' ' HB2' ' A' ' 48' ' ' PRO . 12.7 t70 -49.01 -53.46 19.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.674 -0.694 . . . . 72.13 112.509 -175.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.45 -30.96 67.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.826 0.346 . . . . 73.01 111.349 -178.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.477 ' O ' HG13 ' A' ' 58' ' ' ILE . 67.2 t80 -67.23 -44.64 78.96 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.192 -0.458 . . . . 74.25 110.407 -178.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 87.0 m -55.34 -37.2 67.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.425 0.631 . . . . 75.41 111.557 178.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -80.19 -31.7 38.73 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.796 -0.638 . . . . 63.02 110.771 -174.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.81 -25.19 68.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.031 -0.532 . . . . 74.22 110.263 175.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.533 ' O ' HG13 ' A' ' 62' ' ' ILE . 2.5 mt -86.28 -45.37 16.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.974 -0.557 . . . . 75.44 110.968 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.438 ' HA ' HD12 ' A' ' 62' ' ' ILE . 76.1 mt-30 -59.14 -30.45 68.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.769 0.319 . . . . 74.14 111.283 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.5 m -66.58 -37.96 86.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.352 -0.386 . . . . 73.34 111.152 178.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.5 ' HG2' ' O ' ' A' ' 58' ' ' ILE . 11.1 pt20 -83.19 -20.9 33.8 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.794 0.33 . . . . 71.1 110.943 -178.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.533 HG13 ' O ' ' A' ' 58' ' ' ILE . 83.9 mt -66.5 -31.1 52.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.996 0.427 . . . . 75.12 109.894 177.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 91.9 mt -57.65 -32.85 67.69 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.734 -0.666 . . . . 74.53 110.933 178.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -74.51 -40.47 39.05 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.993 -0.623 . . . . 74.2 111.602 176.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -63.71 -25.99 69.49 Favored Glycine 0 C--N 1.33 0.2 0 C-N-CA 120.992 -0.623 . . . . 72.43 112.286 178.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 62' ' ' ILE . 91.8 mt -66.22 -18.34 65.29 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.706 0.289 . . . . 72.23 110.916 178.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 93.7 mt -85.59 5.97 29.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.076 0.465 . . . . 71.34 110.563 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.9 t -126.11 -42.21 1.88 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.947 -0.57 . . . . 75.11 110.587 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -75.73 5.36 6.34 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.699 0.629 . . . . 72.41 112.699 -173.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 50.4 mm . . . . . 0 C--N 1.322 -0.595 0 CA-C-O 121.653 0.739 . . . . 73.52 109.664 176.016 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.465 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 27.6 ttt . . . . . 0 N--CA 1.455 -0.207 0 CA-C-O 120.729 0.3 . . . . 73.31 110.472 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 53.1 t -85.5 97.65 5.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.373 0.606 . . . . 64.42 110.696 -178.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.689 ' HB ' ' O ' ' A' ' 83' ' ' TYR . 6.7 m -113.65 148.86 35.53 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.307 -0.86 . . . . 50.13 108.854 177.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -73.52 -59.64 2.62 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.007 0.373 . . . . 72.31 112.007 -170.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -82.82 -14.16 54.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.795 0.331 . . . . 75.51 111.448 -174.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.689 ' O ' ' HB ' ' A' ' 80' ' ' THR . 59.4 m-85 -133.99 121.3 21.41 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.334 -0.394 . . . . 74.53 110.482 -177.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.558 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 2.9 mp -81.91 102.56 7.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.089 -0.708 . . . . 71.04 109.089 175.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.465 ' HB ' ' HB3' ' A' ' 78' ' ' MET . 47.3 t -96.69 94.31 4.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.715 -0.675 . . . . 64.33 110.769 -176.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -98.45 115.62 28.91 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.343 -0.614 . . . . 74.51 109.343 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 71.6 mt -82.02 94.66 2.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.939 -0.573 . . . . 73.15 110.673 -176.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.05 74.54 8.08 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.687 -0.688 . . . . 75.04 111.102 -177.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -88.59 92.73 9.31 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.147 -0.686 . . . . 62.25 109.147 173.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.415 ' HA ' ' HD2' ' A' ' 90' ' ' ARG . 13.6 tpt180 -133.68 154.16 51.14 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.818 -0.628 . . . . 75.44 109.726 -178.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.9 t70 69.93 -68.18 0.21 Allowed 'General case' 0 N--CA 1.465 0.317 0 O-C-N 124.082 0.864 . . . . 71.02 111.151 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 177.74 23.62 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.736 -0.745 . . . . 75.32 113.433 178.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.436 ' HA ' HE21 ' A' ' 93' ' ' GLN . 0.0 OUTLIER -138.1 152.5 48.83 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 122.265 -0.55 . . . . 73.12 110.264 178.351 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -89.61 94.58 9.91 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.761 -0.459 . . . . 75.0 109.761 176.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.464 ' HG2' ' OD1' ' A' ' 97' ' ' ASN . 7.3 tt0 -97.31 109.29 22.08 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.137 0.494 . . . . 55.53 109.692 -179.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.526 ' HB3' ' HB ' ' A' ' 109' ' ' ILE . 29.0 tp -90.11 98.64 11.89 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.868 -0.605 . . . . 75.11 110.389 -177.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.475 ' OD1' HG21 ' A' ' 108' ' ' THR . 6.5 m-20 -90.61 93.44 9.27 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.283 0.564 . . . . 73.45 110.532 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.443 ' CG1' ' HD1' ' A' ' 83' ' ' TYR . 56.1 t -92.8 114.18 29.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.658 -0.701 . . . . 72.02 110.677 178.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.558 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 30.7 m -103.32 109.23 20.77 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.845 -0.616 . . . . 64.32 110.077 178.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.578 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 25.2 t70 -62.32 141.23 58.4 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.489 -0.323 . . . . 63.4 110.777 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.07 -26.69 19.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.259 -0.428 . . . . 73.23 110.251 -177.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 32.7 mtmm -70.04 -69.58 0.34 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.374 -0.375 . . . . 73.34 111.149 -174.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 12.0 t -99.05 -26.8 14.11 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.243 0.544 . . . . 74.11 109.716 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.578 ' HA2' ' O ' ' A' ' 100' ' ' ASP . . . 83.65 79.45 1.06 Allowed Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.544 -0.753 . . . . 65.24 112.909 176.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.447 ' H ' ' HB3' ' A' ' 100' ' ' ASP . 68.6 mm-40 -124.69 144.16 50.36 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.587 -0.523 . . . . 74.43 109.587 174.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.9 m -89.05 96.11 10.59 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.123 0.487 . . . . 62.24 110.724 -178.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.419 ' HB3' ' HB ' ' A' ' 98' ' ' VAL . 47.4 t -88.17 80.83 7.51 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.454 -0.573 . . . . 71.15 109.454 177.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.475 HG21 ' OD1' ' A' ' 97' ' ' ASN . 28.2 m -82.35 101.49 10.62 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.901 -0.591 . . . . 73.23 110.709 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.526 ' HB ' ' HB3' ' A' ' 96' ' ' LEU . 54.5 mt -99.88 92.34 2.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.052 -0.522 . . . . 75.24 110.514 -178.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -72.56 106.91 4.81 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.723 -0.473 . . . . 61.1 109.723 175.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.2 t . . . . . 0 C--N 1.323 -0.584 0 N-CA-C 109.688 -0.486 . . . . 75.11 109.688 177.435 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 . . . . . 0 N--CA 1.454 -0.256 0 N-CA-C 109.755 -0.461 . . . . 65.32 109.755 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.3 m -124.24 89.12 52.27 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.106 -0.497 . . . . 73.11 110.742 -175.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -61.67 107.21 0.49 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.881 2.387 . . . . 73.11 112.385 -177.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.7 m -140.43 -36.9 0.47 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.965 -0.562 . . . . 73.25 110.371 175.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -92.45 -33.72 14.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.296 0.569 . . . . 71.23 110.604 176.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -101.47 0.0 35.95 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.839 -0.619 . . . . 73.42 110.665 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -62.38 -62.9 1.44 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.738 -0.664 . . . . 72.13 111.671 -173.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -69.26 -18.24 63.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.235 0.54 . . . . 73.01 110.085 -177.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -73.37 -58.15 3.51 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.553 -0.749 . . . . 74.25 110.658 178.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.412 ' HA ' HG13 ' A' ' 58' ' ' ILE . 6.5 t -70.3 -18.97 63.11 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.229 0.538 . . . . 75.41 110.461 -178.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -61.82 -35.51 78.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.479 -0.782 . . . . 63.02 109.978 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.98 -19.96 31.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.893 -0.594 . . . . 74.22 110.983 -179.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.429 ' O ' HG13 ' A' ' 62' ' ' ILE . 24.7 mt -71.74 -27.7 28.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.052 -0.522 . . . . 75.44 110.891 -177.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -54.88 -35.72 64.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.442 -0.344 . . . . 74.14 111.239 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.9 m -62.43 -50.41 71.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.989 0.424 . . . . 73.34 110.975 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -74.45 -17.23 60.81 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.32 -0.4 . . . . 71.1 110.846 -177.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.545 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 74.5 mt -72.8 -50.17 35.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.522 -0.547 . . . . 75.12 109.522 173.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 95.5 mt -60.45 -42.04 95.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.881 -0.599 . . . . 74.53 110.356 177.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -59.72 -43.85 97.46 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.852 -0.613 . . . . 74.2 112.215 176.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -65.22 -35.49 91.68 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 121.24 -0.505 . . . . 72.43 112.432 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 62' ' ' ILE . 98.0 mt -61.66 -52.12 65.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.674 0.273 . . . . 72.23 110.595 178.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.6 mt -68.7 -31.67 70.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.001 -0.545 . . . . 71.34 111.048 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 38.3 t -56.5 -49.63 74.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.785 -0.643 . . . . 75.11 110.908 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -72.49 -19.67 61.5 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.234 -0.439 . . . . 72.41 111.768 -177.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 66' ' ' LEU . 46.4 mm . . . . . 0 C--N 1.328 -0.366 0 CA-C-O 121.13 0.49 . . . . 73.52 110.154 177.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 27.1 ttt . . . . . 0 N--CA 1.454 -0.255 0 CA-C-O 120.975 0.416 . . . . 73.31 110.42 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 45.4 t -76.71 105.92 6.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.875 -0.602 . . . . 64.42 109.728 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.521 ' HB ' ' O ' ' A' ' 83' ' ' TYR . 5.3 m -82.25 160.06 23.05 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.622 -0.717 . . . . 50.13 110.262 -178.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -54.48 -60.49 3.28 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.136 0.493 . . . . 72.31 111.33 -177.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.814 ' HB3' ' HD3' ' A' ' 101' ' ' ARG . 1.6 m-20 -110.43 -38.56 5.19 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.811 -0.631 . . . . 75.51 111.243 -175.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.521 ' O ' ' HB ' ' A' ' 80' ' ' THR . 17.6 m-85 -78.95 142.25 36.84 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.911 -0.586 . . . . 74.53 111.662 -177.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.557 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 49.9 mm -93.58 89.92 2.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.909 -0.587 . . . . 71.04 110.087 175.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.481 HG21 HG23 ' A' ' 98' ' ' VAL . 93.9 t -95.49 117.79 40.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.762 -0.653 . . . . 64.33 110.127 178.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -118.61 119.25 33.94 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.063 0.459 . . . . 74.51 110.447 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 52.4 mt -96.55 94.66 4.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.79 -0.641 . . . . 73.15 109.401 178.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.538 ' HB3' ' HB2' ' A' ' 95' ' ' GLN . . . -92.11 100.38 13.02 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.179 -0.464 . . . . 75.04 110.996 -177.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -96.24 108.16 20.6 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.956 -0.565 . . . . 62.25 110.334 176.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 -136.99 131.7 33.28 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.133 -0.485 . . . . 75.44 110.252 176.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 61.45 19.99 10.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.974 -0.557 . . . . 71.02 111.35 175.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.26 -6.95 78.53 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.971 -0.633 . . . . 75.32 112.427 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.448 ' HA ' HE21 ' A' ' 93' ' ' GLN . 0.1 OUTLIER -90.75 126.82 36.12 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.194 -0.299 . . . . 73.12 110.194 -179.889 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -93.8 107.29 19.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.205 -0.452 . . . . 75.0 110.122 177.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.538 ' HB2' ' HB3' ' A' ' 88' ' ' ALA . 45.1 mt-30 -99.73 95.66 7.08 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.893 0.378 . . . . 55.53 110.269 175.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 50.3 tp -84.38 94.0 8.4 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.835 -0.62 . . . . 75.11 109.429 177.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -107.56 127.28 53.49 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.316 0.579 . . . . 73.45 110.43 -176.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.481 HG23 HG21 ' A' ' 85' ' ' VAL . 85.2 t -118.39 131.65 70.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.637 -0.71 . . . . 72.02 110.483 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.557 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 15.5 m -104.72 112.64 25.81 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.385 -0.825 . . . . 64.32 108.974 172.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -66.27 153.72 41.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.315 0.578 . . . . 63.4 111.966 -175.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.814 ' HD3' ' HB3' ' A' ' 82' ' ' ASP . 35.8 ptt180 -82.81 -30.39 28.82 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.122 -0.945 . . . . 73.23 111.821 -175.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.64 ' HG3' ' HG3' ' A' ' 101' ' ' ARG . 47.1 mttm -105.26 -62.83 1.3 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.218 0.532 . . . . 73.34 111.473 -172.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.493 ' OG1' ' HG2' ' A' ' 105' ' ' GLN . 42.9 p -78.58 -19.69 52.21 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.734 -0.666 . . . . 74.11 109.921 -177.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 70.08 26.01 74.86 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.354 -0.839 . . . . 65.24 112.413 177.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.493 ' HG2' ' OG1' ' A' ' 103' ' ' THR . 27.3 mm-40 -66.91 125.55 26.29 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.991 -0.374 . . . . 74.43 109.991 177.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.9 m -102.12 92.23 4.67 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.055 -0.72 . . . . 62.24 109.055 175.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.8 t -100.25 121.87 42.16 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.196 -0.456 . . . . 71.15 110.124 -176.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 26.8 m -102.95 102.17 12.22 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.159 -0.473 . . . . 73.23 110.442 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 54.5 mt -93.09 92.25 3.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.458 -0.571 . . . . 75.24 109.458 177.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -89.4 131.2 35.58 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.202 -0.454 . . . . 61.1 110.293 -178.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 46.5 t . . . . . 0 C--N 1.327 -0.387 0 CA-C-O 121.34 0.591 . . . . 75.11 109.743 175.481 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 . . . . . 0 N--CA 1.46 0.061 0 N-CA-C 111.807 0.299 . . . . 65.32 111.807 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 33.4 m -116.17 86.06 16.56 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 109.489 -0.56 . . . . 73.11 109.489 174.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -61.48 104.76 0.32 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.107 2.538 . . . . 73.11 112.292 -175.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.1 p -134.29 -75.61 0.47 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.538 -0.755 . . . . 73.25 110.356 178.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.54 -37.26 71.16 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.936 0.398 . . . . 71.23 110.63 177.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.7 pp -97.56 9.92 41.21 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.826 -0.625 . . . . 73.42 110.797 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.442 ' O ' ' HB2' ' A' ' 56' ' ' GLN . 32.7 t70 -59.09 -52.92 63.67 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.813 -0.631 . . . . 72.13 111.165 -176.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -62.37 -40.48 96.58 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.942 -0.572 . . . . 73.01 110.374 -176.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.566 ' O ' HG13 ' A' ' 58' ' ' ILE . 76.7 t80 -60.11 -63.81 1.17 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.728 -0.669 . . . . 74.25 111.826 -178.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.8 t -69.08 -19.54 64.07 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.876 0.325 . . . . 75.41 111.876 -172.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.442 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 2.7 mp0 -82.38 -36.26 26.95 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.741 0.305 . . . . 63.02 110.498 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.96 -30.69 71.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 74.22 110.474 176.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.707 ' O ' ' HG2' ' A' ' 61' ' ' GLN . 10.6 mt -70.09 -46.16 73.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.028 -0.533 . . . . 75.44 110.38 177.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -66.06 -18.88 65.63 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.167 0.508 . . . . 74.14 110.456 178.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 66.1 m -84.19 -3.26 58.04 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.074 -0.512 . . . . 73.34 111.61 177.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.707 ' HG2' ' O ' ' A' ' 58' ' ' ILE . 2.4 pt20 -105.96 -2.13 23.22 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.149 0.499 . . . . 71.1 110.089 177.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 51.6 mm -76.48 -30.53 19.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.818 -0.628 . . . . 75.12 110.886 -176.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.664 ' H ' HD23 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -61.13 -43.85 98.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.082 -0.508 . . . . 74.53 110.198 -177.245 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -83.98 -31.86 25.09 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.954 -0.641 . . . . 74.2 111.604 176.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.82 -24.26 66.37 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 121.405 -0.426 . . . . 72.43 112.833 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.426 ' O ' HG12 ' A' ' 70' ' ' ILE . 9.7 tt -55.58 -40.9 72.6 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.826 -0.435 . . . . 72.23 109.826 176.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.7 mp -80.53 13.2 2.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.042 -0.526 . . . . 71.34 111.223 -178.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 26.2 t -115.97 -21.01 9.7 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.189 0.518 . . . . 75.11 109.664 174.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -83.77 -26.78 29.37 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.954 -0.566 . . . . 72.41 110.489 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.426 HG12 ' O ' ' A' ' 66' ' ' LEU . 35.8 mm . . . . . 0 C--N 1.327 -0.379 0 CA-C-N 115.805 -0.634 . . . . 73.52 110.634 -177.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 51.8 ttm . . . . . 0 N--CA 1.454 -0.256 0 CA-C-O 121.1 0.476 . . . . 73.31 110.227 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 23.6 t -95.27 83.95 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.823 -0.626 . . . . 64.42 109.873 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.81 -179.15 5.81 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.721 -0.672 . . . . 50.13 110.036 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -74.18 -51.88 14.16 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.727 0.299 . . . . 72.31 110.632 -177.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -122.76 19.02 10.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.802 0.334 . . . . 75.51 111.721 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -135.14 111.56 9.81 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.951 0.405 . . . . 74.53 111.0 177.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.41 ' N ' HD13 ' A' ' 84' ' ' ILE . 4.2 mp -99.97 105.56 17.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.834 -0.621 . . . . 71.04 109.477 177.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.447 ' HB ' HG23 ' A' ' 98' ' ' VAL . 6.3 p -117.78 121.63 67.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.24 0.543 . . . . 64.33 110.547 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -138.38 134.7 34.49 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.591 -0.731 . . . . 74.51 110.27 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.483 ' HA ' ' O ' ' A' ' 95' ' ' GLN . 54.0 mt -89.92 101.41 12.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.112 -0.495 . . . . 73.15 110.102 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -90.85 156.43 18.03 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.972 -0.558 . . . . 75.04 110.038 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.538 ' HA ' ' O ' ' A' ' 93' ' ' GLN . 47.7 t-20 -127.53 127.28 43.69 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.016 0.436 . . . . 62.25 110.249 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -133.69 115.51 14.69 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.872 -0.604 . . . . 75.44 110.069 175.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 62.47 29.69 17.14 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.142 -0.481 . . . . 71.02 111.451 175.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.39 28.27 33.67 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.713 -0.756 . . . . 75.32 112.531 178.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.538 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 26.4 mm-40 -119.53 123.36 43.79 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.798 -0.445 . . . . 73.12 109.798 175.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.421 HD22 ' N ' ' A' ' 94' ' ' LEU . 4.0 mm? -93.34 122.93 36.25 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.052 -0.522 . . . . 75.0 109.621 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.875 ' HG2' ' HG2' ' A' ' 110' ' ' GLN . 24.0 mt-30 -118.18 106.73 13.14 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.165 -0.471 . . . . 55.53 111.714 -177.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 54.1 tp -78.09 86.95 4.23 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.252 -1.018 . . . . 75.11 108.252 172.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -113.1 111.55 22.31 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.987 -0.551 . . . . 73.45 110.83 -172.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.447 HG23 ' HB ' ' A' ' 85' ' ' VAL . 7.2 p -107.39 135.23 46.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.51 -0.768 . . . . 72.02 110.718 -177.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 29.1 m -116.72 124.41 49.6 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.145 -0.48 . . . . 64.32 110.815 178.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.431 ' HB3' ' H ' ' A' ' 105' ' ' GLN . 11.2 t0 -71.64 137.21 47.72 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.224 -0.658 . . . . 63.4 109.224 175.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.584 ' HD2' ' O ' ' A' ' 101' ' ' ARG . 3.5 tmm_? -82.16 -28.37 32.16 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.897 0.379 . . . . 73.23 110.554 -176.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt -103.57 -49.46 3.68 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.164 -0.471 . . . . 73.34 111.114 -174.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.584 ' HB ' ' HG2' ' A' ' 105' ' ' GLN . 0.2 OUTLIER -88.23 -14.64 37.98 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.748 -0.66 . . . . 74.11 110.899 -175.292 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 67.34 17.09 68.0 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.87 -0.605 . . . . 65.24 113.362 178.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.584 ' HG2' ' HB ' ' A' ' 103' ' ' THR . 30.7 mm-40 -62.57 123.84 19.41 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.135 -0.32 . . . . 74.43 110.135 176.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 20.8 m -110.22 97.34 6.84 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.031 -0.531 . . . . 62.24 109.889 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.0 t -103.37 104.28 14.37 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.161 -0.472 . . . . 71.15 109.935 -177.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 28.7 m -101.1 103.15 14.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.894 -0.594 . . . . 73.23 111.182 -178.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 4.4 mp -98.5 97.8 6.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.071 0.462 . . . . 75.24 109.882 176.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.875 ' HG2' ' HG2' ' A' ' 95' ' ' GLN . 69.4 mt-30 -75.62 166.64 23.25 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.144 -0.48 . . . . 61.1 110.334 177.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.9 p . . . . . 0 C--N 1.325 -0.498 0 CA-C-O 121.569 0.699 . . . . 75.11 110.331 173.939 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.477 ' HA ' ' OE1' ' A' ' 46' ' ' GLU . 6.9 mm-40 . . . . . 0 N--CA 1.47 0.562 0 N-CA-C 113.349 0.87 . . . . 65.32 113.349 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.415 HG23 ' O ' ' A' ' 47' ' ' THR . 8.5 t -125.1 85.97 57.37 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-O 121.849 0.833 . . . . 73.11 111.055 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.462 ' HB2' ' HB2' ' A' ' 52' ' ' ASP . 11.5 Cg_exo -71.34 116.76 4.83 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.939 2.426 . . . . 73.11 111.951 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 14.6 m -98.6 -69.77 0.75 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.633 -0.258 . . . . 73.25 110.985 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.77 -40.51 18.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.885 0.374 . . . . 71.23 111.248 -176.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -69.8 -16.94 63.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 73.42 110.908 -178.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.506 ' O ' ' HB2' ' A' ' 56' ' ' GLN . 23.1 t70 -57.37 -50.04 74.23 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.112 -0.495 . . . . 72.13 110.779 -178.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -60.31 -43.19 96.59 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.099 -0.5 . . . . 73.01 110.826 178.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.461 ' O ' HG12 ' A' ' 58' ' ' ILE . 80.9 t80 -60.6 -53.35 58.52 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.066 -0.515 . . . . 74.25 111.169 -179.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.2 t -68.99 -30.2 68.56 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.783 0.325 . . . . 75.41 110.784 -177.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.506 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 1.3 tp-100 -64.77 -44.71 89.17 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.145 0.498 . . . . 63.02 110.047 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.47 -32.99 74.84 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.554 -0.748 . . . . 74.22 111.109 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.59 ' O ' ' HG2' ' A' ' 61' ' ' GLN . 47.0 mm -66.13 -37.75 80.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.982 0.42 . . . . 75.44 110.509 177.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -69.48 -38.9 77.89 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.297 -0.41 . . . . 74.14 110.816 178.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 44.8 m -67.96 -32.14 72.35 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.349 -0.387 . . . . 73.34 111.404 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.59 ' HG2' ' O ' ' A' ' 58' ' ' ILE . 2.5 pt20 -78.42 -9.44 59.29 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.642 0.258 . . . . 71.1 111.222 -176.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.518 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 74.3 mt -62.74 -33.07 58.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.934 0.397 . . . . 75.12 110.088 -178.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 92.5 mt -53.49 -36.38 61.62 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.423 -0.808 . . . . 74.53 111.635 -178.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.65 -30.42 5.86 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.708 -0.758 . . . . 74.2 111.967 178.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -58.38 -34.99 77.04 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 121.542 -0.361 . . . . 72.43 112.952 -178.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 62' ' ' ILE . 88.6 mt -56.55 -38.44 71.9 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.873 0.368 . . . . 72.23 111.063 178.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.1 mt -76.54 -39.18 53.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.045 0.45 . . . . 71.34 110.468 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 16.5 m -66.18 -37.95 86.85 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.836 -0.62 . . . . 75.11 111.513 -177.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -76.45 -8.55 57.39 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.966 0.358 . . . . 72.41 111.966 -175.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.468 HG12 ' O ' ' A' ' 66' ' ' LEU . 43.3 mm . . . . . 0 C--O 1.234 0.249 0 CA-C-O 121.419 0.628 . . . . 73.52 110.195 176.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 57.6 ttp . . . . . 0 C--O 1.236 0.346 0 CA-C-O 120.989 0.423 . . . . 73.31 110.955 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 48.2 t -70.34 102.94 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.446 -0.576 . . . . 64.42 109.446 176.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.2 m -109.6 159.68 16.9 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.015 -0.538 . . . . 50.13 109.597 -177.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -67.82 -47.07 70.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.06 0.457 . . . . 72.31 110.125 -179.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -72.66 -35.8 67.82 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.843 0.683 . . . . 75.51 112.843 -176.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.635 ' HB3' HG11 ' A' ' 98' ' ' VAL . 55.1 m-85 -157.24 169.08 25.58 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.897 0.379 . . . . 74.53 110.828 -175.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.55 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 40.3 mm -97.98 98.93 7.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.364 -0.606 . . . . 71.04 109.364 169.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 41.3 t -85.31 94.42 3.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.002 -0.544 . . . . 64.33 110.178 -178.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -98.2 102.7 14.52 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.271 0.558 . . . . 74.51 110.385 177.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 63.0 mt -88.7 106.46 16.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.657 -0.701 . . . . 73.15 109.52 175.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -106.32 162.27 13.83 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.269 -0.423 . . . . 75.04 110.214 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -138.33 123.54 19.26 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.843 0.354 . . . . 62.25 110.321 178.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 65.0 mtp180 -138.81 132.61 30.87 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.073 -0.512 . . . . 75.44 109.855 176.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 64.56 17.37 10.83 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 123.629 0.581 . . . . 71.02 111.051 178.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.06 -26.3 25.18 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 121.113 -0.565 . . . . 75.32 112.412 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.53 ' HA ' HE21 ' A' ' 93' ' ' GLN . 0.1 OUTLIER -90.25 140.78 29.35 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.062 0.458 . . . . 73.12 110.886 -175.742 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -81.12 144.75 31.47 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.707 -0.678 . . . . 75.0 110.616 179.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -122.76 107.59 12.09 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.511 -0.551 . . . . 55.53 109.511 175.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 55.7 tp -82.26 98.8 8.96 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.867 -0.606 . . . . 75.11 109.425 179.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -107.69 91.84 3.82 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.317 0.58 . . . . 73.45 110.657 -177.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.635 HG11 ' HB3' ' A' ' 83' ' ' TYR . 21.7 t -82.99 108.1 15.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.679 -0.691 . . . . 72.02 109.996 176.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.55 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 25.6 m -90.77 111.66 23.13 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.398 -0.819 . . . . 64.32 108.894 175.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.459 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 13.6 t0 -61.27 133.54 56.0 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.841 -0.618 . . . . 63.4 111.155 -177.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.462 ' HD2' ' C ' ' A' ' 101' ' ' ARG . 1.1 ppt_? -94.93 -7.92 38.56 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.551 -0.75 . . . . 73.23 110.461 -178.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -87.17 -71.92 0.54 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.976 -0.556 . . . . 73.34 110.579 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 57.5 p -97.53 -28.92 13.75 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.278 -0.419 . . . . 74.11 110.566 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 100' ' ' ASP . . . 102.29 22.73 9.56 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 121.071 -0.585 . . . . 65.24 112.867 177.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.445 ' N ' ' HB3' ' A' ' 100' ' ' ASP . 49.4 mt-30 -73.98 131.87 41.84 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.732 0.301 . . . . 74.43 110.545 177.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.5 p -91.41 108.83 20.16 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.234 0.54 . . . . 62.24 111.615 -177.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 10.0 t -96.85 86.07 3.94 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.285 -0.635 . . . . 71.15 109.285 177.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 87.2 m -91.6 104.81 17.25 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.633 -0.712 . . . . 73.23 110.671 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 54.8 mt -115.89 105.13 17.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.972 -0.558 . . . . 75.24 110.487 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -69.97 134.15 48.03 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.9 -0.407 . . . . 61.1 109.9 175.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 52.1 t . . . . . 0 C--N 1.322 -0.612 0 CA-C-O 121.135 0.493 . . . . 75.11 110.009 -179.957 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 121.334 0.588 . . . . 65.32 110.718 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.2 t -139.44 87.91 13.08 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.467 -0.788 . . . . 73.11 110.214 -179.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -65.15 100.55 0.38 Allowed 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.647 2.232 . . . . 73.11 112.757 -176.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.3 p -146.51 -76.18 0.19 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.889 -0.596 . . . . 73.25 110.111 174.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.68 -45.73 85.4 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.001 -0.545 . . . . 71.23 110.895 178.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -79.24 -20.2 48.79 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.984 -0.553 . . . . 73.42 110.849 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -57.33 -65.24 0.66 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.893 -0.594 . . . . 72.13 111.562 -174.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -67.58 -22.85 65.36 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.896 -0.593 . . . . 73.01 110.701 -176.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.55 ' O ' HG13 ' A' ' 58' ' ' ILE . 23.3 t80 -75.43 -55.91 5.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.812 -0.631 . . . . 74.25 111.287 -178.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.3 t -63.41 -26.92 68.96 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.827 0.346 . . . . 75.41 111.757 -174.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -68.6 -35.5 77.43 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.796 0.332 . . . . 63.02 110.672 -178.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.53 -29.66 59.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.043 -0.526 . . . . 74.22 109.944 177.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.55 HG13 ' O ' ' A' ' 54' ' ' PHE . 17.5 mt -65.31 -43.8 94.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.75 -0.659 . . . . 75.44 110.747 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -64.15 -22.84 67.09 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.283 -0.417 . . . . 74.14 111.143 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 58.5 m -86.94 -35.18 19.04 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.437 -0.347 . . . . 73.34 111.385 178.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.544 ' HG2' ' HA ' ' A' ' 58' ' ' ILE . 3.6 pt20 -77.58 -4.57 46.47 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.702 0.26 . . . . 71.1 111.702 -175.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.535 HG13 ' O ' ' A' ' 58' ' ' ILE . 75.4 mt -61.9 -36.26 72.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.906 0.384 . . . . 75.12 110.173 -178.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 8.5 mp -56.79 -47.16 80.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.573 -0.74 . . . . 74.53 110.302 178.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -69.01 -39.14 85.01 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.839 -0.696 . . . . 74.2 112.025 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.45 -43.36 98.83 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 121.234 -0.508 . . . . 72.43 112.216 178.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 62' ' ' ILE . 94.8 mt -58.08 -50.02 74.93 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.651 0.262 . . . . 72.23 110.757 178.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.7 HD12 ' HA ' ' A' ' 91' ' ' ASP . 96.4 mt -62.65 -30.52 71.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.125 -0.489 . . . . 71.34 111.561 -177.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 30.6 t -82.59 -35.09 27.4 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.021 0.438 . . . . 75.11 110.499 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -85.71 13.57 6.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.297 -0.41 . . . . 72.41 111.834 -177.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.434 HG12 ' O ' ' A' ' 66' ' ' LEU . 47.8 mm . . . . . 0 C--N 1.327 -0.407 0 N-CA-C 108.691 -0.855 . . . . 73.52 108.691 169.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 49.4 ttm . . . . . 0 N--CA 1.449 -0.476 0 CA-C-O 120.951 0.405 . . . . 73.31 110.1 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 60.0 t -85.6 95.79 4.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.337 0.589 . . . . 64.42 109.913 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.53 ' OG1' ' HB2' ' A' ' 83' ' ' TYR . 1.5 p -103.09 -179.09 3.85 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.506 -0.77 . . . . 50.13 109.925 176.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 13.3 t30 -85.52 -43.66 13.35 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 111.64 0.237 . . . . 72.31 111.64 -175.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.588 ' OD1' ' HD3' ' A' ' 101' ' ' ARG . 15.3 t70 -108.54 0.95 21.14 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.981 0.42 . . . . 75.51 111.91 -174.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.53 ' HB2' ' OG1' ' A' ' 80' ' ' THR . 96.3 m-85 -121.95 124.77 44.83 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 122.07 -0.394 . . . . 74.53 110.949 177.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.534 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 4.1 mp -101.1 88.53 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.4 -0.963 . . . . 71.04 108.4 171.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.5 p -126.88 137.29 58.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.041 -0.527 . . . . 64.33 111.344 -172.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -141.76 152.22 43.58 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.765 -0.652 . . . . 74.51 110.037 175.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 71.2 mt -92.58 115.4 31.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.675 -0.693 . . . . 73.15 110.452 -176.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -110.93 114.15 27.25 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.207 -0.451 . . . . 75.04 110.663 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -90.98 87.35 6.58 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.337 0.589 . . . . 62.25 109.718 174.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 43.7 ttt180 -109.27 139.57 44.04 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.674 -0.694 . . . . 75.44 110.001 177.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.7 ' HA ' HD12 ' A' ' 67' ' ' LEU . 4.7 t70 68.12 20.89 8.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.564 0.697 . . . . 71.02 110.218 172.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.73 20.77 79.84 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.456 -0.793 . . . . 75.32 112.376 -178.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.453 ' HA ' HE21 ' A' ' 93' ' ' GLN . 0.0 OUTLIER -124.43 140.92 52.49 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.763 -0.458 . . . . 73.12 109.763 179.554 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -79.39 117.5 20.42 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.699 -0.482 . . . . 75.0 109.699 176.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -123.57 122.07 37.23 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.227 -0.442 . . . . 55.53 110.733 -176.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 20.1 tp -99.8 106.47 18.35 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.73 -0.668 . . . . 75.11 109.849 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.432 ' ND2' HG23 ' A' ' 108' ' ' THR . 13.6 m120 -95.01 95.6 8.71 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.46 -0.337 . . . . 73.45 110.401 -178.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.45 ' HB ' ' HB2' ' A' ' 107' ' ' SER . 93.5 t -87.83 102.38 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.495 0 CA-C-O 121.321 0.581 . . . . 72.02 110.578 179.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.534 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 68.9 m -86.09 107.98 18.07 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.537 -0.756 . . . . 64.32 109.835 177.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.5 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 24.2 t70 -63.66 145.04 56.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.805 -0.634 . . . . 63.4 111.286 -178.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.588 ' HD3' ' OD1' ' A' ' 82' ' ' ASP . 33.2 ttt180 -92.94 -22.24 19.33 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.545 -0.752 . . . . 73.23 110.685 -178.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 35.0 mttp -80.25 -68.62 0.66 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.371 0.605 . . . . 73.34 110.545 -176.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 45.8 p -90.47 -43.0 10.54 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.476 -0.784 . . . . 74.11 110.031 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.5 ' HA2' ' O ' ' A' ' 100' ' ' ASP . . . 111.25 4.37 27.25 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 115.472 -0.786 . . . . 65.24 112.904 176.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -61.67 133.61 55.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.914 0.388 . . . . 74.43 110.631 175.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 62.6 m -92.17 100.31 12.95 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.614 -0.513 . . . . 62.24 109.614 174.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.45 ' HB2' ' HB ' ' A' ' 98' ' ' VAL . 14.1 m -73.85 101.25 3.7 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.724 -0.671 . . . . 71.15 109.294 177.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.432 HG23 ' ND2' ' A' ' 97' ' ' ASN . 0.8 OUTLIER -89.53 94.84 10.02 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.015 -0.539 . . . . 73.23 110.808 -174.446 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 35.0 mm -99.87 101.22 11.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.826 -0.624 . . . . 75.24 110.371 -177.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -78.24 154.68 30.81 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.425 -0.352 . . . . 61.1 110.658 175.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--N 1.323 -0.559 0 CA-C-N 115.565 -0.743 . . . . 75.11 111.232 178.401 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 . . . . . 0 N--CA 1.453 -0.278 0 CA-C-O 120.941 0.4 . . . . 65.32 110.094 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 25.2 m -119.71 87.73 38.01 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 115.977 -0.556 . . . . 73.11 111.002 -177.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.422 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 21.0 Cg_endo -61.44 127.91 23.27 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.469 2.112 . . . . 73.11 111.556 178.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.8 m -121.93 -42.32 2.4 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.108 0.48 . . . . 73.25 110.526 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -87.55 -36.09 17.76 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.032 -0.531 . . . . 71.23 110.707 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.408 ' O ' HG22 ' A' ' 55' ' ' THR . 0.6 OUTLIER -98.06 5.07 49.1 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.51 -0.314 . . . . 73.42 110.725 180.0 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.422 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 39.4 t0 -57.3 -64.28 0.94 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.011 -0.54 . . . . 72.13 111.54 -175.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -66.01 -26.11 67.38 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.326 -0.397 . . . . 73.01 110.864 -177.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.526 ' O ' HG13 ' A' ' 58' ' ' ILE . 89.0 t80 -69.62 -60.41 2.34 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.96 -0.564 . . . . 74.25 111.266 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.408 HG22 ' O ' ' A' ' 51' ' ' LEU . 12.9 t -74.04 -20.39 60.32 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.565 0.221 . . . . 75.41 111.48 -172.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -76.14 -33.42 59.4 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.83 0.348 . . . . 63.02 110.543 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.94 -24.02 60.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.147 0.498 . . . . 74.22 110.585 178.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.555 ' O ' HG13 ' A' ' 62' ' ' ILE . 16.1 mt -72.67 -26.69 24.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.74 -0.664 . . . . 75.44 110.718 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -56.76 -37.72 71.46 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.734 0.302 . . . . 74.14 110.958 -178.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.9 m -63.94 -43.19 96.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.089 -0.505 . . . . 73.34 111.436 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -79.81 -21.96 43.62 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 121.026 -0.269 . . . . 71.1 111.232 -175.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.555 HG13 ' O ' ' A' ' 58' ' ' ILE . 79.9 mt -66.05 -35.95 76.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.064 0.459 . . . . 75.12 109.84 177.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 92.3 mt -57.23 -46.47 82.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.579 -0.737 . . . . 74.53 111.121 178.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -65.89 -37.48 93.34 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.86 -0.686 . . . . 74.2 111.914 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.14 -40.67 99.26 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.983 -0.627 . . . . 72.43 112.055 178.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.8 mt -61.98 -41.08 97.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.0 0.428 . . . . 72.23 110.904 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.3 mt -67.37 -32.17 72.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.096 -0.502 . . . . 71.34 110.726 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.3 t -70.55 -24.8 62.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.906 -0.588 . . . . 75.11 110.551 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -69.89 -11.59 60.98 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.295 -0.411 . . . . 72.41 111.663 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 47.1 mm . . . . . 0 C--N 1.324 -0.507 0 CA-C-O 121.424 0.63 . . . . 73.52 109.965 178.28 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.488 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 26.1 ttt . . . . . 0 N--CA 1.451 -0.399 0 CA-C-O 120.862 0.363 . . . . 73.31 110.393 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.6 p -82.68 90.43 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-O 121.905 0.86 . . . . 64.42 110.43 178.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.689 ' HB ' ' O ' ' A' ' 83' ' ' TYR . 7.2 m -97.87 134.29 41.2 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.477 -0.783 . . . . 50.13 109.213 176.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -63.53 -31.9 73.19 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.262 -0.426 . . . . 72.31 111.379 -175.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.613 ' HA ' ' HG2' ' A' ' 101' ' ' ARG . 37.9 t70 -105.48 -8.18 18.23 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.428 -0.351 . . . . 75.51 111.871 -175.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.689 ' O ' ' HB ' ' A' ' 80' ' ' THR . 42.2 m-85 -147.98 134.49 19.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.379 0.609 . . . . 74.53 112.206 -175.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.568 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 49.1 mm -87.17 108.45 18.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.254 -0.647 . . . . 71.04 109.254 172.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.488 ' HB ' ' HB3' ' A' ' 78' ' ' MET . 60.2 t -116.77 113.57 43.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.752 0.31 . . . . 64.33 111.374 -174.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -124.0 144.43 49.83 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.219 0.533 . . . . 74.51 110.135 175.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 62.0 mt -102.19 113.53 38.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.83 -0.623 . . . . 73.15 110.916 -175.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -107.27 110.18 22.15 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.283 -0.417 . . . . 75.04 110.207 176.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -115.61 110.49 19.27 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.951 0.405 . . . . 62.25 110.539 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 -142.94 144.02 32.21 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.536 -0.542 . . . . 75.44 109.536 177.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.59 20.15 11.79 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 123.565 0.541 . . . . 71.02 111.122 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.93 -2.7 88.1 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.045 -0.598 . . . . 75.32 112.439 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.438 ' HA ' HE21 ' A' ' 93' ' ' GLN . 0.1 OUTLIER -93.55 126.65 38.82 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.821 0.343 . . . . 73.12 110.827 -178.059 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -83.88 105.26 14.63 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.01 -0.541 . . . . 75.0 110.23 174.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -106.62 104.89 14.68 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.994 -0.548 . . . . 55.53 109.795 178.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 33.6 tp -89.1 111.93 22.79 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.729 -0.669 . . . . 75.11 110.193 -177.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -95.5 121.1 36.83 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.814 -0.439 . . . . 73.45 109.814 179.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.568 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 7.9 p -128.11 127.06 67.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 121.44 0.638 . . . . 72.02 110.742 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.546 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 6.2 m -113.33 123.97 51.37 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.806 -0.633 . . . . 64.32 110.141 178.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.495 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 32.3 t70 -70.91 149.54 46.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.102 -0.499 . . . . 63.4 110.724 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.613 ' HG2' ' HA ' ' A' ' 82' ' ' ASP . 0.0 OUTLIER -96.73 -11.18 25.4 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.97 -0.292 . . . . 73.23 110.918 -179.08 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 26.7 mttp -89.91 -64.35 1.15 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.623 0.725 . . . . 73.34 109.791 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 46.1 p -86.61 -45.17 11.28 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.862 -1.063 . . . . 74.11 110.066 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.495 ' HA2' ' O ' ' A' ' 100' ' ' ASP . . . 99.02 18.44 24.65 Favored Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 114.902 -1.044 . . . . 65.24 112.311 -178.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.428 ' HA ' ' OE1' ' A' ' 105' ' ' GLN . 12.3 mm-40 -59.43 134.96 57.49 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 120.809 0.338 . . . . 74.43 110.284 175.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.8 m -108.82 102.47 11.49 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.013 -0.539 . . . . 62.24 109.98 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 21.1 t -101.2 125.91 47.87 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.164 -0.471 . . . . 71.15 110.374 -177.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 29.7 m -108.7 97.79 7.39 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.223 0.535 . . . . 73.23 109.604 174.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 60.3 mt -84.83 105.03 13.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.76 -0.654 . . . . 75.24 110.574 -177.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.4 ' HG3' ' O ' ' A' ' 110' ' ' GLN . 9.5 pt20 -101.32 104.47 15.48 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.185 0.517 . . . . 61.1 110.446 179.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 10.5 p . . . . . 0 C--N 1.323 -0.557 0 CA-C-N 115.972 -0.558 . . . . 75.11 109.867 178.787 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.577 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 42.0 mt-10 . . . . . 0 CA--C 1.521 -0.165 0 CA-C-O 120.887 0.375 . . . . 65.32 110.96 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 20.3 m -107.15 86.64 2.61 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.963 -0.562 . . . . 73.11 109.687 175.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.577 ' HD3' ' O ' ' A' ' 46' ' ' GLU . 23.4 Cg_exo -63.24 98.23 0.21 Allowed 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.53 2.153 . . . . 73.11 112.225 -175.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.0 m -117.15 -77.79 0.57 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.896 -0.593 . . . . 73.25 109.91 174.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.86 -41.16 68.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.136 0.493 . . . . 71.23 110.336 178.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.405 ' H ' HD23 ' A' ' 51' ' ' LEU . 2.1 pt? -73.86 -17.97 60.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.778 -0.646 . . . . 73.42 111.214 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.457 ' C ' ' H ' ' A' ' 54' ' ' PHE . 31.8 t70 -61.25 -53.65 54.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.823 0.344 . . . . 72.13 111.079 -176.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -77.43 22.34 0.24 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.902 -0.59 . . . . 73.01 110.991 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.457 ' H ' ' C ' ' A' ' 52' ' ' ASP . 63.5 t80 -132.66 -65.91 0.7 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.321 -0.399 . . . . 74.25 110.731 -178.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.5 t -69.85 -23.79 63.34 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.487 -0.324 . . . . 75.41 111.633 -173.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.426 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 2.2 mp0 -67.6 -30.43 70.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.984 0.421 . . . . 63.02 110.356 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.6 -26.49 37.79 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.067 -0.515 . . . . 74.22 110.192 177.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.545 ' HA ' ' HG2' ' A' ' 61' ' ' GLN . 11.3 mt -69.91 -36.39 69.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.897 -0.592 . . . . 75.44 110.322 179.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -67.49 -32.09 72.67 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.068 -0.515 . . . . 74.14 110.319 178.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 7.1 m -68.45 -39.7 81.38 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.937 -0.574 . . . . 73.34 110.497 176.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.615 ' O ' ' HA3' ' A' ' 65' ' ' GLY . 2.8 pt20 -82.98 13.24 4.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.98 -0.555 . . . . 71.1 111.202 -176.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.537 HG13 ' O ' ' A' ' 58' ' ' ILE . 74.7 mt -88.79 -58.52 3.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.703 -0.48 . . . . 75.12 109.703 172.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 89.4 mt -57.97 -62.22 1.98 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.785 -0.643 . . . . 74.53 111.379 -175.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.59 3.84 78.98 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.406 -0.902 . . . . 74.2 112.255 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.615 ' HA3' ' O ' ' A' ' 61' ' ' GLN . . . -94.21 -41.59 4.24 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.759 -0.734 . . . . 72.43 112.395 -178.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 84.1 mt -60.71 -25.06 66.14 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.066 0.46 . . . . 72.23 110.463 178.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 81.7 mt -63.37 -42.32 98.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.665 -0.698 . . . . 71.34 110.686 178.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.6 m -68.64 -29.75 68.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.076 0.465 . . . . 75.11 110.395 179.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -66.43 -25.45 66.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.865 -0.607 . . . . 72.41 110.607 178.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 51.6 mm . . . . . 0 C--N 1.326 -0.418 0 CA-C-N 116.173 -0.467 . . . . 73.52 110.32 178.356 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.569 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 28.4 ttt . . . . . 0 C--O 1.233 0.212 0 N-CA-C 108.027 -1.101 . . . . 73.31 108.027 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 20.1 t -80.57 102.49 6.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.019 0.438 . . . . 64.42 112.109 -168.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.619 ' HB ' ' O ' ' A' ' 83' ' ' TYR . 5.9 m -108.11 163.34 13.25 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.114 -0.699 . . . . 50.13 109.114 174.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -65.08 -46.54 80.72 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.79 0.329 . . . . 72.31 111.043 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.509 ' HA ' ' HD2' ' A' ' 101' ' ' ARG . 28.2 m-20 -105.51 -79.53 0.56 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.912 0.387 . . . . 75.51 111.129 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.619 ' O ' ' HB ' ' A' ' 80' ' ' THR . 35.1 m-85 -67.46 122.68 18.49 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.816 -0.629 . . . . 74.53 111.524 -175.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.553 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 4.5 mp -84.73 107.08 15.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.627 -0.879 . . . . 71.04 108.627 176.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.569 ' HB ' ' HB3' ' A' ' 78' ' ' MET . 21.2 t -89.56 115.31 28.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.996 -0.547 . . . . 64.33 110.655 -175.202 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.79 ' HB3' ' HB2' ' A' ' 97' ' ' ASN . 13.3 t70 -106.98 106.08 16.44 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.663 -0.495 . . . . 74.51 109.663 177.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 60.0 mt -84.79 124.53 39.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.007 -0.542 . . . . 73.15 110.32 -178.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.428 ' O ' ' HB3' ' A' ' 95' ' ' GLN . . . -135.95 106.96 6.68 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.967 0.358 . . . . 75.04 111.967 -179.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -84.7 85.67 7.41 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.427 -0.953 . . . . 62.25 108.427 169.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.1 ttt180 -100.52 134.8 42.94 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.795 -0.639 . . . . 75.44 109.383 -176.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 68.59 -71.02 0.12 Allowed 'General case' 0 N--CA 1.467 0.41 0 O-C-N 123.87 0.731 . . . . 71.02 110.39 -172.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 178.52 29.62 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 111.753 -0.539 . . . . 75.32 111.753 178.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.433 ' HA ' HE21 ' A' ' 93' ' ' GLN . 0.1 OUTLIER -129.69 150.72 50.88 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 110.044 -0.354 . . . . 73.12 110.044 -177.833 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -79.91 92.6 5.55 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.4 0.619 . . . . 75.0 110.715 178.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.428 ' HB3' ' O ' ' A' ' 88' ' ' ALA . 5.2 tt0 -96.31 114.66 26.37 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.364 -0.834 . . . . 55.53 110.01 179.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 20.0 tp -101.68 112.77 25.46 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.01 -0.541 . . . . 75.11 110.413 -178.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.79 ' HB2' ' HB3' ' A' ' 86' ' ' ASP . 44.2 m-80 -93.54 103.3 15.5 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.109 -0.33 . . . . 73.45 110.109 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.435 ' CG1' ' HD2' ' A' ' 83' ' ' TYR . 68.9 t -93.35 109.22 21.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.534 0.683 . . . . 72.02 110.864 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.553 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 35.7 m -97.58 107.15 19.58 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.318 -0.855 . . . . 64.32 109.741 176.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.445 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 45.1 t0 -72.64 147.37 45.84 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.348 0.594 . . . . 63.4 111.48 -175.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.509 ' HD2' ' HA ' ' A' ' 82' ' ' ASP . 51.1 ttt180 -95.48 -26.42 15.83 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.994 -1.003 . . . . 73.23 109.66 177.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 35.9 mtpt -84.29 -65.99 0.95 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.724 -0.671 . . . . 73.34 110.984 -173.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 72.2 p -86.87 -19.0 29.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.213 0.53 . . . . 74.11 110.296 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.445 ' HA2' ' O ' ' A' ' 100' ' ' ASP . . . 71.82 21.2 79.0 Favored Glycine 0 N--CA 1.452 -0.284 0 CA-C-N 115.233 -0.894 . . . . 65.24 112.903 176.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 83.2 mm-40 -88.63 136.13 33.15 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.619 -0.512 . . . . 74.43 109.619 175.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 19.3 p -97.27 96.37 8.35 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.06 0.457 . . . . 62.24 110.711 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 29.8 m -97.72 106.85 19.23 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.723 -0.671 . . . . 71.15 110.356 -178.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 95.2 m -91.67 126.23 36.68 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.05 -0.523 . . . . 73.23 110.511 177.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 4.3 mp -115.37 111.04 34.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.188 -0.46 . . . . 75.24 109.961 177.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.407 ' HA ' ' HA ' ' A' ' 95' ' ' GLN . 48.0 mt-30 -89.92 104.3 16.88 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.234 -0.439 . . . . 61.1 110.242 177.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 24.9 t . . . . . 0 C--N 1.325 -0.487 0 N-CA-C 109.176 -0.676 . . . . 75.11 109.176 177.853 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 . . . . . 0 N--CA 1.453 -0.283 0 CA-C-O 120.775 0.321 . . . . 65.32 111.467 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 2.5 t -128.56 77.92 76.63 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 121.297 0.57 . . . . 73.11 111.374 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -76.75 96.57 1.1 Allowed 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.047 2.498 . . . . 73.11 111.302 176.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.1 m -125.2 -51.06 1.66 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.007 0.432 . . . . 73.25 110.357 -178.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.82 -49.46 8.4 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.139 0.495 . . . . 71.23 110.472 -179.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.2 pp -75.83 -10.16 59.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.934 -0.575 . . . . 73.42 111.337 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.528 ' HA ' HG21 ' A' ' 55' ' ' THR . 17.8 t70 -57.95 -45.57 86.43 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.905 -0.588 . . . . 72.13 111.068 -179.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -61.34 -17.41 53.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.489 -0.778 . . . . 73.01 111.359 -176.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -98.84 -47.18 5.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.353 -0.385 . . . . 74.25 110.59 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.528 HG21 ' HA ' ' A' ' 52' ' ' ASP . 10.0 t -68.85 -31.49 70.49 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.56 -0.291 . . . . 75.41 111.285 -176.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -68.16 -30.89 70.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.77 0.319 . . . . 63.02 110.499 -178.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.1 -12.9 60.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.007 0.432 . . . . 74.22 111.435 -178.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.6 mm -87.79 -24.55 6.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.381 0.61 . . . . 75.44 110.073 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -64.83 -22.58 67.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.699 -0.682 . . . . 74.14 112.138 -174.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 17.3 p -73.82 -41.65 62.03 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.035 0.383 . . . . 73.34 112.035 -175.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -73.41 -18.08 61.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.803 0.335 . . . . 71.1 111.075 -176.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.578 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 57.2 mt -67.74 -28.36 41.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.179 -0.464 . . . . 75.12 110.515 -178.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.2 mp -58.41 -40.2 81.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.351 -0.386 . . . . 74.53 111.056 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -76.29 -31.46 54.77 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.577 -0.821 . . . . 74.2 112.047 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -73.66 -25.31 72.52 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.058 -0.592 . . . . 72.43 112.623 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.578 ' HG ' ' O ' ' A' ' 62' ' ' ILE . 73.0 mt -55.43 -35.9 65.91 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 122.275 0.23 . . . . 72.23 111.501 -179.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.9 mp -56.45 -30.95 63.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.863 0.363 . . . . 71.34 111.42 -178.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 25.2 t -105.0 -16.0 14.94 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.295 -0.412 . . . . 75.11 111.052 -178.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -89.59 -26.67 20.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.816 0.341 . . . . 72.41 110.954 -176.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 66' ' ' LEU . 48.9 mm . . . . . 0 C--N 1.328 -0.363 0 CA-C-O 121.4 0.619 . . . . 73.52 109.929 177.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 57.6 ttp . . . . . 0 N--CA 1.45 -0.441 0 CA-C-O 120.837 0.351 . . . . 73.31 110.497 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 24.8 t -67.85 126.98 28.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.867 -0.606 . . . . 64.42 109.921 177.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.619 HG22 ' HB2' ' A' ' 83' ' ' TYR . 32.0 m -148.99 140.14 23.07 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.432 -0.581 . . . . 50.13 109.432 178.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 65.6 m-20 -55.16 -62.68 1.5 Allowed 'General case' 0 C--N 1.329 -0.312 0 O-C-N 123.449 0.468 . . . . 72.31 112.093 -174.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -114.92 14.09 17.18 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.005 0.372 . . . . 75.51 112.005 -171.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.619 ' HB2' HG22 ' A' ' 80' ' ' THR . 68.5 m-85 -130.49 126.75 37.65 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.734 -0.386 . . . . 74.53 110.999 -177.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.478 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 4.1 mp -95.49 106.73 18.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.045 -0.724 . . . . 71.04 109.045 176.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.9 p -133.47 121.79 42.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.425 0.631 . . . . 64.33 111.815 -174.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -110.35 134.47 52.26 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.36 -0.836 . . . . 74.51 108.952 176.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.0 mt -83.53 80.26 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.025 -0.732 . . . . 73.15 109.025 178.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -86.61 109.42 19.14 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.429 -0.805 . . . . 75.04 111.323 -174.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -82.78 80.27 8.92 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.981 -0.748 . . . . 62.25 108.981 172.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -100.46 131.46 46.37 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.336 -0.847 . . . . 75.44 109.71 -177.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.5 t70 70.4 5.67 5.46 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 123.941 0.776 . . . . 71.02 111.034 177.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 112.04 -24.48 14.47 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.048 -0.596 . . . . 75.32 112.764 177.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.407 ' HA ' HE21 ' A' ' 93' ' ' GLN . 0.0 OUTLIER -92.59 141.34 28.6 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 122.734 -0.274 . . . . 73.12 110.94 -176.889 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.543 ' HB2' ' HB ' ' A' ' 111' ' ' VAL . 3.5 mm? -71.67 105.63 3.77 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.208 -0.664 . . . . 75.0 109.208 170.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -109.01 111.32 22.92 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.238 0.542 . . . . 55.53 110.649 -178.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 15.1 tp -81.69 99.94 9.2 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.614 -0.721 . . . . 75.11 109.263 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -94.02 106.87 18.83 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.118 -0.492 . . . . 73.45 110.341 -177.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 69.5 t -101.14 114.67 41.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.227 0.537 . . . . 72.02 111.46 -176.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.478 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 86.8 m -101.67 106.25 17.27 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.585 -0.734 . . . . 64.32 109.52 172.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.453 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 15.3 t0 -76.68 145.63 38.63 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.985 -0.552 . . . . 63.4 111.157 -178.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.547 ' HD2' ' O ' ' A' ' 101' ' ' ARG . 5.2 tmm_? -103.43 -25.76 13.14 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.789 -0.641 . . . . 73.23 109.635 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -73.73 -56.55 4.85 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.887 -0.597 . . . . 73.34 111.176 -173.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 71.7 p -109.24 -25.42 10.61 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.268 0.556 . . . . 74.11 110.265 176.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' A' ' 100' ' ' ASP . . . 98.68 13.88 39.3 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.723 -0.672 . . . . 65.24 112.644 177.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.438 ' N ' ' HB3' ' A' ' 100' ' ' ASP . 50.5 mm-40 -65.01 109.57 2.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.319 0.581 . . . . 74.43 111.165 178.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.5 m -87.97 100.13 12.68 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.409 -0.814 . . . . 62.24 109.097 176.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 7.6 t -103.08 141.18 36.27 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.937 0.399 . . . . 71.15 110.224 -175.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 46.6 m -116.69 106.08 13.13 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.075 -0.512 . . . . 73.23 110.664 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.422 ' N ' HD13 ' A' ' 109' ' ' ILE . 4.4 mp -111.52 105.15 18.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.3 -0.409 . . . . 75.24 110.721 -177.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -70.68 157.97 37.07 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.011 0.434 . . . . 61.1 110.843 175.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.543 ' HB ' ' HB2' ' A' ' 94' ' ' LEU . 3.4 p . . . . . 0 C--N 1.322 -0.627 0 CA-C-N 115.381 -0.827 . . . . 75.11 111.685 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 . . . . . 0 N--CA 1.466 0.367 0 CA-C-O 120.728 0.299 . . . . 65.32 111.005 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 28.8 m -134.8 83.4 41.34 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-O 121.05 0.452 . . . . 73.11 110.669 178.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.637 ' HB2' ' HB2' ' A' ' 52' ' ' ASP . 18.4 Cg_endo -93.97 108.49 0.16 Allowed 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 123.491 2.794 . . . . 73.11 112.124 177.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.4 m -110.18 -78.65 0.59 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.386 -0.37 . . . . 73.25 111.049 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.46 -40.64 57.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.758 0.313 . . . . 71.23 111.405 -177.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.7 pp -68.37 -22.6 64.65 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.801 0.334 . . . . 73.42 110.358 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.637 ' HB2' ' HB2' ' A' ' 48' ' ' PRO . 7.7 t70 -61.68 -41.85 98.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.975 -0.557 . . . . 72.13 110.431 177.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 -68.18 -42.42 80.01 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.799 -0.637 . . . . 73.01 109.925 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -68.34 -50.12 55.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.62 -0.718 . . . . 74.25 111.567 -175.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.5 t -67.85 -17.86 64.63 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.787 0.327 . . . . 75.41 111.575 -175.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -75.94 -21.89 56.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.835 0.35 . . . . 63.02 110.935 -177.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -82.93 -19.26 37.57 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.52 0.676 . . . . 74.22 109.867 174.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.493 ' O ' HG13 ' A' ' 62' ' ' ILE . 19.5 mt -79.39 -25.86 12.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.165 -0.925 . . . . 75.44 110.489 -179.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -57.8 -28.62 64.19 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.705 -0.68 . . . . 74.14 111.701 -176.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.7 m -79.13 -35.38 42.23 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.39 -0.368 . . . . 73.34 111.49 -177.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' A' ' 58' ' ' ILE . 11.3 pt20 -82.05 -6.31 59.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.897 0.379 . . . . 71.1 111.627 -174.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.493 HG13 ' O ' ' A' ' 58' ' ' ILE . 67.7 mt -70.82 -31.93 47.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.832 0.348 . . . . 75.12 110.641 -178.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.725 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 8.8 mp -59.4 -46.97 87.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 74.53 111.512 -177.014 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -57.48 -27.26 58.13 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 121.177 -0.535 . . . . 74.2 112.906 -178.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -92.7 -42.63 4.41 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.558 -0.83 . . . . 72.43 112.294 178.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.543 ' HA ' ' HB2' ' A' ' 69' ' ' ASN . 1.3 pp -64.44 -23.75 67.39 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 111.415 0.154 . . . . 72.23 111.415 -176.039 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.725 ' HG ' ' O ' ' A' ' 63' ' ' LEU . 80.7 mt -52.17 -46.27 65.44 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.058 0.456 . . . . 71.34 110.594 177.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.6 t -90.7 -4.91 56.39 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.101 -0.499 . . . . 75.11 110.485 -177.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.543 ' HB2' ' HA ' ' A' ' 66' ' ' LEU . 9.2 m120 -86.22 -21.43 27.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.061 0.457 . . . . 72.41 109.96 174.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.451 HG12 ' O ' ' A' ' 66' ' ' LEU . 51.4 mm . . . . . 0 C--N 1.325 -0.487 0 N-CA-C 108.593 -0.891 . . . . 73.52 108.593 168.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 54.4 ttp . . . . . 0 C--O 1.234 0.248 0 CA-C-O 121.176 0.513 . . . . 73.31 111.044 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 42.5 t -97.11 98.84 7.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.607 -0.724 . . . . 64.42 109.601 177.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.2 140.91 52.44 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.064 -0.516 . . . . 50.13 111.168 -178.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -75.94 60.0 1.33 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.213 0.53 . . . . 72.31 111.736 -177.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -170.75 -41.41 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.402 -0.817 . . . . 75.51 109.165 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -144.66 123.84 12.92 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.483 -0.78 . . . . 74.53 110.183 174.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.583 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 50.6 mm -92.32 109.11 21.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 109.1 -0.704 . . . . 71.04 109.1 173.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 43.9 t -108.42 96.39 4.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.983 0.42 . . . . 64.33 110.406 -178.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -107.68 114.34 28.24 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.962 -0.563 . . . . 74.51 110.049 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 56.3 mt -80.92 86.91 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.233 -0.654 . . . . 73.15 109.233 176.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -98.38 171.36 8.23 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.856 -0.611 . . . . 75.04 110.848 -176.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.518 ' HB2' HD12 ' A' ' 94' ' ' LEU . 51.9 t-20 -146.04 138.38 25.38 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.071 -1.085 . . . . 62.25 108.071 178.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.432 ' O ' ' HB3' ' A' ' 91' ' ' ASP . 14.9 ttp180 -123.15 110.36 15.18 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.032 -0.358 . . . . 75.44 110.032 177.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.432 ' HB3' ' O ' ' A' ' 90' ' ' ARG . 15.6 t70 75.15 -45.57 0.56 Allowed 'General case' 0 N--CA 1.471 0.582 0 O-C-N 123.773 0.67 . . . . 71.02 111.837 177.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -178.46 -27.97 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.882 -0.675 . . . . 75.32 112.35 -178.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.491 ' HA ' HE21 ' A' ' 93' ' ' GLN . 0.1 OUTLIER -93.1 125.08 37.52 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.055 0.455 . . . . 73.12 110.389 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.554 ' HB2' ' HB ' ' A' ' 111' ' ' VAL . 4.2 mm? -61.44 141.69 57.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.536 -0.756 . . . . 75.0 111.114 -178.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.49 ' HA ' HE21 ' A' ' 95' ' ' GLN . 0.0 OUTLIER -131.94 97.92 4.3 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.674 -0.693 . . . . 55.53 109.566 -178.523 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.453 ' HB3' ' HB ' ' A' ' 109' ' ' ILE . 69.4 tp -80.32 113.15 18.3 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.027 -0.533 . . . . 75.11 110.289 -177.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -106.11 113.1 26.44 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.227 -0.442 . . . . 73.45 110.777 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.583 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 46.4 t -110.82 117.35 54.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.531 -0.758 . . . . 72.02 110.33 175.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.543 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 25.7 m -94.28 101.1 13.06 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.519 -0.764 . . . . 64.32 110.25 176.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.537 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 29.4 t70 -67.79 130.36 42.74 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.686 -0.688 . . . . 63.4 109.949 177.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 42.1 ttt180 -98.7 -22.93 15.65 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.915 0.388 . . . . 73.23 110.891 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -68.23 -45.44 73.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.082 -0.508 . . . . 73.34 111.157 -173.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.407 ' OG1' ' HG3' ' A' ' 105' ' ' GLN . 77.6 p -123.4 -32.86 3.34 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.303 0.573 . . . . 74.11 110.369 177.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.537 ' HA2' ' O ' ' A' ' 100' ' ' ASP . . . 103.19 30.04 5.52 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.493 -0.776 . . . . 65.24 112.435 178.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.407 ' HG3' ' OG1' ' A' ' 103' ' ' THR . 47.8 mt-30 -72.95 105.36 4.4 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.179 -0.304 . . . . 74.43 110.179 176.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 33.5 m -67.77 101.35 1.04 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.083 0.468 . . . . 62.24 110.058 176.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.485 ' HB2' ' HB ' ' A' ' 98' ' ' VAL . 23.5 m -99.77 96.38 7.56 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.012 -0.54 . . . . 71.15 110.619 -177.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 24.6 m -104.46 99.72 9.42 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.256 0.55 . . . . 73.23 110.007 176.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.453 ' HB ' ' HB3' ' A' ' 96' ' ' LEU . 4.0 mp -90.67 121.51 41.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.767 -0.651 . . . . 75.24 110.531 -176.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -82.67 110.25 17.56 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.556 -0.535 . . . . 61.1 109.556 176.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.554 ' HB ' ' HB2' ' A' ' 94' ' ' LEU . 51.0 t . . . . . 0 C--N 1.324 -0.53 0 CA-C-N 116.514 -0.312 . . . . 75.11 110.281 -177.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 . . . . . 0 N--CA 1.456 -0.172 0 CA-C-O 121.721 0.772 . . . . 65.32 109.375 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 21.6 m -114.97 86.52 13.62 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.162 -0.926 . . . . 73.11 109.909 178.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.681 ' HB2' ' HB2' ' A' ' 52' ' ' ASP . 48.5 Cg_endo -70.68 83.65 0.85 Allowed 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.24 1.96 . . . . 73.11 112.69 -177.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.6 m -96.57 -54.99 3.06 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.754 -0.657 . . . . 73.25 109.913 173.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -100.78 -27.92 13.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.99 0.424 . . . . 71.23 111.109 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.44 ' HA ' ' HB3' ' A' ' 54' ' ' PHE . 0.8 OUTLIER -87.15 -3.03 59.04 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.997 -0.547 . . . . 73.42 111.591 -176.609 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.681 ' HB2' ' HB2' ' A' ' 48' ' ' PRO . 17.2 t70 -62.59 -69.23 0.27 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.51 -0.314 . . . . 72.13 111.589 -176.098 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -66.09 -23.91 66.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.269 0.557 . . . . 73.01 110.155 177.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.542 ' O ' HG13 ' A' ' 58' ' ' ILE . 85.3 t80 -61.56 -53.42 56.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.583 -0.735 . . . . 74.25 110.817 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.413 ' O ' ' HG3' ' A' ' 59' ' ' GLN . 9.8 t -69.12 -21.42 64.03 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.133 0.492 . . . . 75.41 110.873 -177.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -73.42 -39.65 64.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.242 0.544 . . . . 63.02 109.915 178.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.64 -29.36 69.37 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.646 -0.706 . . . . 74.22 109.998 175.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.574 ' HA ' ' HG2' ' A' ' 61' ' ' GLN . 15.8 mt -64.07 -39.29 84.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.879 -0.6 . . . . 75.44 110.44 176.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.413 ' HG3' ' O ' ' A' ' 55' ' ' THR . 73.0 mt-30 -58.1 -42.29 85.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.279 -0.419 . . . . 74.14 110.438 178.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.5 m -61.16 -45.31 95.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.078 -0.51 . . . . 73.34 110.584 177.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.666 ' O ' ' HA3' ' A' ' 65' ' ' GLY . 3.1 pt20 -80.81 7.74 9.75 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.824 -0.625 . . . . 71.1 110.85 -176.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 58' ' ' ILE . 83.2 mt -100.8 -55.84 5.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.954 -0.758 . . . . 75.12 108.954 168.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 89.6 mt -59.04 -41.42 87.81 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.613 -0.721 . . . . 74.53 111.049 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -108.85 -0.66 32.05 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.713 -0.756 . . . . 74.2 112.199 178.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.666 ' HA3' ' O ' ' A' ' 61' ' ' GLN . . . -85.44 -22.12 52.08 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.847 -0.692 . . . . 72.43 112.492 -176.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 62' ' ' ILE . 90.8 mt -60.08 -30.54 69.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.014 0.435 . . . . 72.23 109.985 176.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 70.3 mt -67.36 -33.07 74.46 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.483 -0.78 . . . . 71.34 110.682 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 9.2 m -73.27 -32.22 64.54 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.047 -0.524 . . . . 75.11 110.388 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -91.34 10.99 25.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.027 -0.533 . . . . 72.41 111.622 -177.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 36.1 mm . . . . . 0 C--N 1.331 -0.23 0 CA-C-O 121.158 0.504 . . . . 73.52 109.964 174.581 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.803 ' HB3' HG12 ' A' ' 85' ' ' VAL . 48.9 ttm . . . . . 0 N--CA 1.452 -0.364 0 N-CA-C 109.865 -0.42 . . . . 73.31 109.865 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 59.9 t -87.79 111.31 21.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.041 -0.527 . . . . 64.42 110.552 -177.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.59 HG22 ' H ' ' A' ' 82' ' ' ASP . 24.5 m -130.67 138.95 50.29 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.902 -0.59 . . . . 50.13 109.819 178.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -67.69 -23.32 65.28 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.946 0.403 . . . . 72.31 111.132 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.59 ' H ' HG22 ' A' ' 80' ' ' THR . 25.0 m-20 -97.66 -19.14 18.46 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.177 -0.465 . . . . 75.51 111.462 -177.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -144.38 136.8 26.58 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.5 0.556 . . . . 74.53 112.5 -171.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.571 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 4.1 mp -98.23 105.68 17.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 108.172 -1.048 . . . . 71.04 108.172 169.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.803 HG12 ' HB3' ' A' ' 78' ' ' MET . 5.6 p -135.98 135.66 50.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.258 0.551 . . . . 64.33 111.75 -174.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -128.43 143.49 51.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.473 -0.785 . . . . 74.51 109.18 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.4 HD12 ' N ' ' A' ' 87' ' ' ILE . 4.3 mp -95.85 86.63 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.355 -0.609 . . . . 73.15 109.355 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -105.26 128.12 53.28 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.784 -0.644 . . . . 75.04 111.223 -175.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -84.36 115.81 22.71 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.037 -0.727 . . . . 62.25 109.037 174.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -130.99 132.51 45.06 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.949 -0.389 . . . . 75.44 109.949 177.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.9 t70 68.11 11.15 8.24 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 124.036 0.835 . . . . 71.02 110.574 179.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 97.59 -0.08 59.49 Favored Glycine 0 N--CA 1.452 -0.248 0 CA-C-N 115.675 -0.693 . . . . 75.32 112.402 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.501 ' HA ' HE21 ' A' ' 93' ' ' GLN . 0.0 OUTLIER -114.29 134.41 54.97 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.752 0.31 . . . . 73.12 110.423 179.171 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -67.0 108.9 2.77 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.117 -0.697 . . . . 75.0 109.117 173.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.406 HE21 ' HB2' ' A' ' 95' ' ' GLN . 6.1 tt0 -105.57 110.41 22.73 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.74 -0.664 . . . . 55.53 110.538 -173.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 17.3 tp -88.24 94.08 9.71 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.865 -0.607 . . . . 75.11 109.75 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -85.83 102.55 13.78 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.195 -0.457 . . . . 73.45 110.499 -179.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 24.6 t -94.39 123.56 46.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.057 0.456 . . . . 72.02 111.119 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.571 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 32.1 m -111.61 107.99 17.32 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.155 -0.475 . . . . 64.32 110.12 174.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.448 ' HB3' ' H ' ' A' ' 105' ' ' GLN . 15.3 t70 -65.99 131.1 45.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.776 -0.647 . . . . 63.4 110.3 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.533 ' NE ' ' HA ' ' A' ' 101' ' ' ARG . 2.8 tpm_? -107.88 17.72 22.14 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.609 0.718 . . . . 73.23 110.796 -177.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.5 mtpm? -107.11 -66.78 0.99 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.855 0.836 . . . . 73.34 109.039 175.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.2 m -91.3 -40.59 11.41 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 114.175 -1.375 . . . . 74.11 109.211 -178.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 98.11 82.98 1.69 Allowed Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.514 -0.767 . . . . 65.24 113.02 177.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.448 ' H ' ' HB3' ' A' ' 100' ' ' ASP . 54.5 mt-30 -143.15 142.31 31.43 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.099 -0.704 . . . . 74.43 109.099 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.9 m -105.06 85.6 2.3 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.48 0.657 . . . . 62.24 110.221 178.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.32 119.74 26.03 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.483 -0.78 . . . . 71.15 109.957 178.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 37.5 m -105.71 107.44 18.44 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.015 0.436 . . . . 73.23 111.291 -176.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 4.5 mp -102.57 97.83 6.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.144 -0.48 . . . . 75.24 109.843 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -79.86 123.74 28.02 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.016 -0.735 . . . . 61.1 109.016 177.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.7 t . . . . . 0 C--N 1.325 -0.461 0 CA-C-O 121.181 0.515 . . . . 75.11 111.072 -175.718 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 . . . . . 0 CA--C 1.526 0.044 0 CA-C-O 121.864 0.84 . . . . 65.32 109.732 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 4.8 t -138.25 87.22 16.13 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 114.923 -1.035 . . . . 73.11 109.443 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.611 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 59.2 Cg_endo -70.93 83.78 0.88 Allowed 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.626 2.217 . . . . 73.11 113.244 -173.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 21.0 m -93.75 -68.0 0.82 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.037 -0.529 . . . . 73.25 110.297 174.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -107.69 -3.97 18.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.195 0.521 . . . . 71.23 111.061 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.402 HD22 ' H ' ' A' ' 51' ' ' LEU . 1.1 pt? -108.09 7.89 27.89 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.947 -0.57 . . . . 73.42 110.139 -178.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.611 ' HB3' ' HB2' ' A' ' 48' ' ' PRO . 19.4 p-10 -68.65 -52.8 27.26 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.7 -0.682 . . . . 72.13 111.246 -174.145 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -65.98 -29.21 69.56 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.985 0.422 . . . . 73.01 110.43 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.506 ' O ' HG13 ' A' ' 58' ' ' ILE . 70.7 t80 -66.36 -62.93 1.21 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.726 -0.67 . . . . 74.25 110.899 -178.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.1 t -66.89 -21.48 66.0 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.01 0.433 . . . . 75.41 110.933 -176.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.493 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 3.9 tp-100 -68.98 -43.36 75.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.253 0.549 . . . . 63.02 109.809 -179.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.52 -32.57 74.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.464 -0.789 . . . . 74.22 110.266 178.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.571 ' O ' HG13 ' A' ' 62' ' ' ILE . 19.6 mt -63.34 -39.88 86.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.901 -0.59 . . . . 75.44 110.644 178.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -64.48 -25.0 67.81 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.254 -0.43 . . . . 74.14 111.057 178.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.2 t -89.7 -38.88 13.54 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.308 -0.406 . . . . 73.34 110.748 -178.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.511 ' HG2' ' HA ' ' A' ' 58' ' ' ILE . 3.6 pt20 -66.91 -13.2 61.48 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.91 0.386 . . . . 71.1 110.878 -177.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.571 HG13 ' O ' ' A' ' 58' ' ' ILE . 76.8 mt -62.53 -33.68 60.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.565 -0.531 . . . . 75.12 109.565 175.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.0 mp -68.09 -28.93 67.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.224 -0.898 . . . . 74.53 110.586 -179.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -62.88 -47.51 88.3 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 111.414 -0.674 . . . . 74.2 111.414 178.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -72.76 -35.07 58.94 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.854 -0.689 . . . . 72.43 111.711 177.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.451 ' C ' ' H ' ' A' ' 68' ' ' SER . 47.1 tp -60.85 -49.41 77.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.018 0.437 . . . . 72.23 110.178 177.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 98.8 mt -79.74 32.28 0.25 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.184 0.516 . . . . 71.34 110.64 178.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.451 ' H ' ' C ' ' A' ' 66' ' ' LEU . 61.5 m -135.75 -50.94 0.73 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.436 -0.802 . . . . 75.11 109.592 174.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -69.67 -26.6 64.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.016 -0.538 . . . . 72.41 111.632 -178.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 50.8 mm . . . . . 0 C--N 1.327 -0.412 0 CA-C-O 121.093 0.473 . . . . 73.52 110.573 -178.246 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 50.5 ttm . . . . . 0 C--O 1.233 0.222 0 N-CA-C 110.212 -0.292 . . . . 73.31 110.212 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.0 p -73.98 125.27 32.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.204 0.526 . . . . 64.42 110.779 -179.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.775 ' HB ' ' O ' ' A' ' 83' ' ' TYR . 17.0 m -138.85 152.59 47.95 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.518 -0.919 . . . . 50.13 108.518 177.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -65.46 -60.04 3.37 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.656 0.613 . . . . 72.31 112.656 -170.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.406 ' CG ' ' HZ3' ' A' ' 102' ' ' LYS . 25.2 t0 -101.39 2.57 39.62 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.446 0.641 . . . . 75.51 111.419 -171.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.775 ' O ' ' HB ' ' A' ' 80' ' ' THR . 60.6 m-85 -146.03 116.31 7.48 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.927 -0.579 . . . . 74.53 110.105 178.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.62 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 3.8 mp -84.68 104.06 12.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.946 -0.761 . . . . 71.04 108.946 175.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 73.5 t -94.73 111.97 26.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.729 -0.669 . . . . 64.33 111.201 -174.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -111.05 100.58 9.23 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.005 0.431 . . . . 74.51 110.448 175.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 58.1 mt -89.49 97.22 6.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.431 -0.581 . . . . 73.15 109.431 176.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -104.58 130.05 52.61 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.062 -0.517 . . . . 75.04 111.599 -174.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.411 ' HA ' ' O ' ' A' ' 93' ' ' GLN . 26.4 t-20 -108.53 87.36 2.48 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.342 -0.614 . . . . 62.25 109.342 171.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.401 ' O ' ' HB3' ' A' ' 91' ' ' ASP . 10.3 ttp180 -106.68 146.14 31.13 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.511 -0.922 . . . . 75.44 108.511 177.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.401 ' HB3' ' O ' ' A' ' 90' ' ' ARG . 24.9 t70 69.13 -70.49 0.14 Allowed 'General case' 0 N--CA 1.469 0.488 0 O-C-N 123.732 0.645 . . . . 71.02 110.53 -176.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 179.18 22.04 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 121.005 -0.617 . . . . 75.32 112.341 176.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.481 ' HA ' HE21 ' A' ' 93' ' ' GLN . 0.1 OUTLIER -126.27 141.59 51.86 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 122.676 -0.308 . . . . 73.12 110.574 -175.864 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -81.41 109.96 16.39 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.192 -0.67 . . . . 75.0 109.192 173.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -113.73 110.71 20.61 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.119 0.485 . . . . 55.53 110.666 -177.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.449 ' HB3' ' O ' ' A' ' 109' ' ' ILE . 59.6 tp -85.71 97.02 9.9 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.557 -0.747 . . . . 75.11 110.206 179.062 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.6 m-20 -95.53 100.36 12.12 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.074 -0.512 . . . . 73.45 110.113 177.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 50.7 t -94.96 111.59 25.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.817 -0.629 . . . . 72.02 110.364 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.62 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 22.8 m -89.94 103.35 16.02 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.873 -0.603 . . . . 64.32 109.665 175.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.588 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 9.8 t70 -58.72 147.64 32.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.096 -0.502 . . . . 63.4 110.842 178.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.4 ' HD2' ' HA ' ' A' ' 101' ' ' ARG . 23.5 tpt180 -113.6 -9.02 13.28 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.856 0.36 . . . . 73.23 111.314 -177.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.406 ' HZ3' ' CG ' ' A' ' 82' ' ' ASP . 27.4 mmtm -78.87 -49.81 12.27 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.005 0.431 . . . . 73.34 110.806 177.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 36.5 p -113.23 -35.62 5.28 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.747 -0.661 . . . . 74.11 109.952 176.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.588 ' HA2' ' O ' ' A' ' 100' ' ' ASP . . . 91.57 81.11 1.42 Allowed Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.461 -0.79 . . . . 65.24 112.242 178.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.472 ' H ' ' HB3' ' A' ' 100' ' ' ASP . 49.6 mt-30 -137.47 139.98 40.93 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.253 -0.647 . . . . 74.43 109.253 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.9 t -84.38 95.45 8.75 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.585 0.707 . . . . 62.24 111.089 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 59.4 m -84.22 102.98 13.03 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.854 -0.612 . . . . 71.15 109.933 176.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 23.8 m -92.15 109.85 21.22 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.289 -0.414 . . . . 73.23 110.857 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.449 ' O ' ' HB3' ' A' ' 96' ' ' LEU . 4.9 mp -117.2 97.91 6.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.947 0.404 . . . . 75.24 109.94 175.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -74.74 153.25 38.91 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.453 -0.339 . . . . 61.1 110.92 178.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 8.4 p . . . . . 0 C--N 1.323 -0.579 0 CA-C-N 115.608 -0.724 . . . . 75.11 110.461 177.305 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 . . . . . 0 N--CA 1.467 0.407 0 CA-C-O 120.691 0.281 . . . . 65.32 111.546 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.0 m -124.53 87.9 53.89 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.386 -0.37 . . . . 73.11 110.726 -175.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -69.97 120.83 7.51 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 123.134 2.556 . . . . 73.11 112.658 -176.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 52.0 m -97.51 -86.15 0.35 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.352 -0.385 . . . . 73.25 111.409 177.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.91 12.83 28.9 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.046 0.451 . . . . 71.23 111.623 -176.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.4 pp -119.01 1.9 11.46 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.276 -0.42 . . . . 73.42 110.572 179.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -63.45 -60.3 3.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.63 -0.714 . . . . 72.13 111.538 -174.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.421 ' HA ' ' HB2' ' A' ' 56' ' ' GLN . 7.7 p30 -78.15 -13.75 59.74 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.921 -0.582 . . . . 73.01 110.906 -175.364 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.543 ' O ' HG13 ' A' ' 58' ' ' ILE . 83.9 t80 -66.55 -58.39 5.3 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.234 -0.439 . . . . 74.25 110.095 176.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.7 t -74.3 -12.29 60.5 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.186 0.517 . . . . 75.41 110.419 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.421 ' HB2' ' HA ' ' A' ' 53' ' ' ASN . 2.1 tp-100 -70.63 -47.75 58.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.759 -0.655 . . . . 63.02 109.643 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.23 -28.24 67.07 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.728 -0.669 . . . . 74.22 110.894 179.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.554 ' O ' HG13 ' A' ' 62' ' ' ILE . 26.6 mt -63.09 -39.52 85.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.163 -0.471 . . . . 75.44 110.649 179.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -64.31 -31.04 72.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.151 -0.477 . . . . 74.14 110.658 179.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.1 m -81.04 -41.52 22.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.146 -0.479 . . . . 73.34 111.339 -178.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.525 ' HG2' ' HA ' ' A' ' 58' ' ' ILE . 4.1 pt20 -66.78 -19.0 65.66 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.518 -0.31 . . . . 71.1 111.49 -176.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.554 HG13 ' O ' ' A' ' 58' ' ' ILE . 86.5 mt -62.23 -47.42 93.18 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 N-CA-C 109.31 -0.626 . . . . 75.12 109.31 175.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.0 mp -64.39 -43.21 95.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.451 -0.795 . . . . 74.53 110.498 178.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -57.5 -44.68 93.65 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 121.226 -0.512 . . . . 74.2 112.578 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -75.21 -44.15 23.68 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.682 -0.77 . . . . 72.43 112.453 178.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.597 ' O ' HG12 ' A' ' 70' ' ' ILE . 57.0 tp -58.72 -50.35 74.21 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 122.313 0.245 . . . . 72.23 111.297 -177.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 85.5 mt -63.34 -17.65 62.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.445 -0.343 . . . . 71.34 111.912 -176.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.1 t -78.27 -45.77 21.96 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.76 -0.459 . . . . 75.11 109.76 178.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -78.5 -11.49 59.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.046 -0.525 . . . . 72.41 111.149 -176.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.597 HG12 ' O ' ' A' ' 66' ' ' LEU . 27.4 mm . . . . . 0 C--N 1.328 -0.35 0 CA-C-O 120.725 0.298 . . . . 73.52 110.478 176.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.567 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 28.0 ttt . . . . . 0 N--CA 1.45 -0.439 0 N-CA-C 109.78 -0.452 . . . . 73.31 109.78 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 19.1 t -86.53 76.12 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.397 0.618 . . . . 64.42 110.267 -176.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.0 -175.44 5.4 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.728 -0.669 . . . . 50.13 110.089 179.139 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -79.67 -43.81 22.06 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.663 0.268 . . . . 72.31 110.772 -177.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.554 ' O ' ' HB2' ' A' ' 101' ' ' ARG . 8.2 t0 -101.6 -76.52 0.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.657 -0.497 . . . . 75.51 109.657 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.489 ' HB3' HG11 ' A' ' 98' ' ' VAL . 17.0 m-85 -79.38 115.4 19.0 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.407 -0.361 . . . . 74.53 111.048 -174.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.437 HD11 ' HB ' ' A' ' 99' ' ' THR . 0.9 OUTLIER -83.83 103.38 11.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.595 0.712 . . . . 71.04 109.197 170.843 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.567 ' HB ' ' HB3' ' A' ' 78' ' ' MET . 37.6 t -94.3 139.65 18.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.639 -0.709 . . . . 64.33 111.195 -169.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -108.73 105.07 14.49 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.573 -0.528 . . . . 74.51 109.573 174.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 74.4 mt -78.72 113.69 18.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.287 -0.415 . . . . 73.15 109.968 178.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -107.8 109.57 21.16 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.184 -0.462 . . . . 75.04 111.128 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.556 ' HA ' ' O ' ' A' ' 93' ' ' GLN . 3.5 t-20 -111.44 83.01 1.7 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.202 0.525 . . . . 62.25 109.726 174.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 30.2 ttp180 -105.27 121.07 43.1 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.959 -0.564 . . . . 75.44 109.744 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.4 t70 69.04 -83.11 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.369 -0.832 . . . . 71.02 111.207 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -144.14 12.13 2.08 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.63 -0.795 . . . . 75.32 112.583 -178.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.556 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -103.24 126.73 50.55 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.769 0.319 . . . . 73.12 111.461 -179.094 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -96.36 98.22 10.09 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.909 -0.774 . . . . 75.0 108.909 168.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -112.36 126.62 55.47 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.213 -0.449 . . . . 55.53 110.396 -175.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 13.6 tp -103.69 100.8 10.63 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.135 -0.484 . . . . 75.11 110.196 -176.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -88.96 97.83 11.41 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.175 -0.466 . . . . 73.45 111.045 -177.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.489 HG11 ' HB3' ' A' ' 83' ' ' TYR . 39.0 t -90.32 115.2 29.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.869 -0.605 . . . . 72.02 110.841 -179.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.437 ' HB ' HD11 ' A' ' 84' ' ' ILE . 47.6 m -104.6 114.79 29.23 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.673 -0.694 . . . . 64.32 109.964 175.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.488 ' HA ' ' HD1' ' A' ' 83' ' ' TYR . 26.0 t70 -60.79 141.97 56.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.97 -0.559 . . . . 63.4 111.105 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.554 ' HB2' ' O ' ' A' ' 82' ' ' ASP . 10.0 tpt180 -88.55 -10.94 47.13 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.151 -0.477 . . . . 73.23 111.367 -174.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm -107.62 -67.71 0.94 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.74 0.305 . . . . 73.34 111.622 -171.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 45.8 p -85.62 -33.09 21.73 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.271 0.558 . . . . 74.11 109.997 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 99.6 23.55 10.89 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.279 -0.873 . . . . 65.24 112.644 177.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.429 ' N ' ' HB3' ' A' ' 100' ' ' ASP . 98.2 mt-30 -59.58 130.68 48.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.725 0.298 . . . . 74.43 110.737 175.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.2 p -102.89 88.4 3.17 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.172 0.51 . . . . 62.24 110.398 176.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 9.7 t -91.21 105.65 17.95 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.766 -0.652 . . . . 71.15 109.489 -178.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.5 m -91.24 107.8 19.45 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.986 -0.552 . . . . 73.23 110.388 -178.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 59.5 mt -110.01 116.0 51.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.416 -0.356 . . . . 75.24 110.882 -175.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -71.71 168.2 18.26 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.003 0.43 . . . . 61.1 111.207 175.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.7 p . . . . . 0 C--N 1.325 -0.5 0 CA-C-N 115.748 -0.66 . . . . 75.11 111.306 -179.338 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 . . . . . 0 N--CA 1.455 -0.186 0 CA-C-O 121.011 0.434 . . . . 65.32 110.28 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 25.8 m -151.11 86.02 4.93 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 116.006 -0.543 . . . . 73.11 109.688 174.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.622 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 28.2 Cg_endo -62.16 110.58 1.05 Allowed 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 122.826 2.351 . . . . 73.11 112.29 -178.041 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 26.7 m -123.69 -25.54 4.3 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.005 -0.543 . . . . 73.25 110.415 177.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.3 -37.33 0.31 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 71.23 111.374 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.2 pp -73.09 -12.6 60.97 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.536 -0.302 . . . . 73.42 111.409 -176.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.622 ' HB3' ' HB2' ' A' ' 48' ' ' PRO . 4.3 p-10 -63.63 -56.59 14.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.289 -0.414 . . . . 72.13 110.864 -178.317 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -64.61 -28.76 69.84 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.229 0.538 . . . . 73.01 110.108 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.438 ' O ' HG13 ' A' ' 58' ' ' ILE . 77.6 t80 -66.26 -49.86 65.71 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.414 -0.812 . . . . 74.25 111.028 179.092 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.434 ' O ' ' HG3' ' A' ' 59' ' ' GLN . 8.9 t -72.46 -19.48 61.55 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.708 0.262 . . . . 75.41 111.708 -176.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.444 ' HG3' ' O ' ' A' ' 52' ' ' ASP . 60.9 mt-30 -64.39 -43.69 93.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.895 0.378 . . . . 63.02 111.096 -178.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.72 -24.89 61.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.337 -0.392 . . . . 74.22 111.422 -178.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 54' ' ' PHE . 8.6 mt -76.35 -18.67 15.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.107 0.479 . . . . 75.44 110.974 -176.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.434 ' HG3' ' O ' ' A' ' 55' ' ' THR . 77.4 mt-30 -67.21 -19.16 65.51 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.374 -0.375 . . . . 74.14 110.98 -178.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 61.0 m -74.87 -34.8 62.29 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.53 -0.304 . . . . 73.34 111.484 178.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.41 ' HG2' ' O ' ' A' ' 58' ' ' ILE . 11.1 pt20 -82.2 -5.58 58.6 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.862 0.363 . . . . 71.1 110.966 -177.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.541 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 67.7 mt -65.34 -36.02 76.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.284 0.564 . . . . 75.12 109.799 175.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 9.2 mp -63.47 -35.7 81.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.414 -0.812 . . . . 74.53 110.622 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -65.7 -40.68 95.92 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.285 -0.726 . . . . 74.2 111.285 175.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -66.33 -19.56 68.62 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 121.147 -0.549 . . . . 72.43 112.385 177.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 62' ' ' ILE . 85.5 mt -74.44 -31.9 62.43 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.046 0.45 . . . . 72.23 110.168 176.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 49.0 mt -74.83 -42.58 57.73 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.996 -0.742 . . . . 71.34 108.996 175.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.8 m -75.52 5.83 5.45 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.107 -0.951 . . . . 75.11 111.246 178.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.92 ' HA ' ' HG3' ' A' ' 90' ' ' ARG . 50.6 t30 -82.43 -25.86 33.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.195 -0.457 . . . . 72.41 110.997 -178.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.0 mp . . . . . 0 C--N 1.324 -0.531 0 CA-C-N 116.204 -0.453 . . . . 73.52 110.997 -175.812 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.756 ' HB3' HG11 ' A' ' 85' ' ' VAL . 47.9 ttm . . . . . 0 N--CA 1.451 -0.424 0 N-CA-C 108.897 -0.779 . . . . 73.31 108.897 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.4 p -88.53 98.31 7.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.867 0.842 . . . . 64.42 111.827 -173.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.7 p -122.77 156.93 33.47 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.209 -0.905 . . . . 50.13 109.451 171.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -78.28 -41.18 34.72 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.811 0.338 . . . . 72.31 111.368 -175.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.699 ' HB3' ' HD3' ' A' ' 102' ' ' LYS . 7.5 m-20 -81.45 -21.68 38.64 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.174 -0.466 . . . . 75.51 111.282 -174.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -137.49 135.89 37.2 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.978 0.418 . . . . 74.53 111.363 -177.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.641 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 4.1 mp -105.93 84.94 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 108.407 -0.96 . . . . 71.04 108.407 172.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.756 HG11 ' HB3' ' A' ' 78' ' ' MET . 2.3 p -91.18 106.8 17.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.642 0.734 . . . . 64.33 110.455 -177.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -111.51 128.0 55.88 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.316 -0.856 . . . . 74.51 110.32 -175.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.499 HG12 HD12 ' A' ' 96' ' ' LEU . 19.4 mt -95.86 103.73 15.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.278 -0.419 . . . . 73.15 110.375 -177.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -88.56 146.76 24.96 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.899 0.381 . . . . 75.04 111.009 -178.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -139.53 110.3 6.76 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.107 -0.497 . . . . 62.25 109.764 178.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.92 ' HG3' ' HA ' ' A' ' 69' ' ' ASN . 66.8 ttt180 -147.12 141.44 26.31 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.024 -0.535 . . . . 75.44 109.565 179.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.2 t70 71.71 2.94 4.48 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.449 0.642 . . . . 71.02 110.452 177.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.524 ' HA3' HG22 ' A' ' 62' ' ' ILE . . . 97.13 -8.62 65.07 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 111.183 -0.767 . . . . 75.32 111.183 -176.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.07 135.33 33.72 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.875 0.369 . . . . 73.12 110.346 179.324 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -91.97 131.51 37.22 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.408 -0.59 . . . . 75.0 109.408 173.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.408 ' HG2' ' ND2' ' A' ' 97' ' ' ASN . 6.2 tt0 -133.48 108.1 8.44 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.0 -0.545 . . . . 55.53 110.468 -178.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.563 ' HB3' ' HB ' ' A' ' 109' ' ' ILE . 44.2 tp -88.83 111.16 21.71 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.757 -0.656 . . . . 75.11 110.295 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.408 ' ND2' ' HG2' ' A' ' 95' ' ' GLN . 48.7 m-80 -104.56 107.41 18.34 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.881 0.372 . . . . 73.45 110.63 178.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.6 t -87.02 107.18 16.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.983 -0.553 . . . . 72.02 110.137 176.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.641 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 28.0 m -89.84 104.1 16.7 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 115.667 -0.697 . . . . 64.32 109.524 177.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.599 ' HB3' ' N ' ' A' ' 105' ' ' GLN . 32.3 t70 -71.11 127.39 32.43 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.335 -0.848 . . . . 63.4 110.865 -177.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.1 tpm_? -99.28 1.94 45.08 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.462 0.648 . . . . 73.23 110.166 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.699 ' HD3' ' HB3' ' A' ' 82' ' ' ASP . 25.3 mmmt -89.45 -57.08 3.01 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.054 -0.521 . . . . 73.34 110.421 -178.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 64.2 p -115.08 -31.35 6.07 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.453 0.644 . . . . 74.11 110.258 178.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' A' ' 100' ' ' ASP . . . 110.01 29.88 3.63 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 115.414 -0.812 . . . . 65.24 112.378 178.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.599 ' N ' ' HB3' ' A' ' 100' ' ' ASP . 84.1 mm-40 -64.04 160.71 17.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.108 0.48 . . . . 74.43 110.17 171.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 27.1 m -140.81 87.46 2.11 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.244 -0.65 . . . . 62.24 109.244 174.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.4 t -85.2 114.73 22.53 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.406 -0.815 . . . . 71.15 109.567 -178.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 19.5 m -102.18 114.79 29.25 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.065 -0.516 . . . . 73.23 110.72 -178.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.563 ' HB ' ' HB3' ' A' ' 96' ' ' LEU . 4.4 mp -105.97 96.6 4.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.048 -0.523 . . . . 75.24 109.767 177.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -93.54 142.72 27.02 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.193 -0.458 . . . . 61.1 109.88 178.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 92.6 t . . . . . 0 C--N 1.325 -0.483 0 N-CA-C 110.189 -0.3 . . . . 75.11 110.189 176.575 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 . . . . . 0 C--O 1.234 0.258 0 CA-C-O 121.386 0.612 . . . . 65.32 109.869 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.425 HG22 ' O ' ' A' ' 47' ' ' THR . 9.9 t -120.59 88.04 42.51 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.19 -0.914 . . . . 73.11 109.877 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -67.6 93.52 0.37 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.306 2.671 . . . . 73.11 113.725 -172.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 72.8 m -105.61 -69.75 0.81 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.089 -0.505 . . . . 73.25 110.607 172.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.39 -38.35 90.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.873 0.368 . . . . 71.23 111.922 -178.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.2 pp -95.4 12.06 30.6 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.166 -0.47 . . . . 73.42 111.67 -175.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 56' ' ' GLN . 15.9 t70 -57.41 -42.87 83.14 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.939 0.399 . . . . 72.13 111.121 -178.165 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -89.09 15.88 8.03 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.172 -0.467 . . . . 73.01 111.2 -177.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.758 ' HE1' ' HG2' ' A' ' 105' ' ' GLN . 67.6 t80 -122.97 -64.8 1.15 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.231 -0.44 . . . . 74.25 110.527 -179.333 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.1 m -66.64 -28.08 68.19 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.323 -0.399 . . . . 75.41 111.586 -175.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.467 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 2.0 mp0 -69.45 -29.62 67.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.829 0.347 . . . . 63.02 110.835 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.61 -26.1 60.63 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.286 0.565 . . . . 74.22 110.116 176.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.403 ' O ' HG13 ' A' ' 62' ' ' ILE . 12.1 mt -71.32 -25.47 25.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.458 -0.792 . . . . 75.44 110.591 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -55.11 -34.14 63.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.605 -0.27 . . . . 74.14 110.861 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 36.0 t -62.56 -48.92 77.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.184 -0.462 . . . . 73.34 111.141 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -73.28 -24.95 60.5 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.818 -0.353 . . . . 71.1 111.05 -176.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.645 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 75.4 mt -76.81 -56.92 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.946 0.403 . . . . 75.12 110.037 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 84.8 mt -62.1 -33.05 73.72 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.998 -0.546 . . . . 74.53 111.678 -175.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -77.33 -24.25 66.26 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.493 -0.86 . . . . 74.2 112.449 179.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -94.2 -20.78 29.32 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.041 -0.6 . . . . 72.43 112.865 -176.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.645 ' HG ' ' O ' ' A' ' 62' ' ' ILE . 69.7 mt -59.25 -15.58 16.3 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.459 0.54 . . . . 72.23 112.459 -176.201 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 84.1 mt -58.69 -41.69 86.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.018 0.437 . . . . 71.34 110.183 177.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.481 ' HB3' ' HB3' ' A' ' 90' ' ' ARG . 19.7 m -71.97 -24.66 61.63 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.875 -0.602 . . . . 75.11 110.751 -179.145 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.432 ' ND2' ' HB1' ' A' ' 88' ' ' ALA . 13.4 m120 -80.85 -22.72 39.65 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.865 -0.607 . . . . 72.41 111.106 -177.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 49.5 mm . . . . . 0 C--N 1.327 -0.396 0 N-CA-C 112.171 0.434 . . . . 73.52 112.171 -174.318 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.745 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 50.0 ttm . . . . . 0 CA--C 1.521 -0.136 0 CA-C-O 121.278 0.561 . . . . 73.31 110.776 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 53.4 t -105.22 106.33 20.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.029 -0.532 . . . . 64.42 110.397 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 14.7 p -127.31 159.4 34.5 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.973 -0.558 . . . . 50.13 110.177 175.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -62.97 -46.17 88.96 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.368 -0.378 . . . . 72.31 110.933 -176.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -77.7 -25.91 49.76 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.106 0.409 . . . . 75.51 112.106 -172.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.421 ' CE1' ' HA ' ' A' ' 100' ' ' ASP . 14.6 m-85 -149.15 136.35 19.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.233 0.54 . . . . 74.53 111.811 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.611 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 51.7 mm -98.42 99.44 8.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.315 -0.624 . . . . 71.04 109.315 175.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.745 ' HB ' ' HB3' ' A' ' 78' ' ' MET . 29.1 t -103.38 86.74 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.288 0.566 . . . . 64.33 110.257 -177.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -91.11 124.01 35.01 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.955 -0.566 . . . . 74.51 109.711 -177.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 70.5 mt -98.16 117.48 43.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.074 -0.512 . . . . 73.15 110.386 -175.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.54 ' HB3' ' HB2' ' A' ' 95' ' ' GLN . . . -110.89 87.83 2.63 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.262 0.553 . . . . 75.04 111.142 -178.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -97.58 107.64 20.19 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.431 -0.951 . . . . 62.25 108.431 171.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.481 ' HB3' ' HB3' ' A' ' 68' ' ' SER . 11.5 tpt180 -160.03 147.56 16.55 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.041 -0.527 . . . . 75.44 109.989 -176.09 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.3 t70 71.21 0.63 3.5 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 123.748 0.655 . . . . 71.02 111.111 173.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 114.37 -23.74 12.1 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 115.808 -0.633 . . . . 75.32 112.443 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.412 HE21 ' HA ' ' A' ' 93' ' ' GLN . 0.0 OUTLIER -95.67 159.07 15.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.351 0.595 . . . . 73.12 111.697 -175.094 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -106.32 116.59 32.19 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.382 -0.826 . . . . 75.0 109.451 175.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.54 ' HB2' ' HB3' ' A' ' 88' ' ' ALA . 19.5 mt-30 -121.05 127.94 52.18 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.242 -0.435 . . . . 55.53 110.15 -179.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 41.3 tp -109.94 121.69 45.83 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 110.041 -0.355 . . . . 75.11 110.041 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.476 ' ND2' HG21 ' A' ' 108' ' ' THR . 0.9 OUTLIER -112.91 102.2 10.22 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.903 -0.406 . . . . 73.45 109.903 177.625 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.611 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 6.4 p -113.9 115.61 50.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.412 0.625 . . . . 72.02 111.281 -178.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.566 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 41.2 m -92.44 123.13 35.53 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.805 -0.634 . . . . 64.32 111.045 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.48 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 26.9 t70 -75.08 158.43 33.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.57 -0.741 . . . . 63.4 110.649 177.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 11.6 mmt180 -115.61 2.54 13.78 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.486 0.55 . . . . 73.23 112.486 -176.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -108.13 -35.58 6.54 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.58 0.705 . . . . 73.34 110.264 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 14.4 p -121.81 -23.2 5.55 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.066 -0.97 . . . . 74.11 110.325 176.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 100' ' ' ASP . . . 83.65 14.56 72.94 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.659 -0.7 . . . . 65.24 111.986 -179.059 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.758 ' HG2' ' HE1' ' A' ' 54' ' ' PHE . 49.7 mt-30 -63.94 101.81 0.42 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.748 0.308 . . . . 74.43 110.404 177.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 98' ' ' VAL . 58.5 m -85.88 109.33 18.64 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.829 -0.434 . . . . 62.24 109.829 177.211 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 17.7 t -86.71 105.34 16.87 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.991 -0.55 . . . . 71.15 109.735 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.476 HG21 ' ND2' ' A' ' 97' ' ' ASN . 8.5 m -92.96 96.1 9.9 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.77 -0.65 . . . . 73.23 109.813 177.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 65.0 mt -102.86 114.33 42.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.179 -0.464 . . . . 75.24 111.539 -174.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.51 ' HG2' ' HG2' ' A' ' 95' ' ' GLN . 43.6 mt-30 -95.09 121.19 36.47 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.456 -0.572 . . . . 61.1 109.456 172.058 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 93.4 t . . . . . 0 C--N 1.327 -0.4 0 CA-C-O 121.174 0.511 . . . . 75.11 111.949 -175.696 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.419 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 30.9 tt0 . . . . . 0 CA--C 1.53 0.192 0 CA-C-O 121.782 0.801 . . . . 65.32 109.621 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 8.2 m -113.02 86.15 8.81 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.116 -0.947 . . . . 73.11 109.236 175.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.419 ' HD3' ' O ' ' A' ' 46' ' ' GLU . 17.1 Cg_exo -66.21 99.22 0.41 Allowed 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.692 2.262 . . . . 73.11 113.157 -173.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.8 m -127.85 -59.46 1.2 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.824 -0.625 . . . . 73.25 109.603 174.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.54 -46.37 15.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.027 -0.533 . . . . 71.23 110.263 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -74.6 -13.35 60.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 73.42 110.778 179.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.614 ' O ' ' HB2' ' A' ' 56' ' ' GLN . 27.0 t70 -62.69 -47.23 84.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.151 -0.477 . . . . 72.13 110.457 -179.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -79.2 9.91 4.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.426 -0.352 . . . . 73.01 110.865 178.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.447 ' O ' HG13 ' A' ' 58' ' ' ILE . 82.4 t80 -109.65 -64.82 1.21 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.759 0.314 . . . . 74.25 110.432 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.464 ' O ' ' HG2' ' A' ' 59' ' ' GLN . 12.9 t -73.5 -18.5 61.1 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.937 0.347 . . . . 75.41 111.937 -174.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.614 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 2.3 mp0 -75.09 -28.11 60.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.802 0.334 . . . . 63.02 110.614 -178.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -79.57 -18.83 50.86 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.536 0.684 . . . . 74.22 109.771 175.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.512 ' O ' HG13 ' A' ' 62' ' ' ILE . 21.7 mt -79.3 -29.06 13.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.37 -0.832 . . . . 75.44 110.604 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' A' ' 55' ' ' THR . 15.1 mm-40 -53.29 -37.61 62.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.132 -0.485 . . . . 74.14 111.136 -178.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.8 m -62.71 -46.55 87.6 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.046 -0.525 . . . . 73.34 111.022 179.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -77.78 -16.14 58.58 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.844 -0.342 . . . . 71.1 111.082 -178.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.512 HG13 ' O ' ' A' ' 58' ' ' ILE . 64.7 mt -71.27 -43.09 74.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.302 -0.629 . . . . 75.12 109.302 172.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 97.1 mt -61.45 -41.56 97.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.926 -0.579 . . . . 74.53 110.096 175.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -65.15 -37.33 93.98 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.771 -0.728 . . . . 74.2 111.714 175.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.21 -37.34 94.37 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 111.784 -0.526 . . . . 72.43 111.784 176.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 62' ' ' ILE . 95.9 mt -56.9 -59.51 4.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.593 0.235 . . . . 72.23 110.998 178.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 pp -65.6 -10.4 35.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.864 0.364 . . . . 71.34 111.741 -176.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 31.4 m -95.86 -46.43 6.56 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.662 0.267 . . . . 75.11 111.246 178.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -92.08 -26.85 18.11 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.399 0.518 . . . . 72.41 112.399 -172.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 36.1 mm . . . . . 0 N--CA 1.465 0.305 0 CA-C-O 121.268 0.556 . . . . 73.52 110.452 -178.981 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 58.9 ttp . . . . . 0 N--CA 1.45 -0.425 0 N-CA-C 109.642 -0.503 . . . . 73.31 109.642 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 60.9 t -74.35 102.81 2.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.243 0.544 . . . . 64.42 111.043 -176.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.657 ' HB ' ' O ' ' A' ' 83' ' ' TYR . 17.5 m -120.95 142.15 50.01 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.376 -0.829 . . . . 50.13 109.28 178.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -70.15 -36.31 74.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.903 0.382 . . . . 72.31 111.08 -174.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -82.4 -40.1 21.74 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.94 -0.573 . . . . 75.51 111.491 -176.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.657 ' O ' ' HB ' ' A' ' 80' ' ' THR . 49.6 m-85 -139.96 120.8 14.46 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.205 -0.294 . . . . 74.53 110.205 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.631 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 4.2 mp -83.68 99.89 6.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.069 -0.715 . . . . 71.04 109.069 178.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.3 t -91.01 106.7 17.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.609 -0.723 . . . . 64.33 111.097 -175.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -105.23 122.91 46.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.058 -0.519 . . . . 74.51 109.693 176.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 56.8 mt -101.55 118.12 47.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.286 -0.416 . . . . 73.15 110.524 -175.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -112.51 88.48 2.83 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.109 0.48 . . . . 75.04 110.492 178.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -95.33 88.54 5.16 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.195 -0.669 . . . . 62.25 109.195 175.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 56.7 ttp180 -130.75 143.06 50.48 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.567 -0.742 . . . . 75.44 109.717 -177.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 37.7 t70 65.7 24.16 11.56 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.64 0.733 . . . . 71.02 110.664 174.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.24 5.15 90.26 Favored Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 115.577 -0.738 . . . . 75.32 112.623 178.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.426 ' HA ' HE21 ' A' ' 93' ' ' GLN . 0.0 OUTLIER -104.4 134.4 47.68 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.873 0.368 . . . . 73.12 110.759 -179.622 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.477 ' HB2' ' HB ' ' A' ' 111' ' ' VAL . 4.5 mm? -91.97 96.34 10.31 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.867 -0.606 . . . . 75.0 109.39 174.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -106.33 110.0 22.1 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.327 0.584 . . . . 55.53 110.695 -179.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 35.8 tp -94.06 109.38 21.14 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.453 -0.794 . . . . 75.11 110.034 -178.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -97.82 93.06 6.15 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.949 0.404 . . . . 73.45 110.52 -179.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 56.0 t -85.01 103.63 12.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.143 0.497 . . . . 72.02 110.369 177.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.631 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 57.9 m -77.31 104.43 7.82 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.204 -0.665 . . . . 64.32 109.204 175.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -69.55 138.45 53.27 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.477 -0.783 . . . . 63.4 111.641 -174.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -108.02 -12.91 15.06 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.384 -0.825 . . . . 73.23 109.716 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -77.74 -55.86 4.99 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.813 -0.631 . . . . 73.34 110.714 -176.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 47.0 p -115.88 -23.15 8.73 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.387 0.613 . . . . 74.11 110.389 178.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 93.11 28.65 11.43 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.551 -0.75 . . . . 65.24 112.121 177.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -101.02 100.8 11.46 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 110.133 -0.321 . . . . 74.43 110.133 177.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 19.0 m -58.64 109.94 0.9 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.328 0.585 . . . . 62.24 110.867 -178.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 7.9 m -89.82 89.61 7.83 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.622 -0.717 . . . . 71.15 110.015 -178.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 45.4 m -83.46 109.3 17.23 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.931 -0.577 . . . . 73.23 110.317 178.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 58.9 mt -108.34 111.23 35.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.923 -0.58 . . . . 75.24 110.907 -177.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -88.96 118.54 28.76 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.981 0.42 . . . . 61.1 110.35 175.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.477 ' HB ' ' HB2' ' A' ' 94' ' ' LEU . 23.0 t . . . . . 0 C--N 1.322 -0.598 0 CA-C-N 115.925 -0.58 . . . . 75.11 109.839 178.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 . . . . . 0 C--O 1.232 0.153 0 CA-C-O 121.128 0.489 . . . . 65.32 110.189 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.7 87.7 3.77 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 115.612 -0.722 . . . . 73.11 110.767 175.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.515 ' CB ' ' HB2' ' A' ' 52' ' ' ASP . 50.7 Cg_endo -70.01 82.9 0.77 Allowed 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.037 1.825 . . . . 73.11 111.653 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.1 m -117.03 -8.96 11.17 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.82 -0.627 . . . . 73.25 110.792 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -165.42 -32.71 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.493 -0.321 . . . . 71.23 111.749 -176.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.9 pp -88.44 -10.07 50.4 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.846 0.313 . . . . 73.42 111.846 -177.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.515 ' HB2' ' CB ' ' A' ' 48' ' ' PRO . 17.4 t70 -56.52 -61.38 2.45 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.237 0.458 . . . . 72.13 112.237 -173.268 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -64.14 -33.3 75.47 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.039 -0.528 . . . . 73.01 110.763 -174.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.562 ' O ' HG13 ' A' ' 58' ' ' ILE . 72.3 t80 -70.76 -59.4 2.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.027 -0.533 . . . . 74.25 111.642 -176.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.2 t -66.26 -23.78 66.46 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.773 0.32 . . . . 75.41 111.327 -173.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -82.72 -34.11 27.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.594 -0.275 . . . . 63.02 110.682 177.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.89 -28.35 69.48 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.824 -0.435 . . . . 74.22 109.824 175.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.586 ' HA ' ' HG2' ' A' ' 61' ' ' GLN . 25.5 mt -62.07 -35.48 68.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.063 -0.517 . . . . 75.44 110.35 176.076 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -68.57 -32.42 72.32 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.149 -0.478 . . . . 74.14 110.847 178.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.662 ' O ' HD21 ' A' ' 63' ' ' LEU . 23.0 m -79.99 -35.43 37.49 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.198 -0.456 . . . . 73.34 110.645 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.586 ' HG2' ' HA ' ' A' ' 58' ' ' ILE . 3.2 pt20 -78.39 -1.31 32.83 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.739 0.304 . . . . 71.1 111.545 -176.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.583 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 69.4 mt -60.69 -29.44 44.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.864 0.364 . . . . 75.12 110.421 177.183 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.673 HD23 ' N ' ' A' ' 64' ' ' GLY . 0.2 OUTLIER -61.05 -19.47 61.42 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.024 -0.535 . . . . 74.53 111.876 -177.385 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.673 ' N ' HD23 ' A' ' 63' ' ' LEU . . . -112.03 -32.3 2.45 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.404 -0.678 . . . . 74.2 111.404 175.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -63.55 -28.29 72.24 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 121.547 -0.358 . . . . 72.43 112.431 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.598 ' O ' HG12 ' A' ' 70' ' ' ILE . 73.6 mt -52.49 -47.69 66.41 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 120.59 0.233 . . . . 72.23 110.761 176.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 71.0 mt -61.31 -30.89 70.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.188 -0.46 . . . . 71.34 111.047 -176.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.9 m -76.9 -36.2 56.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.18 -0.464 . . . . 75.11 110.647 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -77.79 -26.11 49.46 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.368 -0.378 . . . . 72.41 110.647 -179.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.598 HG12 ' O ' ' A' ' 66' ' ' LEU . 30.6 mm . . . . . 0 C--N 1.331 -0.22 0 CA-C-N 116.121 -0.49 . . . . 73.52 110.331 177.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 56.3 ttp . . . . . 0 N--CA 1.447 -0.617 0 N-CA-C 109.603 -0.517 . . . . 73.31 109.603 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 48.8 t -71.01 102.11 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.599 -0.728 . . . . 64.42 109.721 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.419 ' HB ' ' O ' ' A' ' 83' ' ' TYR . 3.7 m -94.24 165.3 12.66 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.019 -0.734 . . . . 50.13 109.019 178.174 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -53.31 -31.45 44.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.872 0.368 . . . . 72.31 111.702 -178.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -139.73 -42.75 0.44 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.905 0.384 . . . . 75.51 110.647 -179.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.419 ' O ' ' HB ' ' A' ' 80' ' ' THR . 75.4 m-85 -76.84 144.31 39.15 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.839 -0.618 . . . . 74.53 111.54 -176.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.49 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 4.3 mp -110.66 100.15 10.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.331 -0.618 . . . . 71.04 109.331 175.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.598 HG23 HG22 ' A' ' 98' ' ' VAL . 12.6 t -106.49 98.4 6.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.279 -0.419 . . . . 64.33 110.806 -175.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -96.19 127.71 42.44 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.137 0.494 . . . . 74.51 110.24 179.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.523 HG21 HD23 ' A' ' 94' ' ' LEU . 60.9 mt -80.73 85.53 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.687 -0.688 . . . . 73.15 109.64 178.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.6 82.9 2.62 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.18 0.514 . . . . 75.04 111.665 -175.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -96.26 101.84 13.54 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.838 -0.619 . . . . 62.25 109.42 175.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 37.7 ttp180 -121.1 97.7 5.64 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.91 0.386 . . . . 75.44 111.083 -177.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 37.1 t70 60.1 82.47 0.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.8 -1.091 . . . . 71.02 111.427 175.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.93 -67.34 3.76 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.445 -0.798 . . . . 75.32 113.386 178.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.502 ' HA ' HE21 ' A' ' 93' ' ' GLN . 0.1 OUTLIER -83.95 159.62 21.23 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.232 0.539 . . . . 73.12 111.126 -173.167 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.523 HD23 HG21 ' A' ' 87' ' ' ILE . 4.8 tt -135.47 134.3 39.43 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.805 -0.634 . . . . 75.0 109.609 -174.027 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.623 ' HG2' ' HG2' ' A' ' 110' ' ' GLN . 22.8 mt-30 -120.6 105.44 10.8 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.881 0.372 . . . . 55.53 110.096 175.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 43.6 tp -83.96 109.91 18.0 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.178 -0.465 . . . . 75.11 110.049 -178.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.504 ' HB3' HG21 ' A' ' 108' ' ' THR . 8.0 p30 -111.62 119.95 40.42 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.465 0.65 . . . . 73.45 111.22 -178.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.598 HG22 HG23 ' A' ' 85' ' ' VAL . 3.2 p -98.25 102.95 14.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.539 0.685 . . . . 72.02 109.478 173.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.843 ' HA ' HG23 ' A' ' 106' ' ' THR . 44.3 m -81.73 105.27 12.73 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.647 -0.706 . . . . 64.32 111.037 -177.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.529 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 11.4 t70 -72.42 143.82 48.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.517 -0.765 . . . . 63.4 109.769 173.369 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -109.17 -11.57 14.9 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.549 -0.296 . . . . 73.23 111.456 -178.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -81.05 -57.02 3.71 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.589 -0.444 . . . . 73.34 110.449 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 51.8 p -107.03 -27.45 10.63 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.094 0.473 . . . . 74.11 110.199 178.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.529 ' HA2' ' O ' ' A' ' 100' ' ' ASP . . . 91.48 20.37 38.17 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.662 -0.699 . . . . 65.24 112.661 175.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -76.49 95.93 3.97 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.681 -0.489 . . . . 74.43 109.681 177.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.843 HG23 ' HA ' ' A' ' 99' ' ' THR . 29.2 p -84.1 91.44 7.67 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.832 -0.622 . . . . 62.24 111.309 -177.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.43 ' HB3' ' CG1' ' A' ' 98' ' ' VAL . 33.1 t -67.14 101.55 0.9 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.129 -0.693 . . . . 71.15 109.129 176.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.504 HG21 ' HB3' ' A' ' 97' ' ' ASN . 10.1 m -104.24 107.04 17.77 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 116.033 -0.53 . . . . 73.23 110.056 -178.457 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 60.3 mt -106.69 114.36 45.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.864 -0.607 . . . . 75.24 110.353 -176.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.623 ' HG2' ' HG2' ' A' ' 95' ' ' GLN . 49.9 mt-30 -66.71 116.98 8.21 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.692 -0.484 . . . . 61.1 109.692 174.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.49 ' HB ' ' HB3' ' A' ' 94' ' ' LEU . 58.8 t . . . . . 0 C--N 1.322 -0.592 0 CA-C-O 121.465 0.65 . . . . 75.11 110.828 -173.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.2 mtt . . . . . 0 N--CA 1.48 1.063 0 CA-C-O 120.823 0.344 . . . . 75.5 110.429 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.87 162.43 29.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 74.23 111.058 -178.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -92.32 73.64 1.46 Allowed Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.85 -0.691 . . . . 65.14 112.138 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.3 p -74.01 119.41 18.18 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.512 0.196 . . . . 73.31 110.999 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.41 ' O ' ' N ' ' A' ' 7' ' ' PHE . 4.2 mpp? 67.61 -71.93 0.1 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.689 0.796 . . . . 75.43 111.305 -178.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 15.2 t 51.56 -65.57 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.652 1.581 . . . . 74.21 113.435 -177.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.41 ' N ' ' O ' ' A' ' 5' ' ' MET . 83.4 m-85 -89.81 -61.06 1.77 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.369 -0.604 . . . . 75.04 109.369 175.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 59.33 28.03 17.26 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.614 0.721 . . . . 73.41 111.181 176.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -108.71 98.41 7.92 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 121.981 -0.45 . . . . 73.24 110.124 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -125.68 -175.7 3.41 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.63 -0.713 . . . . 74.31 109.601 177.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.2 t30 63.67 84.92 0.18 Allowed Pre-proline 0 N--CA 1.467 0.39 0 O-C-N 123.737 0.648 . . . . 70.54 110.521 -177.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -81.43 131.56 7.56 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.942 2.428 . . . . 71.33 112.25 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.5 m120 70.58 103.35 0.06 Allowed 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.41 0.892 . . . . 75.43 113.41 176.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -90.72 146.06 24.3 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.461 -0.791 . . . . 75.23 109.14 166.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.86 -64.27 1.75 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.49 -0.862 . . . . 71.23 112.227 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 140.06 -178.66 19.66 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.956 -0.64 . . . . 73.33 111.8 -179.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -121.59 142.68 36.26 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.705 0.253 . . . . 72.14 110.62 -178.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -90.89 152.01 3.99 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.931 2.421 . . . . 61.41 112.874 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -99.11 153.6 18.77 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.188 -0.671 . . . . 74.52 109.188 176.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -128.63 157.7 40.58 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.946 0.403 . . . . 74.24 110.944 -178.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -105.41 5.12 40.87 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.736 -0.745 . . . . 62.44 111.973 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 72.15 -55.5 0.67 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.773 0.829 . . . . 64.1 111.57 -178.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 56.39 45.95 21.8 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.102 0.477 . . . . 75.42 111.35 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.4 pp -77.23 -6.38 52.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.043 -0.526 . . . . 72.34 111.191 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.43 HD23 ' HA ' ' A' ' 57' ' ' ALA . 89.5 mt 63.9 174.26 0.18 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.503 -0.771 . . . . 74.5 112.618 174.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 -127.25 -82.51 0.61 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.662 -0.699 . . . . 74.45 109.384 175.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.9 p -172.12 134.93 0.75 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.259 -0.882 . . . . 72.43 109.092 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -138.36 116.9 12.09 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.842 0.353 . . . . 74.12 111.279 -177.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 13.9 tm0? -108.01 -36.34 6.37 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.478 -0.564 . . . . 75.1 109.478 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 75.51 -37.49 0.33 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.749 0.82 . . . . 75.25 112.759 173.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.677 ' HG2' ' H ' ' A' ' 32' ' ' ASN . 0.0 OUTLIER 44.78 -84.76 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.794 1.238 . . . . 75.53 114.066 179.528 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.677 ' H ' ' HG2' ' A' ' 31' ' ' GLN . 39.6 t-20 -111.97 134.41 53.55 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.665 0.269 . . . . 64.01 110.677 -171.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.463 ' C ' ' H ' ' A' ' 35' ' ' LYS . 5.6 p -64.55 -51.53 62.35 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.746 -0.464 . . . . 74.21 109.746 174.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 57.9 t80 71.9 -25.4 0.18 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.793 0.837 . . . . 74.43 112.282 173.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.541 ' HG2' HG23 ' A' ' 47' ' ' THR . 22.8 tptm -140.35 31.19 1.92 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.256 0.551 . . . . 71.43 109.719 -178.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.451 ' HB2' ' HD2' ' A' ' 37' ' ' PRO . 2.9 p30 -61.18 156.9 46.97 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.088 -0.505 . . . . 74.53 111.288 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.451 ' HD2' ' HB2' ' A' ' 36' ' ' ASP . 9.5 Cg_endo -50.95 142.98 32.16 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.497 2.798 . . . . 70.22 113.851 -178.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 29.8 t -139.31 135.64 34.01 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.2 -0.909 . . . . 73.21 109.325 178.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 59.4 t80 56.86 68.72 0.82 Allowed 'General case' 0 C--O 1.234 0.252 0 O-C-N 123.778 0.674 . . . . 74.42 110.485 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 17.2 m120 63.06 24.29 14.41 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.422 -0.808 . . . . 75.2 110.784 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.411 ' HB2' ' HB3' ' A' ' 37' ' ' PRO . 26.8 t70 63.52 105.98 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.538 -0.755 . . . . 75.34 111.625 -175.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -88.2 -42.24 12.43 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.851 -0.613 . . . . 70.12 109.863 175.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -169.38 19.36 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.854 -0.612 . . . . 75.22 110.133 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -73.17 -38.38 54.54 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.506 -0.854 . . . . 74.52 112.182 -172.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.3 mt -76.82 -18.45 14.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.665 0.745 . . . . 75.24 109.834 -178.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -95.6 8.91 42.02 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.484 -0.78 . . . . 65.32 111.338 -177.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.541 HG23 ' HG2' ' A' ' 35' ' ' LYS . 9.8 m -115.97 86.57 16.85 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 120.725 0.298 . . . . 73.11 110.304 175.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.413 ' HB2' ' HB2' ' A' ' 52' ' ' ASP . 74.3 Cg_endo -77.37 84.57 1.93 Allowed 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.122 1.881 . . . . 73.11 111.896 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.7 m -86.07 -80.15 0.24 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.896 -0.593 . . . . 73.25 111.159 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -93.84 -37.85 11.54 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.807 0.337 . . . . 71.23 111.355 -177.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -66.64 -13.83 61.68 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.01 -0.541 . . . . 73.42 111.273 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.413 ' HB2' ' HB2' ' A' ' 48' ' ' PRO . 12.7 t70 -49.01 -53.46 19.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.674 -0.694 . . . . 72.13 112.509 -175.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.45 -30.96 67.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.826 0.346 . . . . 73.01 111.349 -178.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.477 ' O ' HG13 ' A' ' 58' ' ' ILE . 67.2 t80 -67.23 -44.64 78.96 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.192 -0.458 . . . . 74.25 110.407 -178.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 87.0 m -55.34 -37.2 67.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.425 0.631 . . . . 75.41 111.557 178.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -80.19 -31.7 38.73 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.796 -0.638 . . . . 63.02 110.771 -174.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.43 ' HA ' HD23 ' A' ' 25' ' ' LEU . . . -63.81 -25.19 68.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.031 -0.532 . . . . 74.22 110.263 175.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.533 ' O ' HG13 ' A' ' 62' ' ' ILE . 2.5 mt -86.28 -45.37 16.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.974 -0.557 . . . . 75.44 110.968 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.438 ' HA ' HD12 ' A' ' 62' ' ' ILE . 76.1 mt-30 -59.14 -30.45 68.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.769 0.319 . . . . 74.14 111.283 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.5 m -66.58 -37.96 86.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.352 -0.386 . . . . 73.34 111.152 178.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.5 ' HG2' ' O ' ' A' ' 58' ' ' ILE . 11.1 pt20 -83.19 -20.9 33.8 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.794 0.33 . . . . 71.1 110.943 -178.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.533 HG13 ' O ' ' A' ' 58' ' ' ILE . 83.9 mt -66.5 -31.1 52.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.996 0.427 . . . . 75.12 109.894 177.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 91.9 mt -57.65 -32.85 67.69 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.734 -0.666 . . . . 74.53 110.933 178.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -74.51 -40.47 39.05 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.993 -0.623 . . . . 74.2 111.602 176.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -63.71 -25.99 69.49 Favored Glycine 0 C--N 1.33 0.2 0 C-N-CA 120.992 -0.623 . . . . 72.43 112.286 178.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 62' ' ' ILE . 91.8 mt -66.22 -18.34 65.29 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.706 0.289 . . . . 72.23 110.916 178.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 93.7 mt -85.59 5.97 29.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.076 0.465 . . . . 71.34 110.563 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.9 t -126.11 -42.21 1.88 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.947 -0.57 . . . . 75.11 110.587 179.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -75.73 5.36 6.34 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.699 0.629 . . . . 72.41 112.699 -173.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 50.4 mm -99.73 -13.57 8.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.653 0.739 . . . . 73.52 109.664 176.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -98.59 8.92 44.32 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.589 -0.732 . . . . 62.21 110.678 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.2 p -86.77 -164.18 1.03 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.851 -0.613 . . . . 70.33 110.45 178.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 122.07 7.74 7.65 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.7 -0.762 . . . . 71.02 112.311 -177.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.527 ' HZ3' ' HB3' ' A' ' 89' ' ' ASN . 17.3 ptpt -57.44 148.12 56.06 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 120.665 0.269 . . . . 75.21 111.262 178.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.68 -10.34 23.38 Favored 'Trans proline' 0 CA--C 1.532 0.407 0 C-N-CA 122.587 2.191 . . . . 73.53 112.666 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -83.74 56.12 5.04 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 121.131 -0.557 . . . . 72.12 112.435 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -106.68 -176.01 2.96 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.003 -0.369 . . . . 72.11 110.003 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.465 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 27.6 ttt -122.42 115.63 22.58 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.729 0.3 . . . . 73.31 110.472 178.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 53.1 t -85.5 97.65 5.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.373 0.606 . . . . 64.42 110.696 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.689 ' HB ' ' O ' ' A' ' 83' ' ' TYR . 6.7 m -113.65 148.86 35.53 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.307 -0.86 . . . . 50.13 108.854 177.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -73.52 -59.64 2.62 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.007 0.373 . . . . 72.31 112.007 -170.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -82.82 -14.16 54.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.795 0.331 . . . . 75.51 111.448 -174.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.689 ' O ' ' HB ' ' A' ' 80' ' ' THR . 59.4 m-85 -133.99 121.3 21.41 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.334 -0.394 . . . . 74.53 110.482 -177.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.558 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 2.9 mp -81.91 102.56 7.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.089 -0.708 . . . . 71.04 109.089 175.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.465 ' HB ' ' HB3' ' A' ' 78' ' ' MET . 47.3 t -96.69 94.31 4.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.715 -0.675 . . . . 64.33 110.769 -176.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -98.45 115.62 28.91 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.343 -0.614 . . . . 74.51 109.343 178.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 71.6 mt -82.02 94.66 2.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.939 -0.573 . . . . 73.15 110.673 -176.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.05 74.54 8.08 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.687 -0.688 . . . . 75.04 111.102 -177.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.527 ' HB3' ' HZ3' ' A' ' 74' ' ' LYS . 3.1 t-20 -88.59 92.73 9.31 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.147 -0.686 . . . . 62.25 109.147 173.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.415 ' HA ' ' HD2' ' A' ' 90' ' ' ARG . 13.6 tpt180 -133.68 154.16 51.14 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.818 -0.628 . . . . 75.44 109.726 -178.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.9 t70 69.93 -68.18 0.21 Allowed 'General case' 0 N--CA 1.465 0.317 0 O-C-N 124.082 0.864 . . . . 71.02 111.151 178.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 177.74 23.62 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.736 -0.745 . . . . 75.32 113.433 178.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.436 ' HA ' HE21 ' A' ' 93' ' ' GLN . 0.0 OUTLIER -138.1 152.5 48.83 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 122.265 -0.55 . . . . 73.12 110.264 178.351 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -89.61 94.58 9.91 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.761 -0.459 . . . . 75.0 109.761 176.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.464 ' HG2' ' OD1' ' A' ' 97' ' ' ASN . 7.3 tt0 -97.31 109.29 22.08 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.137 0.494 . . . . 55.53 109.692 -179.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.526 ' HB3' ' HB ' ' A' ' 109' ' ' ILE . 29.0 tp -90.11 98.64 11.89 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.868 -0.605 . . . . 75.11 110.389 -177.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.475 ' OD1' HG21 ' A' ' 108' ' ' THR . 6.5 m-20 -90.61 93.44 9.27 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.283 0.564 . . . . 73.45 110.532 -179.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.443 ' CG1' ' HD1' ' A' ' 83' ' ' TYR . 56.1 t -92.8 114.18 29.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.658 -0.701 . . . . 72.02 110.677 178.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.558 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 30.7 m -103.32 109.23 20.77 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.845 -0.616 . . . . 64.32 110.077 178.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.578 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 25.2 t70 -62.32 141.23 58.4 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.489 -0.323 . . . . 63.4 110.777 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.07 -26.69 19.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.259 -0.428 . . . . 73.23 110.251 -177.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 32.7 mtmm -70.04 -69.58 0.34 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.374 -0.375 . . . . 73.34 111.149 -174.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 12.0 t -99.05 -26.8 14.11 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.243 0.544 . . . . 74.11 109.716 -179.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.578 ' HA2' ' O ' ' A' ' 100' ' ' ASP . . . 83.65 79.45 1.06 Allowed Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.544 -0.753 . . . . 65.24 112.909 176.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.447 ' H ' ' HB3' ' A' ' 100' ' ' ASP . 68.6 mm-40 -124.69 144.16 50.36 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.587 -0.523 . . . . 74.43 109.587 174.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.9 m -89.05 96.11 10.59 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.123 0.487 . . . . 62.24 110.724 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.419 ' HB3' ' HB ' ' A' ' 98' ' ' VAL . 47.4 t -88.17 80.83 7.51 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.454 -0.573 . . . . 71.15 109.454 177.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.475 HG21 ' OD1' ' A' ' 97' ' ' ASN . 28.2 m -82.35 101.49 10.62 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.901 -0.591 . . . . 73.23 110.709 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.526 ' HB ' ' HB3' ' A' ' 96' ' ' LEU . 54.5 mt -99.88 92.34 2.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.052 -0.522 . . . . 75.24 110.514 -178.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -72.56 106.91 4.81 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.723 -0.473 . . . . 61.1 109.723 175.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.2 t -76.23 104.75 4.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.688 -0.486 . . . . 75.11 109.688 177.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.3 t -147.86 125.46 11.77 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.749 -0.659 . . . . 73.52 110.31 -178.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 92.77 52.7 2.07 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.915 -0.66 . . . . 75.51 113.035 175.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 77.4 mt -106.16 -75.81 0.62 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.011 -0.366 . . . . 75.43 110.011 174.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 66.38 15.33 10.06 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.605 -0.725 . . . . 73.22 111.202 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -100.78 93.49 5.58 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.632 0.729 . . . . 73.42 109.705 173.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -105.26 101.74 11.27 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.496 -0.775 . . . . 63.43 110.547 -176.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 38.3 m -83.3 101.8 11.53 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.306 -0.628 . . . . 75.22 109.306 174.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -57.8 120.27 8.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.983 -0.553 . . . . 74.32 110.587 -177.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -120.92 116.21 24.69 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.84 -0.618 . . . . 75.14 110.352 -177.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -141.08 95.32 2.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.21 -0.45 . . . . 75.24 110.494 178.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 26.0 m80 63.95 -168.96 0.2 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.884 -0.598 . . . . 74.34 111.325 175.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 37.8 m80 58.42 46.71 14.8 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.811 -0.632 . . . . 71.55 110.991 176.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -84.09 11.36 8.14 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.681 -0.69 . . . . 75.21 111.035 -177.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 23.7 t-80 -139.57 109.64 6.44 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.221 -0.445 . . . . 74.34 109.879 175.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -147.14 139.2 24.45 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.692 -0.685 . . . . 73.13 109.998 176.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.619 -0.705 . . . . 63.31 109.56 -176.022 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.418 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.046 0 CA-C-O 120.864 0.364 . . . . 75.5 110.273 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -99.96 141.34 32.91 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.942 0.401 . . . . 74.23 111.374 -176.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -137.09 81.69 0.28 Allowed Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 111.193 -0.763 . . . . 65.14 111.193 177.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.8 t -100.21 -10.4 21.41 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.528 0.204 . . . . 73.31 111.046 -175.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 4.8 mpp? 58.5 -167.17 0.15 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.083 -0.508 . . . . 75.43 110.558 -177.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 16.2 m -141.53 -78.26 0.27 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.608 -0.269 . . . . 74.21 110.452 175.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.414 ' HB3' ' HE2' ' A' ' 9' ' ' PHE . 69.6 m-85 65.63 114.44 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 O-C-N 123.918 0.761 . . . . 75.04 111.327 -178.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -111.26 112.63 24.55 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.518 0.675 . . . . 73.41 111.208 -177.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.414 ' HE2' ' HB3' ' A' ' 7' ' ' PHE . 96.1 m-85 -118.69 99.77 6.99 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.01 -0.541 . . . . 73.24 110.837 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' A' ' 11' ' ' ASN . 73.0 mtp180 -111.47 -17.19 13.15 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.228 -0.442 . . . . 74.31 109.809 174.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 10' ' ' ARG . 40.6 m-80 73.37 155.96 0.16 Allowed Pre-proline 0 N--CA 1.466 0.356 0 O-C-N 123.943 0.777 . . . . 70.54 111.067 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.94 -45.17 43.0 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.091 2.528 . . . . 71.33 113.424 -177.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 72.4 154.94 0.15 Allowed 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.78 0.675 . . . . 75.43 110.459 -178.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 65.11 -175.0 0.18 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.279 0.562 . . . . 75.23 111.414 -178.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -166.57 38.82 0.25 Allowed Glycine 0 N--CA 1.448 -0.501 0 N-CA-C 111.213 -0.755 . . . . 71.23 111.213 176.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 110.58 150.76 12.49 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.959 -0.639 . . . . 73.33 111.66 -176.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -94.81 151.52 39.08 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 110.151 -0.314 . . . . 72.14 110.151 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -75.95 74.67 4.39 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.726 2.284 . . . . 61.41 111.792 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -96.85 -162.06 0.92 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.017 -0.538 . . . . 74.52 110.729 -177.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 44.9 88.57 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.686 0.995 . . . . 74.24 113.686 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.51 -27.9 73.58 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.544 -0.753 . . . . 62.44 111.232 173.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 75.09 -59.77 0.53 Allowed 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.917 0.887 . . . . 64.1 112.271 173.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 27.2 t80 67.65 97.17 0.06 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.553 0.692 . . . . 75.42 110.734 -177.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.0 mp -106.12 -175.28 2.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.448 -0.796 . . . . 72.34 110.954 -177.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 75.6 mt 58.63 72.47 0.52 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.324 -0.853 . . . . 74.5 111.638 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.489 ' O ' ' HA ' ' A' ' 49' ' ' SER . 13.6 m120 -124.43 89.54 3.09 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.08 -0.711 . . . . 74.45 109.08 175.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.2 m -71.43 93.5 1.17 Allowed 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.266 0.555 . . . . 72.43 110.902 -176.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -88.94 149.18 23.42 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.646 -0.706 . . . . 74.12 109.796 177.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -84.36 51.93 2.22 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.067 0.461 . . . . 75.1 111.482 -173.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.64 -35.92 22.33 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.963 -0.562 . . . . 75.25 110.06 177.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.447 ' HG2' ' H ' ' A' ' 32' ' ' ASN . 6.4 tt0 63.11 -167.39 0.21 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.388 -0.824 . . . . 75.53 111.357 177.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.447 ' H ' ' HG2' ' A' ' 31' ' ' GLN . 15.5 m120 73.21 168.58 0.31 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.301 0.64 . . . . 64.01 111.067 -176.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.5 m -86.36 -21.92 26.94 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.438 0.533 . . . . 74.21 112.438 -172.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -133.07 105.14 6.88 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.581 -0.448 . . . . 74.43 111.236 -174.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.412 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 25.1 tptp -132.66 108.46 9.06 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.955 -0.757 . . . . 71.43 108.955 174.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.522 ' HB2' ' HD2' ' A' ' 37' ' ' PRO . 4.0 p-10 -140.65 166.08 25.47 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 115.998 -0.546 . . . . 74.53 110.173 -173.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.522 ' HD2' ' HB2' ' A' ' 36' ' ' ASP . 21.2 Cg_endo -61.6 -26.52 80.54 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.192 1.928 . . . . 70.22 111.629 176.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.2 m 68.07 -74.6 0.07 Allowed 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.414 -0.812 . . . . 73.21 110.807 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -143.71 167.0 23.31 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.735 -0.468 . . . . 74.42 109.735 177.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 70.09 90.35 0.1 Allowed 'General case' 0 C--O 1.234 0.245 0 O-C-N 123.707 0.629 . . . . 75.2 110.379 178.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.7 t0 62.69 93.41 0.05 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.159 -0.928 . . . . 75.34 110.669 -176.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -85.09 30.09 0.61 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.242 -0.89 . . . . 70.12 110.996 -172.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -66.1 -25.31 66.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.82 0.343 . . . . 75.22 110.859 -177.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.563 ' HA2' ' OG1' ' A' ' 47' ' ' THR . . . -64.43 -16.67 60.96 Favored Glycine 0 C--N 1.332 0.339 0 CA-C-N 115.826 -0.625 . . . . 74.52 113.406 -174.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 62.4 mt -64.99 -25.19 37.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.313 0.578 . . . . 75.24 110.63 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -112.28 11.82 20.19 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.937 -0.574 . . . . 65.32 110.923 -176.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.563 ' OG1' ' HA2' ' A' ' 44' ' ' GLY . 47.0 p -124.75 86.7 55.69 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.492 -0.322 . . . . 73.11 110.943 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.434 ' HA ' ' HG ' ' A' ' 51' ' ' LEU . 32.0 Cg_exo -57.66 98.94 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.81 2.34 . . . . 73.11 112.702 -177.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.489 ' HA ' ' O ' ' A' ' 26' ' ' ASN . 14.3 m -104.4 -46.83 4.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.613 -0.721 . . . . 73.25 110.375 176.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.412 ' HB3' ' HB3' ' A' ' 35' ' ' LYS . . . -131.68 -2.65 3.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.466 0.65 . . . . 71.23 110.303 174.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.434 ' HG ' ' HA ' ' A' ' 48' ' ' PRO . 0.7 OUTLIER -95.46 0.55 53.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.672 -0.695 . . . . 73.42 110.394 -178.728 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -68.28 -40.83 81.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.142 -0.481 . . . . 72.13 109.977 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -63.69 -30.73 71.79 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.711 -0.677 . . . . 73.01 110.368 176.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -83.14 -51.57 7.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.819 -0.628 . . . . 74.25 111.322 -177.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.0 t -69.05 -26.43 64.96 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.046 0.387 . . . . 75.41 112.046 -173.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -77.3 -19.87 55.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.86 0.362 . . . . 63.02 110.433 178.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.51 -18.41 48.6 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.477 0.656 . . . . 74.22 109.683 175.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.458 ' O ' HG13 ' A' ' 62' ' ' ILE . 13.3 mt -77.04 -32.22 19.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.636 -0.711 . . . . 75.44 110.182 177.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -61.64 -27.88 68.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 74.14 110.795 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.624 ' O ' HD22 ' A' ' 63' ' ' LEU . 5.9 m -75.87 -43.15 46.95 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.21 -0.45 . . . . 73.34 110.691 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -74.53 -3.81 33.12 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.484 -0.326 . . . . 71.1 111.641 -173.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 58' ' ' ILE . 64.7 mt -66.9 -17.8 23.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.287 0.565 . . . . 75.12 110.0 174.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.624 HD22 ' O ' ' A' ' 60' ' ' SER . 0.5 OUTLIER -63.75 -19.21 64.79 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.857 -0.611 . . . . 74.53 111.199 -179.024 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.606 ' N ' HD21 ' A' ' 63' ' ' LEU . . . -81.68 -30.37 36.25 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 111.101 -0.8 . . . . 74.2 111.101 176.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -69.77 -26.02 74.89 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.081 -0.808 . . . . 72.43 111.081 175.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.428 ' HA ' HD12 ' A' ' 70' ' ' ILE . 86.8 mt -70.49 -5.45 28.86 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.089 0.471 . . . . 72.23 110.647 176.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 87.4 mt -109.41 -66.69 1.04 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.925 -0.579 . . . . 71.34 110.952 178.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 17.8 m -98.51 15.41 25.03 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.865 0.691 . . . . 75.11 112.865 -171.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -129.45 20.73 5.66 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.539 0.685 . . . . 72.41 110.197 178.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.428 HD12 ' HA ' ' A' ' 66' ' ' LEU . 45.2 mm -93.18 -7.12 10.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-O 121.629 0.728 . . . . 73.52 109.319 178.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.412 ' C ' ' HG1' ' A' ' 72' ' ' THR . 44.6 t-20 -52.13 -61.35 2.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.946 -1.025 . . . . 62.21 110.233 177.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.412 ' HG1' ' C ' ' A' ' 71' ' ' ASN . 75.4 p 51.98 24.17 2.5 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.619 0.768 . . . . 70.33 112.996 175.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -76.08 -19.46 78.57 Favored Glycine 0 N--CA 1.454 -0.157 0 C-N-CA 120.768 -0.729 . . . . 71.02 112.883 -178.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.9 150.24 39.46 Favored Pre-proline 0 CA--C 1.532 0.278 0 N-CA-C 111.951 0.352 . . . . 75.21 111.951 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -72.77 -4.91 16.22 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.87 2.38 . . . . 73.53 113.333 -177.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 120.74 -114.95 2.77 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.77 -0.729 . . . . 72.12 112.163 178.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 -132.5 -176.13 3.99 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.113 -0.329 . . . . 72.11 110.113 -178.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 59.6 ttp -116.68 116.2 27.09 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.299 -0.63 . . . . 73.31 109.299 172.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 58.5 t -67.4 103.52 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.096 0.474 . . . . 64.42 111.202 -178.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -108.19 167.6 9.9 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.686 -0.688 . . . . 50.13 110.987 176.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -64.28 -73.88 0.11 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.499 -0.318 . . . . 72.31 111.809 -174.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -120.6 32.96 5.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.809 0.814 . . . . 75.51 109.873 -178.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -125.85 144.17 50.77 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.174 -0.921 . . . . 74.53 110.243 177.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.545 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 4.4 mp -108.55 100.48 10.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.172 -0.677 . . . . 71.04 109.172 175.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.9 p -125.28 110.72 25.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.579 0.704 . . . . 64.33 110.973 -177.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -110.38 143.95 39.87 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.477 -0.783 . . . . 74.51 109.858 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 59.5 mt -87.13 98.68 7.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 109.641 -0.503 . . . . 73.15 109.641 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -88.26 89.44 7.99 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.888 -0.596 . . . . 75.04 111.146 -176.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.468 ' HA ' ' O ' ' A' ' 93' ' ' GLN . 29.0 t-20 -84.97 77.43 10.11 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.901 -0.778 . . . . 62.25 108.901 172.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.404 ' O ' ' HB3' ' A' ' 91' ' ' ASP . 47.3 ttp180 -102.6 144.45 30.99 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.737 -1.12 . . . . 75.44 109.107 -178.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.404 ' HB3' ' O ' ' A' ' 90' ' ' ARG . 11.4 t70 69.05 -67.78 0.2 Allowed 'General case' 0 N--CA 1.467 0.384 0 O-C-N 123.726 0.641 . . . . 71.02 110.664 -177.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 172.34 31.54 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.297 -0.721 . . . . 75.32 111.297 178.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.468 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 26.2 mm-40 -136.82 150.06 48.1 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.048 -0.353 . . . . 73.12 110.048 -178.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.431 ' HB2' ' HB ' ' A' ' 111' ' ' VAL . 3.6 mm? -88.24 101.92 14.32 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.102 -0.333 . . . . 75.0 110.102 178.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -104.74 121.53 43.81 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.012 0.434 . . . . 55.53 110.245 178.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 15.7 tp -103.94 102.68 12.47 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.16 -0.473 . . . . 75.11 110.169 -177.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -96.46 115.25 27.13 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.42 -0.355 . . . . 73.45 110.723 -177.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 39.7 t -99.61 111.26 28.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.171 -0.468 . . . . 72.02 110.821 178.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.545 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 43.6 m -97.75 110.59 23.13 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.813 -0.63 . . . . 64.32 110.391 177.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.428 ' HB3' ' H ' ' A' ' 105' ' ' GLN . 7.1 t70 -71.34 124.97 25.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.941 -0.572 . . . . 63.4 109.923 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.488 ' HD3' ' O ' ' A' ' 101' ' ' ARG . 3.1 tmt_? -82.84 -28.69 29.96 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.599 0.238 . . . . 73.23 110.639 -176.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -84.77 -58.4 2.73 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.491 0.663 . . . . 73.34 110.804 -175.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.7 m -88.68 -25.34 22.42 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.989 -1.005 . . . . 74.11 110.83 -172.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.97 69.32 1.41 Allowed Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.704 -0.68 . . . . 65.24 113.214 177.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.428 ' H ' ' HB3' ' A' ' 100' ' ' ASP . 44.7 mt-30 -136.82 144.75 43.82 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.993 -0.743 . . . . 74.43 108.993 176.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.2 t -110.77 94.41 4.98 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.982 0.896 . . . . 62.24 110.446 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 27.0 t -87.26 113.23 22.8 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.457 -0.792 . . . . 71.15 109.371 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 41.9 m -103.62 111.39 23.85 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.925 -0.58 . . . . 73.23 111.219 -176.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 4.5 mp -108.34 109.47 28.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.097 -0.501 . . . . 75.24 109.649 178.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -91.61 153.83 19.46 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.017 0.436 . . . . 61.1 111.491 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.431 ' HB ' ' HB2' ' A' ' 94' ' ' LEU . 4.4 p -54.71 111.12 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.177 -0.92 . . . . 75.11 111.683 -179.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.8 m -135.81 137.03 41.14 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.154 -0.93 . . . . 73.52 108.839 177.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 173.2 -108.96 0.29 Allowed Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.103 -1.046 . . . . 75.51 112.854 -177.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 87.4 mt -97.73 78.87 2.64 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.947 0.403 . . . . 75.43 111.154 -174.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -115.66 -10.81 11.77 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.126 0.489 . . . . 73.22 110.294 177.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -112.01 173.22 6.46 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.081 -0.509 . . . . 73.42 110.514 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -108.86 133.74 52.48 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.171 -0.468 . . . . 63.43 111.405 -178.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 24.3 m -86.81 112.77 22.04 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.078 -0.51 . . . . 75.22 110.343 174.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 17.6 m -100.23 112.54 24.87 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.506 -0.316 . . . . 74.32 110.413 177.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -90.72 74.43 6.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.952 0.406 . . . . 75.14 110.735 -177.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -149.04 124.69 10.44 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.189 -0.46 . . . . 75.24 110.459 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.429 ' HD2' ' O ' ' A' ' 123' ' ' HIS . 3.4 t-160 -144.72 113.96 7.0 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.491 -0.559 . . . . 74.34 109.491 177.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.449 ' O ' ' HD2' ' A' ' 125' ' ' HIS . 30.3 t60 -66.46 139.4 57.97 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.692 -0.484 . . . . 71.55 109.692 176.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 26.3 m80 -67.97 118.07 10.67 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.114 0.483 . . . . 75.21 111.655 -176.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.449 ' HD2' ' O ' ' A' ' 123' ' ' HIS . 34.8 m-70 -120.97 129.67 53.52 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.546 -0.752 . . . . 74.34 109.259 175.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.538 ' O ' ' HB2' ' A' ' 127' ' ' HIS . 45.9 p-80 -74.47 156.73 36.62 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.945 -0.391 . . . . 73.13 109.945 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.538 ' HB2' ' O ' ' A' ' 126' ' ' HIS . 15.8 m80 . . . . . 0 C--O 1.247 0.951 0 O-C-N 124.039 0.837 . . . . 63.31 110.56 -171.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.203 0 CA-C-O 120.318 0.104 . . . . 75.5 111.132 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 65.43 -168.97 0.2 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.032 0.444 . . . . 74.23 111.711 176.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 120.88 -15.62 9.55 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 121.003 -0.618 . . . . 65.14 111.82 -177.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 35.2 m -73.33 85.13 1.44 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.349 0.595 . . . . 73.31 111.148 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 85.3 mtp -128.88 93.2 3.55 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.531 -0.759 . . . . 75.43 109.132 173.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 48.2 p -94.69 -17.26 22.4 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.013 -0.54 . . . . 74.21 111.37 -175.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 68.07 -58.25 0.46 Allowed 'General case' 0 N--CA 1.466 0.326 0 O-C-N 123.932 0.77 . . . . 75.04 110.747 -176.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 72.51 -64.18 0.4 Allowed 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.804 0.842 . . . . 73.41 112.129 173.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 62.35 -172.14 0.16 Allowed 'General case' 0 C--O 1.234 0.274 0 O-C-N 123.629 0.581 . . . . 73.24 110.286 -175.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -147.93 -43.79 0.16 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.367 -0.379 . . . . 74.31 110.684 175.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 68.94 146.9 0.11 Allowed Pre-proline 0 N--CA 1.468 0.471 0 O-C-N 123.734 0.646 . . . . 70.54 111.882 177.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -68.98 -46.79 1.39 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.43 2.087 . . . . 71.33 111.462 176.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 68.03 120.31 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 O-C-N 124.257 0.973 . . . . 75.43 112.208 178.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 90.0 t80 72.11 121.14 0.04 OUTLIER 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.847 0.832 . . . . 75.23 112.03 177.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -140.19 -165.41 10.28 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 114.857 -1.065 . . . . 71.23 110.584 174.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 132.12 174.7 13.71 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.466 -0.873 . . . . 73.33 112.471 176.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -106.64 143.67 27.5 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 110.36 -0.237 . . . . 72.14 110.36 -178.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.75 126.83 10.39 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.457 2.105 . . . . 61.41 112.126 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -90.55 101.78 14.52 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.708 -0.478 . . . . 74.52 109.708 176.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -115.39 117.39 30.28 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.883 -0.599 . . . . 74.24 110.83 -176.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.81 157.34 23.52 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.749 -0.739 . . . . 62.44 111.992 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.93 142.72 38.21 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.932 0.396 . . . . 64.1 110.783 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -123.54 114.68 20.39 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.866 -0.607 . . . . 75.42 109.684 178.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.601 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 99.0 mt -130.58 133.42 46.18 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.451 -0.341 . . . . 72.34 111.484 -176.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.601 ' HG ' ' O ' ' A' ' 24' ' ' LEU . 4.6 pp 53.5 -179.87 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.671 1.189 . . . . 74.5 114.145 174.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -173.54 121.29 0.34 Allowed 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.133 -0.94 . . . . 74.45 108.855 178.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.3 t -68.65 116.68 9.44 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.001 -0.37 . . . . 72.43 110.001 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -144.08 114.95 7.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.873 0.368 . . . . 74.12 111.419 -176.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 24.9 tp60 -102.14 77.55 1.69 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.874 -0.603 . . . . 75.1 109.505 175.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -147.25 117.24 7.23 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.216 -0.447 . . . . 75.25 110.942 -177.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.417 HE21 ' HB3' ' A' ' 31' ' ' GLN . 0.0 OUTLIER 43.62 38.88 2.1 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.176 0.99 . . . . 75.53 112.213 -179.699 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 21.9 p-10 -121.46 179.54 4.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.25 -0.886 . . . . 64.01 109.668 178.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 30.0 m 71.56 -47.86 0.67 Allowed 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.318 0.647 . . . . 74.21 111.619 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -128.25 106.28 8.92 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.505 0.669 . . . . 74.43 111.695 178.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.408 ' HE2' ' HB2' ' A' ' 35' ' ' LYS . 19.7 ttmm -122.29 176.44 5.86 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.096 -1.075 . . . . 71.43 108.096 174.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -66.3 144.39 98.69 Favored Pre-proline 0 C--N 1.325 -0.499 0 C-N-CA 121.132 -0.227 . . . . 74.53 111.1 -177.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.6 ' HA ' ' HB2' ' A' ' 42' ' ' ASP . 81.1 Cg_exo -48.97 148.34 9.36 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 124.041 3.161 . . . . 70.22 114.338 -177.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 39.3 m -134.4 -23.25 1.67 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.659 -0.7 . . . . 73.21 111.676 -179.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -112.65 55.19 0.7 Allowed 'General case' 0 N--CA 1.464 0.248 0 O-C-N 122.136 -0.353 . . . . 74.42 111.415 -175.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 54.36 79.99 0.13 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.733 -0.667 . . . . 75.2 111.314 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.4 t70 70.75 102.6 0.06 Allowed 'General case' 0 N--CA 1.468 0.444 0 O-C-N 123.882 0.739 . . . . 75.34 110.572 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.6 ' HB2' ' HA ' ' A' ' 37' ' ' PRO . 0.4 OUTLIER -106.43 13.61 28.3 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.991 -0.55 . . . . 70.12 112.254 -172.577 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 83.0 t80 59.61 0.55 0.23 Allowed 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 112.066 0.395 . . . . 75.22 112.066 -175.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.407 ' H ' ' C ' ' A' ' 42' ' ' ASP . . . -91.84 34.44 4.38 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 121.09 -0.576 . . . . 74.52 112.931 -177.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 41.1 mm -96.33 -60.15 2.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 110.304 -0.258 . . . . 75.24 110.304 176.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 68.63 -52.05 0.56 Allowed 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.871 0.868 . . . . 65.32 112.757 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 4.7 t -136.6 88.23 19.95 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-O 121.483 0.659 . . . . 73.11 110.989 -177.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -71.82 84.39 1.04 Allowed 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.398 2.066 . . . . 73.11 111.167 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 12.4 p -127.29 -72.6 0.63 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.659 -0.7 . . . . 73.25 110.786 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.95 -14.78 63.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.132 -0.485 . . . . 71.23 111.92 -177.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.405 ' O ' HG21 ' A' ' 55' ' ' THR . 2.9 pp -115.62 1.69 13.6 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.472 -0.331 . . . . 73.42 111.351 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.617 ' O ' ' HB2' ' A' ' 56' ' ' GLN . 28.3 t70 -68.05 -36.81 80.5 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.451 -0.34 . . . . 72.13 111.397 -174.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -84.66 -38.24 20.05 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.781 0.324 . . . . 73.01 110.922 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.455 ' O ' HG13 ' A' ' 58' ' ' ILE . 60.9 t80 -61.23 -57.99 10.13 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.884 -0.598 . . . . 74.25 111.42 -177.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.405 HG21 ' O ' ' A' ' 51' ' ' LEU . 7.2 t -70.01 -16.72 63.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.186 0.517 . . . . 75.41 110.958 -176.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.617 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 1.5 tp-100 -75.16 -29.96 60.59 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.385 0.612 . . . . 63.02 109.752 -178.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.72 -35.76 44.39 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.563 -0.744 . . . . 74.22 109.926 176.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.569 ' O ' HG13 ' A' ' 62' ' ' ILE . 17.3 mt -62.38 -40.07 86.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.648 -0.705 . . . . 75.44 111.055 -178.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -54.48 -32.85 58.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.429 -0.35 . . . . 74.14 111.413 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.3 t -81.51 -18.4 45.21 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.508 -0.314 . . . . 73.34 111.59 -176.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.526 ' HG2' ' O ' ' A' ' 58' ' ' ILE . 3.4 pt20 -96.63 -17.21 20.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.863 0.363 . . . . 71.1 110.687 -178.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.581 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 84.2 mt -65.15 -41.81 92.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.211 -0.45 . . . . 75.12 110.295 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.2 mp -61.59 -31.1 71.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.709 -0.678 . . . . 74.53 110.967 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -73.14 -41.8 45.9 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.658 -0.782 . . . . 74.2 111.833 178.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -71.33 -19.46 77.55 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 121.295 -0.478 . . . . 72.43 112.814 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.581 ' HG ' ' O ' ' A' ' 62' ' ' ILE . 86.2 mt -57.35 -34.43 68.79 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.884 0.373 . . . . 72.23 110.966 178.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.405 HD12 HH11 ' A' ' 90' ' ' ARG . 97.1 mt -65.87 -36.5 83.6 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.199 -0.455 . . . . 71.34 110.851 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.9 m -71.51 -27.6 63.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.025 0.441 . . . . 75.11 110.255 177.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -72.83 -27.3 61.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.118 0.485 . . . . 72.41 109.927 176.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.518 HG12 ' O ' ' A' ' 66' ' ' LEU . 48.8 mm -71.2 -23.31 23.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.888 -0.596 . . . . 73.52 109.634 175.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -78.46 6.92 7.46 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.728 -0.669 . . . . 62.21 110.574 178.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 46.3 p 52.22 31.0 8.53 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.304 1.041 . . . . 70.33 113.112 172.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.59 31.74 67.84 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 121.076 -0.583 . . . . 71.02 113.388 174.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -56.78 144.23 67.0 Favored Pre-proline 0 C--O 1.235 0.322 0 O-C-N 122.803 -0.233 . . . . 75.21 110.565 174.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -59.49 132.12 44.3 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 122.788 2.326 . . . . 73.53 111.75 177.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -133.04 -85.67 0.27 Allowed Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.6 -0.809 . . . . 72.12 113.176 -177.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.423 ' CB ' ' HA ' ' A' ' 86' ' ' ASP . 23.8 ptt180 -79.4 147.45 32.35 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.193 0.521 . . . . 72.11 111.844 -174.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 45.1 ttm -119.68 131.54 55.45 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.52 -0.764 . . . . 73.31 110.299 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 54.2 t -72.38 124.98 30.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.507 -0.553 . . . . 64.42 109.507 176.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.616 ' HB ' ' O ' ' A' ' 83' ' ' TYR . 2.7 m -127.27 162.35 26.44 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.663 -0.244 . . . . 50.13 110.532 -176.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -72.59 -75.89 0.13 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.954 0.407 . . . . 72.31 111.264 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -88.96 5.98 41.61 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.225 -0.443 . . . . 75.51 111.781 -174.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.616 ' O ' ' HB ' ' A' ' 80' ' ' THR . 60.7 m-85 -143.81 167.65 21.81 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.882 0.372 . . . . 74.53 110.748 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.551 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 40.8 mm -121.88 99.55 7.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 108.762 -0.829 . . . . 71.04 108.762 168.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 37.1 t -85.0 82.38 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.194 0.521 . . . . 64.33 109.977 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.423 ' HA ' ' CB ' ' A' ' 77' ' ' ARG . 26.1 t70 -94.81 98.77 10.98 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.754 -0.657 . . . . 74.51 111.226 -177.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.422 HG12 HD11 ' A' ' 96' ' ' LEU . 58.2 mt -86.82 95.4 4.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.574 -0.528 . . . . 73.15 109.574 175.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -88.14 114.33 24.66 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.954 -0.566 . . . . 75.04 110.457 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.497 ' HA ' ' O ' ' A' ' 93' ' ' GLN . 2.8 t-20 -109.89 111.17 22.42 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.906 -0.588 . . . . 62.25 110.211 178.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.405 HH11 HD12 ' A' ' 67' ' ' LEU . 59.0 ttp85 -127.44 133.74 49.91 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.476 -0.564 . . . . 75.44 109.476 175.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 64.43 -86.05 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 O-C-N 123.861 0.725 . . . . 71.02 110.558 -176.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -148.64 15.1 1.22 Allowed Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 110.996 -0.842 . . . . 75.32 110.996 177.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.497 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -98.11 124.31 42.57 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.814 0.34 . . . . 73.12 110.799 -177.588 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -95.7 101.17 12.83 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.65 -0.87 . . . . 75.0 108.65 171.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -117.45 110.7 18.32 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.184 -0.462 . . . . 55.53 110.754 -174.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.483 ' HG ' HG23 ' A' ' 98' ' ' VAL . 61.1 tp -89.21 109.58 20.44 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.896 -0.593 . . . . 75.11 110.971 -176.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -97.44 88.31 4.36 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.848 -0.427 . . . . 73.45 109.848 178.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.515 ' HB ' ' HB3' ' A' ' 107' ' ' SER . 43.1 t -78.95 102.55 5.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.205 0.526 . . . . 72.02 110.516 178.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.551 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 25.1 m -90.64 106.39 18.47 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.456 -0.793 . . . . 64.32 109.371 176.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -63.02 140.23 58.85 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.061 0.458 . . . . 63.4 110.73 -177.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 24.4 tpp180 -76.6 -35.47 58.09 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.672 -0.694 . . . . 73.23 111.785 -174.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -102.35 -47.44 4.49 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 111.876 0.324 . . . . 73.34 111.876 -169.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 42.7 p -89.9 -26.84 20.25 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.156 0.503 . . . . 74.11 110.486 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.03 19.02 68.21 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.855 -0.688 . . . . 65.24 112.861 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -64.8 124.49 22.11 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.242 -0.281 . . . . 74.43 110.242 174.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 36.9 m -92.92 91.64 7.5 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.234 0.54 . . . . 62.24 109.571 175.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.515 ' HB3' ' HB ' ' A' ' 98' ' ' VAL . 17.1 t -88.45 89.39 7.97 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.869 -0.605 . . . . 71.15 109.589 -179.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 32.1 m -86.84 102.86 14.7 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.78 -0.645 . . . . 73.23 110.257 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 61.4 mt -111.39 109.11 27.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.77 -0.65 . . . . 75.24 110.816 -177.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -76.14 147.48 38.5 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.431 -0.35 . . . . 61.1 110.474 174.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 5.7 p -55.68 128.22 15.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.563 -0.744 . . . . 75.11 110.179 174.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.3 m -98.74 -32.36 11.42 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.208 -0.451 . . . . 73.52 110.493 -177.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 129.98 -139.11 10.7 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.993 -0.622 . . . . 75.51 111.696 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 86.3 mt -99.8 -77.12 0.53 Allowed 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 121.099 -0.24 . . . . 75.43 110.425 178.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 60.64 78.74 0.27 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.883 -0.599 . . . . 73.22 110.944 -177.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -112.09 131.94 55.14 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.694 -0.685 . . . . 73.42 110.055 178.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -94.39 -50.57 5.17 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.115 -0.493 . . . . 63.43 109.851 -179.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 52.7 m 66.81 165.83 0.21 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.204 -0.907 . . . . 75.22 112.282 176.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 21.0 p -74.48 132.71 42.12 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.662 -0.699 . . . . 74.32 110.761 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -91.92 -29.62 16.57 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.173 -0.467 . . . . 75.14 109.968 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 72.19 145.85 0.07 Allowed 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.158 -0.928 . . . . 75.24 111.711 178.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 24.9 p-80 -145.32 140.14 27.55 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.025 -0.732 . . . . 74.34 109.025 171.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -80.94 127.42 32.55 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.684 -0.487 . . . . 71.55 109.684 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 20.0 p-80 -69.26 139.44 54.42 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.734 -0.666 . . . . 75.21 111.303 -174.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 27.6 m170 -87.15 154.08 21.01 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.976 -0.75 . . . . 74.34 108.976 172.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.48 ' O ' ' HB2' ' A' ' 127' ' ' HIS . 5.6 t-160 -89.93 128.02 36.14 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.422 -0.955 . . . . 73.13 108.422 175.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.48 ' HB2' ' O ' ' A' ' 126' ' ' HIS . 36.6 m80 . . . . . 0 C--O 1.252 1.188 0 CA-C-O 117.992 -1.004 . . . . 63.31 109.805 -172.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.5 ptm . . . . . 0 N--CA 1.484 1.243 0 CA-C-O 120.624 0.25 . . . . 75.5 110.565 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.03 -40.78 0.05 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.905 0.383 . . . . 74.23 111.07 -178.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 115.91 60.32 0.34 Allowed Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 111.336 -0.705 . . . . 65.14 111.336 -176.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.406 ' O ' ' HB2' ' A' ' 5' ' ' MET . 14.6 t -69.33 144.24 53.56 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.632 0.253 . . . . 73.31 110.663 -176.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.406 ' HB2' ' O ' ' A' ' 4' ' ' THR . 0.8 OUTLIER 72.04 -55.7 0.66 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.701 0.8 . . . . 75.43 112.037 -178.174 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.0 t 43.72 88.14 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.038 0.935 . . . . 74.21 112.469 -177.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.512 ' HB2' ' CE2' ' A' ' 9' ' ' PHE . 14.4 p90 -82.4 114.53 20.92 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.514 -0.766 . . . . 75.04 110.543 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -110.86 -51.28 2.88 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.535 -0.757 . . . . 73.41 110.774 -176.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.512 ' CE2' ' HB2' ' A' ' 7' ' ' PHE . 77.4 m-85 61.09 39.64 15.92 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.57 0.7 . . . . 73.24 109.267 -177.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.432 HH11 ' HD3' ' A' ' 10' ' ' ARG . 0.8 OUTLIER -82.84 70.93 9.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.914 -1.039 . . . . 74.31 111.787 -174.234 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -144.41 85.18 8.83 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.611 -0.722 . . . . 70.54 110.863 175.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -66.57 -31.82 40.38 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.96 2.44 . . . . 71.33 111.97 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 52.72 59.25 4.61 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.611 -0.722 . . . . 75.43 111.399 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -148.83 128.79 13.48 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.032 -0.531 . . . . 75.23 109.926 -178.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -162.72 -115.38 0.34 Allowed Glycine 0 N--CA 1.45 -0.368 0 N-CA-C 111.1 -0.8 . . . . 71.23 111.1 177.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 120.5 165.33 12.77 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.751 -0.738 . . . . 73.33 112.672 176.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -117.91 144.56 34.83 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 109.353 -0.61 . . . . 72.14 109.353 178.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.98 -56.76 0.22 Allowed 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 122.176 1.917 . . . . 61.41 112.916 -176.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -176.92 -170.58 0.32 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.184 -0.673 . . . . 74.52 109.184 -178.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -125.13 154.84 40.84 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.766 -0.457 . . . . 74.24 109.766 178.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -138.35 132.22 5.72 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.727 -0.749 . . . . 62.44 111.891 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -164.15 117.47 1.41 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.911 -0.403 . . . . 64.1 109.911 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -155.84 122.33 5.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.362 0.601 . . . . 75.42 111.139 -177.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.522 HD11 ' O ' ' A' ' 24' ' ' LEU . 3.0 pp -157.32 131.29 8.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.703 -0.68 . . . . 72.34 110.728 176.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 80.3 mt -135.68 -27.63 1.15 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.525 -0.761 . . . . 74.5 110.975 177.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -63.69 138.45 58.5 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.334 -0.394 . . . . 74.45 110.407 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 10.4 m -68.91 118.65 12.11 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.958 -0.565 . . . . 72.43 111.418 -177.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -120.31 165.87 14.28 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.98 -0.554 . . . . 74.12 110.13 178.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -100.0 128.99 46.01 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 110.071 -0.344 . . . . 75.1 110.071 -178.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.59 178.34 8.02 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.062 -0.517 . . . . 75.25 110.622 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 65.74 177.17 0.21 Allowed 'General case' 0 N--CA 1.466 0.327 0 O-C-N 123.623 0.577 . . . . 75.53 111.445 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 16.6 m120 62.56 3.76 1.2 Allowed 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.335 -0.848 . . . . 64.01 112.992 173.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.0 p -129.3 11.54 5.91 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.084 0.401 . . . . 74.21 112.084 -173.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 82.3 t80 58.93 81.31 0.17 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.687 0.756 . . . . 74.43 110.135 -176.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.54 ' HD2' ' H ' ' A' ' 36' ' ' ASP . 0.0 OUTLIER -174.04 174.93 2.87 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.621 -1.251 . . . . 71.43 107.621 -175.315 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.54 ' H ' ' HD2' ' A' ' 35' ' ' LYS . 4.0 p30 -65.27 143.54 98.8 Favored Pre-proline 0 C--N 1.328 -0.366 0 C-N-CA 120.266 -0.573 . . . . 74.53 109.837 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.66 ' HB2' ' OD1' ' A' ' 42' ' ' ASP . 88.7 Cg_endo -91.0 172.64 3.01 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.227 2.618 . . . . 70.22 112.554 -176.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 5.8 m 174.4 23.63 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.51 0.724 . . . . 73.21 110.912 -170.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.426 ' O ' ' HB3' ' A' ' 42' ' ' ASP . 61.2 t80 -150.7 157.67 43.23 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 120.143 -0.623 . . . . 74.42 111.862 -170.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 65.2 t30 56.89 58.76 3.84 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.769 -0.65 . . . . 75.2 110.987 177.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.1 t70 50.27 74.29 0.22 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.071 -0.968 . . . . 75.34 111.082 -178.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.66 ' OD1' ' HB2' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -158.38 -51.52 0.06 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.032 -0.986 . . . . 70.12 110.067 -176.306 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.409 ' HA ' ' HA ' ' A' ' 38' ' ' SER . 8.7 t80 58.19 -0.35 0.11 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.582 0.956 . . . . 75.22 113.582 174.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.458 ' HA2' ' HG2' ' A' ' 37' ' ' PRO . . . 122.38 55.27 0.21 Allowed Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.474 -0.87 . . . . 74.52 112.752 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 49.7 mm -58.98 -25.39 29.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.112 0.482 . . . . 75.24 110.943 175.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.408 ' HB2' ' CD ' ' A' ' 37' ' ' PRO . 24.0 mm-40 -82.63 4.31 25.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.395 -0.366 . . . . 65.32 111.864 179.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.7 t -137.63 74.79 45.39 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-O 121.885 0.85 . . . . 73.11 109.673 172.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -89.9 99.54 0.3 Allowed 'Trans proline' 0 N--CA 1.448 -1.2 0 C-N-CA 122.941 2.428 . . . . 73.11 112.775 -175.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 38.3 m -129.39 -62.69 0.97 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.849 -0.614 . . . . 73.25 109.759 174.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.83 -43.78 13.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.12 0.486 . . . . 71.23 110.124 178.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.9 pp -75.58 -11.12 59.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.865 -0.607 . . . . 73.42 110.613 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.553 ' O ' ' HB2' ' A' ' 56' ' ' GLN . 26.9 t70 -62.42 -50.48 71.33 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.991 -0.55 . . . . 72.13 110.439 178.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -63.41 -32.47 73.92 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.049 -0.523 . . . . 73.01 110.908 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.523 ' O ' HG13 ' A' ' 58' ' ' ILE . 57.4 t80 -68.11 -55.33 12.83 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.035 -0.53 . . . . 74.25 110.227 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.3 t -67.85 -19.22 65.02 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.25 0.548 . . . . 75.41 110.524 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.553 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 2.8 tp-100 -67.38 -41.3 85.25 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.795 -0.638 . . . . 63.02 109.4 178.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.94 -29.28 61.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.505 -0.771 . . . . 74.22 110.798 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.523 HG13 ' O ' ' A' ' 54' ' ' PHE . 20.7 mt -63.84 -35.61 73.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.123 0.487 . . . . 75.44 110.552 178.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -66.92 -22.14 65.96 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.132 -0.486 . . . . 74.14 111.263 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.3 m -85.93 -30.07 23.11 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.018 -0.537 . . . . 73.34 111.073 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.466 ' HG2' ' O ' ' A' ' 58' ' ' ILE . 3.9 pt20 -83.14 -3.33 57.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.795 0.331 . . . . 71.1 111.093 -176.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.504 HG12 ' O ' ' A' ' 58' ' ' ILE . 47.5 mm -74.95 -37.61 41.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.891 0.377 . . . . 75.12 110.343 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.483 ' H ' HD21 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -65.5 -41.89 92.72 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.008 -0.542 . . . . 74.53 110.792 -175.778 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -77.79 -22.51 69.12 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.631 -0.795 . . . . 74.2 112.346 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -77.22 -6.83 86.63 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.982 -0.627 . . . . 72.43 112.435 -178.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.603 ' O ' HG12 ' A' ' 70' ' ' ILE . 97.9 mt -70.11 -29.66 66.66 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 122.819 -0.224 . . . . 72.23 111.018 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 91.2 mt -54.28 -46.89 72.81 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.308 -0.405 . . . . 71.34 111.995 -175.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -70.8 -21.95 62.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.222 -0.445 . . . . 75.11 111.255 -178.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -94.1 -7.93 41.07 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.311 -0.404 . . . . 72.41 111.032 -178.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.603 HG12 ' O ' ' A' ' 66' ' ' LEU . 31.9 mm -81.07 -26.39 10.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.413 -0.358 . . . . 73.52 110.368 177.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.438 ' C ' ' HG1' ' A' ' 72' ' ' THR . 3.7 t-20 -54.33 -64.47 0.82 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.068 -0.515 . . . . 62.21 111.073 -177.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.438 ' HG1' ' C ' ' A' ' 71' ' ' ASN . 68.9 p 52.15 -168.84 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.611 0.765 . . . . 70.33 112.643 178.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 104.55 2.16 43.64 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.58 -0.819 . . . . 71.02 113.041 175.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.451 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 2.3 pptp? -56.7 144.54 65.18 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-O 120.634 0.254 . . . . 75.21 111.343 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 74' ' ' LYS . 11.5 Cg_exo -71.49 -30.56 14.99 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 122.923 2.415 . . . . 73.53 112.3 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 168.67 -162.37 36.13 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.983 -0.627 . . . . 72.12 111.902 -179.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.469 ' HA ' HD13 ' A' ' 87' ' ' ILE . 29.3 ptt180 -151.04 171.78 16.77 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.279 -0.267 . . . . 72.11 110.279 -178.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.4 ' HB3' HG13 ' A' ' 85' ' ' VAL . 27.5 ttt -100.98 119.03 38.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.986 0.422 . . . . 73.31 111.043 -177.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 46.1 t -81.87 107.39 13.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.088 -0.505 . . . . 64.42 110.154 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.771 ' HB ' ' O ' ' A' ' 83' ' ' TYR . 1.8 m -107.95 168.39 9.31 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.192 -0.458 . . . . 50.13 110.139 -178.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -89.03 -65.33 1.03 Allowed 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.172 0.434 . . . . 72.31 112.172 -175.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -94.66 -2.72 50.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.205 0.526 . . . . 75.51 111.192 -176.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.771 ' O ' ' HB ' ' A' ' 80' ' ' THR . 31.8 m-85 -130.73 149.95 52.14 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.97 -0.752 . . . . 74.53 108.97 177.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.561 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 4.7 mp -117.5 93.92 2.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 108.914 -0.773 . . . . 71.04 108.914 172.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.4 HG13 ' HB3' ' A' ' 78' ' ' MET . 4.9 p -91.57 101.29 12.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.955 0.883 . . . . 64.33 110.216 178.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -93.81 127.26 39.45 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.339 -0.846 . . . . 74.51 109.967 -177.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.469 HD13 ' HA ' ' A' ' 77' ' ' ARG . 63.5 mt -93.37 109.47 21.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.162 -0.472 . . . . 73.15 110.465 -178.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -120.77 176.24 5.63 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.915 -0.584 . . . . 75.04 110.474 179.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -139.11 123.81 18.54 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.691 -0.485 . . . . 62.25 109.691 176.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.453 ' O ' ' HB3' ' A' ' 91' ' ' ASP . 14.8 ptm180 -106.23 99.62 9.19 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.712 -0.676 . . . . 75.44 110.057 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.453 ' HB3' ' O ' ' A' ' 90' ' ' ARG . 4.8 t70 73.38 -57.97 0.61 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.878 -0.601 . . . . 71.02 111.696 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -172.2 32.07 0.12 Allowed Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 111.076 -0.809 . . . . 75.32 111.076 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.42 ' HA ' HE21 ' A' ' 93' ' ' GLN . 0.0 OUTLIER -135.8 124.52 23.85 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.613 -0.514 . . . . 73.12 109.613 -179.175 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -64.37 120.09 11.58 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.14 0.495 . . . . 75.0 110.405 176.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -102.17 115.77 31.26 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.502 -0.772 . . . . 55.53 109.932 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 12.9 tp -92.62 91.05 7.37 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.303 -0.629 . . . . 75.11 109.303 178.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -83.59 96.24 8.58 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.365 -0.38 . . . . 73.45 110.77 -177.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.1 t -88.93 104.87 15.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.332 0.587 . . . . 72.02 110.623 176.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.561 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 31.0 m -96.69 112.48 24.21 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.109 -0.95 . . . . 64.32 109.867 176.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.466 ' HB3' ' N ' ' A' ' 105' ' ' GLN . 12.6 t70 -71.26 130.93 42.66 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.185 -0.462 . . . . 63.4 111.125 178.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 -94.48 -11.47 29.63 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.188 0.518 . . . . 73.23 110.469 -176.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -86.3 -62.48 1.5 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.113 -0.494 . . . . 73.34 111.509 -176.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 63.6 p -111.35 -27.88 8.46 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.018 0.437 . . . . 74.11 111.393 -176.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 103.04 34.41 4.0 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.786 -0.643 . . . . 65.24 112.54 178.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.466 ' N ' ' HB3' ' A' ' 100' ' ' ASP . 51.3 mt-30 -71.84 115.9 11.59 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.984 -0.376 . . . . 74.43 109.984 174.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 21.1 m -86.55 92.16 8.79 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.059 0.457 . . . . 62.24 110.4 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 22.6 t -97.43 86.78 3.95 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.221 0.534 . . . . 71.15 110.126 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.4 m -91.42 95.54 10.03 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.054 -0.521 . . . . 73.23 110.289 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 57.0 mt -102.89 136.29 36.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.827 -0.624 . . . . 75.24 110.577 -175.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -95.59 163.32 13.26 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.859 0.361 . . . . 61.1 110.553 173.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.6 p -66.43 118.69 10.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.002 -0.544 . . . . 75.11 110.518 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 17.6 t -93.64 90.4 6.6 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.16 -0.473 . . . . 73.52 110.462 -178.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 59.8 -130.54 49.82 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.567 -0.742 . . . . 75.51 112.816 178.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 96.0 mt -127.93 17.1 6.78 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.858 0.361 . . . . 75.43 110.595 -177.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -77.71 -38.36 47.46 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.312 -0.403 . . . . 73.22 110.302 178.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 10.0 t30 67.86 134.39 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.449 0 O-C-N 123.921 0.763 . . . . 73.42 112.108 178.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -62.15 105.43 0.59 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.031 -0.532 . . . . 63.43 109.735 175.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.4 m -125.18 175.38 7.44 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.889 0.376 . . . . 75.22 111.242 -173.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 3.3 m -122.17 170.55 9.77 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.991 -0.744 . . . . 74.32 108.991 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -72.11 -39.55 68.81 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 117.81 0.277 . . . . 75.14 111.287 -178.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 64.15 104.72 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.265 0.555 . . . . 75.24 111.474 -178.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -85.28 123.5 30.83 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.864 -0.607 . . . . 74.34 110.327 -177.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 23.2 t60 -86.29 -47.33 9.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.883 0.373 . . . . 71.55 110.616 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 70.3 t60 -108.78 105.94 15.74 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.994 -0.548 . . . . 75.21 110.735 -176.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 23.3 t60 -89.15 -47.75 7.87 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.582 -0.525 . . . . 74.34 109.582 175.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 66.9 t-80 -165.1 141.03 5.49 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.934 -0.765 . . . . 73.13 108.934 178.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 41.3 p-80 . . . . . 0 C--O 1.243 0.743 0 CA-C-O 118.283 -0.865 . . . . 63.31 109.826 179.392 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.2 mtt . . . . . 0 N--CA 1.48 1.063 0 CA-C-O 120.823 0.344 . . . . 75.5 110.429 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.87 162.43 29.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 74.23 111.058 -178.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -92.32 73.64 1.46 Allowed Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.85 -0.691 . . . . 65.14 112.138 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.3 p -74.01 119.41 18.18 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.512 0.196 . . . . 73.31 110.999 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.41 ' O ' ' N ' ' A' ' 7' ' ' PHE . 4.2 mpp? 67.61 -71.93 0.1 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.689 0.796 . . . . 75.43 111.305 -178.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 15.2 t 51.56 -65.57 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.652 1.581 . . . . 74.21 113.435 -177.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.41 ' N ' ' O ' ' A' ' 5' ' ' MET . 83.4 m-85 -89.81 -61.06 1.77 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.369 -0.604 . . . . 75.04 109.369 175.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 59.33 28.03 17.26 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.614 0.721 . . . . 73.41 111.181 176.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -108.71 98.41 7.92 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 121.981 -0.45 . . . . 73.24 110.124 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -125.68 -175.7 3.41 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.63 -0.713 . . . . 74.31 109.601 177.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.2 t30 63.67 84.92 0.18 Allowed Pre-proline 0 N--CA 1.467 0.39 0 O-C-N 123.737 0.648 . . . . 70.54 110.521 -177.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -81.43 131.56 7.56 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.942 2.428 . . . . 71.33 112.25 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.5 m120 70.58 103.35 0.06 Allowed 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.41 0.892 . . . . 75.43 113.41 176.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -90.72 146.06 24.3 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.461 -0.791 . . . . 75.23 109.14 166.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.86 -64.27 1.75 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.49 -0.862 . . . . 71.23 112.227 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 140.06 -178.66 19.66 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.956 -0.64 . . . . 73.33 111.8 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -121.59 142.68 36.26 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.705 0.253 . . . . 72.14 110.62 -178.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -90.89 152.01 3.99 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.931 2.421 . . . . 61.41 112.874 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -99.11 153.6 18.77 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.188 -0.671 . . . . 74.52 109.188 176.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -128.63 157.7 40.58 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.946 0.403 . . . . 74.24 110.944 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -105.41 5.12 40.87 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.736 -0.745 . . . . 62.44 111.973 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 72.15 -55.5 0.67 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.773 0.829 . . . . 64.1 111.57 -178.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 56.39 45.95 21.8 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.102 0.477 . . . . 75.42 111.35 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.4 pp -77.23 -6.38 52.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.043 -0.526 . . . . 72.34 111.191 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.43 HD23 ' HA ' ' A' ' 57' ' ' ALA . 89.5 mt 63.9 174.26 0.18 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.503 -0.771 . . . . 74.5 112.618 174.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 -127.25 -82.51 0.61 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.662 -0.699 . . . . 74.45 109.384 175.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.9 p -172.12 134.93 0.75 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.259 -0.882 . . . . 72.43 109.092 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -138.36 116.9 12.09 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.842 0.353 . . . . 74.12 111.279 -177.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 13.9 tm0? -108.01 -36.34 6.37 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.478 -0.564 . . . . 75.1 109.478 178.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 75.51 -37.49 0.33 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.749 0.82 . . . . 75.25 112.759 173.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.677 ' HG2' ' H ' ' A' ' 32' ' ' ASN . 0.0 OUTLIER 44.78 -84.76 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.794 1.238 . . . . 75.53 114.066 179.528 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.677 ' H ' ' HG2' ' A' ' 31' ' ' GLN . 39.6 t-20 -111.97 134.41 53.55 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.665 0.269 . . . . 64.01 110.677 -171.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.463 ' C ' ' H ' ' A' ' 35' ' ' LYS . 5.6 p -64.55 -51.53 62.35 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.746 -0.464 . . . . 74.21 109.746 174.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 57.9 t80 71.9 -25.4 0.18 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.793 0.837 . . . . 74.43 112.282 173.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.541 ' HG2' HG23 ' A' ' 47' ' ' THR . 22.8 tptm -140.35 31.19 1.92 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.256 0.551 . . . . 71.43 109.719 -178.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.451 ' HB2' ' HD2' ' A' ' 37' ' ' PRO . 2.9 p30 -61.18 156.9 46.97 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.088 -0.505 . . . . 74.53 111.288 -179.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.451 ' HD2' ' HB2' ' A' ' 36' ' ' ASP . 9.5 Cg_endo -50.95 142.98 32.16 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.497 2.798 . . . . 70.22 113.851 -178.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 29.8 t -139.31 135.64 34.01 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.2 -0.909 . . . . 73.21 109.325 178.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 59.4 t80 56.86 68.72 0.82 Allowed 'General case' 0 C--O 1.234 0.252 0 O-C-N 123.778 0.674 . . . . 74.42 110.485 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 17.2 m120 63.06 24.29 14.41 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.422 -0.808 . . . . 75.2 110.784 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.411 ' HB2' ' HB3' ' A' ' 37' ' ' PRO . 26.8 t70 63.52 105.98 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.538 -0.755 . . . . 75.34 111.625 -175.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -88.2 -42.24 12.43 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.851 -0.613 . . . . 70.12 109.863 175.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -169.38 19.36 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.854 -0.612 . . . . 75.22 110.133 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -73.17 -38.38 54.54 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.506 -0.854 . . . . 74.52 112.182 -172.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.3 mt -76.82 -18.45 14.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.665 0.745 . . . . 75.24 109.834 -178.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -95.6 8.91 42.02 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.484 -0.78 . . . . 65.32 111.338 -177.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.541 HG23 ' HG2' ' A' ' 35' ' ' LYS . 9.8 m -115.97 86.57 16.85 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 120.725 0.298 . . . . 73.11 110.304 175.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.413 ' HB2' ' HB2' ' A' ' 52' ' ' ASP . 74.3 Cg_endo -77.37 84.57 1.93 Allowed 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.122 1.881 . . . . 73.11 111.896 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.7 m -86.07 -80.15 0.24 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.896 -0.593 . . . . 73.25 111.159 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -93.84 -37.85 11.54 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.807 0.337 . . . . 71.23 111.355 -177.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -66.64 -13.83 61.68 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.01 -0.541 . . . . 73.42 111.273 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.413 ' HB2' ' HB2' ' A' ' 48' ' ' PRO . 12.7 t70 -49.01 -53.46 19.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.674 -0.694 . . . . 72.13 112.509 -175.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.45 -30.96 67.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.826 0.346 . . . . 73.01 111.349 -178.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.477 ' O ' HG13 ' A' ' 58' ' ' ILE . 67.2 t80 -67.23 -44.64 78.96 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.192 -0.458 . . . . 74.25 110.407 -178.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 87.0 m -55.34 -37.2 67.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.425 0.631 . . . . 75.41 111.557 178.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -80.19 -31.7 38.73 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.796 -0.638 . . . . 63.02 110.771 -174.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.43 ' HA ' HD23 ' A' ' 25' ' ' LEU . . . -63.81 -25.19 68.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.031 -0.532 . . . . 74.22 110.263 175.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.533 ' O ' HG13 ' A' ' 62' ' ' ILE . 2.5 mt -86.28 -45.37 16.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.974 -0.557 . . . . 75.44 110.968 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.438 ' HA ' HD12 ' A' ' 62' ' ' ILE . 76.1 mt-30 -59.14 -30.45 68.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.769 0.319 . . . . 74.14 111.283 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.5 m -66.58 -37.96 86.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.352 -0.386 . . . . 73.34 111.152 178.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.5 ' HG2' ' O ' ' A' ' 58' ' ' ILE . 11.1 pt20 -83.19 -20.9 33.8 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.794 0.33 . . . . 71.1 110.943 -178.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.533 HG13 ' O ' ' A' ' 58' ' ' ILE . 83.9 mt -66.5 -31.1 52.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.996 0.427 . . . . 75.12 109.894 177.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 91.9 mt -57.65 -32.85 67.69 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.734 -0.666 . . . . 74.53 110.933 178.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -74.51 -40.47 39.05 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.993 -0.623 . . . . 74.2 111.602 176.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -63.71 -25.99 69.49 Favored Glycine 0 C--N 1.33 0.2 0 C-N-CA 120.992 -0.623 . . . . 72.43 112.286 178.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 62' ' ' ILE . 91.8 mt -66.22 -18.34 65.29 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.706 0.289 . . . . 72.23 110.916 178.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 93.7 mt -85.59 5.97 29.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.076 0.465 . . . . 71.34 110.563 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.9 t -126.11 -42.21 1.88 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.947 -0.57 . . . . 75.11 110.587 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -75.73 5.36 6.34 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.699 0.629 . . . . 72.41 112.699 -173.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 50.4 mm -99.73 -13.57 8.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.653 0.739 . . . . 73.52 109.664 176.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -98.59 8.92 44.32 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.589 -0.732 . . . . 62.21 110.678 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.2 p -86.77 -164.18 1.03 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.851 -0.613 . . . . 70.33 110.45 178.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 122.07 7.74 7.65 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.7 -0.762 . . . . 71.02 112.311 -177.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.527 ' HZ3' ' HB3' ' A' ' 89' ' ' ASN . 17.3 ptpt -57.44 148.12 56.06 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 120.665 0.269 . . . . 75.21 111.262 178.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.68 -10.34 23.38 Favored 'Trans proline' 0 CA--C 1.532 0.407 0 C-N-CA 122.587 2.191 . . . . 73.53 112.666 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -83.74 56.12 5.04 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 121.131 -0.557 . . . . 72.12 112.435 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -106.68 -176.01 2.96 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.003 -0.369 . . . . 72.11 110.003 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.465 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 27.6 ttt -122.42 115.63 22.58 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.729 0.3 . . . . 73.31 110.472 178.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 53.1 t -85.5 97.65 5.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.373 0.606 . . . . 64.42 110.696 -178.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.689 ' HB ' ' O ' ' A' ' 83' ' ' TYR . 6.7 m -113.65 148.86 35.53 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.307 -0.86 . . . . 50.13 108.854 177.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -73.52 -59.64 2.62 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.007 0.373 . . . . 72.31 112.007 -170.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -82.82 -14.16 54.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.795 0.331 . . . . 75.51 111.448 -174.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.689 ' O ' ' HB ' ' A' ' 80' ' ' THR . 59.4 m-85 -133.99 121.3 21.41 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.334 -0.394 . . . . 74.53 110.482 -177.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.558 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 2.9 mp -81.91 102.56 7.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.089 -0.708 . . . . 71.04 109.089 175.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.465 ' HB ' ' HB3' ' A' ' 78' ' ' MET . 47.3 t -96.69 94.31 4.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.715 -0.675 . . . . 64.33 110.769 -176.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -98.45 115.62 28.91 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.343 -0.614 . . . . 74.51 109.343 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 71.6 mt -82.02 94.66 2.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.939 -0.573 . . . . 73.15 110.673 -176.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.05 74.54 8.08 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.687 -0.688 . . . . 75.04 111.102 -177.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.527 ' HB3' ' HZ3' ' A' ' 74' ' ' LYS . 3.1 t-20 -88.59 92.73 9.31 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.147 -0.686 . . . . 62.25 109.147 173.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.415 ' HA ' ' HD2' ' A' ' 90' ' ' ARG . 13.6 tpt180 -133.68 154.16 51.14 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.818 -0.628 . . . . 75.44 109.726 -178.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.9 t70 69.93 -68.18 0.21 Allowed 'General case' 0 N--CA 1.465 0.317 0 O-C-N 124.082 0.864 . . . . 71.02 111.151 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 177.74 23.62 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.736 -0.745 . . . . 75.32 113.433 178.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.436 ' HA ' HE21 ' A' ' 93' ' ' GLN . 0.0 OUTLIER -138.1 152.5 48.83 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 122.265 -0.55 . . . . 73.12 110.264 178.351 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -89.61 94.58 9.91 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.761 -0.459 . . . . 75.0 109.761 176.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.464 ' HG2' ' OD1' ' A' ' 97' ' ' ASN . 7.3 tt0 -97.31 109.29 22.08 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.137 0.494 . . . . 55.53 109.692 -179.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.526 ' HB3' ' HB ' ' A' ' 109' ' ' ILE . 29.0 tp -90.11 98.64 11.89 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.868 -0.605 . . . . 75.11 110.389 -177.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.475 ' OD1' HG21 ' A' ' 108' ' ' THR . 6.5 m-20 -90.61 93.44 9.27 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.283 0.564 . . . . 73.45 110.532 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.443 ' CG1' ' HD1' ' A' ' 83' ' ' TYR . 56.1 t -92.8 114.18 29.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.658 -0.701 . . . . 72.02 110.677 178.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.558 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 30.7 m -103.32 109.23 20.77 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.845 -0.616 . . . . 64.32 110.077 178.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.578 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 25.2 t70 -62.32 141.23 58.4 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.489 -0.323 . . . . 63.4 110.777 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.07 -26.69 19.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.259 -0.428 . . . . 73.23 110.251 -177.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 32.7 mtmm -70.04 -69.58 0.34 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.374 -0.375 . . . . 73.34 111.149 -174.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 12.0 t -99.05 -26.8 14.11 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.243 0.544 . . . . 74.11 109.716 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.578 ' HA2' ' O ' ' A' ' 100' ' ' ASP . . . 83.65 79.45 1.06 Allowed Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.544 -0.753 . . . . 65.24 112.909 176.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.447 ' H ' ' HB3' ' A' ' 100' ' ' ASP . 68.6 mm-40 -124.69 144.16 50.36 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.587 -0.523 . . . . 74.43 109.587 174.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.9 m -89.05 96.11 10.59 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.123 0.487 . . . . 62.24 110.724 -178.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.419 ' HB3' ' HB ' ' A' ' 98' ' ' VAL . 47.4 t -88.17 80.83 7.51 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.454 -0.573 . . . . 71.15 109.454 177.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.475 HG21 ' OD1' ' A' ' 97' ' ' ASN . 28.2 m -82.35 101.49 10.62 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.901 -0.591 . . . . 73.23 110.709 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.526 ' HB ' ' HB3' ' A' ' 96' ' ' LEU . 54.5 mt -99.88 92.34 2.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.052 -0.522 . . . . 75.24 110.514 -178.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -72.56 106.91 4.81 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.723 -0.473 . . . . 61.1 109.723 175.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.2 t -76.23 104.75 4.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.688 -0.486 . . . . 75.11 109.688 177.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.3 t -147.86 125.46 11.77 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.749 -0.659 . . . . 73.52 110.31 -178.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 92.77 52.7 2.07 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.915 -0.66 . . . . 75.51 113.035 175.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 77.4 mt -106.16 -75.81 0.62 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.011 -0.366 . . . . 75.43 110.011 174.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 66.38 15.33 10.06 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.605 -0.725 . . . . 73.22 111.202 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -100.78 93.49 5.58 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.632 0.729 . . . . 73.42 109.705 173.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -105.26 101.74 11.27 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.496 -0.775 . . . . 63.43 110.547 -176.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 38.3 m -83.3 101.8 11.53 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.306 -0.628 . . . . 75.22 109.306 174.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -57.8 120.27 8.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.983 -0.553 . . . . 74.32 110.587 -177.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -120.92 116.21 24.69 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.84 -0.618 . . . . 75.14 110.352 -177.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -141.08 95.32 2.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.21 -0.45 . . . . 75.24 110.494 178.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 26.0 m80 63.95 -168.96 0.2 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.884 -0.598 . . . . 74.34 111.325 175.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 37.8 m80 58.42 46.71 14.8 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.811 -0.632 . . . . 71.55 110.991 176.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -84.09 11.36 8.14 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.681 -0.69 . . . . 75.21 111.035 -177.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 23.7 t-80 -139.57 109.64 6.44 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.221 -0.445 . . . . 74.34 109.879 175.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -147.14 139.2 24.45 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.692 -0.685 . . . . 73.13 109.998 176.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.619 -0.705 . . . . 63.31 109.56 -176.022 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 N--CA 1.482 1.126 0 N-CA-C 109.957 -0.386 . . . . 75.5 109.957 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -143.17 129.1 19.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.067 0.461 . . . . 74.23 111.171 -178.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -146.39 94.44 0.16 Allowed Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 110.812 -0.915 . . . . 65.14 110.812 178.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 14.4 p -73.0 -70.5 0.35 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 111.721 0.267 . . . . 73.31 111.721 -173.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 82.3 mtp 59.53 -169.65 0.14 Allowed 'General case' 0 N--CA 1.465 0.312 0 O-C-N 123.559 0.537 . . . . 75.43 110.829 -177.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 76.9 p 52.98 92.76 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.666 0.786 . . . . 74.21 112.574 176.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -76.08 145.82 39.81 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.148 -0.478 . . . . 75.04 109.718 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -148.71 94.77 2.32 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.422 0.629 . . . . 73.41 111.165 178.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -167.14 151.56 6.98 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.174 -0.921 . . . . 73.24 109.476 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 -108.57 -76.45 0.61 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.476 -0.329 . . . . 74.31 110.682 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 53.83 65.17 5.75 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-N 115.407 -0.815 . . . . 70.54 110.94 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -76.18 -32.89 3.82 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.903 2.402 . . . . 71.33 112.469 -175.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.7 m120 67.7 113.79 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 O-C-N 123.799 0.687 . . . . 75.43 111.328 -174.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -145.35 175.53 10.23 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.566 -0.743 . . . . 75.23 109.598 -178.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 107.44 -154.27 16.64 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.606 -0.807 . . . . 71.23 112.036 -178.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.63 94.96 1.32 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.885 -0.674 . . . . 73.33 111.707 -178.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -91.76 144.27 29.15 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-O 120.57 0.224 . . . . 72.14 110.675 -176.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.55 149.99 27.6 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.501 2.134 . . . . 61.41 112.253 176.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -141.23 98.55 3.39 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.469 -0.567 . . . . 74.52 109.469 175.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -134.1 145.45 49.36 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.981 -0.554 . . . . 74.24 110.338 -178.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -163.51 -171.31 29.59 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 111.059 -0.817 . . . . 62.44 111.059 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -152.14 104.53 2.97 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 117.029 0.414 . . . . 64.1 111.332 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -112.42 119.51 38.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.099 -0.5 . . . . 75.42 109.657 175.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.478 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 5.4 mp -127.66 171.89 11.26 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 110.043 -0.354 . . . . 72.34 110.043 -179.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 24' ' ' LEU . 0.5 OUTLIER 47.49 -167.89 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.44 1.096 . . . . 74.5 112.814 -179.758 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 29.1 p-10 -166.37 166.79 16.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.904 -0.589 . . . . 74.45 109.686 177.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 10.4 p -119.19 159.14 24.58 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.41 -0.359 . . . . 72.43 110.336 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -155.05 135.16 13.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.403 -0.362 . . . . 74.12 110.841 -178.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -112.43 -83.79 0.59 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.16 -0.473 . . . . 75.1 110.88 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -176.64 175.31 1.72 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.909 -0.587 . . . . 75.25 109.49 -177.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -111.96 134.27 53.63 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.73 0.3 . . . . 75.53 110.388 176.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -70.91 101.09 2.08 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.405 -0.591 . . . . 64.01 109.405 175.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.8 p -145.71 -177.92 5.83 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.319 -0.401 . . . . 74.21 111.103 -173.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.494 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 57.3 m-85 -112.44 27.84 9.29 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.65 -0.5 . . . . 74.43 109.65 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 34' ' ' TYR . 0.3 OUTLIER 70.97 16.35 6.5 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.663 -0.698 . . . . 71.43 109.426 -174.533 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.447 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 5.6 p-10 -74.7 149.57 86.0 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 114.782 -1.099 . . . . 74.53 111.537 -177.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.736 ' HD2' ' HA2' ' A' ' 44' ' ' GLY . 4.1 Cg_exo -77.17 173.84 13.74 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.886 2.391 . . . . 70.22 111.368 173.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.6 t -168.21 146.78 4.43 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.639 -0.504 . . . . 73.21 109.639 -174.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 16.8 t80 69.3 162.52 0.22 Allowed 'General case' 0 CA--C 1.532 0.266 0 O-C-N 123.879 0.737 . . . . 74.42 110.446 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 59.94 57.49 3.06 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.428 -0.351 . . . . 75.2 110.489 -178.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 46.95 24.62 0.38 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.553 1.141 . . . . 75.34 113.466 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -121.55 123.16 41.33 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.588 -0.523 . . . . 70.12 109.588 173.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -130.57 32.05 4.46 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.381 -0.599 . . . . 75.22 109.381 -179.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.736 ' HA2' ' HD2' ' A' ' 37' ' ' PRO . . . 117.75 35.75 1.04 Allowed Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 115.462 -0.79 . . . . 74.52 111.892 -179.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 59.7 mt -84.45 -48.47 16.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.453 -0.573 . . . . 75.24 109.453 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.537 ' HB2' ' HG3' ' A' ' 37' ' ' PRO . 62.9 mm-40 -67.5 123.87 21.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.906 -0.588 . . . . 65.32 109.755 173.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.3 m -124.24 89.12 52.27 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.106 -0.497 . . . . 73.11 110.742 -175.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -61.67 107.21 0.49 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.881 2.387 . . . . 73.11 112.385 -177.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.7 m -140.43 -36.9 0.47 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.965 -0.562 . . . . 73.25 110.371 175.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -92.45 -33.72 14.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.296 0.569 . . . . 71.23 110.604 176.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -101.47 0.0 35.95 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.839 -0.619 . . . . 73.42 110.665 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -62.38 -62.9 1.44 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.738 -0.664 . . . . 72.13 111.671 -173.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -69.26 -18.24 63.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.235 0.54 . . . . 73.01 110.085 -177.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -73.37 -58.15 3.51 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.553 -0.749 . . . . 74.25 110.658 178.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.412 ' HA ' HG13 ' A' ' 58' ' ' ILE . 6.5 t -70.3 -18.97 63.11 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.229 0.538 . . . . 75.41 110.461 -178.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -61.82 -35.51 78.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.479 -0.782 . . . . 63.02 109.978 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.98 -19.96 31.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.893 -0.594 . . . . 74.22 110.983 -179.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.429 ' O ' HG13 ' A' ' 62' ' ' ILE . 24.7 mt -71.74 -27.7 28.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.052 -0.522 . . . . 75.44 110.891 -177.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -54.88 -35.72 64.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.442 -0.344 . . . . 74.14 111.239 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.9 m -62.43 -50.41 71.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.989 0.424 . . . . 73.34 110.975 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -74.45 -17.23 60.81 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.32 -0.4 . . . . 71.1 110.846 -177.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.545 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 74.5 mt -72.8 -50.17 35.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.522 -0.547 . . . . 75.12 109.522 173.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 95.5 mt -60.45 -42.04 95.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.881 -0.599 . . . . 74.53 110.356 177.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -59.72 -43.85 97.46 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.852 -0.613 . . . . 74.2 112.215 176.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -65.22 -35.49 91.68 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 121.24 -0.505 . . . . 72.43 112.432 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 62' ' ' ILE . 98.0 mt -61.66 -52.12 65.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.674 0.273 . . . . 72.23 110.595 178.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.6 mt -68.7 -31.67 70.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.001 -0.545 . . . . 71.34 111.048 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.492 ' OG ' ' HG2' ' A' ' 74' ' ' LYS . 38.3 t -56.5 -49.63 74.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.785 -0.643 . . . . 75.11 110.908 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -72.49 -19.67 61.5 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.234 -0.439 . . . . 72.41 111.768 -177.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 66' ' ' LEU . 46.4 mm -75.89 -36.12 31.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.13 0.49 . . . . 73.52 110.154 177.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -71.3 -57.84 4.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.732 -0.667 . . . . 62.21 110.707 -177.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.3 m -157.09 156.72 33.27 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.454 -0.339 . . . . 70.33 110.373 -176.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -70.64 64.07 0.85 Allowed Glycine 0 C--N 1.332 0.344 0 N-CA-C 111.685 -0.566 . . . . 71.02 111.685 172.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.492 ' HG2' ' OG ' ' A' ' 68' ' ' SER . 2.1 pptp? -56.45 157.95 8.78 Favored Pre-proline 0 C--N 1.324 -0.524 0 C-N-CA 124.142 0.977 . . . . 75.21 113.283 -175.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.41 159.73 36.0 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 123.093 2.529 . . . . 73.53 111.037 171.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -85.82 -165.31 40.45 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 120.86 -0.686 . . . . 72.12 112.686 -178.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 77' ' ' ARG . 5.7 ptp85 -99.64 127.04 45.75 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 122.559 -0.377 . . . . 72.11 110.245 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 27.1 ttt -82.26 107.35 14.87 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.975 0.416 . . . . 73.31 110.42 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 45.4 t -76.71 105.92 6.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.875 -0.602 . . . . 64.42 109.728 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.521 ' HB ' ' O ' ' A' ' 83' ' ' TYR . 5.3 m -82.25 160.06 23.05 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.622 -0.717 . . . . 50.13 110.262 -178.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -54.48 -60.49 3.28 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.136 0.493 . . . . 72.31 111.33 -177.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.814 ' HB3' ' HD3' ' A' ' 101' ' ' ARG . 1.6 m-20 -110.43 -38.56 5.19 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.811 -0.631 . . . . 75.51 111.243 -175.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.521 ' O ' ' HB ' ' A' ' 80' ' ' THR . 17.6 m-85 -78.95 142.25 36.84 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.911 -0.586 . . . . 74.53 111.662 -177.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.557 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 49.9 mm -93.58 89.92 2.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.909 -0.587 . . . . 71.04 110.087 175.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.481 HG21 HG23 ' A' ' 98' ' ' VAL . 93.9 t -95.49 117.79 40.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.762 -0.653 . . . . 64.33 110.127 178.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -118.61 119.25 33.94 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.063 0.459 . . . . 74.51 110.447 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 52.4 mt -96.55 94.66 4.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.79 -0.641 . . . . 73.15 109.401 178.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.538 ' HB3' ' HB2' ' A' ' 95' ' ' GLN . . . -92.11 100.38 13.02 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.179 -0.464 . . . . 75.04 110.996 -177.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -96.24 108.16 20.6 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.956 -0.565 . . . . 62.25 110.334 176.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 -136.99 131.7 33.28 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.133 -0.485 . . . . 75.44 110.252 176.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 61.45 19.99 10.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.974 -0.557 . . . . 71.02 111.35 175.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.26 -6.95 78.53 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.971 -0.633 . . . . 75.32 112.427 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.448 ' HA ' HE21 ' A' ' 93' ' ' GLN . 0.1 OUTLIER -90.75 126.82 36.12 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.194 -0.299 . . . . 73.12 110.194 -179.889 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -93.8 107.29 19.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.205 -0.452 . . . . 75.0 110.122 177.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.538 ' HB2' ' HB3' ' A' ' 88' ' ' ALA . 45.1 mt-30 -99.73 95.66 7.08 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.893 0.378 . . . . 55.53 110.269 175.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 50.3 tp -84.38 94.0 8.4 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.835 -0.62 . . . . 75.11 109.429 177.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -107.56 127.28 53.49 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.316 0.579 . . . . 73.45 110.43 -176.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.481 HG23 HG21 ' A' ' 85' ' ' VAL . 85.2 t -118.39 131.65 70.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.637 -0.71 . . . . 72.02 110.483 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.557 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 15.5 m -104.72 112.64 25.81 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.385 -0.825 . . . . 64.32 108.974 172.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -66.27 153.72 41.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.315 0.578 . . . . 63.4 111.966 -175.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.814 ' HD3' ' HB3' ' A' ' 82' ' ' ASP . 35.8 ptt180 -82.81 -30.39 28.82 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.122 -0.945 . . . . 73.23 111.821 -175.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.64 ' HG3' ' HG3' ' A' ' 101' ' ' ARG . 47.1 mttm -105.26 -62.83 1.3 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.218 0.532 . . . . 73.34 111.473 -172.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.493 ' OG1' ' HG2' ' A' ' 105' ' ' GLN . 42.9 p -78.58 -19.69 52.21 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.734 -0.666 . . . . 74.11 109.921 -177.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 70.08 26.01 74.86 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.354 -0.839 . . . . 65.24 112.413 177.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.493 ' HG2' ' OG1' ' A' ' 103' ' ' THR . 27.3 mm-40 -66.91 125.55 26.29 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.991 -0.374 . . . . 74.43 109.991 177.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.9 m -102.12 92.23 4.67 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.055 -0.72 . . . . 62.24 109.055 175.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.8 t -100.25 121.87 42.16 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.196 -0.456 . . . . 71.15 110.124 -176.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 26.8 m -102.95 102.17 12.22 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.159 -0.473 . . . . 73.23 110.442 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 54.5 mt -93.09 92.25 3.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.458 -0.571 . . . . 75.24 109.458 177.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -89.4 131.2 35.58 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.202 -0.454 . . . . 61.1 110.293 -178.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 46.5 t -78.02 81.37 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.34 0.591 . . . . 75.11 109.743 175.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 21.9 t -161.79 140.39 9.42 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.304 -0.862 . . . . 73.52 109.157 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -89.51 0.37 80.42 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.397 -0.906 . . . . 75.51 111.933 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 96.2 mt -99.37 67.66 1.57 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.936 0.398 . . . . 75.43 111.006 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -92.22 82.21 5.0 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.514 -0.55 . . . . 73.22 109.514 175.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -116.0 -40.91 3.24 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.004 -0.544 . . . . 73.42 110.567 -176.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -67.43 127.92 34.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.05 -0.523 . . . . 63.43 109.779 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 23.1 t -63.96 100.27 0.3 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.167 0.508 . . . . 75.22 110.477 -178.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 27.1 m -96.61 105.91 18.09 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.541 -0.754 . . . . 74.32 109.883 -178.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -142.77 132.58 24.07 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.749 -0.66 . . . . 75.14 109.589 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -128.04 74.5 1.54 Allowed 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.546 -0.539 . . . . 75.24 109.546 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -66.17 110.82 3.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.813 -0.63 . . . . 74.34 110.857 178.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 42.5 p-80 -128.03 110.48 12.54 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.223 -0.899 . . . . 71.55 109.901 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -77.34 74.85 3.9 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.461 0.648 . . . . 75.21 109.996 -178.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -150.07 130.21 13.58 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.406 -0.816 . . . . 74.34 109.848 -178.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 64.1 t-80 -137.44 149.31 46.78 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.725 -0.472 . . . . 73.13 109.725 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 48.5 t60 . . . . . 0 C--O 1.246 0.872 0 CA-C-O 118.23 -0.891 . . . . 63.31 109.563 176.353 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 N--CA 1.484 1.225 0 N-CA-C 110.338 -0.245 . . . . 75.5 110.338 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.29 172.93 12.44 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.513 -0.312 . . . . 74.23 110.293 -178.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 143.06 -97.36 0.2 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.995 -0.622 . . . . 65.14 111.733 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.4 m 57.14 44.84 21.72 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.234 0.54 . . . . 73.31 110.91 178.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 47.9 ttm 56.03 62.95 2.17 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.489 0.662 . . . . 75.43 110.265 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.2 t -86.92 -12.9 46.3 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.965 -0.561 . . . . 74.21 110.392 -177.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 69.21 164.17 0.24 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.588 -0.733 . . . . 75.04 112.062 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.541 HE21 ' HB2' ' A' ' 10' ' ' ARG . 27.9 tt0 -154.74 -46.1 0.09 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.207 -0.906 . . . . 73.41 109.641 179.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 60.3 85.54 0.11 Allowed 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 115.306 -0.861 . . . . 73.24 111.238 -178.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.541 ' HB2' HE21 ' A' ' 8' ' ' GLN . 8.2 tpt180 -116.65 132.17 56.76 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.062 -0.718 . . . . 74.31 109.062 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -130.48 86.81 52.14 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-O 120.769 0.318 . . . . 70.54 110.718 -176.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -73.8 156.28 48.53 Favored 'Trans proline' 0 C--O 1.238 0.486 0 C-N-CA 122.646 2.231 . . . . 71.33 112.112 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 71.99 153.44 0.13 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.549 -0.751 . . . . 75.43 110.791 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -97.02 168.18 10.62 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.959 0.409 . . . . 75.23 111.423 -174.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -96.39 74.9 0.76 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.933 -0.651 . . . . 71.23 111.832 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -126.83 41.3 1.64 Allowed Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.717 -0.754 . . . . 73.33 112.462 -178.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 66.73 156.91 0.13 Allowed Pre-proline 0 N--CA 1.468 0.444 0 C-N-CA 123.364 0.666 . . . . 72.14 111.512 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -74.55 64.51 5.62 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.619 2.213 . . . . 61.41 112.288 177.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -162.83 101.96 1.01 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.717 -0.674 . . . . 74.52 110.237 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -151.87 -51.6 0.12 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.206 -0.452 . . . . 74.24 110.153 177.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 160.8 101.05 0.16 Allowed Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 111.186 -0.766 . . . . 62.44 111.186 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -139.09 -15.97 1.1 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 111.832 0.308 . . . . 64.1 111.832 -174.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 58.26 66.2 1.14 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.341 0.591 . . . . 75.42 109.899 -174.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.0 tp -87.45 94.63 9.75 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.843 -0.617 . . . . 72.34 110.07 -178.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 90.0 mt -118.76 -66.85 1.03 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.929 -0.578 . . . . 74.5 110.428 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 58.0 t30 57.48 76.17 0.33 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.648 -0.705 . . . . 74.45 110.072 -174.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 49.1 m -77.44 84.72 3.84 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.706 -0.679 . . . . 72.43 110.951 -176.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.62 173.59 6.27 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.431 -0.804 . . . . 74.12 109.698 174.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 21.7 tp60 -81.25 -45.82 15.71 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 121.08 -0.248 . . . . 75.1 110.889 -177.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 67.94 166.32 0.24 Allowed 'General case' 0 N--CA 1.466 0.345 0 O-C-N 123.834 0.709 . . . . 75.25 111.644 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -112.52 -85.37 0.58 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.1 -0.5 . . . . 75.53 110.809 -178.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.496 HD21 ' HA ' ' A' ' 35' ' ' LYS . 64.4 t30 59.71 -174.46 0.11 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.709 -0.678 . . . . 64.01 110.412 -177.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.423 ' H ' ' CG ' ' A' ' 32' ' ' ASN . 24.6 m -123.36 101.05 7.14 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 122.069 -0.395 . . . . 74.21 110.699 178.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.739 ' O ' ' HD3' ' A' ' 35' ' ' LYS . 16.9 t80 67.1 27.41 8.61 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 115.821 -0.627 . . . . 74.43 109.655 175.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.739 ' HD3' ' O ' ' A' ' 34' ' ' TYR . 0.0 OUTLIER 49.85 12.57 0.08 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.488 1.515 . . . . 71.43 113.689 179.602 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -120.62 161.93 37.12 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 109.256 -0.646 . . . . 74.53 109.256 175.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.734 ' HB3' ' HB2' ' A' ' 42' ' ' ASP . 76.6 Cg_exo -52.51 144.47 41.17 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.743 2.295 . . . . 70.22 112.673 178.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.9 m -85.33 -80.49 0.21 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.248 -0.433 . . . . 73.21 112.012 -175.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -164.83 165.71 20.3 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 121.249 -0.18 . . . . 74.42 111.466 -174.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 59.52 89.07 0.07 Allowed 'General case' 0 N--CA 1.47 0.55 0 O-C-N 124.112 0.883 . . . . 75.2 112.218 175.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.7 t70 54.84 83.93 0.08 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.497 0.665 . . . . 75.34 110.693 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.734 ' HB2' ' HB3' ' A' ' 37' ' ' PRO . 1.3 p30 -105.45 -82.82 0.52 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.716 -0.674 . . . . 70.12 111.503 -176.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 55.73 30.56 15.83 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.037 0.446 . . . . 75.22 111.886 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -92.81 12.68 69.34 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.693 -0.765 . . . . 74.52 111.838 178.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.452 HG13 ' HG2' ' A' ' 37' ' ' PRO . 48.2 mt -86.32 -36.39 10.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.089 0.471 . . . . 75.24 110.369 -178.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -81.47 -0.43 41.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.782 -0.644 . . . . 65.32 111.807 -176.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 33.4 m -116.17 86.06 16.56 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 109.489 -0.56 . . . . 73.11 109.489 174.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -61.48 104.76 0.32 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.107 2.538 . . . . 73.11 112.292 -175.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.1 p -134.29 -75.61 0.47 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.538 -0.755 . . . . 73.25 110.356 178.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.54 -37.26 71.16 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.936 0.398 . . . . 71.23 110.63 177.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.7 pp -97.56 9.92 41.21 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.826 -0.625 . . . . 73.42 110.797 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.442 ' O ' ' HB2' ' A' ' 56' ' ' GLN . 32.7 t70 -59.09 -52.92 63.67 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.813 -0.631 . . . . 72.13 111.165 -176.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -62.37 -40.48 96.58 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.942 -0.572 . . . . 73.01 110.374 -176.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.566 ' O ' HG13 ' A' ' 58' ' ' ILE . 76.7 t80 -60.11 -63.81 1.17 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.728 -0.669 . . . . 74.25 111.826 -178.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.8 t -69.08 -19.54 64.07 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.876 0.325 . . . . 75.41 111.876 -172.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.442 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 2.7 mp0 -82.38 -36.26 26.95 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.741 0.305 . . . . 63.02 110.498 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.96 -30.69 71.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 74.22 110.474 176.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.707 ' O ' ' HG2' ' A' ' 61' ' ' GLN . 10.6 mt -70.09 -46.16 73.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.028 -0.533 . . . . 75.44 110.38 177.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -66.06 -18.88 65.63 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.167 0.508 . . . . 74.14 110.456 178.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 66.1 m -84.19 -3.26 58.04 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.074 -0.512 . . . . 73.34 111.61 177.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.707 ' HG2' ' O ' ' A' ' 58' ' ' ILE . 2.4 pt20 -105.96 -2.13 23.22 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.149 0.499 . . . . 71.1 110.089 177.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 51.6 mm -76.48 -30.53 19.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.818 -0.628 . . . . 75.12 110.886 -176.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.664 ' H ' HD23 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -61.13 -43.85 98.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.082 -0.508 . . . . 74.53 110.198 -177.245 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -83.98 -31.86 25.09 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.954 -0.641 . . . . 74.2 111.604 176.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.82 -24.26 66.37 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 121.405 -0.426 . . . . 72.43 112.833 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.426 ' O ' HG12 ' A' ' 70' ' ' ILE . 9.7 tt -55.58 -40.9 72.6 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.826 -0.435 . . . . 72.23 109.826 176.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.7 mp -80.53 13.2 2.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.042 -0.526 . . . . 71.34 111.223 -178.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.406 ' HA ' ' ND2' ' A' ' 71' ' ' ASN . 26.2 t -115.97 -21.01 9.7 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.189 0.518 . . . . 75.11 109.664 174.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -83.77 -26.78 29.37 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.954 -0.566 . . . . 72.41 110.489 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.426 HG12 ' O ' ' A' ' 66' ' ' LEU . 35.8 mm -84.34 -4.8 8.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.805 -0.634 . . . . 73.52 110.634 -177.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.468 ' C ' ' HG1' ' A' ' 72' ' ' THR . 94.5 m-20 -80.21 7.27 9.74 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.34 -0.391 . . . . 62.21 111.696 -177.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.468 ' HG1' ' C ' ' A' ' 71' ' ' ASN . 67.9 p 53.3 -163.61 0.09 Allowed 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.291 0.636 . . . . 70.33 111.711 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.417 ' HA3' HD12 ' A' ' 94' ' ' LEU . . . 122.19 -63.13 0.53 Allowed Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.784 -0.722 . . . . 71.02 111.333 178.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 1.111 ' HB3' ' HB ' ' A' ' 87' ' ' ILE . 14.4 pttm -57.48 143.43 74.68 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-O 120.55 0.214 . . . . 75.21 110.99 172.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -81.72 -10.82 11.71 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.4 2.066 . . . . 73.53 111.231 173.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 165.0 150.03 6.04 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 114.836 -1.075 . . . . 72.12 110.84 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 11.9 ptp85 -97.04 171.71 8.3 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.901 -0.407 . . . . 72.11 109.901 177.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 51.8 ttm -125.72 113.45 17.35 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.1 0.476 . . . . 73.31 110.227 175.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 23.6 t -95.27 83.95 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.823 -0.626 . . . . 64.42 109.873 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.81 -179.15 5.81 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.721 -0.672 . . . . 50.13 110.036 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -74.18 -51.88 14.16 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.727 0.299 . . . . 72.31 110.632 -177.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -122.76 19.02 10.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.802 0.334 . . . . 75.51 111.721 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -135.14 111.56 9.81 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.951 0.405 . . . . 74.53 111.0 177.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.41 ' N ' HD13 ' A' ' 84' ' ' ILE . 4.2 mp -99.97 105.56 17.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.834 -0.621 . . . . 71.04 109.477 177.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.447 ' HB ' HG23 ' A' ' 98' ' ' VAL . 6.3 p -117.78 121.63 67.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.24 0.543 . . . . 64.33 110.547 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -138.38 134.7 34.49 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.591 -0.731 . . . . 74.51 110.27 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 1.111 ' HB ' ' HB3' ' A' ' 74' ' ' LYS . 54.0 mt -89.92 101.41 12.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.112 -0.495 . . . . 73.15 110.102 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -90.85 156.43 18.03 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.972 -0.558 . . . . 75.04 110.038 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.538 ' HA ' ' O ' ' A' ' 93' ' ' GLN . 47.7 t-20 -127.53 127.28 43.69 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.016 0.436 . . . . 62.25 110.249 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -133.69 115.51 14.69 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.872 -0.604 . . . . 75.44 110.069 175.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 62.47 29.69 17.14 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.142 -0.481 . . . . 71.02 111.451 175.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.39 28.27 33.67 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.713 -0.756 . . . . 75.32 112.531 178.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.538 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 26.4 mm-40 -119.53 123.36 43.79 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.798 -0.445 . . . . 73.12 109.798 175.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.421 ' N ' HD22 ' A' ' 94' ' ' LEU . 4.0 mm? -93.34 122.93 36.25 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.052 -0.522 . . . . 75.0 109.621 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.875 ' HG2' ' HG2' ' A' ' 110' ' ' GLN . 24.0 mt-30 -118.18 106.73 13.14 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.165 -0.471 . . . . 55.53 111.714 -177.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 54.1 tp -78.09 86.95 4.23 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.252 -1.018 . . . . 75.11 108.252 172.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -113.1 111.55 22.31 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.987 -0.551 . . . . 73.45 110.83 -172.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.447 HG23 ' HB ' ' A' ' 85' ' ' VAL . 7.2 p -107.39 135.23 46.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.51 -0.768 . . . . 72.02 110.718 -177.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 29.1 m -116.72 124.41 49.6 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.145 -0.48 . . . . 64.32 110.815 178.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.431 ' HB3' ' H ' ' A' ' 105' ' ' GLN . 11.2 t0 -71.64 137.21 47.72 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.224 -0.658 . . . . 63.4 109.224 175.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.584 ' O ' ' HD2' ' A' ' 101' ' ' ARG . 3.5 tmm_? -82.16 -28.37 32.16 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.897 0.379 . . . . 73.23 110.554 -176.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt -103.57 -49.46 3.68 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.164 -0.471 . . . . 73.34 111.114 -174.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.584 ' HB ' ' HG2' ' A' ' 105' ' ' GLN . 0.2 OUTLIER -88.23 -14.64 37.98 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.748 -0.66 . . . . 74.11 110.899 -175.292 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 67.34 17.09 68.0 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.87 -0.605 . . . . 65.24 113.362 178.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.584 ' HG2' ' HB ' ' A' ' 103' ' ' THR . 30.7 mm-40 -62.57 123.84 19.41 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.135 -0.32 . . . . 74.43 110.135 176.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 20.8 m -110.22 97.34 6.84 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.031 -0.531 . . . . 62.24 109.889 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.0 t -103.37 104.28 14.37 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.161 -0.472 . . . . 71.15 109.935 -177.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 28.7 m -101.1 103.15 14.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.894 -0.594 . . . . 73.23 111.182 -178.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 4.4 mp -98.5 97.8 6.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.071 0.462 . . . . 75.24 109.882 176.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.875 ' HG2' ' HG2' ' A' ' 95' ' ' GLN . 69.4 mt-30 -75.62 166.64 23.25 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.144 -0.48 . . . . 61.1 110.334 177.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.9 p -55.76 101.4 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.569 0.699 . . . . 75.11 110.331 173.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 6.5 m -129.52 -5.04 4.75 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.711 -0.677 . . . . 73.52 110.428 -176.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -81.91 -84.98 0.76 Allowed Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 120.858 -0.687 . . . . 75.51 112.579 -175.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 89.2 mt 66.94 -81.37 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 108.856 -0.794 . . . . 75.43 108.856 -173.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 42.73 53.29 4.89 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 124.327 1.017 . . . . 73.22 112.442 166.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -64.51 101.62 0.47 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.249 0.547 . . . . 73.42 109.878 -178.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -80.77 118.72 22.55 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.317 -0.856 . . . . 63.43 109.629 -176.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.1 m -132.43 174.82 9.86 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.601 0.238 . . . . 75.22 110.783 -176.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 4.6 m 70.61 20.83 5.63 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.761 0.791 . . . . 74.32 110.48 178.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -101.02 96.85 7.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.834 -0.621 . . . . 75.14 109.351 173.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -95.72 103.63 15.52 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.329 0.585 . . . . 75.24 110.146 -177.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -119.77 93.98 4.25 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.308 -0.86 . . . . 74.34 109.237 -175.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -145.14 94.51 2.54 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.532 0.682 . . . . 71.55 111.823 -177.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -125.0 -174.73 3.11 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.413 -0.812 . . . . 75.21 109.503 173.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 63.15 37.5 11.35 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 107.874 -1.158 . . . . 74.34 107.874 -170.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -103.47 132.89 49.34 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 114.562 -1.199 . . . . 73.13 110.708 -175.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 . . . . . 0 C--O 1.245 0.834 0 N-CA-C 109.032 -0.729 . . . . 63.31 109.032 178.228 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.3 mtt . . . . . 0 N--CA 1.479 0.982 0 N-CA-C 110.166 -0.309 . . . . 75.5 110.166 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 58.81 -161.0 0.26 Allowed 'General case' 0 C--O 1.235 0.311 0 O-C-N 123.636 0.585 . . . . 74.23 111.008 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 94.8 -12.0 69.11 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.821 -0.704 . . . . 65.14 112.572 177.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.8 m 58.55 83.3 0.12 Allowed 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.549 0.69 . . . . 73.31 110.935 -179.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 12.7 tpt -92.03 151.6 20.38 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.654 -0.703 . . . . 75.43 110.403 -177.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 25.3 m 68.8 97.03 0.06 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.821 -0.627 . . . . 74.21 111.091 178.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -68.19 114.38 6.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.139 -0.482 . . . . 75.04 109.931 177.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.1 tm0? -85.01 -34.86 22.26 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.98 -0.554 . . . . 73.41 109.959 -175.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 19.3 t80 55.9 30.73 16.49 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.703 -0.68 . . . . 73.24 111.658 173.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 37.3 mtt180 53.18 54.62 10.01 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.188 0.518 . . . . 74.31 112.397 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.405 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 34.5 m-80 -93.26 145.33 29.83 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 109.285 -0.635 . . . . 70.54 109.285 173.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 11' ' ' ASN . 37.3 Cg_exo -59.98 -36.89 88.43 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.61 2.207 . . . . 71.33 112.617 -175.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.27 153.96 0.06 Allowed 'General case' 0 N--CA 1.473 0.693 0 O-C-N 124.183 0.927 . . . . 75.43 110.697 -177.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -122.53 137.17 54.97 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 121.925 -0.485 . . . . 75.23 110.563 -178.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.19 131.39 7.44 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.843 -0.617 . . . . 71.23 111.701 178.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.66 157.31 34.17 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.827 -0.701 . . . . 73.33 112.174 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -113.54 151.11 44.23 Favored Pre-proline 0 C--N 1.321 -0.646 0 N-CA-C 110.243 -0.28 . . . . 72.14 110.243 -177.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -67.46 -19.5 48.97 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 122.713 2.275 . . . . 61.41 111.934 175.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.6 t30 72.06 -61.78 0.48 Allowed 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.956 0.902 . . . . 74.52 110.574 178.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -118.66 -63.0 1.46 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.947 -0.57 . . . . 74.24 109.777 175.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -164.29 40.13 0.31 Allowed Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 111.034 -0.826 . . . . 62.44 111.034 177.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 65.4 26.2 11.97 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 122.765 0.426 . . . . 64.1 110.872 -178.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 83.9 t80 66.11 102.67 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.187 -0.915 . . . . 75.42 111.262 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 92.9 mt -123.7 -172.97 2.64 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.712 -0.677 . . . . 72.34 110.083 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 45.47 88.26 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.124 0.969 . . . . 74.5 112.391 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -68.19 159.57 30.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.232 -0.894 . . . . 74.45 110.794 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 51.9 m -77.86 87.1 4.08 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.151 0.5 . . . . 72.43 112.131 -174.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.17 112.11 17.17 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.111 -1.07 . . . . 74.12 108.111 167.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -75.2 99.53 4.03 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.561 0.696 . . . . 75.1 111.771 -172.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -176.53 179.97 1.09 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 113.999 -1.455 . . . . 75.25 107.759 176.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -87.72 93.78 9.55 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.085 -0.709 . . . . 75.53 109.085 174.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -79.05 83.42 5.13 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.649 -0.705 . . . . 64.01 111.204 -172.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.9 m -86.6 104.79 16.37 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.558 -0.746 . . . . 74.21 109.839 176.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -138.71 29.73 2.34 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.375 0.607 . . . . 74.43 109.627 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -96.39 6.05 49.59 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.351 -0.84 . . . . 71.43 109.879 -177.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -88.31 151.31 48.53 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.584 -0.735 . . . . 74.53 111.742 -176.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.611 ' HD3' ' HA3' ' A' ' 44' ' ' GLY . 5.1 Cg_endo -47.46 149.3 4.55 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 124.288 3.325 . . . . 70.22 113.979 175.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.2 t -140.31 107.96 5.62 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.652 -0.704 . . . . 73.21 109.28 177.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.7 t80 60.8 96.84 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 O-C-N 123.825 0.703 . . . . 74.42 111.613 -179.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 65.5 22.69 11.85 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.18 -0.463 . . . . 75.2 111.426 177.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.556 ' HA ' ' HB3' ' A' ' 37' ' ' PRO . 24.2 t70 67.03 140.41 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.835 0.826 . . . . 75.34 111.633 -177.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -122.63 -68.47 0.88 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.668 -0.696 . . . . 70.12 110.309 -176.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -146.3 23.96 1.29 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.474 0.654 . . . . 75.22 109.326 -176.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.611 ' HA3' ' HD3' ' A' ' 37' ' ' PRO . . . -109.76 46.12 1.22 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.694 -0.765 . . . . 74.52 112.888 -172.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 62.0 mt -78.18 -66.49 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 110.058 -0.349 . . . . 75.24 110.058 177.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.477 ' HA ' ' OE1' ' A' ' 46' ' ' GLU . 6.9 mm-40 71.13 -34.36 0.3 Allowed 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.349 0.87 . . . . 65.32 113.349 175.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.415 ' O ' HG23 ' A' ' 47' ' ' THR . 8.5 t -125.1 85.97 57.37 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-O 121.849 0.833 . . . . 73.11 111.055 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.462 ' HB2' ' HB2' ' A' ' 52' ' ' ASP . 11.5 Cg_exo -71.34 116.76 4.83 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.939 2.426 . . . . 73.11 111.951 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 14.6 m -98.6 -69.77 0.75 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.633 -0.258 . . . . 73.25 110.985 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.77 -40.51 18.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.885 0.374 . . . . 71.23 111.248 -176.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -69.8 -16.94 63.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 73.42 110.908 -178.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.506 ' O ' ' HB2' ' A' ' 56' ' ' GLN . 23.1 t70 -57.37 -50.04 74.23 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.112 -0.495 . . . . 72.13 110.779 -178.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -60.31 -43.19 96.59 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.099 -0.5 . . . . 73.01 110.826 178.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.461 ' O ' HG12 ' A' ' 58' ' ' ILE . 80.9 t80 -60.6 -53.35 58.52 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.066 -0.515 . . . . 74.25 111.169 -179.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.2 t -68.99 -30.2 68.56 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.783 0.325 . . . . 75.41 110.784 -177.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.506 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 1.3 tp-100 -64.77 -44.71 89.17 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.145 0.498 . . . . 63.02 110.047 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.47 -32.99 74.84 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.554 -0.748 . . . . 74.22 111.109 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.59 ' O ' ' HG2' ' A' ' 61' ' ' GLN . 47.0 mm -66.13 -37.75 80.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.982 0.42 . . . . 75.44 110.509 177.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -69.48 -38.9 77.89 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.297 -0.41 . . . . 74.14 110.816 178.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 44.8 m -67.96 -32.14 72.35 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.349 -0.387 . . . . 73.34 111.404 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.59 ' HG2' ' O ' ' A' ' 58' ' ' ILE . 2.5 pt20 -78.42 -9.44 59.29 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.642 0.258 . . . . 71.1 111.222 -176.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.518 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 74.3 mt -62.74 -33.07 58.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.934 0.397 . . . . 75.12 110.088 -178.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 92.5 mt -53.49 -36.38 61.62 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.423 -0.808 . . . . 74.53 111.635 -178.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.65 -30.42 5.86 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.708 -0.758 . . . . 74.2 111.967 178.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -58.38 -34.99 77.04 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 121.542 -0.361 . . . . 72.43 112.952 -178.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 62' ' ' ILE . 88.6 mt -56.55 -38.44 71.9 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.873 0.368 . . . . 72.23 111.063 178.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.1 mt -76.54 -39.18 53.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.045 0.45 . . . . 71.34 110.468 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 16.5 m -66.18 -37.95 86.85 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.836 -0.62 . . . . 75.11 111.513 -177.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -76.45 -8.55 57.39 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.966 0.358 . . . . 72.41 111.966 -175.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.468 HG12 ' O ' ' A' ' 66' ' ' LEU . 43.3 mm -73.12 -35.74 48.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-O 121.419 0.628 . . . . 73.52 110.195 176.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -68.5 -31.21 70.31 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.581 -0.736 . . . . 62.21 110.797 -177.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.8 p 58.24 9.99 1.15 Allowed 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.23 1.012 . . . . 70.33 112.15 -176.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -84.36 92.51 1.72 Allowed Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.944 -0.646 . . . . 71.02 111.525 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.449 ' O ' ' HD2' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -55.8 143.2 61.33 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-O 121.071 0.462 . . . . 75.21 111.571 178.961 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -83.28 170.5 11.95 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.731 2.287 . . . . 73.53 112.318 -178.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -147.35 74.53 0.29 Allowed Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 120.597 -0.811 . . . . 72.12 112.361 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.451 ' O ' ' HG3' ' A' ' 77' ' ' ARG . 18.8 ptt85 -81.31 101.02 9.51 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.334 0.587 . . . . 72.11 109.617 174.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 57.6 ttp -106.86 109.31 21.18 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.949 -0.569 . . . . 73.31 110.955 -176.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 48.2 t -70.34 102.94 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.446 -0.576 . . . . 64.42 109.446 176.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.2 m -109.6 159.68 16.9 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.015 -0.538 . . . . 50.13 109.597 -177.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -67.82 -47.07 70.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.06 0.457 . . . . 72.31 110.125 -179.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -72.66 -35.8 67.82 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.843 0.683 . . . . 75.51 112.843 -176.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.635 ' HB3' HG11 ' A' ' 98' ' ' VAL . 55.1 m-85 -157.24 169.08 25.58 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.897 0.379 . . . . 74.53 110.828 -175.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.55 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 40.3 mm -97.98 98.93 7.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.364 -0.606 . . . . 71.04 109.364 169.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 41.3 t -85.31 94.42 3.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.002 -0.544 . . . . 64.33 110.178 -178.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -98.2 102.7 14.52 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.271 0.558 . . . . 74.51 110.385 177.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 63.0 mt -88.7 106.46 16.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.657 -0.701 . . . . 73.15 109.52 175.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -106.32 162.27 13.83 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.269 -0.423 . . . . 75.04 110.214 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -138.33 123.54 19.26 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.843 0.354 . . . . 62.25 110.321 178.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 65.0 mtp180 -138.81 132.61 30.87 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.073 -0.512 . . . . 75.44 109.855 176.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 64.56 17.37 10.83 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 123.629 0.581 . . . . 71.02 111.051 178.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.06 -26.3 25.18 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 121.113 -0.565 . . . . 75.32 112.412 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.53 ' HA ' HE21 ' A' ' 93' ' ' GLN . 0.1 OUTLIER -90.25 140.78 29.35 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.062 0.458 . . . . 73.12 110.886 -175.742 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -81.12 144.75 31.47 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.707 -0.678 . . . . 75.0 110.616 179.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -122.76 107.59 12.09 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.511 -0.551 . . . . 55.53 109.511 175.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 55.7 tp -82.26 98.8 8.96 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.867 -0.606 . . . . 75.11 109.425 179.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -107.69 91.84 3.82 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.317 0.58 . . . . 73.45 110.657 -177.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.635 HG11 ' HB3' ' A' ' 83' ' ' TYR . 21.7 t -82.99 108.1 15.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.679 -0.691 . . . . 72.02 109.996 176.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.55 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 25.6 m -90.77 111.66 23.13 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.398 -0.819 . . . . 64.32 108.894 175.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.459 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 13.6 t0 -61.27 133.54 56.0 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.841 -0.618 . . . . 63.4 111.155 -177.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.462 ' HD2' ' C ' ' A' ' 101' ' ' ARG . 1.1 ppt_? -94.93 -7.92 38.56 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.551 -0.75 . . . . 73.23 110.461 -178.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -87.17 -71.92 0.54 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.976 -0.556 . . . . 73.34 110.579 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 57.5 p -97.53 -28.92 13.75 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.278 -0.419 . . . . 74.11 110.566 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 100' ' ' ASP . . . 102.29 22.73 9.56 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 121.071 -0.585 . . . . 65.24 112.867 177.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.445 ' N ' ' HB3' ' A' ' 100' ' ' ASP . 49.4 mt-30 -73.98 131.87 41.84 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.732 0.301 . . . . 74.43 110.545 177.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.5 p -91.41 108.83 20.16 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.234 0.54 . . . . 62.24 111.615 -177.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 10.0 t -96.85 86.07 3.94 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.285 -0.635 . . . . 71.15 109.285 177.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 87.2 m -91.6 104.81 17.25 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.633 -0.712 . . . . 73.23 110.671 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 54.8 mt -115.89 105.13 17.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.972 -0.558 . . . . 75.24 110.487 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -69.97 134.15 48.03 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.9 -0.407 . . . . 61.1 109.9 175.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 52.1 t -88.64 93.79 4.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.135 0.493 . . . . 75.11 110.009 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.9 p -170.28 -41.58 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.547 -0.751 . . . . 73.52 110.644 -176.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 101.39 81.68 1.6 Allowed Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 111.352 -0.699 . . . . 75.51 111.352 -178.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 96.2 mt -82.45 -69.85 0.59 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 110.721 -0.103 . . . . 75.43 110.721 -175.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 44.56 33.87 1.0 Allowed 'General case' 0 N--CA 1.474 0.742 0 O-C-N 124.181 0.926 . . . . 73.22 111.652 -177.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -68.22 -57.53 5.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.702 -0.681 . . . . 73.42 110.983 -177.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 64.03 171.25 0.18 Allowed 'General case' 0 N--CA 1.469 0.477 0 O-C-N 123.744 0.653 . . . . 63.43 111.46 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 19.5 m 60.08 -155.94 0.35 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.804 -0.635 . . . . 75.22 110.719 177.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 49.5 p 58.42 105.61 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.129 0.972 . . . . 74.32 112.758 177.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 17.6 t70 74.52 120.5 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 114.642 -1.163 . . . . 75.14 112.094 176.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -149.98 36.76 0.69 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.413 -0.812 . . . . 75.24 109.339 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 22.8 p-80 -77.33 -29.15 53.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.291 -0.868 . . . . 74.34 112.364 -170.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 54.6 m-70 63.35 -85.79 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 122.507 0.323 . . . . 71.55 110.791 -173.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 19.0 p80 -122.76 15.82 10.19 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.132 -0.692 . . . . 75.21 109.132 175.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 13.1 p-80 57.85 111.69 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.346 1.459 . . . . 74.34 112.467 -175.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -62.99 -22.6 66.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.676 -1.147 . . . . 73.13 111.545 175.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 83.2 t60 . . . . . 0 C--O 1.246 0.92 0 CA-C-O 118.801 -0.619 . . . . 63.31 109.477 179.798 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 pmm? . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 109.974 -0.38 . . . . 75.5 109.974 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.47 -76.51 0.13 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.65 0.262 . . . . 74.23 110.879 -178.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 63.39 67.27 2.14 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 121.011 -0.614 . . . . 65.14 111.901 -177.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.9 m -130.5 148.37 52.3 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 122.658 -0.319 . . . . 73.31 110.859 -176.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 27.0 ptt? 47.05 93.29 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.655 1.182 . . . . 75.43 112.904 179.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 21.0 p -84.8 -83.53 0.16 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.356 -0.838 . . . . 74.21 110.885 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -99.45 123.64 43.9 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.257 -0.429 . . . . 75.04 110.488 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -120.18 94.5 4.4 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.816 -0.629 . . . . 73.41 110.028 178.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -94.12 119.23 32.67 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.268 -0.424 . . . . 73.24 109.945 179.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 -91.92 176.72 6.41 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.161 -0.472 . . . . 74.31 110.435 -178.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -117.47 88.31 28.28 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-O 121.316 0.579 . . . . 70.54 110.541 176.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -69.51 80.17 0.82 Allowed 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 122.256 1.971 . . . . 71.33 111.569 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 66.49 -176.08 0.19 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.366 -0.833 . . . . 75.43 109.769 -175.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -107.35 177.57 4.8 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 110.089 -0.337 . . . . 75.23 110.089 -178.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -101.04 175.27 26.02 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.758 -0.734 . . . . 71.23 111.795 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.97 -106.29 0.64 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.722 -0.751 . . . . 73.33 112.382 178.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -108.17 142.96 26.42 Favored Pre-proline 0 C--N 1.319 -0.752 0 C-N-CA 121.019 -0.273 . . . . 72.14 111.349 -177.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -74.05 -33.2 6.23 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 123.046 2.497 . . . . 61.41 110.396 169.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 29.3 t30 -134.89 123.91 24.17 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.77 -1.104 . . . . 74.52 108.665 173.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -83.65 140.78 31.96 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.756 0.312 . . . . 74.24 110.32 -178.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -150.76 -157.88 8.02 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.771 -0.728 . . . . 62.44 112.079 -178.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.437 ' C ' ' H ' ' A' ' 24' ' ' LEU . . . 63.63 -166.42 0.23 Allowed 'General case' 0 C--O 1.236 0.377 0 C-N-CA 122.962 0.505 . . . . 64.1 111.124 -179.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 75.0 t80 75.17 -29.82 0.19 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.499 0.719 . . . . 75.42 111.544 177.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.437 ' H ' ' C ' ' A' ' 22' ' ' ALA . 89.7 mt -66.25 104.33 1.17 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.916 0.389 . . . . 72.34 110.605 179.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 94.2 mt -122.89 129.71 51.96 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.932 -0.576 . . . . 74.5 110.208 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -98.31 101.81 13.37 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.267 -0.424 . . . . 74.45 109.869 176.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.3 m -86.86 176.95 7.44 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.974 -0.557 . . . . 72.43 110.094 -179.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.4 170.35 16.53 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.394 -0.366 . . . . 74.12 110.044 176.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 71.69 160.54 0.22 Allowed 'General case' 0 N--CA 1.469 0.475 0 O-C-N 123.848 0.718 . . . . 75.1 110.471 -175.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 63.84 -166.84 0.22 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.809 -0.632 . . . . 75.25 110.561 -178.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 32.5 mm-40 64.63 18.62 11.49 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.098 0.475 . . . . 75.53 110.394 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -139.59 -160.2 1.04 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.613 -0.721 . . . . 64.01 109.164 -179.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.6 t 73.72 80.42 0.13 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.575 0.702 . . . . 74.21 110.746 175.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -105.2 -14.64 15.31 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.398 -0.819 . . . . 74.43 110.589 177.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.4 mptt 63.82 34.22 12.06 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 122.472 1.129 . . . . 71.43 108.269 -167.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.501 ' HB2' ' HD2' ' A' ' 37' ' ' PRO . 8.0 p-10 -79.43 165.61 47.01 Favored Pre-proline 0 N--CA 1.448 -0.536 0 CA-C-N 113.322 -1.763 . . . . 74.53 110.715 -177.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.501 ' HD2' ' HB2' ' A' ' 36' ' ' ASP . 84.4 Cg_exo -48.24 144.0 13.71 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.537 2.825 . . . . 70.22 114.564 -174.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 45.4 m -138.14 -63.39 0.56 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.942 -1.026 . . . . 73.21 108.264 173.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -175.97 106.58 0.08 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.61 -0.723 . . . . 74.42 109.985 171.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 63.4 t30 75.74 137.27 0.06 Allowed 'General case' 0 N--CA 1.47 0.568 0 O-C-N 124.103 0.877 . . . . 75.2 111.537 178.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.1 t70 68.93 29.76 4.83 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 122.049 0.928 . . . . 75.34 109.793 -176.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -83.92 60.79 6.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.004 -0.998 . . . . 70.12 110.903 -176.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.463 ' CE2' HD22 ' A' ' 51' ' ' LEU . 54.7 m-85 -82.45 5.39 20.68 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.456 -0.338 . . . . 75.22 111.491 -177.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.08 -15.01 66.84 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.932 -0.651 . . . . 74.52 112.09 176.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 45.4 mt -78.41 -20.33 13.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.868 -0.419 . . . . 75.24 109.868 176.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 64.0 86.61 0.12 Allowed 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.192 -0.913 . . . . 65.32 110.718 -174.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.2 t -139.44 87.91 13.08 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.467 -0.788 . . . . 73.11 110.214 -179.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -65.15 100.55 0.38 Allowed 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.647 2.232 . . . . 73.11 112.757 -176.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.3 p -146.51 -76.18 0.19 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.889 -0.596 . . . . 73.25 110.111 174.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.68 -45.73 85.4 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.001 -0.545 . . . . 71.23 110.895 178.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.463 HD22 ' CE2' ' A' ' 43' ' ' PHE . 2.6 pt? -79.24 -20.2 48.79 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.984 -0.553 . . . . 73.42 110.849 179.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -57.33 -65.24 0.66 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.893 -0.594 . . . . 72.13 111.562 -174.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -67.58 -22.85 65.36 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.896 -0.593 . . . . 73.01 110.701 -176.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.55 ' O ' HG13 ' A' ' 58' ' ' ILE . 23.3 t80 -75.43 -55.91 5.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.812 -0.631 . . . . 74.25 111.287 -178.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.3 t -63.41 -26.92 68.96 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.827 0.346 . . . . 75.41 111.757 -174.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -68.6 -35.5 77.43 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.796 0.332 . . . . 63.02 110.672 -178.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.53 -29.66 59.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.043 -0.526 . . . . 74.22 109.944 177.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.55 HG13 ' O ' ' A' ' 54' ' ' PHE . 17.5 mt -65.31 -43.8 94.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.75 -0.659 . . . . 75.44 110.747 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -64.15 -22.84 67.09 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.283 -0.417 . . . . 74.14 111.143 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 58.5 m -86.94 -35.18 19.04 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.437 -0.347 . . . . 73.34 111.385 178.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.544 ' HG2' ' HA ' ' A' ' 58' ' ' ILE . 3.6 pt20 -77.58 -4.57 46.47 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.702 0.26 . . . . 71.1 111.702 -175.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.535 HG13 ' O ' ' A' ' 58' ' ' ILE . 75.4 mt -61.9 -36.26 72.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.906 0.384 . . . . 75.12 110.173 -178.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 8.5 mp -56.79 -47.16 80.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.573 -0.74 . . . . 74.53 110.302 178.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -69.01 -39.14 85.01 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.839 -0.696 . . . . 74.2 112.025 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.45 -43.36 98.83 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 121.234 -0.508 . . . . 72.43 112.216 178.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 62' ' ' ILE . 94.8 mt -58.08 -50.02 74.93 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.651 0.262 . . . . 72.23 110.757 178.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.7 HD12 ' HA ' ' A' ' 91' ' ' ASP . 96.4 mt -62.65 -30.52 71.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.125 -0.489 . . . . 71.34 111.561 -177.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 30.6 t -82.59 -35.09 27.4 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.021 0.438 . . . . 75.11 110.499 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -85.71 13.57 6.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.297 -0.41 . . . . 72.41 111.834 -177.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.434 HG12 ' O ' ' A' ' 66' ' ' LEU . 47.8 mm -71.73 -29.57 34.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 108.691 -0.855 . . . . 73.52 108.691 169.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -89.99 29.68 1.17 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.466 -0.788 . . . . 62.21 110.499 -177.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.4 p -74.84 -56.97 4.22 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.455 -0.572 . . . . 70.33 109.455 173.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -104.14 82.61 0.37 Allowed Glycine 0 N--CA 1.442 -0.916 0 N-CA-C 110.586 -1.006 . . . . 71.02 110.586 171.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.705 ' HB3' ' HZ3' ' A' ' 74' ' ' LYS . 0.5 OUTLIER -55.86 144.28 57.68 Favored Pre-proline 0 C--O 1.235 0.34 0 CA-C-O 120.917 0.389 . . . . 75.21 111.869 -176.386 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 74' ' ' LYS . 7.6 Cg_exo -73.37 -164.38 0.2 Allowed 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 123.332 2.688 . . . . 73.53 112.535 -178.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -59.12 107.4 1.19 Allowed Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.778 -0.647 . . . . 72.12 112.711 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 24.6 ptt180 -103.52 149.98 24.34 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 110.397 -0.223 . . . . 72.11 110.397 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 49.4 ttm -79.07 103.97 9.38 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.951 0.405 . . . . 73.31 110.1 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 60.0 t -85.6 95.79 4.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.337 0.589 . . . . 64.42 109.913 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.53 ' OG1' ' HB2' ' A' ' 83' ' ' TYR . 1.5 p -103.09 -179.09 3.85 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.506 -0.77 . . . . 50.13 109.925 176.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 13.3 t30 -85.52 -43.66 13.35 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 111.64 0.237 . . . . 72.31 111.64 -175.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.588 ' OD1' ' HD3' ' A' ' 101' ' ' ARG . 15.3 t70 -108.54 0.95 21.14 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.981 0.42 . . . . 75.51 111.91 -174.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.53 ' HB2' ' OG1' ' A' ' 80' ' ' THR . 96.3 m-85 -121.95 124.77 44.83 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 122.07 -0.394 . . . . 74.53 110.949 177.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.534 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 4.1 mp -101.1 88.53 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.4 -0.963 . . . . 71.04 108.4 171.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.5 p -126.88 137.29 58.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.041 -0.527 . . . . 64.33 111.344 -172.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -141.76 152.22 43.58 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.765 -0.652 . . . . 74.51 110.037 175.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 71.2 mt -92.58 115.4 31.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.675 -0.693 . . . . 73.15 110.452 -176.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -110.93 114.15 27.25 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.207 -0.451 . . . . 75.04 110.663 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -90.98 87.35 6.58 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.337 0.589 . . . . 62.25 109.718 174.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 43.7 ttt180 -109.27 139.57 44.04 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.674 -0.694 . . . . 75.44 110.001 177.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.7 ' HA ' HD12 ' A' ' 67' ' ' LEU . 4.7 t70 68.12 20.89 8.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.564 0.697 . . . . 71.02 110.218 172.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.73 20.77 79.84 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.456 -0.793 . . . . 75.32 112.376 -178.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.453 ' HA ' HE21 ' A' ' 93' ' ' GLN . 0.0 OUTLIER -124.43 140.92 52.49 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.763 -0.458 . . . . 73.12 109.763 179.554 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -79.39 117.5 20.42 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.699 -0.482 . . . . 75.0 109.699 176.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -123.57 122.07 37.23 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.227 -0.442 . . . . 55.53 110.733 -176.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 20.1 tp -99.8 106.47 18.35 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.73 -0.668 . . . . 75.11 109.849 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.432 ' ND2' HG23 ' A' ' 108' ' ' THR . 13.6 m120 -95.01 95.6 8.71 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.46 -0.337 . . . . 73.45 110.401 -178.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.45 ' HB ' ' HB2' ' A' ' 107' ' ' SER . 93.5 t -87.83 102.38 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.495 0 CA-C-O 121.321 0.581 . . . . 72.02 110.578 179.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.534 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 68.9 m -86.09 107.98 18.07 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.537 -0.756 . . . . 64.32 109.835 177.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.5 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 24.2 t70 -63.66 145.04 56.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.805 -0.634 . . . . 63.4 111.286 -178.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.588 ' HD3' ' OD1' ' A' ' 82' ' ' ASP . 33.2 ttt180 -92.94 -22.24 19.33 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.545 -0.752 . . . . 73.23 110.685 -178.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 35.0 mttp -80.25 -68.62 0.66 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.371 0.605 . . . . 73.34 110.545 -176.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 45.8 p -90.47 -43.0 10.54 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.476 -0.784 . . . . 74.11 110.031 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.5 ' HA2' ' O ' ' A' ' 100' ' ' ASP . . . 111.25 4.37 27.25 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 115.472 -0.786 . . . . 65.24 112.904 176.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -61.67 133.61 55.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.914 0.388 . . . . 74.43 110.631 175.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 62.6 m -92.17 100.31 12.95 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.614 -0.513 . . . . 62.24 109.614 174.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.45 ' HB2' ' HB ' ' A' ' 98' ' ' VAL . 14.1 m -73.85 101.25 3.7 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.724 -0.671 . . . . 71.15 109.294 177.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.432 HG23 ' ND2' ' A' ' 97' ' ' ASN . 0.8 OUTLIER -89.53 94.84 10.02 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.015 -0.539 . . . . 73.23 110.808 -174.446 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 35.0 mm -99.87 101.22 11.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.826 -0.624 . . . . 75.24 110.371 -177.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -78.24 154.68 30.81 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.425 -0.352 . . . . 61.1 110.658 175.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.2 p -54.83 126.65 12.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.565 -0.743 . . . . 75.11 111.232 178.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 35.6 t -159.63 156.19 27.49 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.125 -0.489 . . . . 73.52 110.212 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -155.57 26.1 0.59 Allowed Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 110.936 -0.866 . . . . 75.51 110.936 176.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 83.9 mt -103.78 81.59 1.9 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 120.985 0.421 . . . . 75.43 111.327 -174.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -117.6 38.95 3.45 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.991 -0.55 . . . . 73.22 109.68 176.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -82.86 119.14 24.0 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.623 -0.717 . . . . 73.42 110.683 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -150.06 -69.16 0.2 Allowed 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.648 -0.871 . . . . 63.43 108.648 176.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 11.2 t 55.19 74.67 0.35 Allowed 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.344 -0.844 . . . . 75.22 110.941 176.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 85.5 m -152.79 127.72 9.63 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.853 -0.612 . . . . 74.32 110.181 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -87.44 92.7 9.18 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.162 0.506 . . . . 75.14 109.781 176.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.538 ' HB2' ' CD2' ' A' ' 123' ' ' HIS . 47.9 p90 -123.36 127.92 49.16 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.781 -0.645 . . . . 75.24 110.548 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -90.49 -73.82 0.51 Allowed 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.688 -0.856 . . . . 74.34 108.688 175.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.538 ' CD2' ' HB2' ' A' ' 121' ' ' PHE . 72.9 m-70 63.35 104.11 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.333 -0.849 . . . . 71.55 112.965 175.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -160.96 -24.04 0.06 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.392 -0.822 . . . . 75.21 109.975 173.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 67.4 -176.17 0.2 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.747 -0.661 . . . . 74.34 111.593 178.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -132.57 133.32 43.55 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.727 -0.669 . . . . 73.13 109.888 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.022 -0.989 . . . . 63.31 109.681 173.56 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.477 0.898 0 N-CA-C 110.229 -0.286 . . . . 75.5 110.229 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 66.76 -68.48 0.14 Allowed 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.971 0.795 . . . . 74.23 110.832 -176.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.525 ' O ' ' HG3' ' A' ' 5' ' ' MET . . . -170.3 85.12 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 111.024 -0.831 . . . . 65.14 111.024 177.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.8 m -68.83 108.63 3.52 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.963 0.411 . . . . 73.31 110.296 -178.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.525 ' HG3' ' O ' ' A' ' 3' ' ' GLY . 52.2 mtt -114.57 124.54 52.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.344 -0.389 . . . . 75.43 111.122 -174.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.1 t -141.7 -43.47 0.35 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.098 -0.501 . . . . 74.21 109.926 174.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 56.39 112.94 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.909 0.884 . . . . 75.04 112.107 179.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -99.08 90.62 4.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.146 -0.479 . . . . 73.41 111.013 -176.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -119.25 101.07 7.72 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.757 -0.656 . . . . 73.24 109.864 177.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.412 ' O ' ' HB2' ' A' ' 11' ' ' ASN . 25.0 mmt180 -124.63 -71.55 0.71 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.31 -0.404 . . . . 74.31 110.662 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 10' ' ' ARG . 94.3 m-20 71.02 147.84 0.12 Allowed Pre-proline 0 N--CA 1.47 0.568 0 O-C-N 123.878 0.736 . . . . 70.54 111.533 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.33 -52.77 5.01 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.963 2.442 . . . . 71.33 112.439 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 62.61 81.64 0.2 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.924 -0.58 . . . . 75.43 111.042 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -85.64 165.72 16.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.858 -0.61 . . . . 75.23 110.762 -179.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -111.47 -56.99 0.47 Allowed Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 111.323 -0.711 . . . . 71.23 111.323 176.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.16 175.1 30.3 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.848 -0.691 . . . . 73.33 112.523 178.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -123.69 150.5 61.93 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 109.896 -0.409 . . . . 72.14 109.896 -177.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -64.32 -37.05 42.18 Favored 'Trans proline' 0 C--O 1.236 0.399 0 C-N-CA 122.829 2.353 . . . . 61.41 112.793 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 71.04 139.8 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 O-C-N 123.83 0.706 . . . . 74.52 111.051 -178.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -116.46 143.69 45.26 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.075 -0.511 . . . . 74.24 109.976 -178.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -111.14 147.17 17.78 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 121.002 -0.618 . . . . 62.44 111.691 178.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -128.81 132.7 47.86 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.843 0.322 . . . . 64.1 110.524 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -132.02 105.93 7.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.274 0.559 . . . . 75.42 110.602 178.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.3 mp -128.35 95.05 4.04 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.671 -0.695 . . . . 72.34 110.421 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.9 mp -123.85 -51.7 1.8 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.436 -0.347 . . . . 74.5 110.175 178.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 54.1 t30 65.7 -85.34 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 O-C-N 123.902 0.751 . . . . 74.45 110.782 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.4 p -173.74 130.55 0.42 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.918 -0.401 . . . . 72.43 109.918 179.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -111.32 86.99 2.44 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.072 -0.513 . . . . 74.12 109.705 178.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -120.83 123.44 42.59 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.16 -0.473 . . . . 75.1 110.741 -178.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -132.95 84.63 2.15 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.924 -0.58 . . . . 75.25 110.192 177.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -106.22 141.44 37.55 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.167 -0.47 . . . . 75.53 110.206 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -109.88 96.75 6.45 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.055 -0.521 . . . . 64.01 110.863 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.5 p -91.77 107.53 19.27 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.963 -0.754 . . . . 74.21 108.963 172.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -81.1 -16.06 54.17 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.328 0.492 . . . . 74.43 112.328 -167.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.511 ' O ' ' HB2' ' A' ' 42' ' ' ASP . 59.0 tttt -87.93 79.34 8.08 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.439 0.638 . . . . 71.43 110.321 -176.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.536 ' HB2' ' HD2' ' A' ' 37' ' ' PRO . 2.0 p30 -103.22 165.06 14.26 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.256 -0.884 . . . . 74.53 110.9 -176.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.536 ' HD2' ' HB2' ' A' ' 36' ' ' ASP . 46.0 Cg_endo -69.77 -34.57 14.26 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.43 2.087 . . . . 70.22 112.404 177.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 70.8 m -159.22 -54.61 0.06 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.134 -0.485 . . . . 73.21 109.833 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -175.81 146.61 0.74 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.915 -0.584 . . . . 74.42 109.754 173.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.7 t30 71.37 103.97 0.06 Allowed 'General case' 0 N--CA 1.469 0.482 0 O-C-N 123.762 0.664 . . . . 75.2 110.916 177.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.2 t70 71.51 113.9 0.05 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.026 -0.988 . . . . 75.34 111.125 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.513 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 8.5 p-10 -82.68 -11.07 58.62 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.481 -0.781 . . . . 70.12 110.956 -176.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -83.78 9.35 12.09 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.044 -0.525 . . . . 75.22 110.818 -178.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -80.08 10.92 38.62 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.071 -0.585 . . . . 74.52 112.341 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 63.1 mt -85.31 -52.5 12.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.913 0.387 . . . . 75.24 110.176 178.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -115.59 138.71 50.79 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.307 -0.406 . . . . 65.32 110.094 176.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 25.2 m -119.71 87.73 38.01 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 115.977 -0.556 . . . . 73.11 111.002 -177.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.422 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 21.0 Cg_endo -61.44 127.91 23.27 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.469 2.112 . . . . 73.11 111.556 178.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.8 m -121.93 -42.32 2.4 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.108 0.48 . . . . 73.25 110.526 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -87.55 -36.09 17.76 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.032 -0.531 . . . . 71.23 110.707 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.408 ' O ' HG22 ' A' ' 55' ' ' THR . 0.6 OUTLIER -98.06 5.07 49.1 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.51 -0.314 . . . . 73.42 110.725 180.0 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.422 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 39.4 t0 -57.3 -64.28 0.94 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.011 -0.54 . . . . 72.13 111.54 -175.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -66.01 -26.11 67.38 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.326 -0.397 . . . . 73.01 110.864 -177.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.526 ' O ' HG13 ' A' ' 58' ' ' ILE . 89.0 t80 -69.62 -60.41 2.34 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.96 -0.564 . . . . 74.25 111.266 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.408 HG22 ' O ' ' A' ' 51' ' ' LEU . 12.9 t -74.04 -20.39 60.32 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.565 0.221 . . . . 75.41 111.48 -172.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -76.14 -33.42 59.4 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.83 0.348 . . . . 63.02 110.543 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.94 -24.02 60.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.147 0.498 . . . . 74.22 110.585 178.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.555 ' O ' HG13 ' A' ' 62' ' ' ILE . 16.1 mt -72.67 -26.69 24.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.74 -0.664 . . . . 75.44 110.718 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -56.76 -37.72 71.46 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.734 0.302 . . . . 74.14 110.958 -178.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.9 m -63.94 -43.19 96.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.089 -0.505 . . . . 73.34 111.436 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -79.81 -21.96 43.62 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 121.026 -0.269 . . . . 71.1 111.232 -175.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.555 HG13 ' O ' ' A' ' 58' ' ' ILE . 79.9 mt -66.05 -35.95 76.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.064 0.459 . . . . 75.12 109.84 177.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 92.3 mt -57.23 -46.47 82.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.579 -0.737 . . . . 74.53 111.121 178.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -65.89 -37.48 93.34 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.86 -0.686 . . . . 74.2 111.914 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.14 -40.67 99.26 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.983 -0.627 . . . . 72.43 112.055 178.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.8 mt -61.98 -41.08 97.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.0 0.428 . . . . 72.23 110.904 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.3 mt -67.37 -32.17 72.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.096 -0.502 . . . . 71.34 110.726 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.3 t -70.55 -24.8 62.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.906 -0.588 . . . . 75.11 110.551 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -69.89 -11.59 60.98 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.295 -0.411 . . . . 72.41 111.663 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 47.1 mm -87.68 -17.25 8.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.424 0.63 . . . . 73.52 109.965 178.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -106.69 -52.16 2.82 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.824 -0.626 . . . . 62.21 110.786 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 21.5 p 51.39 30.18 5.89 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 114.12 1.155 . . . . 70.33 114.12 175.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -157.61 15.44 0.31 Allowed Glycine 0 CA--C 1.517 0.18 0 C-N-CA 120.141 -1.028 . . . . 71.02 112.954 177.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.448 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -57.67 144.08 74.16 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.747 0.308 . . . . 75.21 111.56 -178.889 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 74' ' ' LYS . 5.4 Cg_exo -80.0 -17.64 10.6 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.768 2.312 . . . . 73.53 111.273 172.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 119.76 -125.93 6.52 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.807 -0.633 . . . . 72.12 111.76 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 77' ' ' ARG . 14.5 ptt180 -139.93 164.47 29.9 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.766 -0.457 . . . . 72.11 109.766 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.488 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 26.1 ttt -110.19 117.15 32.93 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.862 0.363 . . . . 73.31 110.393 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.6 p -82.68 90.43 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-O 121.905 0.86 . . . . 64.42 110.43 178.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.689 ' HB ' ' O ' ' A' ' 83' ' ' TYR . 7.2 m -97.87 134.29 41.2 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.477 -0.783 . . . . 50.13 109.213 176.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -63.53 -31.9 73.19 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.262 -0.426 . . . . 72.31 111.379 -175.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.613 ' HA ' ' HG2' ' A' ' 101' ' ' ARG . 37.9 t70 -105.48 -8.18 18.23 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.428 -0.351 . . . . 75.51 111.871 -175.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.689 ' O ' ' HB ' ' A' ' 80' ' ' THR . 42.2 m-85 -147.98 134.49 19.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.379 0.609 . . . . 74.53 112.206 -175.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.568 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 49.1 mm -87.17 108.45 18.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.254 -0.647 . . . . 71.04 109.254 172.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.488 ' HB ' ' HB3' ' A' ' 78' ' ' MET . 60.2 t -116.77 113.57 43.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.752 0.31 . . . . 64.33 111.374 -174.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -124.0 144.43 49.83 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.219 0.533 . . . . 74.51 110.135 175.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 62.0 mt -102.19 113.53 38.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.83 -0.623 . . . . 73.15 110.916 -175.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -107.27 110.18 22.15 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.283 -0.417 . . . . 75.04 110.207 176.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -115.61 110.49 19.27 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.951 0.405 . . . . 62.25 110.539 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 -142.94 144.02 32.21 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.536 -0.542 . . . . 75.44 109.536 177.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.59 20.15 11.79 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 123.565 0.541 . . . . 71.02 111.122 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.93 -2.7 88.1 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.045 -0.598 . . . . 75.32 112.439 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.438 ' HA ' HE21 ' A' ' 93' ' ' GLN . 0.1 OUTLIER -93.55 126.65 38.82 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.821 0.343 . . . . 73.12 110.827 -178.059 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -83.88 105.26 14.63 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.01 -0.541 . . . . 75.0 110.23 174.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -106.62 104.89 14.68 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.994 -0.548 . . . . 55.53 109.795 178.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 33.6 tp -89.1 111.93 22.79 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.729 -0.669 . . . . 75.11 110.193 -177.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -95.5 121.1 36.83 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.814 -0.439 . . . . 73.45 109.814 179.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.568 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 7.9 p -128.11 127.06 67.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 121.44 0.638 . . . . 72.02 110.742 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.546 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 6.2 m -113.33 123.97 51.37 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.806 -0.633 . . . . 64.32 110.141 178.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.495 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 32.3 t70 -70.91 149.54 46.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.102 -0.499 . . . . 63.4 110.724 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.613 ' HG2' ' HA ' ' A' ' 82' ' ' ASP . 0.0 OUTLIER -96.73 -11.18 25.4 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.97 -0.292 . . . . 73.23 110.918 -179.08 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 26.7 mttp -89.91 -64.35 1.15 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.623 0.725 . . . . 73.34 109.791 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 46.1 p -86.61 -45.17 11.28 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.862 -1.063 . . . . 74.11 110.066 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.495 ' HA2' ' O ' ' A' ' 100' ' ' ASP . . . 99.02 18.44 24.65 Favored Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 114.902 -1.044 . . . . 65.24 112.311 -178.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.428 ' HA ' ' OE1' ' A' ' 105' ' ' GLN . 12.3 mm-40 -59.43 134.96 57.49 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 120.809 0.338 . . . . 74.43 110.284 175.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.8 m -108.82 102.47 11.49 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.013 -0.539 . . . . 62.24 109.98 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 21.1 t -101.2 125.91 47.87 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.164 -0.471 . . . . 71.15 110.374 -177.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 29.7 m -108.7 97.79 7.39 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.223 0.535 . . . . 73.23 109.604 174.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 60.3 mt -84.83 105.03 13.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.76 -0.654 . . . . 75.24 110.574 -177.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.4 ' HG3' ' O ' ' A' ' 110' ' ' GLN . 9.5 pt20 -101.32 104.47 15.48 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.185 0.517 . . . . 61.1 110.446 179.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 10.5 p -67.86 126.99 28.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.972 -0.558 . . . . 75.11 109.867 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.4 m -116.04 125.3 52.27 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.928 0.394 . . . . 73.52 110.462 -178.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 168.71 50.93 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.922 -0.656 . . . . 75.51 111.912 -177.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 89.1 mt -115.18 100.14 7.93 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.246 0.545 . . . . 75.43 110.582 -178.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -129.02 -36.14 1.79 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.369 -0.832 . . . . 73.22 110.042 175.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 71.05 128.88 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 O-C-N 124.076 0.86 . . . . 73.42 111.12 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -81.17 -26.07 36.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.627 -0.715 . . . . 63.43 111.673 -176.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 49.3 m 62.3 -167.06 0.21 Allowed 'General case' 0 CA--C 1.533 0.317 0 O-C-N 123.299 0.374 . . . . 75.22 110.327 -176.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.5 p -114.42 -79.62 0.59 Allowed 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.776 -0.369 . . . . 74.32 111.711 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 19.0 t70 62.38 95.39 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 O-C-N 123.852 0.72 . . . . 75.14 110.472 -173.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -132.55 125.83 31.44 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.945 -0.571 . . . . 75.24 109.952 178.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -86.7 107.26 18.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.635 0.731 . . . . 74.34 110.639 -177.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 13.8 p80 -114.28 118.16 33.15 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.933 -0.766 . . . . 71.55 108.933 175.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -150.2 142.58 24.3 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.981 -0.554 . . . . 75.21 110.287 -175.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -114.1 125.39 53.91 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.121 -0.49 . . . . 74.34 110.758 176.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -93.01 -47.83 6.8 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.197 -1.038 . . . . 73.13 108.197 169.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 14.0 t-80 . . . . . 0 C--O 1.249 1.046 0 CA-C-N 114.938 -1.028 . . . . 63.31 108.831 174.78 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.479 1.008 0 CA-C-O 120.629 0.252 . . . . 75.5 110.502 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -139.75 118.05 12.04 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.413 -0.358 . . . . 74.23 110.527 178.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 170.7 39.79 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 111.188 -0.765 . . . . 65.14 111.188 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.3 m -84.82 88.96 7.44 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.153 0.502 . . . . 73.31 110.82 -175.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 87.1 mtp -95.91 86.42 4.33 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.017 -0.538 . . . . 75.43 109.997 177.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.4 m -70.24 -53.6 16.28 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.611 -0.722 . . . . 74.21 110.599 -179.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -84.0 117.54 23.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.146 0.498 . . . . 75.04 110.186 178.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -138.69 42.9 2.13 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.378 0.608 . . . . 73.41 110.537 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -91.61 102.93 15.57 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.495 -0.775 . . . . 73.24 109.531 176.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.02 136.75 38.71 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.256 -0.429 . . . . 74.31 110.196 -175.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 57.6 t30 66.32 86.27 0.14 Allowed Pre-proline 0 N--CA 1.469 0.516 0 O-C-N 123.665 0.603 . . . . 70.54 111.642 175.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -68.75 -25.76 33.31 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.915 2.41 . . . . 71.33 111.637 176.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.3 t30 71.34 116.74 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.604 -0.726 . . . . 75.43 111.476 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -148.34 110.67 4.65 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.772 -0.649 . . . . 75.23 110.879 178.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -106.19 115.89 4.93 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 111.378 -0.689 . . . . 71.23 111.378 175.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -90.15 169.03 34.39 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.73 -0.748 . . . . 73.33 112.008 -178.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.416 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 12.4 m120 -93.94 143.1 25.93 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 109.927 -0.397 . . . . 72.14 109.927 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 17' ' ' ASN . 5.1 Cg_exo -77.58 -28.57 5.29 Favored 'Trans proline' 0 CA--C 1.529 0.264 0 C-N-CA 122.946 2.431 . . . . 61.41 112.39 176.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 65.33 179.77 0.19 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.894 -0.594 . . . . 74.52 111.709 179.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -154.16 135.68 14.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.073 -0.512 . . . . 74.24 110.657 178.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -172.55 77.65 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.633 -0.794 . . . . 62.44 112.719 -178.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -149.84 114.36 5.26 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.849 0.357 . . . . 64.1 110.19 178.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.413 ' HB2' ' HG ' ' A' ' 25' ' ' LEU . 78.6 m-85 -109.1 -25.05 10.87 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.002 -0.545 . . . . 75.42 111.113 -175.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.4 mp 59.12 58.15 3.22 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.936 -0.574 . . . . 72.34 110.277 -176.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.413 ' HG ' ' HB2' ' A' ' 23' ' ' PHE . 98.2 mt -84.26 56.58 3.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.633 -0.712 . . . . 74.5 111.129 -176.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -87.15 81.59 7.95 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.732 -0.47 . . . . 74.45 109.732 177.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.4 m -89.36 -56.56 3.22 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.034 -0.53 . . . . 72.43 110.469 -178.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 64.61 -82.38 0.03 OUTLIER 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.668 -0.696 . . . . 74.12 112.148 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 67.18 -73.59 0.08 Allowed 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 123.377 0.671 . . . . 75.1 110.727 -174.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 66.95 135.39 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.627 0.771 . . . . 75.25 112.545 177.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.8 mp0 -88.15 8.2 28.06 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.454 -0.793 . . . . 75.53 109.76 176.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 59.1 t30 69.57 177.53 0.26 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.081 -0.963 . . . . 64.01 110.709 178.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.7 m -101.78 19.64 17.82 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.127 0.417 . . . . 74.21 112.127 -175.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 21.8 m-30 -76.91 79.44 3.48 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.292 -0.633 . . . . 74.43 109.292 174.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -96.82 83.62 3.45 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.321 0.581 . . . . 71.43 110.839 -175.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.554 ' HB2' ' HD2' ' A' ' 37' ' ' PRO . 5.1 p-10 -162.81 158.26 18.81 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 114.739 -1.119 . . . . 74.53 108.587 175.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.796 ' HG3' ' HA ' ' A' ' 45' ' ' ILE . 10.0 Cg_endo -52.18 151.26 17.42 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 123.432 2.754 . . . . 70.22 114.571 -173.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.9 m 75.6 13.92 2.88 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 114.753 -1.112 . . . . 73.21 112.147 176.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -121.52 83.77 2.14 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.494 -0.558 . . . . 74.42 109.494 171.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 66.84 4.83 3.65 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.34 -0.846 . . . . 75.2 111.338 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -165.75 134.82 3.25 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.283 -0.636 . . . . 75.34 109.283 178.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -121.47 25.25 9.49 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.78 0.324 . . . . 70.12 110.722 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -106.68 -23.52 12.41 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.426 -0.352 . . . . 75.22 111.062 -176.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.447 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . -83.02 36.91 2.69 Favored Glycine 0 CA--C 1.518 0.223 0 C-N-CA 120.608 -0.806 . . . . 74.52 112.337 178.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.796 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 61.5 mt -58.86 -56.24 18.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.876 0.369 . . . . 75.24 111.435 -175.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.577 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 42.0 mt-10 -100.01 28.31 4.93 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.28 -0.418 . . . . 65.32 110.96 -177.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 20.3 m -107.15 86.64 2.61 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.963 -0.562 . . . . 73.11 109.687 175.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.577 ' HD3' ' O ' ' A' ' 46' ' ' GLU . 23.4 Cg_exo -63.24 98.23 0.21 Allowed 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.53 2.153 . . . . 73.11 112.225 -175.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.0 m -117.15 -77.79 0.57 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.896 -0.593 . . . . 73.25 109.91 174.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.86 -41.16 68.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.136 0.493 . . . . 71.23 110.336 178.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.405 ' H ' HD23 ' A' ' 51' ' ' LEU . 2.1 pt? -73.86 -17.97 60.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.778 -0.646 . . . . 73.42 111.214 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.457 ' C ' ' H ' ' A' ' 54' ' ' PHE . 31.8 t70 -61.25 -53.65 54.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.823 0.344 . . . . 72.13 111.079 -176.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -77.43 22.34 0.24 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.902 -0.59 . . . . 73.01 110.991 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.457 ' H ' ' C ' ' A' ' 52' ' ' ASP . 63.5 t80 -132.66 -65.91 0.7 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.321 -0.399 . . . . 74.25 110.731 -178.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.5 t -69.85 -23.79 63.34 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.487 -0.324 . . . . 75.41 111.633 -173.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.426 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 2.2 mp0 -67.6 -30.43 70.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.984 0.421 . . . . 63.02 110.356 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.6 -26.49 37.79 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.067 -0.515 . . . . 74.22 110.192 177.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.545 ' HA ' ' HG2' ' A' ' 61' ' ' GLN . 11.3 mt -69.91 -36.39 69.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.897 -0.592 . . . . 75.44 110.322 179.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -67.49 -32.09 72.67 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.068 -0.515 . . . . 74.14 110.319 178.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 7.1 m -68.45 -39.7 81.38 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.937 -0.574 . . . . 73.34 110.497 176.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.615 ' O ' ' HA3' ' A' ' 65' ' ' GLY . 2.8 pt20 -82.98 13.24 4.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.98 -0.555 . . . . 71.1 111.202 -176.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.537 HG13 ' O ' ' A' ' 58' ' ' ILE . 74.7 mt -88.79 -58.52 3.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.703 -0.48 . . . . 75.12 109.703 172.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 89.4 mt -57.97 -62.22 1.98 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.785 -0.643 . . . . 74.53 111.379 -175.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.59 3.84 78.98 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.406 -0.902 . . . . 74.2 112.255 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.615 ' HA3' ' O ' ' A' ' 61' ' ' GLN . . . -94.21 -41.59 4.24 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.759 -0.734 . . . . 72.43 112.395 -178.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 84.1 mt -60.71 -25.06 66.14 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.066 0.46 . . . . 72.23 110.463 178.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 81.7 mt -63.37 -42.32 98.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.665 -0.698 . . . . 71.34 110.686 178.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.6 m -68.64 -29.75 68.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.076 0.465 . . . . 75.11 110.395 179.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -66.43 -25.45 66.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.865 -0.607 . . . . 72.41 110.607 178.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 51.6 mm -76.42 -31.84 21.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.173 -0.467 . . . . 73.52 110.32 178.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -79.89 -45.69 18.16 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.118 -0.492 . . . . 62.21 111.298 -178.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 66.3 p 57.37 178.41 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.919 0.888 . . . . 70.33 111.795 -175.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.01 23.12 76.11 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.938 -0.649 . . . . 71.02 111.787 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.444 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -56.73 142.66 71.27 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.315 -0.442 . . . . 75.21 112.156 -177.549 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 74' ' ' LYS . 9.8 Cg_endo -90.44 -164.81 0.16 Allowed 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 123.564 2.842 . . . . 73.53 110.951 173.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 176.48 -123.42 0.9 Allowed Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 119.373 -1.394 . . . . 72.12 113.856 176.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 14.0 ptt180 -59.63 129.59 42.68 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.619 0.97 . . . . 72.11 113.619 -171.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.569 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 28.4 ttt -122.54 116.65 24.26 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.027 -1.101 . . . . 73.31 108.027 166.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 20.1 t -80.57 102.49 6.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.019 0.438 . . . . 64.42 112.109 -168.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.619 ' HB ' ' O ' ' A' ' 83' ' ' TYR . 5.9 m -108.11 163.34 13.25 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.114 -0.699 . . . . 50.13 109.114 174.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -65.08 -46.54 80.72 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.79 0.329 . . . . 72.31 111.043 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.509 ' HA ' ' HD2' ' A' ' 101' ' ' ARG . 28.2 m-20 -105.51 -79.53 0.56 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.912 0.387 . . . . 75.51 111.129 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.619 ' O ' ' HB ' ' A' ' 80' ' ' THR . 35.1 m-85 -67.46 122.68 18.49 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.816 -0.629 . . . . 74.53 111.524 -175.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.553 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 4.5 mp -84.73 107.08 15.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.627 -0.879 . . . . 71.04 108.627 176.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.569 ' HB ' ' HB3' ' A' ' 78' ' ' MET . 21.2 t -89.56 115.31 28.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.996 -0.547 . . . . 64.33 110.655 -175.202 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.79 ' HB3' ' HB2' ' A' ' 97' ' ' ASN . 13.3 t70 -106.98 106.08 16.44 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.663 -0.495 . . . . 74.51 109.663 177.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 60.0 mt -84.79 124.53 39.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.007 -0.542 . . . . 73.15 110.32 -178.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.428 ' O ' ' HB3' ' A' ' 95' ' ' GLN . . . -135.95 106.96 6.68 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.967 0.358 . . . . 75.04 111.967 -179.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -84.7 85.67 7.41 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.427 -0.953 . . . . 62.25 108.427 169.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.1 ttt180 -100.52 134.8 42.94 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.795 -0.639 . . . . 75.44 109.383 -176.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 68.59 -71.02 0.12 Allowed 'General case' 0 N--CA 1.467 0.41 0 O-C-N 123.87 0.731 . . . . 71.02 110.39 -172.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 178.52 29.62 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 111.753 -0.539 . . . . 75.32 111.753 178.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.433 ' HA ' HE21 ' A' ' 93' ' ' GLN . 0.1 OUTLIER -129.69 150.72 50.88 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 110.044 -0.354 . . . . 73.12 110.044 -177.833 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -79.91 92.6 5.55 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.4 0.619 . . . . 75.0 110.715 178.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.428 ' HB3' ' O ' ' A' ' 88' ' ' ALA . 5.2 tt0 -96.31 114.66 26.37 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.364 -0.834 . . . . 55.53 110.01 179.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 20.0 tp -101.68 112.77 25.46 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.01 -0.541 . . . . 75.11 110.413 -178.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.79 ' HB2' ' HB3' ' A' ' 86' ' ' ASP . 44.2 m-80 -93.54 103.3 15.5 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.109 -0.33 . . . . 73.45 110.109 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.435 ' CG1' ' HD2' ' A' ' 83' ' ' TYR . 68.9 t -93.35 109.22 21.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.534 0.683 . . . . 72.02 110.864 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.553 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 35.7 m -97.58 107.15 19.58 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.318 -0.855 . . . . 64.32 109.741 176.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.445 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 45.1 t0 -72.64 147.37 45.84 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.348 0.594 . . . . 63.4 111.48 -175.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.509 ' HD2' ' HA ' ' A' ' 82' ' ' ASP . 51.1 ttt180 -95.48 -26.42 15.83 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.994 -1.003 . . . . 73.23 109.66 177.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 35.9 mtpt -84.29 -65.99 0.95 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.724 -0.671 . . . . 73.34 110.984 -173.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 72.2 p -86.87 -19.0 29.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.213 0.53 . . . . 74.11 110.296 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.445 ' HA2' ' O ' ' A' ' 100' ' ' ASP . . . 71.82 21.2 79.0 Favored Glycine 0 N--CA 1.452 -0.284 0 CA-C-N 115.233 -0.894 . . . . 65.24 112.903 176.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 83.2 mm-40 -88.63 136.13 33.15 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.619 -0.512 . . . . 74.43 109.619 175.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 19.3 p -97.27 96.37 8.35 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.06 0.457 . . . . 62.24 110.711 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 29.8 m -97.72 106.85 19.23 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.723 -0.671 . . . . 71.15 110.356 -178.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 95.2 m -91.67 126.23 36.68 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.05 -0.523 . . . . 73.23 110.511 177.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 4.3 mp -115.37 111.04 34.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.188 -0.46 . . . . 75.24 109.961 177.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.407 ' HA ' ' HA ' ' A' ' 95' ' ' GLN . 48.0 mt-30 -89.92 104.3 16.88 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.234 -0.439 . . . . 61.1 110.242 177.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 24.9 t -85.89 91.44 3.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.176 -0.676 . . . . 75.11 109.176 177.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 9.7 m -104.3 -37.67 7.16 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 113.345 0.869 . . . . 73.52 113.345 -169.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -105.97 23.0 30.32 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 119.92 -1.134 . . . . 75.51 114.851 -167.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 93.0 mt 54.4 70.47 0.61 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.526 0.679 . . . . 75.43 110.242 178.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -99.43 22.77 10.22 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.26 -0.882 . . . . 73.22 111.672 -170.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -166.21 166.4 16.91 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.604 -0.517 . . . . 73.42 109.604 178.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 53.3 t30 72.87 96.24 0.07 Allowed 'General case' 0 N--CA 1.466 0.348 0 O-C-N 123.883 0.74 . . . . 63.43 110.626 -178.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 33.8 t -147.4 144.53 28.75 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.656 -0.702 . . . . 75.22 109.177 -178.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 9.6 m 70.56 155.57 0.14 Allowed 'General case' 0 CA--C 1.535 0.396 0 O-C-N 123.74 0.65 . . . . 74.32 110.514 -176.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -85.27 146.48 27.03 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.973 0.416 . . . . 75.14 110.398 178.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -102.52 110.55 22.52 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.849 -0.614 . . . . 75.24 110.55 -179.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -74.43 136.83 42.35 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.086 -0.507 . . . . 74.34 109.808 178.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 60.0 t60 -67.01 104.91 1.5 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.625 -0.509 . . . . 71.55 109.625 179.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.511 ' CG ' ' H ' ' A' ' 125' ' ' HIS . 2.2 p80 -53.46 -75.91 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.543 0 O-C-N 123.808 0.692 . . . . 75.21 112.241 -172.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.511 ' H ' ' CG ' ' A' ' 124' ' ' HIS . 54.3 t-80 66.32 134.32 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.461 0.648 . . . . 74.34 112.208 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -115.72 -51.41 2.67 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.08 -0.509 . . . . 73.13 109.888 172.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 . . . . . 0 C--O 1.247 0.942 0 CA-C-O 118.417 -0.801 . . . . 63.31 109.38 176.965 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.0 mtm . . . . . 0 N--CA 1.48 1.033 0 CA-C-O 120.995 0.426 . . . . 75.5 110.279 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -116.74 123.36 47.0 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.88 -0.6 . . . . 74.23 110.175 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 139.94 146.68 4.9 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.359 -0.696 . . . . 65.14 111.359 -178.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.9 t -65.56 -31.02 71.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.684 0.242 . . . . 73.31 111.077 -177.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 15.9 tpt -161.87 -38.65 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.677 -0.238 . . . . 75.43 111.179 -179.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.7 m 58.95 76.07 0.37 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.706 0.765 . . . . 74.21 110.035 -173.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -95.93 -32.85 12.42 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.441 -0.799 . . . . 75.04 110.82 -175.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -170.58 -66.67 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.264 -0.426 . . . . 73.41 110.318 -178.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 71.5 t80 61.15 85.16 0.12 Allowed 'General case' 0 C--O 1.231 0.12 0 CA-C-O 121.591 0.71 . . . . 73.24 110.556 -177.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.461 ' O ' ' HD3' ' A' ' 12' ' ' PRO . 38.7 ttt180 -105.33 146.37 29.48 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.715 -0.675 . . . . 74.31 109.967 178.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -73.44 92.55 0.04 OUTLIER Pre-proline 0 N--CA 1.466 0.355 0 C-N-CA 124.067 0.947 . . . . 70.54 111.707 178.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 10' ' ' ARG . 1.3 Cg_endo -77.35 125.8 7.99 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.993 2.462 . . . . 71.33 113.198 -167.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 51.2 t30 71.94 121.81 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.303 -0.862 . . . . 75.43 112.316 173.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -138.22 130.64 29.09 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.242 -0.89 . . . . 75.23 109.145 175.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -159.17 122.31 1.13 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.572 -0.823 . . . . 71.23 112.148 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -138.52 133.03 6.05 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 121.001 -0.618 . . . . 73.33 111.861 178.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.408 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 19.2 m120 -96.85 144.08 27.23 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 109.98 -0.378 . . . . 72.14 109.98 178.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 17' ' ' ASN . 6.3 Cg_exo -75.78 -55.91 0.06 OUTLIER 'Trans proline' 0 CA--C 1.53 0.289 0 C-N-CA 122.831 2.354 . . . . 61.41 112.708 -178.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 39.7 t-20 -158.97 139.67 12.6 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.413 -0.588 . . . . 74.52 109.413 -177.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -88.44 -28.39 20.92 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.839 0.352 . . . . 74.24 110.812 -177.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -122.53 -106.09 1.86 Allowed Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.43 -0.89 . . . . 62.44 113.164 -174.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 71.82 155.09 0.15 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.628 0.771 . . . . 64.1 111.685 -174.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 65.8 t80 64.01 86.04 0.13 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.369 -0.832 . . . . 75.42 111.479 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.716 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 3.2 mm? -126.21 141.07 52.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.895 -0.593 . . . . 72.34 110.693 178.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.716 ' HG ' ' O ' ' A' ' 24' ' ' LEU . 1.7 pp 64.59 153.03 0.05 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.688 1.195 . . . . 74.5 113.11 173.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -139.73 94.3 2.76 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.172 -0.922 . . . . 74.45 109.85 174.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.466 ' HB3' HD21 ' A' ' 81' ' ' ASN . 39.0 m 69.34 -67.66 0.21 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.741 -0.663 . . . . 72.43 112.201 178.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 63.71 -86.35 0.02 OUTLIER 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.796 0.838 . . . . 74.12 111.772 -177.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 52.3 tp60 -145.23 117.32 8.34 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.045 0.45 . . . . 75.1 110.664 -176.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.43 ' O ' ' HB3' ' A' ' 31' ' ' GLN . . . -172.64 -157.2 0.1 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.357 -0.838 . . . . 75.25 108.758 -178.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.458 ' O ' ' HB3' ' A' ' 32' ' ' ASN . 28.0 tp60 75.32 -17.82 0.48 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.351 0.5 . . . . 75.53 112.351 170.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.458 ' HB3' ' O ' ' A' ' 31' ' ' GLN . 26.7 t-20 71.52 112.27 0.06 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.238 0.542 . . . . 64.01 109.561 -170.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.4 m -74.99 98.65 3.65 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.079 -0.509 . . . . 74.21 111.03 -174.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -61.27 131.56 50.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.794 -0.639 . . . . 74.43 109.348 175.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 48.8 tttt -99.81 16.56 23.28 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.28 0.562 . . . . 71.43 110.029 -178.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.538 ' HB2' ' HD2' ' A' ' 37' ' ' PRO . 0.6 OUTLIER -131.31 162.51 55.47 Favored Pre-proline 0 C--N 1.325 -0.488 0 N-CA-C 108.818 -0.808 . . . . 74.53 108.818 175.965 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.605 ' HG2' ' HB3' ' A' ' 42' ' ' ASP . 28.1 Cg_endo -62.21 -19.99 68.52 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.716 2.277 . . . . 70.22 114.913 -170.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.577 ' HB3' ' HB2' ' A' ' 42' ' ' ASP . 38.4 t -136.14 -71.04 0.46 Allowed 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.254 -0.578 . . . . 73.21 111.974 -174.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -179.82 140.74 0.14 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.433 -0.581 . . . . 74.42 109.433 -170.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.505 ' C ' HD21 ' A' ' 40' ' ' ASN . 0.1 OUTLIER 54.09 29.46 10.36 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.832 0.678 . . . . 75.2 112.832 173.655 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.7 t70 72.39 85.64 0.12 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.159 -0.928 . . . . 75.34 110.53 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.605 ' HB3' ' HG2' ' A' ' 37' ' ' PRO . 20.7 t70 -82.79 -22.59 34.2 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.767 -1.106 . . . . 70.12 111.032 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 40.5 p90 47.21 25.61 0.57 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.285 1.034 . . . . 75.22 112.965 -178.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -82.77 13.46 42.61 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.83 -0.7 . . . . 74.52 112.241 177.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 45.0 mt -69.75 -26.54 30.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.574 0.702 . . . . 75.24 110.013 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -75.87 -9.31 58.5 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.034 -0.984 . . . . 65.32 111.467 -177.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 2.5 t -128.56 77.92 76.63 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 121.297 0.57 . . . . 73.11 111.374 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -76.75 96.57 1.1 Allowed 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.047 2.498 . . . . 73.11 111.302 176.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.1 m -125.2 -51.06 1.66 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.007 0.432 . . . . 73.25 110.357 -178.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.82 -49.46 8.4 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.139 0.495 . . . . 71.23 110.472 -179.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.2 pp -75.83 -10.16 59.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.934 -0.575 . . . . 73.42 111.337 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.528 ' HA ' HG21 ' A' ' 55' ' ' THR . 17.8 t70 -57.95 -45.57 86.43 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.905 -0.588 . . . . 72.13 111.068 -179.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -61.34 -17.41 53.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.489 -0.778 . . . . 73.01 111.359 -176.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -98.84 -47.18 5.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.353 -0.385 . . . . 74.25 110.59 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.528 HG21 ' HA ' ' A' ' 52' ' ' ASP . 10.0 t -68.85 -31.49 70.49 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.56 -0.291 . . . . 75.41 111.285 -176.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -68.16 -30.89 70.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.77 0.319 . . . . 63.02 110.499 -178.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.1 -12.9 60.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.007 0.432 . . . . 74.22 111.435 -178.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.6 mm -87.79 -24.55 6.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.381 0.61 . . . . 75.44 110.073 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -64.83 -22.58 67.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.699 -0.682 . . . . 74.14 112.138 -174.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 17.3 p -73.82 -41.65 62.03 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.035 0.383 . . . . 73.34 112.035 -175.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -73.41 -18.08 61.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.803 0.335 . . . . 71.1 111.075 -176.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.578 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 57.2 mt -67.74 -28.36 41.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.179 -0.464 . . . . 75.12 110.515 -178.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.2 mp -58.41 -40.2 81.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.351 -0.386 . . . . 74.53 111.056 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -76.29 -31.46 54.77 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.577 -0.821 . . . . 74.2 112.047 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -73.66 -25.31 72.52 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.058 -0.592 . . . . 72.43 112.623 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.578 ' HG ' ' O ' ' A' ' 62' ' ' ILE . 73.0 mt -55.43 -35.9 65.91 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 122.275 0.23 . . . . 72.23 111.501 -179.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.9 mp -56.45 -30.95 63.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.863 0.363 . . . . 71.34 111.42 -178.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 25.2 t -105.0 -16.0 14.94 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.295 -0.412 . . . . 75.11 111.052 -178.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -89.59 -26.67 20.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.816 0.341 . . . . 72.41 110.954 -176.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 66' ' ' LEU . 48.9 mm -75.79 -21.29 15.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.4 0.619 . . . . 73.52 109.929 177.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -68.53 -20.29 64.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.883 -0.599 . . . . 62.21 110.066 176.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 73.2 p 54.28 -169.62 0.06 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.229 -0.896 . . . . 70.33 111.716 -177.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 88.93 -50.06 3.66 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.807 -0.711 . . . . 71.02 112.802 177.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.591 ' HD2' ' O ' ' A' ' 75' ' ' PRO . 0.2 OUTLIER -56.01 152.21 22.16 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 122.303 0.241 . . . . 75.21 111.44 -175.92 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.591 ' O ' ' HD2' ' A' ' 74' ' ' LYS . 38.3 Cg_exo -61.37 177.6 0.8 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.362 2.708 . . . . 73.53 113.329 -177.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -93.27 -151.83 28.48 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.712 -0.756 . . . . 72.12 112.49 -178.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -114.34 162.1 17.05 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.742 0.306 . . . . 72.11 110.439 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 57.6 ttp -106.25 134.5 49.28 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.837 0.351 . . . . 73.31 110.497 -176.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 24.8 t -67.85 126.98 28.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.867 -0.606 . . . . 64.42 109.921 177.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.619 HG22 ' HB2' ' A' ' 83' ' ' TYR . 32.0 m -148.99 140.14 23.07 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.432 -0.581 . . . . 50.13 109.432 178.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.466 HD21 ' HB3' ' A' ' 27' ' ' SER . 65.6 m-20 -55.16 -62.68 1.5 Allowed 'General case' 0 C--N 1.329 -0.312 0 O-C-N 123.449 0.468 . . . . 72.31 112.093 -174.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -114.92 14.09 17.18 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.005 0.372 . . . . 75.51 112.005 -171.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.619 ' HB2' HG22 ' A' ' 80' ' ' THR . 68.5 m-85 -130.49 126.75 37.65 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.734 -0.386 . . . . 74.53 110.999 -177.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.478 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 4.1 mp -95.49 106.73 18.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.045 -0.724 . . . . 71.04 109.045 176.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.9 p -133.47 121.79 42.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.425 0.631 . . . . 64.33 111.815 -174.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -110.35 134.47 52.26 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.36 -0.836 . . . . 74.51 108.952 176.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.0 mt -83.53 80.26 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.025 -0.732 . . . . 73.15 109.025 178.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -86.61 109.42 19.14 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.429 -0.805 . . . . 75.04 111.323 -174.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -82.78 80.27 8.92 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.981 -0.748 . . . . 62.25 108.981 172.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -100.46 131.46 46.37 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.336 -0.847 . . . . 75.44 109.71 -177.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.5 t70 70.4 5.67 5.46 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 123.941 0.776 . . . . 71.02 111.034 177.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 112.04 -24.48 14.47 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.048 -0.596 . . . . 75.32 112.764 177.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.407 ' HA ' HE21 ' A' ' 93' ' ' GLN . 0.0 OUTLIER -92.59 141.34 28.6 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 122.734 -0.274 . . . . 73.12 110.94 -176.889 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.543 ' HB2' ' HB ' ' A' ' 111' ' ' VAL . 3.5 mm? -71.67 105.63 3.77 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.208 -0.664 . . . . 75.0 109.208 170.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -109.01 111.32 22.92 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.238 0.542 . . . . 55.53 110.649 -178.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 15.1 tp -81.69 99.94 9.2 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.614 -0.721 . . . . 75.11 109.263 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -94.02 106.87 18.83 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.118 -0.492 . . . . 73.45 110.341 -177.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 69.5 t -101.14 114.67 41.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.227 0.537 . . . . 72.02 111.46 -176.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.478 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 86.8 m -101.67 106.25 17.27 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.585 -0.734 . . . . 64.32 109.52 172.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.453 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 15.3 t0 -76.68 145.63 38.63 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.985 -0.552 . . . . 63.4 111.157 -178.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.547 ' O ' ' HD2' ' A' ' 101' ' ' ARG . 5.2 tmm_? -103.43 -25.76 13.14 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.789 -0.641 . . . . 73.23 109.635 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -73.73 -56.55 4.85 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.887 -0.597 . . . . 73.34 111.176 -173.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 71.7 p -109.24 -25.42 10.61 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.268 0.556 . . . . 74.11 110.265 176.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' A' ' 100' ' ' ASP . . . 98.68 13.88 39.3 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.723 -0.672 . . . . 65.24 112.644 177.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.438 ' N ' ' HB3' ' A' ' 100' ' ' ASP . 50.5 mm-40 -65.01 109.57 2.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.319 0.581 . . . . 74.43 111.165 178.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.5 m -87.97 100.13 12.68 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.409 -0.814 . . . . 62.24 109.097 176.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 7.6 t -103.08 141.18 36.27 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.937 0.399 . . . . 71.15 110.224 -175.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 46.6 m -116.69 106.08 13.13 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.075 -0.512 . . . . 73.23 110.664 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.422 ' N ' HD13 ' A' ' 109' ' ' ILE . 4.4 mp -111.52 105.15 18.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.3 -0.409 . . . . 75.24 110.721 -177.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -70.68 157.97 37.07 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.011 0.434 . . . . 61.1 110.843 175.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.543 ' HB ' ' HB2' ' A' ' 94' ' ' LEU . 3.4 p -59.41 114.61 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.381 -0.827 . . . . 75.11 111.685 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.7 p -90.22 -35.56 15.27 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.492 -0.777 . . . . 73.52 110.294 177.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 142.72 97.27 0.26 Allowed Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 111.153 -0.779 . . . . 75.51 111.153 -179.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 74.9 mt -86.64 -60.17 2.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.321 0.105 . . . . 75.43 111.088 -173.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 63.66 107.63 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 O-C-N 123.872 0.732 . . . . 73.22 111.474 -177.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -111.07 148.88 31.66 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.106 -0.497 . . . . 73.42 110.936 -177.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -108.72 110.33 21.7 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.886 -1.153 . . . . 63.43 107.886 172.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.0 t -65.8 -71.97 0.17 Allowed 'General case' 0 C--N 1.328 -0.358 0 O-C-N 123.223 0.327 . . . . 75.22 111.263 -171.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.0 m -153.06 128.58 10.0 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.632 -0.258 . . . . 74.32 110.746 -177.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -107.51 137.64 45.17 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.757 -0.46 . . . . 75.14 109.757 174.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -82.96 136.82 34.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.265 -0.425 . . . . 75.24 111.575 -172.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 79.4 m-70 -129.77 174.95 9.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.705 -0.68 . . . . 74.34 109.234 175.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 66.5 -167.48 0.21 Allowed 'General case' 0 N--CA 1.467 0.392 0 O-C-N 123.521 0.513 . . . . 71.55 111.52 178.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 6.8 t60 59.16 78.54 0.26 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.18 -0.918 . . . . 75.21 111.691 177.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -176.9 159.3 1.71 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.455 -0.793 . . . . 74.34 109.025 174.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 28.9 m80 -107.17 168.1 9.45 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 121.013 -0.275 . . . . 73.13 110.529 178.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.384 -0.817 . . . . 63.31 110.279 -175.804 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.0 ttm . . . . . 0 N--CA 1.478 0.945 0 N-CA-C 110.46 -0.2 . . . . 75.5 110.46 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.27 175.42 0.18 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.508 0.671 . . . . 74.23 112.473 177.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -89.46 -131.9 4.44 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.766 -0.73 . . . . 65.14 112.134 175.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.5 m -111.31 -62.36 1.56 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 110.005 -0.368 . . . . 73.31 110.005 177.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 27.0 ttt -179.49 -59.91 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.847 -0.615 . . . . 75.43 110.185 177.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 28.2 m 71.38 148.12 0.08 Allowed 'General case' 0 CA--C 1.536 0.433 0 O-C-N 123.388 0.43 . . . . 74.21 110.508 -178.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -78.73 -54.58 5.95 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 122.109 -0.369 . . . . 75.04 111.815 -176.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -112.53 21.35 15.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.736 0.303 . . . . 73.41 111.459 -174.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 55.7 t80 63.99 -80.28 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.642 -0.708 . . . . 73.24 111.712 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -158.31 82.53 0.84 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.886 0.374 . . . . 74.31 110.055 -177.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -128.75 86.61 57.06 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 116.09 -0.505 . . . . 70.54 110.096 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -74.64 107.39 2.45 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 123.279 2.653 . . . . 71.33 113.354 -174.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 22.0 m120 68.97 121.59 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 O-C-N 124.227 0.955 . . . . 75.43 112.785 173.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -97.64 136.65 37.7 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.286 -0.87 . . . . 75.23 109.035 175.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 130.94 133.09 3.47 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.478 -0.867 . . . . 71.23 111.401 -176.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 138.12 -76.25 0.36 Allowed Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.262 -0.735 . . . . 73.33 111.262 -177.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.425 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 6.0 m-20 66.07 146.42 0.1 Allowed Pre-proline 0 N--CA 1.469 0.52 0 C-N-CA 123.104 0.562 . . . . 72.14 111.841 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 17' ' ' ASN . 24.1 Cg_exo -65.11 -28.41 56.76 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.431 2.087 . . . . 61.41 111.44 174.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -105.29 104.97 14.8 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.796 -0.638 . . . . 74.52 109.482 177.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -140.54 149.35 42.32 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.355 -0.384 . . . . 74.24 110.119 -178.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 159.76 -69.95 0.24 Allowed Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.841 -0.695 . . . . 62.44 112.455 177.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 64.99 98.95 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 O-C-N 124.134 0.549 . . . . 64.1 111.373 -176.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -68.69 112.66 5.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.967 -0.56 . . . . 75.42 110.5 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.655 HD13 ' HG ' ' A' ' 25' ' ' LEU . 2.6 pp -137.58 9.4 2.89 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.941 -0.572 . . . . 72.34 110.911 -177.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.655 ' HG ' HD13 ' A' ' 24' ' ' LEU . 97.7 mt -117.42 162.22 18.3 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.93 -0.577 . . . . 74.5 110.419 178.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 62.7 t30 66.62 102.13 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 O-C-N 123.856 0.722 . . . . 74.45 111.457 178.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.8 m -86.12 172.55 10.49 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.75 -0.659 . . . . 72.43 110.632 -179.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -95.24 115.71 27.79 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.668 0.27 . . . . 74.12 110.478 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -110.67 171.58 7.38 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.175 -0.466 . . . . 75.1 110.043 -179.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 71.95 -48.89 0.68 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.616 0.766 . . . . 75.25 111.439 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -81.06 151.4 28.39 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.121 -0.49 . . . . 75.53 109.872 176.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 55.5 t30 72.19 141.75 0.06 Allowed 'General case' 0 N--CA 1.469 0.522 0 O-C-N 123.976 0.797 . . . . 64.01 111.094 -176.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.3 m 63.15 58.3 1.46 Allowed 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.902 -0.59 . . . . 74.21 110.813 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 99.7 m-85 -81.48 77.01 8.39 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.872 -0.604 . . . . 74.43 111.51 -174.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm -129.0 -164.99 1.45 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.102 -0.703 . . . . 71.43 109.102 174.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -70.37 143.42 90.6 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-O 121.062 0.458 . . . . 74.53 110.863 -177.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.849 ' HB3' ' H ' ' A' ' 43' ' ' PHE . 13.6 Cg_endo -57.1 164.07 6.98 Favored 'Trans proline' 0 N--CA 1.473 0.318 0 C-N-CA 123.983 3.122 . . . . 70.22 113.864 178.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.5 t -65.65 -69.92 0.27 Allowed 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.705 -0.68 . . . . 73.21 109.977 176.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -140.26 152.7 46.13 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.554 0.216 . . . . 74.42 110.778 177.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 20.1 m120 59.07 30.56 20.39 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.853 -0.612 . . . . 75.2 112.587 172.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.499 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 11.9 t70 62.05 36.27 15.48 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.204 0.526 . . . . 75.34 110.789 176.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -45.2 -67.59 0.27 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.219 -0.9 . . . . 70.12 111.786 178.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.849 ' H ' ' HB3' ' A' ' 37' ' ' PRO . 11.3 m-85 -105.48 36.2 2.59 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.684 0.278 . . . . 75.22 110.773 175.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -79.08 3.35 65.96 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.802 -0.713 . . . . 74.52 111.978 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 58.3 mt -107.33 -42.64 6.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.291 -0.455 . . . . 75.24 110.568 -179.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 63.35 -165.45 0.24 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.889 -0.596 . . . . 65.32 111.005 -178.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 28.8 m -134.8 83.4 41.34 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-O 121.05 0.452 . . . . 73.11 110.669 178.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.637 ' HB2' ' HB2' ' A' ' 52' ' ' ASP . 18.4 Cg_endo -93.97 108.49 0.16 Allowed 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 123.491 2.794 . . . . 73.11 112.124 177.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.4 m -110.18 -78.65 0.59 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.386 -0.37 . . . . 73.25 111.049 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.46 -40.64 57.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.758 0.313 . . . . 71.23 111.405 -177.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.7 pp -68.37 -22.6 64.65 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.801 0.334 . . . . 73.42 110.358 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.637 ' HB2' ' HB2' ' A' ' 48' ' ' PRO . 7.7 t70 -61.68 -41.85 98.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.975 -0.557 . . . . 72.13 110.431 177.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 -68.18 -42.42 80.01 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.799 -0.637 . . . . 73.01 109.925 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -68.34 -50.12 55.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.62 -0.718 . . . . 74.25 111.567 -175.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.5 t -67.85 -17.86 64.63 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.787 0.327 . . . . 75.41 111.575 -175.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -75.94 -21.89 56.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.835 0.35 . . . . 63.02 110.935 -177.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -82.93 -19.26 37.57 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.52 0.676 . . . . 74.22 109.867 174.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.493 ' O ' HG13 ' A' ' 62' ' ' ILE . 19.5 mt -79.39 -25.86 12.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.165 -0.925 . . . . 75.44 110.489 -179.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -57.8 -28.62 64.19 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.705 -0.68 . . . . 74.14 111.701 -176.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.7 m -79.13 -35.38 42.23 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.39 -0.368 . . . . 73.34 111.49 -177.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' A' ' 58' ' ' ILE . 11.3 pt20 -82.05 -6.31 59.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.897 0.379 . . . . 71.1 111.627 -174.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.493 HG13 ' O ' ' A' ' 58' ' ' ILE . 67.7 mt -70.82 -31.93 47.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.832 0.348 . . . . 75.12 110.641 -178.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.725 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 8.8 mp -59.4 -46.97 87.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 74.53 111.512 -177.014 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -57.48 -27.26 58.13 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 121.177 -0.535 . . . . 74.2 112.906 -178.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -92.7 -42.63 4.41 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.558 -0.83 . . . . 72.43 112.294 178.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.543 ' HA ' ' HB2' ' A' ' 69' ' ' ASN . 1.3 pp -64.44 -23.75 67.39 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 111.415 0.154 . . . . 72.23 111.415 -176.039 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.725 ' HG ' ' O ' ' A' ' 63' ' ' LEU . 80.7 mt -52.17 -46.27 65.44 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.058 0.456 . . . . 71.34 110.594 177.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.6 t -90.7 -4.91 56.39 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.101 -0.499 . . . . 75.11 110.485 -177.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.543 ' HB2' ' HA ' ' A' ' 66' ' ' LEU . 9.2 m120 -86.22 -21.43 27.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.061 0.457 . . . . 72.41 109.96 174.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.451 HG12 ' O ' ' A' ' 66' ' ' LEU . 51.4 mm -72.59 -31.7 38.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 108.593 -0.891 . . . . 73.52 108.593 168.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -68.78 -56.08 9.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.074 -0.967 . . . . 62.21 109.767 175.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 48.5 m -97.69 101.43 12.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.883 -0.598 . . . . 70.33 111.26 178.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -76.68 82.87 1.05 Allowed Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.5 -0.773 . . . . 71.02 111.344 177.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -55.03 142.17 57.49 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.484 -0.358 . . . . 75.21 110.88 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -66.46 -47.58 2.97 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 122.768 2.312 . . . . 73.53 112.076 -178.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 175.83 116.21 0.45 Allowed Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 115.68 -0.691 . . . . 72.12 111.734 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.472 ' HD2' ' O ' ' A' ' 77' ' ' ARG . 0.1 OUTLIER -90.47 143.21 26.97 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.666 0.27 . . . . 72.11 110.359 177.536 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 54.4 ttp -85.87 114.52 22.86 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.176 0.513 . . . . 73.31 111.044 -174.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 42.5 t -97.11 98.84 7.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.607 -0.724 . . . . 64.42 109.601 177.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.2 140.91 52.44 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.064 -0.516 . . . . 50.13 111.168 -178.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -75.94 60.0 1.33 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.213 0.53 . . . . 72.31 111.736 -177.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -170.75 -41.41 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.402 -0.817 . . . . 75.51 109.165 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -144.66 123.84 12.92 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.483 -0.78 . . . . 74.53 110.183 174.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.583 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 50.6 mm -92.32 109.11 21.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 109.1 -0.704 . . . . 71.04 109.1 173.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 43.9 t -108.42 96.39 4.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.983 0.42 . . . . 64.33 110.406 -178.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.458 ' OD1' ' HG2' ' A' ' 77' ' ' ARG . 10.9 t70 -107.68 114.34 28.24 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.962 -0.563 . . . . 74.51 110.049 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 56.3 mt -80.92 86.91 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.233 -0.654 . . . . 73.15 109.233 176.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -98.38 171.36 8.23 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.856 -0.611 . . . . 75.04 110.848 -176.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.518 ' HB2' HD12 ' A' ' 94' ' ' LEU . 51.9 t-20 -146.04 138.38 25.38 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.071 -1.085 . . . . 62.25 108.071 178.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.432 ' O ' ' HB3' ' A' ' 91' ' ' ASP . 14.9 ttp180 -123.15 110.36 15.18 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.032 -0.358 . . . . 75.44 110.032 177.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.432 ' HB3' ' O ' ' A' ' 90' ' ' ARG . 15.6 t70 75.15 -45.57 0.56 Allowed 'General case' 0 N--CA 1.471 0.582 0 O-C-N 123.773 0.67 . . . . 71.02 111.837 177.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -178.46 -27.97 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.882 -0.675 . . . . 75.32 112.35 -178.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.491 ' HA ' HE21 ' A' ' 93' ' ' GLN . 0.1 OUTLIER -93.1 125.08 37.52 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.055 0.455 . . . . 73.12 110.389 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.554 ' HB2' ' HB ' ' A' ' 111' ' ' VAL . 4.2 mm? -61.44 141.69 57.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.536 -0.756 . . . . 75.0 111.114 -178.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.49 ' HA ' HE21 ' A' ' 95' ' ' GLN . 0.0 OUTLIER -131.94 97.92 4.3 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.674 -0.693 . . . . 55.53 109.566 -178.523 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.453 ' HB3' ' HB ' ' A' ' 109' ' ' ILE . 69.4 tp -80.32 113.15 18.3 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.027 -0.533 . . . . 75.11 110.289 -177.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -106.11 113.1 26.44 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.227 -0.442 . . . . 73.45 110.777 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.583 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 46.4 t -110.82 117.35 54.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.531 -0.758 . . . . 72.02 110.33 175.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.543 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 25.7 m -94.28 101.1 13.06 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.519 -0.764 . . . . 64.32 110.25 176.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.537 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 29.4 t70 -67.79 130.36 42.74 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.686 -0.688 . . . . 63.4 109.949 177.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 42.1 ttt180 -98.7 -22.93 15.65 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.915 0.388 . . . . 73.23 110.891 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -68.23 -45.44 73.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.082 -0.508 . . . . 73.34 111.157 -173.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.407 ' OG1' ' HG3' ' A' ' 105' ' ' GLN . 77.6 p -123.4 -32.86 3.34 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.303 0.573 . . . . 74.11 110.369 177.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.537 ' HA2' ' O ' ' A' ' 100' ' ' ASP . . . 103.19 30.04 5.52 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.493 -0.776 . . . . 65.24 112.435 178.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.407 ' HG3' ' OG1' ' A' ' 103' ' ' THR . 47.8 mt-30 -72.95 105.36 4.4 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.179 -0.304 . . . . 74.43 110.179 176.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 33.5 m -67.77 101.35 1.04 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.083 0.468 . . . . 62.24 110.058 176.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.485 ' HB2' ' HB ' ' A' ' 98' ' ' VAL . 23.5 m -99.77 96.38 7.56 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.012 -0.54 . . . . 71.15 110.619 -177.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 24.6 m -104.46 99.72 9.42 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.256 0.55 . . . . 73.23 110.007 176.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.453 ' HB ' ' HB3' ' A' ' 96' ' ' LEU . 4.0 mp -90.67 121.51 41.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.767 -0.651 . . . . 75.24 110.531 -176.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -82.67 110.25 17.56 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.556 -0.535 . . . . 61.1 109.556 176.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.554 ' HB ' ' HB2' ' A' ' 94' ' ' LEU . 51.0 t -87.87 129.19 39.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.514 -0.312 . . . . 75.11 110.281 -177.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.6 t 69.24 -155.48 0.16 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.745 -0.661 . . . . 73.52 109.724 -176.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 94.16 -71.33 1.22 Allowed Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 111.199 -0.76 . . . . 75.51 111.199 -177.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 94.6 mt -96.93 75.13 2.66 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.044 0.449 . . . . 75.43 110.043 177.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -139.83 132.78 29.36 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.58 -0.736 . . . . 73.22 109.936 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 34.4 p30 -162.33 167.74 23.33 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.623 -0.262 . . . . 73.42 110.937 179.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -150.02 151.55 33.46 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.862 0.363 . . . . 63.43 110.887 175.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 12.1 t -116.75 152.7 33.79 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.673 -0.862 . . . . 75.22 108.673 174.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 8.9 t -59.8 126.42 27.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.3 0.571 . . . . 74.32 110.674 -178.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -80.33 91.54 5.67 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.594 0.711 . . . . 75.14 111.262 -176.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -67.28 138.37 56.8 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.176 -0.675 . . . . 75.24 109.176 175.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 60.2 m-70 -68.08 123.54 20.94 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.258 0.551 . . . . 74.34 110.866 -175.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 52.9 m-70 -88.45 139.61 30.31 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.183 -0.917 . . . . 71.55 111.209 -171.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.509 ' CD2' ' H ' ' A' ' 125' ' ' HIS . 1.3 t-160 -135.76 -164.26 1.52 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.272 -1.01 . . . . 75.21 108.272 173.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.509 ' H ' ' CD2' ' A' ' 124' ' ' HIS . 48.3 t60 -111.92 94.05 4.76 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.062 0.458 . . . . 74.34 111.121 -173.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.509 ' O ' ' HB2' ' A' ' 127' ' ' HIS . 10.1 t60 -94.58 174.68 6.99 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.976 -1.12 . . . . 73.13 107.976 173.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.509 ' HB2' ' O ' ' A' ' 126' ' ' HIS . 8.9 m-70 . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.106 -0.95 . . . . 63.31 110.564 -178.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.0 ttm . . . . . 0 N--CA 1.478 0.954 0 CA-C-O 121.134 0.493 . . . . 75.5 109.976 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.77 155.46 41.72 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.96 -0.564 . . . . 74.23 110.696 -177.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -89.95 -77.93 1.33 Allowed Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 111.597 -0.601 . . . . 65.14 111.597 177.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.4 HG21 ' HG3' ' A' ' 5' ' ' MET . 26.9 m 72.91 150.09 0.1 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 122.81 0.444 . . . . 73.31 111.758 178.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.4 ' HG3' HG21 ' A' ' 4' ' ' THR . 72.8 mtm 74.47 81.69 0.11 Allowed 'General case' 0 C--O 1.236 0.342 0 C-N-CA 123.477 0.711 . . . . 75.43 112.586 176.148 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 89.4 m -106.87 99.76 9.3 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.907 -0.775 . . . . 74.21 108.907 168.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -128.14 126.4 41.02 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.338 0.59 . . . . 75.04 112.454 -170.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -139.13 90.61 2.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.435 -0.802 . . . . 73.41 109.933 172.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.597 ' HD2' ' HG3' ' A' ' 10' ' ' ARG . 31.2 p90 -102.59 173.11 6.48 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.834 -0.621 . . . . 73.24 110.015 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.597 ' HG3' ' HD2' ' A' ' 9' ' ' PHE . 72.7 mtp180 68.74 -169.02 0.18 Allowed 'General case' 0 C--O 1.236 0.365 0 O-C-N 124.022 0.826 . . . . 74.31 110.307 -174.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 62.18 81.13 0.24 Allowed Pre-proline 0 CA--C 1.532 0.255 0 O-C-N 123.483 0.489 . . . . 70.54 110.602 -178.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -78.12 -39.49 0.46 Allowed 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.702 2.268 . . . . 71.33 113.539 -176.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.413 ' CG ' ' H ' ' A' ' 14' ' ' PHE . 66.6 t30 63.73 -175.04 0.16 Allowed 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 109.573 -0.528 . . . . 75.43 109.573 -174.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.413 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 72.7 t80 74.32 134.93 0.05 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.294 0.569 . . . . 75.23 111.208 176.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -96.45 149.78 19.41 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.814 -0.707 . . . . 71.23 112.714 -178.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -72.68 121.95 8.18 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.861 -0.685 . . . . 73.33 111.521 177.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.2 143.37 26.02 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-O 120.642 0.258 . . . . 72.14 110.677 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -66.98 -29.35 40.87 Favored 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 122.556 2.171 . . . . 61.41 111.364 175.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 65.06 23.36 12.46 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.523 -0.762 . . . . 74.52 111.18 179.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -75.4 146.44 40.79 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.977 -0.556 . . . . 74.24 109.831 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -133.87 173.56 21.21 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.439 -0.886 . . . . 62.44 112.641 -176.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -91.96 4.24 53.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.528 0.164 . . . . 64.1 111.207 -178.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 13.9 p90 44.37 79.91 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.071 0.949 . . . . 75.42 112.819 178.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.4 ' N ' HD21 ' A' ' 24' ' ' LEU . 2.5 pt? -146.37 134.1 21.14 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.753 -0.658 . . . . 72.34 110.453 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 81.6 mt -85.52 -69.04 0.69 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.467 -0.333 . . . . 74.5 110.608 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.8 m120 60.4 38.84 19.19 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.045 -0.525 . . . . 74.45 111.469 178.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.1 m -72.62 156.06 39.38 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.085 -0.507 . . . . 72.43 110.081 177.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -109.37 8.14 25.35 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.444 -0.343 . . . . 74.12 110.905 -176.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 62.7 -164.54 0.25 Allowed 'General case' 0 N--CA 1.465 0.307 0 O-C-N 123.563 0.54 . . . . 75.1 110.652 -177.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.98 168.84 12.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.219 0.533 . . . . 75.25 111.366 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -130.32 166.95 19.31 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.802 -0.636 . . . . 75.53 110.125 -177.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -88.63 174.0 8.3 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.335 -0.393 . . . . 64.01 110.154 177.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.8 m -87.22 -44.48 11.43 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.53 -0.305 . . . . 74.21 111.355 -176.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 67.92 8.97 6.83 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.549 0.69 . . . . 74.43 110.542 -174.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -161.21 79.18 0.59 Allowed 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 107.692 -1.225 . . . . 71.43 107.692 175.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -105.04 151.85 39.55 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.269 -0.878 . . . . 74.53 111.089 -172.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.472 ' HD3' HG13 ' A' ' 45' ' ' ILE . 48.0 Cg_endo -69.9 -12.81 33.36 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.608 2.205 . . . . 70.22 111.505 176.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.0 m 69.2 6.42 5.65 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.257 -0.883 . . . . 73.21 112.167 176.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.491 ' HD1' ' ND2' ' A' ' 40' ' ' ASN . 2.8 t80 -162.96 139.49 7.36 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.966 -0.383 . . . . 74.42 109.966 175.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.491 ' ND2' ' HD1' ' A' ' 39' ' ' TYR . 38.0 m-80 65.21 68.8 0.49 Allowed 'General case' 0 C--O 1.235 0.301 0 O-C-N 123.992 0.807 . . . . 75.2 110.137 -177.275 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.3 t70 71.84 140.42 0.05 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.165 -0.925 . . . . 75.34 110.801 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -82.79 -2.7 55.25 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 122.111 -0.368 . . . . 70.12 111.398 -176.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -112.56 20.68 16.39 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 109.484 -0.561 . . . . 75.22 109.484 170.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -76.2 39.88 1.45 Allowed Glycine 0 C--N 1.335 0.527 0 CA-C-N 115.791 -0.64 . . . . 74.52 113.766 -173.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.472 HG13 ' HD3' ' A' ' 37' ' ' PRO . 17.8 mt -118.17 25.07 4.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 107.869 -1.16 . . . . 75.24 107.869 174.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 56.63 46.04 21.03 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 114.459 -1.246 . . . . 65.32 109.375 -174.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 21.6 m -114.97 86.52 13.62 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.162 -0.926 . . . . 73.11 109.909 178.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.681 ' HB2' ' HB2' ' A' ' 52' ' ' ASP . 48.5 Cg_endo -70.68 83.65 0.85 Allowed 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.24 1.96 . . . . 73.11 112.69 -177.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.6 m -96.57 -54.99 3.06 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.754 -0.657 . . . . 73.25 109.913 173.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -100.78 -27.92 13.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.99 0.424 . . . . 71.23 111.109 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.44 ' HA ' ' HB3' ' A' ' 54' ' ' PHE . 0.8 OUTLIER -87.15 -3.03 59.04 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.997 -0.547 . . . . 73.42 111.591 -176.609 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.681 ' HB2' ' HB2' ' A' ' 48' ' ' PRO . 17.2 t70 -62.59 -69.23 0.27 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.51 -0.314 . . . . 72.13 111.589 -176.098 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -66.09 -23.91 66.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.269 0.557 . . . . 73.01 110.155 177.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.542 ' O ' HG13 ' A' ' 58' ' ' ILE . 85.3 t80 -61.56 -53.42 56.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.583 -0.735 . . . . 74.25 110.817 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.413 ' O ' ' HG3' ' A' ' 59' ' ' GLN . 9.8 t -69.12 -21.42 64.03 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.133 0.492 . . . . 75.41 110.873 -177.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -73.42 -39.65 64.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.242 0.544 . . . . 63.02 109.915 178.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.64 -29.36 69.37 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.646 -0.706 . . . . 74.22 109.998 175.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.574 ' HA ' ' HG2' ' A' ' 61' ' ' GLN . 15.8 mt -64.07 -39.29 84.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.879 -0.6 . . . . 75.44 110.44 176.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.413 ' HG3' ' O ' ' A' ' 55' ' ' THR . 73.0 mt-30 -58.1 -42.29 85.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.279 -0.419 . . . . 74.14 110.438 178.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.5 m -61.16 -45.31 95.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.078 -0.51 . . . . 73.34 110.584 177.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.666 ' O ' ' HA3' ' A' ' 65' ' ' GLY . 3.1 pt20 -80.81 7.74 9.75 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.824 -0.625 . . . . 71.1 110.85 -176.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 58' ' ' ILE . 83.2 mt -100.8 -55.84 5.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.954 -0.758 . . . . 75.12 108.954 168.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 89.6 mt -59.04 -41.42 87.81 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.613 -0.721 . . . . 74.53 111.049 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -108.85 -0.66 32.05 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.713 -0.756 . . . . 74.2 112.199 178.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.666 ' HA3' ' O ' ' A' ' 61' ' ' GLN . . . -85.44 -22.12 52.08 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.847 -0.692 . . . . 72.43 112.492 -176.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 62' ' ' ILE . 90.8 mt -60.08 -30.54 69.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.014 0.435 . . . . 72.23 109.985 176.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 70.3 mt -67.36 -33.07 74.46 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.483 -0.78 . . . . 71.34 110.682 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 9.2 m -73.27 -32.22 64.54 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.047 -0.524 . . . . 75.11 110.388 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -91.34 10.99 25.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.027 -0.533 . . . . 72.41 111.622 -177.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 36.1 mm -66.11 -34.7 71.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.158 0.504 . . . . 73.52 109.964 174.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -62.85 -60.58 3.28 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.711 -0.677 . . . . 62.21 110.728 176.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.5 m 73.66 -44.49 0.58 Allowed 'General case' 0 CA--C 1.535 0.401 0 O-C-N 123.631 0.582 . . . . 70.33 112.489 175.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.39 12.59 13.48 Favored Glycine 0 CA--C 1.519 0.314 0 N-CA-C 114.005 0.362 . . . . 71.02 114.005 -173.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.33 146.34 53.32 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.953 0.376 . . . . 75.21 110.211 175.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -58.27 -55.67 2.06 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.938 2.425 . . . . 73.53 112.979 -174.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 174.2 -154.97 20.58 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 119.838 -1.173 . . . . 72.12 113.089 -178.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 -127.94 176.02 7.92 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.564 -0.318 . . . . 72.11 110.367 -174.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.803 ' HB3' HG12 ' A' ' 85' ' ' VAL . 48.9 ttm -130.77 115.23 16.35 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.865 -0.42 . . . . 73.31 109.865 176.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 59.9 t -87.79 111.31 21.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.041 -0.527 . . . . 64.42 110.552 -177.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.59 HG22 ' H ' ' A' ' 82' ' ' ASP . 24.5 m -130.67 138.95 50.29 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.902 -0.59 . . . . 50.13 109.819 178.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -67.69 -23.32 65.28 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.946 0.403 . . . . 72.31 111.132 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.59 ' H ' HG22 ' A' ' 80' ' ' THR . 25.0 m-20 -97.66 -19.14 18.46 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.177 -0.465 . . . . 75.51 111.462 -177.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -144.38 136.8 26.58 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.5 0.556 . . . . 74.53 112.5 -171.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.571 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 4.1 mp -98.23 105.68 17.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 108.172 -1.048 . . . . 71.04 108.172 169.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.803 HG12 ' HB3' ' A' ' 78' ' ' MET . 5.6 p -135.98 135.66 50.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.258 0.551 . . . . 64.33 111.75 -174.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -128.43 143.49 51.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.473 -0.785 . . . . 74.51 109.18 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.4 HD12 ' N ' ' A' ' 87' ' ' ILE . 4.3 mp -95.85 86.63 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.355 -0.609 . . . . 73.15 109.355 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -105.26 128.12 53.28 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.784 -0.644 . . . . 75.04 111.223 -175.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -84.36 115.81 22.71 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.037 -0.727 . . . . 62.25 109.037 174.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -130.99 132.51 45.06 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.949 -0.389 . . . . 75.44 109.949 177.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.9 t70 68.11 11.15 8.24 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 124.036 0.835 . . . . 71.02 110.574 179.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 97.59 -0.08 59.49 Favored Glycine 0 N--CA 1.452 -0.248 0 CA-C-N 115.675 -0.693 . . . . 75.32 112.402 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.501 ' HA ' HE21 ' A' ' 93' ' ' GLN . 0.0 OUTLIER -114.29 134.41 54.97 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.752 0.31 . . . . 73.12 110.423 179.171 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -67.0 108.9 2.77 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.117 -0.697 . . . . 75.0 109.117 173.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.406 HE21 ' HB2' ' A' ' 95' ' ' GLN . 6.1 tt0 -105.57 110.41 22.73 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.74 -0.664 . . . . 55.53 110.538 -173.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 17.3 tp -88.24 94.08 9.71 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.865 -0.607 . . . . 75.11 109.75 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -85.83 102.55 13.78 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.195 -0.457 . . . . 73.45 110.499 -179.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 24.6 t -94.39 123.56 46.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.057 0.456 . . . . 72.02 111.119 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.571 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 32.1 m -111.61 107.99 17.32 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.155 -0.475 . . . . 64.32 110.12 174.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.448 ' HB3' ' H ' ' A' ' 105' ' ' GLN . 15.3 t70 -65.99 131.1 45.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.776 -0.647 . . . . 63.4 110.3 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.533 ' NE ' ' HA ' ' A' ' 101' ' ' ARG . 2.8 tpm_? -107.88 17.72 22.14 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.609 0.718 . . . . 73.23 110.796 -177.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.5 mtpm? -107.11 -66.78 0.99 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.855 0.836 . . . . 73.34 109.039 175.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.2 m -91.3 -40.59 11.41 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 114.175 -1.375 . . . . 74.11 109.211 -178.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 98.11 82.98 1.69 Allowed Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.514 -0.767 . . . . 65.24 113.02 177.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.448 ' H ' ' HB3' ' A' ' 100' ' ' ASP . 54.5 mt-30 -143.15 142.31 31.43 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.099 -0.704 . . . . 74.43 109.099 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.9 m -105.06 85.6 2.3 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.48 0.657 . . . . 62.24 110.221 178.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.32 119.74 26.03 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.483 -0.78 . . . . 71.15 109.957 178.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 37.5 m -105.71 107.44 18.44 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.015 0.436 . . . . 73.23 111.291 -176.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 4.5 mp -102.57 97.83 6.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.144 -0.48 . . . . 75.24 109.843 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -79.86 123.74 28.02 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.016 -0.735 . . . . 61.1 109.016 177.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.7 t -64.56 101.96 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.181 0.515 . . . . 75.11 111.072 -175.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.9 p -81.65 -26.88 34.41 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.478 -0.783 . . . . 73.52 110.576 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 131.78 92.37 0.56 Allowed Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.914 -0.66 . . . . 75.51 111.512 -177.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 96.0 mt -126.92 94.85 4.14 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.694 0.283 . . . . 75.43 110.599 -177.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -105.97 95.18 5.6 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.442 0.639 . . . . 73.22 110.088 176.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -143.12 150.57 39.66 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.253 -0.885 . . . . 73.42 109.991 178.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -171.36 163.36 6.95 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.188 -0.46 . . . . 63.43 109.916 -178.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 24.6 m 58.54 78.35 0.26 Allowed 'General case' 0 C--N 1.33 -0.282 0 O-C-N 123.616 0.573 . . . . 75.22 111.697 178.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -76.72 117.11 18.01 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.08 -0.509 . . . . 74.32 110.418 176.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -75.17 -45.33 41.39 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.057 -0.52 . . . . 75.14 110.952 -177.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -72.44 99.31 2.44 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.87 0.843 . . . . 75.24 110.375 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -117.14 17.6 14.77 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.524 -0.762 . . . . 74.34 110.571 -177.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 46.8 m80 72.23 100.55 0.07 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.171 -0.922 . . . . 71.55 112.469 174.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -132.86 8.85 4.15 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.712 0.768 . . . . 75.21 108.93 173.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.401 ' CE1' ' HA ' ' A' ' 127' ' ' HIS . 13.3 t-80 -120.28 118.34 30.17 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.763 -1.108 . . . . 74.34 109.795 -175.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -79.44 4.59 15.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.445 -0.343 . . . . 73.13 111.563 -176.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.401 ' HA ' ' CE1' ' A' ' 125' ' ' HIS . 23.2 t-160 . . . . . 0 C--O 1.247 0.938 0 CA-C-O 117.99 -1.005 . . . . 63.31 109.917 -174.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ptt? . . . . . 0 N--CA 1.481 1.095 0 N-CA-C 110.138 -0.319 . . . . 75.5 110.138 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.99 -167.02 0.22 Allowed 'General case' 0 C--O 1.234 0.284 0 O-C-N 123.832 0.708 . . . . 74.23 111.228 178.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 106.37 100.18 2.64 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.936 -0.65 . . . . 65.14 111.853 179.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.3 p -69.43 101.09 1.49 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.178 0.513 . . . . 73.31 111.066 -179.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.415 ' O ' ' HB ' ' A' ' 6' ' ' THR . 26.9 ptt? -137.08 167.89 20.66 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.673 -0.694 . . . . 75.43 109.696 -176.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.415 ' HB ' ' O ' ' A' ' 5' ' ' MET . 90.9 m 74.45 131.92 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.575 0.702 . . . . 74.21 112.092 175.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -109.36 -78.45 0.59 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.914 -0.585 . . . . 75.04 110.905 178.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 48.86 19.64 0.28 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.352 1.061 . . . . 73.41 112.961 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -96.02 178.65 5.34 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 110.444 -0.206 . . . . 73.24 110.444 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 76.2 mtp85 62.27 80.92 0.21 Allowed 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.532 0.682 . . . . 74.31 110.877 -177.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 36.7 t-20 -77.9 140.72 62.86 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.038 -0.983 . . . . 70.54 109.268 -178.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -48.42 151.36 4.77 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.622 2.881 . . . . 71.33 113.463 176.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 57.9 t30 62.21 88.86 0.09 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.262 -0.881 . . . . 75.43 110.972 -177.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -136.44 122.57 20.34 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.433 -0.803 . . . . 75.23 110.137 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.62 -32.88 2.11 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.661 -0.699 . . . . 71.23 111.601 -178.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 112.88 161.59 15.06 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.93 -0.653 . . . . 73.33 112.859 177.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -106.0 145.08 30.2 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 109.719 -0.475 . . . . 72.14 109.719 175.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -63.86 115.84 3.33 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 122.801 2.334 . . . . 61.41 112.403 178.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -114.78 166.43 11.76 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.007 -0.542 . . . . 74.52 110.3 -178.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -69.36 136.01 51.13 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.119 -0.326 . . . . 74.24 110.119 178.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -101.99 160.18 17.87 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.802 -0.713 . . . . 62.44 112.71 -177.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.59 141.46 39.5 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.933 0.396 . . . . 64.1 110.935 178.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -119.0 104.18 10.25 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.888 -0.596 . . . . 75.42 110.553 -178.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -169.31 134.21 1.48 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.008 -0.542 . . . . 72.34 110.733 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 93.0 mt -121.14 69.7 0.9 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.84 -0.618 . . . . 74.5 109.34 175.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -124.57 -27.23 3.74 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.687 -0.688 . . . . 74.45 110.904 -174.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 19.9 m -102.48 110.29 22.19 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.354 -0.385 . . . . 72.43 110.785 -178.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -101.46 159.28 15.41 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.094 -0.503 . . . . 74.12 110.146 176.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -86.11 111.16 20.09 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.027 0.441 . . . . 75.1 110.592 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -75.4 151.37 38.16 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.85 -0.613 . . . . 75.25 110.446 179.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 70.8 mm-40 -85.0 86.26 7.4 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.274 0.559 . . . . 75.53 110.055 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -135.93 29.28 3.15 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.779 -0.646 . . . . 64.01 110.72 -177.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.0 p -55.59 105.56 0.19 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 121.517 0.675 . . . . 74.21 111.132 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -139.14 12.78 2.62 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.275 -0.875 . . . . 74.43 109.726 -172.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 49.7 tptt 68.36 37.24 2.78 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.141 -0.936 . . . . 71.43 108.722 -173.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.429 ' HB2' ' HD2' ' A' ' 37' ' ' PRO . 5.9 p-10 -80.48 158.13 71.75 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 114.696 -1.138 . . . . 74.53 110.919 -178.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.533 ' HD3' HG12 ' A' ' 45' ' ' ILE . 31.3 Cg_endo -65.47 -29.9 52.98 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.736 2.29 . . . . 70.22 112.398 178.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 42.0 m 66.53 -70.09 0.11 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.458 0.703 . . . . 73.21 111.457 -177.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -95.06 150.96 19.61 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.532 -0.304 . . . . 74.42 110.591 179.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 20.0 m120 63.92 74.32 0.42 Allowed 'General case' 0 C--N 1.329 -0.323 0 O-C-N 123.966 0.791 . . . . 75.2 111.205 176.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.3 t70 65.99 117.9 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.198 -0.91 . . . . 75.34 111.708 179.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.467 ' HA ' ' HG2' ' A' ' 37' ' ' PRO . 10.9 p-10 -83.96 3.93 31.99 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.878 -0.601 . . . . 70.12 111.551 -175.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -99.51 6.17 45.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.533 -0.303 . . . . 75.22 110.427 176.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -77.54 47.38 2.71 Favored Glycine 0 CA--C 1.521 0.422 0 C-N-CA 121.207 -0.52 . . . . 74.52 113.027 -177.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.533 HG12 ' HD3' ' A' ' 37' ' ' PRO . 11.6 mt -112.19 8.24 8.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 108.808 -0.812 . . . . 75.24 108.808 177.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 53.79 64.74 1.73 Allowed 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 114.755 -1.111 . . . . 65.32 109.732 -171.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 4.8 t -138.25 87.22 16.13 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 114.923 -1.035 . . . . 73.11 109.443 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.611 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 59.2 Cg_endo -70.93 83.78 0.88 Allowed 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.626 2.217 . . . . 73.11 113.244 -173.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 21.0 m -93.75 -68.0 0.82 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.037 -0.529 . . . . 73.25 110.297 174.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -107.69 -3.97 18.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.195 0.521 . . . . 71.23 111.061 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.402 HD22 ' H ' ' A' ' 51' ' ' LEU . 1.1 pt? -108.09 7.89 27.89 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.947 -0.57 . . . . 73.42 110.139 -178.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.611 ' HB3' ' HB2' ' A' ' 48' ' ' PRO . 19.4 p-10 -68.65 -52.8 27.26 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.7 -0.682 . . . . 72.13 111.246 -174.145 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -65.98 -29.21 69.56 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.985 0.422 . . . . 73.01 110.43 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.506 ' O ' HG13 ' A' ' 58' ' ' ILE . 70.7 t80 -66.36 -62.93 1.21 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.726 -0.67 . . . . 74.25 110.899 -178.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.1 t -66.89 -21.48 66.0 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.01 0.433 . . . . 75.41 110.933 -176.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.493 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 3.9 tp-100 -68.98 -43.36 75.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.253 0.549 . . . . 63.02 109.809 -179.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.52 -32.57 74.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.464 -0.789 . . . . 74.22 110.266 178.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.571 ' O ' HG13 ' A' ' 62' ' ' ILE . 19.6 mt -63.34 -39.88 86.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.901 -0.59 . . . . 75.44 110.644 178.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -64.48 -25.0 67.81 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.254 -0.43 . . . . 74.14 111.057 178.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.2 t -89.7 -38.88 13.54 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.308 -0.406 . . . . 73.34 110.748 -178.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.511 ' HG2' ' HA ' ' A' ' 58' ' ' ILE . 3.6 pt20 -66.91 -13.2 61.48 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.91 0.386 . . . . 71.1 110.878 -177.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.571 HG13 ' O ' ' A' ' 58' ' ' ILE . 76.8 mt -62.53 -33.68 60.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.565 -0.531 . . . . 75.12 109.565 175.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.0 mp -68.09 -28.93 67.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.224 -0.898 . . . . 74.53 110.586 -179.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -62.88 -47.51 88.3 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 111.414 -0.674 . . . . 74.2 111.414 178.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -72.76 -35.07 58.94 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.854 -0.689 . . . . 72.43 111.711 177.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.451 ' C ' ' H ' ' A' ' 68' ' ' SER . 47.1 tp -60.85 -49.41 77.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.018 0.437 . . . . 72.23 110.178 177.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 98.8 mt -79.74 32.28 0.25 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.184 0.516 . . . . 71.34 110.64 178.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.451 ' H ' ' C ' ' A' ' 66' ' ' LEU . 61.5 m -135.75 -50.94 0.73 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.436 -0.802 . . . . 75.11 109.592 174.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -69.67 -26.6 64.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.016 -0.538 . . . . 72.41 111.632 -178.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 50.8 mm -82.73 -19.59 10.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.093 0.473 . . . . 73.52 110.573 -178.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.466 ' HB3' ' OD1' ' A' ' 89' ' ' ASN . 51.8 m-20 -66.62 -61.11 2.15 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.214 -0.448 . . . . 62.21 110.852 -176.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.463 HG21 ' HG2' ' A' ' 74' ' ' LYS . 16.0 m -154.58 150.98 28.31 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.546 -0.539 . . . . 70.33 109.546 -178.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -82.97 -44.76 6.97 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.997 -0.621 . . . . 71.02 112.49 -178.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.463 ' HG2' HG21 ' A' ' 72' ' ' THR . 63.0 pttt -57.97 144.13 75.99 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-O 120.689 0.28 . . . . 75.21 110.393 175.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 74' ' ' LYS . 11.6 Cg_exo -70.71 -33.65 12.64 Favored 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.544 2.163 . . . . 73.53 112.121 -178.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' A' ' 87' ' ' ILE . . . 88.68 -27.67 7.01 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 121.006 -0.616 . . . . 72.12 111.828 -177.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.415 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 4.4 tmt_? -66.59 121.11 14.63 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.93 -0.396 . . . . 72.11 109.93 178.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 50.5 ttm -115.5 122.3 45.3 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.981 -0.554 . . . . 73.31 110.212 -178.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.411 ' HB ' ' NH1' ' A' ' 77' ' ' ARG . 8.0 p -73.98 125.27 32.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.204 0.526 . . . . 64.42 110.779 -179.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.775 ' HB ' ' O ' ' A' ' 83' ' ' TYR . 17.0 m -138.85 152.59 47.95 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.518 -0.919 . . . . 50.13 108.518 177.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -65.46 -60.04 3.37 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.656 0.613 . . . . 72.31 112.656 -170.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.406 ' CG ' ' HZ3' ' A' ' 102' ' ' LYS . 25.2 t0 -101.39 2.57 39.62 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.446 0.641 . . . . 75.51 111.419 -171.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.775 ' O ' ' HB ' ' A' ' 80' ' ' THR . 60.6 m-85 -146.03 116.31 7.48 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.927 -0.579 . . . . 74.53 110.105 178.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.62 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 3.8 mp -84.68 104.06 12.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.946 -0.761 . . . . 71.04 108.946 175.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 73.5 t -94.73 111.97 26.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.729 -0.669 . . . . 64.33 111.201 -174.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.415 ' HA ' ' HA ' ' A' ' 77' ' ' ARG . 26.8 t70 -111.05 100.58 9.23 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.005 0.431 . . . . 74.51 110.448 175.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.495 ' O ' ' HA3' ' A' ' 76' ' ' GLY . 58.1 mt -89.49 97.22 6.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.431 -0.581 . . . . 73.15 109.431 176.04 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -104.58 130.05 52.61 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.062 -0.517 . . . . 75.04 111.599 -174.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.466 ' OD1' ' HB3' ' A' ' 71' ' ' ASN . 26.4 t-20 -108.53 87.36 2.48 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.342 -0.614 . . . . 62.25 109.342 171.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.401 ' O ' ' HB3' ' A' ' 91' ' ' ASP . 10.3 ttp180 -106.68 146.14 31.13 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.511 -0.922 . . . . 75.44 108.511 177.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.401 ' HB3' ' O ' ' A' ' 90' ' ' ARG . 24.9 t70 69.13 -70.49 0.14 Allowed 'General case' 0 N--CA 1.469 0.488 0 O-C-N 123.732 0.645 . . . . 71.02 110.53 -176.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 179.18 22.04 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 121.005 -0.617 . . . . 75.32 112.341 176.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.481 ' HA ' HE21 ' A' ' 93' ' ' GLN . 0.1 OUTLIER -126.27 141.59 51.86 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 122.676 -0.308 . . . . 73.12 110.574 -175.864 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -81.41 109.96 16.39 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.192 -0.67 . . . . 75.0 109.192 173.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -113.73 110.71 20.61 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.119 0.485 . . . . 55.53 110.666 -177.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.449 ' HB3' ' O ' ' A' ' 109' ' ' ILE . 59.6 tp -85.71 97.02 9.9 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.557 -0.747 . . . . 75.11 110.206 179.062 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.6 m-20 -95.53 100.36 12.12 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.074 -0.512 . . . . 73.45 110.113 177.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 50.7 t -94.96 111.59 25.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.817 -0.629 . . . . 72.02 110.364 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.62 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 22.8 m -89.94 103.35 16.02 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.873 -0.603 . . . . 64.32 109.665 175.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.588 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 9.8 t70 -58.72 147.64 32.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.096 -0.502 . . . . 63.4 110.842 178.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.4 ' HD2' ' HA ' ' A' ' 101' ' ' ARG . 23.5 tpt180 -113.6 -9.02 13.28 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.856 0.36 . . . . 73.23 111.314 -177.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.406 ' HZ3' ' CG ' ' A' ' 82' ' ' ASP . 27.4 mmtm -78.87 -49.81 12.27 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.005 0.431 . . . . 73.34 110.806 177.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 36.5 p -113.23 -35.62 5.28 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.747 -0.661 . . . . 74.11 109.952 176.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.588 ' HA2' ' O ' ' A' ' 100' ' ' ASP . . . 91.57 81.11 1.42 Allowed Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.461 -0.79 . . . . 65.24 112.242 178.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.472 ' H ' ' HB3' ' A' ' 100' ' ' ASP . 49.6 mt-30 -137.47 139.98 40.93 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.253 -0.647 . . . . 74.43 109.253 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.9 t -84.38 95.45 8.75 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.585 0.707 . . . . 62.24 111.089 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 59.4 m -84.22 102.98 13.03 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.854 -0.612 . . . . 71.15 109.933 176.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 23.8 m -92.15 109.85 21.22 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.289 -0.414 . . . . 73.23 110.857 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.449 ' O ' ' HB3' ' A' ' 96' ' ' LEU . 4.9 mp -117.2 97.91 6.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.947 0.404 . . . . 75.24 109.94 175.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -74.74 153.25 38.91 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.453 -0.339 . . . . 61.1 110.92 178.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 8.4 p -58.88 132.36 23.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.608 -0.724 . . . . 75.11 110.461 177.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.49 91.23 6.85 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.421 -0.585 . . . . 73.52 109.421 179.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -78.56 47.89 3.09 Favored Glycine 0 N--CA 1.453 -0.167 0 CA-C-N 115.966 -0.561 . . . . 75.51 112.509 -178.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 96.2 mt -124.08 83.35 2.13 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.005 0.431 . . . . 75.43 110.29 -178.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -130.78 -27.21 2.13 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.874 -0.603 . . . . 73.22 110.134 176.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 50.34 178.88 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.622 1.169 . . . . 73.42 113.31 177.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -165.17 121.4 1.42 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.33 0.586 . . . . 63.43 110.946 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 48.9 m -143.54 91.56 2.27 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.7 -0.852 . . . . 75.22 108.7 172.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 17.4 m -120.67 97.69 5.67 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.861 -0.609 . . . . 74.32 111.023 -174.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -150.56 104.49 3.21 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.195 -0.457 . . . . 75.14 111.143 177.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -141.99 97.87 3.22 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.975 -0.75 . . . . 75.24 108.975 171.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -76.28 105.68 7.47 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.715 -0.675 . . . . 74.34 111.733 -171.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -79.88 111.96 16.71 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.638 -0.875 . . . . 71.55 108.638 171.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -129.31 -23.38 2.97 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.74 -0.384 . . . . 75.21 111.525 -176.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 29.7 m170 66.71 168.65 0.23 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.426 0.631 . . . . 74.34 111.111 -178.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 12.8 p80 -123.47 140.01 53.43 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.964 -0.754 . . . . 73.13 108.964 172.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 . . . . . 0 C--O 1.247 0.947 0 O-C-N 123.825 0.703 . . . . 63.31 110.473 -178.256 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.2 mtt . . . . . 0 N--CA 1.481 1.08 0 N-CA-C 110.445 -0.206 . . . . 75.5 110.445 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 68.9 -65.97 0.26 Allowed 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.451 0.7 . . . . 74.23 112.436 178.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.46 77.36 1.06 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 121.378 -0.439 . . . . 65.14 112.796 -177.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.9 t -151.11 33.13 0.59 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.872 0.844 . . . . 73.31 109.566 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 20.6 ptp -94.32 126.78 39.79 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.947 -0.57 . . . . 75.43 111.754 -176.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 25.2 m -121.94 121.85 38.04 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.682 -0.69 . . . . 74.21 109.818 177.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -117.64 -70.63 0.78 Allowed 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.781 -0.367 . . . . 75.04 111.969 -175.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 59.01 39.52 23.37 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 122.195 0.997 . . . . 73.41 108.636 -174.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -78.73 -27.18 44.83 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.385 -1.28 . . . . 73.24 111.543 -170.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 -80.17 125.68 30.14 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.993 0.425 . . . . 74.31 110.717 -176.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.409 ' HB2' ' HD2' ' A' ' 12' ' ' PRO . 8.3 p30 -84.25 156.63 62.99 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.876 -0.602 . . . . 70.54 110.126 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.409 ' HD2' ' HB2' ' A' ' 11' ' ' ASN . 11.5 Cg_endo -56.11 -40.53 84.3 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.851 2.367 . . . . 71.33 112.857 -179.482 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 67.84 123.27 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 O-C-N 123.825 0.703 . . . . 75.43 111.928 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -124.09 154.27 40.22 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.993 -0.549 . . . . 75.23 109.77 176.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 128.12 112.84 1.7 Allowed Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.613 -0.803 . . . . 71.23 112.024 -178.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -169.76 -170.51 34.3 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 110.982 -0.847 . . . . 73.33 110.982 178.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.515 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 84.8 m-20 65.17 166.29 0.12 Allowed Pre-proline 0 N--CA 1.468 0.427 0 O-C-N 123.62 0.247 . . . . 72.14 110.968 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.515 ' HD2' ' HB3' ' A' ' 17' ' ' ASN . 46.1 Cg_endo -71.61 63.51 3.0 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 121.802 1.668 . . . . 61.41 111.031 172.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -119.79 91.74 3.62 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.224 -0.898 . . . . 74.52 108.643 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -105.6 117.3 33.67 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.79 -0.641 . . . . 74.24 110.047 -173.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -72.14 96.92 0.72 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 121.064 -0.589 . . . . 62.44 111.679 177.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -92.49 72.51 5.15 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.194 0.521 . . . . 64.1 110.725 -177.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -129.53 137.24 50.67 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.675 -0.693 . . . . 75.42 110.206 177.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.739 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 94.9 mt -137.23 168.82 18.87 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.538 -0.542 . . . . 72.34 109.538 177.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.739 ' HG ' ' O ' ' A' ' 24' ' ' LEU . 4.0 pp 53.58 -173.19 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 O-C-N 124.09 0.869 . . . . 74.5 111.897 178.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -162.44 174.47 12.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.445 -0.343 . . . . 74.45 110.491 177.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 45.2 p -156.19 151.94 27.23 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.084 -0.507 . . . . 72.43 110.748 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.18 129.88 34.78 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.074 -0.713 . . . . 74.12 109.074 172.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -99.87 170.9 8.21 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.9 -0.32 . . . . 75.1 111.013 -172.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 67.28 -168.39 0.2 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.549 -0.75 . . . . 75.25 111.375 -179.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 57.6 53.6 7.15 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.351 0.596 . . . . 75.53 110.068 -176.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.769 ' HB2' ' HB3' ' A' ' 36' ' ' ASP . 4.3 p-10 -64.27 -50.44 67.89 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.43 -0.804 . . . . 64.01 110.579 178.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 50.4 m 61.44 -76.5 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 O-C-N 123.866 0.729 . . . . 74.21 112.348 178.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -140.36 1.71 1.8 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.496 -0.32 . . . . 74.43 111.83 -175.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -98.8 4.61 47.66 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.428 -0.509 . . . . 71.43 110.484 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.769 ' HB3' ' HB2' ' A' ' 32' ' ' ASN . 5.9 p-10 -80.93 144.72 55.72 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.863 -0.608 . . . . 74.53 110.707 -178.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 36' ' ' ASP . 13.5 Cg_exo -71.48 156.17 58.58 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 123.238 2.625 . . . . 70.22 112.538 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.4 m -149.81 -39.04 0.14 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.876 -0.602 . . . . 73.21 110.023 177.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -156.36 135.86 12.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.133 -0.485 . . . . 74.42 110.366 174.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.6 t30 72.13 10.59 6.02 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.65 -0.705 . . . . 75.2 110.99 177.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -150.54 147.92 28.05 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.09 -0.505 . . . . 75.34 110.043 177.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -151.67 19.61 0.71 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.479 0.657 . . . . 70.12 109.363 173.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -105.08 -16.21 14.86 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.437 -0.801 . . . . 75.22 110.594 -174.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -82.56 39.11 2.66 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.941 -0.647 . . . . 74.52 112.786 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.418 HG13 ' HG2' ' A' ' 37' ' ' PRO . 57.9 mt -122.66 -65.05 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 110.019 -0.363 . . . . 75.24 110.019 177.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 67.43 -70.51 0.12 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.444 -0.798 . . . . 65.32 111.546 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.0 m -124.53 87.9 53.89 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.386 -0.37 . . . . 73.11 110.726 -175.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -69.97 120.83 7.51 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 123.134 2.556 . . . . 73.11 112.658 -176.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 52.0 m -97.51 -86.15 0.35 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.352 -0.385 . . . . 73.25 111.409 177.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.91 12.83 28.9 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.046 0.451 . . . . 71.23 111.623 -176.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.4 pp -119.01 1.9 11.46 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.276 -0.42 . . . . 73.42 110.572 179.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -63.45 -60.3 3.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.63 -0.714 . . . . 72.13 111.538 -174.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.421 ' HA ' ' HB2' ' A' ' 56' ' ' GLN . 7.7 p30 -78.15 -13.75 59.74 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.921 -0.582 . . . . 73.01 110.906 -175.364 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.543 ' O ' HG13 ' A' ' 58' ' ' ILE . 83.9 t80 -66.55 -58.39 5.3 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.234 -0.439 . . . . 74.25 110.095 176.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.7 t -74.3 -12.29 60.5 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.186 0.517 . . . . 75.41 110.419 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.421 ' HB2' ' HA ' ' A' ' 53' ' ' ASN . 2.1 tp-100 -70.63 -47.75 58.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.759 -0.655 . . . . 63.02 109.643 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.23 -28.24 67.07 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.728 -0.669 . . . . 74.22 110.894 179.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.554 ' O ' HG13 ' A' ' 62' ' ' ILE . 26.6 mt -63.09 -39.52 85.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.163 -0.471 . . . . 75.44 110.649 179.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -64.31 -31.04 72.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.151 -0.477 . . . . 74.14 110.658 179.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.1 m -81.04 -41.52 22.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.146 -0.479 . . . . 73.34 111.339 -178.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.525 ' HG2' ' HA ' ' A' ' 58' ' ' ILE . 4.1 pt20 -66.78 -19.0 65.66 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.518 -0.31 . . . . 71.1 111.49 -176.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.554 HG13 ' O ' ' A' ' 58' ' ' ILE . 86.5 mt -62.23 -47.42 93.18 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 N-CA-C 109.31 -0.626 . . . . 75.12 109.31 175.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.0 mp -64.39 -43.21 95.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.451 -0.795 . . . . 74.53 110.498 178.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -57.5 -44.68 93.65 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 121.226 -0.512 . . . . 74.2 112.578 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -75.21 -44.15 23.68 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.682 -0.77 . . . . 72.43 112.453 178.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.597 ' O ' HG12 ' A' ' 70' ' ' ILE . 57.0 tp -58.72 -50.35 74.21 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 122.313 0.245 . . . . 72.23 111.297 -177.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 85.5 mt -63.34 -17.65 62.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.445 -0.343 . . . . 71.34 111.912 -176.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.1 t -78.27 -45.77 21.96 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.76 -0.459 . . . . 75.11 109.76 178.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -78.5 -11.49 59.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.046 -0.525 . . . . 72.41 111.149 -176.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.597 HG12 ' O ' ' A' ' 66' ' ' LEU . 27.4 mm -61.34 -38.86 80.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.725 0.298 . . . . 73.52 110.478 176.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -62.74 -72.05 0.14 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.988 -0.551 . . . . 62.21 110.235 -178.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.472 HG22 ' HG3' ' A' ' 74' ' ' LYS . 16.7 m -135.5 97.7 3.75 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.319 -0.623 . . . . 70.33 109.319 174.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -90.84 16.54 58.1 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.862 -0.685 . . . . 71.02 113.762 -170.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.546 ' HB2' ' HD2' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -56.96 156.31 13.47 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 117.257 0.528 . . . . 75.21 109.975 174.746 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.546 ' HD2' ' HB2' ' A' ' 74' ' ' LYS . 44.1 Cg_exo -23.11 -55.63 0.05 OUTLIER 'Trans proline' 0 C--N 1.358 1.075 1 C-N-CA 125.306 4.004 . . . . 73.53 115.519 -172.018 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.48 -55.22 4.65 Favored Glycine 0 C--O 1.228 -0.236 0 C-N-CA 120.877 -0.678 . . . . 72.12 112.436 177.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 42.2 ptt85 -69.82 108.15 3.83 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.158 0.504 . . . . 72.11 110.592 176.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.567 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 28.0 ttt -91.01 105.03 17.54 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.757 -0.656 . . . . 73.31 109.78 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 19.1 t -86.53 76.12 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.397 0.618 . . . . 64.42 110.267 -176.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.0 -175.44 5.4 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.728 -0.669 . . . . 50.13 110.089 179.139 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -79.67 -43.81 22.06 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.663 0.268 . . . . 72.31 110.772 -177.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.554 ' O ' ' HB2' ' A' ' 101' ' ' ARG . 8.2 t0 -101.6 -76.52 0.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.657 -0.497 . . . . 75.51 109.657 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.489 ' HB3' HG11 ' A' ' 98' ' ' VAL . 17.0 m-85 -79.38 115.4 19.0 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.407 -0.361 . . . . 74.53 111.048 -174.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.437 HD11 ' HB ' ' A' ' 99' ' ' THR . 0.9 OUTLIER -83.83 103.38 11.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.595 0.712 . . . . 71.04 109.197 170.843 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.567 ' HB ' ' HB3' ' A' ' 78' ' ' MET . 37.6 t -94.3 139.65 18.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.639 -0.709 . . . . 64.33 111.195 -169.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -108.73 105.07 14.49 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.573 -0.528 . . . . 74.51 109.573 174.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 74.4 mt -78.72 113.69 18.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.287 -0.415 . . . . 73.15 109.968 178.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -107.8 109.57 21.16 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.184 -0.462 . . . . 75.04 111.128 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.556 ' HA ' ' O ' ' A' ' 93' ' ' GLN . 3.5 t-20 -111.44 83.01 1.7 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.202 0.525 . . . . 62.25 109.726 174.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 30.2 ttp180 -105.27 121.07 43.1 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.959 -0.564 . . . . 75.44 109.744 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.4 t70 69.04 -83.11 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.369 -0.832 . . . . 71.02 111.207 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -144.14 12.13 2.08 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.63 -0.795 . . . . 75.32 112.583 -178.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.556 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -103.24 126.73 50.55 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.769 0.319 . . . . 73.12 111.461 -179.094 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -96.36 98.22 10.09 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.909 -0.774 . . . . 75.0 108.909 168.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -112.36 126.62 55.47 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.213 -0.449 . . . . 55.53 110.396 -175.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 13.6 tp -103.69 100.8 10.63 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.135 -0.484 . . . . 75.11 110.196 -176.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -88.96 97.83 11.41 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.175 -0.466 . . . . 73.45 111.045 -177.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.489 HG11 ' HB3' ' A' ' 83' ' ' TYR . 39.0 t -90.32 115.2 29.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.869 -0.605 . . . . 72.02 110.841 -179.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.437 ' HB ' HD11 ' A' ' 84' ' ' ILE . 47.6 m -104.6 114.79 29.23 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.673 -0.694 . . . . 64.32 109.964 175.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.488 ' HA ' ' HD1' ' A' ' 83' ' ' TYR . 26.0 t70 -60.79 141.97 56.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.97 -0.559 . . . . 63.4 111.105 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.554 ' HB2' ' O ' ' A' ' 82' ' ' ASP . 10.0 tpt180 -88.55 -10.94 47.13 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.151 -0.477 . . . . 73.23 111.367 -174.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm -107.62 -67.71 0.94 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.74 0.305 . . . . 73.34 111.622 -171.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 45.8 p -85.62 -33.09 21.73 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.271 0.558 . . . . 74.11 109.997 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 99.6 23.55 10.89 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.279 -0.873 . . . . 65.24 112.644 177.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.429 ' N ' ' HB3' ' A' ' 100' ' ' ASP . 98.2 mt-30 -59.58 130.68 48.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.725 0.298 . . . . 74.43 110.737 175.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.2 p -102.89 88.4 3.17 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.172 0.51 . . . . 62.24 110.398 176.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 9.7 t -91.21 105.65 17.95 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.766 -0.652 . . . . 71.15 109.489 -178.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.5 m -91.24 107.8 19.45 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.986 -0.552 . . . . 73.23 110.388 -178.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 59.5 mt -110.01 116.0 51.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.416 -0.356 . . . . 75.24 110.882 -175.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -71.71 168.2 18.26 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.003 0.43 . . . . 61.1 111.207 175.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.7 p -69.57 110.66 3.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.748 -0.66 . . . . 75.11 111.306 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 9.2 t -108.67 95.21 5.5 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.92 -0.582 . . . . 73.52 109.976 177.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -106.04 50.62 0.8 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.686 -0.769 . . . . 75.51 112.116 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 93.4 mt -120.26 116.55 25.79 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.129 -0.323 . . . . 75.43 110.129 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -123.66 93.32 3.9 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.071 -0.513 . . . . 73.22 110.959 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -88.47 88.58 7.67 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.914 0.388 . . . . 73.42 110.015 176.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -78.37 134.13 37.47 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.985 -0.552 . . . . 63.43 110.526 -178.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 56.1 m -144.09 150.67 38.51 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.932 -0.395 . . . . 75.22 109.932 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.0 t -103.6 148.53 25.89 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.836 0.351 . . . . 74.32 110.198 -178.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -96.68 112.72 24.35 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.348 -0.387 . . . . 75.14 110.214 -178.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -112.46 177.29 4.69 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.233 -0.44 . . . . 75.24 110.937 -174.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 28.9 t60 60.39 83.07 0.15 Allowed 'General case' 0 C--N 1.33 -0.254 0 O-C-N 123.695 0.622 . . . . 74.34 110.818 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -112.18 146.28 38.37 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.056 -0.52 . . . . 71.55 110.785 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -102.05 128.7 48.39 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.295 -0.632 . . . . 75.21 109.295 177.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 65.6 m170 -100.35 -49.48 4.23 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 121.024 -0.27 . . . . 74.34 111.52 -174.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 25.6 p80 -152.38 -178.79 7.04 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.957 0.408 . . . . 73.13 111.304 -173.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 . . . . . 0 C--O 1.245 0.818 0 CA-C-N 115.711 -0.677 . . . . 63.31 109.224 172.483 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 ttt . . . . . 0 N--CA 1.48 1.042 0 N-CA-C 109.914 -0.402 . . . . 75.5 109.914 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 66.11 107.58 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 O-C-N 123.822 0.702 . . . . 74.23 111.126 -176.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.26 -3.92 71.84 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 115.841 -0.618 . . . . 65.14 113.257 -176.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 27.8 m -69.37 103.41 1.99 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.846 0.355 . . . . 73.31 110.696 178.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.508 ' HE1' ' CZ ' ' A' ' 7' ' ' PHE . 22.9 ttt -146.65 104.5 3.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.08 -0.509 . . . . 75.43 109.964 -178.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.4 p -126.1 129.41 49.03 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.946 0.403 . . . . 74.21 111.449 -176.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.508 ' CZ ' ' HE1' ' A' ' 5' ' ' MET . 71.0 m-85 -102.42 -47.14 4.57 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.053 -0.522 . . . . 75.04 110.896 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 80.5 mm-40 59.42 47.38 11.21 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.517 0.675 . . . . 73.41 109.254 -171.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -87.79 150.91 23.27 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.138 -0.937 . . . . 73.24 110.333 -174.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.8 ptt85 -111.53 163.88 13.58 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.189 -0.46 . . . . 74.31 111.466 -176.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -139.38 86.25 14.54 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 109.579 -0.526 . . . . 70.54 109.579 175.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -68.85 -45.15 2.3 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.986 2.457 . . . . 71.33 112.685 -176.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.4 t30 69.37 114.92 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 O-C-N 123.867 0.729 . . . . 75.43 110.473 -177.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -76.68 169.26 18.61 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.126 -0.488 . . . . 75.23 111.272 -175.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -95.16 161.32 23.32 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.813 -0.708 . . . . 71.23 112.713 -175.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.34 -77.59 0.7 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.044 -0.598 . . . . 73.33 112.535 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.445 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 4.8 m-20 -101.37 144.42 28.53 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-O 120.684 0.278 . . . . 72.14 110.797 -178.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 17' ' ' ASN . 3.6 Cg_exo -75.43 -55.13 0.07 OUTLIER 'Trans proline' 0 CA--C 1.53 0.306 0 C-N-CA 122.894 2.396 . . . . 61.41 111.86 176.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -170.75 169.69 6.88 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.496 -0.927 . . . . 74.52 108.496 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 74.01 113.55 0.06 Allowed 'General case' 0 N--CA 1.467 0.416 0 O-C-N 123.751 0.657 . . . . 74.24 110.97 178.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -128.61 -71.38 0.14 Allowed Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.625 -0.797 . . . . 62.44 112.82 -176.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -143.22 146.94 34.1 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.884 0.373 . . . . 64.1 111.416 -175.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -130.24 110.46 11.56 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.911 -0.586 . . . . 75.42 109.706 175.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.727 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 6.6 mp -102.82 -167.43 1.39 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.132 -0.486 . . . . 72.34 110.201 -178.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.727 ' HG ' ' O ' ' A' ' 24' ' ' LEU . 4.3 pp 58.99 -178.05 0.08 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.456 1.102 . . . . 74.5 112.051 -177.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -143.94 154.94 43.83 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.743 -0.465 . . . . 74.45 109.743 -175.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.9 p -69.25 -84.07 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 121.269 -0.172 . . . . 72.43 110.786 176.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -170.43 89.71 0.15 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.772 0.32 . . . . 74.12 111.322 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -90.41 24.04 2.74 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.472 0.653 . . . . 75.1 110.25 177.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.82 0.66 56.37 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.538 -0.755 . . . . 75.25 110.666 178.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -109.97 138.62 46.09 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.041 -0.527 . . . . 75.53 110.929 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -65.98 111.07 3.15 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.9 -0.591 . . . . 64.01 110.129 177.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.5 t 60.07 82.91 0.15 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.374 -0.83 . . . . 74.21 110.147 -175.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -82.56 -15.66 51.45 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.617 -0.719 . . . . 74.43 110.724 -177.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.7 ttmt 72.48 -163.64 0.11 Allowed 'General case' 0 C--O 1.233 0.209 0 N-CA-C 108.761 -0.829 . . . . 71.43 108.761 -177.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.479 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 9.1 p-10 -72.89 143.23 84.03 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-O 120.688 0.28 . . . . 74.53 110.287 179.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.534 ' HB2' ' O ' ' A' ' 41' ' ' ASP . 5.7 Cg_exo -79.55 144.7 17.95 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.845 2.363 . . . . 70.22 111.63 177.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.2 m -136.84 5.37 2.85 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 111.786 0.291 . . . . 73.21 111.786 -173.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -125.49 91.97 3.52 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.918 -0.313 . . . . 74.42 111.059 -177.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 61.62 6.76 1.63 Allowed 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.96 0.726 . . . . 75.2 112.96 174.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.534 ' O ' ' HB2' ' A' ' 37' ' ' PRO . 8.9 t70 -144.2 152.34 40.72 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.299 -0.41 . . . . 75.34 110.115 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.431 ' HA ' ' HG2' ' A' ' 37' ' ' PRO . 8.6 p-10 -145.61 12.72 1.33 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.951 -0.568 . . . . 70.12 109.559 174.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.459 ' C ' ' H ' ' A' ' 45' ' ' ILE . 94.5 m-85 -100.55 -11.45 20.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.678 -0.692 . . . . 75.22 110.713 -179.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -73.08 24.08 0.86 Allowed Glycine 0 CA--C 1.52 0.402 0 CA-C-N 116.2 -0.455 . . . . 74.52 113.35 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.459 ' H ' ' C ' ' A' ' 43' ' ' PHE . 57.4 mt -79.29 -30.43 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 109.477 -0.564 . . . . 75.24 109.477 176.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -77.03 140.02 40.22 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.564 -0.743 . . . . 65.32 110.28 -178.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 25.8 m -151.11 86.02 4.93 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 116.006 -0.543 . . . . 73.11 109.688 174.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.622 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 28.2 Cg_endo -62.16 110.58 1.05 Allowed 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 122.826 2.351 . . . . 73.11 112.29 -178.041 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 26.7 m -123.69 -25.54 4.3 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.005 -0.543 . . . . 73.25 110.415 177.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.3 -37.33 0.31 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 71.23 111.374 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.2 pp -73.09 -12.6 60.97 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.536 -0.302 . . . . 73.42 111.409 -176.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.622 ' HB3' ' HB2' ' A' ' 48' ' ' PRO . 4.3 p-10 -63.63 -56.59 14.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.289 -0.414 . . . . 72.13 110.864 -178.317 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -64.61 -28.76 69.84 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.229 0.538 . . . . 73.01 110.108 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.438 ' O ' HG13 ' A' ' 58' ' ' ILE . 77.6 t80 -66.26 -49.86 65.71 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.414 -0.812 . . . . 74.25 111.028 179.092 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.434 ' O ' ' HG3' ' A' ' 59' ' ' GLN . 8.9 t -72.46 -19.48 61.55 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.708 0.262 . . . . 75.41 111.708 -176.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.444 ' HG3' ' O ' ' A' ' 52' ' ' ASP . 60.9 mt-30 -64.39 -43.69 93.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.895 0.378 . . . . 63.02 111.096 -178.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.72 -24.89 61.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.337 -0.392 . . . . 74.22 111.422 -178.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 54' ' ' PHE . 8.6 mt -76.35 -18.67 15.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.107 0.479 . . . . 75.44 110.974 -176.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.434 ' HG3' ' O ' ' A' ' 55' ' ' THR . 77.4 mt-30 -67.21 -19.16 65.51 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.374 -0.375 . . . . 74.14 110.98 -178.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 61.0 m -74.87 -34.8 62.29 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.53 -0.304 . . . . 73.34 111.484 178.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.41 ' HG2' ' O ' ' A' ' 58' ' ' ILE . 11.1 pt20 -82.2 -5.58 58.6 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.862 0.363 . . . . 71.1 110.966 -177.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.541 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 67.7 mt -65.34 -36.02 76.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.284 0.564 . . . . 75.12 109.799 175.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 9.2 mp -63.47 -35.7 81.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.414 -0.812 . . . . 74.53 110.622 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -65.7 -40.68 95.92 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.285 -0.726 . . . . 74.2 111.285 175.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -66.33 -19.56 68.62 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 121.147 -0.549 . . . . 72.43 112.385 177.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 62' ' ' ILE . 85.5 mt -74.44 -31.9 62.43 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.046 0.45 . . . . 72.23 110.168 176.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 49.0 mt -74.83 -42.58 57.73 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.996 -0.742 . . . . 71.34 108.996 175.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.8 m -75.52 5.83 5.45 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.107 -0.951 . . . . 75.11 111.246 178.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.92 ' HA ' ' HG3' ' A' ' 90' ' ' ARG . 50.6 t30 -82.43 -25.86 33.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.195 -0.457 . . . . 72.41 110.997 -178.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.0 mp -84.59 -50.67 14.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.204 -0.453 . . . . 73.52 110.997 -175.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -111.08 -88.48 0.51 Allowed 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.192 -0.603 . . . . 62.21 111.004 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 92.0 m -168.38 126.46 1.12 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.098 -0.704 . . . . 70.33 109.098 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -152.32 42.56 0.68 Allowed Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.119 -1.039 . . . . 71.02 111.937 178.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.62 ' HB2' ' O ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -56.96 144.97 66.54 Favored Pre-proline 0 C--N 1.327 -0.376 0 O-C-N 123.517 0.187 . . . . 75.21 110.978 179.937 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.43 ' HD3' ' HB2' ' A' ' 89' ' ' ASN . 16.1 Cg_endo -58.05 -44.06 42.88 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.951 2.434 . . . . 73.53 112.929 -175.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 168.26 -156.89 28.76 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.474 -0.869 . . . . 72.12 112.133 -179.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -150.76 175.46 11.96 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 110.146 -0.316 . . . . 72.11 110.146 -177.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.756 ' HB3' HG11 ' A' ' 85' ' ' VAL . 47.9 ttm -121.95 121.07 36.24 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.897 -0.779 . . . . 73.31 108.897 173.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.4 p -88.53 98.31 7.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.867 0.842 . . . . 64.42 111.827 -173.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.7 p -122.77 156.93 33.47 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.209 -0.905 . . . . 50.13 109.451 171.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -78.28 -41.18 34.72 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.811 0.338 . . . . 72.31 111.368 -175.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.699 ' HB3' ' HD3' ' A' ' 102' ' ' LYS . 7.5 m-20 -81.45 -21.68 38.64 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.174 -0.466 . . . . 75.51 111.282 -174.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -137.49 135.89 37.2 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.978 0.418 . . . . 74.53 111.363 -177.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.641 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 4.1 mp -105.93 84.94 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 108.407 -0.96 . . . . 71.04 108.407 172.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.756 HG11 ' HB3' ' A' ' 78' ' ' MET . 2.3 p -91.18 106.8 17.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.642 0.734 . . . . 64.33 110.455 -177.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -111.51 128.0 55.88 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.316 -0.856 . . . . 74.51 110.32 -175.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.62 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 19.4 mt -95.86 103.73 15.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.278 -0.419 . . . . 73.15 110.375 -177.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -88.56 146.76 24.96 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.899 0.381 . . . . 75.04 111.009 -178.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.43 ' HB2' ' HD3' ' A' ' 75' ' ' PRO . 3.3 t-20 -139.53 110.3 6.76 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.107 -0.497 . . . . 62.25 109.764 178.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.92 ' HG3' ' HA ' ' A' ' 69' ' ' ASN . 66.8 ttt180 -147.12 141.44 26.31 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.024 -0.535 . . . . 75.44 109.565 179.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.2 t70 71.71 2.94 4.48 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.449 0.642 . . . . 71.02 110.452 177.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.524 ' HA3' HG22 ' A' ' 62' ' ' ILE . . . 97.13 -8.62 65.07 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 111.183 -0.767 . . . . 75.32 111.183 -176.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.07 135.33 33.72 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.875 0.369 . . . . 73.12 110.346 179.324 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -91.97 131.51 37.22 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.408 -0.59 . . . . 75.0 109.408 173.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.408 ' HG2' ' ND2' ' A' ' 97' ' ' ASN . 6.2 tt0 -133.48 108.1 8.44 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.0 -0.545 . . . . 55.53 110.468 -178.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.563 ' HB3' ' HB ' ' A' ' 109' ' ' ILE . 44.2 tp -88.83 111.16 21.71 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.757 -0.656 . . . . 75.11 110.295 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.408 ' ND2' ' HG2' ' A' ' 95' ' ' GLN . 48.7 m-80 -104.56 107.41 18.34 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.881 0.372 . . . . 73.45 110.63 178.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.6 t -87.02 107.18 16.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.983 -0.553 . . . . 72.02 110.137 176.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.641 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 28.0 m -89.84 104.1 16.7 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 115.667 -0.697 . . . . 64.32 109.524 177.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.599 ' HB3' ' N ' ' A' ' 105' ' ' GLN . 32.3 t70 -71.11 127.39 32.43 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.335 -0.848 . . . . 63.4 110.865 -177.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.1 tpm_? -99.28 1.94 45.08 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.462 0.648 . . . . 73.23 110.166 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.699 ' HD3' ' HB3' ' A' ' 82' ' ' ASP . 25.3 mmmt -89.45 -57.08 3.01 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.054 -0.521 . . . . 73.34 110.421 -178.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 64.2 p -115.08 -31.35 6.07 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.453 0.644 . . . . 74.11 110.258 178.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' A' ' 100' ' ' ASP . . . 110.01 29.88 3.63 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 115.414 -0.812 . . . . 65.24 112.378 178.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.599 ' N ' ' HB3' ' A' ' 100' ' ' ASP . 84.1 mm-40 -64.04 160.71 17.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.108 0.48 . . . . 74.43 110.17 171.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 27.1 m -140.81 87.46 2.11 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.244 -0.65 . . . . 62.24 109.244 174.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.4 t -85.2 114.73 22.53 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.406 -0.815 . . . . 71.15 109.567 -178.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 19.5 m -102.18 114.79 29.25 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.065 -0.516 . . . . 73.23 110.72 -178.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.563 ' HB ' ' HB3' ' A' ' 96' ' ' LEU . 4.4 mp -105.97 96.6 4.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.048 -0.523 . . . . 75.24 109.767 177.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -93.54 142.72 27.02 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.193 -0.458 . . . . 61.1 109.88 178.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 92.6 t -68.38 124.13 23.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 110.189 -0.3 . . . . 75.11 110.189 176.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.3 m -58.88 -52.39 65.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.833 -0.621 . . . . 73.52 111.268 -177.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 175.19 153.29 10.04 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.518 -0.848 . . . . 75.51 112.411 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.518 HD12 HD13 ' A' ' 62' ' ' ILE . 56.9 mt -119.92 93.09 3.94 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.387 -0.597 . . . . 75.43 109.387 179.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -133.47 100.16 4.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.408 -0.36 . . . . 73.22 111.784 -173.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 175.2 131.73 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.878 -0.601 . . . . 73.42 109.885 177.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -106.34 -71.46 0.75 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 121.012 -0.275 . . . . 63.43 110.465 177.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 39.4 t 70.71 145.28 0.06 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.636 0.731 . . . . 75.22 112.294 176.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 17.2 m -145.59 145.22 30.89 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.703 -0.68 . . . . 74.32 110.107 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -136.98 137.72 39.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.181 0.515 . . . . 75.14 110.702 174.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -115.04 144.93 42.85 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.777 -0.823 . . . . 75.24 108.777 170.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 9.6 p-80 -144.95 119.56 9.76 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.149 0.5 . . . . 74.34 111.462 -174.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 44.1 m-70 -101.65 -163.3 1.0 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.444 -0.798 . . . . 71.55 110.268 177.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 6.4 p-80 56.08 -174.23 0.06 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.611 1.165 . . . . 75.21 112.401 179.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 32.9 m170 62.28 49.9 4.07 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.168 0.509 . . . . 74.34 110.999 -174.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 16.6 t-80 -94.42 -1.5 53.53 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.64 0.734 . . . . 73.13 109.172 177.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 . . . . . 0 C--O 1.245 0.818 0 CA-C-N 115.314 -0.857 . . . . 63.31 109.251 176.649 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.4 mtm . . . . . 0 N--CA 1.481 1.12 0 N-CA-C 110.341 -0.244 . . . . 75.5 110.341 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -121.05 152.93 38.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.666 0.27 . . . . 74.23 110.958 -179.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 107.84 -42.69 1.87 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.115 -0.564 . . . . 65.14 112.105 178.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.1 m -110.61 36.89 2.93 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.481 0.658 . . . . 73.31 109.913 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 50.9 ttm -91.81 131.19 37.34 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.773 -0.649 . . . . 75.43 109.517 178.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 35.6 p -75.69 89.39 2.8 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.659 0.614 . . . . 74.21 112.659 -172.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -141.44 -71.39 0.35 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.926 -0.579 . . . . 75.04 111.008 175.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -88.04 -46.0 9.7 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.296 -0.411 . . . . 73.41 111.863 -176.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 67.88 157.21 0.13 Allowed 'General case' 0 N--CA 1.468 0.458 0 O-C-N 123.72 0.637 . . . . 73.24 110.934 -176.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.49 ' HA ' ' HE ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -75.59 -37.93 59.48 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.429 -0.35 . . . . 74.31 110.576 175.942 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 65.12 86.31 0.14 Allowed Pre-proline 0 N--CA 1.467 0.376 0 O-C-N 123.988 0.805 . . . . 70.54 110.884 178.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -64.74 140.41 67.52 Favored 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 123.039 2.493 . . . . 71.33 112.93 -177.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.8 m120 71.52 172.6 0.31 Allowed 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.6 -0.727 . . . . 75.43 111.953 176.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -134.07 147.75 50.94 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.553 -0.749 . . . . 75.23 110.028 -177.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.53 64.6 4.01 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 121.19 -0.528 . . . . 71.23 112.354 178.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -156.6 79.16 0.18 Allowed Glycine 0 N--CA 1.451 -0.314 0 N-CA-C 111.401 -0.68 . . . . 73.33 111.401 179.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -92.67 155.52 41.84 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-O 120.399 0.143 . . . . 72.14 111.076 -174.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -58.39 137.54 80.96 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.865 2.377 . . . . 61.41 111.769 176.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -140.68 144.73 35.81 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.25 -0.432 . . . . 74.52 110.831 -175.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 43.5 t30 68.1 105.53 0.05 Allowed 'General case' 0 N--CA 1.468 0.45 0 O-C-N 124.105 0.878 . . . . 74.24 111.954 178.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -134.12 57.2 0.7 Allowed Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 111.424 -0.67 . . . . 62.44 111.424 177.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.53 68.25 4.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.327 0.584 . . . . 64.1 111.244 -178.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.608 ' HE1' ' HA ' ' A' ' 26' ' ' ASN . 3.5 t80 -167.71 100.98 0.48 Allowed 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.387 -0.968 . . . . 75.42 108.387 177.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.4 mt -109.55 -2.62 17.47 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.135 0.42 . . . . 72.34 112.135 -169.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 87.5 mt -101.57 -68.27 0.83 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.911 -0.316 . . . . 74.5 111.437 -178.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.608 ' HA ' ' HE1' ' A' ' 23' ' ' PHE . 28.2 t-20 66.27 98.83 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.624 0.726 . . . . 74.45 110.467 -175.08 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.5 m -83.96 95.84 8.66 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.54 -0.755 . . . . 72.43 110.771 -174.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.18 -52.65 21.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.981 -0.554 . . . . 74.12 110.844 179.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 61.55 23.64 13.89 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.843 -0.617 . . . . 75.1 110.579 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -139.08 152.18 47.32 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.155 -0.475 . . . . 75.25 110.303 -178.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -99.49 -82.31 0.44 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.913 -0.585 . . . . 75.53 109.84 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 179.02 122.08 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.958 -1.127 . . . . 64.01 107.958 177.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.3 t -86.38 -4.22 59.13 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 121.192 -0.203 . . . . 74.21 111.291 -173.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -142.16 97.79 3.2 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 121.174 0.512 . . . . 74.43 110.672 -176.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 21.5 pttm -93.29 1.95 56.79 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.786 0.803 . . . . 71.43 109.097 178.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -104.99 145.32 30.5 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 114.938 -1.028 . . . . 74.53 110.134 -174.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.561 ' HA ' ' HB2' ' A' ' 42' ' ' ASP . 37.1 Cg_endo -66.27 143.84 72.23 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.192 1.928 . . . . 70.22 111.989 178.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.9 m -119.62 -37.94 3.07 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.205 -0.665 . . . . 73.21 109.205 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -102.43 13.04 35.61 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.198 -0.91 . . . . 74.42 109.474 175.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.4 t30 69.73 4.39 4.71 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.056 -0.974 . . . . 75.2 110.874 179.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -144.49 69.09 1.26 Allowed 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.808 -0.812 . . . . 75.34 108.808 178.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.561 ' HB2' ' HA ' ' A' ' 37' ' ' PRO . 7.8 m-20 -132.43 -85.2 0.47 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.702 -0.681 . . . . 70.12 110.937 -175.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -141.85 31.3 1.62 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.451 0.643 . . . . 75.22 109.974 -177.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -76.54 48.38 2.56 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 121.032 -0.604 . . . . 74.52 112.559 -178.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 21.0 mt -106.35 -39.88 5.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.484 0.659 . . . . 75.24 109.797 -177.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -76.64 -20.43 56.7 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.323 -0.853 . . . . 65.32 109.869 178.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.425 HG22 ' O ' ' A' ' 47' ' ' THR . 9.9 t -120.59 88.04 42.51 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.19 -0.914 . . . . 73.11 109.877 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -67.6 93.52 0.37 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.306 2.671 . . . . 73.11 113.725 -172.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 72.8 m -105.61 -69.75 0.81 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.089 -0.505 . . . . 73.25 110.607 172.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.39 -38.35 90.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.873 0.368 . . . . 71.23 111.922 -178.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.2 pp -95.4 12.06 30.6 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.166 -0.47 . . . . 73.42 111.67 -175.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 56' ' ' GLN . 15.9 t70 -57.41 -42.87 83.14 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.939 0.399 . . . . 72.13 111.121 -178.165 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -89.09 15.88 8.03 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.172 -0.467 . . . . 73.01 111.2 -177.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.758 ' HE1' ' HG2' ' A' ' 105' ' ' GLN . 67.6 t80 -122.97 -64.8 1.15 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.231 -0.44 . . . . 74.25 110.527 -179.333 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.1 m -66.64 -28.08 68.19 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.323 -0.399 . . . . 75.41 111.586 -175.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.467 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 2.0 mp0 -69.45 -29.62 67.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.829 0.347 . . . . 63.02 110.835 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.61 -26.1 60.63 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.286 0.565 . . . . 74.22 110.116 176.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.403 ' O ' HG13 ' A' ' 62' ' ' ILE . 12.1 mt -71.32 -25.47 25.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.458 -0.792 . . . . 75.44 110.591 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -55.11 -34.14 63.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.605 -0.27 . . . . 74.14 110.861 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 36.0 t -62.56 -48.92 77.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.184 -0.462 . . . . 73.34 111.141 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -73.28 -24.95 60.5 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.818 -0.353 . . . . 71.1 111.05 -176.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.645 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 75.4 mt -76.81 -56.92 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.946 0.403 . . . . 75.12 110.037 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 84.8 mt -62.1 -33.05 73.72 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.998 -0.546 . . . . 74.53 111.678 -175.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -77.33 -24.25 66.26 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.493 -0.86 . . . . 74.2 112.449 179.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -94.2 -20.78 29.32 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.041 -0.6 . . . . 72.43 112.865 -176.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.645 ' HG ' ' O ' ' A' ' 62' ' ' ILE . 69.7 mt -59.25 -15.58 16.3 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.459 0.54 . . . . 72.23 112.459 -176.201 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 84.1 mt -58.69 -41.69 86.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.018 0.437 . . . . 71.34 110.183 177.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.481 ' HB3' ' HB3' ' A' ' 90' ' ' ARG . 19.7 m -71.97 -24.66 61.63 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.875 -0.602 . . . . 75.11 110.751 -179.145 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.432 ' ND2' ' HB1' ' A' ' 88' ' ' ALA . 13.4 m120 -80.85 -22.72 39.65 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.865 -0.607 . . . . 72.41 111.106 -177.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 49.5 mm -100.65 -37.38 5.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 112.171 0.434 . . . . 73.52 112.171 -174.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -61.6 -88.19 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.497 0.925 . . . . 62.21 113.497 -170.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 53.2 m -170.44 144.0 2.39 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.535 -0.543 . . . . 70.33 109.535 -173.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.573 ' HA3' ' O ' ' A' ' 89' ' ' ASN . . . 143.96 -67.26 0.44 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 121.12 -0.562 . . . . 71.02 111.985 175.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.466 ' N ' ' HD3' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -54.3 143.09 46.97 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-O 120.807 0.337 . . . . 75.21 110.978 179.24 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 74' ' ' LYS . 2.8 Cg_exo -78.29 -24.84 7.56 Favored 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 122.882 2.388 . . . . 73.53 112.087 174.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -176.85 165.93 36.38 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.686 -0.768 . . . . 72.12 112.652 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 77' ' ' ARG . 1.9 ptm180 -121.54 142.78 49.74 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.401 -0.592 . . . . 72.11 109.401 178.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.745 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 50.0 ttm -94.88 104.7 16.6 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.278 0.561 . . . . 73.31 110.776 -176.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 53.4 t -105.22 106.33 20.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.029 -0.532 . . . . 64.42 110.397 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 14.7 p -127.31 159.4 34.5 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.973 -0.558 . . . . 50.13 110.177 175.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -62.97 -46.17 88.96 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.368 -0.378 . . . . 72.31 110.933 -176.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -77.7 -25.91 49.76 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.106 0.409 . . . . 75.51 112.106 -172.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.421 ' CE1' ' HA ' ' A' ' 100' ' ' ASP . 14.6 m-85 -149.15 136.35 19.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.233 0.54 . . . . 74.53 111.811 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.611 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 51.7 mm -98.42 99.44 8.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.315 -0.624 . . . . 71.04 109.315 175.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.745 ' HB ' ' HB3' ' A' ' 78' ' ' MET . 29.1 t -103.38 86.74 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.288 0.566 . . . . 64.33 110.257 -177.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -91.11 124.01 35.01 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.955 -0.566 . . . . 74.51 109.711 -177.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 70.5 mt -98.16 117.48 43.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.074 -0.512 . . . . 73.15 110.386 -175.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.54 ' HB3' ' HB2' ' A' ' 95' ' ' GLN . . . -110.89 87.83 2.63 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.262 0.553 . . . . 75.04 111.142 -178.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.573 ' O ' ' HA3' ' A' ' 73' ' ' GLY . 2.9 t-20 -97.58 107.64 20.19 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.431 -0.951 . . . . 62.25 108.431 171.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.481 ' HB3' ' HB3' ' A' ' 68' ' ' SER . 11.5 tpt180 -160.03 147.56 16.55 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.041 -0.527 . . . . 75.44 109.989 -176.09 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.3 t70 71.21 0.63 3.5 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 123.748 0.655 . . . . 71.02 111.111 173.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 114.37 -23.74 12.1 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 115.808 -0.633 . . . . 75.32 112.443 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.412 HE21 ' HA ' ' A' ' 93' ' ' GLN . 0.0 OUTLIER -95.67 159.07 15.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.351 0.595 . . . . 73.12 111.697 -175.094 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -106.32 116.59 32.19 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.382 -0.826 . . . . 75.0 109.451 175.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.54 ' HB2' ' HB3' ' A' ' 88' ' ' ALA . 19.5 mt-30 -121.05 127.94 52.18 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.242 -0.435 . . . . 55.53 110.15 -179.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 41.3 tp -109.94 121.69 45.83 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 110.041 -0.355 . . . . 75.11 110.041 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.476 ' ND2' HG21 ' A' ' 108' ' ' THR . 0.9 OUTLIER -112.91 102.2 10.22 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.903 -0.406 . . . . 73.45 109.903 177.625 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.611 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 6.4 p -113.9 115.61 50.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.412 0.625 . . . . 72.02 111.281 -178.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.566 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 41.2 m -92.44 123.13 35.53 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.805 -0.634 . . . . 64.32 111.045 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.48 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 26.9 t70 -75.08 158.43 33.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.57 -0.741 . . . . 63.4 110.649 177.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 11.6 mmt180 -115.61 2.54 13.78 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.486 0.55 . . . . 73.23 112.486 -176.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -108.13 -35.58 6.54 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.58 0.705 . . . . 73.34 110.264 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 14.4 p -121.81 -23.2 5.55 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.066 -0.97 . . . . 74.11 110.325 176.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 100' ' ' ASP . . . 83.65 14.56 72.94 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.659 -0.7 . . . . 65.24 111.986 -179.059 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.758 ' HG2' ' HE1' ' A' ' 54' ' ' PHE . 49.7 mt-30 -63.94 101.81 0.42 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.748 0.308 . . . . 74.43 110.404 177.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 98' ' ' VAL . 58.5 m -85.88 109.33 18.64 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.829 -0.434 . . . . 62.24 109.829 177.211 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 17.7 t -86.71 105.34 16.87 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.991 -0.55 . . . . 71.15 109.735 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.476 HG21 ' ND2' ' A' ' 97' ' ' ASN . 8.5 m -92.96 96.1 9.9 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.77 -0.65 . . . . 73.23 109.813 177.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 65.0 mt -102.86 114.33 42.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.179 -0.464 . . . . 75.24 111.539 -174.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.51 ' HG2' ' HG2' ' A' ' 95' ' ' GLN . 43.6 mt-30 -95.09 121.19 36.47 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.456 -0.572 . . . . 61.1 109.456 172.058 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 93.4 t -65.66 124.54 20.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.174 0.511 . . . . 75.11 111.949 -175.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.6 m -93.42 -174.29 3.46 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.492 -0.776 . . . . 73.52 110.306 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -120.28 -158.22 10.45 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.195 -1.002 . . . . 75.51 111.929 176.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 77.1 mt -144.88 -62.19 0.36 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.609 0.204 . . . . 75.43 111.086 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 62.45 86.46 0.11 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.813 -0.631 . . . . 73.22 109.656 -174.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -170.52 98.7 0.25 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.772 -0.649 . . . . 73.42 109.96 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -104.56 -37.82 7.0 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.053 -0.521 . . . . 63.43 111.171 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 50.0 m 62.14 91.77 0.06 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.219 0.533 . . . . 75.22 110.565 -178.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.8 p -76.11 86.64 2.98 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.358 0.599 . . . . 74.32 111.318 -178.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.42 ' OD2' ' HD2' ' A' ' 122' ' ' HIS . 33.5 t70 -101.31 -73.1 0.66 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.689 -0.687 . . . . 75.14 110.221 -178.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 64.72 -82.84 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.652 -0.703 . . . . 75.24 112.541 175.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.42 ' HD2' ' OD2' ' A' ' 120' ' ' ASP . 91.3 m-70 66.27 102.58 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.35 0.66 . . . . 74.34 111.401 -173.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -82.72 91.43 7.01 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.417 -0.586 . . . . 71.55 109.417 174.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 17.7 p80 -100.11 121.74 41.88 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.702 -0.681 . . . . 75.21 110.594 -176.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 51.3 t60 -119.03 161.82 19.61 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.241 -1.022 . . . . 74.34 108.241 178.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 6.7 p80 59.17 170.12 0.07 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.06 0.944 . . . . 73.13 111.592 -177.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 44.0 t-80 . . . . . 0 C--O 1.244 0.816 0 CA-C-O 118.13 -0.938 . . . . 63.31 110.123 178.293 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 110.094 -0.336 . . . . 75.5 110.094 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 65.27 59.76 0.8 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.299 0.571 . . . . 74.23 111.386 178.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -129.31 124.24 4.44 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 115.65 -0.705 . . . . 65.14 111.627 177.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.2 t -81.74 143.77 31.59 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.133 0.492 . . . . 73.31 110.836 -177.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.14 124.47 47.8 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.097 -0.501 . . . . 75.43 109.746 176.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 26.7 m -153.65 -48.53 0.09 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.391 -0.368 . . . . 74.21 111.129 -178.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -64.57 -80.9 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.372 -0.376 . . . . 75.04 111.636 -178.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 49.33 61.23 3.25 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.051 0.54 . . . . 73.41 111.55 176.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -113.67 172.32 7.05 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.197 -0.456 . . . . 73.24 111.315 -174.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -164.11 108.87 1.0 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.653 -0.703 . . . . 74.31 109.536 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.3 t30 65.07 87.87 0.12 Allowed Pre-proline 0 N--CA 1.466 0.371 0 O-C-N 123.22 0.325 . . . . 70.54 111.036 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.78 -33.25 80.2 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 123.072 2.515 . . . . 71.33 112.572 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 25.2 t30 73.24 106.48 0.07 Allowed 'General case' 0 N--CA 1.467 0.388 0 O-C-N 123.798 0.686 . . . . 75.43 112.098 174.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -123.21 104.74 9.35 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.596 -0.729 . . . . 75.23 109.24 173.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 174.25 51.69 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.621 -0.8 . . . . 71.23 112.251 -179.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -100.5 103.39 2.61 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.997 -0.621 . . . . 73.33 111.663 178.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.421 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 50.3 m-80 -117.54 148.88 43.83 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 110.381 -0.229 . . . . 72.14 110.381 -177.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 17' ' ' ASN . 5.5 Cg_exo -77.5 94.11 1.07 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.282 2.655 . . . . 61.41 113.62 -175.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 47.02 -87.92 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 114.329 1.233 . . . . 74.52 114.329 172.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -177.59 -179.76 0.85 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.756 0.312 . . . . 74.24 110.236 -170.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -120.44 -46.27 0.37 Allowed Glycine 0 N--CA 1.452 -0.294 0 N-CA-C 111.299 -0.72 . . . . 62.44 111.299 175.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 63.75 -168.51 0.2 Allowed 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 123.414 0.685 . . . . 64.1 111.809 176.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -131.43 145.5 51.83 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.113 -0.494 . . . . 75.42 110.027 -177.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.534 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 5.4 mp -112.57 114.43 27.07 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.111 -0.329 . . . . 72.34 110.111 179.13 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 24' ' ' LEU . 4.4 pp 48.81 -166.14 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 O-C-N 124.074 0.859 . . . . 74.5 112.095 178.272 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -172.42 -85.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.789 -0.448 . . . . 74.45 109.789 173.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.5 p 176.09 136.75 0.05 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.695 -0.684 . . . . 72.43 109.174 177.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -142.55 125.53 16.22 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.667 0.27 . . . . 74.12 110.759 -178.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -128.06 126.43 41.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.114 -0.494 . . . . 75.1 110.087 178.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -98.73 7.17 46.39 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.087 -0.506 . . . . 75.25 111.767 -173.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -90.3 83.44 5.96 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.413 0.625 . . . . 75.53 111.084 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -161.29 -176.28 5.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.403 -0.817 . . . . 64.01 109.422 178.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.9 m 62.18 37.11 14.58 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 121.318 0.58 . . . . 74.21 111.053 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -93.96 11.67 28.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.773 -0.649 . . . . 74.43 110.655 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.436 ' HG3' ' H ' ' A' ' 36' ' ' ASP . 17.3 tptm -107.82 176.32 5.18 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.853 -0.795 . . . . 71.43 108.853 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.436 ' H ' ' HG3' ' A' ' 35' ' ' LYS . 10.1 m-20 -44.24 142.98 2.06 Favored Pre-proline 0 N--CA 1.467 0.411 0 O-C-N 123.758 0.662 . . . . 74.53 112.246 -175.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.52 ' HG3' HG12 ' A' ' 45' ' ' ILE . 18.0 Cg_endo -59.16 152.74 57.35 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 123.419 2.746 . . . . 70.22 113.545 -175.185 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 28.2 t -146.58 38.34 1.02 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.77 -1.105 . . . . 73.21 108.447 -178.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.411 ' O ' ' HB2' ' A' ' 40' ' ' ASN . 24.4 t80 73.02 160.54 0.23 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-N 114.705 -1.134 . . . . 74.42 109.958 -174.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.411 ' HB2' ' O ' ' A' ' 39' ' ' TYR . 91.1 m-20 71.74 3.83 4.82 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.218 0.607 . . . . 75.2 111.073 -177.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -174.69 130.29 0.33 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.334 -0.987 . . . . 75.34 108.334 175.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -127.02 21.3 6.84 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.153 0.502 . . . . 70.12 110.773 -177.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -111.12 -21.32 12.0 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.781 -0.645 . . . . 75.22 110.772 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -75.6 46.82 2.03 Favored Glycine 0 C--O 1.223 -0.588 0 C-N-CA 121.152 -0.547 . . . . 74.52 112.858 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.52 HG12 ' HG3' ' A' ' 37' ' ' PRO . 10.4 mt -99.45 -6.69 9.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.143 -0.688 . . . . 75.24 109.143 178.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.419 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 30.9 tt0 64.58 24.47 13.03 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.027 -0.988 . . . . 65.32 109.621 -174.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 8.2 m -113.02 86.15 8.81 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.116 -0.947 . . . . 73.11 109.236 175.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.419 ' HD3' ' O ' ' A' ' 46' ' ' GLU . 17.1 Cg_exo -66.21 99.22 0.41 Allowed 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.692 2.262 . . . . 73.11 113.157 -173.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.8 m -127.85 -59.46 1.2 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.824 -0.625 . . . . 73.25 109.603 174.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.54 -46.37 15.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.027 -0.533 . . . . 71.23 110.263 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -74.6 -13.35 60.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 73.42 110.778 179.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.614 ' O ' ' HB2' ' A' ' 56' ' ' GLN . 27.0 t70 -62.69 -47.23 84.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.151 -0.477 . . . . 72.13 110.457 -179.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -79.2 9.91 4.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.426 -0.352 . . . . 73.01 110.865 178.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.447 ' O ' HG13 ' A' ' 58' ' ' ILE . 82.4 t80 -109.65 -64.82 1.21 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.759 0.314 . . . . 74.25 110.432 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.464 ' O ' ' HG2' ' A' ' 59' ' ' GLN . 12.9 t -73.5 -18.5 61.1 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.937 0.347 . . . . 75.41 111.937 -174.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.614 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 2.3 mp0 -75.09 -28.11 60.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.802 0.334 . . . . 63.02 110.614 -178.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -79.57 -18.83 50.86 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.536 0.684 . . . . 74.22 109.771 175.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.512 ' O ' HG13 ' A' ' 62' ' ' ILE . 21.7 mt -79.3 -29.06 13.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.37 -0.832 . . . . 75.44 110.604 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' A' ' 55' ' ' THR . 15.1 mm-40 -53.29 -37.61 62.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.132 -0.485 . . . . 74.14 111.136 -178.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.8 m -62.71 -46.55 87.6 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.046 -0.525 . . . . 73.34 111.022 179.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -77.78 -16.14 58.58 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.844 -0.342 . . . . 71.1 111.082 -178.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.512 HG13 ' O ' ' A' ' 58' ' ' ILE . 64.7 mt -71.27 -43.09 74.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.302 -0.629 . . . . 75.12 109.302 172.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 97.1 mt -61.45 -41.56 97.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.926 -0.579 . . . . 74.53 110.096 175.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -65.15 -37.33 93.98 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.771 -0.728 . . . . 74.2 111.714 175.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.21 -37.34 94.37 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 111.784 -0.526 . . . . 72.43 111.784 176.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 62' ' ' ILE . 95.9 mt -56.9 -59.51 4.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.593 0.235 . . . . 72.23 110.998 178.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 pp -65.6 -10.4 35.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.864 0.364 . . . . 71.34 111.741 -176.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 31.4 m -95.86 -46.43 6.56 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.662 0.267 . . . . 75.11 111.246 178.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -92.08 -26.85 18.11 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.399 0.518 . . . . 72.41 112.399 -172.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 36.1 mm -66.58 -20.97 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 121.268 0.556 . . . . 73.52 110.452 -178.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.424 ' N ' HD21 ' A' ' 71' ' ' ASN . 0.9 OUTLIER -68.36 -28.81 67.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.106 0.479 . . . . 62.21 110.28 175.925 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.8 m -96.9 -49.35 5.07 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.106 -0.497 . . . . 70.33 110.638 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 85.11 -89.72 1.62 Allowed Glycine 0 N--CA 1.449 -0.433 0 N-CA-C 111.682 -0.567 . . . . 71.02 111.682 -178.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -57.82 153.77 30.61 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.595 -0.302 . . . . 75.21 110.203 174.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.43 123.79 14.67 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.17 1.914 . . . . 73.53 111.809 177.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -96.55 64.67 1.07 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.627 -0.797 . . . . 72.12 112.494 -176.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -165.33 125.12 1.81 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.084 0.468 . . . . 72.11 110.923 178.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 58.9 ttp -112.58 108.19 17.18 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.907 -0.588 . . . . 73.31 109.642 178.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 60.9 t -74.35 102.81 2.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.243 0.544 . . . . 64.42 111.043 -176.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.657 ' HB ' ' O ' ' A' ' 83' ' ' TYR . 17.5 m -120.95 142.15 50.01 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.376 -0.829 . . . . 50.13 109.28 178.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -70.15 -36.31 74.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.903 0.382 . . . . 72.31 111.08 -174.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -82.4 -40.1 21.74 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.94 -0.573 . . . . 75.51 111.491 -176.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.657 ' O ' ' HB ' ' A' ' 80' ' ' THR . 49.6 m-85 -139.96 120.8 14.46 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.205 -0.294 . . . . 74.53 110.205 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.631 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 4.2 mp -83.68 99.89 6.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.069 -0.715 . . . . 71.04 109.069 178.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.3 t -91.01 106.7 17.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.609 -0.723 . . . . 64.33 111.097 -175.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -105.23 122.91 46.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.058 -0.519 . . . . 74.51 109.693 176.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 56.8 mt -101.55 118.12 47.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.286 -0.416 . . . . 73.15 110.524 -175.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -112.51 88.48 2.83 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.109 0.48 . . . . 75.04 110.492 178.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -95.33 88.54 5.16 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.195 -0.669 . . . . 62.25 109.195 175.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 56.7 ttp180 -130.75 143.06 50.48 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.567 -0.742 . . . . 75.44 109.717 -177.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 37.7 t70 65.7 24.16 11.56 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.64 0.733 . . . . 71.02 110.664 174.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.24 5.15 90.26 Favored Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 115.577 -0.738 . . . . 75.32 112.623 178.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.426 ' HA ' HE21 ' A' ' 93' ' ' GLN . 0.0 OUTLIER -104.4 134.4 47.68 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.873 0.368 . . . . 73.12 110.759 -179.622 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.477 ' HB2' ' HB ' ' A' ' 111' ' ' VAL . 4.5 mm? -91.97 96.34 10.31 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.867 -0.606 . . . . 75.0 109.39 174.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -106.33 110.0 22.1 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.327 0.584 . . . . 55.53 110.695 -179.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 35.8 tp -94.06 109.38 21.14 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.453 -0.794 . . . . 75.11 110.034 -178.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -97.82 93.06 6.15 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.949 0.404 . . . . 73.45 110.52 -179.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 56.0 t -85.01 103.63 12.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.143 0.497 . . . . 72.02 110.369 177.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.631 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 57.9 m -77.31 104.43 7.82 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.204 -0.665 . . . . 64.32 109.204 175.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -69.55 138.45 53.27 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.477 -0.783 . . . . 63.4 111.641 -174.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -108.02 -12.91 15.06 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.384 -0.825 . . . . 73.23 109.716 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -77.74 -55.86 4.99 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.813 -0.631 . . . . 73.34 110.714 -176.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 47.0 p -115.88 -23.15 8.73 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.387 0.613 . . . . 74.11 110.389 178.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 93.11 28.65 11.43 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.551 -0.75 . . . . 65.24 112.121 177.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -101.02 100.8 11.46 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 110.133 -0.321 . . . . 74.43 110.133 177.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 19.0 m -58.64 109.94 0.9 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.328 0.585 . . . . 62.24 110.867 -178.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 7.9 m -89.82 89.61 7.83 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.622 -0.717 . . . . 71.15 110.015 -178.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 45.4 m -83.46 109.3 17.23 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.931 -0.577 . . . . 73.23 110.317 178.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 58.9 mt -108.34 111.23 35.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.923 -0.58 . . . . 75.24 110.907 -177.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -88.96 118.54 28.76 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.981 0.42 . . . . 61.1 110.35 175.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.477 ' HB ' ' HB2' ' A' ' 94' ' ' LEU . 23.0 t -75.51 161.7 4.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.925 -0.58 . . . . 75.11 109.839 178.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.422 ' HB2' ' O ' ' A' ' 111' ' ' VAL . 37.1 m 75.48 25.41 1.24 Allowed 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.293 0.637 . . . . 73.52 110.682 -178.042 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -83.09 -44.43 7.08 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.752 -0.658 . . . . 75.51 111.769 178.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 58.4 mt -96.09 94.96 7.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.04 0.448 . . . . 75.43 110.887 179.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -101.13 148.34 25.19 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.01 -0.541 . . . . 73.22 109.854 177.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -145.07 115.34 7.54 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.92 -0.4 . . . . 73.42 109.92 -178.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -83.95 119.97 25.54 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.162 -0.472 . . . . 63.43 110.623 -177.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 50.4 m -144.16 143.2 30.98 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.951 -0.388 . . . . 75.22 109.951 177.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.7 t -161.91 152.5 17.47 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.919 0.39 . . . . 74.32 111.162 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -130.55 125.18 33.59 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.85 -0.796 . . . . 75.14 108.85 174.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.419 ' O ' ' HB2' ' A' ' 122' ' ' HIS . 33.5 t80 -92.1 -76.17 0.46 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.591 -0.277 . . . . 75.24 111.391 -169.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.419 ' HB2' ' O ' ' A' ' 121' ' ' PHE . 54.2 m170 69.2 157.36 0.15 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.497 0.665 . . . . 74.34 111.692 -176.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 43.0 m170 -117.42 -55.54 2.3 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.756 -0.656 . . . . 71.55 109.459 173.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -172.22 -60.24 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.871 -0.604 . . . . 75.21 109.66 176.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 63.93 169.52 0.16 Allowed 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.84 0.681 . . . . 74.34 112.84 177.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 8.4 p-80 -176.14 152.69 1.18 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.089 -0.96 . . . . 73.13 109.552 172.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.359 -0.829 . . . . 63.31 109.171 173.612 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 N--CA 1.479 1.018 0 CA-C-O 120.897 0.379 . . . . 75.5 110.203 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.69 130.37 9.11 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.175 -0.466 . . . . 74.23 110.35 179.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -101.94 113.11 4.53 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.934 -0.65 . . . . 65.14 111.572 178.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.54 ' HA ' ' HE1' ' A' ' 7' ' ' PHE . 5.6 p -98.12 88.74 4.29 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.034 0.445 . . . . 73.31 110.418 177.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 56.7 ttp -61.73 -43.13 99.45 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.544 -0.753 . . . . 75.43 110.139 178.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.7 t -167.21 -64.61 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.974 -0.557 . . . . 74.21 110.935 173.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.54 ' HE1' ' HA ' ' A' ' 4' ' ' THR . 97.9 m-85 60.16 113.75 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.387 0.613 . . . . 75.04 111.97 -178.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -127.13 88.12 2.76 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.187 0.518 . . . . 73.41 109.887 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.511 ' CE2' ' HB3' ' A' ' 11' ' ' ASN . 86.5 t80 -151.01 126.2 9.93 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.676 -0.693 . . . . 73.24 110.061 -178.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.423 ' N ' ' HD3' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -102.1 92.91 4.97 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.804 -0.443 . . . . 74.31 109.804 -178.698 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.511 ' HB3' ' CE2' ' A' ' 9' ' ' PHE . 27.3 p30 -89.25 146.11 35.5 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-O 120.826 0.346 . . . . 70.54 110.666 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -73.91 -19.77 20.36 Favored 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 122.704 2.269 . . . . 71.33 112.166 177.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 64.76 102.76 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.678 -0.692 . . . . 75.43 111.13 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -120.49 140.69 51.07 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.154 -0.475 . . . . 75.23 110.837 178.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -89.97 -143.18 10.11 Favored Glycine 0 N--CA 1.444 -0.787 0 N-CA-C 111.332 -0.707 . . . . 71.23 111.332 174.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -148.32 -105.41 0.38 Allowed Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.499 -0.857 . . . . 73.33 112.545 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.405 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 50.8 m-80 -121.24 146.85 45.57 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 110.173 -0.306 . . . . 72.14 110.173 -178.083 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 17' ' ' ASN . 16.9 Cg_exo -68.35 -31.21 28.76 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.642 2.228 . . . . 61.41 111.33 176.189 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 11.7 t30 68.71 126.62 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.327 -0.851 . . . . 74.52 111.266 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -82.32 152.14 26.41 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.974 -0.557 . . . . 74.24 110.914 -177.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -88.67 -177.43 46.78 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.731 -0.747 . . . . 62.44 111.656 177.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -89.83 157.08 18.07 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.09 0.472 . . . . 64.1 111.077 -178.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -132.65 131.99 41.95 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.679 -0.692 . . . . 75.42 109.42 176.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.8 mp -115.68 115.78 26.96 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.949 0.404 . . . . 72.34 111.043 -176.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.9 mt -131.88 108.53 9.47 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.723 -0.671 . . . . 74.5 109.99 177.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -95.79 163.86 12.99 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.297 -0.41 . . . . 74.45 110.813 -177.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 26.2 m -122.21 23.5 9.81 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.062 -0.517 . . . . 72.43 110.899 -176.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 67.5 -163.14 0.22 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.701 -0.682 . . . . 74.12 111.125 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.5 tp60 -116.86 169.6 9.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.291 -0.413 . . . . 75.1 110.187 -175.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -75.16 128.76 36.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.787 0.327 . . . . 75.25 110.565 178.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.3 pm0 -100.74 149.83 23.4 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.55 -0.295 . . . . 75.53 111.335 -177.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -174.77 122.73 0.25 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.943 -0.572 . . . . 64.01 110.445 176.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.3 m 51.31 48.57 22.75 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.138 -0.483 . . . . 74.21 111.563 177.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -73.63 -15.49 61.26 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.87 -0.604 . . . . 74.43 112.219 -174.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.407 ' HG2' ' H ' ' A' ' 36' ' ' ASP . 20.3 ttmt 70.37 -162.85 0.16 Allowed 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.871 -0.418 . . . . 71.43 109.871 -177.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.471 ' HB2' ' HD2' ' A' ' 37' ' ' PRO . 6.1 p-10 -78.74 160.59 71.64 Favored Pre-proline 0 C--O 1.235 0.318 0 CA-C-O 120.295 0.093 . . . . 74.53 110.988 -177.023 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.733 ' HA ' ' OD2' ' A' ' 42' ' ' ASP . 73.9 Cg_exo -43.22 143.52 2.11 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.945 3.097 . . . . 70.22 115.271 -175.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.0 m -117.78 21.25 13.03 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.82 -1.082 . . . . 73.21 110.263 178.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 52.7 t80 75.1 164.93 0.28 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.524 -0.762 . . . . 74.42 111.244 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 66.9 t30 71.84 -175.99 0.18 Allowed 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.873 -0.788 . . . . 75.2 108.873 -172.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -60.87 110.25 1.28 Allowed 'General case' 0 C--O 1.234 0.258 0 N-CA-C 108.33 -0.989 . . . . 75.34 108.33 171.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.733 ' OD2' ' HA ' ' A' ' 37' ' ' PRO . 14.9 t70 -128.18 -53.24 1.29 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.526 -0.761 . . . . 70.12 112.335 -160.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.575 ' O ' ' HG2' ' A' ' 46' ' ' GLU . 40.5 m-85 57.63 24.56 10.64 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.161 0.8 . . . . 75.22 113.161 -178.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -75.46 19.34 2.47 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 121.154 -0.545 . . . . 74.52 112.692 176.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.477 ' HA ' HD23 ' A' ' 51' ' ' LEU . 54.3 mt -91.24 -19.84 6.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.378 0.609 . . . . 75.24 109.631 178.276 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.575 ' HG2' ' O ' ' A' ' 43' ' ' PHE . 11.7 pt-20 -86.9 0.67 54.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.656 -0.702 . . . . 65.32 110.189 178.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.7 87.7 3.77 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 115.612 -0.722 . . . . 73.11 110.767 175.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.515 ' CB ' ' HB2' ' A' ' 52' ' ' ASP . 50.7 Cg_endo -70.01 82.9 0.77 Allowed 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.037 1.825 . . . . 73.11 111.653 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.1 m -117.03 -8.96 11.17 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.82 -0.627 . . . . 73.25 110.792 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -165.42 -32.71 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.493 -0.321 . . . . 71.23 111.749 -176.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.477 HD23 ' HA ' ' A' ' 45' ' ' ILE . 3.9 pp -88.44 -10.07 50.4 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.846 0.313 . . . . 73.42 111.846 -177.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.515 ' HB2' ' CB ' ' A' ' 48' ' ' PRO . 17.4 t70 -56.52 -61.38 2.45 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.237 0.458 . . . . 72.13 112.237 -173.268 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -64.14 -33.3 75.47 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.039 -0.528 . . . . 73.01 110.763 -174.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.562 ' O ' HG13 ' A' ' 58' ' ' ILE . 72.3 t80 -70.76 -59.4 2.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.027 -0.533 . . . . 74.25 111.642 -176.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.2 t -66.26 -23.78 66.46 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.773 0.32 . . . . 75.41 111.327 -173.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -82.72 -34.11 27.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.594 -0.275 . . . . 63.02 110.682 177.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.89 -28.35 69.48 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.824 -0.435 . . . . 74.22 109.824 175.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.586 ' HA ' ' HG2' ' A' ' 61' ' ' GLN . 25.5 mt -62.07 -35.48 68.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.063 -0.517 . . . . 75.44 110.35 176.076 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -68.57 -32.42 72.32 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.149 -0.478 . . . . 74.14 110.847 178.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.662 ' O ' HD21 ' A' ' 63' ' ' LEU . 23.0 m -79.99 -35.43 37.49 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.198 -0.456 . . . . 73.34 110.645 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.586 ' HG2' ' HA ' ' A' ' 58' ' ' ILE . 3.2 pt20 -78.39 -1.31 32.83 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.739 0.304 . . . . 71.1 111.545 -176.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.583 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 69.4 mt -60.69 -29.44 44.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.864 0.364 . . . . 75.12 110.421 177.183 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.673 HD23 ' N ' ' A' ' 64' ' ' GLY . 0.2 OUTLIER -61.05 -19.47 61.42 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.024 -0.535 . . . . 74.53 111.876 -177.385 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.673 ' N ' HD23 ' A' ' 63' ' ' LEU . . . -112.03 -32.3 2.45 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.404 -0.678 . . . . 74.2 111.404 175.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -63.55 -28.29 72.24 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 121.547 -0.358 . . . . 72.43 112.431 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.598 ' O ' HG12 ' A' ' 70' ' ' ILE . 73.6 mt -52.49 -47.69 66.41 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 120.59 0.233 . . . . 72.23 110.761 176.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 71.0 mt -61.31 -30.89 70.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.188 -0.46 . . . . 71.34 111.047 -176.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.9 m -76.9 -36.2 56.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.18 -0.464 . . . . 75.11 110.647 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -77.79 -26.11 49.46 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.368 -0.378 . . . . 72.41 110.647 -179.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.598 HG12 ' O ' ' A' ' 66' ' ' LEU . 30.6 mm -64.64 -36.81 78.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.121 -0.49 . . . . 73.52 110.331 177.051 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.532 ' C ' HD21 ' A' ' 71' ' ' ASN . 0.2 OUTLIER -56.61 -50.89 70.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.331 -0.395 . . . . 62.21 109.967 178.605 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.1 m 67.62 111.54 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 O-C-N 123.645 0.59 . . . . 70.33 111.039 -178.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 172.18 -45.59 0.18 Allowed Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.755 -0.736 . . . . 71.02 112.094 -178.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -56.57 144.67 63.5 Favored Pre-proline 0 C--O 1.234 0.252 0 CA-C-O 120.618 0.247 . . . . 75.21 110.932 178.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.541 ' HD2' HD12 ' A' ' 87' ' ' ILE . 20.2 Cg_exo -67.98 -5.69 15.24 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.901 2.401 . . . . 73.53 112.389 177.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 106.81 166.75 22.46 Favored Glycine 0 N--CA 1.442 -0.921 0 N-CA-C 111.194 -0.762 . . . . 72.12 111.194 -178.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.441 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 6.7 ptp180 -65.15 128.74 37.05 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.562 -0.533 . . . . 72.11 109.562 175.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 56.3 ttp -78.9 103.71 9.03 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.603 -0.517 . . . . 73.31 109.603 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 48.8 t -71.01 102.11 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.599 -0.728 . . . . 64.42 109.721 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.419 ' HB ' ' O ' ' A' ' 83' ' ' TYR . 3.7 m -94.24 165.3 12.66 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.019 -0.734 . . . . 50.13 109.019 178.174 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -53.31 -31.45 44.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.872 0.368 . . . . 72.31 111.702 -178.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -139.73 -42.75 0.44 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.905 0.384 . . . . 75.51 110.647 -179.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.419 ' O ' ' HB ' ' A' ' 80' ' ' THR . 75.4 m-85 -76.84 144.31 39.15 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.839 -0.618 . . . . 74.53 111.54 -176.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.49 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 4.3 mp -110.66 100.15 10.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.331 -0.618 . . . . 71.04 109.331 175.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.598 HG23 HG22 ' A' ' 98' ' ' VAL . 12.6 t -106.49 98.4 6.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.279 -0.419 . . . . 64.33 110.806 -175.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.441 ' HA ' ' HA ' ' A' ' 77' ' ' ARG . 33.2 t70 -96.19 127.71 42.44 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.137 0.494 . . . . 74.51 110.24 179.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.541 HD12 ' HD2' ' A' ' 75' ' ' PRO . 60.9 mt -80.73 85.53 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.687 -0.688 . . . . 73.15 109.64 178.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.6 82.9 2.62 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.18 0.514 . . . . 75.04 111.665 -175.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -96.26 101.84 13.54 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.838 -0.619 . . . . 62.25 109.42 175.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 37.7 ttp180 -121.1 97.7 5.64 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.91 0.386 . . . . 75.44 111.083 -177.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 37.1 t70 60.1 82.47 0.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.8 -1.091 . . . . 71.02 111.427 175.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.93 -67.34 3.76 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.445 -0.798 . . . . 75.32 113.386 178.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.502 ' HA ' HE21 ' A' ' 93' ' ' GLN . 0.1 OUTLIER -83.95 159.62 21.23 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.232 0.539 . . . . 73.12 111.126 -173.167 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.523 HD23 HG21 ' A' ' 87' ' ' ILE . 4.8 tt -135.47 134.3 39.43 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.805 -0.634 . . . . 75.0 109.609 -174.027 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.623 ' HG2' ' HG2' ' A' ' 110' ' ' GLN . 22.8 mt-30 -120.6 105.44 10.8 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.881 0.372 . . . . 55.53 110.096 175.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 43.6 tp -83.96 109.91 18.0 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.178 -0.465 . . . . 75.11 110.049 -178.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.504 ' HB3' HG21 ' A' ' 108' ' ' THR . 8.0 p30 -111.62 119.95 40.42 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.465 0.65 . . . . 73.45 111.22 -178.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.598 HG22 HG23 ' A' ' 85' ' ' VAL . 3.2 p -98.25 102.95 14.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.539 0.685 . . . . 72.02 109.478 173.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.843 ' HA ' HG23 ' A' ' 106' ' ' THR . 44.3 m -81.73 105.27 12.73 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.647 -0.706 . . . . 64.32 111.037 -177.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.529 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 11.4 t70 -72.42 143.82 48.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.517 -0.765 . . . . 63.4 109.769 173.369 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -109.17 -11.57 14.9 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.549 -0.296 . . . . 73.23 111.456 -178.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -81.05 -57.02 3.71 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.589 -0.444 . . . . 73.34 110.449 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 51.8 p -107.03 -27.45 10.63 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.094 0.473 . . . . 74.11 110.199 178.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.529 ' HA2' ' O ' ' A' ' 100' ' ' ASP . . . 91.48 20.37 38.17 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.662 -0.699 . . . . 65.24 112.661 175.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -76.49 95.93 3.97 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.681 -0.489 . . . . 74.43 109.681 177.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.843 HG23 ' HA ' ' A' ' 99' ' ' THR . 29.2 p -84.1 91.44 7.67 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.832 -0.622 . . . . 62.24 111.309 -177.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.43 ' HB3' ' CG1' ' A' ' 98' ' ' VAL . 33.1 t -67.14 101.55 0.9 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.129 -0.693 . . . . 71.15 109.129 176.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.504 HG21 ' HB3' ' A' ' 97' ' ' ASN . 10.1 m -104.24 107.04 17.77 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 116.033 -0.53 . . . . 73.23 110.056 -178.457 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 60.3 mt -106.69 114.36 45.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.864 -0.607 . . . . 75.24 110.353 -176.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.623 ' HG2' ' HG2' ' A' ' 95' ' ' GLN . 49.9 mt-30 -66.71 116.98 8.21 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.692 -0.484 . . . . 61.1 109.692 174.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.49 ' HB ' ' HB3' ' A' ' 94' ' ' LEU . 58.8 t -74.3 98.52 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.465 0.65 . . . . 75.11 110.828 -173.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.8 t -151.24 -55.3 0.15 Allowed 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.163 -1.051 . . . . 73.52 108.163 175.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 64.59 47.93 78.51 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.655 -0.702 . . . . 75.51 112.746 174.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 91.1 mt -96.81 -57.28 2.33 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 110.225 -0.287 . . . . 75.43 110.225 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 75.0 mm-40 54.61 95.62 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.855 0.722 . . . . 73.22 110.605 -173.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -58.53 98.09 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.476 -0.783 . . . . 73.42 112.124 -171.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -175.71 93.1 0.06 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.329 -1.36 . . . . 63.43 107.329 178.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 10.8 t -82.64 146.08 29.3 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.36 0.6 . . . . 75.22 111.387 -169.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 19.5 p -120.46 161.77 20.67 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.261 -0.882 . . . . 74.32 110.073 179.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -106.85 111.88 24.6 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.717 -0.475 . . . . 75.14 109.717 176.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -59.09 -49.65 77.08 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.146 -0.687 . . . . 75.24 109.146 178.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 70.72 116.81 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 114.928 -1.033 . . . . 74.34 112.551 168.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 60.1 m170 -92.35 148.38 22.17 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.054 -0.721 . . . . 71.55 109.054 171.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 52.3 p-80 -117.64 125.3 50.49 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.85 -0.34 . . . . 75.21 110.394 -176.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 42.8 m80 -127.19 -67.04 0.86 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.499 -0.318 . . . . 74.34 111.049 -179.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 68.4 m80 52.98 72.2 0.44 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.064 -0.516 . . . . 73.13 110.101 -174.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 73.8 t60 . . . . . 0 C--O 1.248 0.989 0 CA-C-O 117.941 -1.028 . . . . 63.31 110.311 -172.834 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 . . . . . 0 N--CA 1.451 -0.412 0 CA-C-O 120.516 0.198 . . . . 65.319999999999993 111.338 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 9.8 m -115.97 86.57 16.85 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 120.725 0.298 . . . . 60.32 110.304 175.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -77.37 84.57 1.93 Allowed 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.122 1.881 . . . . 72.099999999999994 111.896 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.7 m -86.07 -80.15 0.24 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.896 -0.593 . . . . 71.450000000000003 111.159 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -93.84 -37.85 11.54 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.807 0.337 . . . . 71.230000000000004 111.355 -177.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.582 HD23 ' H ' ' A' ' 51' ' ' LEU . 1.7 pt? -66.64 -13.83 61.68 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.01 -0.541 . . . . 73.420000000000002 111.273 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -49.01 -53.46 19.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.674 -0.694 . . . . 63.020000000000003 112.509 -175.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.45 -30.96 67.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.826 0.346 . . . . 73.010000000000005 111.349 -178.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.496 ' O ' HG13 ' A' ' 58' ' ' ILE . 67.2 t80 -67.23 -44.64 78.96 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.192 -0.458 . . . . 74.25 110.407 -178.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 87.0 m -55.34 -37.2 67.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.425 0.631 . . . . 75.409999999999997 111.557 178.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -80.19 -31.7 38.73 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.796 -0.638 . . . . 51.200000000000003 110.771 -174.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.81 -25.19 68.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.031 -0.532 . . . . 74.219999999999999 110.263 175.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.531 ' O ' HG13 ' A' ' 62' ' ' ILE . 2.5 mt -86.28 -45.37 16.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.974 -0.557 . . . . 75.030000000000001 110.968 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.454 ' HA ' HD12 ' A' ' 62' ' ' ILE . 76.1 mt-30 -59.14 -30.45 68.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.769 0.319 . . . . 51.229999999999997 111.283 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.5 m -66.58 -37.96 86.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.352 -0.386 . . . . 73.340000000000003 111.152 178.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.527 ' HG2' ' O ' ' A' ' 58' ' ' ILE . 11.1 pt20 -83.19 -20.9 33.8 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.794 0.33 . . . . 64.209999999999994 110.943 -178.394 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.531 HG13 ' O ' ' A' ' 58' ' ' ILE . 83.9 mt -66.5 -31.1 52.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.996 0.427 . . . . 75.120000000000005 109.894 177.399 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 91.9 mt -57.65 -32.85 67.69 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.734 -0.666 . . . . 74.530000000000001 110.933 178.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -74.51 -40.47 39.05 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.993 -0.623 . . . . 54.140000000000001 111.602 176.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -63.71 -25.99 69.49 Favored Glycine 0 C--N 1.33 0.2 0 C-N-CA 120.992 -0.623 . . . . 33.530000000000001 112.286 178.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 62' ' ' ILE . 91.8 mt -66.22 -18.34 65.29 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.706 0.289 . . . . 72.230000000000004 110.916 178.482 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 93.7 mt -85.59 5.97 29.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.076 0.465 . . . . 70.319999999999993 110.563 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.9 t -126.11 -42.21 1.88 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.947 -0.57 . . . . 75.109999999999999 110.587 179.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.414 ' ND2' HD21 ' A' ' 97' ' ' ASN . 86.7 m-20 -75.73 5.36 6.34 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.699 0.629 . . . . 53.439999999999998 112.699 -173.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.402 HG12 ' O ' ' A' ' 66' ' ' LEU . 50.4 mm . . . . . 0 C--N 1.322 -0.595 0 CA-C-O 121.653 0.739 . . . . 71.409999999999997 109.664 176.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.464 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 27.6 ttt . . . . . 0 N--CA 1.455 -0.207 0 CA-C-O 120.729 0.3 . . . . 73.310000000000002 110.472 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 53.1 t -85.5 97.65 5.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.373 0.606 . . . . 63.219999999999999 110.696 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.697 ' HB ' ' O ' ' A' ' 83' ' ' TYR . 6.7 m -113.65 148.86 35.53 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.307 -0.86 . . . . 43.310000000000002 108.854 177.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -73.52 -59.64 2.62 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.007 0.373 . . . . 72.310000000000002 112.007 -170.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -82.82 -14.16 54.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.795 0.331 . . . . 75.510000000000005 111.448 -174.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.697 ' O ' ' HB ' ' A' ' 80' ' ' THR . 59.4 m-85 -133.99 121.3 21.41 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.334 -0.394 . . . . 63.340000000000003 110.482 -177.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.569 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 2.9 mp -81.91 102.56 7.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.089 -0.708 . . . . 71.040000000000006 109.089 175.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.464 ' HB ' ' HB3' ' A' ' 78' ' ' MET . 47.3 t -96.69 94.31 4.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.715 -0.675 . . . . 64.329999999999998 110.769 -176.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -98.45 115.62 28.91 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.343 -0.614 . . . . 74.510000000000005 109.343 178.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 71.6 mt -82.02 94.66 2.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.939 -0.573 . . . . 73.150000000000006 110.673 -176.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.05 74.54 8.08 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.687 -0.688 . . . . 54.140000000000001 111.102 -177.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -88.59 92.73 9.31 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.147 -0.686 . . . . 62.210000000000001 109.147 173.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.441 ' HA ' ' HD2' ' A' ' 90' ' ' ARG . 13.6 tpt180 -133.68 154.16 51.14 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.818 -0.628 . . . . 75.439999999999998 109.726 -178.266 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.9 t70 69.93 -68.18 0.21 Allowed 'General case' 0 N--CA 1.465 0.317 0 O-C-N 124.082 0.864 . . . . 71.019999999999996 111.151 178.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 177.74 23.62 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.736 -0.745 . . . . 75.319999999999993 113.433 178.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -138.1 152.5 48.83 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 122.265 -0.55 . . . . 62.409999999999997 110.264 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -89.61 94.58 9.91 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.761 -0.459 . . . . 52.240000000000002 109.761 176.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.474 ' HG2' ' OD1' ' A' ' 97' ' ' ASN . 7.3 tt0 -97.31 109.29 22.08 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.137 0.494 . . . . 55.530000000000001 109.692 -179.102 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.543 ' HB3' ' HB ' ' A' ' 109' ' ' ILE . 29.0 tp -90.11 98.64 11.89 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.868 -0.605 . . . . 75.109999999999999 110.389 -177.234 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.483 ' OD1' HG23 ' A' ' 108' ' ' THR . 6.5 m-20 -90.61 93.44 9.27 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.283 0.564 . . . . 43.409999999999997 110.532 -179.008 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.439 ' CG1' ' HD1' ' A' ' 83' ' ' TYR . 56.1 t -92.8 114.18 29.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.658 -0.701 . . . . 72.019999999999996 110.677 178.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.569 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 30.7 m -103.32 109.23 20.77 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.845 -0.616 . . . . 64.319999999999993 110.077 178.027 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.587 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 25.2 t70 -62.32 141.23 58.4 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.489 -0.323 . . . . 63.399999999999999 110.777 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.07 -26.69 19.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.259 -0.428 . . . . 70.420000000000002 110.251 -177.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 32.7 mtmm -70.04 -69.58 0.34 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.374 -0.375 . . . . 73.140000000000001 111.149 -174.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 12.0 t -99.05 -26.8 14.11 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.243 0.544 . . . . 72.120000000000005 109.716 -179.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.587 ' HA2' ' O ' ' A' ' 100' ' ' ASP . . . 83.65 79.45 1.06 Allowed Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.544 -0.753 . . . . 65.239999999999995 112.909 176.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.491 ' H ' ' HB3' ' A' ' 100' ' ' ASP . 68.6 mm-40 -124.69 144.16 50.36 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.587 -0.523 . . . . 72.040000000000006 109.587 174.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.9 m -89.05 96.11 10.59 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.123 0.487 . . . . 61.32 110.724 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.435 ' HB3' ' HB ' ' A' ' 98' ' ' VAL . 47.4 t -88.17 80.83 7.51 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.454 -0.573 . . . . 71.150000000000006 109.454 177.23 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.483 HG23 ' OD1' ' A' ' 97' ' ' ASN . 28.2 m -82.35 101.49 10.62 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.901 -0.591 . . . . 61.340000000000003 110.709 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.543 ' HB ' ' HB3' ' A' ' 96' ' ' LEU . 54.5 mt -99.88 92.34 2.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.052 -0.522 . . . . 73.010000000000005 110.514 -178.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -72.56 106.91 4.81 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.723 -0.473 . . . . 61.100000000000001 109.723 175.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.2 t . . . . . 0 C--N 1.323 -0.584 0 N-CA-C 109.688 -0.486 . . . . 75.109999999999999 109.688 177.435 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 . . . . . 0 N--CA 1.456 -0.157 0 CA-C-O 120.804 0.335 . . . . 65.319999999999993 110.923 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 47.0 p -124.75 86.7 55.69 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.492 -0.322 . . . . 60.32 110.943 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.405 ' HA ' ' HG ' ' A' ' 51' ' ' LEU . 32.0 Cg_exo -57.66 98.94 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.81 2.34 . . . . 72.099999999999994 112.702 -177.552 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 14.3 m -104.4 -46.83 4.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.613 -0.721 . . . . 71.450000000000003 110.375 176.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.68 -2.65 3.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.466 0.65 . . . . 71.230000000000004 110.303 174.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.484 HD23 ' H ' ' A' ' 51' ' ' LEU . 0.7 OUTLIER -95.46 0.55 53.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.672 -0.695 . . . . 73.420000000000002 110.394 -178.728 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -68.28 -40.83 81.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.142 -0.481 . . . . 63.020000000000003 109.977 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -63.69 -30.73 71.79 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.711 -0.677 . . . . 73.010000000000005 110.368 176.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -83.14 -51.57 7.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.819 -0.628 . . . . 74.25 111.322 -177.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.0 t -69.05 -26.43 64.96 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.046 0.387 . . . . 75.409999999999997 112.046 -173.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -77.3 -19.87 55.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.86 0.362 . . . . 51.200000000000003 110.433 178.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.51 -18.41 48.6 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.477 0.656 . . . . 74.219999999999999 109.683 175.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.469 ' O ' HG13 ' A' ' 62' ' ' ILE . 13.3 mt -77.04 -32.22 19.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.636 -0.711 . . . . 75.030000000000001 110.182 177.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -61.64 -27.88 68.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 51.229999999999997 110.795 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.635 ' O ' HD22 ' A' ' 63' ' ' LEU . 5.9 m -75.87 -43.15 46.95 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.21 -0.45 . . . . 73.340000000000003 110.691 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.41 ' HG2' ' O ' ' A' ' 58' ' ' ILE . 21.0 pt20 -74.53 -3.81 33.12 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.484 -0.326 . . . . 64.209999999999994 111.641 -173.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 58' ' ' ILE . 64.7 mt -66.9 -17.8 23.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.287 0.565 . . . . 75.120000000000005 110.0 174.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.635 HD22 ' O ' ' A' ' 60' ' ' SER . 0.5 OUTLIER -63.75 -19.21 64.79 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.857 -0.611 . . . . 74.530000000000001 111.199 -179.024 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.613 ' N ' HD23 ' A' ' 63' ' ' LEU . . . -81.68 -30.37 36.25 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 111.101 -0.8 . . . . 54.140000000000001 111.101 176.165 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -69.77 -26.02 74.89 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.081 -0.808 . . . . 33.530000000000001 111.081 175.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.493 ' HA ' HD11 ' A' ' 70' ' ' ILE . 86.8 mt -70.49 -5.45 28.86 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.089 0.471 . . . . 72.230000000000004 110.647 176.299 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 87.4 mt -109.41 -66.69 1.04 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.925 -0.579 . . . . 70.319999999999993 110.952 178.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 17.8 m -98.51 15.41 25.03 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.865 0.691 . . . . 75.109999999999999 112.865 -171.083 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -129.45 20.73 5.66 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.539 0.685 . . . . 53.439999999999998 110.197 178.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.493 HD11 ' HA ' ' A' ' 66' ' ' LEU . 45.2 mm . . . . . 0 C--O 1.235 0.323 0 CA-C-O 121.629 0.728 . . . . 71.409999999999997 109.319 178.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 59.6 ttp . . . . . 0 N--CA 1.453 -0.284 0 N-CA-C 109.299 -0.63 . . . . 73.310000000000002 109.299 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 58.5 t -67.4 103.52 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.096 0.474 . . . . 63.219999999999999 111.202 -178.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -108.19 167.6 9.9 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.686 -0.688 . . . . 43.310000000000002 110.987 176.314 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -64.28 -73.88 0.11 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.499 -0.318 . . . . 72.310000000000002 111.809 -174.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -120.6 32.96 5.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.809 0.814 . . . . 75.510000000000005 109.873 -178.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -125.85 144.17 50.77 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.174 -0.921 . . . . 63.340000000000003 110.243 177.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.562 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 4.4 mp -108.55 100.48 10.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.172 -0.677 . . . . 71.040000000000006 109.172 175.364 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.9 p -125.28 110.72 25.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.579 0.704 . . . . 64.329999999999998 110.973 -177.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -110.38 143.95 39.87 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.477 -0.783 . . . . 74.510000000000005 109.858 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 59.5 mt -87.13 98.68 7.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 109.641 -0.503 . . . . 73.150000000000006 109.641 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -88.26 89.44 7.99 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.888 -0.596 . . . . 54.140000000000001 111.146 -176.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.481 ' HA ' ' O ' ' A' ' 93' ' ' GLN . 15.0 t30 -84.97 77.43 10.11 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.901 -0.778 . . . . 62.210000000000001 108.901 172.321 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.411 ' O ' ' HB3' ' A' ' 91' ' ' ASP . 47.3 ttp180 -102.6 144.45 30.99 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.737 -1.12 . . . . 75.439999999999998 109.107 -178.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.411 ' HB3' ' O ' ' A' ' 90' ' ' ARG . 11.4 t70 69.05 -67.78 0.2 Allowed 'General case' 0 N--CA 1.467 0.384 0 O-C-N 123.726 0.641 . . . . 71.019999999999996 110.664 -177.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 172.34 31.54 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.297 -0.721 . . . . 75.319999999999993 111.297 178.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.481 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 26.2 mm-40 -136.82 150.06 48.1 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.048 -0.353 . . . . 62.409999999999997 110.048 -178.072 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.448 ' HB2' ' HB ' ' A' ' 111' ' ' VAL . 3.6 mm? -88.24 101.92 14.32 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.102 -0.333 . . . . 52.240000000000002 110.102 178.145 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.403 ' HG2' ' ND2' ' A' ' 97' ' ' ASN . 41.2 tt0 -104.74 121.53 43.81 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.012 0.434 . . . . 55.530000000000001 110.245 178.294 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 15.7 tp -103.94 102.68 12.47 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.16 -0.473 . . . . 75.109999999999999 110.169 -177.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.403 ' ND2' ' HG2' ' A' ' 95' ' ' GLN . 20.1 m-80 -96.46 115.25 27.13 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.42 -0.355 . . . . 43.409999999999997 110.723 -177.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 39.7 t -99.61 111.26 28.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.171 -0.468 . . . . 72.019999999999996 110.821 178.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.562 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 43.6 m -97.75 110.59 23.13 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.813 -0.63 . . . . 64.319999999999993 110.391 177.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.489 ' HB3' ' H ' ' A' ' 105' ' ' GLN . 7.1 t70 -71.34 124.97 25.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.941 -0.572 . . . . 63.399999999999999 109.923 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.489 ' HD3' ' O ' ' A' ' 101' ' ' ARG . 3.1 tmt_? -82.84 -28.69 29.96 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.599 0.238 . . . . 70.420000000000002 110.639 -176.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -84.77 -58.4 2.73 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.491 0.663 . . . . 73.140000000000001 110.804 -175.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.7 m -88.68 -25.34 22.42 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.989 -1.005 . . . . 72.120000000000005 110.83 -172.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.97 69.32 1.41 Allowed Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.704 -0.68 . . . . 65.239999999999995 113.214 177.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.489 ' H ' ' HB3' ' A' ' 100' ' ' ASP . 44.7 mt-30 -136.82 144.75 43.82 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.993 -0.743 . . . . 72.040000000000006 108.993 176.338 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.2 t -110.77 94.41 4.98 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.982 0.896 . . . . 61.32 110.446 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 27.0 t -87.26 113.23 22.8 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.457 -0.792 . . . . 71.150000000000006 109.371 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 41.9 m -103.62 111.39 23.85 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.925 -0.58 . . . . 61.340000000000003 111.219 -176.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.401 HD12 ' N ' ' A' ' 109' ' ' ILE . 4.5 mp -108.34 109.47 28.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.097 -0.501 . . . . 73.010000000000005 109.649 178.061 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -91.61 153.83 19.46 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.017 0.436 . . . . 61.100000000000001 111.491 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.448 ' HB ' ' HB2' ' A' ' 94' ' ' LEU . 4.4 p . . . . . 0 C--N 1.325 -0.479 0 CA-C-N 115.177 -0.92 . . . . 75.109999999999999 111.683 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 N--CA 1.469 0.504 0 N-CA-C 112.757 0.651 . . . . 65.319999999999993 112.757 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 4.7 t -136.6 88.23 19.95 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-O 121.483 0.659 . . . . 60.32 110.989 -177.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -71.82 84.39 1.04 Allowed 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.398 2.066 . . . . 72.099999999999994 111.167 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 12.4 p -127.29 -72.6 0.63 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.659 -0.7 . . . . 71.450000000000003 110.786 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.95 -14.78 63.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.132 -0.485 . . . . 71.230000000000004 111.92 -177.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.421 ' O ' HG22 ' A' ' 55' ' ' THR . 2.9 pp -115.62 1.69 13.6 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.472 -0.331 . . . . 73.420000000000002 111.351 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.627 ' O ' ' HB2' ' A' ' 56' ' ' GLN . 28.3 t70 -68.05 -36.81 80.5 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.451 -0.34 . . . . 63.020000000000003 111.397 -174.217 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -84.66 -38.24 20.05 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.781 0.324 . . . . 73.010000000000005 110.922 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.469 ' O ' HG13 ' A' ' 58' ' ' ILE . 60.9 t80 -61.23 -57.99 10.13 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.884 -0.598 . . . . 74.25 111.42 -177.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.421 HG22 ' O ' ' A' ' 51' ' ' LEU . 7.2 t -70.01 -16.72 63.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.186 0.517 . . . . 75.409999999999997 110.958 -176.04 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.627 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 1.5 tp-100 -75.16 -29.96 60.59 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.385 0.612 . . . . 51.200000000000003 109.752 -178.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.72 -35.76 44.39 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.563 -0.744 . . . . 74.219999999999999 109.926 176.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.575 ' O ' HG13 ' A' ' 62' ' ' ILE . 17.3 mt -62.38 -40.07 86.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.648 -0.705 . . . . 75.030000000000001 111.055 -178.371 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -54.48 -32.85 58.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.429 -0.35 . . . . 51.229999999999997 111.413 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.3 t -81.51 -18.4 45.21 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.508 -0.314 . . . . 73.340000000000003 111.59 -176.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.547 ' HG2' ' O ' ' A' ' 58' ' ' ILE . 12.8 pt20 -96.63 -17.21 20.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.863 0.363 . . . . 64.209999999999994 110.687 -178.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.592 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 84.2 mt -65.15 -41.81 92.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.211 -0.45 . . . . 75.120000000000005 110.295 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.2 mp -61.59 -31.1 71.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.709 -0.678 . . . . 74.530000000000001 110.967 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -73.14 -41.8 45.9 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.658 -0.782 . . . . 54.140000000000001 111.833 178.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -71.33 -19.46 77.55 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 121.295 -0.478 . . . . 33.530000000000001 112.814 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' A' ' 62' ' ' ILE . 86.2 mt -57.35 -34.43 68.79 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.884 0.373 . . . . 72.230000000000004 110.966 178.34 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.432 HD12 HH11 ' A' ' 90' ' ' ARG . 97.1 mt -65.87 -36.5 83.6 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.199 -0.455 . . . . 70.319999999999993 110.851 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.9 m -71.51 -27.6 63.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.025 0.441 . . . . 75.109999999999999 110.255 177.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -72.83 -27.3 61.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.118 0.485 . . . . 53.439999999999998 109.927 176.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.531 HG12 ' O ' ' A' ' 66' ' ' LEU . 48.8 mm . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 115.888 -0.596 . . . . 71.409999999999997 109.634 175.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 45.1 ttm . . . . . 0 N--CA 1.453 -0.283 0 N-CA-C 110.299 -0.26 . . . . 73.310000000000002 110.299 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 54.2 t -72.38 124.98 30.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.507 -0.553 . . . . 63.219999999999999 109.507 176.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.625 ' HB ' ' O ' ' A' ' 83' ' ' TYR . 2.7 m -127.27 162.35 26.44 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.663 -0.244 . . . . 43.310000000000002 110.532 -176.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -72.59 -75.89 0.13 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.954 0.407 . . . . 72.310000000000002 111.264 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -88.96 5.98 41.61 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.225 -0.443 . . . . 75.510000000000005 111.781 -174.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.625 ' O ' ' HB ' ' A' ' 80' ' ' THR . 60.7 m-85 -143.81 167.65 21.81 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.882 0.372 . . . . 63.340000000000003 110.748 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.571 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 40.8 mm -121.88 99.55 7.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 108.762 -0.829 . . . . 71.040000000000006 108.762 168.397 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.439 HG13 HD11 ' A' ' 96' ' ' LEU . 37.1 t -85.0 82.38 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.194 0.521 . . . . 64.329999999999998 109.977 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -94.81 98.77 10.98 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.754 -0.657 . . . . 74.510000000000005 111.226 -177.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.467 HG12 HD13 ' A' ' 96' ' ' LEU . 58.2 mt -86.82 95.4 4.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.574 -0.528 . . . . 73.150000000000006 109.574 175.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -88.14 114.33 24.66 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.954 -0.566 . . . . 54.140000000000001 110.457 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.508 ' HA ' ' O ' ' A' ' 93' ' ' GLN . 2.8 t-20 -109.89 111.17 22.42 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.906 -0.588 . . . . 62.210000000000001 110.211 178.188 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.432 HH11 HD12 ' A' ' 67' ' ' LEU . 59.0 ttp85 -127.44 133.74 49.91 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.476 -0.564 . . . . 75.439999999999998 109.476 175.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 64.43 -86.05 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 O-C-N 123.861 0.725 . . . . 71.019999999999996 110.558 -176.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -148.64 15.1 1.22 Allowed Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 110.996 -0.842 . . . . 75.319999999999993 110.996 177.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.508 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -98.11 124.31 42.57 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.814 0.34 . . . . 62.409999999999997 110.799 -177.588 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -95.7 101.17 12.83 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.65 -0.87 . . . . 52.240000000000002 108.65 171.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -117.45 110.7 18.32 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.184 -0.462 . . . . 55.530000000000001 110.754 -174.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.502 ' HG ' HG23 ' A' ' 98' ' ' VAL . 61.1 tp -89.21 109.58 20.44 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.896 -0.593 . . . . 75.109999999999999 110.971 -176.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -97.44 88.31 4.36 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.848 -0.427 . . . . 43.409999999999997 109.848 178.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.539 ' HB ' ' HB3' ' A' ' 107' ' ' SER . 43.1 t -78.95 102.55 5.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.205 0.526 . . . . 72.019999999999996 110.516 178.507 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.571 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 25.1 m -90.64 106.39 18.47 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.456 -0.793 . . . . 64.319999999999993 109.371 176.363 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -63.02 140.23 58.85 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.061 0.458 . . . . 63.399999999999999 110.73 -177.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 24.4 tpp180 -76.6 -35.47 58.09 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.672 -0.694 . . . . 70.420000000000002 111.785 -174.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -102.35 -47.44 4.49 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 111.876 0.324 . . . . 73.140000000000001 111.876 -169.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 42.7 p -89.9 -26.84 20.25 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.156 0.503 . . . . 72.120000000000005 110.486 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.03 19.02 68.21 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.855 -0.688 . . . . 65.239999999999995 112.861 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -64.8 124.49 22.11 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.242 -0.281 . . . . 72.040000000000006 110.242 174.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 36.9 m -92.92 91.64 7.5 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.234 0.54 . . . . 61.32 109.571 175.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.539 ' HB3' ' HB ' ' A' ' 98' ' ' VAL . 17.1 t -88.45 89.39 7.97 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.869 -0.605 . . . . 71.150000000000006 109.589 -179.117 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 32.1 m -86.84 102.86 14.7 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.78 -0.645 . . . . 61.340000000000003 110.257 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 61.4 mt -111.39 109.11 27.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.77 -0.65 . . . . 73.010000000000005 110.816 -177.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -76.14 147.48 38.5 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.431 -0.35 . . . . 61.100000000000001 110.474 174.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 5.7 p . . . . . 0 C--N 1.322 -0.587 0 CA-C-N 115.563 -0.744 . . . . 75.109999999999999 110.179 174.374 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 . . . . . 0 CA--C 1.529 0.16 0 N-CA-C 111.864 0.32 . . . . 65.319999999999993 111.864 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.7 t -137.63 74.79 45.39 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-O 121.885 0.85 . . . . 60.32 109.673 172.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -89.9 99.54 0.3 Allowed 'Trans proline' 0 N--CA 1.448 -1.2 0 C-N-CA 122.941 2.428 . . . . 72.099999999999994 112.775 -175.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 38.3 m -129.39 -62.69 0.97 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.849 -0.614 . . . . 71.450000000000003 109.759 174.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.83 -43.78 13.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.12 0.486 . . . . 71.230000000000004 110.124 178.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.9 pp -75.58 -11.12 59.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.865 -0.607 . . . . 73.420000000000002 110.613 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.562 ' O ' ' HB2' ' A' ' 56' ' ' GLN . 26.9 t70 -62.42 -50.48 71.33 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.991 -0.55 . . . . 63.020000000000003 110.439 178.454 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -63.41 -32.47 73.92 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.049 -0.523 . . . . 73.010000000000005 110.908 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.535 ' O ' HG13 ' A' ' 58' ' ' ILE . 57.4 t80 -68.11 -55.33 12.83 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.035 -0.53 . . . . 74.25 110.227 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.3 t -67.85 -19.22 65.02 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.25 0.548 . . . . 75.409999999999997 110.524 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.562 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 2.8 tp-100 -67.38 -41.3 85.25 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.795 -0.638 . . . . 51.200000000000003 109.4 178.016 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.94 -29.28 61.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.505 -0.771 . . . . 74.219999999999999 110.798 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.535 HG13 ' O ' ' A' ' 54' ' ' PHE . 20.7 mt -63.84 -35.61 73.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.123 0.487 . . . . 75.030000000000001 110.552 178.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -66.92 -22.14 65.96 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.132 -0.486 . . . . 51.229999999999997 111.263 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.3 m -85.93 -30.07 23.11 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.018 -0.537 . . . . 73.340000000000003 111.073 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 58' ' ' ILE . 13.7 pt20 -83.14 -3.33 57.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.795 0.331 . . . . 64.209999999999994 111.093 -176.423 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.513 HG12 ' O ' ' A' ' 58' ' ' ILE . 47.5 mm -74.95 -37.61 41.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.891 0.377 . . . . 75.120000000000005 110.343 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.567 ' H ' HD22 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -65.5 -41.89 92.72 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.008 -0.542 . . . . 74.530000000000001 110.792 -175.778 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -77.79 -22.51 69.12 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.631 -0.795 . . . . 54.140000000000001 112.346 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -77.22 -6.83 86.63 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.982 -0.627 . . . . 33.530000000000001 112.435 -178.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.616 ' O ' HG12 ' A' ' 70' ' ' ILE . 97.9 mt -70.11 -29.66 66.66 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 122.819 -0.224 . . . . 72.230000000000004 111.018 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 91.2 mt -54.28 -46.89 72.81 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.308 -0.405 . . . . 70.319999999999993 111.995 -175.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -70.8 -21.95 62.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.222 -0.445 . . . . 75.109999999999999 111.255 -178.294 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -94.1 -7.93 41.07 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.311 -0.404 . . . . 53.439999999999998 111.032 -178.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.616 HG12 ' O ' ' A' ' 66' ' ' LEU . 31.9 mm . . . . . 0 C--N 1.325 -0.468 0 CA-C-N 116.413 -0.358 . . . . 71.409999999999997 110.368 177.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.409 ' HB3' HG13 ' A' ' 85' ' ' VAL . 27.5 ttt . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.986 0.422 . . . . 73.310000000000002 111.043 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 46.1 t -81.87 107.39 13.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.088 -0.505 . . . . 63.219999999999999 110.154 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.779 ' HB ' ' O ' ' A' ' 83' ' ' TYR . 1.8 m -107.95 168.39 9.31 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.192 -0.458 . . . . 43.310000000000002 110.139 -178.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.44 ' H ' HG22 ' A' ' 80' ' ' THR . 22.3 p-10 -89.03 -65.33 1.03 Allowed 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.172 0.434 . . . . 72.310000000000002 112.172 -175.116 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -94.66 -2.72 50.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.205 0.526 . . . . 75.510000000000005 111.192 -176.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.779 ' O ' ' HB ' ' A' ' 80' ' ' THR . 31.8 m-85 -130.73 149.95 52.14 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.97 -0.752 . . . . 63.340000000000003 108.97 177.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.581 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 4.7 mp -117.5 93.92 2.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 108.914 -0.773 . . . . 71.040000000000006 108.914 172.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.409 HG13 ' HB3' ' A' ' 78' ' ' MET . 4.9 p -91.57 101.29 12.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.955 0.883 . . . . 64.329999999999998 110.216 178.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -93.81 127.26 39.45 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.339 -0.846 . . . . 74.510000000000005 109.967 -177.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 63.5 mt -93.37 109.47 21.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.162 -0.472 . . . . 73.150000000000006 110.465 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -120.77 176.24 5.63 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.915 -0.584 . . . . 54.140000000000001 110.474 179.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -139.11 123.81 18.54 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.691 -0.485 . . . . 62.210000000000001 109.691 176.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.44 ' O ' ' HB3' ' A' ' 91' ' ' ASP . 14.8 ptm180 -106.23 99.62 9.19 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.712 -0.676 . . . . 75.439999999999998 110.057 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.44 ' HB3' ' O ' ' A' ' 90' ' ' ARG . 4.8 t70 73.38 -57.97 0.61 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.878 -0.601 . . . . 71.019999999999996 111.696 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -172.2 32.07 0.12 Allowed Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 111.076 -0.809 . . . . 75.319999999999993 111.076 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -135.8 124.52 23.85 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.613 -0.514 . . . . 62.409999999999997 109.613 -179.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -64.37 120.09 11.58 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.14 0.495 . . . . 52.240000000000002 110.405 176.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.423 HE22 ' HG3' ' A' ' 110' ' ' GLN . 24.2 tp60 -102.17 115.77 31.26 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.502 -0.772 . . . . 55.530000000000001 109.932 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 12.9 tp -92.62 91.05 7.37 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.303 -0.629 . . . . 75.109999999999999 109.303 178.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -83.59 96.24 8.58 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.365 -0.38 . . . . 43.409999999999997 110.77 -177.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.412 ' HB ' ' HB3' ' A' ' 107' ' ' SER . 47.1 t -88.93 104.87 15.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.332 0.587 . . . . 72.019999999999996 110.623 176.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.581 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 31.0 m -96.69 112.48 24.21 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.109 -0.95 . . . . 64.319999999999993 109.867 176.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.477 ' HB3' ' N ' ' A' ' 105' ' ' GLN . 12.6 t70 -71.26 130.93 42.66 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.185 -0.462 . . . . 63.399999999999999 111.125 178.236 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 -94.48 -11.47 29.63 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.188 0.518 . . . . 70.420000000000002 110.469 -176.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -86.3 -62.48 1.5 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.113 -0.494 . . . . 73.140000000000001 111.509 -176.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 63.6 p -111.35 -27.88 8.46 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.018 0.437 . . . . 72.120000000000005 111.393 -176.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 103.04 34.41 4.0 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.786 -0.643 . . . . 65.239999999999995 112.54 178.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.477 ' N ' ' HB3' ' A' ' 100' ' ' ASP . 51.3 mt-30 -71.84 115.9 11.59 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.984 -0.376 . . . . 72.040000000000006 109.984 174.217 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 21.1 m -86.55 92.16 8.79 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.059 0.457 . . . . 61.32 110.4 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.412 ' HB3' ' HB ' ' A' ' 98' ' ' VAL . 22.6 t -97.43 86.78 3.95 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.221 0.534 . . . . 71.150000000000006 110.126 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.4 m -91.42 95.54 10.03 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.054 -0.521 . . . . 61.340000000000003 110.289 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 57.0 mt -102.89 136.29 36.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.827 -0.624 . . . . 73.010000000000005 110.577 -175.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.423 ' HG3' HE22 ' A' ' 95' ' ' GLN . 32.4 mt-30 -95.59 163.32 13.26 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.859 0.361 . . . . 61.100000000000001 110.553 173.04 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.6 p . . . . . 0 C--N 1.324 -0.529 0 CA-C-N 116.002 -0.544 . . . . 75.109999999999999 110.518 176.167 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 . . . . . 0 N--CA 1.451 -0.412 0 CA-C-O 120.516 0.198 . . . . 65.319999999999993 111.338 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 9.8 m -115.97 86.57 16.85 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 120.725 0.298 . . . . 60.32 110.304 175.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -77.37 84.57 1.93 Allowed 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.122 1.881 . . . . 72.099999999999994 111.896 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.7 m -86.07 -80.15 0.24 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.896 -0.593 . . . . 71.450000000000003 111.159 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -93.84 -37.85 11.54 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.807 0.337 . . . . 71.230000000000004 111.355 -177.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.582 HD23 ' H ' ' A' ' 51' ' ' LEU . 1.7 pt? -66.64 -13.83 61.68 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.01 -0.541 . . . . 73.420000000000002 111.273 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -49.01 -53.46 19.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.674 -0.694 . . . . 63.020000000000003 112.509 -175.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.45 -30.96 67.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.826 0.346 . . . . 73.010000000000005 111.349 -178.348 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.496 ' O ' HG13 ' A' ' 58' ' ' ILE . 67.2 t80 -67.23 -44.64 78.96 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.192 -0.458 . . . . 74.25 110.407 -178.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 87.0 m -55.34 -37.2 67.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.425 0.631 . . . . 75.409999999999997 111.557 178.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -80.19 -31.7 38.73 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.796 -0.638 . . . . 51.200000000000003 110.771 -174.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.81 -25.19 68.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.031 -0.532 . . . . 74.219999999999999 110.263 175.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.531 ' O ' HG13 ' A' ' 62' ' ' ILE . 2.5 mt -86.28 -45.37 16.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.974 -0.557 . . . . 75.030000000000001 110.968 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.454 ' HA ' HD12 ' A' ' 62' ' ' ILE . 76.1 mt-30 -59.14 -30.45 68.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.769 0.319 . . . . 51.229999999999997 111.283 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.5 m -66.58 -37.96 86.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.352 -0.386 . . . . 73.340000000000003 111.152 178.208 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.527 ' HG2' ' O ' ' A' ' 58' ' ' ILE . 11.1 pt20 -83.19 -20.9 33.8 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.794 0.33 . . . . 64.209999999999994 110.943 -178.394 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.531 HG13 ' O ' ' A' ' 58' ' ' ILE . 83.9 mt -66.5 -31.1 52.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.996 0.427 . . . . 75.120000000000005 109.894 177.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 91.9 mt -57.65 -32.85 67.69 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.734 -0.666 . . . . 74.530000000000001 110.933 178.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -74.51 -40.47 39.05 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.993 -0.623 . . . . 54.140000000000001 111.602 176.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -63.71 -25.99 69.49 Favored Glycine 0 C--N 1.33 0.2 0 C-N-CA 120.992 -0.623 . . . . 33.530000000000001 112.286 178.259 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 62' ' ' ILE . 91.8 mt -66.22 -18.34 65.29 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.706 0.289 . . . . 72.230000000000004 110.916 178.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 93.7 mt -85.59 5.97 29.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.076 0.465 . . . . 70.319999999999993 110.563 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.9 t -126.11 -42.21 1.88 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.947 -0.57 . . . . 75.109999999999999 110.587 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.414 ' ND2' HD21 ' A' ' 97' ' ' ASN . 86.7 m-20 -75.73 5.36 6.34 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.699 0.629 . . . . 53.439999999999998 112.699 -173.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.402 HG12 ' O ' ' A' ' 66' ' ' LEU . 50.4 mm . . . . . 0 C--N 1.322 -0.595 0 CA-C-O 121.653 0.739 . . . . 71.409999999999997 109.664 176.016 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.464 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 27.6 ttt . . . . . 0 N--CA 1.455 -0.207 0 CA-C-O 120.729 0.3 . . . . 73.310000000000002 110.472 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 53.1 t -85.5 97.65 5.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.373 0.606 . . . . 63.219999999999999 110.696 -178.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.697 ' HB ' ' O ' ' A' ' 83' ' ' TYR . 6.7 m -113.65 148.86 35.53 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.307 -0.86 . . . . 43.310000000000002 108.854 177.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -73.52 -59.64 2.62 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.007 0.373 . . . . 72.310000000000002 112.007 -170.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -82.82 -14.16 54.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.795 0.331 . . . . 75.510000000000005 111.448 -174.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.697 ' O ' ' HB ' ' A' ' 80' ' ' THR . 59.4 m-85 -133.99 121.3 21.41 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.334 -0.394 . . . . 63.340000000000003 110.482 -177.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.569 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 2.9 mp -81.91 102.56 7.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.089 -0.708 . . . . 71.040000000000006 109.089 175.301 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.464 ' HB ' ' HB3' ' A' ' 78' ' ' MET . 47.3 t -96.69 94.31 4.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.715 -0.675 . . . . 64.329999999999998 110.769 -176.569 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -98.45 115.62 28.91 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.343 -0.614 . . . . 74.510000000000005 109.343 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 71.6 mt -82.02 94.66 2.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.939 -0.573 . . . . 73.150000000000006 110.673 -176.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.05 74.54 8.08 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.687 -0.688 . . . . 54.140000000000001 111.102 -177.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -88.59 92.73 9.31 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.147 -0.686 . . . . 62.210000000000001 109.147 173.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.441 ' HA ' ' HD2' ' A' ' 90' ' ' ARG . 13.6 tpt180 -133.68 154.16 51.14 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.818 -0.628 . . . . 75.439999999999998 109.726 -178.266 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.9 t70 69.93 -68.18 0.21 Allowed 'General case' 0 N--CA 1.465 0.317 0 O-C-N 124.082 0.864 . . . . 71.019999999999996 111.151 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 177.74 23.62 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.736 -0.745 . . . . 75.319999999999993 113.433 178.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -138.1 152.5 48.83 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 122.265 -0.55 . . . . 62.409999999999997 110.264 178.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -89.61 94.58 9.91 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.761 -0.459 . . . . 52.240000000000002 109.761 176.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.474 ' HG2' ' OD1' ' A' ' 97' ' ' ASN . 7.3 tt0 -97.31 109.29 22.08 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.137 0.494 . . . . 55.530000000000001 109.692 -179.102 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.543 ' HB3' ' HB ' ' A' ' 109' ' ' ILE . 29.0 tp -90.11 98.64 11.89 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.868 -0.605 . . . . 75.109999999999999 110.389 -177.234 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.483 ' OD1' HG23 ' A' ' 108' ' ' THR . 6.5 m-20 -90.61 93.44 9.27 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.283 0.564 . . . . 43.409999999999997 110.532 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.439 ' CG1' ' HD1' ' A' ' 83' ' ' TYR . 56.1 t -92.8 114.18 29.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.658 -0.701 . . . . 72.019999999999996 110.677 178.432 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.569 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 30.7 m -103.32 109.23 20.77 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.845 -0.616 . . . . 64.319999999999993 110.077 178.027 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.587 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 25.2 t70 -62.32 141.23 58.4 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.489 -0.323 . . . . 63.399999999999999 110.777 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.07 -26.69 19.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.259 -0.428 . . . . 70.420000000000002 110.251 -177.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 32.7 mtmm -70.04 -69.58 0.34 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.374 -0.375 . . . . 73.140000000000001 111.149 -174.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 12.0 t -99.05 -26.8 14.11 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.243 0.544 . . . . 72.120000000000005 109.716 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.587 ' HA2' ' O ' ' A' ' 100' ' ' ASP . . . 83.65 79.45 1.06 Allowed Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.544 -0.753 . . . . 65.239999999999995 112.909 176.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.491 ' H ' ' HB3' ' A' ' 100' ' ' ASP . 68.6 mm-40 -124.69 144.16 50.36 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.587 -0.523 . . . . 72.040000000000006 109.587 174.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.9 m -89.05 96.11 10.59 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.123 0.487 . . . . 61.32 110.724 -178.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.435 ' HB3' ' HB ' ' A' ' 98' ' ' VAL . 47.4 t -88.17 80.83 7.51 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.454 -0.573 . . . . 71.150000000000006 109.454 177.23 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.483 HG23 ' OD1' ' A' ' 97' ' ' ASN . 28.2 m -82.35 101.49 10.62 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.901 -0.591 . . . . 61.340000000000003 110.709 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.543 ' HB ' ' HB3' ' A' ' 96' ' ' LEU . 54.5 mt -99.88 92.34 2.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.052 -0.522 . . . . 73.010000000000005 110.514 -178.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -72.56 106.91 4.81 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.723 -0.473 . . . . 61.100000000000001 109.723 175.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.2 t . . . . . 0 C--N 1.323 -0.584 0 N-CA-C 109.688 -0.486 . . . . 75.109999999999999 109.688 177.435 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 . . . . . 0 N--CA 1.454 -0.256 0 N-CA-C 109.755 -0.461 . . . . 65.319999999999993 109.755 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.3 m -124.24 89.12 52.27 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.106 -0.497 . . . . 60.32 110.742 -175.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.404 ' C ' ' HB2' ' A' ' 52' ' ' ASP . 24.3 Cg_exo -61.67 107.21 0.49 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.881 2.387 . . . . 72.099999999999994 112.385 -177.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.7 m -140.43 -36.9 0.47 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.965 -0.562 . . . . 71.450000000000003 110.371 175.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -92.45 -33.72 14.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.296 0.569 . . . . 71.230000000000004 110.604 176.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.431 ' H ' HD23 ' A' ' 51' ' ' LEU . 0.7 OUTLIER -101.47 0.0 35.95 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.839 -0.619 . . . . 73.420000000000002 110.665 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' A' ' 56' ' ' GLN . 14.9 t70 -62.38 -62.9 1.44 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.738 -0.664 . . . . 63.020000000000003 111.671 -173.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -69.26 -18.24 63.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.235 0.54 . . . . 73.010000000000005 110.085 -177.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -73.37 -58.15 3.51 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.553 -0.749 . . . . 74.25 110.658 178.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.5 t -70.3 -18.97 63.11 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.229 0.538 . . . . 75.409999999999997 110.461 -178.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.405 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 3.1 tp-100 -61.82 -35.51 78.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.479 -0.782 . . . . 51.200000000000003 109.978 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.98 -19.96 31.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.893 -0.594 . . . . 74.219999999999999 110.983 -179.257 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.426 ' O ' HG13 ' A' ' 62' ' ' ILE . 24.7 mt -71.74 -27.7 28.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.052 -0.522 . . . . 75.030000000000001 110.891 -177.293 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -54.88 -35.72 64.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.442 -0.344 . . . . 51.229999999999997 111.239 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.9 m -62.43 -50.41 71.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.989 0.424 . . . . 73.340000000000003 110.975 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -74.45 -17.23 60.81 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.32 -0.4 . . . . 64.209999999999994 110.846 -177.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.554 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 74.5 mt -72.8 -50.17 35.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.522 -0.547 . . . . 75.120000000000005 109.522 173.214 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 95.5 mt -60.45 -42.04 95.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.881 -0.599 . . . . 74.530000000000001 110.356 177.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.401 ' HA2' ' HD2' ' A' ' 90' ' ' ARG . . . -59.72 -43.85 97.46 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.852 -0.613 . . . . 54.140000000000001 112.215 176.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -65.22 -35.49 91.68 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 121.24 -0.505 . . . . 33.530000000000001 112.432 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' A' ' 62' ' ' ILE . 98.0 mt -61.66 -52.12 65.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.674 0.273 . . . . 72.230000000000004 110.595 178.343 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.6 mt -68.7 -31.67 70.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.001 -0.545 . . . . 70.319999999999993 111.048 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 38.3 t -56.5 -49.63 74.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.785 -0.643 . . . . 75.109999999999999 110.908 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -72.49 -19.67 61.5 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.234 -0.439 . . . . 53.439999999999998 111.768 -177.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.488 HG12 ' O ' ' A' ' 66' ' ' LEU . 46.4 mm . . . . . 0 C--N 1.328 -0.366 0 CA-C-O 121.13 0.49 . . . . 71.409999999999997 110.154 177.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 27.1 ttt . . . . . 0 N--CA 1.454 -0.255 0 CA-C-O 120.975 0.416 . . . . 73.310000000000002 110.42 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 45.4 t -76.71 105.92 6.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.875 -0.602 . . . . 63.219999999999999 109.728 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.52 ' HB ' ' O ' ' A' ' 83' ' ' TYR . 5.3 m -82.25 160.06 23.05 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.622 -0.717 . . . . 43.310000000000002 110.262 -178.399 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -54.48 -60.49 3.28 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.136 0.493 . . . . 72.310000000000002 111.33 -177.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.848 ' HB3' ' HD3' ' A' ' 101' ' ' ARG . 1.6 m-20 -110.43 -38.56 5.19 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.811 -0.631 . . . . 75.510000000000005 111.243 -175.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.52 ' O ' ' HB ' ' A' ' 80' ' ' THR . 17.6 m-85 -78.95 142.25 36.84 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.911 -0.586 . . . . 63.340000000000003 111.662 -177.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.57 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 49.9 mm -93.58 89.92 2.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.909 -0.587 . . . . 71.040000000000006 110.087 175.22 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.541 HG22 HG22 ' A' ' 98' ' ' VAL . 93.9 t -95.49 117.79 40.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.762 -0.653 . . . . 64.329999999999998 110.127 178.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -118.61 119.25 33.94 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.063 0.459 . . . . 74.510000000000005 110.447 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 52.4 mt -96.55 94.66 4.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.79 -0.641 . . . . 73.150000000000006 109.401 178.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.543 ' HB3' ' HB2' ' A' ' 95' ' ' GLN . . . -92.11 100.38 13.02 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.179 -0.464 . . . . 54.140000000000001 110.996 -177.112 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -96.24 108.16 20.6 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.956 -0.565 . . . . 62.210000000000001 110.334 176.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.401 ' HD2' ' HA2' ' A' ' 64' ' ' GLY . 1.6 mtp180 -136.99 131.7 33.28 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.133 -0.485 . . . . 75.439999999999998 110.252 176.125 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 61.45 19.99 10.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.974 -0.557 . . . . 71.019999999999996 111.35 175.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.26 -6.95 78.53 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.971 -0.633 . . . . 75.319999999999993 112.427 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 -90.75 126.82 36.12 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.194 -0.299 . . . . 62.409999999999997 110.194 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -93.8 107.29 19.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.205 -0.452 . . . . 52.240000000000002 110.122 177.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.543 ' HB2' ' HB3' ' A' ' 88' ' ' ALA . 45.1 mt-30 -99.73 95.66 7.08 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.893 0.378 . . . . 55.530000000000001 110.269 175.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 50.3 tp -84.38 94.0 8.4 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.835 -0.62 . . . . 75.109999999999999 109.429 177.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -107.56 127.28 53.49 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.316 0.579 . . . . 43.409999999999997 110.43 -176.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.541 HG22 HG22 ' A' ' 85' ' ' VAL . 85.2 t -118.39 131.65 70.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.637 -0.71 . . . . 72.019999999999996 110.483 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.57 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 15.5 m -104.72 112.64 25.81 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.385 -0.825 . . . . 64.319999999999993 108.974 172.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -66.27 153.72 41.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.315 0.578 . . . . 63.399999999999999 111.966 -175.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.848 ' HD3' ' HB3' ' A' ' 82' ' ' ASP . 35.8 ptt180 -82.81 -30.39 28.82 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.122 -0.945 . . . . 70.420000000000002 111.821 -175.397 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.638 ' HG3' ' HG3' ' A' ' 101' ' ' ARG . 47.1 mttm -105.26 -62.83 1.3 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.218 0.532 . . . . 73.140000000000001 111.473 -172.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.514 ' OG1' ' HG2' ' A' ' 105' ' ' GLN . 42.9 p -78.58 -19.69 52.21 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.734 -0.666 . . . . 72.120000000000005 109.921 -177.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 70.08 26.01 74.86 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.354 -0.839 . . . . 65.239999999999995 112.413 177.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.514 ' HG2' ' OG1' ' A' ' 103' ' ' THR . 27.3 mm-40 -66.91 125.55 26.29 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.991 -0.374 . . . . 72.040000000000006 109.991 177.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.9 m -102.12 92.23 4.67 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.055 -0.72 . . . . 61.32 109.055 175.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.8 t -100.25 121.87 42.16 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.196 -0.456 . . . . 71.150000000000006 110.124 -176.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 26.8 m -102.95 102.17 12.22 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.159 -0.473 . . . . 61.340000000000003 110.442 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 54.5 mt -93.09 92.25 3.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.458 -0.571 . . . . 73.010000000000005 109.458 177.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -89.4 131.2 35.58 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.202 -0.454 . . . . 61.100000000000001 110.293 -178.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 46.5 t . . . . . 0 C--N 1.327 -0.387 0 CA-C-O 121.34 0.591 . . . . 75.109999999999999 109.743 175.481 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 . . . . . 0 N--CA 1.46 0.061 0 N-CA-C 111.807 0.299 . . . . 65.319999999999993 111.807 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 33.4 m -116.17 86.06 16.56 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 109.489 -0.56 . . . . 60.32 109.489 174.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -61.48 104.76 0.32 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.107 2.538 . . . . 72.099999999999994 112.292 -175.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.1 p -134.29 -75.61 0.47 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.538 -0.755 . . . . 71.450000000000003 110.356 178.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.54 -37.26 71.16 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.936 0.398 . . . . 71.230000000000004 110.63 177.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.409 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 3.7 pp -97.56 9.92 41.21 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.826 -0.625 . . . . 73.420000000000002 110.797 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.439 ' O ' ' HB2' ' A' ' 56' ' ' GLN . 32.7 t70 -59.09 -52.92 63.67 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.813 -0.631 . . . . 63.020000000000003 111.165 -176.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -62.37 -40.48 96.58 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.942 -0.572 . . . . 73.010000000000005 110.374 -176.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.583 ' O ' HG13 ' A' ' 58' ' ' ILE . 76.7 t80 -60.11 -63.81 1.17 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.728 -0.669 . . . . 74.25 111.826 -178.418 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.8 t -69.08 -19.54 64.07 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.876 0.325 . . . . 75.409999999999997 111.876 -172.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.439 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 2.7 mp0 -82.38 -36.26 26.95 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.741 0.305 . . . . 51.200000000000003 110.498 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.96 -30.69 71.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 74.219999999999999 110.474 176.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.721 ' O ' ' HG2' ' A' ' 61' ' ' GLN . 10.6 mt -70.09 -46.16 73.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.028 -0.533 . . . . 75.030000000000001 110.38 177.623 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -66.06 -18.88 65.63 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.167 0.508 . . . . 51.229999999999997 110.456 178.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 66.1 m -84.19 -3.26 58.04 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.074 -0.512 . . . . 73.340000000000003 111.61 177.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.721 ' HG2' ' O ' ' A' ' 58' ' ' ILE . 9.1 pt20 -105.96 -2.13 23.22 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.149 0.499 . . . . 64.209999999999994 110.089 177.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 51.6 mm -76.48 -30.53 19.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.818 -0.628 . . . . 75.120000000000005 110.886 -176.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.724 ' H ' HD22 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -61.13 -43.85 98.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.082 -0.508 . . . . 74.530000000000001 110.198 -177.245 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -83.98 -31.86 25.09 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.954 -0.641 . . . . 54.140000000000001 111.604 176.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.82 -24.26 66.37 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 121.405 -0.426 . . . . 33.530000000000001 112.833 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.444 ' O ' HG12 ' A' ' 70' ' ' ILE . 9.7 tt -55.58 -40.9 72.6 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.826 -0.435 . . . . 72.230000000000004 109.826 176.153 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.7 mp -80.53 13.2 2.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.042 -0.526 . . . . 70.319999999999993 111.223 -178.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 26.2 t -115.97 -21.01 9.7 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.189 0.518 . . . . 75.109999999999999 109.664 174.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -83.77 -26.78 29.37 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.954 -0.566 . . . . 53.439999999999998 110.489 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.444 HG12 ' O ' ' A' ' 66' ' ' LEU . 35.8 mm . . . . . 0 C--N 1.327 -0.379 0 CA-C-N 115.805 -0.634 . . . . 71.409999999999997 110.634 -177.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 51.8 ttm . . . . . 0 N--CA 1.454 -0.256 0 CA-C-O 121.1 0.476 . . . . 73.310000000000002 110.227 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 23.6 t -95.27 83.95 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.823 -0.626 . . . . 63.219999999999999 109.873 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.81 -179.15 5.81 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.721 -0.672 . . . . 43.310000000000002 110.036 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -74.18 -51.88 14.16 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.727 0.299 . . . . 72.310000000000002 110.632 -177.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -122.76 19.02 10.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.802 0.334 . . . . 75.510000000000005 111.721 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -135.14 111.56 9.81 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.951 0.405 . . . . 63.340000000000003 111.0 177.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.42 HD12 ' N ' ' A' ' 84' ' ' ILE . 4.2 mp -99.97 105.56 17.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.834 -0.621 . . . . 71.040000000000006 109.477 177.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.441 ' HB ' HG23 ' A' ' 98' ' ' VAL . 6.3 p -117.78 121.63 67.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.24 0.543 . . . . 64.329999999999998 110.547 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -138.38 134.7 34.49 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.591 -0.731 . . . . 74.510000000000005 110.27 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.488 ' HA ' ' O ' ' A' ' 95' ' ' GLN . 54.0 mt -89.92 101.41 12.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.112 -0.495 . . . . 73.150000000000006 110.102 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -90.85 156.43 18.03 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.972 -0.558 . . . . 54.140000000000001 110.038 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.552 ' HA ' ' O ' ' A' ' 93' ' ' GLN . 47.7 t-20 -127.53 127.28 43.69 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.016 0.436 . . . . 62.210000000000001 110.249 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -133.69 115.51 14.69 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.872 -0.604 . . . . 75.439999999999998 110.069 175.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 62.47 29.69 17.14 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.142 -0.481 . . . . 71.019999999999996 111.451 175.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.39 28.27 33.67 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.713 -0.756 . . . . 75.319999999999993 112.531 178.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.552 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 26.4 mm-40 -119.53 123.36 43.79 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.798 -0.445 . . . . 62.409999999999997 109.798 175.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -93.34 122.93 36.25 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.052 -0.522 . . . . 52.240000000000002 109.621 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.919 ' HG2' ' HG2' ' A' ' 110' ' ' GLN . 76.6 mt-30 -118.18 106.73 13.14 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.165 -0.471 . . . . 55.530000000000001 111.714 -177.126 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 54.1 tp -78.09 86.95 4.23 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.252 -1.018 . . . . 75.109999999999999 108.252 172.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -113.1 111.55 22.31 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.987 -0.551 . . . . 43.409999999999997 110.83 -172.145 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.441 HG23 ' HB ' ' A' ' 85' ' ' VAL . 7.2 p -107.39 135.23 46.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.51 -0.768 . . . . 72.019999999999996 110.718 -177.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 29.1 m -116.72 124.41 49.6 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.145 -0.48 . . . . 64.319999999999993 110.815 178.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.474 ' HB3' ' H ' ' A' ' 105' ' ' GLN . 11.2 t0 -71.64 137.21 47.72 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.224 -0.658 . . . . 63.399999999999999 109.224 175.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.585 ' O ' ' HD2' ' A' ' 101' ' ' ARG . 3.5 tmm_? -82.16 -28.37 32.16 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.897 0.379 . . . . 70.420000000000002 110.554 -176.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt -103.57 -49.46 3.68 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.164 -0.471 . . . . 73.140000000000001 111.114 -174.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.608 ' HB ' ' HG2' ' A' ' 105' ' ' GLN . 0.2 OUTLIER -88.23 -14.64 37.98 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.748 -0.66 . . . . 72.120000000000005 110.899 -175.292 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 67.34 17.09 68.0 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.87 -0.605 . . . . 65.239999999999995 113.362 178.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.608 ' HG2' ' HB ' ' A' ' 103' ' ' THR . 30.7 mm-40 -62.57 123.84 19.41 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.135 -0.32 . . . . 72.040000000000006 110.135 176.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 20.8 m -110.22 97.34 6.84 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.031 -0.531 . . . . 61.32 109.889 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.0 t -103.37 104.28 14.37 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.161 -0.472 . . . . 71.150000000000006 109.935 -177.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 28.7 m -101.1 103.15 14.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.894 -0.594 . . . . 61.340000000000003 111.182 -178.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 4.4 mp -98.5 97.8 6.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.071 0.462 . . . . 73.010000000000005 109.882 176.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.919 ' HG2' ' HG2' ' A' ' 95' ' ' GLN . 69.4 mt-30 -75.62 166.64 23.25 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.144 -0.48 . . . . 61.100000000000001 110.334 177.392 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.9 p . . . . . 0 C--N 1.325 -0.498 0 CA-C-O 121.569 0.699 . . . . 75.109999999999999 110.331 173.939 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.462 ' HA ' ' OE1' ' A' ' 46' ' ' GLU . 6.9 mm-40 . . . . . 0 N--CA 1.47 0.562 0 N-CA-C 113.349 0.87 . . . . 65.319999999999993 113.349 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.406 ' O ' HG23 ' A' ' 47' ' ' THR . 8.5 t -125.1 85.97 57.37 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-O 121.849 0.833 . . . . 60.32 111.055 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.448 ' HB2' ' HB2' ' A' ' 52' ' ' ASP . 11.5 Cg_exo -71.34 116.76 4.83 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.939 2.426 . . . . 72.099999999999994 111.951 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 14.6 m -98.6 -69.77 0.75 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.633 -0.258 . . . . 71.450000000000003 110.985 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.77 -40.51 18.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.885 0.374 . . . . 71.230000000000004 111.248 -176.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.582 HD23 ' H ' ' A' ' 51' ' ' LEU . 1.9 pt? -69.8 -16.94 63.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 73.420000000000002 110.908 -178.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.518 ' O ' ' HB2' ' A' ' 56' ' ' GLN . 23.1 t70 -57.37 -50.04 74.23 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.112 -0.495 . . . . 63.020000000000003 110.779 -178.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -60.31 -43.19 96.59 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.099 -0.5 . . . . 73.010000000000005 110.826 178.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.474 ' O ' HG12 ' A' ' 58' ' ' ILE . 80.9 t80 -60.6 -53.35 58.52 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.066 -0.515 . . . . 74.25 111.169 -179.392 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.2 t -68.99 -30.2 68.56 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.783 0.325 . . . . 75.409999999999997 110.784 -177.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.518 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 1.3 tp-100 -64.77 -44.71 89.17 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.145 0.498 . . . . 51.200000000000003 110.047 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.47 -32.99 74.84 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.554 -0.748 . . . . 74.219999999999999 111.109 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.607 ' O ' ' HG2' ' A' ' 61' ' ' GLN . 47.0 mm -66.13 -37.75 80.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.982 0.42 . . . . 75.030000000000001 110.509 177.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -69.48 -38.9 77.89 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.297 -0.41 . . . . 51.229999999999997 110.816 178.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 44.8 m -67.96 -32.14 72.35 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.349 -0.387 . . . . 73.340000000000003 111.404 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.607 ' HG2' ' O ' ' A' ' 58' ' ' ILE . 10.0 pt20 -78.42 -9.44 59.29 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.642 0.258 . . . . 64.209999999999994 111.222 -176.562 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.53 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 74.3 mt -62.74 -33.07 58.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.934 0.397 . . . . 75.120000000000005 110.088 -178.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 92.5 mt -53.49 -36.38 61.62 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.423 -0.808 . . . . 74.530000000000001 111.635 -178.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.65 -30.42 5.86 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.708 -0.758 . . . . 54.140000000000001 111.967 178.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -58.38 -34.99 77.04 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 121.542 -0.361 . . . . 33.530000000000001 112.952 -178.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' A' ' 62' ' ' ILE . 88.6 mt -56.55 -38.44 71.9 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.873 0.368 . . . . 72.230000000000004 111.063 178.474 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.1 mt -76.54 -39.18 53.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.045 0.45 . . . . 70.319999999999993 110.468 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 16.5 m -66.18 -37.95 86.85 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.836 -0.62 . . . . 75.109999999999999 111.513 -177.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -76.45 -8.55 57.39 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.966 0.358 . . . . 53.439999999999998 111.966 -175.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 66' ' ' LEU . 43.3 mm . . . . . 0 C--O 1.234 0.249 0 CA-C-O 121.419 0.628 . . . . 71.409999999999997 110.195 176.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 57.6 ttp . . . . . 0 C--O 1.236 0.346 0 CA-C-O 120.989 0.423 . . . . 73.310000000000002 110.955 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 48.2 t -70.34 102.94 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.446 -0.576 . . . . 63.219999999999999 109.446 176.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.2 m -109.6 159.68 16.9 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.015 -0.538 . . . . 43.310000000000002 109.597 -177.091 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -67.82 -47.07 70.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.06 0.457 . . . . 72.310000000000002 110.125 -179.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -72.66 -35.8 67.82 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.843 0.683 . . . . 75.510000000000005 112.843 -176.05 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.646 ' HB3' HG13 ' A' ' 98' ' ' VAL . 55.1 m-85 -157.24 169.08 25.58 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.897 0.379 . . . . 63.340000000000003 110.828 -175.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.57 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 40.3 mm -97.98 98.93 7.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.364 -0.606 . . . . 71.040000000000006 109.364 169.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 41.3 t -85.31 94.42 3.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.002 -0.544 . . . . 64.329999999999998 110.178 -178.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -98.2 102.7 14.52 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.271 0.558 . . . . 74.510000000000005 110.385 177.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 63.0 mt -88.7 106.46 16.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.657 -0.701 . . . . 73.150000000000006 109.52 175.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -106.32 162.27 13.83 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.269 -0.423 . . . . 54.140000000000001 110.214 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -138.33 123.54 19.26 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.843 0.354 . . . . 62.210000000000001 110.321 178.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 65.0 mtp180 -138.81 132.61 30.87 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.073 -0.512 . . . . 75.439999999999998 109.855 176.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 64.56 17.37 10.83 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 123.629 0.581 . . . . 71.019999999999996 111.051 178.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.06 -26.3 25.18 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 121.113 -0.565 . . . . 75.319999999999993 112.412 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -90.25 140.78 29.35 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.062 0.458 . . . . 62.409999999999997 110.886 -175.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -81.12 144.75 31.47 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.707 -0.678 . . . . 52.240000000000002 110.616 179.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -122.76 107.59 12.09 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.511 -0.551 . . . . 55.530000000000001 109.511 175.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 55.7 tp -82.26 98.8 8.96 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.867 -0.606 . . . . 75.109999999999999 109.425 179.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -107.69 91.84 3.82 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.317 0.58 . . . . 43.409999999999997 110.657 -177.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.646 HG13 ' HB3' ' A' ' 83' ' ' TYR . 21.7 t -82.99 108.1 15.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.679 -0.691 . . . . 72.019999999999996 109.996 176.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.57 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 25.6 m -90.77 111.66 23.13 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.398 -0.819 . . . . 64.319999999999993 108.894 175.36 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.462 ' HA ' ' HD2' ' A' ' 83' ' ' TYR . 13.6 t0 -61.27 133.54 56.0 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.841 -0.618 . . . . 63.399999999999999 111.155 -177.247 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.463 ' C ' ' HD2' ' A' ' 101' ' ' ARG . 1.1 ppt_? -94.93 -7.92 38.56 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.551 -0.75 . . . . 70.420000000000002 110.461 -178.281 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -87.17 -71.92 0.54 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.976 -0.556 . . . . 73.140000000000001 110.579 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 57.5 p -97.53 -28.92 13.75 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.278 -0.419 . . . . 72.120000000000005 110.566 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 100' ' ' ASP . . . 102.29 22.73 9.56 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 121.071 -0.585 . . . . 65.239999999999995 112.867 177.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.458 ' N ' ' HB3' ' A' ' 100' ' ' ASP . 49.4 mt-30 -73.98 131.87 41.84 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.732 0.301 . . . . 72.040000000000006 110.545 177.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.5 p -91.41 108.83 20.16 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.234 0.54 . . . . 61.32 111.615 -177.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 10.0 t -96.85 86.07 3.94 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.285 -0.635 . . . . 71.150000000000006 109.285 177.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 87.2 m -91.6 104.81 17.25 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.633 -0.712 . . . . 61.340000000000003 110.671 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 54.8 mt -115.89 105.13 17.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.972 -0.558 . . . . 73.010000000000005 110.487 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -69.97 134.15 48.03 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.9 -0.407 . . . . 61.100000000000001 109.9 175.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 52.1 t . . . . . 0 C--N 1.322 -0.612 0 CA-C-O 121.135 0.493 . . . . 75.109999999999999 110.009 -179.957 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 121.334 0.588 . . . . 65.319999999999993 110.718 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.2 t -139.44 87.91 13.08 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.467 -0.788 . . . . 60.32 110.214 -179.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.464 ' HA ' HD21 ' A' ' 51' ' ' LEU . 15.0 Cg_exo -65.15 100.55 0.38 Allowed 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.647 2.232 . . . . 72.099999999999994 112.757 -176.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.3 p -146.51 -76.18 0.19 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.889 -0.596 . . . . 71.450000000000003 110.111 174.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.68 -45.73 85.4 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.001 -0.545 . . . . 71.230000000000004 110.895 178.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.497 HD23 ' H ' ' A' ' 51' ' ' LEU . 2.6 pt? -79.24 -20.2 48.79 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.984 -0.553 . . . . 73.420000000000002 110.849 179.253 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -57.33 -65.24 0.66 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.893 -0.594 . . . . 63.020000000000003 111.562 -174.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -67.58 -22.85 65.36 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.896 -0.593 . . . . 73.010000000000005 110.701 -176.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.563 ' O ' HG13 ' A' ' 58' ' ' ILE . 23.3 t80 -75.43 -55.91 5.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.812 -0.631 . . . . 74.25 111.287 -178.1 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.3 t -63.41 -26.92 68.96 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.827 0.346 . . . . 75.409999999999997 111.757 -174.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -68.6 -35.5 77.43 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.796 0.332 . . . . 51.200000000000003 110.672 -178.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.53 -29.66 59.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.043 -0.526 . . . . 74.219999999999999 109.944 177.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.563 HG13 ' O ' ' A' ' 54' ' ' PHE . 17.5 mt -65.31 -43.8 94.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.75 -0.659 . . . . 75.030000000000001 110.747 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -64.15 -22.84 67.09 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.283 -0.417 . . . . 51.229999999999997 111.143 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 58.5 m -86.94 -35.18 19.04 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.437 -0.347 . . . . 73.340000000000003 111.385 178.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.541 ' HG2' ' HA ' ' A' ' 58' ' ' ILE . 12.9 pt20 -77.58 -4.57 46.47 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.702 0.26 . . . . 64.209999999999994 111.702 -175.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.549 HG13 ' O ' ' A' ' 58' ' ' ILE . 75.4 mt -61.9 -36.26 72.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.906 0.384 . . . . 75.120000000000005 110.173 -178.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 8.5 mp -56.79 -47.16 80.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.573 -0.74 . . . . 74.530000000000001 110.302 178.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -69.01 -39.14 85.01 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.839 -0.696 . . . . 54.140000000000001 112.025 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.45 -43.36 98.83 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 121.234 -0.508 . . . . 33.530000000000001 112.216 178.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 62' ' ' ILE . 94.8 mt -58.08 -50.02 74.93 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.651 0.262 . . . . 72.230000000000004 110.757 178.402 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.72 HD13 ' HA ' ' A' ' 91' ' ' ASP . 96.4 mt -62.65 -30.52 71.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.125 -0.489 . . . . 70.319999999999993 111.561 -177.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 30.6 t -82.59 -35.09 27.4 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.021 0.438 . . . . 75.109999999999999 110.499 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -85.71 13.57 6.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.297 -0.41 . . . . 53.439999999999998 111.834 -177.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.429 HG12 ' O ' ' A' ' 66' ' ' LEU . 47.8 mm . . . . . 0 C--N 1.327 -0.407 0 N-CA-C 108.691 -0.855 . . . . 71.409999999999997 108.691 169.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 49.4 ttm . . . . . 0 N--CA 1.449 -0.476 0 CA-C-O 120.951 0.405 . . . . 73.310000000000002 110.1 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 60.0 t -85.6 95.79 4.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.337 0.589 . . . . 63.219999999999999 109.913 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.546 ' OG1' ' HB2' ' A' ' 83' ' ' TYR . 1.5 p -103.09 -179.09 3.85 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.506 -0.77 . . . . 43.310000000000002 109.925 176.227 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 13.3 t30 -85.52 -43.66 13.35 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 111.64 0.237 . . . . 72.310000000000002 111.64 -175.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.596 ' OD1' ' HD3' ' A' ' 101' ' ' ARG . 15.3 t70 -108.54 0.95 21.14 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.981 0.42 . . . . 75.510000000000005 111.91 -174.285 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.546 ' HB2' ' OG1' ' A' ' 80' ' ' THR . 96.3 m-85 -121.95 124.77 44.83 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 122.07 -0.394 . . . . 63.340000000000003 110.949 177.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.553 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 4.1 mp -101.1 88.53 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.4 -0.963 . . . . 71.040000000000006 108.4 171.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.5 p -126.88 137.29 58.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.041 -0.527 . . . . 64.329999999999998 111.344 -172.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -141.76 152.22 43.58 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.765 -0.652 . . . . 74.510000000000005 110.037 175.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 71.2 mt -92.58 115.4 31.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.675 -0.693 . . . . 73.150000000000006 110.452 -176.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -110.93 114.15 27.25 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.207 -0.451 . . . . 54.140000000000001 110.663 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -90.98 87.35 6.58 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.337 0.589 . . . . 62.210000000000001 109.718 174.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.412 ' HG2' ' HB2' ' A' ' 91' ' ' ASP . 43.7 ttt180 -109.27 139.57 44.04 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.674 -0.694 . . . . 75.439999999999998 110.001 177.501 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.72 ' HA ' HD13 ' A' ' 67' ' ' LEU . 4.7 t70 68.12 20.89 8.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.564 0.697 . . . . 71.019999999999996 110.218 172.119 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.73 20.77 79.84 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.456 -0.793 . . . . 75.319999999999993 112.376 -178.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 9.1 mm-40 -124.43 140.92 52.49 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.763 -0.458 . . . . 62.409999999999997 109.763 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -79.39 117.5 20.42 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.699 -0.482 . . . . 52.240000000000002 109.699 176.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -123.57 122.07 37.23 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.227 -0.442 . . . . 55.530000000000001 110.733 -176.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 20.1 tp -99.8 106.47 18.35 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.73 -0.668 . . . . 75.109999999999999 109.849 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 21.2 m-80 -95.01 95.6 8.71 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.46 -0.337 . . . . 43.409999999999997 110.401 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.46 ' HB ' ' HB2' ' A' ' 107' ' ' SER . 93.5 t -87.83 102.38 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.495 0 CA-C-O 121.321 0.581 . . . . 72.019999999999996 110.578 179.016 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.553 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 68.9 m -86.09 107.98 18.07 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.537 -0.756 . . . . 64.319999999999993 109.835 177.324 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.5 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 24.2 t70 -63.66 145.04 56.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.805 -0.634 . . . . 63.399999999999999 111.286 -178.042 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.596 ' HD3' ' OD1' ' A' ' 82' ' ' ASP . 33.2 ttt180 -92.94 -22.24 19.33 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.545 -0.752 . . . . 70.420000000000002 110.685 -178.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 35.0 mttp -80.25 -68.62 0.66 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.371 0.605 . . . . 73.140000000000001 110.545 -176.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 45.8 p -90.47 -43.0 10.54 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.476 -0.784 . . . . 72.120000000000005 110.031 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.5 ' HA2' ' O ' ' A' ' 100' ' ' ASP . . . 111.25 4.37 27.25 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 115.472 -0.786 . . . . 65.239999999999995 112.904 176.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -61.67 133.61 55.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.914 0.388 . . . . 72.040000000000006 110.631 175.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 62.6 m -92.17 100.31 12.95 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.614 -0.513 . . . . 61.32 109.614 174.139 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.46 ' HB2' ' HB ' ' A' ' 98' ' ' VAL . 14.1 m -73.85 101.25 3.7 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.724 -0.671 . . . . 71.150000000000006 109.294 177.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -89.53 94.84 10.02 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.015 -0.539 . . . . 61.340000000000003 110.808 -174.446 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 35.0 mm -99.87 101.22 11.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.826 -0.624 . . . . 73.010000000000005 110.371 -177.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -78.24 154.68 30.81 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.425 -0.352 . . . . 61.100000000000001 110.658 175.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--N 1.323 -0.559 0 CA-C-N 115.565 -0.743 . . . . 75.109999999999999 111.232 178.401 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 . . . . . 0 N--CA 1.453 -0.278 0 CA-C-O 120.941 0.4 . . . . 65.319999999999993 110.094 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 25.2 m -119.71 87.73 38.01 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 115.977 -0.556 . . . . 60.32 111.002 -177.194 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.423 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 21.0 Cg_endo -61.44 127.91 23.27 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.469 2.112 . . . . 72.099999999999994 111.556 178.458 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.8 m -121.93 -42.32 2.4 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.108 0.48 . . . . 71.450000000000003 110.526 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -87.55 -36.09 17.76 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.032 -0.531 . . . . 71.230000000000004 110.707 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.429 ' O ' HG22 ' A' ' 55' ' ' THR . 0.6 OUTLIER -98.06 5.07 49.1 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.51 -0.314 . . . . 73.420000000000002 110.725 180.0 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.423 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 39.4 t0 -57.3 -64.28 0.94 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.011 -0.54 . . . . 63.020000000000003 111.54 -175.116 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -66.01 -26.11 67.38 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.326 -0.397 . . . . 73.010000000000005 110.864 -177.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.538 ' O ' HG13 ' A' ' 58' ' ' ILE . 89.0 t80 -69.62 -60.41 2.34 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.96 -0.564 . . . . 74.25 111.266 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.429 HG22 ' O ' ' A' ' 51' ' ' LEU . 12.9 t -74.04 -20.39 60.32 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.565 0.221 . . . . 75.409999999999997 111.48 -172.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -76.14 -33.42 59.4 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.83 0.348 . . . . 51.200000000000003 110.543 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.94 -24.02 60.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.147 0.498 . . . . 74.219999999999999 110.585 178.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.557 ' O ' HG13 ' A' ' 62' ' ' ILE . 16.1 mt -72.67 -26.69 24.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.74 -0.664 . . . . 75.030000000000001 110.718 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -56.76 -37.72 71.46 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.734 0.302 . . . . 51.229999999999997 110.958 -178.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.9 m -63.94 -43.19 96.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.089 -0.505 . . . . 73.340000000000003 111.436 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -79.81 -21.96 43.62 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 121.026 -0.269 . . . . 64.209999999999994 111.232 -175.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.557 HG13 ' O ' ' A' ' 58' ' ' ILE . 79.9 mt -66.05 -35.95 76.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.064 0.459 . . . . 75.120000000000005 109.84 177.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 92.3 mt -57.23 -46.47 82.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.579 -0.737 . . . . 74.530000000000001 111.121 178.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -65.89 -37.48 93.34 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.86 -0.686 . . . . 54.140000000000001 111.914 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.14 -40.67 99.26 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.983 -0.627 . . . . 33.530000000000001 112.055 178.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.8 mt -61.98 -41.08 97.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.0 0.428 . . . . 72.230000000000004 110.904 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.3 mt -67.37 -32.17 72.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.096 -0.502 . . . . 70.319999999999993 110.726 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.3 t -70.55 -24.8 62.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.906 -0.588 . . . . 75.109999999999999 110.551 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -69.89 -11.59 60.98 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.295 -0.411 . . . . 53.439999999999998 111.663 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 47.1 mm . . . . . 0 C--N 1.324 -0.507 0 CA-C-O 121.424 0.63 . . . . 71.409999999999997 109.965 178.28 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.498 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 26.1 ttt . . . . . 0 N--CA 1.451 -0.399 0 CA-C-O 120.862 0.363 . . . . 73.310000000000002 110.393 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.6 p -82.68 90.43 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-O 121.905 0.86 . . . . 63.219999999999999 110.43 178.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.7 ' HB ' ' O ' ' A' ' 83' ' ' TYR . 7.2 m -97.87 134.29 41.2 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.477 -0.783 . . . . 43.310000000000002 109.213 176.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -63.53 -31.9 73.19 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.262 -0.426 . . . . 72.310000000000002 111.379 -175.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.661 ' HA ' ' HG2' ' A' ' 101' ' ' ARG . 37.9 t70 -105.48 -8.18 18.23 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.428 -0.351 . . . . 75.510000000000005 111.871 -175.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.7 ' O ' ' HB ' ' A' ' 80' ' ' THR . 42.2 m-85 -147.98 134.49 19.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.379 0.609 . . . . 63.340000000000003 112.206 -175.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.572 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 49.1 mm -87.17 108.45 18.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.254 -0.647 . . . . 71.040000000000006 109.254 172.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.498 ' HB ' ' HB3' ' A' ' 78' ' ' MET . 60.2 t -116.77 113.57 43.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.752 0.31 . . . . 64.329999999999998 111.374 -174.479 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -124.0 144.43 49.83 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.219 0.533 . . . . 74.510000000000005 110.135 175.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 62.0 mt -102.19 113.53 38.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.83 -0.623 . . . . 73.150000000000006 110.916 -175.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -107.27 110.18 22.15 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.283 -0.417 . . . . 54.140000000000001 110.207 176.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -115.61 110.49 19.27 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.951 0.405 . . . . 62.210000000000001 110.539 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 -142.94 144.02 32.21 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.536 -0.542 . . . . 75.439999999999998 109.536 177.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.59 20.15 11.79 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 123.565 0.541 . . . . 71.019999999999996 111.122 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.93 -2.7 88.1 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.045 -0.598 . . . . 75.319999999999993 112.439 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 20.6 mm-40 -93.55 126.65 38.82 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.821 0.343 . . . . 62.409999999999997 110.827 -178.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -83.88 105.26 14.63 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.01 -0.541 . . . . 52.240000000000002 110.23 174.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -106.62 104.89 14.68 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.994 -0.548 . . . . 55.530000000000001 109.795 178.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 33.6 tp -89.1 111.93 22.79 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.729 -0.669 . . . . 75.109999999999999 110.193 -177.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -95.5 121.1 36.83 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.814 -0.439 . . . . 43.409999999999997 109.814 179.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.572 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 7.9 p -128.11 127.06 67.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 121.44 0.638 . . . . 72.019999999999996 110.742 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.561 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 6.2 m -113.33 123.97 51.37 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.806 -0.633 . . . . 64.319999999999993 110.141 178.355 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.495 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 32.3 t70 -70.91 149.54 46.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.102 -0.499 . . . . 63.399999999999999 110.724 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.661 ' HG2' ' HA ' ' A' ' 82' ' ' ASP . 0.0 OUTLIER -96.73 -11.18 25.4 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.97 -0.292 . . . . 70.420000000000002 110.918 -179.08 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 26.7 mttp -89.91 -64.35 1.15 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.623 0.725 . . . . 73.140000000000001 109.791 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 46.1 p -86.61 -45.17 11.28 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.862 -1.063 . . . . 72.120000000000005 110.066 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.495 ' HA2' ' O ' ' A' ' 100' ' ' ASP . . . 99.02 18.44 24.65 Favored Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 114.902 -1.044 . . . . 65.239999999999995 112.311 -178.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.442 ' HA ' ' OE1' ' A' ' 105' ' ' GLN . 12.3 mm-40 -59.43 134.96 57.49 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 120.809 0.338 . . . . 72.040000000000006 110.284 175.219 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.8 m -108.82 102.47 11.49 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.013 -0.539 . . . . 61.32 109.98 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.404 ' HB3' ' CG1' ' A' ' 98' ' ' VAL . 21.1 t -101.2 125.91 47.87 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.164 -0.471 . . . . 71.150000000000006 110.374 -177.222 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 29.7 m -108.7 97.79 7.39 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.223 0.535 . . . . 61.340000000000003 109.604 174.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 60.3 mt -84.83 105.03 13.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.76 -0.654 . . . . 73.010000000000005 110.574 -177.115 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' A' ' 110' ' ' GLN . 9.5 pt20 -101.32 104.47 15.48 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.185 0.517 . . . . 61.100000000000001 110.446 179.069 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 10.5 p . . . . . 0 C--N 1.323 -0.557 0 CA-C-N 115.972 -0.558 . . . . 75.109999999999999 109.867 178.787 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.594 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 42.0 mt-10 . . . . . 0 CA--C 1.521 -0.165 0 CA-C-O 120.887 0.375 . . . . 65.319999999999993 110.96 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 20.3 m -107.15 86.64 2.61 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.963 -0.562 . . . . 60.32 109.687 175.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.594 ' HD3' ' O ' ' A' ' 46' ' ' GLU . 23.4 Cg_exo -63.24 98.23 0.21 Allowed 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.53 2.153 . . . . 72.099999999999994 112.225 -175.672 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.0 m -117.15 -77.79 0.57 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.896 -0.593 . . . . 71.450000000000003 109.91 174.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.86 -41.16 68.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.136 0.493 . . . . 71.230000000000004 110.336 178.269 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.639 HD23 ' H ' ' A' ' 51' ' ' LEU . 2.1 pt? -73.86 -17.97 60.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.778 -0.646 . . . . 73.420000000000002 111.214 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.467 ' HB2' ' C ' ' A' ' 48' ' ' PRO . 31.8 t70 -61.25 -53.65 54.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.823 0.344 . . . . 63.020000000000003 111.079 -176.367 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -77.43 22.34 0.24 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.902 -0.59 . . . . 73.010000000000005 110.991 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.442 ' O ' HG13 ' A' ' 58' ' ' ILE . 63.5 t80 -132.66 -65.91 0.7 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.321 -0.399 . . . . 74.25 110.731 -178.431 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.412 HG22 ' O ' ' A' ' 51' ' ' LEU . 10.5 t -69.85 -23.79 63.34 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.487 -0.324 . . . . 75.409999999999997 111.633 -173.232 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.43 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 2.2 mp0 -67.6 -30.43 70.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.984 0.421 . . . . 51.200000000000003 110.356 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.6 -26.49 37.79 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.067 -0.515 . . . . 74.219999999999999 110.192 177.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.546 ' O ' HG13 ' A' ' 62' ' ' ILE . 11.3 mt -69.91 -36.39 69.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.897 -0.592 . . . . 75.030000000000001 110.322 179.01 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -67.49 -32.09 72.67 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.068 -0.515 . . . . 51.229999999999997 110.319 178.107 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 7.1 m -68.45 -39.7 81.38 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.937 -0.574 . . . . 73.340000000000003 110.497 176.161 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.614 ' O ' ' HA3' ' A' ' 65' ' ' GLY . 12.9 pt20 -82.98 13.24 4.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.98 -0.555 . . . . 64.209999999999994 111.202 -176.251 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.546 HG13 ' O ' ' A' ' 58' ' ' ILE . 74.7 mt -88.79 -58.52 3.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.703 -0.48 . . . . 75.120000000000005 109.703 172.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 89.4 mt -57.97 -62.22 1.98 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.785 -0.643 . . . . 74.530000000000001 111.379 -175.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.59 3.84 78.98 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.406 -0.902 . . . . 54.140000000000001 112.255 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.614 ' HA3' ' O ' ' A' ' 61' ' ' GLN . . . -94.21 -41.59 4.24 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.759 -0.734 . . . . 33.530000000000001 112.395 -178.461 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.409 ' O ' HG12 ' A' ' 70' ' ' ILE . 84.1 mt -60.71 -25.06 66.14 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.066 0.46 . . . . 72.230000000000004 110.463 178.239 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 81.7 mt -63.37 -42.32 98.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.665 -0.698 . . . . 70.319999999999993 110.686 178.043 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.6 m -68.64 -29.75 68.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.076 0.465 . . . . 75.109999999999999 110.395 179.116 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -66.43 -25.45 66.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.865 -0.607 . . . . 53.439999999999998 110.607 178.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.409 HG12 ' O ' ' A' ' 66' ' ' LEU . 51.6 mm . . . . . 0 C--N 1.326 -0.418 0 CA-C-N 116.173 -0.467 . . . . 71.409999999999997 110.32 178.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.579 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 28.4 ttt . . . . . 0 C--O 1.233 0.212 0 N-CA-C 108.027 -1.101 . . . . 73.310000000000002 108.027 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 20.1 t -80.57 102.49 6.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.019 0.438 . . . . 63.219999999999999 112.109 -168.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.609 ' HB ' ' O ' ' A' ' 83' ' ' TYR . 5.9 m -108.11 163.34 13.25 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.114 -0.699 . . . . 43.310000000000002 109.114 174.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -65.08 -46.54 80.72 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.79 0.329 . . . . 72.310000000000002 111.043 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.542 ' HA ' ' HD2' ' A' ' 101' ' ' ARG . 28.2 m-20 -105.51 -79.53 0.56 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.912 0.387 . . . . 75.510000000000005 111.129 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.609 ' O ' ' HB ' ' A' ' 80' ' ' THR . 35.1 m-85 -67.46 122.68 18.49 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.816 -0.629 . . . . 63.340000000000003 111.524 -175.413 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.58 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 4.5 mp -84.73 107.08 15.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.627 -0.879 . . . . 71.040000000000006 108.627 176.242 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.579 ' HB ' ' HB3' ' A' ' 78' ' ' MET . 21.2 t -89.56 115.31 28.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.996 -0.547 . . . . 64.329999999999998 110.655 -175.202 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.812 ' HB3' ' HB2' ' A' ' 97' ' ' ASN . 13.3 t70 -106.98 106.08 16.44 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.663 -0.495 . . . . 74.510000000000005 109.663 177.104 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 60.0 mt -84.79 124.53 39.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.007 -0.542 . . . . 73.150000000000006 110.32 -178.342 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.433 ' O ' ' HB3' ' A' ' 95' ' ' GLN . . . -135.95 106.96 6.68 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.967 0.358 . . . . 54.140000000000001 111.967 -179.129 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -84.7 85.67 7.41 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.427 -0.953 . . . . 62.210000000000001 108.427 169.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.1 ttt180 -100.52 134.8 42.94 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.795 -0.639 . . . . 75.439999999999998 109.383 -176.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 68.59 -71.02 0.12 Allowed 'General case' 0 N--CA 1.467 0.41 0 O-C-N 123.87 0.731 . . . . 71.019999999999996 110.39 -172.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 178.52 29.62 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 111.753 -0.539 . . . . 75.319999999999993 111.753 178.035 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -129.69 150.72 50.88 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 110.044 -0.354 . . . . 62.409999999999997 110.044 -177.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -79.91 92.6 5.55 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.4 0.619 . . . . 52.240000000000002 110.715 178.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.433 ' HB3' ' O ' ' A' ' 88' ' ' ALA . 37.8 tt0 -96.31 114.66 26.37 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.364 -0.834 . . . . 55.530000000000001 110.01 179.173 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 20.0 tp -101.68 112.77 25.46 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.01 -0.541 . . . . 75.109999999999999 110.413 -178.07 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.812 ' HB2' ' HB3' ' A' ' 86' ' ' ASP . 44.2 m-80 -93.54 103.3 15.5 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.109 -0.33 . . . . 43.409999999999997 110.109 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.434 ' CG1' ' HD2' ' A' ' 83' ' ' TYR . 68.9 t -93.35 109.22 21.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.534 0.683 . . . . 72.019999999999996 110.864 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.58 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 35.7 m -97.58 107.15 19.58 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.318 -0.855 . . . . 64.319999999999993 109.741 176.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.438 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 45.1 t0 -72.64 147.37 45.84 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.348 0.594 . . . . 63.399999999999999 111.48 -175.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.542 ' HD2' ' HA ' ' A' ' 82' ' ' ASP . 51.1 ttt180 -95.48 -26.42 15.83 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.994 -1.003 . . . . 70.420000000000002 109.66 177.457 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 35.9 mtpt -84.29 -65.99 0.95 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.724 -0.671 . . . . 73.140000000000001 110.984 -173.291 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 72.2 p -86.87 -19.0 29.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.213 0.53 . . . . 72.120000000000005 110.296 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.438 ' HA2' ' O ' ' A' ' 100' ' ' ASP . . . 71.82 21.2 79.0 Favored Glycine 0 N--CA 1.452 -0.284 0 CA-C-N 115.233 -0.894 . . . . 65.239999999999995 112.903 176.664 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 83.2 mm-40 -88.63 136.13 33.15 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.619 -0.512 . . . . 72.040000000000006 109.619 175.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 19.3 p -97.27 96.37 8.35 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.06 0.457 . . . . 61.32 110.711 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 29.8 m -97.72 106.85 19.23 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.723 -0.671 . . . . 71.150000000000006 110.356 -178.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 95.2 m -91.67 126.23 36.68 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.05 -0.523 . . . . 61.340000000000003 110.511 177.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 4.3 mp -115.37 111.04 34.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.188 -0.46 . . . . 73.010000000000005 109.961 177.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 95' ' ' GLN . 48.0 mt-30 -89.92 104.3 16.88 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.234 -0.439 . . . . 61.100000000000001 110.242 177.646 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 24.9 t . . . . . 0 C--N 1.325 -0.487 0 N-CA-C 109.176 -0.676 . . . . 75.109999999999999 109.176 177.853 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 . . . . . 0 N--CA 1.453 -0.283 0 CA-C-O 120.775 0.321 . . . . 65.319999999999993 111.467 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 2.5 t -128.56 77.92 76.63 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 121.297 0.57 . . . . 60.32 111.374 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -76.75 96.57 1.1 Allowed 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.047 2.498 . . . . 72.099999999999994 111.302 176.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.1 m -125.2 -51.06 1.66 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.007 0.432 . . . . 71.450000000000003 110.357 -178.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.82 -49.46 8.4 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.139 0.495 . . . . 71.230000000000004 110.472 -179.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.409 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 3.2 pp -75.83 -10.16 59.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.934 -0.575 . . . . 73.420000000000002 111.337 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.535 ' HA ' HG22 ' A' ' 55' ' ' THR . 17.8 t70 -57.95 -45.57 86.43 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.905 -0.588 . . . . 63.020000000000003 111.068 -179.364 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -61.34 -17.41 53.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.489 -0.778 . . . . 73.010000000000005 111.359 -176.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -98.84 -47.18 5.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.353 -0.385 . . . . 74.25 110.59 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.535 HG22 ' HA ' ' A' ' 52' ' ' ASP . 10.0 t -68.85 -31.49 70.49 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.56 -0.291 . . . . 75.409999999999997 111.285 -176.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -68.16 -30.89 70.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.77 0.319 . . . . 51.200000000000003 110.499 -178.13 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.1 -12.9 60.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.007 0.432 . . . . 74.219999999999999 111.435 -178.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.6 mm -87.79 -24.55 6.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.381 0.61 . . . . 75.030000000000001 110.073 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -64.83 -22.58 67.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.699 -0.682 . . . . 51.229999999999997 112.138 -174.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 17.3 p -73.82 -41.65 62.03 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.035 0.383 . . . . 73.340000000000003 112.035 -175.036 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -73.41 -18.08 61.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.803 0.335 . . . . 64.209999999999994 111.075 -176.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.591 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 57.2 mt -67.74 -28.36 41.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.179 -0.464 . . . . 75.120000000000005 110.515 -178.646 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.2 mp -58.41 -40.2 81.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.351 -0.386 . . . . 74.530000000000001 111.056 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -76.29 -31.46 54.77 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.577 -0.821 . . . . 54.140000000000001 112.047 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -73.66 -25.31 72.52 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.058 -0.592 . . . . 33.530000000000001 112.623 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.591 ' HG ' ' O ' ' A' ' 62' ' ' ILE . 73.0 mt -55.43 -35.9 65.91 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 122.275 0.23 . . . . 72.230000000000004 111.501 -179.069 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.9 mp -56.45 -30.95 63.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.863 0.363 . . . . 70.319999999999993 111.42 -178.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 25.2 t -105.0 -16.0 14.94 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.295 -0.412 . . . . 75.109999999999999 111.052 -178.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -89.59 -26.67 20.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.816 0.341 . . . . 53.439999999999998 110.954 -176.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.432 HG12 ' O ' ' A' ' 66' ' ' LEU . 48.9 mm . . . . . 0 C--N 1.328 -0.363 0 CA-C-O 121.4 0.619 . . . . 71.409999999999997 109.929 177.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 57.6 ttp . . . . . 0 N--CA 1.45 -0.441 0 CA-C-O 120.837 0.351 . . . . 73.310000000000002 110.497 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 24.8 t -67.85 126.98 28.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.867 -0.606 . . . . 63.219999999999999 109.921 177.01 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.595 HG21 ' HB2' ' A' ' 83' ' ' TYR . 32.0 m -148.99 140.14 23.07 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.432 -0.581 . . . . 43.310000000000002 109.432 178.736 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 65.6 m-20 -55.16 -62.68 1.5 Allowed 'General case' 0 C--N 1.329 -0.312 0 O-C-N 123.449 0.468 . . . . 72.310000000000002 112.093 -174.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -114.92 14.09 17.18 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.005 0.372 . . . . 75.510000000000005 112.005 -171.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.595 ' HB2' HG21 ' A' ' 80' ' ' THR . 68.5 m-85 -130.49 126.75 37.65 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.734 -0.386 . . . . 63.340000000000003 110.999 -177.163 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.495 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 4.1 mp -95.49 106.73 18.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.045 -0.724 . . . . 71.040000000000006 109.045 176.731 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.9 p -133.47 121.79 42.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.425 0.631 . . . . 64.329999999999998 111.815 -174.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -110.35 134.47 52.26 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.36 -0.836 . . . . 74.510000000000005 108.952 176.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.0 mt -83.53 80.26 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.025 -0.732 . . . . 73.150000000000006 109.025 178.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -86.61 109.42 19.14 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.429 -0.805 . . . . 54.140000000000001 111.323 -174.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -82.78 80.27 8.92 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.981 -0.748 . . . . 62.210000000000001 108.981 172.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -100.46 131.46 46.37 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.336 -0.847 . . . . 75.439999999999998 109.71 -177.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.5 t70 70.4 5.67 5.46 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 123.941 0.776 . . . . 71.019999999999996 111.034 177.325 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 112.04 -24.48 14.47 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.048 -0.596 . . . . 75.319999999999993 112.764 177.5 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -92.59 141.34 28.6 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 122.734 -0.274 . . . . 62.409999999999997 110.94 -176.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.562 ' HB2' ' HB ' ' A' ' 111' ' ' VAL . 3.5 mm? -71.67 105.63 3.77 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.208 -0.664 . . . . 52.240000000000002 109.208 170.488 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -109.01 111.32 22.92 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.238 0.542 . . . . 55.530000000000001 110.649 -178.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 15.1 tp -81.69 99.94 9.2 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.614 -0.721 . . . . 75.109999999999999 109.263 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -94.02 106.87 18.83 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.118 -0.492 . . . . 43.409999999999997 110.341 -177.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 69.5 t -101.14 114.67 41.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.227 0.537 . . . . 72.019999999999996 111.46 -176.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.495 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 86.8 m -101.67 106.25 17.27 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.585 -0.734 . . . . 64.319999999999993 109.52 172.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.452 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 15.3 t0 -76.68 145.63 38.63 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.985 -0.552 . . . . 63.399999999999999 111.157 -178.167 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.54 ' O ' ' HD2' ' A' ' 101' ' ' ARG . 5.2 tmm_? -103.43 -25.76 13.14 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.789 -0.641 . . . . 70.420000000000002 109.635 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -73.73 -56.55 4.85 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.887 -0.597 . . . . 73.140000000000001 111.176 -173.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 71.7 p -109.24 -25.42 10.61 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.268 0.556 . . . . 72.120000000000005 110.265 176.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' A' ' 100' ' ' ASP . . . 98.68 13.88 39.3 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.723 -0.672 . . . . 65.239999999999995 112.644 177.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.45 ' N ' ' HB3' ' A' ' 100' ' ' ASP . 50.5 mm-40 -65.01 109.57 2.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.319 0.581 . . . . 72.040000000000006 111.165 178.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.5 m -87.97 100.13 12.68 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.409 -0.814 . . . . 61.32 109.097 176.111 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 7.6 t -103.08 141.18 36.27 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.937 0.399 . . . . 71.150000000000006 110.224 -175.054 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 46.6 m -116.69 106.08 13.13 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.075 -0.512 . . . . 61.340000000000003 110.664 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.425 HD12 ' N ' ' A' ' 109' ' ' ILE . 4.4 mp -111.52 105.15 18.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.3 -0.409 . . . . 73.010000000000005 110.721 -177.339 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -70.68 157.97 37.07 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.011 0.434 . . . . 61.100000000000001 110.843 175.072 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.562 ' HB ' ' HB2' ' A' ' 94' ' ' LEU . 3.4 p . . . . . 0 C--N 1.322 -0.627 0 CA-C-N 115.381 -0.827 . . . . 75.109999999999999 111.685 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 . . . . . 0 N--CA 1.466 0.367 0 CA-C-O 120.728 0.299 . . . . 65.319999999999993 111.005 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 28.8 m -134.8 83.4 41.34 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-O 121.05 0.452 . . . . 60.32 110.669 178.203 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.635 ' HB2' ' HB2' ' A' ' 52' ' ' ASP . 18.4 Cg_endo -93.97 108.49 0.16 Allowed 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 123.491 2.794 . . . . 72.099999999999994 112.124 177.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.4 m -110.18 -78.65 0.59 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.386 -0.37 . . . . 71.450000000000003 111.049 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.46 -40.64 57.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.758 0.313 . . . . 71.230000000000004 111.405 -177.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.7 pp -68.37 -22.6 64.65 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.801 0.334 . . . . 73.420000000000002 110.358 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.635 ' HB2' ' HB2' ' A' ' 48' ' ' PRO . 7.7 t70 -61.68 -41.85 98.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.975 -0.557 . . . . 63.020000000000003 110.431 177.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 -68.18 -42.42 80.01 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.799 -0.637 . . . . 73.010000000000005 109.925 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -68.34 -50.12 55.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.62 -0.718 . . . . 74.25 111.567 -175.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.5 t -67.85 -17.86 64.63 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.787 0.327 . . . . 75.409999999999997 111.575 -175.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -75.94 -21.89 56.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.835 0.35 . . . . 51.200000000000003 110.935 -177.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -82.93 -19.26 37.57 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.52 0.676 . . . . 74.219999999999999 109.867 174.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.504 ' O ' HG13 ' A' ' 62' ' ' ILE . 19.5 mt -79.39 -25.86 12.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.165 -0.925 . . . . 75.030000000000001 110.489 -179.2 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -57.8 -28.62 64.19 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.705 -0.68 . . . . 51.229999999999997 111.701 -176.152 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.7 m -79.13 -35.38 42.23 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.39 -0.368 . . . . 73.340000000000003 111.49 -177.143 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.443 ' HG2' ' O ' ' A' ' 58' ' ' ILE . 11.3 pt20 -82.05 -6.31 59.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.897 0.379 . . . . 64.209999999999994 111.627 -174.062 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.504 HG13 ' O ' ' A' ' 58' ' ' ILE . 67.7 mt -70.82 -31.93 47.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.832 0.348 . . . . 75.120000000000005 110.641 -178.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.736 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 8.8 mp -59.4 -46.97 87.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 74.530000000000001 111.512 -177.014 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -57.48 -27.26 58.13 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 121.177 -0.535 . . . . 54.140000000000001 112.906 -178.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -92.7 -42.63 4.41 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.558 -0.83 . . . . 33.530000000000001 112.294 178.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.559 ' HA ' ' HB2' ' A' ' 69' ' ' ASN . 1.3 pp -64.44 -23.75 67.39 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 111.415 0.154 . . . . 72.230000000000004 111.415 -176.039 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.736 ' HG ' ' O ' ' A' ' 63' ' ' LEU . 80.7 mt -52.17 -46.27 65.44 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.058 0.456 . . . . 70.319999999999993 110.594 177.319 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.6 t -90.7 -4.91 56.39 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.101 -0.499 . . . . 75.109999999999999 110.485 -177.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.559 ' HB2' ' HA ' ' A' ' 66' ' ' LEU . 90.6 m-20 -86.22 -21.43 27.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.061 0.457 . . . . 53.439999999999998 109.96 174.224 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.466 HG12 ' O ' ' A' ' 66' ' ' LEU . 51.4 mm . . . . . 0 C--N 1.325 -0.487 0 N-CA-C 108.593 -0.891 . . . . 71.409999999999997 108.593 168.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 54.4 ttp . . . . . 0 C--O 1.234 0.248 0 CA-C-O 121.176 0.513 . . . . 73.310000000000002 111.044 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 42.5 t -97.11 98.84 7.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.607 -0.724 . . . . 63.219999999999999 109.601 177.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.2 140.91 52.44 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.064 -0.516 . . . . 43.310000000000002 111.168 -178.381 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -75.94 60.0 1.33 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.213 0.53 . . . . 72.310000000000002 111.736 -177.263 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -170.75 -41.41 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.402 -0.817 . . . . 75.510000000000005 109.165 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -144.66 123.84 12.92 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.483 -0.78 . . . . 63.340000000000003 110.183 174.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.581 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 50.6 mm -92.32 109.11 21.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 109.1 -0.704 . . . . 71.040000000000006 109.1 173.034 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 43.9 t -108.42 96.39 4.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.983 0.42 . . . . 64.329999999999998 110.406 -178.141 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -107.68 114.34 28.24 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.962 -0.563 . . . . 74.510000000000005 110.049 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 56.3 mt -80.92 86.91 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.233 -0.654 . . . . 73.150000000000006 109.233 176.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -98.38 171.36 8.23 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.856 -0.611 . . . . 54.140000000000001 110.848 -176.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.527 ' HB2' HD13 ' A' ' 94' ' ' LEU . 51.9 t-20 -146.04 138.38 25.38 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.071 -1.085 . . . . 62.210000000000001 108.071 178.576 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.443 ' O ' ' HB3' ' A' ' 91' ' ' ASP . 14.9 ttp180 -123.15 110.36 15.18 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.032 -0.358 . . . . 75.439999999999998 110.032 177.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.443 ' HB3' ' O ' ' A' ' 90' ' ' ARG . 15.6 t70 75.15 -45.57 0.56 Allowed 'General case' 0 N--CA 1.471 0.582 0 O-C-N 123.773 0.67 . . . . 71.019999999999996 111.837 177.194 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -178.46 -27.97 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.882 -0.675 . . . . 75.319999999999993 112.35 -178.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 22.5 mm-40 -93.1 125.08 37.52 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.055 0.455 . . . . 62.409999999999997 110.389 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.585 ' HB2' ' HB ' ' A' ' 111' ' ' VAL . 4.2 mm? -61.44 141.69 57.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.536 -0.756 . . . . 52.240000000000002 111.114 -178.095 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -131.94 97.92 4.3 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.674 -0.693 . . . . 55.530000000000001 109.566 -178.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.472 ' HB3' ' HB ' ' A' ' 109' ' ' ILE . 69.4 tp -80.32 113.15 18.3 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.027 -0.533 . . . . 75.109999999999999 110.289 -177.822 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -106.11 113.1 26.44 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.227 -0.442 . . . . 43.409999999999997 110.777 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.581 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 46.4 t -110.82 117.35 54.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.531 -0.758 . . . . 72.019999999999996 110.33 175.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.546 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 25.7 m -94.28 101.1 13.06 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.519 -0.764 . . . . 64.319999999999993 110.25 176.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.532 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 29.4 t70 -67.79 130.36 42.74 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.686 -0.688 . . . . 63.399999999999999 109.949 177.197 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 42.1 ttt180 -98.7 -22.93 15.65 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.915 0.388 . . . . 70.420000000000002 110.891 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -68.23 -45.44 73.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.082 -0.508 . . . . 73.140000000000001 111.157 -173.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.415 ' OG1' ' HG3' ' A' ' 105' ' ' GLN . 77.6 p -123.4 -32.86 3.34 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.303 0.573 . . . . 72.120000000000005 110.369 177.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.532 ' HA2' ' O ' ' A' ' 100' ' ' ASP . . . 103.19 30.04 5.52 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.493 -0.776 . . . . 65.239999999999995 112.435 178.531 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.416 ' N ' ' HB3' ' A' ' 100' ' ' ASP . 47.8 mt-30 -72.95 105.36 4.4 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.179 -0.304 . . . . 72.040000000000006 110.179 176.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 33.5 m -67.77 101.35 1.04 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.083 0.468 . . . . 61.32 110.058 176.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.519 ' HB2' ' HB ' ' A' ' 98' ' ' VAL . 23.5 m -99.77 96.38 7.56 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.012 -0.54 . . . . 71.150000000000006 110.619 -177.491 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 24.6 m -104.46 99.72 9.42 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.256 0.55 . . . . 61.340000000000003 110.007 176.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.472 ' HB ' ' HB3' ' A' ' 96' ' ' LEU . 4.0 mp -90.67 121.51 41.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.767 -0.651 . . . . 73.010000000000005 110.531 -176.378 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -82.67 110.25 17.56 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.556 -0.535 . . . . 61.100000000000001 109.556 176.196 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.585 ' HB ' ' HB2' ' A' ' 94' ' ' LEU . 51.0 t . . . . . 0 C--N 1.324 -0.53 0 CA-C-N 116.514 -0.312 . . . . 75.109999999999999 110.281 -177.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 . . . . . 0 N--CA 1.456 -0.172 0 CA-C-O 121.721 0.772 . . . . 65.319999999999993 109.375 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 21.6 m -114.97 86.52 13.62 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.162 -0.926 . . . . 60.32 109.909 178.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.682 ' HB2' ' HB2' ' A' ' 52' ' ' ASP . 48.5 Cg_endo -70.68 83.65 0.85 Allowed 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.24 1.96 . . . . 72.099999999999994 112.69 -177.109 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.6 m -96.57 -54.99 3.06 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.754 -0.657 . . . . 71.450000000000003 109.913 173.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -100.78 -27.92 13.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.99 0.424 . . . . 71.230000000000004 111.109 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.511 HD23 ' H ' ' A' ' 51' ' ' LEU . 0.8 OUTLIER -87.15 -3.03 59.04 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.997 -0.547 . . . . 73.420000000000002 111.591 -176.609 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.682 ' HB2' ' HB2' ' A' ' 48' ' ' PRO . 17.2 t70 -62.59 -69.23 0.27 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.51 -0.314 . . . . 63.020000000000003 111.589 -176.098 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -66.09 -23.91 66.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.269 0.557 . . . . 73.010000000000005 110.155 177.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.559 ' O ' HG13 ' A' ' 58' ' ' ILE . 85.3 t80 -61.56 -53.42 56.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.583 -0.735 . . . . 74.25 110.817 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.428 ' O ' ' HG3' ' A' ' 59' ' ' GLN . 9.8 t -69.12 -21.42 64.03 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.133 0.492 . . . . 75.409999999999997 110.873 -177.597 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -73.42 -39.65 64.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.242 0.544 . . . . 51.200000000000003 109.915 178.028 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.64 -29.36 69.37 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.646 -0.706 . . . . 74.219999999999999 109.998 175.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.58 ' HA ' ' HG2' ' A' ' 61' ' ' GLN . 15.8 mt -64.07 -39.29 84.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.879 -0.6 . . . . 75.030000000000001 110.44 176.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.428 ' HG3' ' O ' ' A' ' 55' ' ' THR . 73.0 mt-30 -58.1 -42.29 85.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.279 -0.419 . . . . 51.229999999999997 110.438 178.687 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.5 m -61.16 -45.31 95.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.078 -0.51 . . . . 73.340000000000003 110.584 177.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.671 ' O ' ' HA3' ' A' ' 65' ' ' GLY . 13.6 pt20 -80.81 7.74 9.75 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.824 -0.625 . . . . 64.209999999999994 110.85 -176.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.517 HG13 ' O ' ' A' ' 58' ' ' ILE . 83.2 mt -100.8 -55.84 5.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.954 -0.758 . . . . 75.120000000000005 108.954 168.553 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 89.6 mt -59.04 -41.42 87.81 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.613 -0.721 . . . . 74.530000000000001 111.049 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -108.85 -0.66 32.05 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.713 -0.756 . . . . 54.140000000000001 112.199 178.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.671 ' HA3' ' O ' ' A' ' 61' ' ' GLN . . . -85.44 -22.12 52.08 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.847 -0.692 . . . . 33.530000000000001 112.492 -176.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 62' ' ' ILE . 90.8 mt -60.08 -30.54 69.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.014 0.435 . . . . 72.230000000000004 109.985 176.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 70.3 mt -67.36 -33.07 74.46 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.483 -0.78 . . . . 70.319999999999993 110.682 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 9.2 m -73.27 -32.22 64.54 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.047 -0.524 . . . . 75.109999999999999 110.388 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -91.34 10.99 25.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.027 -0.533 . . . . 53.439999999999998 111.622 -177.086 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 36.1 mm . . . . . 0 C--N 1.331 -0.23 0 CA-C-O 121.158 0.504 . . . . 71.409999999999997 109.964 174.581 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.825 ' HB3' HG13 ' A' ' 85' ' ' VAL . 48.9 ttm . . . . . 0 N--CA 1.452 -0.364 0 N-CA-C 109.865 -0.42 . . . . 73.310000000000002 109.865 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 59.9 t -87.79 111.31 21.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.041 -0.527 . . . . 63.219999999999999 110.552 -177.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.663 HG22 ' H ' ' A' ' 82' ' ' ASP . 24.5 m -130.67 138.95 50.29 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.902 -0.59 . . . . 43.310000000000002 109.819 178.548 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -67.69 -23.32 65.28 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.946 0.403 . . . . 72.310000000000002 111.132 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.663 ' H ' HG22 ' A' ' 80' ' ' THR . 25.0 m-20 -97.66 -19.14 18.46 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.177 -0.465 . . . . 75.510000000000005 111.462 -177.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -144.38 136.8 26.58 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.5 0.556 . . . . 63.340000000000003 112.5 -171.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.593 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 4.1 mp -98.23 105.68 17.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 108.172 -1.048 . . . . 71.040000000000006 108.172 169.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.825 HG13 ' HB3' ' A' ' 78' ' ' MET . 5.6 p -135.98 135.66 50.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.258 0.551 . . . . 64.329999999999998 111.75 -174.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -128.43 143.49 51.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.473 -0.785 . . . . 74.510000000000005 109.18 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.41 HD12 ' N ' ' A' ' 87' ' ' ILE . 4.3 mp -95.85 86.63 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.355 -0.609 . . . . 73.150000000000006 109.355 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -105.26 128.12 53.28 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.784 -0.644 . . . . 54.140000000000001 111.223 -175.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -84.36 115.81 22.71 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.037 -0.727 . . . . 62.210000000000001 109.037 174.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -130.99 132.51 45.06 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.949 -0.389 . . . . 75.439999999999998 109.949 177.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.9 t70 68.11 11.15 8.24 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 124.036 0.835 . . . . 71.019999999999996 110.574 179.432 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 97.59 -0.08 59.49 Favored Glycine 0 N--CA 1.452 -0.248 0 CA-C-N 115.675 -0.693 . . . . 75.319999999999993 112.402 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -114.29 134.41 54.97 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.752 0.31 . . . . 62.409999999999997 110.423 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.4 HD13 ' HA ' ' A' ' 94' ' ' LEU . 4.0 mm? -67.0 108.9 2.77 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.117 -0.697 . . . . 52.240000000000002 109.117 173.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.409 HE21 ' HB2' ' A' ' 95' ' ' GLN . 6.1 tt0 -105.57 110.41 22.73 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.74 -0.664 . . . . 55.530000000000001 110.538 -173.81 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 17.3 tp -88.24 94.08 9.71 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.865 -0.607 . . . . 75.109999999999999 109.75 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -85.83 102.55 13.78 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.195 -0.457 . . . . 43.409999999999997 110.499 -179.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 24.6 t -94.39 123.56 46.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.057 0.456 . . . . 72.019999999999996 111.119 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.593 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 32.1 m -111.61 107.99 17.32 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.155 -0.475 . . . . 64.319999999999993 110.12 174.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.502 ' HB3' ' H ' ' A' ' 105' ' ' GLN . 15.3 t70 -65.99 131.1 45.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.776 -0.647 . . . . 63.399999999999999 110.3 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.557 ' HA ' ' NE ' ' A' ' 101' ' ' ARG . 2.8 tpm_? -107.88 17.72 22.14 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.609 0.718 . . . . 70.420000000000002 110.796 -177.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.5 mtpm? -107.11 -66.78 0.99 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.855 0.836 . . . . 73.140000000000001 109.039 175.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.2 m -91.3 -40.59 11.41 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 114.175 -1.375 . . . . 72.120000000000005 109.211 -178.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 98.11 82.98 1.69 Allowed Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.514 -0.767 . . . . 65.239999999999995 113.02 177.152 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.502 ' H ' ' HB3' ' A' ' 100' ' ' ASP . 54.5 mt-30 -143.15 142.31 31.43 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.099 -0.704 . . . . 72.040000000000006 109.099 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.9 m -105.06 85.6 2.3 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.48 0.657 . . . . 61.32 110.221 178.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.32 119.74 26.03 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.483 -0.78 . . . . 71.150000000000006 109.957 178.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 37.5 m -105.71 107.44 18.44 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.015 0.436 . . . . 61.340000000000003 111.291 -176.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.401 ' N ' HD12 ' A' ' 109' ' ' ILE . 4.5 mp -102.57 97.83 6.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.144 -0.48 . . . . 73.010000000000005 109.843 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -79.86 123.74 28.02 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.016 -0.735 . . . . 61.100000000000001 109.016 177.098 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.7 t . . . . . 0 C--N 1.325 -0.461 0 CA-C-O 121.181 0.515 . . . . 75.109999999999999 111.072 -175.718 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 . . . . . 0 CA--C 1.526 0.044 0 CA-C-O 121.864 0.84 . . . . 65.319999999999993 109.732 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 4.8 t -138.25 87.22 16.13 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 114.923 -1.035 . . . . 60.32 109.443 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.633 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 59.2 Cg_endo -70.93 83.78 0.88 Allowed 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.626 2.217 . . . . 72.099999999999994 113.244 -173.26 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 21.0 m -93.75 -68.0 0.82 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.037 -0.529 . . . . 71.450000000000003 110.297 174.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -107.69 -3.97 18.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.195 0.521 . . . . 71.230000000000004 111.061 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.474 HD23 ' H ' ' A' ' 51' ' ' LEU . 1.1 pt? -108.09 7.89 27.89 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.947 -0.57 . . . . 73.420000000000002 110.139 -178.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.633 ' HB3' ' HB2' ' A' ' 48' ' ' PRO . 19.4 p-10 -68.65 -52.8 27.26 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.7 -0.682 . . . . 63.020000000000003 111.246 -174.145 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -65.98 -29.21 69.56 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.985 0.422 . . . . 73.010000000000005 110.43 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.519 ' O ' HG13 ' A' ' 58' ' ' ILE . 70.7 t80 -66.36 -62.93 1.21 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.726 -0.67 . . . . 74.25 110.899 -178.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.1 t -66.89 -21.48 66.0 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.01 0.433 . . . . 75.409999999999997 110.933 -176.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.51 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 3.9 tp-100 -68.98 -43.36 75.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.253 0.549 . . . . 51.200000000000003 109.809 -179.495 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.52 -32.57 74.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.464 -0.789 . . . . 74.219999999999999 110.266 178.195 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.579 ' O ' HG13 ' A' ' 62' ' ' ILE . 19.6 mt -63.34 -39.88 86.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.901 -0.59 . . . . 75.030000000000001 110.644 178.571 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -64.48 -25.0 67.81 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.254 -0.43 . . . . 51.229999999999997 111.057 178.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.2 t -89.7 -38.88 13.54 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.308 -0.406 . . . . 73.340000000000003 110.748 -178.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.503 ' HG2' ' HA ' ' A' ' 58' ' ' ILE . 13.9 pt20 -66.91 -13.2 61.48 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.91 0.386 . . . . 64.209999999999994 110.878 -177.607 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.579 HG13 ' O ' ' A' ' 58' ' ' ILE . 76.8 mt -62.53 -33.68 60.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.565 -0.531 . . . . 75.120000000000005 109.565 175.22 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.0 mp -68.09 -28.93 67.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.224 -0.898 . . . . 74.530000000000001 110.586 -179.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -62.88 -47.51 88.3 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 111.414 -0.674 . . . . 54.140000000000001 111.414 178.37 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -72.76 -35.07 58.94 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.854 -0.689 . . . . 33.530000000000001 111.711 177.326 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.416 ' C ' ' H ' ' A' ' 68' ' ' SER . 47.1 tp -60.85 -49.41 77.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.018 0.437 . . . . 72.230000000000004 110.178 177.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 98.8 mt -79.74 32.28 0.25 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.184 0.516 . . . . 70.319999999999993 110.64 178.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.416 ' H ' ' C ' ' A' ' 66' ' ' LEU . 61.5 m -135.75 -50.94 0.73 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.436 -0.802 . . . . 75.109999999999999 109.592 174.168 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -69.67 -26.6 64.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.016 -0.538 . . . . 53.439999999999998 111.632 -178.114 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 50.8 mm . . . . . 0 C--N 1.327 -0.412 0 CA-C-O 121.093 0.473 . . . . 71.409999999999997 110.573 -178.246 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 50.5 ttm . . . . . 0 C--O 1.233 0.222 0 N-CA-C 110.212 -0.292 . . . . 73.310000000000002 110.212 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.0 p -73.98 125.27 32.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.204 0.526 . . . . 63.219999999999999 110.779 -179.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.786 ' HB ' ' O ' ' A' ' 83' ' ' TYR . 17.0 m -138.85 152.59 47.95 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.518 -0.919 . . . . 43.310000000000002 108.518 177.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -65.46 -60.04 3.37 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.656 0.613 . . . . 72.310000000000002 112.656 -170.47 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -101.39 2.57 39.62 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.446 0.641 . . . . 75.510000000000005 111.419 -171.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.786 ' O ' ' HB ' ' A' ' 80' ' ' THR . 60.6 m-85 -146.03 116.31 7.48 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.927 -0.579 . . . . 63.340000000000003 110.105 178.116 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.645 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 3.8 mp -84.68 104.06 12.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.946 -0.761 . . . . 71.040000000000006 108.946 175.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 73.5 t -94.73 111.97 26.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.729 -0.669 . . . . 64.329999999999998 111.201 -174.389 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -111.05 100.58 9.23 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.005 0.431 . . . . 74.510000000000005 110.448 175.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 58.1 mt -89.49 97.22 6.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.431 -0.581 . . . . 73.150000000000006 109.431 176.04 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -104.58 130.05 52.61 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.062 -0.517 . . . . 54.140000000000001 111.599 -174.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.422 ' HA ' ' O ' ' A' ' 93' ' ' GLN . 7.8 t30 -108.53 87.36 2.48 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.342 -0.614 . . . . 62.210000000000001 109.342 171.126 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.408 ' O ' ' HB3' ' A' ' 91' ' ' ASP . 10.3 ttp180 -106.68 146.14 31.13 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.511 -0.922 . . . . 75.439999999999998 108.511 177.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.408 ' HB3' ' O ' ' A' ' 90' ' ' ARG . 24.9 t70 69.13 -70.49 0.14 Allowed 'General case' 0 N--CA 1.469 0.488 0 O-C-N 123.732 0.645 . . . . 71.019999999999996 110.53 -176.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 179.18 22.04 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 121.005 -0.617 . . . . 75.319999999999993 112.341 176.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.422 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 13.8 mm-40 -126.27 141.59 51.86 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 122.676 -0.308 . . . . 62.409999999999997 110.574 -175.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -81.41 109.96 16.39 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.192 -0.67 . . . . 52.240000000000002 109.192 173.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.443 HE21 ' HB2' ' A' ' 95' ' ' GLN . 6.0 tt0 -113.73 110.71 20.61 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.119 0.485 . . . . 55.530000000000001 110.666 -177.637 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.46 ' HB3' ' O ' ' A' ' 109' ' ' ILE . 59.6 tp -85.71 97.02 9.9 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.557 -0.747 . . . . 75.109999999999999 110.206 179.062 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.6 m-20 -95.53 100.36 12.12 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.074 -0.512 . . . . 43.409999999999997 110.113 177.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 50.7 t -94.96 111.59 25.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.817 -0.629 . . . . 72.019999999999996 110.364 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.645 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 22.8 m -89.94 103.35 16.02 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.873 -0.603 . . . . 64.319999999999993 109.665 175.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.595 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 9.8 t70 -58.72 147.64 32.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.096 -0.502 . . . . 63.399999999999999 110.842 178.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.401 ' HD2' ' HA ' ' A' ' 101' ' ' ARG . 23.5 tpt180 -113.6 -9.02 13.28 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.856 0.36 . . . . 70.420000000000002 111.314 -177.2 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm -78.87 -49.81 12.27 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.005 0.431 . . . . 73.140000000000001 110.806 177.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 36.5 p -113.23 -35.62 5.28 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.747 -0.661 . . . . 72.120000000000005 109.952 176.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.595 ' HA2' ' O ' ' A' ' 100' ' ' ASP . . . 91.57 81.11 1.42 Allowed Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.461 -0.79 . . . . 65.239999999999995 112.242 178.078 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.537 ' H ' ' HB3' ' A' ' 100' ' ' ASP . 49.6 mt-30 -137.47 139.98 40.93 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.253 -0.647 . . . . 72.040000000000006 109.253 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.9 t -84.38 95.45 8.75 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.585 0.707 . . . . 61.32 111.089 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 59.4 m -84.22 102.98 13.03 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.854 -0.612 . . . . 71.150000000000006 109.933 176.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 23.8 m -92.15 109.85 21.22 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.289 -0.414 . . . . 61.340000000000003 110.857 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.46 ' O ' ' HB3' ' A' ' 96' ' ' LEU . 4.9 mp -117.2 97.91 6.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.947 0.404 . . . . 73.010000000000005 109.94 175.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -74.74 153.25 38.91 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.453 -0.339 . . . . 61.100000000000001 110.92 178.212 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 8.4 p . . . . . 0 C--N 1.323 -0.579 0 CA-C-N 115.608 -0.724 . . . . 75.109999999999999 110.461 177.305 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 . . . . . 0 N--CA 1.467 0.407 0 CA-C-O 120.691 0.281 . . . . 65.319999999999993 111.546 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.0 m -124.53 87.9 53.89 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.386 -0.37 . . . . 60.32 110.726 -175.122 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -69.97 120.83 7.51 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 123.134 2.556 . . . . 72.099999999999994 112.658 -176.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 52.0 m -97.51 -86.15 0.35 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.352 -0.385 . . . . 71.450000000000003 111.409 177.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.91 12.83 28.9 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.046 0.451 . . . . 71.230000000000004 111.623 -176.333 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.4 pp -119.01 1.9 11.46 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.276 -0.42 . . . . 73.420000000000002 110.572 179.061 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -63.45 -60.3 3.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.63 -0.714 . . . . 63.020000000000003 111.538 -174.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.436 ' HA ' ' HB2' ' A' ' 56' ' ' GLN . 7.7 p30 -78.15 -13.75 59.74 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.921 -0.582 . . . . 73.010000000000005 110.906 -175.364 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.551 ' O ' HG13 ' A' ' 58' ' ' ILE . 83.9 t80 -66.55 -58.39 5.3 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.234 -0.439 . . . . 74.25 110.095 176.181 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.7 t -74.3 -12.29 60.5 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.186 0.517 . . . . 75.409999999999997 110.419 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.436 ' HB2' ' HA ' ' A' ' 53' ' ' ASN . 2.1 tp-100 -70.63 -47.75 58.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.759 -0.655 . . . . 51.200000000000003 109.643 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.23 -28.24 67.07 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.728 -0.669 . . . . 74.219999999999999 110.894 179.232 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.56 ' O ' HG13 ' A' ' 62' ' ' ILE . 26.6 mt -63.09 -39.52 85.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.163 -0.471 . . . . 75.030000000000001 110.649 179.523 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -64.31 -31.04 72.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.151 -0.477 . . . . 51.229999999999997 110.658 179.406 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.1 m -81.04 -41.52 22.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.146 -0.479 . . . . 73.340000000000003 111.339 -178.459 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.521 ' HG2' ' HA ' ' A' ' 58' ' ' ILE . 13.8 pt20 -66.78 -19.0 65.66 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.518 -0.31 . . . . 64.209999999999994 111.49 -176.169 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.56 HG13 ' O ' ' A' ' 58' ' ' ILE . 86.5 mt -62.23 -47.42 93.18 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 N-CA-C 109.31 -0.626 . . . . 75.120000000000005 109.31 175.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.0 mp -64.39 -43.21 95.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.451 -0.795 . . . . 74.530000000000001 110.498 178.149 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -57.5 -44.68 93.65 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 121.226 -0.512 . . . . 54.140000000000001 112.578 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -75.21 -44.15 23.68 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.682 -0.77 . . . . 33.530000000000001 112.453 178.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.604 ' O ' HG12 ' A' ' 70' ' ' ILE . 57.0 tp -58.72 -50.35 74.21 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 122.313 0.245 . . . . 72.230000000000004 111.297 -177.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 85.5 mt -63.34 -17.65 62.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.445 -0.343 . . . . 70.319999999999993 111.912 -176.377 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.1 t -78.27 -45.77 21.96 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.76 -0.459 . . . . 75.109999999999999 109.76 178.035 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -78.5 -11.49 59.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.046 -0.525 . . . . 53.439999999999998 111.149 -176.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.604 HG12 ' O ' ' A' ' 66' ' ' LEU . 27.4 mm . . . . . 0 C--N 1.328 -0.35 0 CA-C-O 120.725 0.298 . . . . 71.409999999999997 110.478 176.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.588 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 28.0 ttt . . . . . 0 N--CA 1.45 -0.439 0 N-CA-C 109.78 -0.452 . . . . 73.310000000000002 109.78 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 19.1 t -86.53 76.12 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.397 0.618 . . . . 63.219999999999999 110.267 -176.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.0 -175.44 5.4 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.728 -0.669 . . . . 43.310000000000002 110.089 179.139 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -79.67 -43.81 22.06 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.663 0.268 . . . . 72.310000000000002 110.772 -177.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.559 ' O ' ' HB2' ' A' ' 101' ' ' ARG . 8.2 t0 -101.6 -76.52 0.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.657 -0.497 . . . . 75.510000000000005 109.657 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.507 ' HB3' HG13 ' A' ' 98' ' ' VAL . 17.0 m-85 -79.38 115.4 19.0 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.407 -0.361 . . . . 63.340000000000003 111.048 -174.266 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.464 HD12 ' HB ' ' A' ' 99' ' ' THR . 0.9 OUTLIER -83.83 103.38 11.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.595 0.712 . . . . 71.040000000000006 109.197 170.843 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.588 ' HB ' ' HB3' ' A' ' 78' ' ' MET . 37.6 t -94.3 139.65 18.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.639 -0.709 . . . . 64.329999999999998 111.195 -169.713 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -108.73 105.07 14.49 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.573 -0.528 . . . . 74.510000000000005 109.573 174.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 74.4 mt -78.72 113.69 18.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.287 -0.415 . . . . 73.150000000000006 109.968 178.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -107.8 109.57 21.16 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.184 -0.462 . . . . 54.140000000000001 111.128 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.564 ' HA ' ' O ' ' A' ' 93' ' ' GLN . 3.5 t-20 -111.44 83.01 1.7 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.202 0.525 . . . . 62.210000000000001 109.726 174.401 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 90' ' ' ARG . 30.2 ttp180 -105.27 121.07 43.1 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.959 -0.564 . . . . 75.439999999999998 109.744 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.4 t70 69.04 -83.11 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.369 -0.832 . . . . 71.019999999999996 111.207 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -144.14 12.13 2.08 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.63 -0.795 . . . . 75.319999999999993 112.583 -178.262 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.564 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 16.6 mm-40 -103.24 126.73 50.55 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.769 0.319 . . . . 62.409999999999997 111.461 -179.094 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 94' ' ' LEU . 4.3 mm? -96.36 98.22 10.09 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.909 -0.774 . . . . 52.240000000000002 108.909 168.326 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.44 HE21 ' HB2' ' A' ' 95' ' ' GLN . 4.6 tt0 -112.36 126.62 55.47 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.213 -0.449 . . . . 55.530000000000001 110.396 -175.432 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 13.6 tp -103.69 100.8 10.63 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.135 -0.484 . . . . 75.109999999999999 110.196 -176.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -88.96 97.83 11.41 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.175 -0.466 . . . . 43.409999999999997 111.045 -177.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.507 HG13 ' HB3' ' A' ' 83' ' ' TYR . 39.0 t -90.32 115.2 29.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.869 -0.605 . . . . 72.019999999999996 110.841 -179.603 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.464 ' HB ' HD12 ' A' ' 84' ' ' ILE . 47.6 m -104.6 114.79 29.23 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.673 -0.694 . . . . 64.319999999999993 109.964 175.583 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.506 ' HA ' ' HD1' ' A' ' 83' ' ' TYR . 26.0 t70 -60.79 141.97 56.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.97 -0.559 . . . . 63.399999999999999 111.105 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.559 ' HB2' ' O ' ' A' ' 82' ' ' ASP . 10.0 tpt180 -88.55 -10.94 47.13 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.151 -0.477 . . . . 70.420000000000002 111.367 -174.235 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm -107.62 -67.71 0.94 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.74 0.305 . . . . 73.140000000000001 111.622 -171.298 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 45.8 p -85.62 -33.09 21.73 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.271 0.558 . . . . 72.120000000000005 109.997 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 99.6 23.55 10.89 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.279 -0.873 . . . . 65.239999999999995 112.644 177.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.445 ' N ' ' HB3' ' A' ' 100' ' ' ASP . 98.2 mt-30 -59.58 130.68 48.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.725 0.298 . . . . 72.040000000000006 110.737 175.656 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.2 p -102.89 88.4 3.17 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.172 0.51 . . . . 61.32 110.398 176.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 9.7 t -91.21 105.65 17.95 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.766 -0.652 . . . . 71.150000000000006 109.489 -178.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.5 m -91.24 107.8 19.45 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.986 -0.552 . . . . 61.340000000000003 110.388 -178.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 59.5 mt -110.01 116.0 51.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.416 -0.356 . . . . 73.010000000000005 110.882 -175.478 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -71.71 168.2 18.26 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.003 0.43 . . . . 61.100000000000001 111.207 175.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.7 p . . . . . 0 C--N 1.325 -0.5 0 CA-C-N 115.748 -0.66 . . . . 75.109999999999999 111.306 -179.338 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 . . . . . 0 N--CA 1.455 -0.186 0 CA-C-O 121.011 0.434 . . . . 65.319999999999993 110.28 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 25.8 m -151.11 86.02 4.93 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 116.006 -0.543 . . . . 60.32 109.688 174.273 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.643 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 28.2 Cg_endo -62.16 110.58 1.05 Allowed 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 122.826 2.351 . . . . 72.099999999999994 112.29 -178.041 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 26.7 m -123.69 -25.54 4.3 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.005 -0.543 . . . . 71.450000000000003 110.415 177.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.3 -37.33 0.31 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 71.230000000000004 111.374 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.2 pp -73.09 -12.6 60.97 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.536 -0.302 . . . . 73.420000000000002 111.409 -176.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.643 ' HB3' ' HB2' ' A' ' 48' ' ' PRO . 4.3 p-10 -63.63 -56.59 14.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.289 -0.414 . . . . 63.020000000000003 110.864 -178.317 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -64.61 -28.76 69.84 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.229 0.538 . . . . 73.010000000000005 110.108 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.444 ' O ' HG13 ' A' ' 58' ' ' ILE . 77.6 t80 -66.26 -49.86 65.71 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.414 -0.812 . . . . 74.25 111.028 179.092 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.445 ' O ' ' HG3' ' A' ' 59' ' ' GLN . 8.9 t -72.46 -19.48 61.55 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.708 0.262 . . . . 75.409999999999997 111.708 -176.195 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.438 ' HG3' ' O ' ' A' ' 52' ' ' ASP . 60.9 mt-30 -64.39 -43.69 93.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.895 0.378 . . . . 51.200000000000003 111.096 -178.508 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.72 -24.89 61.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.337 -0.392 . . . . 74.219999999999999 111.422 -178.346 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.444 HG13 ' O ' ' A' ' 54' ' ' PHE . 8.6 mt -76.35 -18.67 15.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.107 0.479 . . . . 75.030000000000001 110.974 -176.365 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.445 ' HG3' ' O ' ' A' ' 55' ' ' THR . 77.4 mt-30 -67.21 -19.16 65.51 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.374 -0.375 . . . . 51.229999999999997 110.98 -178.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 61.0 m -74.87 -34.8 62.29 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.53 -0.304 . . . . 73.340000000000003 111.484 178.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.436 ' HG2' ' O ' ' A' ' 58' ' ' ILE . 11.1 pt20 -82.2 -5.58 58.6 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.862 0.363 . . . . 64.209999999999994 110.966 -177.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.554 HG23 ' HA3' ' A' ' 92' ' ' GLY . 67.7 mt -65.34 -36.02 76.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.284 0.564 . . . . 75.120000000000005 109.799 175.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 9.2 mp -63.47 -35.7 81.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.414 -0.812 . . . . 74.530000000000001 110.622 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -65.7 -40.68 95.92 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.285 -0.726 . . . . 54.140000000000001 111.285 175.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -66.33 -19.56 68.62 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 121.147 -0.549 . . . . 33.530000000000001 112.385 177.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 62' ' ' ILE . 85.5 mt -74.44 -31.9 62.43 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.046 0.45 . . . . 72.230000000000004 110.168 176.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 49.0 mt -74.83 -42.58 57.73 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.996 -0.742 . . . . 70.319999999999993 108.996 175.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.8 m -75.52 5.83 5.45 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.107 -0.951 . . . . 75.109999999999999 111.246 178.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.956 ' HA ' ' HG3' ' A' ' 90' ' ' ARG . 50.6 t30 -82.43 -25.86 33.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.195 -0.457 . . . . 53.439999999999998 110.997 -178.362 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.0 mp . . . . . 0 C--N 1.324 -0.531 0 CA-C-N 116.204 -0.453 . . . . 71.409999999999997 110.997 -175.812 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.761 ' HB3' HG13 ' A' ' 85' ' ' VAL . 47.9 ttm . . . . . 0 N--CA 1.451 -0.424 0 N-CA-C 108.897 -0.779 . . . . 73.310000000000002 108.897 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.4 p -88.53 98.31 7.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.867 0.842 . . . . 63.219999999999999 111.827 -173.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.7 p -122.77 156.93 33.47 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.209 -0.905 . . . . 43.310000000000002 109.451 171.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -78.28 -41.18 34.72 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.811 0.338 . . . . 72.310000000000002 111.368 -175.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.713 ' HB3' ' HD3' ' A' ' 102' ' ' LYS . 7.5 m-20 -81.45 -21.68 38.64 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.174 -0.466 . . . . 75.510000000000005 111.282 -174.728 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -137.49 135.89 37.2 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.978 0.418 . . . . 63.340000000000003 111.363 -177.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.669 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 4.1 mp -105.93 84.94 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 108.407 -0.96 . . . . 71.040000000000006 108.407 172.231 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.761 HG13 ' HB3' ' A' ' 78' ' ' MET . 2.3 p -91.18 106.8 17.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.642 0.734 . . . . 64.329999999999998 110.455 -177.769 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -111.51 128.0 55.88 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.316 -0.856 . . . . 74.510000000000005 110.32 -175.283 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.51 HG12 HD13 ' A' ' 96' ' ' LEU . 19.4 mt -95.86 103.73 15.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.278 -0.419 . . . . 73.150000000000006 110.375 -177.268 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -88.56 146.76 24.96 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.899 0.381 . . . . 54.140000000000001 111.009 -178.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -139.53 110.3 6.76 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.107 -0.497 . . . . 62.210000000000001 109.764 178.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.956 ' HG3' ' HA ' ' A' ' 69' ' ' ASN . 66.8 ttt180 -147.12 141.44 26.31 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.024 -0.535 . . . . 75.439999999999998 109.565 179.27 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.2 t70 71.71 2.94 4.48 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.449 0.642 . . . . 71.019999999999996 110.452 177.172 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.554 ' HA3' HG23 ' A' ' 62' ' ' ILE . . . 97.13 -8.62 65.07 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 111.183 -0.767 . . . . 75.319999999999993 111.183 -176.009 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -90.07 135.33 33.72 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.875 0.369 . . . . 62.409999999999997 110.346 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 94' ' ' LEU . 4.4 mm? -91.97 131.51 37.22 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.408 -0.59 . . . . 52.240000000000002 109.408 173.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.414 ' HG2' ' ND2' ' A' ' 97' ' ' ASN . 6.2 tt0 -133.48 108.1 8.44 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.0 -0.545 . . . . 55.530000000000001 110.468 -178.657 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.588 ' HB3' ' HB ' ' A' ' 109' ' ' ILE . 44.2 tp -88.83 111.16 21.71 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.757 -0.656 . . . . 75.109999999999999 110.295 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.414 ' ND2' ' HG2' ' A' ' 95' ' ' GLN . 48.7 m-80 -104.56 107.41 18.34 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.881 0.372 . . . . 43.409999999999997 110.63 178.156 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.6 t -87.02 107.18 16.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.983 -0.553 . . . . 72.019999999999996 110.137 176.008 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.669 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 28.0 m -89.84 104.1 16.7 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 115.667 -0.697 . . . . 64.319999999999993 109.524 177.241 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.609 ' HB3' ' N ' ' A' ' 105' ' ' GLN . 32.3 t70 -71.11 127.39 32.43 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.335 -0.848 . . . . 63.399999999999999 110.865 -177.446 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.413 ' HA ' ' NE ' ' A' ' 101' ' ' ARG . 5.1 tpm_? -99.28 1.94 45.08 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.462 0.648 . . . . 70.420000000000002 110.166 -178.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.713 ' HD3' ' HB3' ' A' ' 82' ' ' ASP . 25.3 mmmt -89.45 -57.08 3.01 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.054 -0.521 . . . . 73.140000000000001 110.421 -178.179 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 64.2 p -115.08 -31.35 6.07 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.453 0.644 . . . . 72.120000000000005 110.258 178.35 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.43 ' HA2' ' O ' ' A' ' 100' ' ' ASP . . . 110.01 29.88 3.63 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 115.414 -0.812 . . . . 65.239999999999995 112.378 178.348 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.609 ' N ' ' HB3' ' A' ' 100' ' ' ASP . 84.1 mm-40 -64.04 160.71 17.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.108 0.48 . . . . 72.040000000000006 110.17 171.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 27.1 m -140.81 87.46 2.11 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.244 -0.65 . . . . 61.32 109.244 174.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.4 t -85.2 114.73 22.53 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.406 -0.815 . . . . 71.150000000000006 109.567 -178.284 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 19.5 m -102.18 114.79 29.25 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.065 -0.516 . . . . 61.340000000000003 110.72 -178.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.588 ' HB ' ' HB3' ' A' ' 96' ' ' LEU . 4.4 mp -105.97 96.6 4.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.048 -0.523 . . . . 73.010000000000005 109.767 177.289 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -93.54 142.72 27.02 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.193 -0.458 . . . . 61.100000000000001 109.88 178.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 92.6 t . . . . . 0 C--N 1.325 -0.483 0 N-CA-C 110.189 -0.3 . . . . 75.109999999999999 110.189 176.575 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 . . . . . 0 C--O 1.234 0.258 0 CA-C-O 121.386 0.612 . . . . 65.319999999999993 109.869 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.425 HG23 ' O ' ' A' ' 47' ' ' THR . 9.9 t -120.59 88.04 42.51 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.19 -0.914 . . . . 60.32 109.877 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -67.6 93.52 0.37 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.306 2.671 . . . . 72.099999999999994 113.725 -172.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 72.8 m -105.61 -69.75 0.81 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.089 -0.505 . . . . 71.450000000000003 110.607 172.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.39 -38.35 90.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.873 0.368 . . . . 71.230000000000004 111.922 -178.059 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.426 ' HG ' ' H ' ' A' ' 51' ' ' LEU . 3.2 pp -95.4 12.06 30.6 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.166 -0.47 . . . . 73.420000000000002 111.67 -175.415 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' ' 56' ' ' GLN . 15.9 t70 -57.41 -42.87 83.14 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.939 0.399 . . . . 63.020000000000003 111.121 -178.165 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -89.09 15.88 8.03 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.172 -0.467 . . . . 73.010000000000005 111.2 -177.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.765 ' HE1' ' HG2' ' A' ' 105' ' ' GLN . 67.6 t80 -122.97 -64.8 1.15 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.231 -0.44 . . . . 74.25 110.527 -179.333 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.1 m -66.64 -28.08 68.19 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.323 -0.399 . . . . 75.409999999999997 111.586 -175.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.471 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 0.7 OUTLIER -69.45 -29.62 67.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.829 0.347 . . . . 51.200000000000003 110.835 179.402 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.61 -26.1 60.63 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.286 0.565 . . . . 74.219999999999999 110.116 176.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.401 ' O ' HG13 ' A' ' 62' ' ' ILE . 12.1 mt -71.32 -25.47 25.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.458 -0.792 . . . . 75.030000000000001 110.591 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -55.11 -34.14 63.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.605 -0.27 . . . . 51.229999999999997 110.861 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 36.0 t -62.56 -48.92 77.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.184 -0.462 . . . . 73.340000000000003 111.141 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -73.28 -24.95 60.5 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.818 -0.353 . . . . 64.209999999999994 111.05 -176.07 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.659 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 75.4 mt -76.81 -56.92 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.946 0.403 . . . . 75.120000000000005 110.037 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 84.8 mt -62.1 -33.05 73.72 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.998 -0.546 . . . . 74.530000000000001 111.678 -175.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -77.33 -24.25 66.26 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.493 -0.86 . . . . 54.140000000000001 112.449 179.218 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -94.2 -20.78 29.32 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.041 -0.6 . . . . 33.530000000000001 112.865 -176.248 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.659 ' HG ' ' O ' ' A' ' 62' ' ' ILE . 69.7 mt -59.25 -15.58 16.3 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.459 0.54 . . . . 72.230000000000004 112.459 -176.201 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 84.1 mt -58.69 -41.69 86.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.018 0.437 . . . . 70.319999999999993 110.183 177.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.502 ' HB2' ' HB1' ' A' ' 88' ' ' ALA . 19.7 m -71.97 -24.66 61.63 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.875 -0.602 . . . . 75.109999999999999 110.751 -179.145 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.446 ' ND2' ' HB2' ' A' ' 88' ' ' ALA . 13.4 m120 -80.85 -22.72 39.65 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.865 -0.607 . . . . 53.439999999999998 111.106 -177.384 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.413 HG12 ' O ' ' A' ' 66' ' ' LEU . 49.5 mm . . . . . 0 C--N 1.327 -0.396 0 N-CA-C 112.171 0.434 . . . . 71.409999999999997 112.171 -174.318 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.752 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 50.0 ttm . . . . . 0 CA--C 1.521 -0.136 0 CA-C-O 121.278 0.561 . . . . 73.310000000000002 110.776 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 53.4 t -105.22 106.33 20.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.029 -0.532 . . . . 63.219999999999999 110.397 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 14.7 p -127.31 159.4 34.5 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.973 -0.558 . . . . 43.310000000000002 110.177 175.338 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -62.97 -46.17 88.96 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.368 -0.378 . . . . 72.310000000000002 110.933 -176.334 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -77.7 -25.91 49.76 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.106 0.409 . . . . 75.510000000000005 112.106 -172.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.421 ' CE1' ' HA ' ' A' ' 100' ' ' ASP . 14.6 m-85 -149.15 136.35 19.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.233 0.54 . . . . 63.340000000000003 111.811 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.614 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 51.7 mm -98.42 99.44 8.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.315 -0.624 . . . . 71.040000000000006 109.315 175.196 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.752 ' HB ' ' HB3' ' A' ' 78' ' ' MET . 29.1 t -103.38 86.74 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.288 0.566 . . . . 64.329999999999998 110.257 -177.439 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -91.11 124.01 35.01 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.955 -0.566 . . . . 74.510000000000005 109.711 -177.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 70.5 mt -98.16 117.48 43.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.074 -0.512 . . . . 73.150000000000006 110.386 -175.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.584 ' HB3' ' HB2' ' A' ' 95' ' ' GLN . . . -110.89 87.83 2.63 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.262 0.553 . . . . 54.140000000000001 111.142 -178.17 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -97.58 107.64 20.19 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.431 -0.951 . . . . 62.210000000000001 108.431 171.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.483 ' HB3' ' HB3' ' A' ' 68' ' ' SER . 11.5 tpt180 -160.03 147.56 16.55 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.041 -0.527 . . . . 75.439999999999998 109.989 -176.09 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.3 t70 71.21 0.63 3.5 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 123.748 0.655 . . . . 71.019999999999996 111.111 173.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 114.37 -23.74 12.1 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 115.808 -0.633 . . . . 75.319999999999993 112.443 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 -95.67 159.07 15.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.351 0.595 . . . . 62.409999999999997 111.697 -175.094 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -106.32 116.59 32.19 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.382 -0.826 . . . . 52.240000000000002 109.451 175.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.584 ' HB2' ' HB3' ' A' ' 88' ' ' ALA . 66.5 mt-30 -121.05 127.94 52.18 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.242 -0.435 . . . . 55.530000000000001 110.15 -179.322 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 41.3 tp -109.94 121.69 45.83 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 110.041 -0.355 . . . . 75.109999999999999 110.041 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -112.91 102.2 10.22 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.903 -0.406 . . . . 43.409999999999997 109.903 177.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.614 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 6.4 p -113.9 115.61 50.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.412 0.625 . . . . 72.019999999999996 111.281 -178.5 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.581 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 41.2 m -92.44 123.13 35.53 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.805 -0.634 . . . . 64.319999999999993 111.045 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.476 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 26.9 t70 -75.08 158.43 33.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.57 -0.741 . . . . 63.399999999999999 110.649 177.359 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 11.6 mmt180 -115.61 2.54 13.78 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.486 0.55 . . . . 70.420000000000002 112.486 -176.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -108.13 -35.58 6.54 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.58 0.705 . . . . 73.140000000000001 110.264 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 14.4 p -121.81 -23.2 5.55 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.066 -0.97 . . . . 72.120000000000005 110.325 176.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.476 ' HA2' ' O ' ' A' ' 100' ' ' ASP . . . 83.65 14.56 72.94 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.659 -0.7 . . . . 65.239999999999995 111.986 -179.059 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.765 ' HG2' ' HE1' ' A' ' 54' ' ' PHE . 49.7 mt-30 -63.94 101.81 0.42 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.748 0.308 . . . . 72.040000000000006 110.404 177.481 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 98' ' ' VAL . 58.5 m -85.88 109.33 18.64 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.829 -0.434 . . . . 61.32 109.829 177.211 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 17.7 t -86.71 105.34 16.87 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.991 -0.55 . . . . 71.150000000000006 109.735 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 8.5 m -92.96 96.1 9.9 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.77 -0.65 . . . . 61.340000000000003 109.813 177.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 65.0 mt -102.86 114.33 42.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.179 -0.464 . . . . 73.010000000000005 111.539 -174.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.505 ' HG2' ' HG2' ' A' ' 95' ' ' GLN . 43.6 mt-30 -95.09 121.19 36.47 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.456 -0.572 . . . . 61.100000000000001 109.456 172.058 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 93.4 t . . . . . 0 C--N 1.327 -0.4 0 CA-C-O 121.174 0.511 . . . . 75.109999999999999 111.949 -175.696 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.433 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 30.9 tt0 . . . . . 0 CA--C 1.53 0.192 0 CA-C-O 121.782 0.801 . . . . 65.319999999999993 109.621 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 8.2 m -113.02 86.15 8.81 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.116 -0.947 . . . . 60.32 109.236 175.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' A' ' 46' ' ' GLU . 17.1 Cg_exo -66.21 99.22 0.41 Allowed 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.692 2.262 . . . . 72.099999999999994 113.157 -173.528 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.8 m -127.85 -59.46 1.2 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.824 -0.625 . . . . 71.450000000000003 109.603 174.237 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.54 -46.37 15.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.027 -0.533 . . . . 71.230000000000004 110.263 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.54 HD23 ' H ' ' A' ' 51' ' ' LEU . 1.4 pt? -74.6 -13.35 60.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 73.420000000000002 110.778 179.317 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.621 ' O ' ' HB2' ' A' ' 56' ' ' GLN . 27.0 t70 -62.69 -47.23 84.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.151 -0.477 . . . . 63.020000000000003 110.457 -179.441 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -79.2 9.91 4.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.426 -0.352 . . . . 73.010000000000005 110.865 178.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.456 ' O ' HG13 ' A' ' 58' ' ' ILE . 82.4 t80 -109.65 -64.82 1.21 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.759 0.314 . . . . 74.25 110.432 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.47 ' O ' ' HG2' ' A' ' 59' ' ' GLN . 12.9 t -73.5 -18.5 61.1 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.937 0.347 . . . . 75.409999999999997 111.937 -174.102 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.621 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 2.3 mp0 -75.09 -28.11 60.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.802 0.334 . . . . 51.200000000000003 110.614 -178.287 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -79.57 -18.83 50.86 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.536 0.684 . . . . 74.219999999999999 109.771 175.121 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.516 ' O ' HG13 ' A' ' 62' ' ' ILE . 21.7 mt -79.3 -29.06 13.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.37 -0.832 . . . . 75.030000000000001 110.604 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.47 ' HG2' ' O ' ' A' ' 55' ' ' THR . 15.1 mm-40 -53.29 -37.61 62.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.132 -0.485 . . . . 51.229999999999997 111.136 -178.665 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.8 m -62.71 -46.55 87.6 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.046 -0.525 . . . . 73.340000000000003 111.022 179.423 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -77.78 -16.14 58.58 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.844 -0.342 . . . . 64.209999999999994 111.082 -178.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.516 HG13 ' O ' ' A' ' 58' ' ' ILE . 64.7 mt -71.27 -43.09 74.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.302 -0.629 . . . . 75.120000000000005 109.302 172.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 97.1 mt -61.45 -41.56 97.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.926 -0.579 . . . . 74.530000000000001 110.096 175.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -65.15 -37.33 93.98 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.771 -0.728 . . . . 54.140000000000001 111.714 175.034 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.21 -37.34 94.37 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 111.784 -0.526 . . . . 33.530000000000001 111.784 176.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 62' ' ' ILE . 95.9 mt -56.9 -59.51 4.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.593 0.235 . . . . 72.230000000000004 110.998 178.089 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 pp -65.6 -10.4 35.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.864 0.364 . . . . 70.319999999999993 111.741 -176.152 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.405 ' HA ' ' HG3' ' A' ' 90' ' ' ARG . 31.4 m -95.86 -46.43 6.56 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.662 0.267 . . . . 75.109999999999999 111.246 178.56 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -92.08 -26.85 18.11 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.399 0.518 . . . . 53.439999999999998 112.399 -172.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 36.1 mm . . . . . 0 N--CA 1.465 0.305 0 CA-C-O 121.268 0.556 . . . . 71.409999999999997 110.452 -178.981 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 58.9 ttp . . . . . 0 N--CA 1.45 -0.425 0 N-CA-C 109.642 -0.503 . . . . 73.310000000000002 109.642 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 60.9 t -74.35 102.81 2.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.243 0.544 . . . . 63.219999999999999 111.043 -176.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.666 ' HB ' ' O ' ' A' ' 83' ' ' TYR . 17.5 m -120.95 142.15 50.01 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.376 -0.829 . . . . 43.310000000000002 109.28 178.399 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -70.15 -36.31 74.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.903 0.382 . . . . 72.310000000000002 111.08 -174.136 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -82.4 -40.1 21.74 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.94 -0.573 . . . . 75.510000000000005 111.491 -176.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.666 ' O ' ' HB ' ' A' ' 80' ' ' THR . 49.6 m-85 -139.96 120.8 14.46 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.205 -0.294 . . . . 63.340000000000003 110.205 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.66 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 4.2 mp -83.68 99.89 6.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.069 -0.715 . . . . 71.040000000000006 109.069 178.451 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.3 t -91.01 106.7 17.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.609 -0.723 . . . . 64.329999999999998 111.097 -175.11 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -105.23 122.91 46.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.058 -0.519 . . . . 74.510000000000005 109.693 176.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 56.8 mt -101.55 118.12 47.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.286 -0.416 . . . . 73.150000000000006 110.524 -175.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -112.51 88.48 2.83 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.109 0.48 . . . . 54.140000000000001 110.492 178.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -95.33 88.54 5.16 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.195 -0.669 . . . . 62.210000000000001 109.195 175.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.405 ' HG3' ' HA ' ' A' ' 68' ' ' SER . 56.7 ttp180 -130.75 143.06 50.48 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.567 -0.742 . . . . 75.439999999999998 109.717 -177.117 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 37.7 t70 65.7 24.16 11.56 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.64 0.733 . . . . 71.019999999999996 110.664 174.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.24 5.15 90.26 Favored Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 115.577 -0.738 . . . . 75.319999999999993 112.623 178.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -104.4 134.4 47.68 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.873 0.368 . . . . 62.409999999999997 110.759 -179.622 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.491 ' HB2' ' HB ' ' A' ' 111' ' ' VAL . 4.5 mm? -91.97 96.34 10.31 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.867 -0.606 . . . . 52.240000000000002 109.39 174.628 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -106.33 110.0 22.1 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.327 0.584 . . . . 55.530000000000001 110.695 -179.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 35.8 tp -94.06 109.38 21.14 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.453 -0.794 . . . . 75.109999999999999 110.034 -178.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -97.82 93.06 6.15 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.949 0.404 . . . . 43.409999999999997 110.52 -179.056 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 56.0 t -85.01 103.63 12.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.143 0.497 . . . . 72.019999999999996 110.369 177.519 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.66 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 57.9 m -77.31 104.43 7.82 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.204 -0.665 . . . . 64.319999999999993 109.204 175.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -69.55 138.45 53.27 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.477 -0.783 . . . . 63.399999999999999 111.641 -174.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -108.02 -12.91 15.06 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.384 -0.825 . . . . 70.420000000000002 109.716 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -77.74 -55.86 4.99 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.813 -0.631 . . . . 73.140000000000001 110.714 -176.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 47.0 p -115.88 -23.15 8.73 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.387 0.613 . . . . 72.120000000000005 110.389 178.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 93.11 28.65 11.43 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.551 -0.75 . . . . 65.239999999999995 112.121 177.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -101.02 100.8 11.46 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 110.133 -0.321 . . . . 72.040000000000006 110.133 177.457 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 19.0 m -58.64 109.94 0.9 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.328 0.585 . . . . 61.32 110.867 -178.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 7.9 m -89.82 89.61 7.83 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.622 -0.717 . . . . 71.150000000000006 110.015 -178.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 45.4 m -83.46 109.3 17.23 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.931 -0.577 . . . . 61.340000000000003 110.317 178.289 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 58.9 mt -108.34 111.23 35.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.923 -0.58 . . . . 73.010000000000005 110.907 -177.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -88.96 118.54 28.76 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.981 0.42 . . . . 61.100000000000001 110.35 175.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.491 ' HB ' ' HB2' ' A' ' 94' ' ' LEU . 23.0 t . . . . . 0 C--N 1.322 -0.598 0 CA-C-N 115.925 -0.58 . . . . 75.109999999999999 109.839 178.211 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 . . . . . 0 C--O 1.232 0.153 0 CA-C-O 121.128 0.489 . . . . 65.319999999999993 110.189 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.7 87.7 3.77 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 115.612 -0.722 . . . . 60.32 110.767 175.248 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.521 ' CB ' ' HB2' ' A' ' 52' ' ' ASP . 50.7 Cg_endo -70.01 82.9 0.77 Allowed 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.037 1.825 . . . . 72.099999999999994 111.653 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.1 m -117.03 -8.96 11.17 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.82 -0.627 . . . . 71.450000000000003 110.792 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -165.42 -32.71 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.493 -0.321 . . . . 71.230000000000004 111.749 -176.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.402 ' O ' HG22 ' A' ' 55' ' ' THR . 3.9 pp -88.44 -10.07 50.4 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.846 0.313 . . . . 73.420000000000002 111.846 -177.723 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.521 ' HB2' ' CB ' ' A' ' 48' ' ' PRO . 17.4 t70 -56.52 -61.38 2.45 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.237 0.458 . . . . 63.020000000000003 112.237 -173.268 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -64.14 -33.3 75.47 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.039 -0.528 . . . . 73.010000000000005 110.763 -174.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.578 ' O ' HG13 ' A' ' 58' ' ' ILE . 72.3 t80 -70.76 -59.4 2.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.027 -0.533 . . . . 74.25 111.642 -176.615 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.402 HG22 ' O ' ' A' ' 51' ' ' LEU . 14.2 t -66.26 -23.78 66.46 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.773 0.32 . . . . 75.409999999999997 111.327 -173.162 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -82.72 -34.11 27.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.594 -0.275 . . . . 51.200000000000003 110.682 177.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.89 -28.35 69.48 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.824 -0.435 . . . . 74.219999999999999 109.824 175.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.586 ' HA ' ' HG2' ' A' ' 61' ' ' GLN . 25.5 mt -62.07 -35.48 68.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.063 -0.517 . . . . 75.030000000000001 110.35 176.076 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -68.57 -32.42 72.32 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.149 -0.478 . . . . 51.229999999999997 110.847 178.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.681 ' O ' HD22 ' A' ' 63' ' ' LEU . 23.0 m -79.99 -35.43 37.49 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.198 -0.456 . . . . 73.340000000000003 110.645 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.586 ' HG2' ' HA ' ' A' ' 58' ' ' ILE . 12.2 pt20 -78.39 -1.31 32.83 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.739 0.304 . . . . 64.209999999999994 111.545 -176.666 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.597 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 69.4 mt -60.69 -29.44 44.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.864 0.364 . . . . 75.120000000000005 110.421 177.183 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.685 HD23 ' N ' ' A' ' 64' ' ' GLY . 0.2 OUTLIER -61.05 -19.47 61.42 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.024 -0.535 . . . . 74.530000000000001 111.876 -177.385 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.685 ' N ' HD23 ' A' ' 63' ' ' LEU . . . -112.03 -32.3 2.45 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.404 -0.678 . . . . 54.140000000000001 111.404 175.292 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -63.55 -28.29 72.24 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 121.547 -0.358 . . . . 33.530000000000001 112.431 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.613 ' O ' HG12 ' A' ' 70' ' ' ILE . 73.6 mt -52.49 -47.69 66.41 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 120.59 0.233 . . . . 72.230000000000004 110.761 176.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.433 ' HB2' ' HD2' ' A' ' 90' ' ' ARG . 71.0 mt -61.31 -30.89 70.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.188 -0.46 . . . . 70.319999999999993 111.047 -176.321 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.9 m -76.9 -36.2 56.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.18 -0.464 . . . . 75.109999999999999 110.647 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -77.79 -26.11 49.46 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.368 -0.378 . . . . 53.439999999999998 110.647 -179.367 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.613 HG12 ' O ' ' A' ' 66' ' ' LEU . 30.6 mm . . . . . 0 C--N 1.331 -0.22 0 CA-C-N 116.121 -0.49 . . . . 71.409999999999997 110.331 177.051 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 56.3 ttp . . . . . 0 N--CA 1.447 -0.617 0 N-CA-C 109.603 -0.517 . . . . 73.310000000000002 109.603 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 48.8 t -71.01 102.11 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.599 -0.728 . . . . 63.219999999999999 109.721 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.413 ' HB ' ' O ' ' A' ' 83' ' ' TYR . 3.7 m -94.24 165.3 12.66 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.019 -0.734 . . . . 43.310000000000002 109.019 178.174 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -53.31 -31.45 44.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.872 0.368 . . . . 72.310000000000002 111.702 -178.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -139.73 -42.75 0.44 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.905 0.384 . . . . 75.510000000000005 110.647 -179.275 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.413 ' O ' ' HB ' ' A' ' 80' ' ' THR . 75.4 m-85 -76.84 144.31 39.15 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.839 -0.618 . . . . 63.340000000000003 111.54 -176.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.505 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 4.3 mp -110.66 100.15 10.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.331 -0.618 . . . . 71.040000000000006 109.331 175.741 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.605 HG22 HG23 ' A' ' 98' ' ' VAL . 12.6 t -106.49 98.4 6.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.279 -0.419 . . . . 64.329999999999998 110.806 -175.445 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -96.19 127.71 42.44 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.137 0.494 . . . . 74.510000000000005 110.24 179.256 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.542 HG23 HD21 ' A' ' 94' ' ' LEU . 60.9 mt -80.73 85.53 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.687 -0.688 . . . . 73.150000000000006 109.64 178.448 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.6 82.9 2.62 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.18 0.514 . . . . 54.140000000000001 111.665 -175.165 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -96.26 101.84 13.54 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.838 -0.619 . . . . 62.210000000000001 109.42 175.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.433 ' HD2' ' HB2' ' A' ' 67' ' ' LEU . 37.7 ttp180 -121.1 97.7 5.64 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.91 0.386 . . . . 75.439999999999998 111.083 -177.454 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 37.1 t70 60.1 82.47 0.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.8 -1.091 . . . . 71.019999999999996 111.427 175.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.93 -67.34 3.76 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.445 -0.798 . . . . 75.319999999999993 113.386 178.011 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 19.6 mm-40 -83.95 159.62 21.23 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.232 0.539 . . . . 62.409999999999997 111.126 -173.167 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.542 HD21 HG23 ' A' ' 87' ' ' ILE . 4.8 tt -135.47 134.3 39.43 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.805 -0.634 . . . . 52.240000000000002 109.609 -174.027 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.636 ' HG2' ' HG2' ' A' ' 110' ' ' GLN . 74.2 mt-30 -120.6 105.44 10.8 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.881 0.372 . . . . 55.530000000000001 110.096 175.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 43.6 tp -83.96 109.91 18.0 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.178 -0.465 . . . . 75.109999999999999 110.049 -178.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.534 ' HB3' HG23 ' A' ' 108' ' ' THR . 8.0 p30 -111.62 119.95 40.42 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.465 0.65 . . . . 43.409999999999997 111.22 -178.641 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.605 HG23 HG22 ' A' ' 85' ' ' VAL . 3.2 p -98.25 102.95 14.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.539 0.685 . . . . 72.019999999999996 109.478 173.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.86 ' HA ' HG22 ' A' ' 106' ' ' THR . 44.3 m -81.73 105.27 12.73 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.647 -0.706 . . . . 64.319999999999993 111.037 -177.329 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.533 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 11.4 t70 -72.42 143.82 48.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.517 -0.765 . . . . 63.399999999999999 109.769 173.369 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -109.17 -11.57 14.9 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.549 -0.296 . . . . 70.420000000000002 111.456 -178.538 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -81.05 -57.02 3.71 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.589 -0.444 . . . . 73.140000000000001 110.449 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 51.8 p -107.03 -27.45 10.63 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.094 0.473 . . . . 72.120000000000005 110.199 178.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.533 ' HA2' ' O ' ' A' ' 100' ' ' ASP . . . 91.48 20.37 38.17 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.662 -0.699 . . . . 65.239999999999995 112.661 175.657 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -76.49 95.93 3.97 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.681 -0.489 . . . . 72.040000000000006 109.681 177.03 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.86 HG22 ' HA ' ' A' ' 99' ' ' THR . 29.2 p -84.1 91.44 7.67 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.832 -0.622 . . . . 61.32 111.309 -177.003 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.444 ' HB3' ' CG1' ' A' ' 98' ' ' VAL . 33.1 t -67.14 101.55 0.9 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.129 -0.693 . . . . 71.150000000000006 109.129 176.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.534 HG23 ' HB3' ' A' ' 97' ' ' ASN . 10.1 m -104.24 107.04 17.77 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 116.033 -0.53 . . . . 61.340000000000003 110.056 -178.457 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 60.3 mt -106.69 114.36 45.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.864 -0.607 . . . . 73.010000000000005 110.353 -176.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.636 ' HG2' ' HG2' ' A' ' 95' ' ' GLN . 49.9 mt-30 -66.71 116.98 8.21 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.692 -0.484 . . . . 61.100000000000001 109.692 174.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.507 ' HB ' ' HB3' ' A' ' 94' ' ' LEU . 58.8 t . . . . . 0 C--N 1.322 -0.592 0 CA-C-O 121.465 0.65 . . . . 75.109999999999999 110.828 -173.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.2 mtt . . . . . 0 N--CA 1.48 1.063 0 CA-C-O 120.823 0.344 . . . . 75.5 110.429 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.87 162.43 29.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 74.230000000000004 111.058 -178.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -92.32 73.64 1.46 Allowed Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.85 -0.691 . . . . 65.140000000000001 112.138 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.3 p -74.01 119.41 18.18 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.512 0.196 . . . . 72.25 110.999 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.418 ' O ' ' N ' ' A' ' 7' ' ' PHE . 4.2 mpp? 67.61 -71.93 0.1 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.689 0.796 . . . . 75.430000000000007 111.305 -178.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.427 HG23 ' H ' ' A' ' 7' ' ' PHE . 15.2 t 51.56 -65.57 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.652 1.581 . . . . 74.209999999999994 113.435 -177.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.427 ' H ' HG23 ' A' ' 6' ' ' THR . 83.4 m-85 -89.81 -61.06 1.77 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.369 -0.604 . . . . 75.040000000000006 109.369 175.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 59.33 28.03 17.26 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.614 0.721 . . . . 73.409999999999997 111.181 176.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -108.71 98.41 7.92 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 121.981 -0.45 . . . . 73.239999999999995 110.124 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -125.68 -175.7 3.41 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.63 -0.713 . . . . 72.030000000000001 109.601 177.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.2 t30 63.67 84.92 0.18 Allowed Pre-proline 0 N--CA 1.467 0.39 0 O-C-N 123.737 0.648 . . . . 63.140000000000001 110.521 -177.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -81.43 131.56 7.56 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.942 2.428 . . . . 71.329999999999998 112.25 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.5 m120 70.58 103.35 0.06 Allowed 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.41 0.892 . . . . 75.430000000000007 113.41 176.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -90.72 146.06 24.3 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.461 -0.791 . . . . 75.230000000000004 109.14 166.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.86 -64.27 1.75 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.49 -0.862 . . . . 71.230000000000004 112.227 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 140.06 -178.66 19.66 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.956 -0.64 . . . . 73.329999999999998 111.8 -179.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -121.59 142.68 36.26 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.705 0.253 . . . . 72.140000000000001 110.62 -178.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -90.89 152.01 3.99 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.931 2.421 . . . . 61.409999999999997 112.874 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -99.11 153.6 18.77 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.188 -0.671 . . . . 74.519999999999996 109.188 176.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -128.63 157.7 40.58 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.946 0.403 . . . . 74.239999999999995 110.944 -178.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -105.41 5.12 40.87 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.736 -0.745 . . . . 62.439999999999998 111.973 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 72.15 -55.5 0.67 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.773 0.829 . . . . 64.099999999999994 111.57 -178.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 56.39 45.95 21.8 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.102 0.477 . . . . 71.25 111.35 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.4 pp -77.23 -6.38 52.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.043 -0.526 . . . . 62.32 111.191 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 89.5 mt 63.9 174.26 0.18 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.503 -0.771 . . . . 52.439999999999998 112.618 174.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 -127.25 -82.51 0.61 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.662 -0.699 . . . . 73.200000000000003 109.384 175.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.9 p -172.12 134.93 0.75 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.259 -0.882 . . . . 71.349999999999994 109.092 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -138.36 116.9 12.09 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.842 0.353 . . . . 74.120000000000005 111.279 -177.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 13.9 tm0? -108.01 -36.34 6.37 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.478 -0.564 . . . . 65.310000000000002 109.478 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.409 ' HB2' ' HB2' ' A' ' 54' ' ' PHE . . . 75.51 -37.49 0.33 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.749 0.82 . . . . 75.25 112.759 173.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.683 ' HG2' ' H ' ' A' ' 32' ' ' ASN . 2.0 pm0 44.78 -84.76 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.794 1.238 . . . . 75.530000000000001 114.066 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.683 ' H ' ' HG2' ' A' ' 31' ' ' GLN . 39.6 t-20 -111.97 134.41 53.55 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.665 0.269 . . . . 64.010000000000005 110.677 -171.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.421 ' C ' ' H ' ' A' ' 35' ' ' LYS . 5.6 p -64.55 -51.53 62.35 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.746 -0.464 . . . . 74.209999999999994 109.746 174.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 57.9 t80 71.9 -25.4 0.18 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.793 0.837 . . . . 74.430000000000007 112.282 173.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.552 ' HG2' HG21 ' A' ' 47' ' ' THR . 22.8 tptm -140.35 31.19 1.92 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.256 0.551 . . . . 71.430000000000007 109.719 -178.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.454 ' HB2' ' HD2' ' A' ' 37' ' ' PRO . 2.9 p30 -61.18 156.9 46.97 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.088 -0.505 . . . . 74.530000000000001 111.288 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.454 ' HD2' ' HB2' ' A' ' 36' ' ' ASP . 9.5 Cg_endo -50.95 142.98 32.16 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.497 2.798 . . . . 70.219999999999999 113.851 -178.079 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 29.8 t -139.31 135.64 34.01 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.2 -0.909 . . . . 62.109999999999999 109.325 178.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 59.4 t80 56.86 68.72 0.82 Allowed 'General case' 0 C--O 1.234 0.252 0 O-C-N 123.778 0.674 . . . . 74.420000000000002 110.485 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 17.2 m120 63.06 24.29 14.41 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.422 -0.808 . . . . 75.200000000000003 110.784 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.42 ' HB2' ' HB3' ' A' ' 37' ' ' PRO . 26.8 t70 63.52 105.98 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.538 -0.755 . . . . 75.340000000000003 111.625 -175.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -88.2 -42.24 12.43 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.851 -0.613 . . . . 70.120000000000005 109.863 175.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -169.38 19.36 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.854 -0.612 . . . . 75.219999999999999 110.133 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -73.17 -38.38 54.54 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.506 -0.854 . . . . 74.519999999999996 112.182 -172.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.3 mt -76.82 -18.45 14.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.665 0.745 . . . . 75.239999999999995 109.834 -178.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -95.6 8.91 42.02 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.484 -0.78 . . . . 65.319999999999993 111.338 -177.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.552 HG21 ' HG2' ' A' ' 35' ' ' LYS . 9.8 m -115.97 86.57 16.85 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 120.725 0.298 . . . . 60.32 110.304 175.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -77.37 84.57 1.93 Allowed 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.122 1.881 . . . . 72.099999999999994 111.896 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.7 m -86.07 -80.15 0.24 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.896 -0.593 . . . . 71.450000000000003 111.159 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -93.84 -37.85 11.54 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.807 0.337 . . . . 71.230000000000004 111.355 -177.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.582 HD23 ' H ' ' A' ' 51' ' ' LEU . 1.7 pt? -66.64 -13.83 61.68 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.01 -0.541 . . . . 73.420000000000002 111.273 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -49.01 -53.46 19.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.674 -0.694 . . . . 63.020000000000003 112.509 -175.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.45 -30.96 67.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.826 0.346 . . . . 73.010000000000005 111.349 -178.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.496 ' O ' HG13 ' A' ' 58' ' ' ILE . 67.2 t80 -67.23 -44.64 78.96 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.192 -0.458 . . . . 74.25 110.407 -178.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 87.0 m -55.34 -37.2 67.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.425 0.631 . . . . 75.409999999999997 111.557 178.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -80.19 -31.7 38.73 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.796 -0.638 . . . . 51.200000000000003 110.771 -174.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.81 -25.19 68.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.031 -0.532 . . . . 74.219999999999999 110.263 175.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.531 ' O ' HG13 ' A' ' 62' ' ' ILE . 2.5 mt -86.28 -45.37 16.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.974 -0.557 . . . . 75.030000000000001 110.968 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.454 ' HA ' HD12 ' A' ' 62' ' ' ILE . 76.1 mt-30 -59.14 -30.45 68.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.769 0.319 . . . . 51.229999999999997 111.283 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.5 m -66.58 -37.96 86.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.352 -0.386 . . . . 73.340000000000003 111.152 178.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.527 ' HG2' ' O ' ' A' ' 58' ' ' ILE . 11.1 pt20 -83.19 -20.9 33.8 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.794 0.33 . . . . 64.209999999999994 110.943 -178.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.531 HG13 ' O ' ' A' ' 58' ' ' ILE . 83.9 mt -66.5 -31.1 52.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.996 0.427 . . . . 75.120000000000005 109.894 177.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 91.9 mt -57.65 -32.85 67.69 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.734 -0.666 . . . . 74.530000000000001 110.933 178.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -74.51 -40.47 39.05 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.993 -0.623 . . . . 54.140000000000001 111.602 176.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -63.71 -25.99 69.49 Favored Glycine 0 C--N 1.33 0.2 0 C-N-CA 120.992 -0.623 . . . . 33.530000000000001 112.286 178.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 62' ' ' ILE . 91.8 mt -66.22 -18.34 65.29 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.706 0.289 . . . . 72.230000000000004 110.916 178.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 93.7 mt -85.59 5.97 29.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.076 0.465 . . . . 70.319999999999993 110.563 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.9 t -126.11 -42.21 1.88 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.947 -0.57 . . . . 75.109999999999999 110.587 179.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.414 ' ND2' HD21 ' A' ' 97' ' ' ASN . 86.7 m-20 -75.73 5.36 6.34 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.699 0.629 . . . . 53.439999999999998 112.699 -173.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.402 HG12 ' O ' ' A' ' 66' ' ' LEU . 50.4 mm -99.73 -13.57 8.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.653 0.739 . . . . 71.409999999999997 109.664 176.016 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -98.59 8.92 44.32 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.589 -0.732 . . . . 61.43 110.678 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.2 p -86.77 -164.18 1.03 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.851 -0.613 . . . . 53.310000000000002 110.45 178.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 122.07 7.74 7.65 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.7 -0.762 . . . . 71.019999999999996 112.311 -177.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -57.44 148.12 56.06 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 120.665 0.269 . . . . 51.439999999999998 111.262 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.68 -10.34 23.38 Favored 'Trans proline' 0 CA--C 1.532 0.407 0 C-N-CA 122.587 2.191 . . . . 65.030000000000001 112.666 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -83.74 56.12 5.04 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 121.131 -0.557 . . . . 72.120000000000005 112.435 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -106.68 -176.01 2.96 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.003 -0.369 . . . . 45.020000000000003 110.003 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.464 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 27.6 ttt -122.42 115.63 22.58 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.729 0.3 . . . . 73.310000000000002 110.472 178.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 53.1 t -85.5 97.65 5.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.373 0.606 . . . . 63.219999999999999 110.696 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.697 ' HB ' ' O ' ' A' ' 83' ' ' TYR . 6.7 m -113.65 148.86 35.53 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.307 -0.86 . . . . 43.310000000000002 108.854 177.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -73.52 -59.64 2.62 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.007 0.373 . . . . 72.310000000000002 112.007 -170.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -82.82 -14.16 54.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.795 0.331 . . . . 75.510000000000005 111.448 -174.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.697 ' O ' ' HB ' ' A' ' 80' ' ' THR . 59.4 m-85 -133.99 121.3 21.41 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.334 -0.394 . . . . 63.340000000000003 110.482 -177.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.569 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 2.9 mp -81.91 102.56 7.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.089 -0.708 . . . . 71.040000000000006 109.089 175.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.464 ' HB ' ' HB3' ' A' ' 78' ' ' MET . 47.3 t -96.69 94.31 4.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.715 -0.675 . . . . 64.329999999999998 110.769 -176.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -98.45 115.62 28.91 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.343 -0.614 . . . . 74.510000000000005 109.343 178.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 71.6 mt -82.02 94.66 2.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.939 -0.573 . . . . 73.150000000000006 110.673 -176.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.05 74.54 8.08 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.687 -0.688 . . . . 54.140000000000001 111.102 -177.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -88.59 92.73 9.31 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.147 -0.686 . . . . 62.210000000000001 109.147 173.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.441 ' HA ' ' HD2' ' A' ' 90' ' ' ARG . 13.6 tpt180 -133.68 154.16 51.14 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.818 -0.628 . . . . 75.439999999999998 109.726 -178.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.9 t70 69.93 -68.18 0.21 Allowed 'General case' 0 N--CA 1.465 0.317 0 O-C-N 124.082 0.864 . . . . 71.019999999999996 111.151 178.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 177.74 23.62 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.736 -0.745 . . . . 75.319999999999993 113.433 178.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -138.1 152.5 48.83 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 122.265 -0.55 . . . . 62.409999999999997 110.264 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -89.61 94.58 9.91 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.761 -0.459 . . . . 52.240000000000002 109.761 176.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.474 ' HG2' ' OD1' ' A' ' 97' ' ' ASN . 7.3 tt0 -97.31 109.29 22.08 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.137 0.494 . . . . 55.530000000000001 109.692 -179.102 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.543 ' HB3' ' HB ' ' A' ' 109' ' ' ILE . 29.0 tp -90.11 98.64 11.89 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.868 -0.605 . . . . 75.109999999999999 110.389 -177.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.483 ' OD1' HG23 ' A' ' 108' ' ' THR . 6.5 m-20 -90.61 93.44 9.27 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.283 0.564 . . . . 43.409999999999997 110.532 -179.008 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.439 ' CG1' ' HD1' ' A' ' 83' ' ' TYR . 56.1 t -92.8 114.18 29.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.658 -0.701 . . . . 72.019999999999996 110.677 178.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.569 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 30.7 m -103.32 109.23 20.77 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.845 -0.616 . . . . 64.319999999999993 110.077 178.027 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.587 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 25.2 t70 -62.32 141.23 58.4 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.489 -0.323 . . . . 63.399999999999999 110.777 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.07 -26.69 19.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.259 -0.428 . . . . 70.420000000000002 110.251 -177.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 32.7 mtmm -70.04 -69.58 0.34 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.374 -0.375 . . . . 73.140000000000001 111.149 -174.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 12.0 t -99.05 -26.8 14.11 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.243 0.544 . . . . 72.120000000000005 109.716 -179.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.587 ' HA2' ' O ' ' A' ' 100' ' ' ASP . . . 83.65 79.45 1.06 Allowed Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.544 -0.753 . . . . 65.239999999999995 112.909 176.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.491 ' H ' ' HB3' ' A' ' 100' ' ' ASP . 68.6 mm-40 -124.69 144.16 50.36 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.587 -0.523 . . . . 72.040000000000006 109.587 174.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.9 m -89.05 96.11 10.59 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.123 0.487 . . . . 61.32 110.724 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.435 ' HB3' ' HB ' ' A' ' 98' ' ' VAL . 47.4 t -88.17 80.83 7.51 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.454 -0.573 . . . . 71.150000000000006 109.454 177.23 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.483 HG23 ' OD1' ' A' ' 97' ' ' ASN . 28.2 m -82.35 101.49 10.62 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.901 -0.591 . . . . 61.340000000000003 110.709 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.543 ' HB ' ' HB3' ' A' ' 96' ' ' LEU . 54.5 mt -99.88 92.34 2.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.052 -0.522 . . . . 73.010000000000005 110.514 -178.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -72.56 106.91 4.81 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.723 -0.473 . . . . 61.100000000000001 109.723 175.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.2 t -76.23 104.75 4.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.688 -0.486 . . . . 75.109999999999999 109.688 177.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.3 t -147.86 125.46 11.77 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.749 -0.659 . . . . 73.519999999999996 110.31 -178.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 92.77 52.7 2.07 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.915 -0.66 . . . . 53.210000000000001 113.035 175.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 77.4 mt -106.16 -75.81 0.62 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.011 -0.366 . . . . 71.239999999999995 110.011 174.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 66.38 15.33 10.06 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.605 -0.725 . . . . 62.340000000000003 111.202 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -100.78 93.49 5.58 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.632 0.729 . . . . 63.439999999999998 109.705 173.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -105.26 101.74 11.27 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.496 -0.775 . . . . 61.130000000000003 110.547 -176.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 38.3 m -83.3 101.8 11.53 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.306 -0.628 . . . . 75.219999999999999 109.306 174.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -57.8 120.27 8.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.983 -0.553 . . . . 73.200000000000003 110.587 -177.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -120.92 116.21 24.69 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.84 -0.618 . . . . 62.409999999999997 110.352 -177.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -141.08 95.32 2.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.21 -0.45 . . . . 75.239999999999995 110.494 178.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 26.0 m80 63.95 -168.96 0.2 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.884 -0.598 . . . . 74.340000000000003 111.325 175.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 37.8 m80 58.42 46.71 14.8 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.811 -0.632 . . . . 64.150000000000006 110.991 176.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -84.09 11.36 8.14 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.681 -0.69 . . . . 75.209999999999994 111.035 -177.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 23.7 t-80 -139.57 109.64 6.44 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.221 -0.445 . . . . 71.409999999999997 109.879 175.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -147.14 139.2 24.45 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.692 -0.685 . . . . 73.129999999999995 109.998 176.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.619 -0.705 . . . . 54.43 109.56 -176.022 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.046 0 CA-C-O 120.864 0.364 . . . . 75.5 110.273 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -99.96 141.34 32.91 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.942 0.401 . . . . 74.230000000000004 111.374 -176.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -137.09 81.69 0.28 Allowed Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 111.193 -0.763 . . . . 65.140000000000001 111.193 177.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.8 t -100.21 -10.4 21.41 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.528 0.204 . . . . 72.25 111.046 -175.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 4.8 mpp? 58.5 -167.17 0.15 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.083 -0.508 . . . . 75.430000000000007 110.558 -177.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 16.2 m -141.53 -78.26 0.27 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.608 -0.269 . . . . 74.209999999999994 110.452 175.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.426 ' HB3' ' HE2' ' A' ' 9' ' ' PHE . 69.6 m-85 65.63 114.44 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 O-C-N 123.918 0.761 . . . . 75.040000000000006 111.327 -178.295 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -111.26 112.63 24.55 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.518 0.675 . . . . 73.409999999999997 111.208 -177.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.426 ' HE2' ' HB3' ' A' ' 7' ' ' PHE . 96.1 m-85 -118.69 99.77 6.99 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.01 -0.541 . . . . 73.239999999999995 110.837 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.461 ' O ' ' HB2' ' A' ' 11' ' ' ASN . 73.0 mtp180 -111.47 -17.19 13.15 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.228 -0.442 . . . . 72.030000000000001 109.809 174.173 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 10' ' ' ARG . 40.6 m-80 73.37 155.96 0.16 Allowed Pre-proline 0 N--CA 1.466 0.356 0 O-C-N 123.943 0.777 . . . . 63.140000000000001 111.067 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.94 -45.17 43.0 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.091 2.528 . . . . 71.329999999999998 113.424 -177.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.3 t30 72.4 154.94 0.15 Allowed 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.78 0.675 . . . . 75.430000000000007 110.459 -178.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 65.11 -175.0 0.18 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.279 0.562 . . . . 75.230000000000004 111.414 -178.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -166.57 38.82 0.25 Allowed Glycine 0 N--CA 1.448 -0.501 0 N-CA-C 111.213 -0.755 . . . . 71.230000000000004 111.213 176.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 110.58 150.76 12.49 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.959 -0.639 . . . . 73.329999999999998 111.66 -176.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.406 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 91.1 m-20 -94.81 151.52 39.08 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 110.151 -0.314 . . . . 72.140000000000001 110.151 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 17' ' ' ASN . 5.0 Cg_exo -75.95 74.67 4.39 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.726 2.284 . . . . 61.409999999999997 111.792 178.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -96.85 -162.06 0.92 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.017 -0.538 . . . . 74.519999999999996 110.729 -177.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 44.9 88.57 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.686 0.995 . . . . 74.239999999999995 113.686 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.51 -27.9 73.58 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.544 -0.753 . . . . 62.439999999999998 111.232 173.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 75.09 -59.77 0.53 Allowed 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.917 0.887 . . . . 64.099999999999994 112.271 173.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 27.2 t80 67.65 97.17 0.06 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.553 0.692 . . . . 71.25 110.734 -177.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.0 mp -106.12 -175.28 2.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.448 -0.796 . . . . 62.32 110.954 -177.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 75.6 mt 58.63 72.47 0.52 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.324 -0.853 . . . . 52.439999999999998 111.638 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.503 ' O ' ' HA ' ' A' ' 49' ' ' SER . 93.0 m-20 -124.43 89.54 3.09 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.08 -0.711 . . . . 73.200000000000003 109.08 175.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.2 m -71.43 93.5 1.17 Allowed 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.266 0.555 . . . . 71.349999999999994 110.902 -176.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -88.94 149.18 23.42 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.646 -0.706 . . . . 74.120000000000005 109.796 177.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -84.36 51.93 2.22 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.067 0.461 . . . . 65.310000000000002 111.482 -173.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.64 -35.92 22.33 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.963 -0.562 . . . . 75.25 110.06 177.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.444 ' HG2' ' H ' ' A' ' 32' ' ' ASN . 6.4 tt0 63.11 -167.39 0.21 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.388 -0.824 . . . . 75.530000000000001 111.357 177.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.444 ' H ' ' HG2' ' A' ' 31' ' ' GLN . 15.5 m120 73.21 168.58 0.31 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.301 0.64 . . . . 64.010000000000005 111.067 -176.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.5 m -86.36 -21.92 26.94 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.438 0.533 . . . . 74.209999999999994 112.438 -172.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -133.07 105.14 6.88 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.581 -0.448 . . . . 74.430000000000007 111.236 -174.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.444 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 25.1 tptp -132.66 108.46 9.06 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.955 -0.757 . . . . 71.430000000000007 108.955 174.091 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.527 ' HB2' ' HD2' ' A' ' 37' ' ' PRO . 4.0 p-10 -140.65 166.08 25.47 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 115.998 -0.546 . . . . 74.530000000000001 110.173 -173.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.527 ' HD2' ' HB2' ' A' ' 36' ' ' ASP . 21.2 Cg_endo -61.6 -26.52 80.54 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.192 1.928 . . . . 70.219999999999999 111.629 176.071 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.2 m 68.07 -74.6 0.07 Allowed 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.414 -0.812 . . . . 62.109999999999999 110.807 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -143.71 167.0 23.31 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.735 -0.468 . . . . 74.420000000000002 109.735 177.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 70.09 90.35 0.1 Allowed 'General case' 0 C--O 1.234 0.245 0 O-C-N 123.707 0.629 . . . . 75.200000000000003 110.379 178.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.7 t0 62.69 93.41 0.05 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.159 -0.928 . . . . 75.340000000000003 110.669 -176.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -85.09 30.09 0.61 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.242 -0.89 . . . . 70.120000000000005 110.996 -172.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -66.1 -25.31 66.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.82 0.343 . . . . 75.219999999999999 110.859 -177.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.568 ' HA2' ' OG1' ' A' ' 47' ' ' THR . . . -64.43 -16.67 60.96 Favored Glycine 0 C--N 1.332 0.339 0 CA-C-N 115.826 -0.625 . . . . 74.519999999999996 113.406 -174.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 62.4 mt -64.99 -25.19 37.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.313 0.578 . . . . 75.239999999999995 110.63 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -112.28 11.82 20.19 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.937 -0.574 . . . . 65.319999999999993 110.923 -176.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.568 ' OG1' ' HA2' ' A' ' 44' ' ' GLY . 47.0 p -124.75 86.7 55.69 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.492 -0.322 . . . . 60.32 110.943 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.405 ' HA ' ' HG ' ' A' ' 51' ' ' LEU . 32.0 Cg_exo -57.66 98.94 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.81 2.34 . . . . 72.099999999999994 112.702 -177.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.503 ' HA ' ' O ' ' A' ' 26' ' ' ASN . 14.3 m -104.4 -46.83 4.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.613 -0.721 . . . . 71.450000000000003 110.375 176.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.444 ' HB3' ' HB3' ' A' ' 35' ' ' LYS . . . -131.68 -2.65 3.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.466 0.65 . . . . 71.230000000000004 110.303 174.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.484 HD23 ' H ' ' A' ' 51' ' ' LEU . 0.7 OUTLIER -95.46 0.55 53.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.672 -0.695 . . . . 73.420000000000002 110.394 -178.728 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -68.28 -40.83 81.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.142 -0.481 . . . . 63.020000000000003 109.977 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -63.69 -30.73 71.79 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.711 -0.677 . . . . 73.010000000000005 110.368 176.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -83.14 -51.57 7.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.819 -0.628 . . . . 74.25 111.322 -177.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.0 t -69.05 -26.43 64.96 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.046 0.387 . . . . 75.409999999999997 112.046 -173.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -77.3 -19.87 55.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.86 0.362 . . . . 51.200000000000003 110.433 178.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.51 -18.41 48.6 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.477 0.656 . . . . 74.219999999999999 109.683 175.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.469 ' O ' HG13 ' A' ' 62' ' ' ILE . 13.3 mt -77.04 -32.22 19.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.636 -0.711 . . . . 75.030000000000001 110.182 177.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -61.64 -27.88 68.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 51.229999999999997 110.795 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.635 ' O ' HD22 ' A' ' 63' ' ' LEU . 5.9 m -75.87 -43.15 46.95 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.21 -0.45 . . . . 73.340000000000003 110.691 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.41 ' HG2' ' O ' ' A' ' 58' ' ' ILE . 21.0 pt20 -74.53 -3.81 33.12 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.484 -0.326 . . . . 64.209999999999994 111.641 -173.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 58' ' ' ILE . 64.7 mt -66.9 -17.8 23.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.287 0.565 . . . . 75.120000000000005 110.0 174.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.635 HD22 ' O ' ' A' ' 60' ' ' SER . 0.5 OUTLIER -63.75 -19.21 64.79 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.857 -0.611 . . . . 74.530000000000001 111.199 -179.024 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.613 ' N ' HD23 ' A' ' 63' ' ' LEU . . . -81.68 -30.37 36.25 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 111.101 -0.8 . . . . 54.140000000000001 111.101 176.165 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -69.77 -26.02 74.89 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.081 -0.808 . . . . 33.530000000000001 111.081 175.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.493 ' HA ' HD11 ' A' ' 70' ' ' ILE . 86.8 mt -70.49 -5.45 28.86 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.089 0.471 . . . . 72.230000000000004 110.647 176.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 87.4 mt -109.41 -66.69 1.04 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.925 -0.579 . . . . 70.319999999999993 110.952 178.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 17.8 m -98.51 15.41 25.03 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.865 0.691 . . . . 75.109999999999999 112.865 -171.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -129.45 20.73 5.66 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.539 0.685 . . . . 53.439999999999998 110.197 178.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.493 HD11 ' HA ' ' A' ' 66' ' ' LEU . 45.2 mm -93.18 -7.12 10.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-O 121.629 0.728 . . . . 71.409999999999997 109.319 178.149 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 -52.13 -61.35 2.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.946 -1.025 . . . . 61.43 110.233 177.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 75.4 p 51.98 24.17 2.5 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.619 0.768 . . . . 53.310000000000002 112.996 175.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -76.08 -19.46 78.57 Favored Glycine 0 N--CA 1.454 -0.157 0 C-N-CA 120.768 -0.729 . . . . 71.019999999999996 112.883 -178.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.9 150.24 39.46 Favored Pre-proline 0 CA--C 1.532 0.278 0 N-CA-C 111.951 0.352 . . . . 51.439999999999998 111.951 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -72.77 -4.91 16.22 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.87 2.38 . . . . 65.030000000000001 113.333 -177.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 120.74 -114.95 2.77 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.77 -0.729 . . . . 72.120000000000005 112.163 178.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.403 ' HB2' ' O ' ' A' ' 85' ' ' VAL . 6.5 ptp180 -132.5 -176.13 3.99 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.113 -0.329 . . . . 45.020000000000003 110.113 -178.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 59.6 ttp -116.68 116.2 27.09 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.299 -0.63 . . . . 73.310000000000002 109.299 172.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 58.5 t -67.4 103.52 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.096 0.474 . . . . 63.219999999999999 111.202 -178.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -108.19 167.6 9.9 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.686 -0.688 . . . . 43.310000000000002 110.987 176.314 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -64.28 -73.88 0.11 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.499 -0.318 . . . . 72.310000000000002 111.809 -174.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -120.6 32.96 5.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.809 0.814 . . . . 75.510000000000005 109.873 -178.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -125.85 144.17 50.77 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.174 -0.921 . . . . 63.340000000000003 110.243 177.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.562 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 4.4 mp -108.55 100.48 10.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.172 -0.677 . . . . 71.040000000000006 109.172 175.364 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.403 ' O ' ' HB2' ' A' ' 77' ' ' ARG . 3.9 p -125.28 110.72 25.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.579 0.704 . . . . 64.329999999999998 110.973 -177.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -110.38 143.95 39.87 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.477 -0.783 . . . . 74.510000000000005 109.858 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 59.5 mt -87.13 98.68 7.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 109.641 -0.503 . . . . 73.150000000000006 109.641 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -88.26 89.44 7.99 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.888 -0.596 . . . . 54.140000000000001 111.146 -176.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.481 ' HA ' ' O ' ' A' ' 93' ' ' GLN . 15.0 t30 -84.97 77.43 10.11 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.901 -0.778 . . . . 62.210000000000001 108.901 172.321 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.411 ' O ' ' HB3' ' A' ' 91' ' ' ASP . 47.3 ttp180 -102.6 144.45 30.99 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.737 -1.12 . . . . 75.439999999999998 109.107 -178.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.411 ' HB3' ' O ' ' A' ' 90' ' ' ARG . 11.4 t70 69.05 -67.78 0.2 Allowed 'General case' 0 N--CA 1.467 0.384 0 O-C-N 123.726 0.641 . . . . 71.019999999999996 110.664 -177.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 172.34 31.54 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.297 -0.721 . . . . 75.319999999999993 111.297 178.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.481 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 26.2 mm-40 -136.82 150.06 48.1 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.048 -0.353 . . . . 62.409999999999997 110.048 -178.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.448 ' HB2' ' HB ' ' A' ' 111' ' ' VAL . 3.6 mm? -88.24 101.92 14.32 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.102 -0.333 . . . . 52.240000000000002 110.102 178.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.403 ' HG2' ' ND2' ' A' ' 97' ' ' ASN . 41.2 tt0 -104.74 121.53 43.81 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.012 0.434 . . . . 55.530000000000001 110.245 178.294 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 15.7 tp -103.94 102.68 12.47 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.16 -0.473 . . . . 75.109999999999999 110.169 -177.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.403 ' ND2' ' HG2' ' A' ' 95' ' ' GLN . 20.1 m-80 -96.46 115.25 27.13 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.42 -0.355 . . . . 43.409999999999997 110.723 -177.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 39.7 t -99.61 111.26 28.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.171 -0.468 . . . . 72.019999999999996 110.821 178.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.562 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 43.6 m -97.75 110.59 23.13 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.813 -0.63 . . . . 64.319999999999993 110.391 177.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.489 ' HB3' ' H ' ' A' ' 105' ' ' GLN . 7.1 t70 -71.34 124.97 25.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.941 -0.572 . . . . 63.399999999999999 109.923 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.489 ' HD3' ' O ' ' A' ' 101' ' ' ARG . 3.1 tmt_? -82.84 -28.69 29.96 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.599 0.238 . . . . 70.420000000000002 110.639 -176.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -84.77 -58.4 2.73 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.491 0.663 . . . . 73.140000000000001 110.804 -175.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.7 m -88.68 -25.34 22.42 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.989 -1.005 . . . . 72.120000000000005 110.83 -172.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.97 69.32 1.41 Allowed Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.704 -0.68 . . . . 65.239999999999995 113.214 177.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.489 ' H ' ' HB3' ' A' ' 100' ' ' ASP . 44.7 mt-30 -136.82 144.75 43.82 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.993 -0.743 . . . . 72.040000000000006 108.993 176.338 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.2 t -110.77 94.41 4.98 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.982 0.896 . . . . 61.32 110.446 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 27.0 t -87.26 113.23 22.8 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.457 -0.792 . . . . 71.150000000000006 109.371 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 41.9 m -103.62 111.39 23.85 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.925 -0.58 . . . . 61.340000000000003 111.219 -176.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.401 HD12 ' N ' ' A' ' 109' ' ' ILE . 4.5 mp -108.34 109.47 28.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.097 -0.501 . . . . 73.010000000000005 109.649 178.061 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -91.61 153.83 19.46 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.017 0.436 . . . . 61.100000000000001 111.491 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.448 ' HB ' ' HB2' ' A' ' 94' ' ' LEU . 4.4 p -54.71 111.12 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.177 -0.92 . . . . 75.109999999999999 111.683 -179.068 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.8 m -135.81 137.03 41.14 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.154 -0.93 . . . . 73.519999999999996 108.839 177.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 173.2 -108.96 0.29 Allowed Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.103 -1.046 . . . . 53.210000000000001 112.854 -177.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 87.4 mt -97.73 78.87 2.64 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.947 0.403 . . . . 71.239999999999995 111.154 -174.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -115.66 -10.81 11.77 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.126 0.489 . . . . 62.340000000000003 110.294 177.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -112.01 173.22 6.46 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.081 -0.509 . . . . 63.439999999999998 110.514 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -108.86 133.74 52.48 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.171 -0.468 . . . . 61.130000000000003 111.405 -178.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 24.3 m -86.81 112.77 22.04 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.078 -0.51 . . . . 75.219999999999999 110.343 174.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 17.6 m -100.23 112.54 24.87 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.506 -0.316 . . . . 73.200000000000003 110.413 177.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -90.72 74.43 6.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.952 0.406 . . . . 62.409999999999997 110.735 -177.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -149.04 124.69 10.44 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.189 -0.46 . . . . 75.239999999999995 110.459 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -144.72 113.96 7.0 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.491 -0.559 . . . . 74.340000000000003 109.491 177.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 30.3 t60 -66.46 139.4 57.97 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.692 -0.484 . . . . 64.150000000000006 109.692 176.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 26.3 m80 -67.97 118.07 10.67 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.114 0.483 . . . . 75.209999999999994 111.655 -176.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 53.9 m80 -120.97 129.67 53.52 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.546 -0.752 . . . . 71.409999999999997 109.259 175.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.541 ' O ' ' HB2' ' A' ' 127' ' ' HIS . 45.9 p-80 -74.47 156.73 36.62 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.945 -0.391 . . . . 73.129999999999995 109.945 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.541 ' HB2' ' O ' ' A' ' 126' ' ' HIS . 15.8 m80 . . . . . 0 C--O 1.247 0.951 0 O-C-N 124.039 0.837 . . . . 54.43 110.56 -171.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.203 0 CA-C-O 120.318 0.104 . . . . 75.5 111.132 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 65.43 -168.97 0.2 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.032 0.444 . . . . 74.230000000000004 111.711 176.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 120.88 -15.62 9.55 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 121.003 -0.618 . . . . 65.140000000000001 111.82 -177.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 35.2 m -73.33 85.13 1.44 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.349 0.595 . . . . 72.25 111.148 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 85.3 mtp -128.88 93.2 3.55 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.531 -0.759 . . . . 75.430000000000007 109.132 173.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 48.2 p -94.69 -17.26 22.4 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.013 -0.54 . . . . 74.209999999999994 111.37 -175.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 68.07 -58.25 0.46 Allowed 'General case' 0 N--CA 1.466 0.326 0 O-C-N 123.932 0.77 . . . . 75.040000000000006 110.747 -176.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 72.51 -64.18 0.4 Allowed 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.804 0.842 . . . . 73.409999999999997 112.129 173.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 62.35 -172.14 0.16 Allowed 'General case' 0 C--O 1.234 0.274 0 O-C-N 123.629 0.581 . . . . 73.239999999999995 110.286 -175.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -147.93 -43.79 0.16 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.367 -0.379 . . . . 72.030000000000001 110.684 175.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 68.94 146.9 0.11 Allowed Pre-proline 0 N--CA 1.468 0.471 0 O-C-N 123.734 0.646 . . . . 63.140000000000001 111.882 177.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -68.98 -46.79 1.39 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.43 2.087 . . . . 71.329999999999998 111.462 176.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 68.03 120.31 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 O-C-N 124.257 0.973 . . . . 75.430000000000007 112.208 178.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 90.0 t80 72.11 121.14 0.04 OUTLIER 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.847 0.832 . . . . 75.230000000000004 112.03 177.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -140.19 -165.41 10.28 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 114.857 -1.065 . . . . 71.230000000000004 110.584 174.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 132.12 174.7 13.71 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.466 -0.873 . . . . 73.329999999999998 112.471 176.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -106.64 143.67 27.5 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 110.36 -0.237 . . . . 72.140000000000001 110.36 -178.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.75 126.83 10.39 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.457 2.105 . . . . 61.409999999999997 112.126 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -90.55 101.78 14.52 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.708 -0.478 . . . . 74.519999999999996 109.708 176.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -115.39 117.39 30.28 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.883 -0.599 . . . . 74.239999999999995 110.83 -176.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.81 157.34 23.52 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.749 -0.739 . . . . 62.439999999999998 111.992 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.93 142.72 38.21 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.932 0.396 . . . . 64.099999999999994 110.783 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -123.54 114.68 20.39 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.866 -0.607 . . . . 71.25 109.684 178.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.618 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 99.0 mt -130.58 133.42 46.18 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.451 -0.341 . . . . 62.32 111.484 -176.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.618 ' HG ' ' O ' ' A' ' 24' ' ' LEU . 4.6 pp 53.5 -179.87 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.671 1.189 . . . . 52.439999999999998 114.145 174.188 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -173.54 121.29 0.34 Allowed 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.133 -0.94 . . . . 73.200000000000003 108.855 178.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.3 t -68.65 116.68 9.44 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.001 -0.37 . . . . 71.349999999999994 110.001 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -144.08 114.95 7.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.873 0.368 . . . . 74.120000000000005 111.419 -176.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 24.9 tp60 -102.14 77.55 1.69 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.874 -0.603 . . . . 65.310000000000002 109.505 175.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -147.25 117.24 7.23 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.216 -0.447 . . . . 75.25 110.942 -177.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 43.62 38.88 2.1 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.176 0.99 . . . . 75.530000000000001 112.213 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 21.9 p-10 -121.46 179.54 4.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.25 -0.886 . . . . 64.010000000000005 109.668 178.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 30.0 m 71.56 -47.86 0.67 Allowed 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.318 0.647 . . . . 74.209999999999994 111.619 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -128.25 106.28 8.92 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.505 0.669 . . . . 74.430000000000007 111.695 178.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.7 ttmm -122.29 176.44 5.86 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.096 -1.075 . . . . 71.430000000000007 108.096 174.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.41 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 6.6 p-10 -66.3 144.39 98.69 Favored Pre-proline 0 C--N 1.325 -0.499 0 C-N-CA 121.132 -0.227 . . . . 74.530000000000001 111.1 -177.256 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.504 ' HA ' ' HB2' ' A' ' 42' ' ' ASP . 81.1 Cg_exo -48.97 148.34 9.36 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 124.041 3.161 . . . . 70.219999999999999 114.338 -177.108 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 39.3 m -134.4 -23.25 1.67 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.659 -0.7 . . . . 62.109999999999999 111.676 -179.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -112.65 55.19 0.7 Allowed 'General case' 0 N--CA 1.464 0.248 0 O-C-N 122.136 -0.353 . . . . 74.420000000000002 111.415 -175.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 54.36 79.99 0.13 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.733 -0.667 . . . . 75.200000000000003 111.314 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.4 t70 70.75 102.6 0.06 Allowed 'General case' 0 N--CA 1.468 0.444 0 O-C-N 123.882 0.739 . . . . 75.340000000000003 110.572 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.504 ' HB2' ' HA ' ' A' ' 37' ' ' PRO . 0.4 OUTLIER -106.43 13.61 28.3 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.991 -0.55 . . . . 70.120000000000005 112.254 -172.577 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 83.0 t80 59.61 0.55 0.23 Allowed 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 112.066 0.395 . . . . 75.219999999999999 112.066 -175.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -91.84 34.44 4.38 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 121.09 -0.576 . . . . 74.519999999999996 112.931 -177.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 41.1 mm -96.33 -60.15 2.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 110.304 -0.258 . . . . 75.239999999999995 110.304 176.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 68.63 -52.05 0.56 Allowed 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.871 0.868 . . . . 65.319999999999993 112.757 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 4.7 t -136.6 88.23 19.95 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-O 121.483 0.659 . . . . 60.32 110.989 -177.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -71.82 84.39 1.04 Allowed 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.398 2.066 . . . . 72.099999999999994 111.167 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 12.4 p -127.29 -72.6 0.63 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.659 -0.7 . . . . 71.450000000000003 110.786 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.95 -14.78 63.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.132 -0.485 . . . . 71.230000000000004 111.92 -177.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.421 ' O ' HG22 ' A' ' 55' ' ' THR . 2.9 pp -115.62 1.69 13.6 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.472 -0.331 . . . . 73.420000000000002 111.351 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.627 ' O ' ' HB2' ' A' ' 56' ' ' GLN . 28.3 t70 -68.05 -36.81 80.5 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.451 -0.34 . . . . 63.020000000000003 111.397 -174.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -84.66 -38.24 20.05 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.781 0.324 . . . . 73.010000000000005 110.922 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.469 ' O ' HG13 ' A' ' 58' ' ' ILE . 60.9 t80 -61.23 -57.99 10.13 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.884 -0.598 . . . . 74.25 111.42 -177.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.421 HG22 ' O ' ' A' ' 51' ' ' LEU . 7.2 t -70.01 -16.72 63.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.186 0.517 . . . . 75.409999999999997 110.958 -176.04 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.627 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 1.5 tp-100 -75.16 -29.96 60.59 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.385 0.612 . . . . 51.200000000000003 109.752 -178.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.72 -35.76 44.39 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.563 -0.744 . . . . 74.219999999999999 109.926 176.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.575 ' O ' HG13 ' A' ' 62' ' ' ILE . 17.3 mt -62.38 -40.07 86.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.648 -0.705 . . . . 75.030000000000001 111.055 -178.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -54.48 -32.85 58.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.429 -0.35 . . . . 51.229999999999997 111.413 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.3 t -81.51 -18.4 45.21 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.508 -0.314 . . . . 73.340000000000003 111.59 -176.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.547 ' HG2' ' O ' ' A' ' 58' ' ' ILE . 12.8 pt20 -96.63 -17.21 20.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.863 0.363 . . . . 64.209999999999994 110.687 -178.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.592 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 84.2 mt -65.15 -41.81 92.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.211 -0.45 . . . . 75.120000000000005 110.295 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.2 mp -61.59 -31.1 71.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.709 -0.678 . . . . 74.530000000000001 110.967 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -73.14 -41.8 45.9 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.658 -0.782 . . . . 54.140000000000001 111.833 178.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -71.33 -19.46 77.55 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 121.295 -0.478 . . . . 33.530000000000001 112.814 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' A' ' 62' ' ' ILE . 86.2 mt -57.35 -34.43 68.79 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.884 0.373 . . . . 72.230000000000004 110.966 178.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.432 HD12 HH11 ' A' ' 90' ' ' ARG . 97.1 mt -65.87 -36.5 83.6 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.199 -0.455 . . . . 70.319999999999993 110.851 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.9 m -71.51 -27.6 63.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.025 0.441 . . . . 75.109999999999999 110.255 177.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -72.83 -27.3 61.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.118 0.485 . . . . 53.439999999999998 109.927 176.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.531 HG12 ' O ' ' A' ' 66' ' ' LEU . 48.8 mm -71.2 -23.31 23.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.888 -0.596 . . . . 71.409999999999997 109.634 175.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -78.46 6.92 7.46 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.728 -0.669 . . . . 61.43 110.574 178.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 46.3 p 52.22 31.0 8.53 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.304 1.041 . . . . 53.310000000000002 113.112 172.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.59 31.74 67.84 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 121.076 -0.583 . . . . 71.019999999999996 113.388 174.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 22.0 ptmt -56.78 144.23 67.0 Favored Pre-proline 0 C--O 1.235 0.322 0 O-C-N 122.803 -0.233 . . . . 51.439999999999998 110.565 174.038 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 74' ' ' LYS . 34.6 Cg_exo -59.49 132.12 44.3 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 122.788 2.326 . . . . 65.030000000000001 111.75 177.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -133.04 -85.67 0.27 Allowed Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.6 -0.809 . . . . 72.120000000000005 113.176 -177.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.432 ' CB ' ' HA ' ' A' ' 86' ' ' ASP . 23.8 ptt180 -79.4 147.45 32.35 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.193 0.521 . . . . 45.020000000000003 111.844 -174.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 45.1 ttm -119.68 131.54 55.45 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.52 -0.764 . . . . 73.310000000000002 110.299 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 54.2 t -72.38 124.98 30.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.507 -0.553 . . . . 63.219999999999999 109.507 176.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.625 ' HB ' ' O ' ' A' ' 83' ' ' TYR . 2.7 m -127.27 162.35 26.44 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.663 -0.244 . . . . 43.310000000000002 110.532 -176.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -72.59 -75.89 0.13 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.954 0.407 . . . . 72.310000000000002 111.264 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -88.96 5.98 41.61 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.225 -0.443 . . . . 75.510000000000005 111.781 -174.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.625 ' O ' ' HB ' ' A' ' 80' ' ' THR . 60.7 m-85 -143.81 167.65 21.81 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.882 0.372 . . . . 63.340000000000003 110.748 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.571 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 40.8 mm -121.88 99.55 7.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 108.762 -0.829 . . . . 71.040000000000006 108.762 168.397 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.439 HG13 HD11 ' A' ' 96' ' ' LEU . 37.1 t -85.0 82.38 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.194 0.521 . . . . 64.329999999999998 109.977 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.432 ' HA ' ' CB ' ' A' ' 77' ' ' ARG . 26.1 t70 -94.81 98.77 10.98 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.754 -0.657 . . . . 74.510000000000005 111.226 -177.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.467 HG12 HD13 ' A' ' 96' ' ' LEU . 58.2 mt -86.82 95.4 4.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.574 -0.528 . . . . 73.150000000000006 109.574 175.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -88.14 114.33 24.66 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.954 -0.566 . . . . 54.140000000000001 110.457 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.508 ' HA ' ' O ' ' A' ' 93' ' ' GLN . 2.8 t-20 -109.89 111.17 22.42 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.906 -0.588 . . . . 62.210000000000001 110.211 178.188 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.432 HH11 HD12 ' A' ' 67' ' ' LEU . 59.0 ttp85 -127.44 133.74 49.91 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.476 -0.564 . . . . 75.439999999999998 109.476 175.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 64.43 -86.05 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 O-C-N 123.861 0.725 . . . . 71.019999999999996 110.558 -176.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -148.64 15.1 1.22 Allowed Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 110.996 -0.842 . . . . 75.319999999999993 110.996 177.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.508 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -98.11 124.31 42.57 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.814 0.34 . . . . 62.409999999999997 110.799 -177.588 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -95.7 101.17 12.83 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.65 -0.87 . . . . 52.240000000000002 108.65 171.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -117.45 110.7 18.32 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.184 -0.462 . . . . 55.530000000000001 110.754 -174.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.502 ' HG ' HG23 ' A' ' 98' ' ' VAL . 61.1 tp -89.21 109.58 20.44 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.896 -0.593 . . . . 75.109999999999999 110.971 -176.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -97.44 88.31 4.36 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.848 -0.427 . . . . 43.409999999999997 109.848 178.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.539 ' HB ' ' HB3' ' A' ' 107' ' ' SER . 43.1 t -78.95 102.55 5.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.205 0.526 . . . . 72.019999999999996 110.516 178.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.571 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 25.1 m -90.64 106.39 18.47 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.456 -0.793 . . . . 64.319999999999993 109.371 176.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -63.02 140.23 58.85 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.061 0.458 . . . . 63.399999999999999 110.73 -177.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 24.4 tpp180 -76.6 -35.47 58.09 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.672 -0.694 . . . . 70.420000000000002 111.785 -174.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -102.35 -47.44 4.49 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 111.876 0.324 . . . . 73.140000000000001 111.876 -169.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 42.7 p -89.9 -26.84 20.25 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.156 0.503 . . . . 72.120000000000005 110.486 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.03 19.02 68.21 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.855 -0.688 . . . . 65.239999999999995 112.861 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -64.8 124.49 22.11 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.242 -0.281 . . . . 72.040000000000006 110.242 174.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 36.9 m -92.92 91.64 7.5 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.234 0.54 . . . . 61.32 109.571 175.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.539 ' HB3' ' HB ' ' A' ' 98' ' ' VAL . 17.1 t -88.45 89.39 7.97 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.869 -0.605 . . . . 71.150000000000006 109.589 -179.117 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 32.1 m -86.84 102.86 14.7 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.78 -0.645 . . . . 61.340000000000003 110.257 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 61.4 mt -111.39 109.11 27.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.77 -0.65 . . . . 73.010000000000005 110.816 -177.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -76.14 147.48 38.5 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.431 -0.35 . . . . 61.100000000000001 110.474 174.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 5.7 p -55.68 128.22 15.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.563 -0.744 . . . . 75.109999999999999 110.179 174.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.3 m -98.74 -32.36 11.42 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.208 -0.451 . . . . 73.519999999999996 110.493 -177.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 129.98 -139.11 10.7 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.993 -0.622 . . . . 53.210000000000001 111.696 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 86.3 mt -99.8 -77.12 0.53 Allowed 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 121.099 -0.24 . . . . 71.239999999999995 110.425 178.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 60.64 78.74 0.27 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.883 -0.599 . . . . 62.340000000000003 110.944 -177.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -112.09 131.94 55.14 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.694 -0.685 . . . . 63.439999999999998 110.055 178.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -94.39 -50.57 5.17 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.115 -0.493 . . . . 61.130000000000003 109.851 -179.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 52.7 m 66.81 165.83 0.21 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.204 -0.907 . . . . 75.219999999999999 112.282 176.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 21.0 p -74.48 132.71 42.12 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.662 -0.699 . . . . 73.200000000000003 110.761 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -91.92 -29.62 16.57 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.173 -0.467 . . . . 62.409999999999997 109.968 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 72.19 145.85 0.07 Allowed 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.158 -0.928 . . . . 75.239999999999995 111.711 178.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 24.9 p-80 -145.32 140.14 27.55 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.025 -0.732 . . . . 74.340000000000003 109.025 171.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -80.94 127.42 32.55 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.684 -0.487 . . . . 64.150000000000006 109.684 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 20.0 p-80 -69.26 139.44 54.42 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.734 -0.666 . . . . 75.209999999999994 111.303 -174.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 27.6 m170 -87.15 154.08 21.01 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.976 -0.75 . . . . 71.409999999999997 108.976 172.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.481 ' O ' ' HB2' ' A' ' 127' ' ' HIS . 5.6 t-160 -89.93 128.02 36.14 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.422 -0.955 . . . . 73.129999999999995 108.422 175.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.481 ' HB2' ' O ' ' A' ' 126' ' ' HIS . 36.6 m80 . . . . . 0 C--O 1.252 1.188 0 CA-C-O 117.992 -1.004 . . . . 54.43 109.805 -172.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.5 ptm . . . . . 0 N--CA 1.484 1.243 0 CA-C-O 120.624 0.25 . . . . 75.5 110.565 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.03 -40.78 0.05 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.905 0.383 . . . . 74.230000000000004 111.07 -178.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 115.91 60.32 0.34 Allowed Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 111.336 -0.705 . . . . 65.140000000000001 111.336 -176.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.408 ' O ' ' HB2' ' A' ' 5' ' ' MET . 14.6 t -69.33 144.24 53.56 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.632 0.253 . . . . 72.25 110.663 -176.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.408 ' HB2' ' O ' ' A' ' 4' ' ' THR . 0.8 OUTLIER 72.04 -55.7 0.66 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.701 0.8 . . . . 75.430000000000007 112.037 -178.174 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.0 t 43.72 88.14 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.038 0.935 . . . . 74.209999999999994 112.469 -177.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.527 ' HB2' ' CE2' ' A' ' 9' ' ' PHE . 14.4 p90 -82.4 114.53 20.92 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.514 -0.766 . . . . 75.040000000000006 110.543 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -110.86 -51.28 2.88 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.535 -0.757 . . . . 73.409999999999997 110.774 -176.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.527 ' CE2' ' HB2' ' A' ' 7' ' ' PHE . 77.4 m-85 61.09 39.64 15.92 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.57 0.7 . . . . 73.239999999999995 109.267 -177.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.446 HH11 ' HD3' ' A' ' 10' ' ' ARG . 0.8 OUTLIER -82.84 70.93 9.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.914 -1.039 . . . . 72.030000000000001 111.787 -174.234 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -144.41 85.18 8.83 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.611 -0.722 . . . . 63.140000000000001 110.863 175.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -66.57 -31.82 40.38 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.96 2.44 . . . . 71.329999999999998 111.97 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 52.72 59.25 4.61 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.611 -0.722 . . . . 75.430000000000007 111.399 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -148.83 128.79 13.48 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.032 -0.531 . . . . 75.230000000000004 109.926 -178.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -162.72 -115.38 0.34 Allowed Glycine 0 N--CA 1.45 -0.368 0 N-CA-C 111.1 -0.8 . . . . 71.230000000000004 111.1 177.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 120.5 165.33 12.77 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.751 -0.738 . . . . 73.329999999999998 112.672 176.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -117.91 144.56 34.83 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 109.353 -0.61 . . . . 72.140000000000001 109.353 178.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.98 -56.76 0.22 Allowed 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 122.176 1.917 . . . . 61.409999999999997 112.916 -176.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -176.92 -170.58 0.32 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.184 -0.673 . . . . 74.519999999999996 109.184 -178.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -125.13 154.84 40.84 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.766 -0.457 . . . . 74.239999999999995 109.766 178.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -138.35 132.22 5.72 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.727 -0.749 . . . . 62.439999999999998 111.891 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -164.15 117.47 1.41 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.911 -0.403 . . . . 64.099999999999994 109.911 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -155.84 122.33 5.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.362 0.601 . . . . 71.25 111.139 -177.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.533 HD12 ' O ' ' A' ' 24' ' ' LEU . 3.0 pp -157.32 131.29 8.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.703 -0.68 . . . . 62.32 110.728 176.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 80.3 mt -135.68 -27.63 1.15 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.525 -0.761 . . . . 52.439999999999998 110.975 177.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -63.69 138.45 58.5 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.334 -0.394 . . . . 73.200000000000003 110.407 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 10.4 m -68.91 118.65 12.11 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.958 -0.565 . . . . 71.349999999999994 111.418 -177.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -120.31 165.87 14.28 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.98 -0.554 . . . . 74.120000000000005 110.13 178.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -100.0 128.99 46.01 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 110.071 -0.344 . . . . 65.310000000000002 110.071 -178.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.59 178.34 8.02 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.062 -0.517 . . . . 75.25 110.622 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 65.74 177.17 0.21 Allowed 'General case' 0 N--CA 1.466 0.327 0 O-C-N 123.623 0.577 . . . . 75.530000000000001 111.445 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 16.6 m120 62.56 3.76 1.2 Allowed 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.335 -0.848 . . . . 64.010000000000005 112.992 173.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.0 p -129.3 11.54 5.91 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.084 0.401 . . . . 74.209999999999994 112.084 -173.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 82.3 t80 58.93 81.31 0.17 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.687 0.756 . . . . 74.430000000000007 110.135 -176.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.535 ' HD2' ' H ' ' A' ' 36' ' ' ASP . 0.0 OUTLIER -174.04 174.93 2.87 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.621 -1.251 . . . . 71.430000000000007 107.621 -175.315 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.535 ' H ' ' HD2' ' A' ' 35' ' ' LYS . 4.0 p30 -65.27 143.54 98.8 Favored Pre-proline 0 C--N 1.328 -0.366 0 C-N-CA 120.266 -0.573 . . . . 74.530000000000001 109.837 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.658 ' HB2' ' OD1' ' A' ' 42' ' ' ASP . 88.7 Cg_endo -91.0 172.64 3.01 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.227 2.618 . . . . 70.219999999999999 112.554 -176.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.452 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 5.8 m 174.4 23.63 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.51 0.724 . . . . 62.109999999999999 110.912 -170.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.429 ' O ' ' HB3' ' A' ' 42' ' ' ASP . 61.2 t80 -150.7 157.67 43.23 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 120.143 -0.623 . . . . 74.420000000000002 111.862 -170.38 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 65.2 t30 56.89 58.76 3.84 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.769 -0.65 . . . . 75.200000000000003 110.987 177.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.1 t70 50.27 74.29 0.22 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.071 -0.968 . . . . 75.340000000000003 111.082 -178.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.658 ' OD1' ' HB2' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -158.38 -51.52 0.06 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.032 -0.986 . . . . 70.120000000000005 110.067 -176.306 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.452 ' HA ' ' HA ' ' A' ' 38' ' ' SER . 8.7 t80 58.19 -0.35 0.11 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.582 0.956 . . . . 75.219999999999999 113.582 174.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.438 ' HA2' ' HG2' ' A' ' 37' ' ' PRO . . . 122.38 55.27 0.21 Allowed Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.474 -0.87 . . . . 74.519999999999996 112.752 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 49.7 mm -58.98 -25.39 29.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.112 0.482 . . . . 75.239999999999995 110.943 175.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.433 ' HB2' ' HD3' ' A' ' 37' ' ' PRO . 24.0 mm-40 -82.63 4.31 25.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.395 -0.366 . . . . 65.319999999999993 111.864 179.168 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.7 t -137.63 74.79 45.39 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-O 121.885 0.85 . . . . 60.32 109.673 172.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -89.9 99.54 0.3 Allowed 'Trans proline' 0 N--CA 1.448 -1.2 0 C-N-CA 122.941 2.428 . . . . 72.099999999999994 112.775 -175.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 38.3 m -129.39 -62.69 0.97 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.849 -0.614 . . . . 71.450000000000003 109.759 174.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.83 -43.78 13.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.12 0.486 . . . . 71.230000000000004 110.124 178.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.9 pp -75.58 -11.12 59.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.865 -0.607 . . . . 73.420000000000002 110.613 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.562 ' O ' ' HB2' ' A' ' 56' ' ' GLN . 26.9 t70 -62.42 -50.48 71.33 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.991 -0.55 . . . . 63.020000000000003 110.439 178.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -63.41 -32.47 73.92 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.049 -0.523 . . . . 73.010000000000005 110.908 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.535 ' O ' HG13 ' A' ' 58' ' ' ILE . 57.4 t80 -68.11 -55.33 12.83 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.035 -0.53 . . . . 74.25 110.227 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.3 t -67.85 -19.22 65.02 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.25 0.548 . . . . 75.409999999999997 110.524 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.562 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 2.8 tp-100 -67.38 -41.3 85.25 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.795 -0.638 . . . . 51.200000000000003 109.4 178.016 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.94 -29.28 61.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.505 -0.771 . . . . 74.219999999999999 110.798 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.535 HG13 ' O ' ' A' ' 54' ' ' PHE . 20.7 mt -63.84 -35.61 73.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.123 0.487 . . . . 75.030000000000001 110.552 178.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -66.92 -22.14 65.96 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.132 -0.486 . . . . 51.229999999999997 111.263 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.3 m -85.93 -30.07 23.11 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.018 -0.537 . . . . 73.340000000000003 111.073 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 58' ' ' ILE . 13.7 pt20 -83.14 -3.33 57.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.795 0.331 . . . . 64.209999999999994 111.093 -176.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.513 HG12 ' O ' ' A' ' 58' ' ' ILE . 47.5 mm -74.95 -37.61 41.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.891 0.377 . . . . 75.120000000000005 110.343 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.567 ' H ' HD22 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -65.5 -41.89 92.72 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.008 -0.542 . . . . 74.530000000000001 110.792 -175.778 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -77.79 -22.51 69.12 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.631 -0.795 . . . . 54.140000000000001 112.346 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -77.22 -6.83 86.63 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.982 -0.627 . . . . 33.530000000000001 112.435 -178.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.616 ' O ' HG12 ' A' ' 70' ' ' ILE . 97.9 mt -70.11 -29.66 66.66 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 122.819 -0.224 . . . . 72.230000000000004 111.018 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 91.2 mt -54.28 -46.89 72.81 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.308 -0.405 . . . . 70.319999999999993 111.995 -175.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -70.8 -21.95 62.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.222 -0.445 . . . . 75.109999999999999 111.255 -178.294 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -94.1 -7.93 41.07 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.311 -0.404 . . . . 53.439999999999998 111.032 -178.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.616 HG12 ' O ' ' A' ' 66' ' ' LEU . 31.9 mm -81.07 -26.39 10.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.413 -0.358 . . . . 71.409999999999997 110.368 177.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -54.33 -64.47 0.82 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.068 -0.515 . . . . 61.43 111.073 -177.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 68.9 p 52.15 -168.84 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.611 0.765 . . . . 53.310000000000002 112.643 178.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 104.55 2.16 43.64 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.58 -0.819 . . . . 71.019999999999996 113.041 175.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.467 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 2.3 pptp? -56.7 144.54 65.18 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-O 120.634 0.254 . . . . 51.439999999999998 111.343 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 74' ' ' LYS . 11.5 Cg_exo -71.49 -30.56 14.99 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 122.923 2.415 . . . . 65.030000000000001 112.3 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 168.67 -162.37 36.13 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.983 -0.627 . . . . 72.120000000000005 111.902 -179.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.489 ' HA ' HD12 ' A' ' 87' ' ' ILE . 29.3 ptt180 -151.04 171.78 16.77 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.279 -0.267 . . . . 45.020000000000003 110.279 -178.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.409 ' HB3' HG13 ' A' ' 85' ' ' VAL . 27.5 ttt -100.98 119.03 38.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.986 0.422 . . . . 73.310000000000002 111.043 -177.067 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 46.1 t -81.87 107.39 13.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.088 -0.505 . . . . 63.219999999999999 110.154 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.779 ' HB ' ' O ' ' A' ' 83' ' ' TYR . 1.8 m -107.95 168.39 9.31 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.192 -0.458 . . . . 43.310000000000002 110.139 -178.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.44 ' H ' HG22 ' A' ' 80' ' ' THR . 22.3 p-10 -89.03 -65.33 1.03 Allowed 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.172 0.434 . . . . 72.310000000000002 112.172 -175.116 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -94.66 -2.72 50.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.205 0.526 . . . . 75.510000000000005 111.192 -176.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.779 ' O ' ' HB ' ' A' ' 80' ' ' THR . 31.8 m-85 -130.73 149.95 52.14 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.97 -0.752 . . . . 63.340000000000003 108.97 177.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.581 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 4.7 mp -117.5 93.92 2.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 108.914 -0.773 . . . . 71.040000000000006 108.914 172.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.409 HG13 ' HB3' ' A' ' 78' ' ' MET . 4.9 p -91.57 101.29 12.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.955 0.883 . . . . 64.329999999999998 110.216 178.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -93.81 127.26 39.45 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.339 -0.846 . . . . 74.510000000000005 109.967 -177.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.489 HD12 ' HA ' ' A' ' 77' ' ' ARG . 63.5 mt -93.37 109.47 21.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.162 -0.472 . . . . 73.150000000000006 110.465 -178.478 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -120.77 176.24 5.63 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.915 -0.584 . . . . 54.140000000000001 110.474 179.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -139.11 123.81 18.54 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.691 -0.485 . . . . 62.210000000000001 109.691 176.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.44 ' O ' ' HB3' ' A' ' 91' ' ' ASP . 14.8 ptm180 -106.23 99.62 9.19 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.712 -0.676 . . . . 75.439999999999998 110.057 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.44 ' HB3' ' O ' ' A' ' 90' ' ' ARG . 4.8 t70 73.38 -57.97 0.61 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.878 -0.601 . . . . 71.019999999999996 111.696 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -172.2 32.07 0.12 Allowed Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 111.076 -0.809 . . . . 75.319999999999993 111.076 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -135.8 124.52 23.85 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.613 -0.514 . . . . 62.409999999999997 109.613 -179.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -64.37 120.09 11.58 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.14 0.495 . . . . 52.240000000000002 110.405 176.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.423 HE22 ' HG3' ' A' ' 110' ' ' GLN . 24.2 tp60 -102.17 115.77 31.26 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.502 -0.772 . . . . 55.530000000000001 109.932 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 12.9 tp -92.62 91.05 7.37 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.303 -0.629 . . . . 75.109999999999999 109.303 178.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -83.59 96.24 8.58 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.365 -0.38 . . . . 43.409999999999997 110.77 -177.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.412 ' HB ' ' HB3' ' A' ' 107' ' ' SER . 47.1 t -88.93 104.87 15.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.332 0.587 . . . . 72.019999999999996 110.623 176.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.581 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 31.0 m -96.69 112.48 24.21 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.109 -0.95 . . . . 64.319999999999993 109.867 176.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.477 ' HB3' ' N ' ' A' ' 105' ' ' GLN . 12.6 t70 -71.26 130.93 42.66 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.185 -0.462 . . . . 63.399999999999999 111.125 178.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 -94.48 -11.47 29.63 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.188 0.518 . . . . 70.420000000000002 110.469 -176.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -86.3 -62.48 1.5 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.113 -0.494 . . . . 73.140000000000001 111.509 -176.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 63.6 p -111.35 -27.88 8.46 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.018 0.437 . . . . 72.120000000000005 111.393 -176.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 103.04 34.41 4.0 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.786 -0.643 . . . . 65.239999999999995 112.54 178.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.477 ' N ' ' HB3' ' A' ' 100' ' ' ASP . 51.3 mt-30 -71.84 115.9 11.59 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.984 -0.376 . . . . 72.040000000000006 109.984 174.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 21.1 m -86.55 92.16 8.79 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.059 0.457 . . . . 61.32 110.4 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.412 ' HB3' ' HB ' ' A' ' 98' ' ' VAL . 22.6 t -97.43 86.78 3.95 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.221 0.534 . . . . 71.150000000000006 110.126 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.4 m -91.42 95.54 10.03 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.054 -0.521 . . . . 61.340000000000003 110.289 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 57.0 mt -102.89 136.29 36.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.827 -0.624 . . . . 73.010000000000005 110.577 -175.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.423 ' HG3' HE22 ' A' ' 95' ' ' GLN . 32.4 mt-30 -95.59 163.32 13.26 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.859 0.361 . . . . 61.100000000000001 110.553 173.04 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.6 p -66.43 118.69 10.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.002 -0.544 . . . . 75.109999999999999 110.518 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 17.6 t -93.64 90.4 6.6 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.16 -0.473 . . . . 73.519999999999996 110.462 -178.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 59.8 -130.54 49.82 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.567 -0.742 . . . . 53.210000000000001 112.816 178.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 96.0 mt -127.93 17.1 6.78 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.858 0.361 . . . . 71.239999999999995 110.595 -177.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -77.71 -38.36 47.46 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.312 -0.403 . . . . 62.340000000000003 110.302 178.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 10.0 t30 67.86 134.39 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.449 0 O-C-N 123.921 0.763 . . . . 63.439999999999998 112.108 178.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -62.15 105.43 0.59 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.031 -0.532 . . . . 61.130000000000003 109.735 175.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.4 m -125.18 175.38 7.44 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.889 0.376 . . . . 75.219999999999999 111.242 -173.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.449 HG22 ' H ' ' A' ' 120' ' ' ASP . 3.3 m -122.17 170.55 9.77 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.991 -0.744 . . . . 73.200000000000003 108.991 178.031 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.449 ' H ' HG22 ' A' ' 119' ' ' THR . 2.6 p-10 -72.11 -39.55 68.81 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 117.81 0.277 . . . . 62.409999999999997 111.287 -178.028 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 64.15 104.72 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.265 0.555 . . . . 75.239999999999995 111.474 -178.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -85.28 123.5 30.83 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.864 -0.607 . . . . 74.340000000000003 110.327 -177.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 23.2 t60 -86.29 -47.33 9.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.883 0.373 . . . . 64.150000000000006 110.616 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 70.3 t60 -108.78 105.94 15.74 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.994 -0.548 . . . . 75.209999999999994 110.735 -176.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 23.3 t60 -89.15 -47.75 7.87 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.582 -0.525 . . . . 71.409999999999997 109.582 175.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 66.9 t-80 -165.1 141.03 5.49 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.934 -0.765 . . . . 73.129999999999995 108.934 178.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 41.3 p-80 . . . . . 0 C--O 1.243 0.743 0 CA-C-O 118.283 -0.865 . . . . 54.43 109.826 179.392 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.2 mtt . . . . . 0 N--CA 1.48 1.063 0 CA-C-O 120.823 0.344 . . . . 75.5 110.429 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.87 162.43 29.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 74.230000000000004 111.058 -178.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -92.32 73.64 1.46 Allowed Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.85 -0.691 . . . . 65.140000000000001 112.138 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.3 p -74.01 119.41 18.18 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.512 0.196 . . . . 72.25 110.999 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.418 ' O ' ' N ' ' A' ' 7' ' ' PHE . 4.2 mpp? 67.61 -71.93 0.1 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.689 0.796 . . . . 75.430000000000007 111.305 -178.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.427 HG23 ' H ' ' A' ' 7' ' ' PHE . 15.2 t 51.56 -65.57 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.652 1.581 . . . . 74.209999999999994 113.435 -177.255 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.427 ' H ' HG23 ' A' ' 6' ' ' THR . 83.4 m-85 -89.81 -61.06 1.77 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.369 -0.604 . . . . 75.040000000000006 109.369 175.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 59.33 28.03 17.26 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.614 0.721 . . . . 73.409999999999997 111.181 176.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -108.71 98.41 7.92 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 121.981 -0.45 . . . . 73.239999999999995 110.124 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -125.68 -175.7 3.41 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.63 -0.713 . . . . 72.030000000000001 109.601 177.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.2 t30 63.67 84.92 0.18 Allowed Pre-proline 0 N--CA 1.467 0.39 0 O-C-N 123.737 0.648 . . . . 63.140000000000001 110.521 -177.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -81.43 131.56 7.56 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.942 2.428 . . . . 71.329999999999998 112.25 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.5 m120 70.58 103.35 0.06 Allowed 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.41 0.892 . . . . 75.430000000000007 113.41 176.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -90.72 146.06 24.3 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.461 -0.791 . . . . 75.230000000000004 109.14 166.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.86 -64.27 1.75 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.49 -0.862 . . . . 71.230000000000004 112.227 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 140.06 -178.66 19.66 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.956 -0.64 . . . . 73.329999999999998 111.8 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -121.59 142.68 36.26 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.705 0.253 . . . . 72.140000000000001 110.62 -178.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -90.89 152.01 3.99 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.931 2.421 . . . . 61.409999999999997 112.874 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -99.11 153.6 18.77 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.188 -0.671 . . . . 74.519999999999996 109.188 176.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -128.63 157.7 40.58 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.946 0.403 . . . . 74.239999999999995 110.944 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -105.41 5.12 40.87 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.736 -0.745 . . . . 62.439999999999998 111.973 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 72.15 -55.5 0.67 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.773 0.829 . . . . 64.099999999999994 111.57 -178.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 56.39 45.95 21.8 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.102 0.477 . . . . 71.25 111.35 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.4 pp -77.23 -6.38 52.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.043 -0.526 . . . . 62.32 111.191 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 89.5 mt 63.9 174.26 0.18 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.503 -0.771 . . . . 52.439999999999998 112.618 174.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 -127.25 -82.51 0.61 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.662 -0.699 . . . . 73.200000000000003 109.384 175.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.9 p -172.12 134.93 0.75 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.259 -0.882 . . . . 71.349999999999994 109.092 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -138.36 116.9 12.09 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.842 0.353 . . . . 74.120000000000005 111.279 -177.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 13.9 tm0? -108.01 -36.34 6.37 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.478 -0.564 . . . . 65.310000000000002 109.478 178.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.409 ' HB2' ' HB2' ' A' ' 54' ' ' PHE . . . 75.51 -37.49 0.33 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.749 0.82 . . . . 75.25 112.759 173.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.683 ' HG2' ' H ' ' A' ' 32' ' ' ASN . 2.0 pm0 44.78 -84.76 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.794 1.238 . . . . 75.530000000000001 114.066 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.683 ' H ' ' HG2' ' A' ' 31' ' ' GLN . 39.6 t-20 -111.97 134.41 53.55 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.665 0.269 . . . . 64.010000000000005 110.677 -171.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.421 ' C ' ' H ' ' A' ' 35' ' ' LYS . 5.6 p -64.55 -51.53 62.35 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.746 -0.464 . . . . 74.209999999999994 109.746 174.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 57.9 t80 71.9 -25.4 0.18 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.793 0.837 . . . . 74.430000000000007 112.282 173.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.552 ' HG2' HG21 ' A' ' 47' ' ' THR . 22.8 tptm -140.35 31.19 1.92 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.256 0.551 . . . . 71.430000000000007 109.719 -178.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.454 ' HB2' ' HD2' ' A' ' 37' ' ' PRO . 2.9 p30 -61.18 156.9 46.97 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.088 -0.505 . . . . 74.530000000000001 111.288 -179.02 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.454 ' HD2' ' HB2' ' A' ' 36' ' ' ASP . 9.5 Cg_endo -50.95 142.98 32.16 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.497 2.798 . . . . 70.219999999999999 113.851 -178.079 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 29.8 t -139.31 135.64 34.01 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.2 -0.909 . . . . 62.109999999999999 109.325 178.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 59.4 t80 56.86 68.72 0.82 Allowed 'General case' 0 C--O 1.234 0.252 0 O-C-N 123.778 0.674 . . . . 74.420000000000002 110.485 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 17.2 m120 63.06 24.29 14.41 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.422 -0.808 . . . . 75.200000000000003 110.784 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.42 ' HB2' ' HB3' ' A' ' 37' ' ' PRO . 26.8 t70 63.52 105.98 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.538 -0.755 . . . . 75.340000000000003 111.625 -175.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -88.2 -42.24 12.43 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.851 -0.613 . . . . 70.120000000000005 109.863 175.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -169.38 19.36 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.854 -0.612 . . . . 75.219999999999999 110.133 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -73.17 -38.38 54.54 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.506 -0.854 . . . . 74.519999999999996 112.182 -172.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.3 mt -76.82 -18.45 14.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.665 0.745 . . . . 75.239999999999995 109.834 -178.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -95.6 8.91 42.02 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.484 -0.78 . . . . 65.319999999999993 111.338 -177.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.552 HG21 ' HG2' ' A' ' 35' ' ' LYS . 9.8 m -115.97 86.57 16.85 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 120.725 0.298 . . . . 60.32 110.304 175.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -77.37 84.57 1.93 Allowed 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.122 1.881 . . . . 72.099999999999994 111.896 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.7 m -86.07 -80.15 0.24 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.896 -0.593 . . . . 71.450000000000003 111.159 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -93.84 -37.85 11.54 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.807 0.337 . . . . 71.230000000000004 111.355 -177.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.582 HD23 ' H ' ' A' ' 51' ' ' LEU . 1.7 pt? -66.64 -13.83 61.68 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.01 -0.541 . . . . 73.420000000000002 111.273 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -49.01 -53.46 19.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.674 -0.694 . . . . 63.020000000000003 112.509 -175.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.45 -30.96 67.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.826 0.346 . . . . 73.010000000000005 111.349 -178.348 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.496 ' O ' HG13 ' A' ' 58' ' ' ILE . 67.2 t80 -67.23 -44.64 78.96 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.192 -0.458 . . . . 74.25 110.407 -178.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 87.0 m -55.34 -37.2 67.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.425 0.631 . . . . 75.409999999999997 111.557 178.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -80.19 -31.7 38.73 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.796 -0.638 . . . . 51.200000000000003 110.771 -174.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.81 -25.19 68.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.031 -0.532 . . . . 74.219999999999999 110.263 175.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.531 ' O ' HG13 ' A' ' 62' ' ' ILE . 2.5 mt -86.28 -45.37 16.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.974 -0.557 . . . . 75.030000000000001 110.968 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.454 ' HA ' HD12 ' A' ' 62' ' ' ILE . 76.1 mt-30 -59.14 -30.45 68.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.769 0.319 . . . . 51.229999999999997 111.283 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.5 m -66.58 -37.96 86.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.352 -0.386 . . . . 73.340000000000003 111.152 178.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.527 ' HG2' ' O ' ' A' ' 58' ' ' ILE . 11.1 pt20 -83.19 -20.9 33.8 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.794 0.33 . . . . 64.209999999999994 110.943 -178.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.531 HG13 ' O ' ' A' ' 58' ' ' ILE . 83.9 mt -66.5 -31.1 52.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.996 0.427 . . . . 75.120000000000005 109.894 177.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 91.9 mt -57.65 -32.85 67.69 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.734 -0.666 . . . . 74.530000000000001 110.933 178.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -74.51 -40.47 39.05 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.993 -0.623 . . . . 54.140000000000001 111.602 176.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -63.71 -25.99 69.49 Favored Glycine 0 C--N 1.33 0.2 0 C-N-CA 120.992 -0.623 . . . . 33.530000000000001 112.286 178.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 62' ' ' ILE . 91.8 mt -66.22 -18.34 65.29 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.706 0.289 . . . . 72.230000000000004 110.916 178.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 93.7 mt -85.59 5.97 29.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.076 0.465 . . . . 70.319999999999993 110.563 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.9 t -126.11 -42.21 1.88 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.947 -0.57 . . . . 75.109999999999999 110.587 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.414 ' ND2' HD21 ' A' ' 97' ' ' ASN . 86.7 m-20 -75.73 5.36 6.34 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.699 0.629 . . . . 53.439999999999998 112.699 -173.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.402 HG12 ' O ' ' A' ' 66' ' ' LEU . 50.4 mm -99.73 -13.57 8.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.653 0.739 . . . . 71.409999999999997 109.664 176.016 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -98.59 8.92 44.32 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.589 -0.732 . . . . 61.43 110.678 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.2 p -86.77 -164.18 1.03 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.851 -0.613 . . . . 53.310000000000002 110.45 178.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 122.07 7.74 7.65 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.7 -0.762 . . . . 71.019999999999996 112.311 -177.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -57.44 148.12 56.06 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 120.665 0.269 . . . . 51.439999999999998 111.262 178.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.68 -10.34 23.38 Favored 'Trans proline' 0 CA--C 1.532 0.407 0 C-N-CA 122.587 2.191 . . . . 65.030000000000001 112.666 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -83.74 56.12 5.04 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 121.131 -0.557 . . . . 72.120000000000005 112.435 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -106.68 -176.01 2.96 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.003 -0.369 . . . . 45.020000000000003 110.003 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.464 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 27.6 ttt -122.42 115.63 22.58 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.729 0.3 . . . . 73.310000000000002 110.472 178.5 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 53.1 t -85.5 97.65 5.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.373 0.606 . . . . 63.219999999999999 110.696 -178.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.697 ' HB ' ' O ' ' A' ' 83' ' ' TYR . 6.7 m -113.65 148.86 35.53 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.307 -0.86 . . . . 43.310000000000002 108.854 177.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -73.52 -59.64 2.62 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.007 0.373 . . . . 72.310000000000002 112.007 -170.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -82.82 -14.16 54.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.795 0.331 . . . . 75.510000000000005 111.448 -174.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.697 ' O ' ' HB ' ' A' ' 80' ' ' THR . 59.4 m-85 -133.99 121.3 21.41 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.334 -0.394 . . . . 63.340000000000003 110.482 -177.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.569 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 2.9 mp -81.91 102.56 7.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.089 -0.708 . . . . 71.040000000000006 109.089 175.301 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.464 ' HB ' ' HB3' ' A' ' 78' ' ' MET . 47.3 t -96.69 94.31 4.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.715 -0.675 . . . . 64.329999999999998 110.769 -176.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -98.45 115.62 28.91 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.343 -0.614 . . . . 74.510000000000005 109.343 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 71.6 mt -82.02 94.66 2.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.939 -0.573 . . . . 73.150000000000006 110.673 -176.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.05 74.54 8.08 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.687 -0.688 . . . . 54.140000000000001 111.102 -177.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -88.59 92.73 9.31 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.147 -0.686 . . . . 62.210000000000001 109.147 173.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.441 ' HA ' ' HD2' ' A' ' 90' ' ' ARG . 13.6 tpt180 -133.68 154.16 51.14 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.818 -0.628 . . . . 75.439999999999998 109.726 -178.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.9 t70 69.93 -68.18 0.21 Allowed 'General case' 0 N--CA 1.465 0.317 0 O-C-N 124.082 0.864 . . . . 71.019999999999996 111.151 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 177.74 23.62 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.736 -0.745 . . . . 75.319999999999993 113.433 178.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -138.1 152.5 48.83 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 122.265 -0.55 . . . . 62.409999999999997 110.264 178.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -89.61 94.58 9.91 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.761 -0.459 . . . . 52.240000000000002 109.761 176.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.474 ' HG2' ' OD1' ' A' ' 97' ' ' ASN . 7.3 tt0 -97.31 109.29 22.08 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.137 0.494 . . . . 55.530000000000001 109.692 -179.102 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.543 ' HB3' ' HB ' ' A' ' 109' ' ' ILE . 29.0 tp -90.11 98.64 11.89 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.868 -0.605 . . . . 75.109999999999999 110.389 -177.234 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.483 ' OD1' HG23 ' A' ' 108' ' ' THR . 6.5 m-20 -90.61 93.44 9.27 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.283 0.564 . . . . 43.409999999999997 110.532 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.439 ' CG1' ' HD1' ' A' ' 83' ' ' TYR . 56.1 t -92.8 114.18 29.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.658 -0.701 . . . . 72.019999999999996 110.677 178.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.569 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 30.7 m -103.32 109.23 20.77 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.845 -0.616 . . . . 64.319999999999993 110.077 178.027 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.587 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 25.2 t70 -62.32 141.23 58.4 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.489 -0.323 . . . . 63.399999999999999 110.777 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.07 -26.69 19.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.259 -0.428 . . . . 70.420000000000002 110.251 -177.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 32.7 mtmm -70.04 -69.58 0.34 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.374 -0.375 . . . . 73.140000000000001 111.149 -174.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 12.0 t -99.05 -26.8 14.11 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.243 0.544 . . . . 72.120000000000005 109.716 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.587 ' HA2' ' O ' ' A' ' 100' ' ' ASP . . . 83.65 79.45 1.06 Allowed Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.544 -0.753 . . . . 65.239999999999995 112.909 176.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.491 ' H ' ' HB3' ' A' ' 100' ' ' ASP . 68.6 mm-40 -124.69 144.16 50.36 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.587 -0.523 . . . . 72.040000000000006 109.587 174.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.9 m -89.05 96.11 10.59 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.123 0.487 . . . . 61.32 110.724 -178.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.435 ' HB3' ' HB ' ' A' ' 98' ' ' VAL . 47.4 t -88.17 80.83 7.51 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.454 -0.573 . . . . 71.150000000000006 109.454 177.23 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.483 HG23 ' OD1' ' A' ' 97' ' ' ASN . 28.2 m -82.35 101.49 10.62 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.901 -0.591 . . . . 61.340000000000003 110.709 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.543 ' HB ' ' HB3' ' A' ' 96' ' ' LEU . 54.5 mt -99.88 92.34 2.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.052 -0.522 . . . . 73.010000000000005 110.514 -178.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -72.56 106.91 4.81 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.723 -0.473 . . . . 61.100000000000001 109.723 175.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.2 t -76.23 104.75 4.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.688 -0.486 . . . . 75.109999999999999 109.688 177.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.3 t -147.86 125.46 11.77 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.749 -0.659 . . . . 73.519999999999996 110.31 -178.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 92.77 52.7 2.07 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.915 -0.66 . . . . 53.210000000000001 113.035 175.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 77.4 mt -106.16 -75.81 0.62 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.011 -0.366 . . . . 71.239999999999995 110.011 174.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 66.38 15.33 10.06 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.605 -0.725 . . . . 62.340000000000003 111.202 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -100.78 93.49 5.58 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.632 0.729 . . . . 63.439999999999998 109.705 173.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -105.26 101.74 11.27 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.496 -0.775 . . . . 61.130000000000003 110.547 -176.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 38.3 m -83.3 101.8 11.53 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.306 -0.628 . . . . 75.219999999999999 109.306 174.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -57.8 120.27 8.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.983 -0.553 . . . . 73.200000000000003 110.587 -177.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -120.92 116.21 24.69 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.84 -0.618 . . . . 62.409999999999997 110.352 -177.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -141.08 95.32 2.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.21 -0.45 . . . . 75.239999999999995 110.494 178.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 26.0 m80 63.95 -168.96 0.2 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.884 -0.598 . . . . 74.340000000000003 111.325 175.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 37.8 m80 58.42 46.71 14.8 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.811 -0.632 . . . . 64.150000000000006 110.991 176.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -84.09 11.36 8.14 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.681 -0.69 . . . . 75.209999999999994 111.035 -177.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 23.7 t-80 -139.57 109.64 6.44 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.221 -0.445 . . . . 71.409999999999997 109.879 175.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -147.14 139.2 24.45 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.692 -0.685 . . . . 73.129999999999995 109.998 176.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.619 -0.705 . . . . 54.43 109.56 -176.022 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 N--CA 1.482 1.126 0 N-CA-C 109.957 -0.386 . . . . 75.5 109.957 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -143.17 129.1 19.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.067 0.461 . . . . 74.230000000000004 111.171 -178.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -146.39 94.44 0.16 Allowed Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 110.812 -0.915 . . . . 65.140000000000001 110.812 178.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 14.4 p -73.0 -70.5 0.35 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 111.721 0.267 . . . . 72.25 111.721 -173.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 82.3 mtp 59.53 -169.65 0.14 Allowed 'General case' 0 N--CA 1.465 0.312 0 O-C-N 123.559 0.537 . . . . 75.430000000000007 110.829 -177.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 76.9 p 52.98 92.76 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.666 0.786 . . . . 74.209999999999994 112.574 176.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -76.08 145.82 39.81 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.148 -0.478 . . . . 75.040000000000006 109.718 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -148.71 94.77 2.32 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.422 0.629 . . . . 73.409999999999997 111.165 178.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -167.14 151.56 6.98 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.174 -0.921 . . . . 73.239999999999995 109.476 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 -108.57 -76.45 0.61 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.476 -0.329 . . . . 72.030000000000001 110.682 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 53.83 65.17 5.75 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-N 115.407 -0.815 . . . . 63.140000000000001 110.94 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -76.18 -32.89 3.82 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.903 2.402 . . . . 71.329999999999998 112.469 -175.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.7 m120 67.7 113.79 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 O-C-N 123.799 0.687 . . . . 75.430000000000007 111.328 -174.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -145.35 175.53 10.23 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.566 -0.743 . . . . 75.230000000000004 109.598 -178.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 107.44 -154.27 16.64 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.606 -0.807 . . . . 71.230000000000004 112.036 -178.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.63 94.96 1.32 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.885 -0.674 . . . . 73.329999999999998 111.707 -178.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -91.76 144.27 29.15 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-O 120.57 0.224 . . . . 72.140000000000001 110.675 -176.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.55 149.99 27.6 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.501 2.134 . . . . 61.409999999999997 112.253 176.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -141.23 98.55 3.39 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.469 -0.567 . . . . 74.519999999999996 109.469 175.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -134.1 145.45 49.36 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.981 -0.554 . . . . 74.239999999999995 110.338 -178.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -163.51 -171.31 29.59 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 111.059 -0.817 . . . . 62.439999999999998 111.059 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -152.14 104.53 2.97 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 117.029 0.414 . . . . 64.099999999999994 111.332 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -112.42 119.51 38.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.099 -0.5 . . . . 71.25 109.657 175.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.492 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 5.4 mp -127.66 171.89 11.26 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 110.043 -0.354 . . . . 62.32 110.043 -179.202 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 24' ' ' LEU . 0.5 OUTLIER 47.49 -167.89 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.44 1.096 . . . . 52.439999999999998 112.814 -179.758 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 29.1 p-10 -166.37 166.79 16.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.904 -0.589 . . . . 73.200000000000003 109.686 177.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 10.4 p -119.19 159.14 24.58 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.41 -0.359 . . . . 71.349999999999994 110.336 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -155.05 135.16 13.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.403 -0.362 . . . . 74.120000000000005 110.841 -178.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -112.43 -83.79 0.59 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.16 -0.473 . . . . 65.310000000000002 110.88 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -176.64 175.31 1.72 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.909 -0.587 . . . . 75.25 109.49 -177.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -111.96 134.27 53.63 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.73 0.3 . . . . 75.530000000000001 110.388 176.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -70.91 101.09 2.08 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.405 -0.591 . . . . 64.010000000000005 109.405 175.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.8 p -145.71 -177.92 5.83 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.319 -0.401 . . . . 74.209999999999994 111.103 -173.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.494 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 57.3 m-85 -112.44 27.84 9.29 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.65 -0.5 . . . . 74.430000000000007 109.65 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 34' ' ' TYR . 0.3 OUTLIER 70.97 16.35 6.5 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.663 -0.698 . . . . 71.430000000000007 109.426 -174.533 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.459 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 5.6 p-10 -74.7 149.57 86.0 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 114.782 -1.099 . . . . 74.530000000000001 111.537 -177.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.748 ' HD2' ' HA2' ' A' ' 44' ' ' GLY . 4.1 Cg_exo -77.17 173.84 13.74 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.886 2.391 . . . . 70.219999999999999 111.368 173.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.6 t -168.21 146.78 4.43 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.639 -0.504 . . . . 62.109999999999999 109.639 -174.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 16.8 t80 69.3 162.52 0.22 Allowed 'General case' 0 CA--C 1.532 0.266 0 O-C-N 123.879 0.737 . . . . 74.420000000000002 110.446 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 59.94 57.49 3.06 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.428 -0.351 . . . . 75.200000000000003 110.489 -178.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 46.95 24.62 0.38 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.553 1.141 . . . . 75.340000000000003 113.466 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -121.55 123.16 41.33 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.588 -0.523 . . . . 70.120000000000005 109.588 173.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -130.57 32.05 4.46 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.381 -0.599 . . . . 75.219999999999999 109.381 -179.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.748 ' HA2' ' HD2' ' A' ' 37' ' ' PRO . . . 117.75 35.75 1.04 Allowed Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 115.462 -0.79 . . . . 74.519999999999996 111.892 -179.025 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 59.7 mt -84.45 -48.47 16.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.453 -0.573 . . . . 75.239999999999995 109.453 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.583 ' HB2' ' HG3' ' A' ' 37' ' ' PRO . 62.9 mm-40 -67.5 123.87 21.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.906 -0.588 . . . . 65.319999999999993 109.755 173.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.3 m -124.24 89.12 52.27 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.106 -0.497 . . . . 60.32 110.742 -175.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.404 ' C ' ' HB2' ' A' ' 52' ' ' ASP . 24.3 Cg_exo -61.67 107.21 0.49 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.881 2.387 . . . . 72.099999999999994 112.385 -177.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.7 m -140.43 -36.9 0.47 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.965 -0.562 . . . . 71.450000000000003 110.371 175.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -92.45 -33.72 14.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.296 0.569 . . . . 71.230000000000004 110.604 176.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.431 ' H ' HD23 ' A' ' 51' ' ' LEU . 0.7 OUTLIER -101.47 0.0 35.95 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.839 -0.619 . . . . 73.420000000000002 110.665 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' A' ' 56' ' ' GLN . 14.9 t70 -62.38 -62.9 1.44 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.738 -0.664 . . . . 63.020000000000003 111.671 -173.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -69.26 -18.24 63.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.235 0.54 . . . . 73.010000000000005 110.085 -177.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -73.37 -58.15 3.51 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.553 -0.749 . . . . 74.25 110.658 178.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.5 t -70.3 -18.97 63.11 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.229 0.538 . . . . 75.409999999999997 110.461 -178.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.405 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 3.1 tp-100 -61.82 -35.51 78.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.479 -0.782 . . . . 51.200000000000003 109.978 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.98 -19.96 31.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.893 -0.594 . . . . 74.219999999999999 110.983 -179.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.426 ' O ' HG13 ' A' ' 62' ' ' ILE . 24.7 mt -71.74 -27.7 28.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.052 -0.522 . . . . 75.030000000000001 110.891 -177.293 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -54.88 -35.72 64.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.442 -0.344 . . . . 51.229999999999997 111.239 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.9 m -62.43 -50.41 71.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.989 0.424 . . . . 73.340000000000003 110.975 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -74.45 -17.23 60.81 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.32 -0.4 . . . . 64.209999999999994 110.846 -177.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.554 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 74.5 mt -72.8 -50.17 35.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.522 -0.547 . . . . 75.120000000000005 109.522 173.214 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 95.5 mt -60.45 -42.04 95.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.881 -0.599 . . . . 74.530000000000001 110.356 177.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.401 ' HA2' ' HD2' ' A' ' 90' ' ' ARG . . . -59.72 -43.85 97.46 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.852 -0.613 . . . . 54.140000000000001 112.215 176.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -65.22 -35.49 91.68 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 121.24 -0.505 . . . . 33.530000000000001 112.432 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' A' ' 62' ' ' ILE . 98.0 mt -61.66 -52.12 65.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.674 0.273 . . . . 72.230000000000004 110.595 178.343 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.6 mt -68.7 -31.67 70.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.001 -0.545 . . . . 70.319999999999993 111.048 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.501 ' OG ' ' HG2' ' A' ' 74' ' ' LYS . 38.3 t -56.5 -49.63 74.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.785 -0.643 . . . . 75.109999999999999 110.908 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -72.49 -19.67 61.5 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.234 -0.439 . . . . 53.439999999999998 111.768 -177.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.488 HG12 ' O ' ' A' ' 66' ' ' LEU . 46.4 mm -75.89 -36.12 31.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.13 0.49 . . . . 71.409999999999997 110.154 177.28 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -71.3 -57.84 4.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.732 -0.667 . . . . 61.43 110.707 -177.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.3 m -157.09 156.72 33.27 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.454 -0.339 . . . . 53.310000000000002 110.373 -176.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -70.64 64.07 0.85 Allowed Glycine 0 C--N 1.332 0.344 0 N-CA-C 111.685 -0.566 . . . . 71.019999999999996 111.685 172.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.501 ' HG2' ' OG ' ' A' ' 68' ' ' SER . 2.1 pptp? -56.45 157.95 8.78 Favored Pre-proline 0 C--N 1.324 -0.524 0 C-N-CA 124.142 0.977 . . . . 51.439999999999998 113.283 -175.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.41 159.73 36.0 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 123.093 2.529 . . . . 65.030000000000001 111.037 171.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -85.82 -165.31 40.45 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 120.86 -0.686 . . . . 72.120000000000005 112.686 -178.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.433 HH11 ' HD2' ' A' ' 77' ' ' ARG . 5.7 ptp85 -99.64 127.04 45.75 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 122.559 -0.377 . . . . 45.020000000000003 110.245 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 27.1 ttt -82.26 107.35 14.87 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.975 0.416 . . . . 73.310000000000002 110.42 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 45.4 t -76.71 105.92 6.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.875 -0.602 . . . . 63.219999999999999 109.728 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.52 ' HB ' ' O ' ' A' ' 83' ' ' TYR . 5.3 m -82.25 160.06 23.05 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.622 -0.717 . . . . 43.310000000000002 110.262 -178.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -54.48 -60.49 3.28 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.136 0.493 . . . . 72.310000000000002 111.33 -177.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.848 ' HB3' ' HD3' ' A' ' 101' ' ' ARG . 1.6 m-20 -110.43 -38.56 5.19 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.811 -0.631 . . . . 75.510000000000005 111.243 -175.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.52 ' O ' ' HB ' ' A' ' 80' ' ' THR . 17.6 m-85 -78.95 142.25 36.84 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.911 -0.586 . . . . 63.340000000000003 111.662 -177.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.57 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 49.9 mm -93.58 89.92 2.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.909 -0.587 . . . . 71.040000000000006 110.087 175.22 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.541 HG22 HG22 ' A' ' 98' ' ' VAL . 93.9 t -95.49 117.79 40.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.762 -0.653 . . . . 64.329999999999998 110.127 178.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -118.61 119.25 33.94 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.063 0.459 . . . . 74.510000000000005 110.447 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 52.4 mt -96.55 94.66 4.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.79 -0.641 . . . . 73.150000000000006 109.401 178.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.543 ' HB3' ' HB2' ' A' ' 95' ' ' GLN . . . -92.11 100.38 13.02 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.179 -0.464 . . . . 54.140000000000001 110.996 -177.112 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -96.24 108.16 20.6 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.956 -0.565 . . . . 62.210000000000001 110.334 176.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.401 ' HD2' ' HA2' ' A' ' 64' ' ' GLY . 1.6 mtp180 -136.99 131.7 33.28 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.133 -0.485 . . . . 75.439999999999998 110.252 176.125 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 61.45 19.99 10.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.974 -0.557 . . . . 71.019999999999996 111.35 175.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.26 -6.95 78.53 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.971 -0.633 . . . . 75.319999999999993 112.427 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 -90.75 126.82 36.12 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.194 -0.299 . . . . 62.409999999999997 110.194 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -93.8 107.29 19.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.205 -0.452 . . . . 52.240000000000002 110.122 177.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.543 ' HB2' ' HB3' ' A' ' 88' ' ' ALA . 45.1 mt-30 -99.73 95.66 7.08 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.893 0.378 . . . . 55.530000000000001 110.269 175.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 50.3 tp -84.38 94.0 8.4 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.835 -0.62 . . . . 75.109999999999999 109.429 177.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -107.56 127.28 53.49 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.316 0.579 . . . . 43.409999999999997 110.43 -176.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.541 HG22 HG22 ' A' ' 85' ' ' VAL . 85.2 t -118.39 131.65 70.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.637 -0.71 . . . . 72.019999999999996 110.483 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.57 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 15.5 m -104.72 112.64 25.81 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.385 -0.825 . . . . 64.319999999999993 108.974 172.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -66.27 153.72 41.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.315 0.578 . . . . 63.399999999999999 111.966 -175.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.848 ' HD3' ' HB3' ' A' ' 82' ' ' ASP . 35.8 ptt180 -82.81 -30.39 28.82 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.122 -0.945 . . . . 70.420000000000002 111.821 -175.397 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.638 ' HG3' ' HG3' ' A' ' 101' ' ' ARG . 47.1 mttm -105.26 -62.83 1.3 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.218 0.532 . . . . 73.140000000000001 111.473 -172.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.514 ' OG1' ' HG2' ' A' ' 105' ' ' GLN . 42.9 p -78.58 -19.69 52.21 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.734 -0.666 . . . . 72.120000000000005 109.921 -177.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 70.08 26.01 74.86 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.354 -0.839 . . . . 65.239999999999995 112.413 177.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.514 ' HG2' ' OG1' ' A' ' 103' ' ' THR . 27.3 mm-40 -66.91 125.55 26.29 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.991 -0.374 . . . . 72.040000000000006 109.991 177.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.9 m -102.12 92.23 4.67 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.055 -0.72 . . . . 61.32 109.055 175.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.8 t -100.25 121.87 42.16 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.196 -0.456 . . . . 71.150000000000006 110.124 -176.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 26.8 m -102.95 102.17 12.22 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.159 -0.473 . . . . 61.340000000000003 110.442 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 54.5 mt -93.09 92.25 3.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.458 -0.571 . . . . 73.010000000000005 109.458 177.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -89.4 131.2 35.58 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.202 -0.454 . . . . 61.100000000000001 110.293 -178.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 46.5 t -78.02 81.37 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.34 0.591 . . . . 75.109999999999999 109.743 175.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 21.9 t -161.79 140.39 9.42 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.304 -0.862 . . . . 73.519999999999996 109.157 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -89.51 0.37 80.42 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.397 -0.906 . . . . 53.210000000000001 111.933 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 96.2 mt -99.37 67.66 1.57 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.936 0.398 . . . . 71.239999999999995 111.006 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -92.22 82.21 5.0 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.514 -0.55 . . . . 62.340000000000003 109.514 175.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -116.0 -40.91 3.24 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.004 -0.544 . . . . 63.439999999999998 110.567 -176.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -67.43 127.92 34.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.05 -0.523 . . . . 61.130000000000003 109.779 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 23.1 t -63.96 100.27 0.3 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.167 0.508 . . . . 75.219999999999999 110.477 -178.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 27.1 m -96.61 105.91 18.09 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.541 -0.754 . . . . 73.200000000000003 109.883 -178.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -142.77 132.58 24.07 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.749 -0.66 . . . . 62.409999999999997 109.589 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -128.04 74.5 1.54 Allowed 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.546 -0.539 . . . . 75.239999999999995 109.546 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -66.17 110.82 3.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.813 -0.63 . . . . 74.340000000000003 110.857 178.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 42.5 p-80 -128.03 110.48 12.54 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.223 -0.899 . . . . 64.150000000000006 109.901 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -77.34 74.85 3.9 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.461 0.648 . . . . 75.209999999999994 109.996 -178.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -150.07 130.21 13.58 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.406 -0.816 . . . . 71.409999999999997 109.848 -178.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 64.1 t-80 -137.44 149.31 46.78 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.725 -0.472 . . . . 73.129999999999995 109.725 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 48.5 t60 . . . . . 0 C--O 1.246 0.872 0 CA-C-O 118.23 -0.891 . . . . 54.43 109.563 176.353 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 N--CA 1.484 1.225 0 N-CA-C 110.338 -0.245 . . . . 75.5 110.338 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.29 172.93 12.44 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.513 -0.312 . . . . 74.230000000000004 110.293 -178.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 143.06 -97.36 0.2 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.995 -0.622 . . . . 65.140000000000001 111.733 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.4 m 57.14 44.84 21.72 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.234 0.54 . . . . 72.25 110.91 178.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 47.9 ttm 56.03 62.95 2.17 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.489 0.662 . . . . 75.430000000000007 110.265 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.2 t -86.92 -12.9 46.3 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.965 -0.561 . . . . 74.209999999999994 110.392 -177.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 69.21 164.17 0.24 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.588 -0.733 . . . . 75.040000000000006 112.062 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -154.74 -46.1 0.09 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.207 -0.906 . . . . 73.409999999999997 109.641 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 60.3 85.54 0.11 Allowed 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 115.306 -0.861 . . . . 73.239999999999995 111.238 -178.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -116.65 132.17 56.76 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.062 -0.718 . . . . 72.030000000000001 109.062 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -130.48 86.81 52.14 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-O 120.769 0.318 . . . . 63.140000000000001 110.718 -176.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -73.8 156.28 48.53 Favored 'Trans proline' 0 C--O 1.238 0.486 0 C-N-CA 122.646 2.231 . . . . 71.329999999999998 112.112 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 71.99 153.44 0.13 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.549 -0.751 . . . . 75.430000000000007 110.791 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -97.02 168.18 10.62 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.959 0.409 . . . . 75.230000000000004 111.423 -174.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -96.39 74.9 0.76 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.933 -0.651 . . . . 71.230000000000004 111.832 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -126.83 41.3 1.64 Allowed Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.717 -0.754 . . . . 73.329999999999998 112.462 -178.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 66.73 156.91 0.13 Allowed Pre-proline 0 N--CA 1.468 0.444 0 C-N-CA 123.364 0.666 . . . . 72.140000000000001 111.512 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -74.55 64.51 5.62 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.619 2.213 . . . . 61.409999999999997 112.288 177.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -162.83 101.96 1.01 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.717 -0.674 . . . . 74.519999999999996 110.237 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -151.87 -51.6 0.12 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.206 -0.452 . . . . 74.239999999999995 110.153 177.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 160.8 101.05 0.16 Allowed Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 111.186 -0.766 . . . . 62.439999999999998 111.186 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -139.09 -15.97 1.1 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 111.832 0.308 . . . . 64.099999999999994 111.832 -174.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 58.26 66.2 1.14 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.341 0.591 . . . . 71.25 109.899 -174.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.0 tp -87.45 94.63 9.75 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.843 -0.617 . . . . 62.32 110.07 -178.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 90.0 mt -118.76 -66.85 1.03 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.929 -0.578 . . . . 52.439999999999998 110.428 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 58.0 t30 57.48 76.17 0.33 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.648 -0.705 . . . . 73.200000000000003 110.072 -174.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 49.1 m -77.44 84.72 3.84 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.706 -0.679 . . . . 71.349999999999994 110.951 -176.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.62 173.59 6.27 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.431 -0.804 . . . . 74.120000000000005 109.698 174.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 21.7 tp60 -81.25 -45.82 15.71 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 121.08 -0.248 . . . . 65.310000000000002 110.889 -177.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 67.94 166.32 0.24 Allowed 'General case' 0 N--CA 1.466 0.345 0 O-C-N 123.834 0.709 . . . . 75.25 111.644 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -112.52 -85.37 0.58 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.1 -0.5 . . . . 75.530000000000001 110.809 -178.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.554 HD22 ' HA ' ' A' ' 35' ' ' LYS . 64.4 t30 59.71 -174.46 0.11 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.709 -0.678 . . . . 64.010000000000005 110.412 -177.126 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.6 m -123.36 101.05 7.14 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 122.069 -0.395 . . . . 74.209999999999994 110.699 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.735 ' O ' ' HD3' ' A' ' 35' ' ' LYS . 16.9 t80 67.1 27.41 8.61 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 115.821 -0.627 . . . . 74.430000000000007 109.655 175.064 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.735 ' HD3' ' O ' ' A' ' 34' ' ' TYR . 0.0 OUTLIER 49.85 12.57 0.08 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.488 1.515 . . . . 71.430000000000007 113.689 179.602 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -120.62 161.93 37.12 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 109.256 -0.646 . . . . 74.530000000000001 109.256 175.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.784 ' HB3' ' HB2' ' A' ' 42' ' ' ASP . 76.6 Cg_exo -52.51 144.47 41.17 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.743 2.295 . . . . 70.219999999999999 112.673 178.12 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.9 m -85.33 -80.49 0.21 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.248 -0.433 . . . . 62.109999999999999 112.012 -175.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -164.83 165.71 20.3 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 121.249 -0.18 . . . . 74.420000000000002 111.466 -174.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 59.52 89.07 0.07 Allowed 'General case' 0 N--CA 1.47 0.55 0 O-C-N 124.112 0.883 . . . . 75.200000000000003 112.218 175.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.7 t70 54.84 83.93 0.08 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.497 0.665 . . . . 75.340000000000003 110.693 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.784 ' HB2' ' HB3' ' A' ' 37' ' ' PRO . 1.3 p30 -105.45 -82.82 0.52 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.716 -0.674 . . . . 70.120000000000005 111.503 -176.137 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 55.73 30.56 15.83 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.037 0.446 . . . . 75.219999999999999 111.886 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -92.81 12.68 69.34 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.693 -0.765 . . . . 74.519999999999996 111.838 178.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.488 HG13 ' HG2' ' A' ' 37' ' ' PRO . 48.2 mt -86.32 -36.39 10.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.089 0.471 . . . . 75.239999999999995 110.369 -178.034 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -81.47 -0.43 41.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.782 -0.644 . . . . 65.319999999999993 111.807 -176.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 33.4 m -116.17 86.06 16.56 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 109.489 -0.56 . . . . 60.32 109.489 174.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -61.48 104.76 0.32 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.107 2.538 . . . . 72.099999999999994 112.292 -175.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.1 p -134.29 -75.61 0.47 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.538 -0.755 . . . . 71.450000000000003 110.356 178.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.54 -37.26 71.16 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.936 0.398 . . . . 71.230000000000004 110.63 177.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.409 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 3.7 pp -97.56 9.92 41.21 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.826 -0.625 . . . . 73.420000000000002 110.797 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.439 ' O ' ' HB2' ' A' ' 56' ' ' GLN . 32.7 t70 -59.09 -52.92 63.67 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.813 -0.631 . . . . 63.020000000000003 111.165 -176.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -62.37 -40.48 96.58 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.942 -0.572 . . . . 73.010000000000005 110.374 -176.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.583 ' O ' HG13 ' A' ' 58' ' ' ILE . 76.7 t80 -60.11 -63.81 1.17 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.728 -0.669 . . . . 74.25 111.826 -178.418 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.8 t -69.08 -19.54 64.07 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.876 0.325 . . . . 75.409999999999997 111.876 -172.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.439 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 2.7 mp0 -82.38 -36.26 26.95 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.741 0.305 . . . . 51.200000000000003 110.498 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.96 -30.69 71.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 74.219999999999999 110.474 176.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.721 ' O ' ' HG2' ' A' ' 61' ' ' GLN . 10.6 mt -70.09 -46.16 73.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.028 -0.533 . . . . 75.030000000000001 110.38 177.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -66.06 -18.88 65.63 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.167 0.508 . . . . 51.229999999999997 110.456 178.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 66.1 m -84.19 -3.26 58.04 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.074 -0.512 . . . . 73.340000000000003 111.61 177.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.721 ' HG2' ' O ' ' A' ' 58' ' ' ILE . 9.1 pt20 -105.96 -2.13 23.22 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.149 0.499 . . . . 64.209999999999994 110.089 177.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 51.6 mm -76.48 -30.53 19.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.818 -0.628 . . . . 75.120000000000005 110.886 -176.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.724 ' H ' HD22 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -61.13 -43.85 98.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.082 -0.508 . . . . 74.530000000000001 110.198 -177.245 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -83.98 -31.86 25.09 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.954 -0.641 . . . . 54.140000000000001 111.604 176.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.82 -24.26 66.37 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 121.405 -0.426 . . . . 33.530000000000001 112.833 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.444 ' O ' HG12 ' A' ' 70' ' ' ILE . 9.7 tt -55.58 -40.9 72.6 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.826 -0.435 . . . . 72.230000000000004 109.826 176.153 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.7 mp -80.53 13.2 2.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.042 -0.526 . . . . 70.319999999999993 111.223 -178.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.412 ' HA ' ' ND2' ' A' ' 71' ' ' ASN . 26.2 t -115.97 -21.01 9.7 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.189 0.518 . . . . 75.109999999999999 109.664 174.273 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -83.77 -26.78 29.37 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.954 -0.566 . . . . 53.439999999999998 110.489 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.444 HG12 ' O ' ' A' ' 66' ' ' LEU . 35.8 mm -84.34 -4.8 8.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.805 -0.634 . . . . 71.409999999999997 110.634 -177.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.412 ' ND2' ' HA ' ' A' ' 68' ' ' SER . 94.5 m-20 -80.21 7.27 9.74 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.34 -0.391 . . . . 61.43 111.696 -177.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 67.9 p 53.3 -163.61 0.09 Allowed 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.291 0.636 . . . . 53.310000000000002 111.711 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.439 ' HA3' HD11 ' A' ' 94' ' ' LEU . . . 122.19 -63.13 0.53 Allowed Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.784 -0.722 . . . . 71.019999999999996 111.333 178.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 1.103 ' HB3' ' HB ' ' A' ' 87' ' ' ILE . 14.4 pttm -57.48 143.43 74.68 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-O 120.55 0.214 . . . . 51.439999999999998 110.99 172.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -81.72 -10.82 11.71 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.4 2.066 . . . . 65.030000000000001 111.231 173.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 165.0 150.03 6.04 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 114.836 -1.075 . . . . 72.120000000000005 110.84 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 11.9 ptp85 -97.04 171.71 8.3 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.901 -0.407 . . . . 45.020000000000003 109.901 177.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 51.8 ttm -125.72 113.45 17.35 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.1 0.476 . . . . 73.310000000000002 110.227 175.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 23.6 t -95.27 83.95 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.823 -0.626 . . . . 63.219999999999999 109.873 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.81 -179.15 5.81 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.721 -0.672 . . . . 43.310000000000002 110.036 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -74.18 -51.88 14.16 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.727 0.299 . . . . 72.310000000000002 110.632 -177.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -122.76 19.02 10.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.802 0.334 . . . . 75.510000000000005 111.721 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -135.14 111.56 9.81 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.951 0.405 . . . . 63.340000000000003 111.0 177.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.42 HD12 ' N ' ' A' ' 84' ' ' ILE . 4.2 mp -99.97 105.56 17.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.834 -0.621 . . . . 71.040000000000006 109.477 177.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.441 ' HB ' HG23 ' A' ' 98' ' ' VAL . 6.3 p -117.78 121.63 67.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.24 0.543 . . . . 64.329999999999998 110.547 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -138.38 134.7 34.49 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.591 -0.731 . . . . 74.510000000000005 110.27 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 1.103 ' HB ' ' HB3' ' A' ' 74' ' ' LYS . 54.0 mt -89.92 101.41 12.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.112 -0.495 . . . . 73.150000000000006 110.102 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -90.85 156.43 18.03 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.972 -0.558 . . . . 54.140000000000001 110.038 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.552 ' HA ' ' O ' ' A' ' 93' ' ' GLN . 47.7 t-20 -127.53 127.28 43.69 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.016 0.436 . . . . 62.210000000000001 110.249 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -133.69 115.51 14.69 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.872 -0.604 . . . . 75.439999999999998 110.069 175.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 62.47 29.69 17.14 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.142 -0.481 . . . . 71.019999999999996 111.451 175.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.39 28.27 33.67 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.713 -0.756 . . . . 75.319999999999993 112.531 178.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.552 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 26.4 mm-40 -119.53 123.36 43.79 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.798 -0.445 . . . . 62.409999999999997 109.798 175.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.439 HD11 ' HA3' ' A' ' 73' ' ' GLY . 4.0 mm? -93.34 122.93 36.25 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.052 -0.522 . . . . 52.240000000000002 109.621 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.919 ' HG2' ' HG2' ' A' ' 110' ' ' GLN . 76.6 mt-30 -118.18 106.73 13.14 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.165 -0.471 . . . . 55.530000000000001 111.714 -177.126 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 54.1 tp -78.09 86.95 4.23 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.252 -1.018 . . . . 75.109999999999999 108.252 172.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -113.1 111.55 22.31 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.987 -0.551 . . . . 43.409999999999997 110.83 -172.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.441 HG23 ' HB ' ' A' ' 85' ' ' VAL . 7.2 p -107.39 135.23 46.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.51 -0.768 . . . . 72.019999999999996 110.718 -177.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 29.1 m -116.72 124.41 49.6 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.145 -0.48 . . . . 64.319999999999993 110.815 178.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.474 ' HB3' ' H ' ' A' ' 105' ' ' GLN . 11.2 t0 -71.64 137.21 47.72 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.224 -0.658 . . . . 63.399999999999999 109.224 175.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.585 ' HD2' ' O ' ' A' ' 101' ' ' ARG . 3.5 tmm_? -82.16 -28.37 32.16 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.897 0.379 . . . . 70.420000000000002 110.554 -176.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt -103.57 -49.46 3.68 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.164 -0.471 . . . . 73.140000000000001 111.114 -174.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.608 ' HB ' ' HG2' ' A' ' 105' ' ' GLN . 0.2 OUTLIER -88.23 -14.64 37.98 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.748 -0.66 . . . . 72.120000000000005 110.899 -175.292 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 67.34 17.09 68.0 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.87 -0.605 . . . . 65.239999999999995 113.362 178.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.608 ' HG2' ' HB ' ' A' ' 103' ' ' THR . 14.9 mm100 -62.57 123.84 19.41 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.135 -0.32 . . . . 72.040000000000006 110.135 176.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 20.8 m -110.22 97.34 6.84 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.031 -0.531 . . . . 61.32 109.889 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.0 t -103.37 104.28 14.37 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.161 -0.472 . . . . 71.150000000000006 109.935 -177.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 28.7 m -101.1 103.15 14.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.894 -0.594 . . . . 61.340000000000003 111.182 -178.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 4.4 mp -98.5 97.8 6.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.071 0.462 . . . . 73.010000000000005 109.882 176.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.919 ' HG2' ' HG2' ' A' ' 95' ' ' GLN . 69.4 mt-30 -75.62 166.64 23.25 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.144 -0.48 . . . . 61.100000000000001 110.334 177.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.9 p -55.76 101.4 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.569 0.699 . . . . 75.109999999999999 110.331 173.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 6.5 m -129.52 -5.04 4.75 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.711 -0.677 . . . . 73.519999999999996 110.428 -176.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -81.91 -84.98 0.76 Allowed Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 120.858 -0.687 . . . . 53.210000000000001 112.579 -175.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 89.2 mt 66.94 -81.37 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 108.856 -0.794 . . . . 71.239999999999995 108.856 -173.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 42.73 53.29 4.89 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 124.327 1.017 . . . . 62.340000000000003 112.442 166.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -64.51 101.62 0.47 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.249 0.547 . . . . 63.439999999999998 109.878 -178.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -80.77 118.72 22.55 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.317 -0.856 . . . . 61.130000000000003 109.629 -176.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.1 m -132.43 174.82 9.86 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.601 0.238 . . . . 75.219999999999999 110.783 -176.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 4.6 m 70.61 20.83 5.63 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.761 0.791 . . . . 73.200000000000003 110.48 178.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -101.02 96.85 7.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.834 -0.621 . . . . 62.409999999999997 109.351 173.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -95.72 103.63 15.52 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.329 0.585 . . . . 75.239999999999995 110.146 -177.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -119.77 93.98 4.25 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.308 -0.86 . . . . 74.340000000000003 109.237 -175.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 3.6 p80 -145.14 94.51 2.54 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.532 0.682 . . . . 64.150000000000006 111.823 -177.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -125.0 -174.73 3.11 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.413 -0.812 . . . . 75.209999999999994 109.503 173.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 63.15 37.5 11.35 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 107.874 -1.158 . . . . 71.409999999999997 107.874 -170.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -103.47 132.89 49.34 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 114.562 -1.199 . . . . 73.129999999999995 110.708 -175.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 . . . . . 0 C--O 1.245 0.834 0 N-CA-C 109.032 -0.729 . . . . 54.43 109.032 178.228 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.3 mtt . . . . . 0 N--CA 1.479 0.982 0 N-CA-C 110.166 -0.309 . . . . 75.5 110.166 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 58.81 -161.0 0.26 Allowed 'General case' 0 C--O 1.235 0.311 0 O-C-N 123.636 0.585 . . . . 74.230000000000004 111.008 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 94.8 -12.0 69.11 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.821 -0.704 . . . . 65.140000000000001 112.572 177.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.8 m 58.55 83.3 0.12 Allowed 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.549 0.69 . . . . 72.25 110.935 -179.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 12.7 tpt -92.03 151.6 20.38 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.654 -0.703 . . . . 75.430000000000007 110.403 -177.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 25.3 m 68.8 97.03 0.06 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.821 -0.627 . . . . 74.209999999999994 111.091 178.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -68.19 114.38 6.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.139 -0.482 . . . . 75.040000000000006 109.931 177.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.1 tm0? -85.01 -34.86 22.26 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.98 -0.554 . . . . 73.409999999999997 109.959 -175.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 19.3 t80 55.9 30.73 16.49 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.703 -0.68 . . . . 73.239999999999995 111.658 173.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 37.3 mtt180 53.18 54.62 10.01 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.188 0.518 . . . . 72.030000000000001 112.397 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.421 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 34.5 m-80 -93.26 145.33 29.83 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 109.285 -0.635 . . . . 63.140000000000001 109.285 173.019 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 11' ' ' ASN . 37.3 Cg_exo -59.98 -36.89 88.43 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.61 2.207 . . . . 71.329999999999998 112.617 -175.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 64.27 153.96 0.06 Allowed 'General case' 0 N--CA 1.473 0.693 0 O-C-N 124.183 0.927 . . . . 75.430000000000007 110.697 -177.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -122.53 137.17 54.97 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 121.925 -0.485 . . . . 75.230000000000004 110.563 -178.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.19 131.39 7.44 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.843 -0.617 . . . . 71.230000000000004 111.701 178.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.66 157.31 34.17 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.827 -0.701 . . . . 73.329999999999998 112.174 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -113.54 151.11 44.23 Favored Pre-proline 0 C--N 1.321 -0.646 0 N-CA-C 110.243 -0.28 . . . . 72.140000000000001 110.243 -177.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -67.46 -19.5 48.97 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 122.713 2.275 . . . . 61.409999999999997 111.934 175.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.6 t30 72.06 -61.78 0.48 Allowed 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.956 0.902 . . . . 74.519999999999996 110.574 178.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -118.66 -63.0 1.46 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.947 -0.57 . . . . 74.239999999999995 109.777 175.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -164.29 40.13 0.31 Allowed Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 111.034 -0.826 . . . . 62.439999999999998 111.034 177.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 65.4 26.2 11.97 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 122.765 0.426 . . . . 64.099999999999994 110.872 -178.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 83.9 t80 66.11 102.67 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.187 -0.915 . . . . 71.25 111.262 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 92.9 mt -123.7 -172.97 2.64 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.712 -0.677 . . . . 62.32 110.083 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 45.47 88.26 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.124 0.969 . . . . 52.439999999999998 112.391 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -68.19 159.57 30.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.232 -0.894 . . . . 73.200000000000003 110.794 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 51.9 m -77.86 87.1 4.08 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.151 0.5 . . . . 71.349999999999994 112.131 -174.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.17 112.11 17.17 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.111 -1.07 . . . . 74.120000000000005 108.111 167.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -75.2 99.53 4.03 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.561 0.696 . . . . 65.310000000000002 111.771 -172.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -176.53 179.97 1.09 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 113.999 -1.455 . . . . 75.25 107.759 176.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -87.72 93.78 9.55 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.085 -0.709 . . . . 75.530000000000001 109.085 174.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -79.05 83.42 5.13 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.649 -0.705 . . . . 64.010000000000005 111.204 -172.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.9 m -86.6 104.79 16.37 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.558 -0.746 . . . . 74.209999999999994 109.839 176.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -138.71 29.73 2.34 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.375 0.607 . . . . 74.430000000000007 109.627 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -96.39 6.05 49.59 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.351 -0.84 . . . . 71.430000000000007 109.879 -177.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -88.31 151.31 48.53 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.584 -0.735 . . . . 74.530000000000001 111.742 -176.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.616 ' HD3' ' HA3' ' A' ' 44' ' ' GLY . 5.1 Cg_endo -47.46 149.3 4.55 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 124.288 3.325 . . . . 70.219999999999999 113.979 175.361 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.2 t -140.31 107.96 5.62 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.652 -0.704 . . . . 62.109999999999999 109.28 177.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.7 t80 60.8 96.84 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 O-C-N 123.825 0.703 . . . . 74.420000000000002 111.613 -179.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 65.5 22.69 11.85 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.18 -0.463 . . . . 75.200000000000003 111.426 177.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.572 ' HA ' ' HB3' ' A' ' 37' ' ' PRO . 24.2 t70 67.03 140.41 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.835 0.826 . . . . 75.340000000000003 111.633 -177.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -122.63 -68.47 0.88 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.668 -0.696 . . . . 70.120000000000005 110.309 -176.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -146.3 23.96 1.29 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.474 0.654 . . . . 75.219999999999999 109.326 -176.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.616 ' HA3' ' HD3' ' A' ' 37' ' ' PRO . . . -109.76 46.12 1.22 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.694 -0.765 . . . . 74.519999999999996 112.888 -172.076 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 62.0 mt -78.18 -66.49 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 110.058 -0.349 . . . . 75.239999999999995 110.058 177.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.462 ' OE1' ' HA ' ' A' ' 46' ' ' GLU . 6.9 mm-40 71.13 -34.36 0.3 Allowed 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.349 0.87 . . . . 65.319999999999993 113.349 175.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.406 ' O ' HG23 ' A' ' 47' ' ' THR . 8.5 t -125.1 85.97 57.37 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-O 121.849 0.833 . . . . 60.32 111.055 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.448 ' HB2' ' HB2' ' A' ' 52' ' ' ASP . 11.5 Cg_exo -71.34 116.76 4.83 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.939 2.426 . . . . 72.099999999999994 111.951 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 14.6 m -98.6 -69.77 0.75 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.633 -0.258 . . . . 71.450000000000003 110.985 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.77 -40.51 18.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.885 0.374 . . . . 71.230000000000004 111.248 -176.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.582 HD23 ' H ' ' A' ' 51' ' ' LEU . 1.9 pt? -69.8 -16.94 63.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 73.420000000000002 110.908 -178.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.518 ' O ' ' HB2' ' A' ' 56' ' ' GLN . 23.1 t70 -57.37 -50.04 74.23 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.112 -0.495 . . . . 63.020000000000003 110.779 -178.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -60.31 -43.19 96.59 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.099 -0.5 . . . . 73.010000000000005 110.826 178.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.474 ' O ' HG12 ' A' ' 58' ' ' ILE . 80.9 t80 -60.6 -53.35 58.52 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.066 -0.515 . . . . 74.25 111.169 -179.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.2 t -68.99 -30.2 68.56 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.783 0.325 . . . . 75.409999999999997 110.784 -177.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.518 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 1.3 tp-100 -64.77 -44.71 89.17 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.145 0.498 . . . . 51.200000000000003 110.047 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.47 -32.99 74.84 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.554 -0.748 . . . . 74.219999999999999 111.109 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.607 ' O ' ' HG2' ' A' ' 61' ' ' GLN . 47.0 mm -66.13 -37.75 80.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.982 0.42 . . . . 75.030000000000001 110.509 177.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -69.48 -38.9 77.89 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.297 -0.41 . . . . 51.229999999999997 110.816 178.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 44.8 m -67.96 -32.14 72.35 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.349 -0.387 . . . . 73.340000000000003 111.404 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.607 ' HG2' ' O ' ' A' ' 58' ' ' ILE . 10.0 pt20 -78.42 -9.44 59.29 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.642 0.258 . . . . 64.209999999999994 111.222 -176.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.53 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 74.3 mt -62.74 -33.07 58.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.934 0.397 . . . . 75.120000000000005 110.088 -178.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 92.5 mt -53.49 -36.38 61.62 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.423 -0.808 . . . . 74.530000000000001 111.635 -178.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.65 -30.42 5.86 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.708 -0.758 . . . . 54.140000000000001 111.967 178.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -58.38 -34.99 77.04 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 121.542 -0.361 . . . . 33.530000000000001 112.952 -178.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' A' ' 62' ' ' ILE . 88.6 mt -56.55 -38.44 71.9 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.873 0.368 . . . . 72.230000000000004 111.063 178.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.1 mt -76.54 -39.18 53.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.045 0.45 . . . . 70.319999999999993 110.468 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 16.5 m -66.18 -37.95 86.85 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.836 -0.62 . . . . 75.109999999999999 111.513 -177.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -76.45 -8.55 57.39 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.966 0.358 . . . . 53.439999999999998 111.966 -175.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 66' ' ' LEU . 43.3 mm -73.12 -35.74 48.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-O 121.419 0.628 . . . . 71.409999999999997 110.195 176.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -68.5 -31.21 70.31 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.581 -0.736 . . . . 61.43 110.797 -177.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.8 p 58.24 9.99 1.15 Allowed 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.23 1.012 . . . . 53.310000000000002 112.15 -176.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -84.36 92.51 1.72 Allowed Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.944 -0.646 . . . . 71.019999999999996 111.525 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.465 ' HD2' ' O ' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -55.8 143.2 61.33 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-O 121.071 0.462 . . . . 51.439999999999998 111.571 178.961 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -83.28 170.5 11.95 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.731 2.287 . . . . 65.030000000000001 112.318 -178.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -147.35 74.53 0.29 Allowed Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 120.597 -0.811 . . . . 72.120000000000005 112.361 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.45 ' O ' ' HG3' ' A' ' 77' ' ' ARG . 18.8 ptt85 -81.31 101.02 9.51 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.334 0.587 . . . . 45.020000000000003 109.617 174.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 57.6 ttp -106.86 109.31 21.18 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.949 -0.569 . . . . 73.310000000000002 110.955 -176.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 48.2 t -70.34 102.94 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.446 -0.576 . . . . 63.219999999999999 109.446 176.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.2 m -109.6 159.68 16.9 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.015 -0.538 . . . . 43.310000000000002 109.597 -177.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -67.82 -47.07 70.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.06 0.457 . . . . 72.310000000000002 110.125 -179.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -72.66 -35.8 67.82 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.843 0.683 . . . . 75.510000000000005 112.843 -176.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.646 ' HB3' HG13 ' A' ' 98' ' ' VAL . 55.1 m-85 -157.24 169.08 25.58 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.897 0.379 . . . . 63.340000000000003 110.828 -175.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.57 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 40.3 mm -97.98 98.93 7.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.364 -0.606 . . . . 71.040000000000006 109.364 169.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 41.3 t -85.31 94.42 3.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.002 -0.544 . . . . 64.329999999999998 110.178 -178.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -98.2 102.7 14.52 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.271 0.558 . . . . 74.510000000000005 110.385 177.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 63.0 mt -88.7 106.46 16.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.657 -0.701 . . . . 73.150000000000006 109.52 175.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -106.32 162.27 13.83 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.269 -0.423 . . . . 54.140000000000001 110.214 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -138.33 123.54 19.26 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.843 0.354 . . . . 62.210000000000001 110.321 178.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 65.0 mtp180 -138.81 132.61 30.87 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.073 -0.512 . . . . 75.439999999999998 109.855 176.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 64.56 17.37 10.83 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 123.629 0.581 . . . . 71.019999999999996 111.051 178.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.06 -26.3 25.18 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 121.113 -0.565 . . . . 75.319999999999993 112.412 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -90.25 140.78 29.35 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.062 0.458 . . . . 62.409999999999997 110.886 -175.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -81.12 144.75 31.47 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.707 -0.678 . . . . 52.240000000000002 110.616 179.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -122.76 107.59 12.09 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.511 -0.551 . . . . 55.530000000000001 109.511 175.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 55.7 tp -82.26 98.8 8.96 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.867 -0.606 . . . . 75.109999999999999 109.425 179.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -107.69 91.84 3.82 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.317 0.58 . . . . 43.409999999999997 110.657 -177.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.646 HG13 ' HB3' ' A' ' 83' ' ' TYR . 21.7 t -82.99 108.1 15.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.679 -0.691 . . . . 72.019999999999996 109.996 176.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.57 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 25.6 m -90.77 111.66 23.13 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.398 -0.819 . . . . 64.319999999999993 108.894 175.36 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.462 ' HA ' ' HD2' ' A' ' 83' ' ' TYR . 13.6 t0 -61.27 133.54 56.0 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.841 -0.618 . . . . 63.399999999999999 111.155 -177.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.463 ' C ' ' HD2' ' A' ' 101' ' ' ARG . 1.1 ppt_? -94.93 -7.92 38.56 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.551 -0.75 . . . . 70.420000000000002 110.461 -178.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -87.17 -71.92 0.54 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.976 -0.556 . . . . 73.140000000000001 110.579 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 57.5 p -97.53 -28.92 13.75 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.278 -0.419 . . . . 72.120000000000005 110.566 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 100' ' ' ASP . . . 102.29 22.73 9.56 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 121.071 -0.585 . . . . 65.239999999999995 112.867 177.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.458 ' N ' ' HB3' ' A' ' 100' ' ' ASP . 49.4 mt-30 -73.98 131.87 41.84 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.732 0.301 . . . . 72.040000000000006 110.545 177.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.5 p -91.41 108.83 20.16 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.234 0.54 . . . . 61.32 111.615 -177.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 10.0 t -96.85 86.07 3.94 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.285 -0.635 . . . . 71.150000000000006 109.285 177.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 87.2 m -91.6 104.81 17.25 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.633 -0.712 . . . . 61.340000000000003 110.671 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 54.8 mt -115.89 105.13 17.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.972 -0.558 . . . . 73.010000000000005 110.487 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -69.97 134.15 48.03 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.9 -0.407 . . . . 61.100000000000001 109.9 175.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 52.1 t -88.64 93.79 4.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.135 0.493 . . . . 75.109999999999999 110.009 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.9 p -170.28 -41.58 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.547 -0.751 . . . . 73.519999999999996 110.644 -176.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 101.39 81.68 1.6 Allowed Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 111.352 -0.699 . . . . 53.210000000000001 111.352 -178.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 96.2 mt -82.45 -69.85 0.59 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 110.721 -0.103 . . . . 71.239999999999995 110.721 -175.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 44.56 33.87 1.0 Allowed 'General case' 0 N--CA 1.474 0.742 0 O-C-N 124.181 0.926 . . . . 62.340000000000003 111.652 -177.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -68.22 -57.53 5.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.702 -0.681 . . . . 63.439999999999998 110.983 -177.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 64.03 171.25 0.18 Allowed 'General case' 0 N--CA 1.469 0.477 0 O-C-N 123.744 0.653 . . . . 61.130000000000003 111.46 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 19.5 m 60.08 -155.94 0.35 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.804 -0.635 . . . . 75.219999999999999 110.719 177.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 49.5 p 58.42 105.61 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.129 0.972 . . . . 73.200000000000003 112.758 177.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 17.6 t70 74.52 120.5 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 114.642 -1.163 . . . . 62.409999999999997 112.094 176.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -149.98 36.76 0.69 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.413 -0.812 . . . . 75.239999999999995 109.339 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 22.8 p-80 -77.33 -29.15 53.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.291 -0.868 . . . . 74.340000000000003 112.364 -170.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 54.6 m-70 63.35 -85.79 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 122.507 0.323 . . . . 64.150000000000006 110.791 -173.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 19.0 p80 -122.76 15.82 10.19 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.132 -0.692 . . . . 75.209999999999994 109.132 175.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 13.1 p-80 57.85 111.69 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.346 1.459 . . . . 71.409999999999997 112.467 -175.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -62.99 -22.6 66.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.676 -1.147 . . . . 73.129999999999995 111.545 175.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 83.2 t60 . . . . . 0 C--O 1.246 0.92 0 CA-C-O 118.801 -0.619 . . . . 54.43 109.477 179.798 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 pmm? . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 109.974 -0.38 . . . . 75.5 109.974 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.47 -76.51 0.13 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.65 0.262 . . . . 74.230000000000004 110.879 -178.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 63.39 67.27 2.14 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 121.011 -0.614 . . . . 65.140000000000001 111.901 -177.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.9 m -130.5 148.37 52.3 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 122.658 -0.319 . . . . 72.25 110.859 -176.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 27.0 ptt? 47.05 93.29 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.655 1.182 . . . . 75.430000000000007 112.904 179.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 21.0 p -84.8 -83.53 0.16 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.356 -0.838 . . . . 74.209999999999994 110.885 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -99.45 123.64 43.9 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.257 -0.429 . . . . 75.040000000000006 110.488 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -120.18 94.5 4.4 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.816 -0.629 . . . . 73.409999999999997 110.028 178.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -94.12 119.23 32.67 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.268 -0.424 . . . . 73.239999999999995 109.945 179.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.4 ' HG3' ' HD3' ' A' ' 12' ' ' PRO . 14.3 ptt180 -91.92 176.72 6.41 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.161 -0.472 . . . . 72.030000000000001 110.435 -178.084 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -117.47 88.31 28.28 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-O 121.316 0.579 . . . . 63.140000000000001 110.541 176.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.4 ' HD3' ' HG3' ' A' ' 10' ' ' ARG . 47.4 Cg_endo -69.51 80.17 0.82 Allowed 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 122.256 1.971 . . . . 71.329999999999998 111.569 178.102 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 66.49 -176.08 0.19 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.366 -0.833 . . . . 75.430000000000007 109.769 -175.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -107.35 177.57 4.8 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 110.089 -0.337 . . . . 75.230000000000004 110.089 -178.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -101.04 175.27 26.02 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.758 -0.734 . . . . 71.230000000000004 111.795 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.97 -106.29 0.64 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.722 -0.751 . . . . 73.329999999999998 112.382 178.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -108.17 142.96 26.42 Favored Pre-proline 0 C--N 1.319 -0.752 0 C-N-CA 121.019 -0.273 . . . . 72.140000000000001 111.349 -177.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -74.05 -33.2 6.23 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 123.046 2.497 . . . . 61.409999999999997 110.396 169.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 29.3 t30 -134.89 123.91 24.17 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.77 -1.104 . . . . 74.519999999999996 108.665 173.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -83.65 140.78 31.96 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.756 0.312 . . . . 74.239999999999995 110.32 -178.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -150.76 -157.88 8.02 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.771 -0.728 . . . . 62.439999999999998 112.079 -178.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 63.63 -166.42 0.23 Allowed 'General case' 0 C--O 1.236 0.377 0 C-N-CA 122.962 0.505 . . . . 64.099999999999994 111.124 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 75.0 t80 75.17 -29.82 0.19 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.499 0.719 . . . . 71.25 111.544 177.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 89.7 mt -66.25 104.33 1.17 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.916 0.389 . . . . 62.32 110.605 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 94.2 mt -122.89 129.71 51.96 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.932 -0.576 . . . . 52.439999999999998 110.208 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -98.31 101.81 13.37 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.267 -0.424 . . . . 73.200000000000003 109.869 176.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.3 m -86.86 176.95 7.44 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.974 -0.557 . . . . 71.349999999999994 110.094 -179.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.4 170.35 16.53 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.394 -0.366 . . . . 74.120000000000005 110.044 176.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 71.69 160.54 0.22 Allowed 'General case' 0 N--CA 1.469 0.475 0 O-C-N 123.848 0.718 . . . . 65.310000000000002 110.471 -175.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 63.84 -166.84 0.22 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.809 -0.632 . . . . 75.25 110.561 -178.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 32.5 mm-40 64.63 18.62 11.49 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.098 0.475 . . . . 75.530000000000001 110.394 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -139.59 -160.2 1.04 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.613 -0.721 . . . . 64.010000000000005 109.164 -179.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.6 t 73.72 80.42 0.13 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.575 0.702 . . . . 74.209999999999994 110.746 175.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -105.2 -14.64 15.31 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.398 -0.819 . . . . 74.430000000000007 110.589 177.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.4 mptt 63.82 34.22 12.06 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 122.472 1.129 . . . . 71.430000000000007 108.269 -167.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.523 ' HB2' ' HD2' ' A' ' 37' ' ' PRO . 8.0 p-10 -79.43 165.61 47.01 Favored Pre-proline 0 N--CA 1.448 -0.536 0 CA-C-N 113.322 -1.763 . . . . 74.530000000000001 110.715 -177.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.523 ' HD2' ' HB2' ' A' ' 36' ' ' ASP . 84.4 Cg_exo -48.24 144.0 13.71 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.537 2.825 . . . . 70.219999999999999 114.564 -174.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 45.4 m -138.14 -63.39 0.56 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.942 -1.026 . . . . 62.109999999999999 108.264 173.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -175.97 106.58 0.08 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.61 -0.723 . . . . 74.420000000000002 109.985 171.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 63.4 t30 75.74 137.27 0.06 Allowed 'General case' 0 N--CA 1.47 0.568 0 O-C-N 124.103 0.877 . . . . 75.200000000000003 111.537 178.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.1 t70 68.93 29.76 4.83 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 122.049 0.928 . . . . 75.340000000000003 109.793 -176.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -83.92 60.79 6.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.004 -0.998 . . . . 70.120000000000005 110.903 -176.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.456 ' CE2' HD22 ' A' ' 51' ' ' LEU . 54.7 m-85 -82.45 5.39 20.68 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.456 -0.338 . . . . 75.219999999999999 111.491 -177.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.08 -15.01 66.84 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.932 -0.651 . . . . 74.519999999999996 112.09 176.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 45.4 mt -78.41 -20.33 13.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.868 -0.419 . . . . 75.239999999999995 109.868 176.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 64.0 86.61 0.12 Allowed 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.192 -0.913 . . . . 65.319999999999993 110.718 -174.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.2 t -139.44 87.91 13.08 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.467 -0.788 . . . . 60.32 110.214 -179.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.464 ' HA ' HD21 ' A' ' 51' ' ' LEU . 15.0 Cg_exo -65.15 100.55 0.38 Allowed 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.647 2.232 . . . . 72.099999999999994 112.757 -176.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.3 p -146.51 -76.18 0.19 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.889 -0.596 . . . . 71.450000000000003 110.111 174.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.68 -45.73 85.4 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.001 -0.545 . . . . 71.230000000000004 110.895 178.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.497 HD23 ' H ' ' A' ' 51' ' ' LEU . 2.6 pt? -79.24 -20.2 48.79 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.984 -0.553 . . . . 73.420000000000002 110.849 179.253 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -57.33 -65.24 0.66 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.893 -0.594 . . . . 63.020000000000003 111.562 -174.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -67.58 -22.85 65.36 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.896 -0.593 . . . . 73.010000000000005 110.701 -176.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.563 ' O ' HG13 ' A' ' 58' ' ' ILE . 23.3 t80 -75.43 -55.91 5.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.812 -0.631 . . . . 74.25 111.287 -178.1 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.3 t -63.41 -26.92 68.96 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.827 0.346 . . . . 75.409999999999997 111.757 -174.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -68.6 -35.5 77.43 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.796 0.332 . . . . 51.200000000000003 110.672 -178.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.53 -29.66 59.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.043 -0.526 . . . . 74.219999999999999 109.944 177.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.563 HG13 ' O ' ' A' ' 54' ' ' PHE . 17.5 mt -65.31 -43.8 94.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.75 -0.659 . . . . 75.030000000000001 110.747 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -64.15 -22.84 67.09 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.283 -0.417 . . . . 51.229999999999997 111.143 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 58.5 m -86.94 -35.18 19.04 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.437 -0.347 . . . . 73.340000000000003 111.385 178.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.541 ' HG2' ' HA ' ' A' ' 58' ' ' ILE . 12.9 pt20 -77.58 -4.57 46.47 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.702 0.26 . . . . 64.209999999999994 111.702 -175.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.549 HG13 ' O ' ' A' ' 58' ' ' ILE . 75.4 mt -61.9 -36.26 72.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.906 0.384 . . . . 75.120000000000005 110.173 -178.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 8.5 mp -56.79 -47.16 80.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.573 -0.74 . . . . 74.530000000000001 110.302 178.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -69.01 -39.14 85.01 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.839 -0.696 . . . . 54.140000000000001 112.025 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.45 -43.36 98.83 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 121.234 -0.508 . . . . 33.530000000000001 112.216 178.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 62' ' ' ILE . 94.8 mt -58.08 -50.02 74.93 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.651 0.262 . . . . 72.230000000000004 110.757 178.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.72 HD13 ' HA ' ' A' ' 91' ' ' ASP . 96.4 mt -62.65 -30.52 71.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.125 -0.489 . . . . 70.319999999999993 111.561 -177.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 30.6 t -82.59 -35.09 27.4 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.021 0.438 . . . . 75.109999999999999 110.499 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -85.71 13.57 6.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.297 -0.41 . . . . 53.439999999999998 111.834 -177.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.429 HG12 ' O ' ' A' ' 66' ' ' LEU . 47.8 mm -71.73 -29.57 34.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 108.691 -0.855 . . . . 71.409999999999997 108.691 169.281 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -89.99 29.68 1.17 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.466 -0.788 . . . . 61.43 110.499 -177.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.4 p -74.84 -56.97 4.22 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.455 -0.572 . . . . 53.310000000000002 109.455 173.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -104.14 82.61 0.37 Allowed Glycine 0 N--CA 1.442 -0.916 0 N-CA-C 110.586 -1.006 . . . . 71.019999999999996 110.586 171.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.505 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 0.5 OUTLIER -55.86 144.28 57.68 Favored Pre-proline 0 C--O 1.235 0.34 0 CA-C-O 120.917 0.389 . . . . 51.439999999999998 111.869 -176.386 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.505 ' HD3' ' HA ' ' A' ' 74' ' ' LYS . 7.6 Cg_exo -73.37 -164.38 0.2 Allowed 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 123.332 2.688 . . . . 65.030000000000001 112.535 -178.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -59.12 107.4 1.19 Allowed Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.778 -0.647 . . . . 72.120000000000005 112.711 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 24.6 ptt180 -103.52 149.98 24.34 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 110.397 -0.223 . . . . 45.020000000000003 110.397 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 49.4 ttm -79.07 103.97 9.38 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.951 0.405 . . . . 73.310000000000002 110.1 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 60.0 t -85.6 95.79 4.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.337 0.589 . . . . 63.219999999999999 109.913 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.546 ' OG1' ' HB2' ' A' ' 83' ' ' TYR . 1.5 p -103.09 -179.09 3.85 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.506 -0.77 . . . . 43.310000000000002 109.925 176.227 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 13.3 t30 -85.52 -43.66 13.35 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 111.64 0.237 . . . . 72.310000000000002 111.64 -175.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.596 ' OD1' ' HD3' ' A' ' 101' ' ' ARG . 15.3 t70 -108.54 0.95 21.14 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.981 0.42 . . . . 75.510000000000005 111.91 -174.285 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.546 ' HB2' ' OG1' ' A' ' 80' ' ' THR . 96.3 m-85 -121.95 124.77 44.83 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 122.07 -0.394 . . . . 63.340000000000003 110.949 177.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.553 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 4.1 mp -101.1 88.53 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.4 -0.963 . . . . 71.040000000000006 108.4 171.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.5 p -126.88 137.29 58.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.041 -0.527 . . . . 64.329999999999998 111.344 -172.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -141.76 152.22 43.58 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.765 -0.652 . . . . 74.510000000000005 110.037 175.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 71.2 mt -92.58 115.4 31.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.675 -0.693 . . . . 73.150000000000006 110.452 -176.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -110.93 114.15 27.25 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.207 -0.451 . . . . 54.140000000000001 110.663 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -90.98 87.35 6.58 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.337 0.589 . . . . 62.210000000000001 109.718 174.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.412 ' HG2' ' HB2' ' A' ' 91' ' ' ASP . 43.7 ttt180 -109.27 139.57 44.04 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.674 -0.694 . . . . 75.439999999999998 110.001 177.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.72 ' HA ' HD13 ' A' ' 67' ' ' LEU . 4.7 t70 68.12 20.89 8.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.564 0.697 . . . . 71.019999999999996 110.218 172.119 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.73 20.77 79.84 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.456 -0.793 . . . . 75.319999999999993 112.376 -178.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 9.1 mm-40 -124.43 140.92 52.49 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.763 -0.458 . . . . 62.409999999999997 109.763 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -79.39 117.5 20.42 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.699 -0.482 . . . . 52.240000000000002 109.699 176.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -123.57 122.07 37.23 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.227 -0.442 . . . . 55.530000000000001 110.733 -176.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 20.1 tp -99.8 106.47 18.35 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.73 -0.668 . . . . 75.109999999999999 109.849 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 21.2 m-80 -95.01 95.6 8.71 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.46 -0.337 . . . . 43.409999999999997 110.401 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.46 ' HB ' ' HB2' ' A' ' 107' ' ' SER . 93.5 t -87.83 102.38 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.495 0 CA-C-O 121.321 0.581 . . . . 72.019999999999996 110.578 179.016 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.553 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 68.9 m -86.09 107.98 18.07 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.537 -0.756 . . . . 64.319999999999993 109.835 177.324 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.5 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 24.2 t70 -63.66 145.04 56.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.805 -0.634 . . . . 63.399999999999999 111.286 -178.042 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.596 ' HD3' ' OD1' ' A' ' 82' ' ' ASP . 33.2 ttt180 -92.94 -22.24 19.33 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.545 -0.752 . . . . 70.420000000000002 110.685 -178.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 35.0 mttp -80.25 -68.62 0.66 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.371 0.605 . . . . 73.140000000000001 110.545 -176.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 45.8 p -90.47 -43.0 10.54 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.476 -0.784 . . . . 72.120000000000005 110.031 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.5 ' HA2' ' O ' ' A' ' 100' ' ' ASP . . . 111.25 4.37 27.25 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 115.472 -0.786 . . . . 65.239999999999995 112.904 176.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -61.67 133.61 55.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.914 0.388 . . . . 72.040000000000006 110.631 175.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 62.6 m -92.17 100.31 12.95 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.614 -0.513 . . . . 61.32 109.614 174.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.46 ' HB2' ' HB ' ' A' ' 98' ' ' VAL . 14.1 m -73.85 101.25 3.7 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.724 -0.671 . . . . 71.150000000000006 109.294 177.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -89.53 94.84 10.02 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.015 -0.539 . . . . 61.340000000000003 110.808 -174.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 35.0 mm -99.87 101.22 11.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.826 -0.624 . . . . 73.010000000000005 110.371 -177.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -78.24 154.68 30.81 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.425 -0.352 . . . . 61.100000000000001 110.658 175.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.2 p -54.83 126.65 12.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.565 -0.743 . . . . 75.109999999999999 111.232 178.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 35.6 t -159.63 156.19 27.49 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.125 -0.489 . . . . 73.519999999999996 110.212 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -155.57 26.1 0.59 Allowed Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 110.936 -0.866 . . . . 53.210000000000001 110.936 176.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 83.9 mt -103.78 81.59 1.9 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 120.985 0.421 . . . . 71.239999999999995 111.327 -174.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -117.6 38.95 3.45 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.991 -0.55 . . . . 62.340000000000003 109.68 176.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -82.86 119.14 24.0 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.623 -0.717 . . . . 63.439999999999998 110.683 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -150.06 -69.16 0.2 Allowed 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.648 -0.871 . . . . 61.130000000000003 108.648 176.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 11.2 t 55.19 74.67 0.35 Allowed 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.344 -0.844 . . . . 75.219999999999999 110.941 176.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 85.5 m -152.79 127.72 9.63 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.853 -0.612 . . . . 73.200000000000003 110.181 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -87.44 92.7 9.18 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.162 0.506 . . . . 62.409999999999997 109.781 176.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -123.36 127.92 49.16 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.781 -0.645 . . . . 75.239999999999995 110.548 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -90.49 -73.82 0.51 Allowed 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.688 -0.856 . . . . 74.340000000000003 108.688 175.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 33.3 m80 63.35 104.11 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.333 -0.849 . . . . 64.150000000000006 112.965 175.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -160.96 -24.04 0.06 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.392 -0.822 . . . . 75.209999999999994 109.975 173.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 67.4 -176.17 0.2 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.747 -0.661 . . . . 71.409999999999997 111.593 178.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -132.57 133.32 43.55 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.727 -0.669 . . . . 73.129999999999995 109.888 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.022 -0.989 . . . . 54.43 109.681 173.56 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.477 0.898 0 N-CA-C 110.229 -0.286 . . . . 75.5 110.229 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 66.76 -68.48 0.14 Allowed 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.971 0.795 . . . . 74.230000000000004 110.832 -176.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.533 ' O ' ' HG3' ' A' ' 5' ' ' MET . . . -170.3 85.12 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 111.024 -0.831 . . . . 65.140000000000001 111.024 177.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.8 m -68.83 108.63 3.52 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.963 0.411 . . . . 72.25 110.296 -178.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.533 ' HG3' ' O ' ' A' ' 3' ' ' GLY . 52.2 mtt -114.57 124.54 52.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.344 -0.389 . . . . 75.430000000000007 111.122 -174.542 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.1 t -141.7 -43.47 0.35 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.098 -0.501 . . . . 74.209999999999994 109.926 174.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 56.39 112.94 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.909 0.884 . . . . 75.040000000000006 112.107 179.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -99.08 90.62 4.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.146 -0.479 . . . . 73.409999999999997 111.013 -176.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -119.25 101.07 7.72 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.757 -0.656 . . . . 73.239999999999995 109.864 177.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.408 ' O ' ' HB2' ' A' ' 11' ' ' ASN . 25.0 mmt180 -124.63 -71.55 0.71 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.31 -0.404 . . . . 72.030000000000001 110.662 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 10' ' ' ARG . 94.3 m-20 71.02 147.84 0.12 Allowed Pre-proline 0 N--CA 1.47 0.568 0 O-C-N 123.878 0.736 . . . . 63.140000000000001 111.533 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 11' ' ' ASN . 32.3 Cg_exo -58.33 -52.77 5.01 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.963 2.442 . . . . 71.329999999999998 112.439 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 62.61 81.64 0.2 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.924 -0.58 . . . . 75.430000000000007 111.042 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -85.64 165.72 16.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.858 -0.61 . . . . 75.230000000000004 110.762 -179.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -111.47 -56.99 0.47 Allowed Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 111.323 -0.711 . . . . 71.230000000000004 111.323 176.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.16 175.1 30.3 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.848 -0.691 . . . . 73.329999999999998 112.523 178.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -123.69 150.5 61.93 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 109.896 -0.409 . . . . 72.140000000000001 109.896 -177.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -64.32 -37.05 42.18 Favored 'Trans proline' 0 C--O 1.236 0.399 0 C-N-CA 122.829 2.353 . . . . 61.409999999999997 112.793 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 60.6 t30 71.04 139.8 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 O-C-N 123.83 0.706 . . . . 74.519999999999996 111.051 -178.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -116.46 143.69 45.26 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.075 -0.511 . . . . 74.239999999999995 109.976 -178.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -111.14 147.17 17.78 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 121.002 -0.618 . . . . 62.439999999999998 111.691 178.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -128.81 132.7 47.86 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.843 0.322 . . . . 64.099999999999994 110.524 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -132.02 105.93 7.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.274 0.559 . . . . 71.25 110.602 178.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.3 mp -128.35 95.05 4.04 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.671 -0.695 . . . . 62.32 110.421 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.9 mp -123.85 -51.7 1.8 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.436 -0.347 . . . . 52.439999999999998 110.175 178.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 54.1 t30 65.7 -85.34 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 O-C-N 123.902 0.751 . . . . 73.200000000000003 110.782 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.4 p -173.74 130.55 0.42 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.918 -0.401 . . . . 71.349999999999994 109.918 179.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -111.32 86.99 2.44 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.072 -0.513 . . . . 74.120000000000005 109.705 178.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -120.83 123.44 42.59 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.16 -0.473 . . . . 65.310000000000002 110.741 -178.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -132.95 84.63 2.15 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.924 -0.58 . . . . 75.25 110.192 177.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -106.22 141.44 37.55 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.167 -0.47 . . . . 75.530000000000001 110.206 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -109.88 96.75 6.45 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.055 -0.521 . . . . 64.010000000000005 110.863 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.5 p -91.77 107.53 19.27 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.963 -0.754 . . . . 74.209999999999994 108.963 172.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -81.1 -16.06 54.17 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.328 0.492 . . . . 74.430000000000007 112.328 -167.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.529 ' O ' ' HB2' ' A' ' 42' ' ' ASP . 59.0 tttt -87.93 79.34 8.08 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.439 0.638 . . . . 71.430000000000007 110.321 -176.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.557 ' HB2' ' HD2' ' A' ' 37' ' ' PRO . 2.0 p30 -103.22 165.06 14.26 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.256 -0.884 . . . . 74.530000000000001 110.9 -176.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.557 ' HD2' ' HB2' ' A' ' 36' ' ' ASP . 46.0 Cg_endo -69.77 -34.57 14.26 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.43 2.087 . . . . 70.219999999999999 112.404 177.294 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 70.8 m -159.22 -54.61 0.06 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.134 -0.485 . . . . 62.109999999999999 109.833 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -175.81 146.61 0.74 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.915 -0.584 . . . . 74.420000000000002 109.754 173.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.7 t30 71.37 103.97 0.06 Allowed 'General case' 0 N--CA 1.469 0.482 0 O-C-N 123.762 0.664 . . . . 75.200000000000003 110.916 177.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.2 t70 71.51 113.9 0.05 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.026 -0.988 . . . . 75.340000000000003 111.125 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.529 ' HB2' ' O ' ' A' ' 35' ' ' LYS . 8.5 p-10 -82.68 -11.07 58.62 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.481 -0.781 . . . . 70.120000000000005 110.956 -176.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -83.78 9.35 12.09 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.044 -0.525 . . . . 75.219999999999999 110.818 -178.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -80.08 10.92 38.62 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.071 -0.585 . . . . 74.519999999999996 112.341 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 63.1 mt -85.31 -52.5 12.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.913 0.387 . . . . 75.239999999999995 110.176 178.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -115.59 138.71 50.79 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.307 -0.406 . . . . 65.319999999999993 110.094 176.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 25.2 m -119.71 87.73 38.01 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 115.977 -0.556 . . . . 60.32 111.002 -177.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.423 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 21.0 Cg_endo -61.44 127.91 23.27 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.469 2.112 . . . . 72.099999999999994 111.556 178.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.8 m -121.93 -42.32 2.4 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.108 0.48 . . . . 71.450000000000003 110.526 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -87.55 -36.09 17.76 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.032 -0.531 . . . . 71.230000000000004 110.707 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.429 ' O ' HG22 ' A' ' 55' ' ' THR . 0.6 OUTLIER -98.06 5.07 49.1 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.51 -0.314 . . . . 73.420000000000002 110.725 180.0 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.423 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 39.4 t0 -57.3 -64.28 0.94 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.011 -0.54 . . . . 63.020000000000003 111.54 -175.116 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -66.01 -26.11 67.38 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.326 -0.397 . . . . 73.010000000000005 110.864 -177.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.538 ' O ' HG13 ' A' ' 58' ' ' ILE . 89.0 t80 -69.62 -60.41 2.34 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.96 -0.564 . . . . 74.25 111.266 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.429 HG22 ' O ' ' A' ' 51' ' ' LEU . 12.9 t -74.04 -20.39 60.32 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.565 0.221 . . . . 75.409999999999997 111.48 -172.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -76.14 -33.42 59.4 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.83 0.348 . . . . 51.200000000000003 110.543 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.94 -24.02 60.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.147 0.498 . . . . 74.219999999999999 110.585 178.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.557 ' O ' HG13 ' A' ' 62' ' ' ILE . 16.1 mt -72.67 -26.69 24.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.74 -0.664 . . . . 75.030000000000001 110.718 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -56.76 -37.72 71.46 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.734 0.302 . . . . 51.229999999999997 110.958 -178.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.9 m -63.94 -43.19 96.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.089 -0.505 . . . . 73.340000000000003 111.436 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -79.81 -21.96 43.62 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 121.026 -0.269 . . . . 64.209999999999994 111.232 -175.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.557 HG13 ' O ' ' A' ' 58' ' ' ILE . 79.9 mt -66.05 -35.95 76.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.064 0.459 . . . . 75.120000000000005 109.84 177.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 92.3 mt -57.23 -46.47 82.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.579 -0.737 . . . . 74.530000000000001 111.121 178.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -65.89 -37.48 93.34 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.86 -0.686 . . . . 54.140000000000001 111.914 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.14 -40.67 99.26 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.983 -0.627 . . . . 33.530000000000001 112.055 178.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.8 mt -61.98 -41.08 97.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.0 0.428 . . . . 72.230000000000004 110.904 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.3 mt -67.37 -32.17 72.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.096 -0.502 . . . . 70.319999999999993 110.726 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.3 t -70.55 -24.8 62.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.906 -0.588 . . . . 75.109999999999999 110.551 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -69.89 -11.59 60.98 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.295 -0.411 . . . . 53.439999999999998 111.663 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 47.1 mm -87.68 -17.25 8.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.424 0.63 . . . . 71.409999999999997 109.965 178.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -106.69 -52.16 2.82 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.824 -0.626 . . . . 61.43 110.786 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 21.5 p 51.39 30.18 5.89 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 114.12 1.155 . . . . 53.310000000000002 114.12 175.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -157.61 15.44 0.31 Allowed Glycine 0 CA--C 1.517 0.18 0 C-N-CA 120.141 -1.028 . . . . 71.019999999999996 112.954 177.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.46 ' HD3' ' H ' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -57.67 144.08 74.16 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.747 0.308 . . . . 51.439999999999998 111.56 -178.889 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 74' ' ' LYS . 5.4 Cg_exo -80.0 -17.64 10.6 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.768 2.312 . . . . 65.030000000000001 111.273 172.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 119.76 -125.93 6.52 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.807 -0.633 . . . . 72.120000000000005 111.76 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.437 HH11 ' HD2' ' A' ' 77' ' ' ARG . 14.5 ptt180 -139.93 164.47 29.9 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.766 -0.457 . . . . 45.020000000000003 109.766 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.498 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 26.1 ttt -110.19 117.15 32.93 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.862 0.363 . . . . 73.310000000000002 110.393 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.6 p -82.68 90.43 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-O 121.905 0.86 . . . . 63.219999999999999 110.43 178.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.7 ' HB ' ' O ' ' A' ' 83' ' ' TYR . 7.2 m -97.87 134.29 41.2 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.477 -0.783 . . . . 43.310000000000002 109.213 176.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -63.53 -31.9 73.19 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.262 -0.426 . . . . 72.310000000000002 111.379 -175.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.661 ' HA ' ' HG2' ' A' ' 101' ' ' ARG . 37.9 t70 -105.48 -8.18 18.23 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.428 -0.351 . . . . 75.510000000000005 111.871 -175.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.7 ' O ' ' HB ' ' A' ' 80' ' ' THR . 42.2 m-85 -147.98 134.49 19.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.379 0.609 . . . . 63.340000000000003 112.206 -175.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.572 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 49.1 mm -87.17 108.45 18.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.254 -0.647 . . . . 71.040000000000006 109.254 172.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.498 ' HB ' ' HB3' ' A' ' 78' ' ' MET . 60.2 t -116.77 113.57 43.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.752 0.31 . . . . 64.329999999999998 111.374 -174.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -124.0 144.43 49.83 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.219 0.533 . . . . 74.510000000000005 110.135 175.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 62.0 mt -102.19 113.53 38.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.83 -0.623 . . . . 73.150000000000006 110.916 -175.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -107.27 110.18 22.15 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.283 -0.417 . . . . 54.140000000000001 110.207 176.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -115.61 110.49 19.27 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.951 0.405 . . . . 62.210000000000001 110.539 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 -142.94 144.02 32.21 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.536 -0.542 . . . . 75.439999999999998 109.536 177.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.59 20.15 11.79 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 123.565 0.541 . . . . 71.019999999999996 111.122 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.93 -2.7 88.1 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.045 -0.598 . . . . 75.319999999999993 112.439 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 20.6 mm-40 -93.55 126.65 38.82 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.821 0.343 . . . . 62.409999999999997 110.827 -178.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -83.88 105.26 14.63 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.01 -0.541 . . . . 52.240000000000002 110.23 174.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -106.62 104.89 14.68 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.994 -0.548 . . . . 55.530000000000001 109.795 178.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 33.6 tp -89.1 111.93 22.79 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.729 -0.669 . . . . 75.109999999999999 110.193 -177.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -95.5 121.1 36.83 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.814 -0.439 . . . . 43.409999999999997 109.814 179.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.572 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 7.9 p -128.11 127.06 67.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 121.44 0.638 . . . . 72.019999999999996 110.742 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.561 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 6.2 m -113.33 123.97 51.37 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.806 -0.633 . . . . 64.319999999999993 110.141 178.355 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.495 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 32.3 t70 -70.91 149.54 46.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.102 -0.499 . . . . 63.399999999999999 110.724 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.661 ' HG2' ' HA ' ' A' ' 82' ' ' ASP . 0.0 OUTLIER -96.73 -11.18 25.4 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.97 -0.292 . . . . 70.420000000000002 110.918 -179.08 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 26.7 mttp -89.91 -64.35 1.15 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.623 0.725 . . . . 73.140000000000001 109.791 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 46.1 p -86.61 -45.17 11.28 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.862 -1.063 . . . . 72.120000000000005 110.066 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.495 ' HA2' ' O ' ' A' ' 100' ' ' ASP . . . 99.02 18.44 24.65 Favored Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 114.902 -1.044 . . . . 65.239999999999995 112.311 -178.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.442 ' HA ' ' OE1' ' A' ' 105' ' ' GLN . 12.3 mm-40 -59.43 134.96 57.49 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 120.809 0.338 . . . . 72.040000000000006 110.284 175.219 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.8 m -108.82 102.47 11.49 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.013 -0.539 . . . . 61.32 109.98 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.404 ' HB3' ' CG1' ' A' ' 98' ' ' VAL . 21.1 t -101.2 125.91 47.87 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.164 -0.471 . . . . 71.150000000000006 110.374 -177.222 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 29.7 m -108.7 97.79 7.39 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.223 0.535 . . . . 61.340000000000003 109.604 174.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 60.3 mt -84.83 105.03 13.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.76 -0.654 . . . . 73.010000000000005 110.574 -177.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' A' ' 110' ' ' GLN . 9.5 pt20 -101.32 104.47 15.48 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.185 0.517 . . . . 61.100000000000001 110.446 179.069 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 10.5 p -67.86 126.99 28.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.972 -0.558 . . . . 75.109999999999999 109.867 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.4 m -116.04 125.3 52.27 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.928 0.394 . . . . 73.519999999999996 110.462 -178.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 168.71 50.93 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.922 -0.656 . . . . 53.210000000000001 111.912 -177.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 89.1 mt -115.18 100.14 7.93 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.246 0.545 . . . . 71.239999999999995 110.582 -178.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -129.02 -36.14 1.79 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.369 -0.832 . . . . 62.340000000000003 110.042 175.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 71.05 128.88 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 O-C-N 124.076 0.86 . . . . 63.439999999999998 111.12 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -81.17 -26.07 36.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.627 -0.715 . . . . 61.130000000000003 111.673 -176.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 49.3 m 62.3 -167.06 0.21 Allowed 'General case' 0 CA--C 1.533 0.317 0 O-C-N 123.299 0.374 . . . . 75.219999999999999 110.327 -176.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.5 p -114.42 -79.62 0.59 Allowed 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.776 -0.369 . . . . 73.200000000000003 111.711 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 19.0 t70 62.38 95.39 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 O-C-N 123.852 0.72 . . . . 62.409999999999997 110.472 -173.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -132.55 125.83 31.44 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.945 -0.571 . . . . 75.239999999999995 109.952 178.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -86.7 107.26 18.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.635 0.731 . . . . 74.340000000000003 110.639 -177.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 13.8 p80 -114.28 118.16 33.15 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.933 -0.766 . . . . 64.150000000000006 108.933 175.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -150.2 142.58 24.3 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.981 -0.554 . . . . 75.209999999999994 110.287 -175.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -114.1 125.39 53.91 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.121 -0.49 . . . . 71.409999999999997 110.758 176.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -93.01 -47.83 6.8 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.197 -1.038 . . . . 73.129999999999995 108.197 169.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 14.0 t-80 . . . . . 0 C--O 1.249 1.046 0 CA-C-N 114.938 -1.028 . . . . 54.43 108.831 174.78 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.479 1.008 0 CA-C-O 120.629 0.252 . . . . 75.5 110.502 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -139.75 118.05 12.04 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.413 -0.358 . . . . 74.230000000000004 110.527 178.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 170.7 39.79 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 111.188 -0.765 . . . . 65.140000000000001 111.188 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.3 m -84.82 88.96 7.44 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.153 0.502 . . . . 72.25 110.82 -175.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 87.1 mtp -95.91 86.42 4.33 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.017 -0.538 . . . . 75.430000000000007 109.997 177.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.4 m -70.24 -53.6 16.28 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.611 -0.722 . . . . 74.209999999999994 110.599 -179.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -84.0 117.54 23.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.146 0.498 . . . . 75.040000000000006 110.186 178.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -138.69 42.9 2.13 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.378 0.608 . . . . 73.409999999999997 110.537 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -91.61 102.93 15.57 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.495 -0.775 . . . . 73.239999999999995 109.531 176.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.02 136.75 38.71 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.256 -0.429 . . . . 72.030000000000001 110.196 -175.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 57.6 t30 66.32 86.27 0.14 Allowed Pre-proline 0 N--CA 1.469 0.516 0 O-C-N 123.665 0.603 . . . . 63.140000000000001 111.642 175.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -68.75 -25.76 33.31 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.915 2.41 . . . . 71.329999999999998 111.637 176.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.3 t30 71.34 116.74 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.604 -0.726 . . . . 75.430000000000007 111.476 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -148.34 110.67 4.65 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.772 -0.649 . . . . 75.230000000000004 110.879 178.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -106.19 115.89 4.93 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 111.378 -0.689 . . . . 71.230000000000004 111.378 175.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -90.15 169.03 34.39 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.73 -0.748 . . . . 73.329999999999998 112.008 -178.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.432 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 12.4 m120 -93.94 143.1 25.93 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 109.927 -0.397 . . . . 72.140000000000001 109.927 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 17' ' ' ASN . 5.1 Cg_exo -77.58 -28.57 5.29 Favored 'Trans proline' 0 CA--C 1.529 0.264 0 C-N-CA 122.946 2.431 . . . . 61.409999999999997 112.39 176.249 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 65.33 179.77 0.19 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.894 -0.594 . . . . 74.519999999999996 111.709 179.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -154.16 135.68 14.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.073 -0.512 . . . . 74.239999999999995 110.657 178.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -172.55 77.65 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.633 -0.794 . . . . 62.439999999999998 112.719 -178.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -149.84 114.36 5.26 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.849 0.357 . . . . 64.099999999999994 110.19 178.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.435 ' HB2' ' HG ' ' A' ' 25' ' ' LEU . 78.6 m-85 -109.1 -25.05 10.87 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.002 -0.545 . . . . 71.25 111.113 -175.488 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.4 mp 59.12 58.15 3.22 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.936 -0.574 . . . . 62.32 110.277 -176.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.435 ' HG ' ' HB2' ' A' ' 23' ' ' PHE . 98.2 mt -84.26 56.58 3.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.633 -0.712 . . . . 52.439999999999998 111.129 -176.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -87.15 81.59 7.95 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.732 -0.47 . . . . 73.200000000000003 109.732 177.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.4 m -89.36 -56.56 3.22 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.034 -0.53 . . . . 71.349999999999994 110.469 -178.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 64.61 -82.38 0.03 OUTLIER 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.668 -0.696 . . . . 74.120000000000005 112.148 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 67.18 -73.59 0.08 Allowed 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 123.377 0.671 . . . . 65.310000000000002 110.727 -174.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 66.95 135.39 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.627 0.771 . . . . 75.25 112.545 177.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.8 mp0 -88.15 8.2 28.06 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.454 -0.793 . . . . 75.530000000000001 109.76 176.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 59.1 t30 69.57 177.53 0.26 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.081 -0.963 . . . . 64.010000000000005 110.709 178.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.7 m -101.78 19.64 17.82 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.127 0.417 . . . . 74.209999999999994 112.127 -175.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 21.8 m-30 -76.91 79.44 3.48 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.292 -0.633 . . . . 74.430000000000007 109.292 174.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -96.82 83.62 3.45 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.321 0.581 . . . . 71.430000000000007 110.839 -175.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.565 ' HB2' ' HD2' ' A' ' 37' ' ' PRO . 5.1 p-10 -162.81 158.26 18.81 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 114.739 -1.119 . . . . 74.530000000000001 108.587 175.036 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.78 ' HG3' ' HA ' ' A' ' 45' ' ' ILE . 10.0 Cg_endo -52.18 151.26 17.42 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 123.432 2.754 . . . . 70.219999999999999 114.571 -173.258 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.9 m 75.6 13.92 2.88 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 114.753 -1.112 . . . . 62.109999999999999 112.147 176.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -121.52 83.77 2.14 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.494 -0.558 . . . . 74.420000000000002 109.494 171.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 57.2 t30 66.84 4.83 3.65 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.34 -0.846 . . . . 75.200000000000003 111.338 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -165.75 134.82 3.25 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.283 -0.636 . . . . 75.340000000000003 109.283 178.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -121.47 25.25 9.49 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.78 0.324 . . . . 70.120000000000005 110.722 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -106.68 -23.52 12.41 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.426 -0.352 . . . . 75.219999999999999 111.062 -176.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.462 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . -83.02 36.91 2.69 Favored Glycine 0 CA--C 1.518 0.223 0 C-N-CA 120.608 -0.806 . . . . 74.519999999999996 112.337 178.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.78 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 61.5 mt -58.86 -56.24 18.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.876 0.369 . . . . 75.239999999999995 111.435 -175.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.594 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 42.0 mt-10 -100.01 28.31 4.93 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.28 -0.418 . . . . 65.319999999999993 110.96 -177.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 20.3 m -107.15 86.64 2.61 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.963 -0.562 . . . . 60.32 109.687 175.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.594 ' HD3' ' O ' ' A' ' 46' ' ' GLU . 23.4 Cg_exo -63.24 98.23 0.21 Allowed 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.53 2.153 . . . . 72.099999999999994 112.225 -175.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.0 m -117.15 -77.79 0.57 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.896 -0.593 . . . . 71.450000000000003 109.91 174.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.86 -41.16 68.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.136 0.493 . . . . 71.230000000000004 110.336 178.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.639 HD23 ' H ' ' A' ' 51' ' ' LEU . 2.1 pt? -73.86 -17.97 60.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.778 -0.646 . . . . 73.420000000000002 111.214 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.467 ' HB2' ' C ' ' A' ' 48' ' ' PRO . 31.8 t70 -61.25 -53.65 54.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.823 0.344 . . . . 63.020000000000003 111.079 -176.367 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -77.43 22.34 0.24 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.902 -0.59 . . . . 73.010000000000005 110.991 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.442 ' O ' HG13 ' A' ' 58' ' ' ILE . 63.5 t80 -132.66 -65.91 0.7 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.321 -0.399 . . . . 74.25 110.731 -178.431 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.412 HG22 ' O ' ' A' ' 51' ' ' LEU . 10.5 t -69.85 -23.79 63.34 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.487 -0.324 . . . . 75.409999999999997 111.633 -173.232 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.43 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 2.2 mp0 -67.6 -30.43 70.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.984 0.421 . . . . 51.200000000000003 110.356 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.6 -26.49 37.79 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.067 -0.515 . . . . 74.219999999999999 110.192 177.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.546 ' O ' HG13 ' A' ' 62' ' ' ILE . 11.3 mt -69.91 -36.39 69.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.897 -0.592 . . . . 75.030000000000001 110.322 179.01 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -67.49 -32.09 72.67 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.068 -0.515 . . . . 51.229999999999997 110.319 178.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 7.1 m -68.45 -39.7 81.38 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.937 -0.574 . . . . 73.340000000000003 110.497 176.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.614 ' O ' ' HA3' ' A' ' 65' ' ' GLY . 12.9 pt20 -82.98 13.24 4.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.98 -0.555 . . . . 64.209999999999994 111.202 -176.251 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.546 HG13 ' O ' ' A' ' 58' ' ' ILE . 74.7 mt -88.79 -58.52 3.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.703 -0.48 . . . . 75.120000000000005 109.703 172.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 89.4 mt -57.97 -62.22 1.98 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.785 -0.643 . . . . 74.530000000000001 111.379 -175.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.59 3.84 78.98 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.406 -0.902 . . . . 54.140000000000001 112.255 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.614 ' HA3' ' O ' ' A' ' 61' ' ' GLN . . . -94.21 -41.59 4.24 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.759 -0.734 . . . . 33.530000000000001 112.395 -178.461 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.409 ' O ' HG12 ' A' ' 70' ' ' ILE . 84.1 mt -60.71 -25.06 66.14 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.066 0.46 . . . . 72.230000000000004 110.463 178.239 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 81.7 mt -63.37 -42.32 98.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.665 -0.698 . . . . 70.319999999999993 110.686 178.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.6 m -68.64 -29.75 68.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.076 0.465 . . . . 75.109999999999999 110.395 179.116 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -66.43 -25.45 66.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.865 -0.607 . . . . 53.439999999999998 110.607 178.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.409 HG12 ' O ' ' A' ' 66' ' ' LEU . 51.6 mm -76.42 -31.84 21.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.173 -0.467 . . . . 71.409999999999997 110.32 178.356 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -79.89 -45.69 18.16 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.118 -0.492 . . . . 61.43 111.298 -178.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 66.3 p 57.37 178.41 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.919 0.888 . . . . 53.310000000000002 111.795 -175.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.01 23.12 76.11 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.938 -0.649 . . . . 71.019999999999996 111.787 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -56.73 142.66 71.27 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.315 -0.442 . . . . 51.439999999999998 112.156 -177.549 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 74' ' ' LYS . 9.8 Cg_endo -90.44 -164.81 0.16 Allowed 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 123.564 2.842 . . . . 65.030000000000001 110.951 173.341 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 176.48 -123.42 0.9 Allowed Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 119.373 -1.394 . . . . 72.120000000000005 113.856 176.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 14.0 ptt180 -59.63 129.59 42.68 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.619 0.97 . . . . 45.020000000000003 113.619 -171.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.579 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 28.4 ttt -122.54 116.65 24.26 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.027 -1.101 . . . . 73.310000000000002 108.027 166.212 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 20.1 t -80.57 102.49 6.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.019 0.438 . . . . 63.219999999999999 112.109 -168.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.609 ' HB ' ' O ' ' A' ' 83' ' ' TYR . 5.9 m -108.11 163.34 13.25 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.114 -0.699 . . . . 43.310000000000002 109.114 174.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -65.08 -46.54 80.72 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.79 0.329 . . . . 72.310000000000002 111.043 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.542 ' HA ' ' HD2' ' A' ' 101' ' ' ARG . 28.2 m-20 -105.51 -79.53 0.56 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.912 0.387 . . . . 75.510000000000005 111.129 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.609 ' O ' ' HB ' ' A' ' 80' ' ' THR . 35.1 m-85 -67.46 122.68 18.49 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.816 -0.629 . . . . 63.340000000000003 111.524 -175.413 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.58 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 4.5 mp -84.73 107.08 15.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.627 -0.879 . . . . 71.040000000000006 108.627 176.242 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.579 ' HB ' ' HB3' ' A' ' 78' ' ' MET . 21.2 t -89.56 115.31 28.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.996 -0.547 . . . . 64.329999999999998 110.655 -175.202 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.812 ' HB3' ' HB2' ' A' ' 97' ' ' ASN . 13.3 t70 -106.98 106.08 16.44 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.663 -0.495 . . . . 74.510000000000005 109.663 177.104 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 60.0 mt -84.79 124.53 39.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.007 -0.542 . . . . 73.150000000000006 110.32 -178.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.433 ' O ' ' HB3' ' A' ' 95' ' ' GLN . . . -135.95 106.96 6.68 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.967 0.358 . . . . 54.140000000000001 111.967 -179.129 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -84.7 85.67 7.41 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.427 -0.953 . . . . 62.210000000000001 108.427 169.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.1 ttt180 -100.52 134.8 42.94 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.795 -0.639 . . . . 75.439999999999998 109.383 -176.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 68.59 -71.02 0.12 Allowed 'General case' 0 N--CA 1.467 0.41 0 O-C-N 123.87 0.731 . . . . 71.019999999999996 110.39 -172.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 178.52 29.62 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 111.753 -0.539 . . . . 75.319999999999993 111.753 178.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -129.69 150.72 50.88 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 110.044 -0.354 . . . . 62.409999999999997 110.044 -177.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -79.91 92.6 5.55 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.4 0.619 . . . . 52.240000000000002 110.715 178.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.433 ' HB3' ' O ' ' A' ' 88' ' ' ALA . 37.8 tt0 -96.31 114.66 26.37 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.364 -0.834 . . . . 55.530000000000001 110.01 179.173 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 20.0 tp -101.68 112.77 25.46 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.01 -0.541 . . . . 75.109999999999999 110.413 -178.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.812 ' HB2' ' HB3' ' A' ' 86' ' ' ASP . 44.2 m-80 -93.54 103.3 15.5 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.109 -0.33 . . . . 43.409999999999997 110.109 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.434 ' CG1' ' HD2' ' A' ' 83' ' ' TYR . 68.9 t -93.35 109.22 21.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.534 0.683 . . . . 72.019999999999996 110.864 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.58 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 35.7 m -97.58 107.15 19.58 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.318 -0.855 . . . . 64.319999999999993 109.741 176.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.438 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 45.1 t0 -72.64 147.37 45.84 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.348 0.594 . . . . 63.399999999999999 111.48 -175.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.542 ' HD2' ' HA ' ' A' ' 82' ' ' ASP . 51.1 ttt180 -95.48 -26.42 15.83 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.994 -1.003 . . . . 70.420000000000002 109.66 177.457 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 35.9 mtpt -84.29 -65.99 0.95 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.724 -0.671 . . . . 73.140000000000001 110.984 -173.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 72.2 p -86.87 -19.0 29.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.213 0.53 . . . . 72.120000000000005 110.296 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.438 ' HA2' ' O ' ' A' ' 100' ' ' ASP . . . 71.82 21.2 79.0 Favored Glycine 0 N--CA 1.452 -0.284 0 CA-C-N 115.233 -0.894 . . . . 65.239999999999995 112.903 176.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 83.2 mm-40 -88.63 136.13 33.15 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.619 -0.512 . . . . 72.040000000000006 109.619 175.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 19.3 p -97.27 96.37 8.35 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.06 0.457 . . . . 61.32 110.711 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 29.8 m -97.72 106.85 19.23 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.723 -0.671 . . . . 71.150000000000006 110.356 -178.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 95.2 m -91.67 126.23 36.68 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.05 -0.523 . . . . 61.340000000000003 110.511 177.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 4.3 mp -115.37 111.04 34.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.188 -0.46 . . . . 73.010000000000005 109.961 177.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 95' ' ' GLN . 48.0 mt-30 -89.92 104.3 16.88 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.234 -0.439 . . . . 61.100000000000001 110.242 177.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 24.9 t -85.89 91.44 3.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.176 -0.676 . . . . 75.109999999999999 109.176 177.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 9.7 m -104.3 -37.67 7.16 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 113.345 0.869 . . . . 73.519999999999996 113.345 -169.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -105.97 23.0 30.32 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 119.92 -1.134 . . . . 53.210000000000001 114.851 -167.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 93.0 mt 54.4 70.47 0.61 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.526 0.679 . . . . 71.239999999999995 110.242 178.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -99.43 22.77 10.22 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.26 -0.882 . . . . 62.340000000000003 111.672 -170.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -166.21 166.4 16.91 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.604 -0.517 . . . . 63.439999999999998 109.604 178.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 53.3 t30 72.87 96.24 0.07 Allowed 'General case' 0 N--CA 1.466 0.348 0 O-C-N 123.883 0.74 . . . . 61.130000000000003 110.626 -178.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 33.8 t -147.4 144.53 28.75 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.656 -0.702 . . . . 75.219999999999999 109.177 -178.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 9.6 m 70.56 155.57 0.14 Allowed 'General case' 0 CA--C 1.535 0.396 0 O-C-N 123.74 0.65 . . . . 73.200000000000003 110.514 -176.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -85.27 146.48 27.03 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.973 0.416 . . . . 62.409999999999997 110.398 178.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -102.52 110.55 22.52 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.849 -0.614 . . . . 75.239999999999995 110.55 -179.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -74.43 136.83 42.35 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.086 -0.507 . . . . 74.340000000000003 109.808 178.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 60.0 t60 -67.01 104.91 1.5 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.625 -0.509 . . . . 64.150000000000006 109.625 179.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.495 ' CG ' ' H ' ' A' ' 125' ' ' HIS . 9.9 p-80 -53.46 -75.91 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.543 0 O-C-N 123.808 0.692 . . . . 75.209999999999994 112.241 -172.17 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.495 ' H ' ' CG ' ' A' ' 124' ' ' HIS . 54.3 t-80 66.32 134.32 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.461 0.648 . . . . 71.409999999999997 112.208 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -115.72 -51.41 2.67 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.08 -0.509 . . . . 73.129999999999995 109.888 172.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 . . . . . 0 C--O 1.247 0.942 0 CA-C-O 118.417 -0.801 . . . . 54.43 109.38 176.965 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.0 mtm . . . . . 0 N--CA 1.48 1.033 0 CA-C-O 120.995 0.426 . . . . 75.5 110.279 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -116.74 123.36 47.0 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.88 -0.6 . . . . 74.230000000000004 110.175 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 139.94 146.68 4.9 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.359 -0.696 . . . . 65.140000000000001 111.359 -178.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.9 t -65.56 -31.02 71.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.684 0.242 . . . . 72.25 111.077 -177.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 15.9 tpt -161.87 -38.65 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.677 -0.238 . . . . 75.430000000000007 111.179 -179.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.7 m 58.95 76.07 0.37 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.706 0.765 . . . . 74.209999999999994 110.035 -173.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -95.93 -32.85 12.42 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.441 -0.799 . . . . 75.040000000000006 110.82 -175.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -170.58 -66.67 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.264 -0.426 . . . . 73.409999999999997 110.318 -178.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 71.5 t80 61.15 85.16 0.12 Allowed 'General case' 0 C--O 1.231 0.12 0 CA-C-O 121.591 0.71 . . . . 73.239999999999995 110.556 -177.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.44 ' O ' ' HD3' ' A' ' 12' ' ' PRO . 38.7 ttt180 -105.33 146.37 29.48 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.715 -0.675 . . . . 72.030000000000001 109.967 178.166 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -73.44 92.55 0.04 OUTLIER Pre-proline 0 N--CA 1.466 0.355 0 C-N-CA 124.067 0.947 . . . . 63.140000000000001 111.707 178.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' A' ' 10' ' ' ARG . 1.3 Cg_endo -77.35 125.8 7.99 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.993 2.462 . . . . 71.329999999999998 113.198 -167.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 51.2 t30 71.94 121.81 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.303 -0.862 . . . . 75.430000000000007 112.316 173.072 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -138.22 130.64 29.09 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.242 -0.89 . . . . 75.230000000000004 109.145 175.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -159.17 122.31 1.13 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.572 -0.823 . . . . 71.230000000000004 112.148 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -138.52 133.03 6.05 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 121.001 -0.618 . . . . 73.329999999999998 111.861 178.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.412 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 19.2 m120 -96.85 144.08 27.23 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 109.98 -0.378 . . . . 72.140000000000001 109.98 178.351 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 17' ' ' ASN . 6.3 Cg_exo -75.78 -55.91 0.06 OUTLIER 'Trans proline' 0 CA--C 1.53 0.289 0 C-N-CA 122.831 2.354 . . . . 61.409999999999997 112.708 -178.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 39.7 t-20 -158.97 139.67 12.6 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.413 -0.588 . . . . 74.519999999999996 109.413 -177.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -88.44 -28.39 20.92 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.839 0.352 . . . . 74.239999999999995 110.812 -177.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -122.53 -106.09 1.86 Allowed Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.43 -0.89 . . . . 62.439999999999998 113.164 -174.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 71.82 155.09 0.15 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.628 0.771 . . . . 64.099999999999994 111.685 -174.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 65.8 t80 64.01 86.04 0.13 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.369 -0.832 . . . . 71.25 111.479 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.732 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 3.2 mm? -126.21 141.07 52.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.895 -0.593 . . . . 62.32 110.693 178.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.732 ' HG ' ' O ' ' A' ' 24' ' ' LEU . 1.7 pp 64.59 153.03 0.05 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.688 1.195 . . . . 52.439999999999998 113.11 173.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -139.73 94.3 2.76 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.172 -0.922 . . . . 73.200000000000003 109.85 174.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.538 ' HB3' HD22 ' A' ' 81' ' ' ASN . 39.0 m 69.34 -67.66 0.21 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.741 -0.663 . . . . 71.349999999999994 112.201 178.591 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 63.71 -86.35 0.02 OUTLIER 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.796 0.838 . . . . 74.120000000000005 111.772 -177.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 52.3 tp60 -145.23 117.32 8.34 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.045 0.45 . . . . 65.310000000000002 110.664 -176.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.438 ' O ' ' HB3' ' A' ' 31' ' ' GLN . . . -172.64 -157.2 0.1 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.357 -0.838 . . . . 75.25 108.758 -178.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.47 ' O ' ' HB3' ' A' ' 32' ' ' ASN . 28.0 tp60 75.32 -17.82 0.48 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.351 0.5 . . . . 75.530000000000001 112.351 170.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.47 ' HB3' ' O ' ' A' ' 31' ' ' GLN . 26.7 t-20 71.52 112.27 0.06 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.238 0.542 . . . . 64.010000000000005 109.561 -170.554 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.4 m -74.99 98.65 3.65 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.079 -0.509 . . . . 74.209999999999994 111.03 -174.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -61.27 131.56 50.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.794 -0.639 . . . . 74.430000000000007 109.348 175.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 48.8 tttt -99.81 16.56 23.28 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.28 0.562 . . . . 71.430000000000007 110.029 -178.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.55 ' HB2' ' HD2' ' A' ' 37' ' ' PRO . 0.6 OUTLIER -131.31 162.51 55.47 Favored Pre-proline 0 C--N 1.325 -0.488 0 N-CA-C 108.818 -0.808 . . . . 74.530000000000001 108.818 175.965 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.6 ' HG2' ' HB3' ' A' ' 42' ' ' ASP . 28.1 Cg_endo -62.21 -19.99 68.52 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.716 2.277 . . . . 70.219999999999999 114.913 -170.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.595 ' HB3' ' HB2' ' A' ' 42' ' ' ASP . 38.4 t -136.14 -71.04 0.46 Allowed 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.254 -0.578 . . . . 62.109999999999999 111.974 -174.265 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -179.82 140.74 0.14 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.433 -0.581 . . . . 74.420000000000002 109.433 -170.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.6 p30 54.09 29.46 10.36 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.832 0.678 . . . . 75.200000000000003 112.832 173.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.7 t70 72.39 85.64 0.12 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.159 -0.928 . . . . 75.340000000000003 110.53 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.6 ' HB3' ' HG2' ' A' ' 37' ' ' PRO . 20.7 t70 -82.79 -22.59 34.2 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.767 -1.106 . . . . 70.120000000000005 111.032 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 40.5 p90 47.21 25.61 0.57 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.285 1.034 . . . . 75.219999999999999 112.965 -178.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -82.77 13.46 42.61 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.83 -0.7 . . . . 74.519999999999996 112.241 177.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 45.0 mt -69.75 -26.54 30.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.574 0.702 . . . . 75.239999999999995 110.013 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -75.87 -9.31 58.5 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.034 -0.984 . . . . 65.319999999999993 111.467 -177.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 2.5 t -128.56 77.92 76.63 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 121.297 0.57 . . . . 60.32 111.374 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -76.75 96.57 1.1 Allowed 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.047 2.498 . . . . 72.099999999999994 111.302 176.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.1 m -125.2 -51.06 1.66 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.007 0.432 . . . . 71.450000000000003 110.357 -178.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.82 -49.46 8.4 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.139 0.495 . . . . 71.230000000000004 110.472 -179.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.409 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 3.2 pp -75.83 -10.16 59.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.934 -0.575 . . . . 73.420000000000002 111.337 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.535 ' HA ' HG22 ' A' ' 55' ' ' THR . 17.8 t70 -57.95 -45.57 86.43 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.905 -0.588 . . . . 63.020000000000003 111.068 -179.364 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -61.34 -17.41 53.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.489 -0.778 . . . . 73.010000000000005 111.359 -176.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -98.84 -47.18 5.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.353 -0.385 . . . . 74.25 110.59 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.535 HG22 ' HA ' ' A' ' 52' ' ' ASP . 10.0 t -68.85 -31.49 70.49 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.56 -0.291 . . . . 75.409999999999997 111.285 -176.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -68.16 -30.89 70.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.77 0.319 . . . . 51.200000000000003 110.499 -178.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.1 -12.9 60.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.007 0.432 . . . . 74.219999999999999 111.435 -178.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.6 mm -87.79 -24.55 6.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.381 0.61 . . . . 75.030000000000001 110.073 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -64.83 -22.58 67.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.699 -0.682 . . . . 51.229999999999997 112.138 -174.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 17.3 p -73.82 -41.65 62.03 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.035 0.383 . . . . 73.340000000000003 112.035 -175.036 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -73.41 -18.08 61.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.803 0.335 . . . . 64.209999999999994 111.075 -176.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.591 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 57.2 mt -67.74 -28.36 41.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.179 -0.464 . . . . 75.120000000000005 110.515 -178.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.2 mp -58.41 -40.2 81.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.351 -0.386 . . . . 74.530000000000001 111.056 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -76.29 -31.46 54.77 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.577 -0.821 . . . . 54.140000000000001 112.047 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -73.66 -25.31 72.52 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.058 -0.592 . . . . 33.530000000000001 112.623 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.591 ' HG ' ' O ' ' A' ' 62' ' ' ILE . 73.0 mt -55.43 -35.9 65.91 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 122.275 0.23 . . . . 72.230000000000004 111.501 -179.069 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.9 mp -56.45 -30.95 63.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.863 0.363 . . . . 70.319999999999993 111.42 -178.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 25.2 t -105.0 -16.0 14.94 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.295 -0.412 . . . . 75.109999999999999 111.052 -178.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -89.59 -26.67 20.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.816 0.341 . . . . 53.439999999999998 110.954 -176.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.432 HG12 ' O ' ' A' ' 66' ' ' LEU . 48.9 mm -75.79 -21.29 15.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.4 0.619 . . . . 71.409999999999997 109.929 177.245 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -68.53 -20.29 64.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.883 -0.599 . . . . 61.43 110.066 176.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 73.2 p 54.28 -169.62 0.06 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.229 -0.896 . . . . 53.310000000000002 111.716 -177.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 88.93 -50.06 3.66 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.807 -0.711 . . . . 71.019999999999996 112.802 177.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.592 ' HD2' ' O ' ' A' ' 75' ' ' PRO . 0.2 OUTLIER -56.01 152.21 22.16 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 122.303 0.241 . . . . 51.439999999999998 111.44 -175.92 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.592 ' O ' ' HD2' ' A' ' 74' ' ' LYS . 38.3 Cg_exo -61.37 177.6 0.8 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.362 2.708 . . . . 65.030000000000001 113.329 -177.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -93.27 -151.83 28.48 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.712 -0.756 . . . . 72.120000000000005 112.49 -178.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.475 ' HE ' ' HB3' ' A' ' 77' ' ' ARG . 1.3 ptp180 -114.34 162.1 17.05 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.742 0.306 . . . . 45.020000000000003 110.439 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 57.6 ttp -106.25 134.5 49.28 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.837 0.351 . . . . 73.310000000000002 110.497 -176.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 24.8 t -67.85 126.98 28.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.867 -0.606 . . . . 63.219999999999999 109.921 177.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.595 HG21 ' HB2' ' A' ' 83' ' ' TYR . 32.0 m -148.99 140.14 23.07 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.432 -0.581 . . . . 43.310000000000002 109.432 178.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.538 HD22 ' HB3' ' A' ' 27' ' ' SER . 65.6 m-20 -55.16 -62.68 1.5 Allowed 'General case' 0 C--N 1.329 -0.312 0 O-C-N 123.449 0.468 . . . . 72.310000000000002 112.093 -174.36 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -114.92 14.09 17.18 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.005 0.372 . . . . 75.510000000000005 112.005 -171.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.595 ' HB2' HG21 ' A' ' 80' ' ' THR . 68.5 m-85 -130.49 126.75 37.65 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.734 -0.386 . . . . 63.340000000000003 110.999 -177.163 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.495 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 4.1 mp -95.49 106.73 18.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.045 -0.724 . . . . 71.040000000000006 109.045 176.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.9 p -133.47 121.79 42.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.425 0.631 . . . . 64.329999999999998 111.815 -174.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -110.35 134.47 52.26 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.36 -0.836 . . . . 74.510000000000005 108.952 176.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.0 mt -83.53 80.26 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.025 -0.732 . . . . 73.150000000000006 109.025 178.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.426 ' HA ' ' HD3' ' A' ' 74' ' ' LYS . . . -86.61 109.42 19.14 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.429 -0.805 . . . . 54.140000000000001 111.323 -174.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -82.78 80.27 8.92 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.981 -0.748 . . . . 62.210000000000001 108.981 172.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -100.46 131.46 46.37 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.336 -0.847 . . . . 75.439999999999998 109.71 -177.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.5 t70 70.4 5.67 5.46 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 123.941 0.776 . . . . 71.019999999999996 111.034 177.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 112.04 -24.48 14.47 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.048 -0.596 . . . . 75.319999999999993 112.764 177.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -92.59 141.34 28.6 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 122.734 -0.274 . . . . 62.409999999999997 110.94 -176.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.562 ' HB2' ' HB ' ' A' ' 111' ' ' VAL . 3.5 mm? -71.67 105.63 3.77 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.208 -0.664 . . . . 52.240000000000002 109.208 170.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -109.01 111.32 22.92 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.238 0.542 . . . . 55.530000000000001 110.649 -178.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 15.1 tp -81.69 99.94 9.2 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.614 -0.721 . . . . 75.109999999999999 109.263 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -94.02 106.87 18.83 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.118 -0.492 . . . . 43.409999999999997 110.341 -177.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 69.5 t -101.14 114.67 41.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.227 0.537 . . . . 72.019999999999996 111.46 -176.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.495 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 86.8 m -101.67 106.25 17.27 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.585 -0.734 . . . . 64.319999999999993 109.52 172.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.452 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 15.3 t0 -76.68 145.63 38.63 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.985 -0.552 . . . . 63.399999999999999 111.157 -178.167 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.54 ' HD2' ' O ' ' A' ' 101' ' ' ARG . 5.2 tmm_? -103.43 -25.76 13.14 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.789 -0.641 . . . . 70.420000000000002 109.635 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -73.73 -56.55 4.85 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.887 -0.597 . . . . 73.140000000000001 111.176 -173.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 71.7 p -109.24 -25.42 10.61 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.268 0.556 . . . . 72.120000000000005 110.265 176.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' A' ' 100' ' ' ASP . . . 98.68 13.88 39.3 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.723 -0.672 . . . . 65.239999999999995 112.644 177.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.45 ' N ' ' HB3' ' A' ' 100' ' ' ASP . 50.5 mm-40 -65.01 109.57 2.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.319 0.581 . . . . 72.040000000000006 111.165 178.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.5 m -87.97 100.13 12.68 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.409 -0.814 . . . . 61.32 109.097 176.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 7.6 t -103.08 141.18 36.27 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.937 0.399 . . . . 71.150000000000006 110.224 -175.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 46.6 m -116.69 106.08 13.13 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.075 -0.512 . . . . 61.340000000000003 110.664 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.425 HD12 ' N ' ' A' ' 109' ' ' ILE . 4.4 mp -111.52 105.15 18.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.3 -0.409 . . . . 73.010000000000005 110.721 -177.339 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -70.68 157.97 37.07 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.011 0.434 . . . . 61.100000000000001 110.843 175.072 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.562 ' HB ' ' HB2' ' A' ' 94' ' ' LEU . 3.4 p -59.41 114.61 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.381 -0.827 . . . . 75.109999999999999 111.685 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.7 p -90.22 -35.56 15.27 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.492 -0.777 . . . . 73.519999999999996 110.294 177.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 142.72 97.27 0.26 Allowed Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 111.153 -0.779 . . . . 53.210000000000001 111.153 -179.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 74.9 mt -86.64 -60.17 2.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.321 0.105 . . . . 71.239999999999995 111.088 -173.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 63.66 107.63 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 O-C-N 123.872 0.732 . . . . 62.340000000000003 111.474 -177.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -111.07 148.88 31.66 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.106 -0.497 . . . . 63.439999999999998 110.936 -177.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -108.72 110.33 21.7 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.886 -1.153 . . . . 61.130000000000003 107.886 172.188 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.0 t -65.8 -71.97 0.17 Allowed 'General case' 0 C--N 1.328 -0.358 0 O-C-N 123.223 0.327 . . . . 75.219999999999999 111.263 -171.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.0 m -153.06 128.58 10.0 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.632 -0.258 . . . . 73.200000000000003 110.746 -177.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -107.51 137.64 45.17 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.757 -0.46 . . . . 62.409999999999997 109.757 174.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -82.96 136.82 34.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.265 -0.425 . . . . 75.239999999999995 111.575 -172.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 79.4 m-70 -129.77 174.95 9.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.705 -0.68 . . . . 74.340000000000003 109.234 175.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 66.5 -167.48 0.21 Allowed 'General case' 0 N--CA 1.467 0.392 0 O-C-N 123.521 0.513 . . . . 64.150000000000006 111.52 178.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 6.8 t60 59.16 78.54 0.26 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.18 -0.918 . . . . 75.209999999999994 111.691 177.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -176.9 159.3 1.71 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.455 -0.793 . . . . 71.409999999999997 109.025 174.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 28.9 m80 -107.17 168.1 9.45 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 121.013 -0.275 . . . . 73.129999999999995 110.529 178.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.384 -0.817 . . . . 54.43 110.279 -175.804 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.0 ttm . . . . . 0 N--CA 1.478 0.945 0 N-CA-C 110.46 -0.2 . . . . 75.5 110.46 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.27 175.42 0.18 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.508 0.671 . . . . 74.230000000000004 112.473 177.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -89.46 -131.9 4.44 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.766 -0.73 . . . . 65.140000000000001 112.134 175.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.5 m -111.31 -62.36 1.56 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 110.005 -0.368 . . . . 72.25 110.005 177.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 27.0 ttt -179.49 -59.91 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.847 -0.615 . . . . 75.430000000000007 110.185 177.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 28.2 m 71.38 148.12 0.08 Allowed 'General case' 0 CA--C 1.536 0.433 0 O-C-N 123.388 0.43 . . . . 74.209999999999994 110.508 -178.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -78.73 -54.58 5.95 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 122.109 -0.369 . . . . 75.040000000000006 111.815 -176.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -112.53 21.35 15.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.736 0.303 . . . . 73.409999999999997 111.459 -174.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 55.7 t80 63.99 -80.28 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.642 -0.708 . . . . 73.239999999999995 111.712 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -158.31 82.53 0.84 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.886 0.374 . . . . 72.030000000000001 110.055 -177.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -128.75 86.61 57.06 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 116.09 -0.505 . . . . 63.140000000000001 110.096 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -74.64 107.39 2.45 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 123.279 2.653 . . . . 71.329999999999998 113.354 -174.105 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 22.0 m120 68.97 121.59 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 O-C-N 124.227 0.955 . . . . 75.430000000000007 112.785 173.001 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -97.64 136.65 37.7 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.286 -0.87 . . . . 75.230000000000004 109.035 175.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 130.94 133.09 3.47 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.478 -0.867 . . . . 71.230000000000004 111.401 -176.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 138.12 -76.25 0.36 Allowed Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.262 -0.735 . . . . 73.329999999999998 111.262 -177.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.439 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 6.0 m-20 66.07 146.42 0.1 Allowed Pre-proline 0 N--CA 1.469 0.52 0 C-N-CA 123.104 0.562 . . . . 72.140000000000001 111.841 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 17' ' ' ASN . 24.1 Cg_exo -65.11 -28.41 56.76 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.431 2.087 . . . . 61.409999999999997 111.44 174.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -105.29 104.97 14.8 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.796 -0.638 . . . . 74.519999999999996 109.482 177.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -140.54 149.35 42.32 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.355 -0.384 . . . . 74.239999999999995 110.119 -178.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 159.76 -69.95 0.24 Allowed Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.841 -0.695 . . . . 62.439999999999998 112.455 177.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 64.99 98.95 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 O-C-N 124.134 0.549 . . . . 64.099999999999994 111.373 -176.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -68.69 112.66 5.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.967 -0.56 . . . . 71.25 110.5 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.642 HD12 ' HG ' ' A' ' 25' ' ' LEU . 2.6 pp -137.58 9.4 2.89 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.941 -0.572 . . . . 62.32 110.911 -177.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.642 ' HG ' HD12 ' A' ' 24' ' ' LEU . 97.7 mt -117.42 162.22 18.3 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.93 -0.577 . . . . 52.439999999999998 110.419 178.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 62.7 t30 66.62 102.13 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 O-C-N 123.856 0.722 . . . . 73.200000000000003 111.457 178.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.8 m -86.12 172.55 10.49 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.75 -0.659 . . . . 71.349999999999994 110.632 -179.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -95.24 115.71 27.79 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.668 0.27 . . . . 74.120000000000005 110.478 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -110.67 171.58 7.38 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.175 -0.466 . . . . 65.310000000000002 110.043 -179.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 71.95 -48.89 0.68 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.616 0.766 . . . . 75.25 111.439 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -81.06 151.4 28.39 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.121 -0.49 . . . . 75.530000000000001 109.872 176.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 55.5 t30 72.19 141.75 0.06 Allowed 'General case' 0 N--CA 1.469 0.522 0 O-C-N 123.976 0.797 . . . . 64.010000000000005 111.094 -176.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.3 m 63.15 58.3 1.46 Allowed 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.902 -0.59 . . . . 74.209999999999994 110.813 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 99.7 m-85 -81.48 77.01 8.39 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.872 -0.604 . . . . 74.430000000000007 111.51 -174.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm -129.0 -164.99 1.45 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.102 -0.703 . . . . 71.430000000000007 109.102 174.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -70.37 143.42 90.6 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-O 121.062 0.458 . . . . 74.530000000000001 110.863 -177.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.875 ' HB3' ' H ' ' A' ' 43' ' ' PHE . 13.6 Cg_endo -57.1 164.07 6.98 Favored 'Trans proline' 0 N--CA 1.473 0.318 0 C-N-CA 123.983 3.122 . . . . 70.219999999999999 113.864 178.42 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.5 t -65.65 -69.92 0.27 Allowed 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.705 -0.68 . . . . 62.109999999999999 109.977 176.01 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -140.26 152.7 46.13 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.554 0.216 . . . . 74.420000000000002 110.778 177.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 20.1 m120 59.07 30.56 20.39 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.853 -0.612 . . . . 75.200000000000003 112.587 172.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.538 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 11.9 t70 62.05 36.27 15.48 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.204 0.526 . . . . 75.340000000000003 110.789 176.571 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -45.2 -67.59 0.27 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.219 -0.9 . . . . 70.120000000000005 111.786 178.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.875 ' H ' ' HB3' ' A' ' 37' ' ' PRO . 11.3 m-85 -105.48 36.2 2.59 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.684 0.278 . . . . 75.219999999999999 110.773 175.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -79.08 3.35 65.96 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.802 -0.713 . . . . 74.519999999999996 111.978 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 58.3 mt -107.33 -42.64 6.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.291 -0.455 . . . . 75.239999999999995 110.568 -179.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 63.35 -165.45 0.24 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.889 -0.596 . . . . 65.319999999999993 111.005 -178.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 28.8 m -134.8 83.4 41.34 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-O 121.05 0.452 . . . . 60.32 110.669 178.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.635 ' HB2' ' HB2' ' A' ' 52' ' ' ASP . 18.4 Cg_endo -93.97 108.49 0.16 Allowed 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 123.491 2.794 . . . . 72.099999999999994 112.124 177.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.4 m -110.18 -78.65 0.59 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.386 -0.37 . . . . 71.450000000000003 111.049 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.46 -40.64 57.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.758 0.313 . . . . 71.230000000000004 111.405 -177.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.7 pp -68.37 -22.6 64.65 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.801 0.334 . . . . 73.420000000000002 110.358 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.635 ' HB2' ' HB2' ' A' ' 48' ' ' PRO . 7.7 t70 -61.68 -41.85 98.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.975 -0.557 . . . . 63.020000000000003 110.431 177.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 -68.18 -42.42 80.01 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.799 -0.637 . . . . 73.010000000000005 109.925 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -68.34 -50.12 55.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.62 -0.718 . . . . 74.25 111.567 -175.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.5 t -67.85 -17.86 64.63 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.787 0.327 . . . . 75.409999999999997 111.575 -175.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -75.94 -21.89 56.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.835 0.35 . . . . 51.200000000000003 110.935 -177.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -82.93 -19.26 37.57 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.52 0.676 . . . . 74.219999999999999 109.867 174.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.504 ' O ' HG13 ' A' ' 62' ' ' ILE . 19.5 mt -79.39 -25.86 12.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.165 -0.925 . . . . 75.030000000000001 110.489 -179.2 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -57.8 -28.62 64.19 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.705 -0.68 . . . . 51.229999999999997 111.701 -176.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.7 m -79.13 -35.38 42.23 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.39 -0.368 . . . . 73.340000000000003 111.49 -177.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.443 ' HG2' ' O ' ' A' ' 58' ' ' ILE . 11.3 pt20 -82.05 -6.31 59.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.897 0.379 . . . . 64.209999999999994 111.627 -174.062 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.504 HG13 ' O ' ' A' ' 58' ' ' ILE . 67.7 mt -70.82 -31.93 47.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.832 0.348 . . . . 75.120000000000005 110.641 -178.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.736 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 8.8 mp -59.4 -46.97 87.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 74.530000000000001 111.512 -177.014 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -57.48 -27.26 58.13 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 121.177 -0.535 . . . . 54.140000000000001 112.906 -178.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -92.7 -42.63 4.41 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.558 -0.83 . . . . 33.530000000000001 112.294 178.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.559 ' HA ' ' HB2' ' A' ' 69' ' ' ASN . 1.3 pp -64.44 -23.75 67.39 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 111.415 0.154 . . . . 72.230000000000004 111.415 -176.039 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.736 ' HG ' ' O ' ' A' ' 63' ' ' LEU . 80.7 mt -52.17 -46.27 65.44 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.058 0.456 . . . . 70.319999999999993 110.594 177.319 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.6 t -90.7 -4.91 56.39 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.101 -0.499 . . . . 75.109999999999999 110.485 -177.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.559 ' HB2' ' HA ' ' A' ' 66' ' ' LEU . 90.6 m-20 -86.22 -21.43 27.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.061 0.457 . . . . 53.439999999999998 109.96 174.224 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.466 HG12 ' O ' ' A' ' 66' ' ' LEU . 51.4 mm -72.59 -31.7 38.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 108.593 -0.891 . . . . 71.409999999999997 108.593 168.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -68.78 -56.08 9.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.074 -0.967 . . . . 61.43 109.767 175.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 48.5 m -97.69 101.43 12.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.883 -0.598 . . . . 53.310000000000002 111.26 178.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -76.68 82.87 1.05 Allowed Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.5 -0.773 . . . . 71.019999999999996 111.344 177.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -55.03 142.17 57.49 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.484 -0.358 . . . . 51.439999999999998 110.88 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -66.46 -47.58 2.97 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 122.768 2.312 . . . . 65.030000000000001 112.076 -178.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 175.83 116.21 0.45 Allowed Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 115.68 -0.691 . . . . 72.120000000000005 111.734 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.488 ' HD2' ' O ' ' A' ' 77' ' ' ARG . 0.1 OUTLIER -90.47 143.21 26.97 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.666 0.27 . . . . 45.020000000000003 110.359 177.536 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 54.4 ttp -85.87 114.52 22.86 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.176 0.513 . . . . 73.310000000000002 111.044 -174.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 42.5 t -97.11 98.84 7.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.607 -0.724 . . . . 63.219999999999999 109.601 177.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.2 140.91 52.44 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.064 -0.516 . . . . 43.310000000000002 111.168 -178.381 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -75.94 60.0 1.33 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.213 0.53 . . . . 72.310000000000002 111.736 -177.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -170.75 -41.41 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.402 -0.817 . . . . 75.510000000000005 109.165 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -144.66 123.84 12.92 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.483 -0.78 . . . . 63.340000000000003 110.183 174.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.581 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 50.6 mm -92.32 109.11 21.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 109.1 -0.704 . . . . 71.040000000000006 109.1 173.034 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 43.9 t -108.42 96.39 4.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.983 0.42 . . . . 64.329999999999998 110.406 -178.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.464 ' OD1' ' HG2' ' A' ' 77' ' ' ARG . 10.9 t70 -107.68 114.34 28.24 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.962 -0.563 . . . . 74.510000000000005 110.049 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 56.3 mt -80.92 86.91 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.233 -0.654 . . . . 73.150000000000006 109.233 176.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -98.38 171.36 8.23 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.856 -0.611 . . . . 54.140000000000001 110.848 -176.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.527 ' HB2' HD13 ' A' ' 94' ' ' LEU . 51.9 t-20 -146.04 138.38 25.38 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.071 -1.085 . . . . 62.210000000000001 108.071 178.576 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.443 ' O ' ' HB3' ' A' ' 91' ' ' ASP . 14.9 ttp180 -123.15 110.36 15.18 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.032 -0.358 . . . . 75.439999999999998 110.032 177.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.443 ' HB3' ' O ' ' A' ' 90' ' ' ARG . 15.6 t70 75.15 -45.57 0.56 Allowed 'General case' 0 N--CA 1.471 0.582 0 O-C-N 123.773 0.67 . . . . 71.019999999999996 111.837 177.194 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -178.46 -27.97 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.882 -0.675 . . . . 75.319999999999993 112.35 -178.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 22.5 mm-40 -93.1 125.08 37.52 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.055 0.455 . . . . 62.409999999999997 110.389 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.585 ' HB2' ' HB ' ' A' ' 111' ' ' VAL . 4.2 mm? -61.44 141.69 57.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.536 -0.756 . . . . 52.240000000000002 111.114 -178.095 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -131.94 97.92 4.3 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.674 -0.693 . . . . 55.530000000000001 109.566 -178.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.472 ' HB3' ' HB ' ' A' ' 109' ' ' ILE . 69.4 tp -80.32 113.15 18.3 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.027 -0.533 . . . . 75.109999999999999 110.289 -177.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -106.11 113.1 26.44 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.227 -0.442 . . . . 43.409999999999997 110.777 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.581 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 46.4 t -110.82 117.35 54.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.531 -0.758 . . . . 72.019999999999996 110.33 175.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.546 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 25.7 m -94.28 101.1 13.06 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.519 -0.764 . . . . 64.319999999999993 110.25 176.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.532 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 29.4 t70 -67.79 130.36 42.74 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.686 -0.688 . . . . 63.399999999999999 109.949 177.197 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 42.1 ttt180 -98.7 -22.93 15.65 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.915 0.388 . . . . 70.420000000000002 110.891 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -68.23 -45.44 73.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.082 -0.508 . . . . 73.140000000000001 111.157 -173.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.415 ' OG1' ' HG3' ' A' ' 105' ' ' GLN . 77.6 p -123.4 -32.86 3.34 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.303 0.573 . . . . 72.120000000000005 110.369 177.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.532 ' HA2' ' O ' ' A' ' 100' ' ' ASP . . . 103.19 30.04 5.52 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.493 -0.776 . . . . 65.239999999999995 112.435 178.531 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.416 ' N ' ' HB3' ' A' ' 100' ' ' ASP . 47.8 mt-30 -72.95 105.36 4.4 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.179 -0.304 . . . . 72.040000000000006 110.179 176.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 33.5 m -67.77 101.35 1.04 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.083 0.468 . . . . 61.32 110.058 176.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.519 ' HB2' ' HB ' ' A' ' 98' ' ' VAL . 23.5 m -99.77 96.38 7.56 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.012 -0.54 . . . . 71.150000000000006 110.619 -177.491 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 24.6 m -104.46 99.72 9.42 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.256 0.55 . . . . 61.340000000000003 110.007 176.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.472 ' HB ' ' HB3' ' A' ' 96' ' ' LEU . 4.0 mp -90.67 121.51 41.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.767 -0.651 . . . . 73.010000000000005 110.531 -176.378 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -82.67 110.25 17.56 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.556 -0.535 . . . . 61.100000000000001 109.556 176.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.585 ' HB ' ' HB2' ' A' ' 94' ' ' LEU . 51.0 t -87.87 129.19 39.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.514 -0.312 . . . . 75.109999999999999 110.281 -177.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.6 t 69.24 -155.48 0.16 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.745 -0.661 . . . . 73.519999999999996 109.724 -176.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 94.16 -71.33 1.22 Allowed Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 111.199 -0.76 . . . . 53.210000000000001 111.199 -177.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 94.6 mt -96.93 75.13 2.66 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.044 0.449 . . . . 71.239999999999995 110.043 177.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -139.83 132.78 29.36 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.58 -0.736 . . . . 62.340000000000003 109.936 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 34.4 p30 -162.33 167.74 23.33 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.623 -0.262 . . . . 63.439999999999998 110.937 179.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -150.02 151.55 33.46 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.862 0.363 . . . . 61.130000000000003 110.887 175.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 12.1 t -116.75 152.7 33.79 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.673 -0.862 . . . . 75.219999999999999 108.673 174.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 8.9 t -59.8 126.42 27.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.3 0.571 . . . . 73.200000000000003 110.674 -178.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -80.33 91.54 5.67 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.594 0.711 . . . . 62.409999999999997 111.262 -176.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -67.28 138.37 56.8 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.176 -0.675 . . . . 75.239999999999995 109.176 175.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 60.2 m-70 -68.08 123.54 20.94 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.258 0.551 . . . . 74.340000000000003 110.866 -175.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 52.9 m-70 -88.45 139.61 30.31 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.183 -0.917 . . . . 64.150000000000006 111.209 -171.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -135.76 -164.26 1.52 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.272 -1.01 . . . . 75.209999999999994 108.272 173.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 48.3 t60 -111.92 94.05 4.76 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.062 0.458 . . . . 71.409999999999997 111.121 -173.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.521 ' O ' ' HB2' ' A' ' 127' ' ' HIS . 26.1 t-80 -94.58 174.68 6.99 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.976 -1.12 . . . . 73.129999999999995 107.976 173.434 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.521 ' HB2' ' O ' ' A' ' 126' ' ' HIS . 8.9 m-70 . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.106 -0.95 . . . . 54.43 110.564 -178.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.0 ttm . . . . . 0 N--CA 1.478 0.954 0 CA-C-O 121.134 0.493 . . . . 75.5 109.976 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.77 155.46 41.72 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.96 -0.564 . . . . 74.230000000000004 110.696 -177.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -89.95 -77.93 1.33 Allowed Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 111.597 -0.601 . . . . 65.140000000000001 111.597 177.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.428 HG22 ' HG3' ' A' ' 5' ' ' MET . 26.9 m 72.91 150.09 0.1 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 122.81 0.444 . . . . 72.25 111.758 178.218 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.428 ' HG3' HG22 ' A' ' 4' ' ' THR . 72.8 mtm 74.47 81.69 0.11 Allowed 'General case' 0 C--O 1.236 0.342 0 C-N-CA 123.477 0.711 . . . . 75.430000000000007 112.586 176.148 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 89.4 m -106.87 99.76 9.3 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.907 -0.775 . . . . 74.209999999999994 108.907 168.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -128.14 126.4 41.02 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.338 0.59 . . . . 75.040000000000006 112.454 -170.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -139.13 90.61 2.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.435 -0.802 . . . . 73.409999999999997 109.933 172.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.618 ' HD2' ' HG3' ' A' ' 10' ' ' ARG . 31.2 p90 -102.59 173.11 6.48 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.834 -0.621 . . . . 73.239999999999995 110.015 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.618 ' HG3' ' HD2' ' A' ' 9' ' ' PHE . 72.7 mtp180 68.74 -169.02 0.18 Allowed 'General case' 0 C--O 1.236 0.365 0 O-C-N 124.022 0.826 . . . . 72.030000000000001 110.307 -174.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 62.18 81.13 0.24 Allowed Pre-proline 0 CA--C 1.532 0.255 0 O-C-N 123.483 0.489 . . . . 63.140000000000001 110.602 -178.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -78.12 -39.49 0.46 Allowed 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.702 2.268 . . . . 71.329999999999998 113.539 -176.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 66.6 t30 63.73 -175.04 0.16 Allowed 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 109.573 -0.528 . . . . 75.430000000000007 109.573 -174.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 72.7 t80 74.32 134.93 0.05 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.294 0.569 . . . . 75.230000000000004 111.208 176.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -96.45 149.78 19.41 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.814 -0.707 . . . . 71.230000000000004 112.714 -178.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -72.68 121.95 8.18 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.861 -0.685 . . . . 73.329999999999998 111.521 177.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -97.2 143.37 26.02 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-O 120.642 0.258 . . . . 72.140000000000001 110.677 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -66.98 -29.35 40.87 Favored 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 122.556 2.171 . . . . 61.409999999999997 111.364 175.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 65.06 23.36 12.46 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.523 -0.762 . . . . 74.519999999999996 111.18 179.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -75.4 146.44 40.79 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.977 -0.556 . . . . 74.239999999999995 109.831 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -133.87 173.56 21.21 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.439 -0.886 . . . . 62.439999999999998 112.641 -176.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -91.96 4.24 53.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.528 0.164 . . . . 64.099999999999994 111.207 -178.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 13.9 p90 44.37 79.91 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.071 0.949 . . . . 71.25 112.819 178.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.403 ' N ' HD23 ' A' ' 24' ' ' LEU . 2.5 pt? -146.37 134.1 21.14 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.753 -0.658 . . . . 62.32 110.453 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 81.6 mt -85.52 -69.04 0.69 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.467 -0.333 . . . . 52.439999999999998 110.608 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.8 m120 60.4 38.84 19.19 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.045 -0.525 . . . . 73.200000000000003 111.469 178.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.1 m -72.62 156.06 39.38 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.085 -0.507 . . . . 71.349999999999994 110.081 177.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -109.37 8.14 25.35 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.444 -0.343 . . . . 74.120000000000005 110.905 -176.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 62.7 -164.54 0.25 Allowed 'General case' 0 N--CA 1.465 0.307 0 O-C-N 123.563 0.54 . . . . 65.310000000000002 110.652 -177.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.98 168.84 12.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.219 0.533 . . . . 75.25 111.366 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -130.32 166.95 19.31 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.802 -0.636 . . . . 75.530000000000001 110.125 -177.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -88.63 174.0 8.3 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.335 -0.393 . . . . 64.010000000000005 110.154 177.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.8 m -87.22 -44.48 11.43 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.53 -0.305 . . . . 74.209999999999994 111.355 -176.208 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 67.92 8.97 6.83 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.549 0.69 . . . . 74.430000000000007 110.542 -174.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -161.21 79.18 0.59 Allowed 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 107.692 -1.225 . . . . 71.430000000000007 107.692 175.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -105.04 151.85 39.55 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.269 -0.878 . . . . 74.530000000000001 111.089 -172.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.472 ' HD3' HG13 ' A' ' 45' ' ' ILE . 48.0 Cg_endo -69.9 -12.81 33.36 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.608 2.205 . . . . 70.219999999999999 111.505 176.231 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.0 m 69.2 6.42 5.65 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.257 -0.883 . . . . 62.109999999999999 112.167 176.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -162.96 139.49 7.36 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.966 -0.383 . . . . 74.420000000000002 109.966 175.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 23.2 m120 65.21 68.8 0.49 Allowed 'General case' 0 C--O 1.235 0.301 0 O-C-N 123.992 0.807 . . . . 75.200000000000003 110.137 -177.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.3 t70 71.84 140.42 0.05 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.165 -0.925 . . . . 75.340000000000003 110.801 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -82.79 -2.7 55.25 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 122.111 -0.368 . . . . 70.120000000000005 111.398 -176.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -112.56 20.68 16.39 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 109.484 -0.561 . . . . 75.219999999999999 109.484 170.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -76.2 39.88 1.45 Allowed Glycine 0 C--N 1.335 0.527 0 CA-C-N 115.791 -0.64 . . . . 74.519999999999996 113.766 -173.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.472 HG13 ' HD3' ' A' ' 37' ' ' PRO . 17.8 mt -118.17 25.07 4.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 107.869 -1.16 . . . . 75.239999999999995 107.869 174.466 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 56.63 46.04 21.03 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 114.459 -1.246 . . . . 65.319999999999993 109.375 -174.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 21.6 m -114.97 86.52 13.62 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.162 -0.926 . . . . 60.32 109.909 178.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.682 ' HB2' ' HB2' ' A' ' 52' ' ' ASP . 48.5 Cg_endo -70.68 83.65 0.85 Allowed 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.24 1.96 . . . . 72.099999999999994 112.69 -177.109 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.6 m -96.57 -54.99 3.06 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.754 -0.657 . . . . 71.450000000000003 109.913 173.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -100.78 -27.92 13.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.99 0.424 . . . . 71.230000000000004 111.109 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.511 HD23 ' H ' ' A' ' 51' ' ' LEU . 0.8 OUTLIER -87.15 -3.03 59.04 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.997 -0.547 . . . . 73.420000000000002 111.591 -176.609 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.682 ' HB2' ' HB2' ' A' ' 48' ' ' PRO . 17.2 t70 -62.59 -69.23 0.27 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.51 -0.314 . . . . 63.020000000000003 111.589 -176.098 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -66.09 -23.91 66.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.269 0.557 . . . . 73.010000000000005 110.155 177.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.559 ' O ' HG13 ' A' ' 58' ' ' ILE . 85.3 t80 -61.56 -53.42 56.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.583 -0.735 . . . . 74.25 110.817 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.428 ' O ' ' HG3' ' A' ' 59' ' ' GLN . 9.8 t -69.12 -21.42 64.03 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.133 0.492 . . . . 75.409999999999997 110.873 -177.597 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -73.42 -39.65 64.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.242 0.544 . . . . 51.200000000000003 109.915 178.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.64 -29.36 69.37 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.646 -0.706 . . . . 74.219999999999999 109.998 175.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.58 ' HA ' ' HG2' ' A' ' 61' ' ' GLN . 15.8 mt -64.07 -39.29 84.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.879 -0.6 . . . . 75.030000000000001 110.44 176.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.428 ' HG3' ' O ' ' A' ' 55' ' ' THR . 73.0 mt-30 -58.1 -42.29 85.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.279 -0.419 . . . . 51.229999999999997 110.438 178.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.5 m -61.16 -45.31 95.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.078 -0.51 . . . . 73.340000000000003 110.584 177.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.671 ' O ' ' HA3' ' A' ' 65' ' ' GLY . 13.6 pt20 -80.81 7.74 9.75 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.824 -0.625 . . . . 64.209999999999994 110.85 -176.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.517 HG13 ' O ' ' A' ' 58' ' ' ILE . 83.2 mt -100.8 -55.84 5.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.954 -0.758 . . . . 75.120000000000005 108.954 168.553 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 89.6 mt -59.04 -41.42 87.81 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.613 -0.721 . . . . 74.530000000000001 111.049 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -108.85 -0.66 32.05 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.713 -0.756 . . . . 54.140000000000001 112.199 178.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.671 ' HA3' ' O ' ' A' ' 61' ' ' GLN . . . -85.44 -22.12 52.08 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.847 -0.692 . . . . 33.530000000000001 112.492 -176.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 62' ' ' ILE . 90.8 mt -60.08 -30.54 69.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.014 0.435 . . . . 72.230000000000004 109.985 176.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 70.3 mt -67.36 -33.07 74.46 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.483 -0.78 . . . . 70.319999999999993 110.682 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 9.2 m -73.27 -32.22 64.54 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.047 -0.524 . . . . 75.109999999999999 110.388 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -91.34 10.99 25.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.027 -0.533 . . . . 53.439999999999998 111.622 -177.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 36.1 mm -66.11 -34.7 71.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.158 0.504 . . . . 71.409999999999997 109.964 174.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -62.85 -60.58 3.28 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.711 -0.677 . . . . 61.43 110.728 176.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.5 m 73.66 -44.49 0.58 Allowed 'General case' 0 CA--C 1.535 0.401 0 O-C-N 123.631 0.582 . . . . 53.310000000000002 112.489 175.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.39 12.59 13.48 Favored Glycine 0 CA--C 1.519 0.314 0 N-CA-C 114.005 0.362 . . . . 71.019999999999996 114.005 -173.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.33 146.34 53.32 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.953 0.376 . . . . 51.439999999999998 110.211 175.35 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -58.27 -55.67 2.06 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.938 2.425 . . . . 65.030000000000001 112.979 -174.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 174.2 -154.97 20.58 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 119.838 -1.173 . . . . 72.120000000000005 113.089 -178.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 -127.94 176.02 7.92 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.564 -0.318 . . . . 45.020000000000003 110.367 -174.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.825 ' HB3' HG13 ' A' ' 85' ' ' VAL . 48.9 ttm -130.77 115.23 16.35 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.865 -0.42 . . . . 73.310000000000002 109.865 176.111 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 59.9 t -87.79 111.31 21.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.041 -0.527 . . . . 63.219999999999999 110.552 -177.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.663 HG22 ' H ' ' A' ' 82' ' ' ASP . 24.5 m -130.67 138.95 50.29 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.902 -0.59 . . . . 43.310000000000002 109.819 178.548 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -67.69 -23.32 65.28 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.946 0.403 . . . . 72.310000000000002 111.132 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.663 ' H ' HG22 ' A' ' 80' ' ' THR . 25.0 m-20 -97.66 -19.14 18.46 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.177 -0.465 . . . . 75.510000000000005 111.462 -177.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -144.38 136.8 26.58 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.5 0.556 . . . . 63.340000000000003 112.5 -171.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.593 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 4.1 mp -98.23 105.68 17.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 108.172 -1.048 . . . . 71.040000000000006 108.172 169.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.825 HG13 ' HB3' ' A' ' 78' ' ' MET . 5.6 p -135.98 135.66 50.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.258 0.551 . . . . 64.329999999999998 111.75 -174.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -128.43 143.49 51.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.473 -0.785 . . . . 74.510000000000005 109.18 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.41 HD12 ' N ' ' A' ' 87' ' ' ILE . 4.3 mp -95.85 86.63 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.355 -0.609 . . . . 73.150000000000006 109.355 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -105.26 128.12 53.28 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.784 -0.644 . . . . 54.140000000000001 111.223 -175.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -84.36 115.81 22.71 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.037 -0.727 . . . . 62.210000000000001 109.037 174.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -130.99 132.51 45.06 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.949 -0.389 . . . . 75.439999999999998 109.949 177.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.9 t70 68.11 11.15 8.24 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 124.036 0.835 . . . . 71.019999999999996 110.574 179.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 97.59 -0.08 59.49 Favored Glycine 0 N--CA 1.452 -0.248 0 CA-C-N 115.675 -0.693 . . . . 75.319999999999993 112.402 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -114.29 134.41 54.97 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.752 0.31 . . . . 62.409999999999997 110.423 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.4 HD13 ' HA ' ' A' ' 94' ' ' LEU . 4.0 mm? -67.0 108.9 2.77 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.117 -0.697 . . . . 52.240000000000002 109.117 173.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.409 HE21 ' HB2' ' A' ' 95' ' ' GLN . 6.1 tt0 -105.57 110.41 22.73 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.74 -0.664 . . . . 55.530000000000001 110.538 -173.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 17.3 tp -88.24 94.08 9.71 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.865 -0.607 . . . . 75.109999999999999 109.75 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -85.83 102.55 13.78 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.195 -0.457 . . . . 43.409999999999997 110.499 -179.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 24.6 t -94.39 123.56 46.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.057 0.456 . . . . 72.019999999999996 111.119 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.593 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 32.1 m -111.61 107.99 17.32 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.155 -0.475 . . . . 64.319999999999993 110.12 174.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.502 ' HB3' ' H ' ' A' ' 105' ' ' GLN . 15.3 t70 -65.99 131.1 45.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.776 -0.647 . . . . 63.399999999999999 110.3 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.557 ' HA ' ' NE ' ' A' ' 101' ' ' ARG . 2.8 tpm_? -107.88 17.72 22.14 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.609 0.718 . . . . 70.420000000000002 110.796 -177.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.5 mtpm? -107.11 -66.78 0.99 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.855 0.836 . . . . 73.140000000000001 109.039 175.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.2 m -91.3 -40.59 11.41 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 114.175 -1.375 . . . . 72.120000000000005 109.211 -178.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 98.11 82.98 1.69 Allowed Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.514 -0.767 . . . . 65.239999999999995 113.02 177.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.502 ' H ' ' HB3' ' A' ' 100' ' ' ASP . 54.5 mt-30 -143.15 142.31 31.43 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.099 -0.704 . . . . 72.040000000000006 109.099 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.9 m -105.06 85.6 2.3 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.48 0.657 . . . . 61.32 110.221 178.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.32 119.74 26.03 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.483 -0.78 . . . . 71.150000000000006 109.957 178.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 37.5 m -105.71 107.44 18.44 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.015 0.436 . . . . 61.340000000000003 111.291 -176.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.401 ' N ' HD12 ' A' ' 109' ' ' ILE . 4.5 mp -102.57 97.83 6.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.144 -0.48 . . . . 73.010000000000005 109.843 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -79.86 123.74 28.02 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.016 -0.735 . . . . 61.100000000000001 109.016 177.098 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.7 t -64.56 101.96 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.181 0.515 . . . . 75.109999999999999 111.072 -175.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.9 p -81.65 -26.88 34.41 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.478 -0.783 . . . . 73.519999999999996 110.576 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 131.78 92.37 0.56 Allowed Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.914 -0.66 . . . . 53.210000000000001 111.512 -177.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 96.0 mt -126.92 94.85 4.14 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.694 0.283 . . . . 71.239999999999995 110.599 -177.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -105.97 95.18 5.6 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.442 0.639 . . . . 62.340000000000003 110.088 176.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -143.12 150.57 39.66 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.253 -0.885 . . . . 63.439999999999998 109.991 178.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -171.36 163.36 6.95 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.188 -0.46 . . . . 61.130000000000003 109.916 -178.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 24.6 m 58.54 78.35 0.26 Allowed 'General case' 0 C--N 1.33 -0.282 0 O-C-N 123.616 0.573 . . . . 75.219999999999999 111.697 178.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -76.72 117.11 18.01 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.08 -0.509 . . . . 73.200000000000003 110.418 176.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -75.17 -45.33 41.39 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.057 -0.52 . . . . 62.409999999999997 110.952 -177.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -72.44 99.31 2.44 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.87 0.843 . . . . 75.239999999999995 110.375 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -117.14 17.6 14.77 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.524 -0.762 . . . . 74.340000000000003 110.571 -177.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 46.8 m80 72.23 100.55 0.07 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.171 -0.922 . . . . 64.150000000000006 112.469 174.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -132.86 8.85 4.15 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.712 0.768 . . . . 75.209999999999994 108.93 173.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 50.4 t60 -120.28 118.34 30.17 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.763 -1.108 . . . . 71.409999999999997 109.795 -175.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -79.44 4.59 15.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.445 -0.343 . . . . 73.129999999999995 111.563 -176.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 . . . . . 0 C--O 1.247 0.938 0 CA-C-O 117.99 -1.005 . . . . 54.43 109.917 -174.494 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ptt? . . . . . 0 N--CA 1.481 1.095 0 N-CA-C 110.138 -0.319 . . . . 75.5 110.138 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.99 -167.02 0.22 Allowed 'General case' 0 C--O 1.234 0.284 0 O-C-N 123.832 0.708 . . . . 74.230000000000004 111.228 178.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 106.37 100.18 2.64 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.936 -0.65 . . . . 65.140000000000001 111.853 179.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.3 p -69.43 101.09 1.49 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.178 0.513 . . . . 72.25 111.066 -179.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.418 ' O ' ' HB ' ' A' ' 6' ' ' THR . 26.9 ptt? -137.08 167.89 20.66 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.673 -0.694 . . . . 75.430000000000007 109.696 -176.47 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.418 ' HB ' ' O ' ' A' ' 5' ' ' MET . 90.9 m 74.45 131.92 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.575 0.702 . . . . 74.209999999999994 112.092 175.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -109.36 -78.45 0.59 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.914 -0.585 . . . . 75.040000000000006 110.905 178.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 48.86 19.64 0.28 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.352 1.061 . . . . 73.409999999999997 112.961 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -96.02 178.65 5.34 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 110.444 -0.206 . . . . 73.239999999999995 110.444 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 76.2 mtp85 62.27 80.92 0.21 Allowed 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.532 0.682 . . . . 72.030000000000001 110.877 -177.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 36.7 t-20 -77.9 140.72 62.86 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.038 -0.983 . . . . 63.140000000000001 109.268 -178.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -48.42 151.36 4.77 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.622 2.881 . . . . 71.329999999999998 113.463 176.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 57.9 t30 62.21 88.86 0.09 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.262 -0.881 . . . . 75.430000000000007 110.972 -177.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -136.44 122.57 20.34 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.433 -0.803 . . . . 75.230000000000004 110.137 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.62 -32.88 2.11 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.661 -0.699 . . . . 71.230000000000004 111.601 -178.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 112.88 161.59 15.06 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.93 -0.653 . . . . 73.329999999999998 112.859 177.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -106.0 145.08 30.2 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 109.719 -0.475 . . . . 72.140000000000001 109.719 175.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -63.86 115.84 3.33 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 122.801 2.334 . . . . 61.409999999999997 112.403 178.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -114.78 166.43 11.76 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.007 -0.542 . . . . 74.519999999999996 110.3 -178.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -69.36 136.01 51.13 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.119 -0.326 . . . . 74.239999999999995 110.119 178.037 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -101.99 160.18 17.87 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.802 -0.713 . . . . 62.439999999999998 112.71 -177.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.59 141.46 39.5 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.933 0.396 . . . . 64.099999999999994 110.935 178.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -119.0 104.18 10.25 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.888 -0.596 . . . . 71.25 110.553 -178.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -169.31 134.21 1.48 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.008 -0.542 . . . . 62.32 110.733 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 93.0 mt -121.14 69.7 0.9 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.84 -0.618 . . . . 52.439999999999998 109.34 175.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -124.57 -27.23 3.74 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.687 -0.688 . . . . 73.200000000000003 110.904 -174.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 19.9 m -102.48 110.29 22.19 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.354 -0.385 . . . . 71.349999999999994 110.785 -178.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -101.46 159.28 15.41 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.094 -0.503 . . . . 74.120000000000005 110.146 176.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -86.11 111.16 20.09 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.027 0.441 . . . . 65.310000000000002 110.592 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -75.4 151.37 38.16 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.85 -0.613 . . . . 75.25 110.446 179.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 70.8 mm-40 -85.0 86.26 7.4 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.274 0.559 . . . . 75.530000000000001 110.055 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -135.93 29.28 3.15 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.779 -0.646 . . . . 64.010000000000005 110.72 -177.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.0 p -55.59 105.56 0.19 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 121.517 0.675 . . . . 74.209999999999994 111.132 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -139.14 12.78 2.62 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.275 -0.875 . . . . 74.430000000000007 109.726 -172.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 49.7 tptt 68.36 37.24 2.78 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.141 -0.936 . . . . 71.430000000000007 108.722 -173.154 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.433 ' HB2' ' HD2' ' A' ' 37' ' ' PRO . 5.9 p-10 -80.48 158.13 71.75 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 114.696 -1.138 . . . . 74.530000000000001 110.919 -178.418 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.579 ' HD3' HG12 ' A' ' 45' ' ' ILE . 31.3 Cg_endo -65.47 -29.9 52.98 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.736 2.29 . . . . 70.219999999999999 112.398 178.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 42.0 m 66.53 -70.09 0.11 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.458 0.703 . . . . 62.109999999999999 111.457 -177.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -95.06 150.96 19.61 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.532 -0.304 . . . . 74.420000000000002 110.591 179.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 20.0 m120 63.92 74.32 0.42 Allowed 'General case' 0 C--N 1.329 -0.323 0 O-C-N 123.966 0.791 . . . . 75.200000000000003 111.205 176.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.3 t70 65.99 117.9 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.198 -0.91 . . . . 75.340000000000003 111.708 179.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.505 ' HA ' ' HG2' ' A' ' 37' ' ' PRO . 10.9 p-10 -83.96 3.93 31.99 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.878 -0.601 . . . . 70.120000000000005 111.551 -175.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -99.51 6.17 45.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.533 -0.303 . . . . 75.219999999999999 110.427 176.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -77.54 47.38 2.71 Favored Glycine 0 CA--C 1.521 0.422 0 C-N-CA 121.207 -0.52 . . . . 74.519999999999996 113.027 -177.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.579 HG12 ' HD3' ' A' ' 37' ' ' PRO . 11.6 mt -112.19 8.24 8.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 108.808 -0.812 . . . . 75.239999999999995 108.808 177.443 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 53.79 64.74 1.73 Allowed 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 114.755 -1.111 . . . . 65.319999999999993 109.732 -171.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 4.8 t -138.25 87.22 16.13 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 114.923 -1.035 . . . . 60.32 109.443 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.633 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 59.2 Cg_endo -70.93 83.78 0.88 Allowed 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.626 2.217 . . . . 72.099999999999994 113.244 -173.26 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 21.0 m -93.75 -68.0 0.82 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.037 -0.529 . . . . 71.450000000000003 110.297 174.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -107.69 -3.97 18.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.195 0.521 . . . . 71.230000000000004 111.061 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.474 HD23 ' H ' ' A' ' 51' ' ' LEU . 1.1 pt? -108.09 7.89 27.89 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.947 -0.57 . . . . 73.420000000000002 110.139 -178.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.633 ' HB3' ' HB2' ' A' ' 48' ' ' PRO . 19.4 p-10 -68.65 -52.8 27.26 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.7 -0.682 . . . . 63.020000000000003 111.246 -174.145 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -65.98 -29.21 69.56 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.985 0.422 . . . . 73.010000000000005 110.43 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.519 ' O ' HG13 ' A' ' 58' ' ' ILE . 70.7 t80 -66.36 -62.93 1.21 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.726 -0.67 . . . . 74.25 110.899 -178.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.1 t -66.89 -21.48 66.0 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.01 0.433 . . . . 75.409999999999997 110.933 -176.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.51 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 3.9 tp-100 -68.98 -43.36 75.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.253 0.549 . . . . 51.200000000000003 109.809 -179.495 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.52 -32.57 74.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.464 -0.789 . . . . 74.219999999999999 110.266 178.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.579 ' O ' HG13 ' A' ' 62' ' ' ILE . 19.6 mt -63.34 -39.88 86.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.901 -0.59 . . . . 75.030000000000001 110.644 178.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -64.48 -25.0 67.81 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.254 -0.43 . . . . 51.229999999999997 111.057 178.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.2 t -89.7 -38.88 13.54 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.308 -0.406 . . . . 73.340000000000003 110.748 -178.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.503 ' HG2' ' HA ' ' A' ' 58' ' ' ILE . 13.9 pt20 -66.91 -13.2 61.48 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.91 0.386 . . . . 64.209999999999994 110.878 -177.607 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.579 HG13 ' O ' ' A' ' 58' ' ' ILE . 76.8 mt -62.53 -33.68 60.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.565 -0.531 . . . . 75.120000000000005 109.565 175.22 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.0 mp -68.09 -28.93 67.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.224 -0.898 . . . . 74.530000000000001 110.586 -179.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -62.88 -47.51 88.3 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 111.414 -0.674 . . . . 54.140000000000001 111.414 178.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -72.76 -35.07 58.94 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.854 -0.689 . . . . 33.530000000000001 111.711 177.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.416 ' C ' ' H ' ' A' ' 68' ' ' SER . 47.1 tp -60.85 -49.41 77.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.018 0.437 . . . . 72.230000000000004 110.178 177.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 98.8 mt -79.74 32.28 0.25 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.184 0.516 . . . . 70.319999999999993 110.64 178.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.441 ' HA ' ' ND2' ' A' ' 71' ' ' ASN . 61.5 m -135.75 -50.94 0.73 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.436 -0.802 . . . . 75.109999999999999 109.592 174.168 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -69.67 -26.6 64.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.016 -0.538 . . . . 53.439999999999998 111.632 -178.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 50.8 mm -82.73 -19.59 10.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.093 0.473 . . . . 71.409999999999997 110.573 -178.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.476 ' HB3' ' OD1' ' A' ' 89' ' ' ASN . 51.8 m-20 -66.62 -61.11 2.15 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.214 -0.448 . . . . 61.43 110.852 -176.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.493 HG22 ' HG2' ' A' ' 74' ' ' LYS . 16.0 m -154.58 150.98 28.31 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.546 -0.539 . . . . 53.310000000000002 109.546 -178.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -82.97 -44.76 6.97 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.997 -0.621 . . . . 71.019999999999996 112.49 -178.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.493 ' HG2' HG22 ' A' ' 72' ' ' THR . 63.0 pttt -57.97 144.13 75.99 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-O 120.689 0.28 . . . . 51.439999999999998 110.393 175.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 74' ' ' LYS . 11.6 Cg_exo -70.71 -33.65 12.64 Favored 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.544 2.163 . . . . 65.030000000000001 112.121 -178.47 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.503 ' HA3' ' O ' ' A' ' 87' ' ' ILE . . . 88.68 -27.67 7.01 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 121.006 -0.616 . . . . 72.120000000000005 111.828 -177.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.433 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 4.4 tmt_? -66.59 121.11 14.63 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.93 -0.396 . . . . 45.020000000000003 109.93 178.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 50.5 ttm -115.5 122.3 45.3 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.981 -0.554 . . . . 73.310000000000002 110.212 -178.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.419 ' HB ' ' NH1' ' A' ' 77' ' ' ARG . 8.0 p -73.98 125.27 32.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.204 0.526 . . . . 63.219999999999999 110.779 -179.257 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.786 ' HB ' ' O ' ' A' ' 83' ' ' TYR . 17.0 m -138.85 152.59 47.95 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.518 -0.919 . . . . 43.310000000000002 108.518 177.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -65.46 -60.04 3.37 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.656 0.613 . . . . 72.310000000000002 112.656 -170.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -101.39 2.57 39.62 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.446 0.641 . . . . 75.510000000000005 111.419 -171.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.786 ' O ' ' HB ' ' A' ' 80' ' ' THR . 60.6 m-85 -146.03 116.31 7.48 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.927 -0.579 . . . . 63.340000000000003 110.105 178.116 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.645 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 3.8 mp -84.68 104.06 12.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.946 -0.761 . . . . 71.040000000000006 108.946 175.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 73.5 t -94.73 111.97 26.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.729 -0.669 . . . . 64.329999999999998 111.201 -174.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 77' ' ' ARG . 26.8 t70 -111.05 100.58 9.23 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.005 0.431 . . . . 74.510000000000005 110.448 175.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.503 ' O ' ' HA3' ' A' ' 76' ' ' GLY . 58.1 mt -89.49 97.22 6.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.431 -0.581 . . . . 73.150000000000006 109.431 176.04 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -104.58 130.05 52.61 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.062 -0.517 . . . . 54.140000000000001 111.599 -174.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.476 ' OD1' ' HB3' ' A' ' 71' ' ' ASN . 26.4 t-20 -108.53 87.36 2.48 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.342 -0.614 . . . . 62.210000000000001 109.342 171.126 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.408 ' O ' ' HB3' ' A' ' 91' ' ' ASP . 10.3 ttp180 -106.68 146.14 31.13 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.511 -0.922 . . . . 75.439999999999998 108.511 177.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.408 ' HB3' ' O ' ' A' ' 90' ' ' ARG . 24.9 t70 69.13 -70.49 0.14 Allowed 'General case' 0 N--CA 1.469 0.488 0 O-C-N 123.732 0.645 . . . . 71.019999999999996 110.53 -176.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 179.18 22.04 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 121.005 -0.617 . . . . 75.319999999999993 112.341 176.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.422 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 13.8 mm-40 -126.27 141.59 51.86 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 122.676 -0.308 . . . . 62.409999999999997 110.574 -175.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -81.41 109.96 16.39 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.192 -0.67 . . . . 52.240000000000002 109.192 173.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.443 HE21 ' HB2' ' A' ' 95' ' ' GLN . 6.0 tt0 -113.73 110.71 20.61 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.119 0.485 . . . . 55.530000000000001 110.666 -177.637 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.46 ' HB3' ' O ' ' A' ' 109' ' ' ILE . 59.6 tp -85.71 97.02 9.9 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.557 -0.747 . . . . 75.109999999999999 110.206 179.062 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.6 m-20 -95.53 100.36 12.12 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.074 -0.512 . . . . 43.409999999999997 110.113 177.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 50.7 t -94.96 111.59 25.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.817 -0.629 . . . . 72.019999999999996 110.364 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.645 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 22.8 m -89.94 103.35 16.02 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.873 -0.603 . . . . 64.319999999999993 109.665 175.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.595 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 9.8 t70 -58.72 147.64 32.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.096 -0.502 . . . . 63.399999999999999 110.842 178.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.401 ' HD2' ' HA ' ' A' ' 101' ' ' ARG . 23.5 tpt180 -113.6 -9.02 13.28 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.856 0.36 . . . . 70.420000000000002 111.314 -177.2 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm -78.87 -49.81 12.27 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.005 0.431 . . . . 73.140000000000001 110.806 177.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 36.5 p -113.23 -35.62 5.28 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.747 -0.661 . . . . 72.120000000000005 109.952 176.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.595 ' HA2' ' O ' ' A' ' 100' ' ' ASP . . . 91.57 81.11 1.42 Allowed Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.461 -0.79 . . . . 65.239999999999995 112.242 178.078 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.537 ' H ' ' HB3' ' A' ' 100' ' ' ASP . 49.6 mt-30 -137.47 139.98 40.93 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.253 -0.647 . . . . 72.040000000000006 109.253 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.9 t -84.38 95.45 8.75 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.585 0.707 . . . . 61.32 111.089 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 59.4 m -84.22 102.98 13.03 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.854 -0.612 . . . . 71.150000000000006 109.933 176.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 23.8 m -92.15 109.85 21.22 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.289 -0.414 . . . . 61.340000000000003 110.857 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.46 ' O ' ' HB3' ' A' ' 96' ' ' LEU . 4.9 mp -117.2 97.91 6.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.947 0.404 . . . . 73.010000000000005 109.94 175.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -74.74 153.25 38.91 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.453 -0.339 . . . . 61.100000000000001 110.92 178.212 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 8.4 p -58.88 132.36 23.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.608 -0.724 . . . . 75.109999999999999 110.461 177.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.49 91.23 6.85 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.421 -0.585 . . . . 73.519999999999996 109.421 179.051 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -78.56 47.89 3.09 Favored Glycine 0 N--CA 1.453 -0.167 0 CA-C-N 115.966 -0.561 . . . . 53.210000000000001 112.509 -178.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 96.2 mt -124.08 83.35 2.13 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.005 0.431 . . . . 71.239999999999995 110.29 -178.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -130.78 -27.21 2.13 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.874 -0.603 . . . . 62.340000000000003 110.134 176.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 50.34 178.88 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.622 1.169 . . . . 63.439999999999998 113.31 177.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -165.17 121.4 1.42 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.33 0.586 . . . . 61.130000000000003 110.946 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 48.9 m -143.54 91.56 2.27 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.7 -0.852 . . . . 75.219999999999999 108.7 172.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 17.4 m -120.67 97.69 5.67 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.861 -0.609 . . . . 73.200000000000003 111.023 -174.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -150.56 104.49 3.21 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.195 -0.457 . . . . 62.409999999999997 111.143 177.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -141.99 97.87 3.22 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.975 -0.75 . . . . 75.239999999999995 108.975 171.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 19.0 t-80 -76.28 105.68 7.47 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.715 -0.675 . . . . 74.340000000000003 111.733 -171.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -79.88 111.96 16.71 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.638 -0.875 . . . . 64.150000000000006 108.638 171.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -129.31 -23.38 2.97 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.74 -0.384 . . . . 75.209999999999994 111.525 -176.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 29.7 m170 66.71 168.65 0.23 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.426 0.631 . . . . 71.409999999999997 111.111 -178.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 12.8 p80 -123.47 140.01 53.43 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.964 -0.754 . . . . 73.129999999999995 108.964 172.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 . . . . . 0 C--O 1.247 0.947 0 O-C-N 123.825 0.703 . . . . 54.43 110.473 -178.256 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.2 mtt . . . . . 0 N--CA 1.481 1.08 0 N-CA-C 110.445 -0.206 . . . . 75.5 110.445 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 68.9 -65.97 0.26 Allowed 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.451 0.7 . . . . 74.230000000000004 112.436 178.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.46 77.36 1.06 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 121.378 -0.439 . . . . 65.140000000000001 112.796 -177.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.9 t -151.11 33.13 0.59 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.872 0.844 . . . . 72.25 109.566 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 20.6 ptp -94.32 126.78 39.79 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.947 -0.57 . . . . 75.430000000000007 111.754 -176.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 25.2 m -121.94 121.85 38.04 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.682 -0.69 . . . . 74.209999999999994 109.818 177.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -117.64 -70.63 0.78 Allowed 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.781 -0.367 . . . . 75.040000000000006 111.969 -175.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 59.01 39.52 23.37 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 122.195 0.997 . . . . 73.409999999999997 108.636 -174.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -78.73 -27.18 44.83 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.385 -1.28 . . . . 73.239999999999995 111.543 -170.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 10' ' ' ARG . 44.3 ttp180 -80.17 125.68 30.14 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.993 0.425 . . . . 72.030000000000001 110.717 -176.489 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.408 ' HB2' ' HD2' ' A' ' 12' ' ' PRO . 8.3 p30 -84.25 156.63 62.99 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.876 -0.602 . . . . 63.140000000000001 110.126 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.408 ' HD2' ' HB2' ' A' ' 11' ' ' ASN . 11.5 Cg_endo -56.11 -40.53 84.3 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.851 2.367 . . . . 71.329999999999998 112.857 -179.482 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 67.84 123.27 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 O-C-N 123.825 0.703 . . . . 75.430000000000007 111.928 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -124.09 154.27 40.22 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.993 -0.549 . . . . 75.230000000000004 109.77 176.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 128.12 112.84 1.7 Allowed Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.613 -0.803 . . . . 71.230000000000004 112.024 -178.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -169.76 -170.51 34.3 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 110.982 -0.847 . . . . 73.329999999999998 110.982 178.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.514 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 84.8 m-20 65.17 166.29 0.12 Allowed Pre-proline 0 N--CA 1.468 0.427 0 O-C-N 123.62 0.247 . . . . 72.140000000000001 110.968 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.514 ' HD2' ' HB3' ' A' ' 17' ' ' ASN . 46.1 Cg_endo -71.61 63.51 3.0 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 121.802 1.668 . . . . 61.409999999999997 111.031 172.516 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -119.79 91.74 3.62 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.224 -0.898 . . . . 74.519999999999996 108.643 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -105.6 117.3 33.67 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.79 -0.641 . . . . 74.239999999999995 110.047 -173.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -72.14 96.92 0.72 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 121.064 -0.589 . . . . 62.439999999999998 111.679 177.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -92.49 72.51 5.15 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.194 0.521 . . . . 64.099999999999994 110.725 -177.027 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -129.53 137.24 50.67 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.675 -0.693 . . . . 71.25 110.206 177.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.754 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 94.9 mt -137.23 168.82 18.87 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.538 -0.542 . . . . 62.32 109.538 177.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.754 ' HG ' ' O ' ' A' ' 24' ' ' LEU . 4.0 pp 53.58 -173.19 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 O-C-N 124.09 0.869 . . . . 52.439999999999998 111.897 178.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -162.44 174.47 12.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.445 -0.343 . . . . 73.200000000000003 110.491 177.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 45.2 p -156.19 151.94 27.23 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.084 -0.507 . . . . 71.349999999999994 110.748 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.18 129.88 34.78 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.074 -0.713 . . . . 74.120000000000005 109.074 172.332 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -99.87 170.9 8.21 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.9 -0.32 . . . . 65.310000000000002 111.013 -172.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 67.28 -168.39 0.2 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.549 -0.75 . . . . 75.25 111.375 -179.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 57.6 53.6 7.15 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.351 0.596 . . . . 75.530000000000001 110.068 -176.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.781 ' HB2' ' HB3' ' A' ' 36' ' ' ASP . 4.3 p-10 -64.27 -50.44 67.89 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.43 -0.804 . . . . 64.010000000000005 110.579 178.725 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 50.4 m 61.44 -76.5 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 O-C-N 123.866 0.729 . . . . 74.209999999999994 112.348 178.232 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -140.36 1.71 1.8 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.496 -0.32 . . . . 74.430000000000007 111.83 -175.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -98.8 4.61 47.66 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.428 -0.509 . . . . 71.430000000000007 110.484 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.781 ' HB3' ' HB2' ' A' ' 32' ' ' ASN . 5.9 p-10 -80.93 144.72 55.72 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.863 -0.608 . . . . 74.530000000000001 110.707 -178.451 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.448 ' HG2' HG13 ' A' ' 45' ' ' ILE . 13.5 Cg_exo -71.48 156.17 58.58 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 123.238 2.625 . . . . 70.219999999999999 112.538 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.4 m -149.81 -39.04 0.14 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.876 -0.602 . . . . 62.109999999999999 110.023 177.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -156.36 135.86 12.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.133 -0.485 . . . . 74.420000000000002 110.366 174.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.6 t30 72.13 10.59 6.02 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.65 -0.705 . . . . 75.200000000000003 110.99 177.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -150.54 147.92 28.05 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.09 -0.505 . . . . 75.340000000000003 110.043 177.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -151.67 19.61 0.71 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.479 0.657 . . . . 70.120000000000005 109.363 173.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -105.08 -16.21 14.86 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.437 -0.801 . . . . 75.219999999999999 110.594 -174.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -82.56 39.11 2.66 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.941 -0.647 . . . . 74.519999999999996 112.786 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.448 HG13 ' HG2' ' A' ' 37' ' ' PRO . 57.9 mt -122.66 -65.05 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 110.019 -0.363 . . . . 75.239999999999995 110.019 177.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 67.43 -70.51 0.12 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.444 -0.798 . . . . 65.319999999999993 111.546 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.0 m -124.53 87.9 53.89 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.386 -0.37 . . . . 60.32 110.726 -175.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -69.97 120.83 7.51 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 123.134 2.556 . . . . 72.099999999999994 112.658 -176.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 52.0 m -97.51 -86.15 0.35 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.352 -0.385 . . . . 71.450000000000003 111.409 177.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.91 12.83 28.9 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.046 0.451 . . . . 71.230000000000004 111.623 -176.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.4 pp -119.01 1.9 11.46 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.276 -0.42 . . . . 73.420000000000002 110.572 179.061 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -63.45 -60.3 3.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.63 -0.714 . . . . 63.020000000000003 111.538 -174.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.436 ' HA ' ' HB2' ' A' ' 56' ' ' GLN . 7.7 p30 -78.15 -13.75 59.74 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.921 -0.582 . . . . 73.010000000000005 110.906 -175.364 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.551 ' O ' HG13 ' A' ' 58' ' ' ILE . 83.9 t80 -66.55 -58.39 5.3 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.234 -0.439 . . . . 74.25 110.095 176.181 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.7 t -74.3 -12.29 60.5 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.186 0.517 . . . . 75.409999999999997 110.419 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.436 ' HB2' ' HA ' ' A' ' 53' ' ' ASN . 2.1 tp-100 -70.63 -47.75 58.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.759 -0.655 . . . . 51.200000000000003 109.643 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.23 -28.24 67.07 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.728 -0.669 . . . . 74.219999999999999 110.894 179.232 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.56 ' O ' HG13 ' A' ' 62' ' ' ILE . 26.6 mt -63.09 -39.52 85.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.163 -0.471 . . . . 75.030000000000001 110.649 179.523 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -64.31 -31.04 72.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.151 -0.477 . . . . 51.229999999999997 110.658 179.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.1 m -81.04 -41.52 22.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.146 -0.479 . . . . 73.340000000000003 111.339 -178.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.521 ' HG2' ' HA ' ' A' ' 58' ' ' ILE . 13.8 pt20 -66.78 -19.0 65.66 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.518 -0.31 . . . . 64.209999999999994 111.49 -176.169 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.56 HG13 ' O ' ' A' ' 58' ' ' ILE . 86.5 mt -62.23 -47.42 93.18 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 N-CA-C 109.31 -0.626 . . . . 75.120000000000005 109.31 175.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.0 mp -64.39 -43.21 95.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.451 -0.795 . . . . 74.530000000000001 110.498 178.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -57.5 -44.68 93.65 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 121.226 -0.512 . . . . 54.140000000000001 112.578 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -75.21 -44.15 23.68 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.682 -0.77 . . . . 33.530000000000001 112.453 178.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.604 ' O ' HG12 ' A' ' 70' ' ' ILE . 57.0 tp -58.72 -50.35 74.21 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 122.313 0.245 . . . . 72.230000000000004 111.297 -177.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 85.5 mt -63.34 -17.65 62.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.445 -0.343 . . . . 70.319999999999993 111.912 -176.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.1 t -78.27 -45.77 21.96 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.76 -0.459 . . . . 75.109999999999999 109.76 178.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -78.5 -11.49 59.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.046 -0.525 . . . . 53.439999999999998 111.149 -176.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.604 HG12 ' O ' ' A' ' 66' ' ' LEU . 27.4 mm -61.34 -38.86 80.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.725 0.298 . . . . 71.409999999999997 110.478 176.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.411 ' ND2' ' H ' ' A' ' 91' ' ' ASP . 27.4 m-80 -62.74 -72.05 0.14 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.988 -0.551 . . . . 61.43 110.235 -178.132 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.503 HG22 ' HG3' ' A' ' 74' ' ' LYS . 16.7 m -135.5 97.7 3.75 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.319 -0.623 . . . . 53.310000000000002 109.319 174.681 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -90.84 16.54 58.1 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.862 -0.685 . . . . 71.019999999999996 113.762 -170.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.562 ' HB2' ' HD2' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -56.96 156.31 13.47 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 117.257 0.528 . . . . 51.439999999999998 109.975 174.746 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.562 ' HD2' ' HB2' ' A' ' 74' ' ' LYS . 44.1 Cg_exo -23.11 -55.63 0.05 OUTLIER 'Trans proline' 0 C--N 1.358 1.075 1 C-N-CA 125.306 4.004 . . . . 65.030000000000001 115.519 -172.018 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.42 ' HA2' ' HB ' ' A' ' 87' ' ' ILE . . . 80.48 -55.22 4.65 Favored Glycine 0 C--O 1.228 -0.236 0 C-N-CA 120.877 -0.678 . . . . 72.120000000000005 112.436 177.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 42.2 ptt85 -69.82 108.15 3.83 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.158 0.504 . . . . 45.020000000000003 110.592 176.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.588 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 28.0 ttt -91.01 105.03 17.54 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.757 -0.656 . . . . 73.310000000000002 109.78 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 19.1 t -86.53 76.12 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.397 0.618 . . . . 63.219999999999999 110.267 -176.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.0 -175.44 5.4 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.728 -0.669 . . . . 43.310000000000002 110.089 179.139 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -79.67 -43.81 22.06 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.663 0.268 . . . . 72.310000000000002 110.772 -177.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.559 ' O ' ' HB2' ' A' ' 101' ' ' ARG . 8.2 t0 -101.6 -76.52 0.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.657 -0.497 . . . . 75.510000000000005 109.657 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.507 ' HB3' HG13 ' A' ' 98' ' ' VAL . 17.0 m-85 -79.38 115.4 19.0 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.407 -0.361 . . . . 63.340000000000003 111.048 -174.266 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.464 HD12 ' HB ' ' A' ' 99' ' ' THR . 0.9 OUTLIER -83.83 103.38 11.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.595 0.712 . . . . 71.040000000000006 109.197 170.843 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.588 ' HB ' ' HB3' ' A' ' 78' ' ' MET . 37.6 t -94.3 139.65 18.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.639 -0.709 . . . . 64.329999999999998 111.195 -169.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -108.73 105.07 14.49 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.573 -0.528 . . . . 74.510000000000005 109.573 174.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.42 ' HB ' ' HA2' ' A' ' 76' ' ' GLY . 74.4 mt -78.72 113.69 18.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.287 -0.415 . . . . 73.150000000000006 109.968 178.156 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -107.8 109.57 21.16 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.184 -0.462 . . . . 54.140000000000001 111.128 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.564 ' HA ' ' O ' ' A' ' 93' ' ' GLN . 3.5 t-20 -111.44 83.01 1.7 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.202 0.525 . . . . 62.210000000000001 109.726 174.401 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 90' ' ' ARG . 30.2 ttp180 -105.27 121.07 43.1 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.959 -0.564 . . . . 75.439999999999998 109.744 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.411 ' H ' ' ND2' ' A' ' 71' ' ' ASN . 26.4 t70 69.04 -83.11 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.369 -0.832 . . . . 71.019999999999996 111.207 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -144.14 12.13 2.08 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.63 -0.795 . . . . 75.319999999999993 112.583 -178.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.564 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 16.6 mm-40 -103.24 126.73 50.55 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.769 0.319 . . . . 62.409999999999997 111.461 -179.094 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 94' ' ' LEU . 4.3 mm? -96.36 98.22 10.09 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.909 -0.774 . . . . 52.240000000000002 108.909 168.326 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.44 HE21 ' HB2' ' A' ' 95' ' ' GLN . 4.6 tt0 -112.36 126.62 55.47 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.213 -0.449 . . . . 55.530000000000001 110.396 -175.432 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 13.6 tp -103.69 100.8 10.63 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.135 -0.484 . . . . 75.109999999999999 110.196 -176.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -88.96 97.83 11.41 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.175 -0.466 . . . . 43.409999999999997 111.045 -177.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.507 HG13 ' HB3' ' A' ' 83' ' ' TYR . 39.0 t -90.32 115.2 29.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.869 -0.605 . . . . 72.019999999999996 110.841 -179.603 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.464 ' HB ' HD12 ' A' ' 84' ' ' ILE . 47.6 m -104.6 114.79 29.23 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.673 -0.694 . . . . 64.319999999999993 109.964 175.583 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.506 ' HA ' ' HD1' ' A' ' 83' ' ' TYR . 26.0 t70 -60.79 141.97 56.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.97 -0.559 . . . . 63.399999999999999 111.105 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.559 ' HB2' ' O ' ' A' ' 82' ' ' ASP . 10.0 tpt180 -88.55 -10.94 47.13 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.151 -0.477 . . . . 70.420000000000002 111.367 -174.235 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm -107.62 -67.71 0.94 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.74 0.305 . . . . 73.140000000000001 111.622 -171.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 45.8 p -85.62 -33.09 21.73 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.271 0.558 . . . . 72.120000000000005 109.997 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 99.6 23.55 10.89 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.279 -0.873 . . . . 65.239999999999995 112.644 177.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.445 ' N ' ' HB3' ' A' ' 100' ' ' ASP . 98.2 mt-30 -59.58 130.68 48.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.725 0.298 . . . . 72.040000000000006 110.737 175.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.2 p -102.89 88.4 3.17 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.172 0.51 . . . . 61.32 110.398 176.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 9.7 t -91.21 105.65 17.95 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.766 -0.652 . . . . 71.150000000000006 109.489 -178.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.5 m -91.24 107.8 19.45 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.986 -0.552 . . . . 61.340000000000003 110.388 -178.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 59.5 mt -110.01 116.0 51.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.416 -0.356 . . . . 73.010000000000005 110.882 -175.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -71.71 168.2 18.26 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.003 0.43 . . . . 61.100000000000001 111.207 175.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.7 p -69.57 110.66 3.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.748 -0.66 . . . . 75.109999999999999 111.306 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 9.2 t -108.67 95.21 5.5 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.92 -0.582 . . . . 73.519999999999996 109.976 177.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -106.04 50.62 0.8 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.686 -0.769 . . . . 53.210000000000001 112.116 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 93.4 mt -120.26 116.55 25.79 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.129 -0.323 . . . . 71.239999999999995 110.129 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -123.66 93.32 3.9 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.071 -0.513 . . . . 62.340000000000003 110.959 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -88.47 88.58 7.67 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.914 0.388 . . . . 63.439999999999998 110.015 176.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -78.37 134.13 37.47 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.985 -0.552 . . . . 61.130000000000003 110.526 -178.119 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 56.1 m -144.09 150.67 38.51 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.932 -0.395 . . . . 75.219999999999999 109.932 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.0 t -103.6 148.53 25.89 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.836 0.351 . . . . 73.200000000000003 110.198 -178.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -96.68 112.72 24.35 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.348 -0.387 . . . . 62.409999999999997 110.214 -178.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -112.46 177.29 4.69 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.233 -0.44 . . . . 75.239999999999995 110.937 -174.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 28.9 t60 60.39 83.07 0.15 Allowed 'General case' 0 C--N 1.33 -0.254 0 O-C-N 123.695 0.622 . . . . 74.340000000000003 110.818 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -112.18 146.28 38.37 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.056 -0.52 . . . . 64.150000000000006 110.785 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -102.05 128.7 48.39 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.295 -0.632 . . . . 75.209999999999994 109.295 177.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 65.6 m170 -100.35 -49.48 4.23 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 121.024 -0.27 . . . . 71.409999999999997 111.52 -174.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 25.6 p80 -152.38 -178.79 7.04 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.957 0.408 . . . . 73.129999999999995 111.304 -173.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 . . . . . 0 C--O 1.245 0.818 0 CA-C-N 115.711 -0.677 . . . . 54.43 109.224 172.483 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 ttt . . . . . 0 N--CA 1.48 1.042 0 N-CA-C 109.914 -0.402 . . . . 75.5 109.914 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 66.11 107.58 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 O-C-N 123.822 0.702 . . . . 74.230000000000004 111.126 -176.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.26 -3.92 71.84 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 115.841 -0.618 . . . . 65.140000000000001 113.257 -176.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 27.8 m -69.37 103.41 1.99 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.846 0.355 . . . . 72.25 110.696 178.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 22.9 ttt -146.65 104.5 3.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.08 -0.509 . . . . 75.430000000000007 109.964 -178.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.4 p -126.1 129.41 49.03 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.946 0.403 . . . . 74.209999999999994 111.449 -176.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -102.42 -47.14 4.57 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.053 -0.522 . . . . 75.040000000000006 110.896 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 80.5 mm-40 59.42 47.38 11.21 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.517 0.675 . . . . 73.409999999999997 109.254 -171.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -87.79 150.91 23.27 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.138 -0.937 . . . . 73.239999999999995 110.333 -174.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.8 ptt85 -111.53 163.88 13.58 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.189 -0.46 . . . . 72.030000000000001 111.466 -176.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -139.38 86.25 14.54 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 109.579 -0.526 . . . . 63.140000000000001 109.579 175.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -68.85 -45.15 2.3 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.986 2.457 . . . . 71.329999999999998 112.685 -176.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.4 t30 69.37 114.92 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 O-C-N 123.867 0.729 . . . . 75.430000000000007 110.473 -177.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -76.68 169.26 18.61 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.126 -0.488 . . . . 75.230000000000004 111.272 -175.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -95.16 161.32 23.32 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.813 -0.708 . . . . 71.230000000000004 112.713 -175.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.34 -77.59 0.7 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.044 -0.598 . . . . 73.329999999999998 112.535 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.451 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 4.8 m-20 -101.37 144.42 28.53 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-O 120.684 0.278 . . . . 72.140000000000001 110.797 -178.499 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 17' ' ' ASN . 3.6 Cg_exo -75.43 -55.13 0.07 OUTLIER 'Trans proline' 0 CA--C 1.53 0.306 0 C-N-CA 122.894 2.396 . . . . 61.409999999999997 111.86 176.4 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -170.75 169.69 6.88 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.496 -0.927 . . . . 74.519999999999996 108.496 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 74.01 113.55 0.06 Allowed 'General case' 0 N--CA 1.467 0.416 0 O-C-N 123.751 0.657 . . . . 74.239999999999995 110.97 178.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -128.61 -71.38 0.14 Allowed Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.625 -0.797 . . . . 62.439999999999998 112.82 -176.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -143.22 146.94 34.1 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.884 0.373 . . . . 64.099999999999994 111.416 -175.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -130.24 110.46 11.56 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.911 -0.586 . . . . 71.25 109.706 175.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.751 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 6.6 mp -102.82 -167.43 1.39 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.132 -0.486 . . . . 62.32 110.201 -178.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.751 ' HG ' ' O ' ' A' ' 24' ' ' LEU . 4.3 pp 58.99 -178.05 0.08 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.456 1.102 . . . . 52.439999999999998 112.051 -177.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -143.94 154.94 43.83 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.743 -0.465 . . . . 73.200000000000003 109.743 -175.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.9 p -69.25 -84.07 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 121.269 -0.172 . . . . 71.349999999999994 110.786 176.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -170.43 89.71 0.15 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.772 0.32 . . . . 74.120000000000005 111.322 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -90.41 24.04 2.74 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.472 0.653 . . . . 65.310000000000002 110.25 177.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.82 0.66 56.37 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.538 -0.755 . . . . 75.25 110.666 178.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -109.97 138.62 46.09 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.041 -0.527 . . . . 75.530000000000001 110.929 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -65.98 111.07 3.15 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.9 -0.591 . . . . 64.010000000000005 110.129 177.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.5 t 60.07 82.91 0.15 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.374 -0.83 . . . . 74.209999999999994 110.147 -175.1 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -82.56 -15.66 51.45 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.617 -0.719 . . . . 74.430000000000007 110.724 -177.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.7 ttmt 72.48 -163.64 0.11 Allowed 'General case' 0 C--O 1.233 0.209 0 N-CA-C 108.761 -0.829 . . . . 71.430000000000007 108.761 -177.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.492 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 9.1 p-10 -72.89 143.23 84.03 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-O 120.688 0.28 . . . . 74.530000000000001 110.287 179.189 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.541 ' HB2' ' O ' ' A' ' 41' ' ' ASP . 5.7 Cg_exo -79.55 144.7 17.95 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.845 2.363 . . . . 70.219999999999999 111.63 177.549 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.2 m -136.84 5.37 2.85 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 111.786 0.291 . . . . 62.109999999999999 111.786 -173.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -125.49 91.97 3.52 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.918 -0.313 . . . . 74.420000000000002 111.059 -177.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 61.62 6.76 1.63 Allowed 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.96 0.726 . . . . 75.200000000000003 112.96 174.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.541 ' O ' ' HB2' ' A' ' 37' ' ' PRO . 8.9 t70 -144.2 152.34 40.72 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.299 -0.41 . . . . 75.340000000000003 110.115 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -145.61 12.72 1.33 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.951 -0.568 . . . . 70.120000000000005 109.559 174.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.42 ' C ' ' H ' ' A' ' 45' ' ' ILE . 94.5 m-85 -100.55 -11.45 20.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.678 -0.692 . . . . 75.219999999999999 110.713 -179.641 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -73.08 24.08 0.86 Allowed Glycine 0 CA--C 1.52 0.402 0 CA-C-N 116.2 -0.455 . . . . 74.519999999999996 113.35 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.42 ' H ' ' C ' ' A' ' 43' ' ' PHE . 57.4 mt -79.29 -30.43 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 109.477 -0.564 . . . . 75.239999999999995 109.477 176.536 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -77.03 140.02 40.22 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.564 -0.743 . . . . 65.319999999999993 110.28 -178.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 25.8 m -151.11 86.02 4.93 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 116.006 -0.543 . . . . 60.32 109.688 174.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.643 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 28.2 Cg_endo -62.16 110.58 1.05 Allowed 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 122.826 2.351 . . . . 72.099999999999994 112.29 -178.041 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 26.7 m -123.69 -25.54 4.3 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.005 -0.543 . . . . 71.450000000000003 110.415 177.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.3 -37.33 0.31 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 71.230000000000004 111.374 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.2 pp -73.09 -12.6 60.97 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.536 -0.302 . . . . 73.420000000000002 111.409 -176.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.643 ' HB3' ' HB2' ' A' ' 48' ' ' PRO . 4.3 p-10 -63.63 -56.59 14.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.289 -0.414 . . . . 63.020000000000003 110.864 -178.317 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -64.61 -28.76 69.84 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.229 0.538 . . . . 73.010000000000005 110.108 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.444 ' O ' HG13 ' A' ' 58' ' ' ILE . 77.6 t80 -66.26 -49.86 65.71 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.414 -0.812 . . . . 74.25 111.028 179.092 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.445 ' O ' ' HG3' ' A' ' 59' ' ' GLN . 8.9 t -72.46 -19.48 61.55 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.708 0.262 . . . . 75.409999999999997 111.708 -176.195 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.438 ' HG3' ' O ' ' A' ' 52' ' ' ASP . 60.9 mt-30 -64.39 -43.69 93.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.895 0.378 . . . . 51.200000000000003 111.096 -178.508 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.72 -24.89 61.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.337 -0.392 . . . . 74.219999999999999 111.422 -178.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.444 HG13 ' O ' ' A' ' 54' ' ' PHE . 8.6 mt -76.35 -18.67 15.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.107 0.479 . . . . 75.030000000000001 110.974 -176.365 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.445 ' HG3' ' O ' ' A' ' 55' ' ' THR . 77.4 mt-30 -67.21 -19.16 65.51 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.374 -0.375 . . . . 51.229999999999997 110.98 -178.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 61.0 m -74.87 -34.8 62.29 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.53 -0.304 . . . . 73.340000000000003 111.484 178.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.436 ' HG2' ' O ' ' A' ' 58' ' ' ILE . 11.1 pt20 -82.2 -5.58 58.6 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.862 0.363 . . . . 64.209999999999994 110.966 -177.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.554 HG23 ' HA3' ' A' ' 92' ' ' GLY . 67.7 mt -65.34 -36.02 76.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.284 0.564 . . . . 75.120000000000005 109.799 175.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 9.2 mp -63.47 -35.7 81.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.414 -0.812 . . . . 74.530000000000001 110.622 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -65.7 -40.68 95.92 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.285 -0.726 . . . . 54.140000000000001 111.285 175.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -66.33 -19.56 68.62 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 121.147 -0.549 . . . . 33.530000000000001 112.385 177.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 62' ' ' ILE . 85.5 mt -74.44 -31.9 62.43 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.046 0.45 . . . . 72.230000000000004 110.168 176.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 49.0 mt -74.83 -42.58 57.73 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.996 -0.742 . . . . 70.319999999999993 108.996 175.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.8 m -75.52 5.83 5.45 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.107 -0.951 . . . . 75.109999999999999 111.246 178.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.956 ' HA ' ' HG3' ' A' ' 90' ' ' ARG . 50.6 t30 -82.43 -25.86 33.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.195 -0.457 . . . . 53.439999999999998 110.997 -178.362 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.0 mp -84.59 -50.67 14.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.204 -0.453 . . . . 71.409999999999997 110.997 -175.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -111.08 -88.48 0.51 Allowed 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.192 -0.603 . . . . 61.43 111.004 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 92.0 m -168.38 126.46 1.12 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.098 -0.704 . . . . 53.310000000000002 109.098 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -152.32 42.56 0.68 Allowed Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.119 -1.039 . . . . 71.019999999999996 111.937 178.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.636 ' HB2' ' O ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -56.96 144.97 66.54 Favored Pre-proline 0 C--N 1.327 -0.376 0 O-C-N 123.517 0.187 . . . . 51.439999999999998 110.978 179.937 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.484 ' HD3' ' HB2' ' A' ' 89' ' ' ASN . 16.1 Cg_endo -58.05 -44.06 42.88 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.951 2.434 . . . . 65.030000000000001 112.929 -175.185 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 168.26 -156.89 28.76 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.474 -0.869 . . . . 72.120000000000005 112.133 -179.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -150.76 175.46 11.96 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 110.146 -0.316 . . . . 45.020000000000003 110.146 -177.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.761 ' HB3' HG13 ' A' ' 85' ' ' VAL . 47.9 ttm -121.95 121.07 36.24 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.897 -0.779 . . . . 73.310000000000002 108.897 173.561 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.4 p -88.53 98.31 7.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.867 0.842 . . . . 63.219999999999999 111.827 -173.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.7 p -122.77 156.93 33.47 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.209 -0.905 . . . . 43.310000000000002 109.451 171.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -78.28 -41.18 34.72 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.811 0.338 . . . . 72.310000000000002 111.368 -175.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.713 ' HB3' ' HD3' ' A' ' 102' ' ' LYS . 7.5 m-20 -81.45 -21.68 38.64 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.174 -0.466 . . . . 75.510000000000005 111.282 -174.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -137.49 135.89 37.2 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.978 0.418 . . . . 63.340000000000003 111.363 -177.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.669 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 4.1 mp -105.93 84.94 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 108.407 -0.96 . . . . 71.040000000000006 108.407 172.231 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.761 HG13 ' HB3' ' A' ' 78' ' ' MET . 2.3 p -91.18 106.8 17.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.642 0.734 . . . . 64.329999999999998 110.455 -177.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -111.51 128.0 55.88 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.316 -0.856 . . . . 74.510000000000005 110.32 -175.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.636 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 19.4 mt -95.86 103.73 15.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.278 -0.419 . . . . 73.150000000000006 110.375 -177.268 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -88.56 146.76 24.96 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.899 0.381 . . . . 54.140000000000001 111.009 -178.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.484 ' HB2' ' HD3' ' A' ' 75' ' ' PRO . 54.5 t30 -139.53 110.3 6.76 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.107 -0.497 . . . . 62.210000000000001 109.764 178.492 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.956 ' HG3' ' HA ' ' A' ' 69' ' ' ASN . 66.8 ttt180 -147.12 141.44 26.31 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.024 -0.535 . . . . 75.439999999999998 109.565 179.27 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.2 t70 71.71 2.94 4.48 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.449 0.642 . . . . 71.019999999999996 110.452 177.172 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.554 ' HA3' HG23 ' A' ' 62' ' ' ILE . . . 97.13 -8.62 65.07 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 111.183 -0.767 . . . . 75.319999999999993 111.183 -176.009 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -90.07 135.33 33.72 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.875 0.369 . . . . 62.409999999999997 110.346 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 94' ' ' LEU . 4.4 mm? -91.97 131.51 37.22 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.408 -0.59 . . . . 52.240000000000002 109.408 173.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.414 ' HG2' ' ND2' ' A' ' 97' ' ' ASN . 6.2 tt0 -133.48 108.1 8.44 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.0 -0.545 . . . . 55.530000000000001 110.468 -178.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.588 ' HB3' ' HB ' ' A' ' 109' ' ' ILE . 44.2 tp -88.83 111.16 21.71 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.757 -0.656 . . . . 75.109999999999999 110.295 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.414 ' ND2' ' HG2' ' A' ' 95' ' ' GLN . 48.7 m-80 -104.56 107.41 18.34 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.881 0.372 . . . . 43.409999999999997 110.63 178.156 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.6 t -87.02 107.18 16.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.983 -0.553 . . . . 72.019999999999996 110.137 176.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.669 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 28.0 m -89.84 104.1 16.7 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 115.667 -0.697 . . . . 64.319999999999993 109.524 177.241 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.609 ' HB3' ' N ' ' A' ' 105' ' ' GLN . 32.3 t70 -71.11 127.39 32.43 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.335 -0.848 . . . . 63.399999999999999 110.865 -177.446 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.413 ' HA ' ' NE ' ' A' ' 101' ' ' ARG . 5.1 tpm_? -99.28 1.94 45.08 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.462 0.648 . . . . 70.420000000000002 110.166 -178.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.713 ' HD3' ' HB3' ' A' ' 82' ' ' ASP . 25.3 mmmt -89.45 -57.08 3.01 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.054 -0.521 . . . . 73.140000000000001 110.421 -178.179 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 64.2 p -115.08 -31.35 6.07 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.453 0.644 . . . . 72.120000000000005 110.258 178.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.43 ' HA2' ' O ' ' A' ' 100' ' ' ASP . . . 110.01 29.88 3.63 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 115.414 -0.812 . . . . 65.239999999999995 112.378 178.348 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.609 ' N ' ' HB3' ' A' ' 100' ' ' ASP . 84.1 mm-40 -64.04 160.71 17.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.108 0.48 . . . . 72.040000000000006 110.17 171.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 27.1 m -140.81 87.46 2.11 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.244 -0.65 . . . . 61.32 109.244 174.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.4 t -85.2 114.73 22.53 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.406 -0.815 . . . . 71.150000000000006 109.567 -178.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 19.5 m -102.18 114.79 29.25 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.065 -0.516 . . . . 61.340000000000003 110.72 -178.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.588 ' HB ' ' HB3' ' A' ' 96' ' ' LEU . 4.4 mp -105.97 96.6 4.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.048 -0.523 . . . . 73.010000000000005 109.767 177.289 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -93.54 142.72 27.02 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.193 -0.458 . . . . 61.100000000000001 109.88 178.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 92.6 t -68.38 124.13 23.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 110.189 -0.3 . . . . 75.109999999999999 110.189 176.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.3 m -58.88 -52.39 65.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.833 -0.621 . . . . 73.519999999999996 111.268 -177.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 175.19 153.29 10.04 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.518 -0.848 . . . . 53.210000000000001 112.411 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.531 HD12 HD11 ' A' ' 62' ' ' ILE . 56.9 mt -119.92 93.09 3.94 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.387 -0.597 . . . . 71.239999999999995 109.387 179.171 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -133.47 100.16 4.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.408 -0.36 . . . . 62.340000000000003 111.784 -173.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 175.2 131.73 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.878 -0.601 . . . . 63.439999999999998 109.885 177.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -106.34 -71.46 0.75 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 121.012 -0.275 . . . . 61.130000000000003 110.465 177.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 39.4 t 70.71 145.28 0.06 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.636 0.731 . . . . 75.219999999999999 112.294 176.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 17.2 m -145.59 145.22 30.89 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.703 -0.68 . . . . 73.200000000000003 110.107 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -136.98 137.72 39.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.181 0.515 . . . . 62.409999999999997 110.702 174.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -115.04 144.93 42.85 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.777 -0.823 . . . . 75.239999999999995 108.777 170.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 9.6 p-80 -144.95 119.56 9.76 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.149 0.5 . . . . 74.340000000000003 111.462 -174.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 44.1 m-70 -101.65 -163.3 1.0 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.444 -0.798 . . . . 64.150000000000006 110.268 177.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 19.4 p80 56.08 -174.23 0.06 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.611 1.165 . . . . 75.209999999999994 112.401 179.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 62.28 49.9 4.07 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.168 0.509 . . . . 71.409999999999997 110.999 -174.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 16.6 t-80 -94.42 -1.5 53.53 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.64 0.734 . . . . 73.129999999999995 109.172 177.025 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 . . . . . 0 C--O 1.245 0.818 0 CA-C-N 115.314 -0.857 . . . . 54.43 109.251 176.649 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.4 mtm . . . . . 0 N--CA 1.481 1.12 0 N-CA-C 110.341 -0.244 . . . . 75.5 110.341 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -121.05 152.93 38.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.666 0.27 . . . . 74.230000000000004 110.958 -179.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 107.84 -42.69 1.87 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.115 -0.564 . . . . 65.140000000000001 112.105 178.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.1 m -110.61 36.89 2.93 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.481 0.658 . . . . 72.25 109.913 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 50.9 ttm -91.81 131.19 37.34 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.773 -0.649 . . . . 75.430000000000007 109.517 178.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 35.6 p -75.69 89.39 2.8 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.659 0.614 . . . . 74.209999999999994 112.659 -172.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -141.44 -71.39 0.35 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.926 -0.579 . . . . 75.040000000000006 111.008 175.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -88.04 -46.0 9.7 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.296 -0.411 . . . . 73.409999999999997 111.863 -176.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 67.88 157.21 0.13 Allowed 'General case' 0 N--CA 1.468 0.458 0 O-C-N 123.72 0.637 . . . . 73.239999999999995 110.934 -176.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.496 ' HE ' ' HA ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -75.59 -37.93 59.48 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.429 -0.35 . . . . 72.030000000000001 110.576 175.942 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 61.4 t30 65.12 86.31 0.14 Allowed Pre-proline 0 N--CA 1.467 0.376 0 O-C-N 123.988 0.805 . . . . 63.140000000000001 110.884 178.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -64.74 140.41 67.52 Favored 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 123.039 2.493 . . . . 71.329999999999998 112.93 -177.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 71.52 172.6 0.31 Allowed 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.6 -0.727 . . . . 75.430000000000007 111.953 176.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -134.07 147.75 50.94 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.553 -0.749 . . . . 75.230000000000004 110.028 -177.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.53 64.6 4.01 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 121.19 -0.528 . . . . 71.230000000000004 112.354 178.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -156.6 79.16 0.18 Allowed Glycine 0 N--CA 1.451 -0.314 0 N-CA-C 111.401 -0.68 . . . . 73.329999999999998 111.401 179.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -92.67 155.52 41.84 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-O 120.399 0.143 . . . . 72.140000000000001 111.076 -174.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -58.39 137.54 80.96 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.865 2.377 . . . . 61.409999999999997 111.769 176.204 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -140.68 144.73 35.81 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.25 -0.432 . . . . 74.519999999999996 110.831 -175.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 43.5 t30 68.1 105.53 0.05 Allowed 'General case' 0 N--CA 1.468 0.45 0 O-C-N 124.105 0.878 . . . . 74.239999999999995 111.954 178.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -134.12 57.2 0.7 Allowed Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 111.424 -0.67 . . . . 62.439999999999998 111.424 177.11 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.53 68.25 4.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.327 0.584 . . . . 64.099999999999994 111.244 -178.094 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.609 ' HE1' ' HA ' ' A' ' 26' ' ' ASN . 3.5 t80 -167.71 100.98 0.48 Allowed 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.387 -0.968 . . . . 71.25 108.387 177.612 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.4 mt -109.55 -2.62 17.47 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.135 0.42 . . . . 62.32 112.135 -169.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 87.5 mt -101.57 -68.27 0.83 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.911 -0.316 . . . . 52.439999999999998 111.437 -178.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.609 ' HA ' ' HE1' ' A' ' 23' ' ' PHE . 28.2 t-20 66.27 98.83 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.624 0.726 . . . . 73.200000000000003 110.467 -175.08 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.5 m -83.96 95.84 8.66 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.54 -0.755 . . . . 71.349999999999994 110.771 -174.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.18 -52.65 21.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.981 -0.554 . . . . 74.120000000000005 110.844 179.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 61.55 23.64 13.89 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.843 -0.617 . . . . 65.310000000000002 110.579 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -139.08 152.18 47.32 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.155 -0.475 . . . . 75.25 110.303 -178.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -99.49 -82.31 0.44 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.913 -0.585 . . . . 75.530000000000001 109.84 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 179.02 122.08 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.958 -1.127 . . . . 64.010000000000005 107.958 177.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.3 t -86.38 -4.22 59.13 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 121.192 -0.203 . . . . 74.209999999999994 111.291 -173.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -142.16 97.79 3.2 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 121.174 0.512 . . . . 74.430000000000007 110.672 -176.043 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 21.5 pttm -93.29 1.95 56.79 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.786 0.803 . . . . 71.430000000000007 109.097 178.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -104.99 145.32 30.5 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 114.938 -1.028 . . . . 74.530000000000001 110.134 -174.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.549 ' HA ' ' HB2' ' A' ' 42' ' ' ASP . 37.1 Cg_endo -66.27 143.84 72.23 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.192 1.928 . . . . 70.219999999999999 111.989 178.354 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.9 m -119.62 -37.94 3.07 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.205 -0.665 . . . . 62.109999999999999 109.205 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -102.43 13.04 35.61 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.198 -0.91 . . . . 74.420000000000002 109.474 175.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.4 t30 69.73 4.39 4.71 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.056 -0.974 . . . . 75.200000000000003 110.874 179.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -144.49 69.09 1.26 Allowed 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.808 -0.812 . . . . 75.340000000000003 108.808 178.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.549 ' HB2' ' HA ' ' A' ' 37' ' ' PRO . 7.8 m-20 -132.43 -85.2 0.47 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.702 -0.681 . . . . 70.120000000000005 110.937 -175.417 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -141.85 31.3 1.62 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.451 0.643 . . . . 75.219999999999999 109.974 -177.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.422 ' HA2' ' HD3' ' A' ' 37' ' ' PRO . . . -76.54 48.38 2.56 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 121.032 -0.604 . . . . 74.519999999999996 112.559 -178.269 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 21.0 mt -106.35 -39.88 5.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.484 0.659 . . . . 75.239999999999995 109.797 -177.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -76.64 -20.43 56.7 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.323 -0.853 . . . . 65.319999999999993 109.869 178.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.425 HG23 ' O ' ' A' ' 47' ' ' THR . 9.9 t -120.59 88.04 42.51 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.19 -0.914 . . . . 60.32 109.877 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -67.6 93.52 0.37 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.306 2.671 . . . . 72.099999999999994 113.725 -172.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 72.8 m -105.61 -69.75 0.81 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.089 -0.505 . . . . 71.450000000000003 110.607 172.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.39 -38.35 90.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.873 0.368 . . . . 71.230000000000004 111.922 -178.059 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.426 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 3.2 pp -95.4 12.06 30.6 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.166 -0.47 . . . . 73.420000000000002 111.67 -175.415 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' ' 56' ' ' GLN . 15.9 t70 -57.41 -42.87 83.14 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.939 0.399 . . . . 63.020000000000003 111.121 -178.165 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -89.09 15.88 8.03 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.172 -0.467 . . . . 73.010000000000005 111.2 -177.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.765 ' HE1' ' HG2' ' A' ' 105' ' ' GLN . 67.6 t80 -122.97 -64.8 1.15 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.231 -0.44 . . . . 74.25 110.527 -179.333 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.1 m -66.64 -28.08 68.19 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.323 -0.399 . . . . 75.409999999999997 111.586 -175.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.471 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 0.7 OUTLIER -69.45 -29.62 67.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.829 0.347 . . . . 51.200000000000003 110.835 179.402 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.61 -26.1 60.63 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.286 0.565 . . . . 74.219999999999999 110.116 176.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.401 ' O ' HG13 ' A' ' 62' ' ' ILE . 12.1 mt -71.32 -25.47 25.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.458 -0.792 . . . . 75.030000000000001 110.591 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -55.11 -34.14 63.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.605 -0.27 . . . . 51.229999999999997 110.861 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 36.0 t -62.56 -48.92 77.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.184 -0.462 . . . . 73.340000000000003 111.141 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -73.28 -24.95 60.5 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.818 -0.353 . . . . 64.209999999999994 111.05 -176.07 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.659 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 75.4 mt -76.81 -56.92 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.946 0.403 . . . . 75.120000000000005 110.037 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 84.8 mt -62.1 -33.05 73.72 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.998 -0.546 . . . . 74.530000000000001 111.678 -175.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -77.33 -24.25 66.26 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.493 -0.86 . . . . 54.140000000000001 112.449 179.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -94.2 -20.78 29.32 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.041 -0.6 . . . . 33.530000000000001 112.865 -176.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.659 ' HG ' ' O ' ' A' ' 62' ' ' ILE . 69.7 mt -59.25 -15.58 16.3 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.459 0.54 . . . . 72.230000000000004 112.459 -176.201 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 84.1 mt -58.69 -41.69 86.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.018 0.437 . . . . 70.319999999999993 110.183 177.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.502 ' HB2' ' HB1' ' A' ' 88' ' ' ALA . 19.7 m -71.97 -24.66 61.63 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.875 -0.602 . . . . 75.109999999999999 110.751 -179.145 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.446 ' ND2' ' HB2' ' A' ' 88' ' ' ALA . 13.4 m120 -80.85 -22.72 39.65 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.865 -0.607 . . . . 53.439999999999998 111.106 -177.384 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.413 HG12 ' O ' ' A' ' 66' ' ' LEU . 49.5 mm -100.65 -37.38 5.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 112.171 0.434 . . . . 71.409999999999997 112.171 -174.318 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 68.1 m-20 -61.6 -88.19 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.497 0.925 . . . . 61.43 113.497 -170.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 53.2 m -170.44 144.0 2.39 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.535 -0.543 . . . . 53.310000000000002 109.535 -173.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.571 ' HA3' ' O ' ' A' ' 89' ' ' ASN . . . 143.96 -67.26 0.44 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 121.12 -0.562 . . . . 71.019999999999996 111.985 175.458 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.527 ' HD3' ' H ' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -54.3 143.09 46.97 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-O 120.807 0.337 . . . . 51.439999999999998 110.978 179.24 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 74' ' ' LYS . 2.8 Cg_exo -78.29 -24.84 7.56 Favored 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 122.882 2.388 . . . . 65.030000000000001 112.087 174.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -176.85 165.93 36.38 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.686 -0.768 . . . . 72.120000000000005 112.652 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 77' ' ' ARG . 1.9 ptm180 -121.54 142.78 49.74 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.401 -0.592 . . . . 45.020000000000003 109.401 178.641 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.752 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 50.0 ttm -94.88 104.7 16.6 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.278 0.561 . . . . 73.310000000000002 110.776 -176.649 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 53.4 t -105.22 106.33 20.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.029 -0.532 . . . . 63.219999999999999 110.397 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 14.7 p -127.31 159.4 34.5 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.973 -0.558 . . . . 43.310000000000002 110.177 175.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -62.97 -46.17 88.96 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.368 -0.378 . . . . 72.310000000000002 110.933 -176.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -77.7 -25.91 49.76 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.106 0.409 . . . . 75.510000000000005 112.106 -172.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.421 ' CE1' ' HA ' ' A' ' 100' ' ' ASP . 14.6 m-85 -149.15 136.35 19.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.233 0.54 . . . . 63.340000000000003 111.811 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.614 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 51.7 mm -98.42 99.44 8.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.315 -0.624 . . . . 71.040000000000006 109.315 175.196 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.752 ' HB ' ' HB3' ' A' ' 78' ' ' MET . 29.1 t -103.38 86.74 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.288 0.566 . . . . 64.329999999999998 110.257 -177.439 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -91.11 124.01 35.01 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.955 -0.566 . . . . 74.510000000000005 109.711 -177.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 70.5 mt -98.16 117.48 43.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.074 -0.512 . . . . 73.150000000000006 110.386 -175.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.584 ' HB3' ' HB2' ' A' ' 95' ' ' GLN . . . -110.89 87.83 2.63 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.262 0.553 . . . . 54.140000000000001 111.142 -178.17 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.571 ' O ' ' HA3' ' A' ' 73' ' ' GLY . 2.9 t-20 -97.58 107.64 20.19 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.431 -0.951 . . . . 62.210000000000001 108.431 171.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.483 ' HB3' ' HB3' ' A' ' 68' ' ' SER . 11.5 tpt180 -160.03 147.56 16.55 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.041 -0.527 . . . . 75.439999999999998 109.989 -176.09 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.3 t70 71.21 0.63 3.5 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 123.748 0.655 . . . . 71.019999999999996 111.111 173.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 114.37 -23.74 12.1 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 115.808 -0.633 . . . . 75.319999999999993 112.443 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 -95.67 159.07 15.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.351 0.595 . . . . 62.409999999999997 111.697 -175.094 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -106.32 116.59 32.19 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.382 -0.826 . . . . 52.240000000000002 109.451 175.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.584 ' HB2' ' HB3' ' A' ' 88' ' ' ALA . 66.5 mt-30 -121.05 127.94 52.18 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.242 -0.435 . . . . 55.530000000000001 110.15 -179.322 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 41.3 tp -109.94 121.69 45.83 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 110.041 -0.355 . . . . 75.109999999999999 110.041 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -112.91 102.2 10.22 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.903 -0.406 . . . . 43.409999999999997 109.903 177.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.614 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 6.4 p -113.9 115.61 50.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.412 0.625 . . . . 72.019999999999996 111.281 -178.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.581 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 41.2 m -92.44 123.13 35.53 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.805 -0.634 . . . . 64.319999999999993 111.045 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.476 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 26.9 t70 -75.08 158.43 33.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.57 -0.741 . . . . 63.399999999999999 110.649 177.359 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 11.6 mmt180 -115.61 2.54 13.78 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.486 0.55 . . . . 70.420000000000002 112.486 -176.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -108.13 -35.58 6.54 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.58 0.705 . . . . 73.140000000000001 110.264 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 14.4 p -121.81 -23.2 5.55 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.066 -0.97 . . . . 72.120000000000005 110.325 176.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.476 ' HA2' ' O ' ' A' ' 100' ' ' ASP . . . 83.65 14.56 72.94 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.659 -0.7 . . . . 65.239999999999995 111.986 -179.059 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.765 ' HG2' ' HE1' ' A' ' 54' ' ' PHE . 49.7 mt-30 -63.94 101.81 0.42 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.748 0.308 . . . . 72.040000000000006 110.404 177.481 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 98' ' ' VAL . 58.5 m -85.88 109.33 18.64 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.829 -0.434 . . . . 61.32 109.829 177.211 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 17.7 t -86.71 105.34 16.87 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.991 -0.55 . . . . 71.150000000000006 109.735 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 8.5 m -92.96 96.1 9.9 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.77 -0.65 . . . . 61.340000000000003 109.813 177.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 65.0 mt -102.86 114.33 42.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.179 -0.464 . . . . 73.010000000000005 111.539 -174.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.505 ' HG2' ' HG2' ' A' ' 95' ' ' GLN . 43.6 mt-30 -95.09 121.19 36.47 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.456 -0.572 . . . . 61.100000000000001 109.456 172.058 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 93.4 t -65.66 124.54 20.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.174 0.511 . . . . 75.109999999999999 111.949 -175.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.6 m -93.42 -174.29 3.46 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.492 -0.776 . . . . 73.519999999999996 110.306 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -120.28 -158.22 10.45 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.195 -1.002 . . . . 53.210000000000001 111.929 176.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 77.1 mt -144.88 -62.19 0.36 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.609 0.204 . . . . 71.239999999999995 111.086 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 62.45 86.46 0.11 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.813 -0.631 . . . . 62.340000000000003 109.656 -174.473 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -170.52 98.7 0.25 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.772 -0.649 . . . . 63.439999999999998 109.96 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -104.56 -37.82 7.0 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.053 -0.521 . . . . 61.130000000000003 111.171 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 50.0 m 62.14 91.77 0.06 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.219 0.533 . . . . 75.219999999999999 110.565 -178.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.8 p -76.11 86.64 2.98 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.358 0.599 . . . . 73.200000000000003 111.318 -178.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -101.31 -73.1 0.66 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.689 -0.687 . . . . 62.409999999999997 110.221 -178.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 64.72 -82.84 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.652 -0.703 . . . . 75.239999999999995 112.541 175.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 75.7 m80 66.27 102.58 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.35 0.66 . . . . 74.340000000000003 111.401 -173.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -82.72 91.43 7.01 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.417 -0.586 . . . . 64.150000000000006 109.417 174.045 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 17.7 p80 -100.11 121.74 41.88 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.702 -0.681 . . . . 75.209999999999994 110.594 -176.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 51.3 t60 -119.03 161.82 19.61 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.241 -1.022 . . . . 71.409999999999997 108.241 178.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 6.7 p80 59.17 170.12 0.07 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.06 0.944 . . . . 73.129999999999995 111.592 -177.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 44.0 t-80 . . . . . 0 C--O 1.244 0.816 0 CA-C-O 118.13 -0.938 . . . . 54.43 110.123 178.293 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 110.094 -0.336 . . . . 75.5 110.094 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 65.27 59.76 0.8 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.299 0.571 . . . . 74.230000000000004 111.386 178.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -129.31 124.24 4.44 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 115.65 -0.705 . . . . 65.140000000000001 111.627 177.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.2 t -81.74 143.77 31.59 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.133 0.492 . . . . 72.25 110.836 -177.333 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.14 124.47 47.8 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.097 -0.501 . . . . 75.430000000000007 109.746 176.582 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 26.7 m -153.65 -48.53 0.09 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.391 -0.368 . . . . 74.209999999999994 111.129 -178.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -64.57 -80.9 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.372 -0.376 . . . . 75.040000000000006 111.636 -178.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 49.33 61.23 3.25 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.051 0.54 . . . . 73.409999999999997 111.55 176.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -113.67 172.32 7.05 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.197 -0.456 . . . . 73.239999999999995 111.315 -174.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -164.11 108.87 1.0 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.653 -0.703 . . . . 72.030000000000001 109.536 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.3 t30 65.07 87.87 0.12 Allowed Pre-proline 0 N--CA 1.466 0.371 0 O-C-N 123.22 0.325 . . . . 63.140000000000001 111.036 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.78 -33.25 80.2 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 123.072 2.515 . . . . 71.329999999999998 112.572 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 25.2 t30 73.24 106.48 0.07 Allowed 'General case' 0 N--CA 1.467 0.388 0 O-C-N 123.798 0.686 . . . . 75.430000000000007 112.098 174.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -123.21 104.74 9.35 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.596 -0.729 . . . . 75.230000000000004 109.24 173.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 174.25 51.69 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.621 -0.8 . . . . 71.230000000000004 112.251 -179.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -100.5 103.39 2.61 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.997 -0.621 . . . . 73.329999999999998 111.663 178.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.438 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 50.3 m-80 -117.54 148.88 43.83 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 110.381 -0.229 . . . . 72.140000000000001 110.381 -177.668 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 17' ' ' ASN . 5.5 Cg_exo -77.5 94.11 1.07 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.282 2.655 . . . . 61.409999999999997 113.62 -175.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 47.02 -87.92 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 114.329 1.233 . . . . 74.519999999999996 114.329 172.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -177.59 -179.76 0.85 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.756 0.312 . . . . 74.239999999999995 110.236 -170.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -120.44 -46.27 0.37 Allowed Glycine 0 N--CA 1.452 -0.294 0 N-CA-C 111.299 -0.72 . . . . 62.439999999999998 111.299 175.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 63.75 -168.51 0.2 Allowed 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 123.414 0.685 . . . . 64.099999999999994 111.809 176.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -131.43 145.5 51.83 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.113 -0.494 . . . . 71.25 110.027 -177.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.554 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 5.4 mp -112.57 114.43 27.07 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.111 -0.329 . . . . 62.32 110.111 179.13 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' A' ' 24' ' ' LEU . 4.4 pp 48.81 -166.14 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 O-C-N 124.074 0.859 . . . . 52.439999999999998 112.095 178.272 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -172.42 -85.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.789 -0.448 . . . . 73.200000000000003 109.789 173.009 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.5 p 176.09 136.75 0.05 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.695 -0.684 . . . . 71.349999999999994 109.174 177.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -142.55 125.53 16.22 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.667 0.27 . . . . 74.120000000000005 110.759 -178.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -128.06 126.43 41.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.114 -0.494 . . . . 65.310000000000002 110.087 178.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -98.73 7.17 46.39 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.087 -0.506 . . . . 75.25 111.767 -173.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -90.3 83.44 5.96 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.413 0.625 . . . . 75.530000000000001 111.084 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -161.29 -176.28 5.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.403 -0.817 . . . . 64.010000000000005 109.422 178.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.9 m 62.18 37.11 14.58 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 121.318 0.58 . . . . 74.209999999999994 111.053 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -93.96 11.67 28.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.773 -0.649 . . . . 74.430000000000007 110.655 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.456 ' HD2' ' HA ' ' A' ' 35' ' ' LYS . 17.3 tptm -107.82 176.32 5.18 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.853 -0.795 . . . . 71.430000000000007 108.853 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.431 ' H ' ' HG3' ' A' ' 35' ' ' LYS . 10.1 m-20 -44.24 142.98 2.06 Favored Pre-proline 0 N--CA 1.467 0.411 0 O-C-N 123.758 0.662 . . . . 74.530000000000001 112.246 -175.686 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.523 ' HG3' HG12 ' A' ' 45' ' ' ILE . 18.0 Cg_endo -59.16 152.74 57.35 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 123.419 2.746 . . . . 70.219999999999999 113.545 -175.185 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 28.2 t -146.58 38.34 1.02 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.77 -1.105 . . . . 62.109999999999999 108.447 -178.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.405 ' O ' ' HB2' ' A' ' 40' ' ' ASN . 24.4 t80 73.02 160.54 0.23 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-N 114.705 -1.134 . . . . 74.420000000000002 109.958 -174.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.405 ' HB2' ' O ' ' A' ' 39' ' ' TYR . 91.1 m-20 71.74 3.83 4.82 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.218 0.607 . . . . 75.200000000000003 111.073 -177.654 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -174.69 130.29 0.33 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.334 -0.987 . . . . 75.340000000000003 108.334 175.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -127.02 21.3 6.84 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.153 0.502 . . . . 70.120000000000005 110.773 -177.257 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -111.12 -21.32 12.0 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.781 -0.645 . . . . 75.219999999999999 110.772 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -75.6 46.82 2.03 Favored Glycine 0 C--O 1.223 -0.588 0 C-N-CA 121.152 -0.547 . . . . 74.519999999999996 112.858 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.523 HG12 ' HG3' ' A' ' 37' ' ' PRO . 10.4 mt -99.45 -6.69 9.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.143 -0.688 . . . . 75.239999999999995 109.143 178.17 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.433 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 30.9 tt0 64.58 24.47 13.03 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.027 -0.988 . . . . 65.319999999999993 109.621 -174.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 8.2 m -113.02 86.15 8.81 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.116 -0.947 . . . . 60.32 109.236 175.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' A' ' 46' ' ' GLU . 17.1 Cg_exo -66.21 99.22 0.41 Allowed 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.692 2.262 . . . . 72.099999999999994 113.157 -173.528 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.8 m -127.85 -59.46 1.2 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.824 -0.625 . . . . 71.450000000000003 109.603 174.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.54 -46.37 15.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.027 -0.533 . . . . 71.230000000000004 110.263 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.54 HD23 ' H ' ' A' ' 51' ' ' LEU . 1.4 pt? -74.6 -13.35 60.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 73.420000000000002 110.778 179.317 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.621 ' O ' ' HB2' ' A' ' 56' ' ' GLN . 27.0 t70 -62.69 -47.23 84.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.151 -0.477 . . . . 63.020000000000003 110.457 -179.441 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -79.2 9.91 4.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.426 -0.352 . . . . 73.010000000000005 110.865 178.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.456 ' O ' HG13 ' A' ' 58' ' ' ILE . 82.4 t80 -109.65 -64.82 1.21 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.759 0.314 . . . . 74.25 110.432 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.47 ' O ' ' HG2' ' A' ' 59' ' ' GLN . 12.9 t -73.5 -18.5 61.1 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.937 0.347 . . . . 75.409999999999997 111.937 -174.102 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.621 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 2.3 mp0 -75.09 -28.11 60.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.802 0.334 . . . . 51.200000000000003 110.614 -178.287 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -79.57 -18.83 50.86 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.536 0.684 . . . . 74.219999999999999 109.771 175.121 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.516 ' O ' HG13 ' A' ' 62' ' ' ILE . 21.7 mt -79.3 -29.06 13.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.37 -0.832 . . . . 75.030000000000001 110.604 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.47 ' HG2' ' O ' ' A' ' 55' ' ' THR . 15.1 mm-40 -53.29 -37.61 62.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.132 -0.485 . . . . 51.229999999999997 111.136 -178.665 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.8 m -62.71 -46.55 87.6 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.046 -0.525 . . . . 73.340000000000003 111.022 179.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -77.78 -16.14 58.58 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.844 -0.342 . . . . 64.209999999999994 111.082 -178.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.516 HG13 ' O ' ' A' ' 58' ' ' ILE . 64.7 mt -71.27 -43.09 74.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.302 -0.629 . . . . 75.120000000000005 109.302 172.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 97.1 mt -61.45 -41.56 97.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.926 -0.579 . . . . 74.530000000000001 110.096 175.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -65.15 -37.33 93.98 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.771 -0.728 . . . . 54.140000000000001 111.714 175.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.21 -37.34 94.37 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 111.784 -0.526 . . . . 33.530000000000001 111.784 176.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 62' ' ' ILE . 95.9 mt -56.9 -59.51 4.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.593 0.235 . . . . 72.230000000000004 110.998 178.089 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 pp -65.6 -10.4 35.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.864 0.364 . . . . 70.319999999999993 111.741 -176.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.405 ' HA ' ' HG3' ' A' ' 90' ' ' ARG . 31.4 m -95.86 -46.43 6.56 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.662 0.267 . . . . 75.109999999999999 111.246 178.56 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -92.08 -26.85 18.11 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.399 0.518 . . . . 53.439999999999998 112.399 -172.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 36.1 mm -66.58 -20.97 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 121.268 0.556 . . . . 71.409999999999997 110.452 -178.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.434 HD22 ' N ' ' A' ' 71' ' ' ASN . 0.9 OUTLIER -68.36 -28.81 67.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.106 0.479 . . . . 61.43 110.28 175.925 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.8 m -96.9 -49.35 5.07 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.106 -0.497 . . . . 53.310000000000002 110.638 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 85.11 -89.72 1.62 Allowed Glycine 0 N--CA 1.449 -0.433 0 N-CA-C 111.682 -0.567 . . . . 71.019999999999996 111.682 -178.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -57.82 153.77 30.61 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.595 -0.302 . . . . 51.439999999999998 110.203 174.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.43 123.79 14.67 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.17 1.914 . . . . 65.030000000000001 111.809 177.068 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -96.55 64.67 1.07 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.627 -0.797 . . . . 72.120000000000005 112.494 -176.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -165.33 125.12 1.81 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.084 0.468 . . . . 45.020000000000003 110.923 178.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 58.9 ttp -112.58 108.19 17.18 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.907 -0.588 . . . . 73.310000000000002 109.642 178.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 60.9 t -74.35 102.81 2.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.243 0.544 . . . . 63.219999999999999 111.043 -176.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.666 ' HB ' ' O ' ' A' ' 83' ' ' TYR . 17.5 m -120.95 142.15 50.01 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.376 -0.829 . . . . 43.310000000000002 109.28 178.399 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -70.15 -36.31 74.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.903 0.382 . . . . 72.310000000000002 111.08 -174.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -82.4 -40.1 21.74 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.94 -0.573 . . . . 75.510000000000005 111.491 -176.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.666 ' O ' ' HB ' ' A' ' 80' ' ' THR . 49.6 m-85 -139.96 120.8 14.46 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.205 -0.294 . . . . 63.340000000000003 110.205 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.66 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 4.2 mp -83.68 99.89 6.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.069 -0.715 . . . . 71.040000000000006 109.069 178.451 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.3 t -91.01 106.7 17.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.609 -0.723 . . . . 64.329999999999998 111.097 -175.11 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -105.23 122.91 46.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.058 -0.519 . . . . 74.510000000000005 109.693 176.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 56.8 mt -101.55 118.12 47.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.286 -0.416 . . . . 73.150000000000006 110.524 -175.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -112.51 88.48 2.83 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.109 0.48 . . . . 54.140000000000001 110.492 178.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -95.33 88.54 5.16 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.195 -0.669 . . . . 62.210000000000001 109.195 175.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.405 ' HG3' ' HA ' ' A' ' 68' ' ' SER . 56.7 ttp180 -130.75 143.06 50.48 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.567 -0.742 . . . . 75.439999999999998 109.717 -177.117 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 37.7 t70 65.7 24.16 11.56 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.64 0.733 . . . . 71.019999999999996 110.664 174.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.24 5.15 90.26 Favored Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 115.577 -0.738 . . . . 75.319999999999993 112.623 178.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -104.4 134.4 47.68 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.873 0.368 . . . . 62.409999999999997 110.759 -179.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.491 ' HB2' ' HB ' ' A' ' 111' ' ' VAL . 4.5 mm? -91.97 96.34 10.31 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.867 -0.606 . . . . 52.240000000000002 109.39 174.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -106.33 110.0 22.1 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.327 0.584 . . . . 55.530000000000001 110.695 -179.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 35.8 tp -94.06 109.38 21.14 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.453 -0.794 . . . . 75.109999999999999 110.034 -178.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -97.82 93.06 6.15 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.949 0.404 . . . . 43.409999999999997 110.52 -179.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 56.0 t -85.01 103.63 12.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.143 0.497 . . . . 72.019999999999996 110.369 177.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.66 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 57.9 m -77.31 104.43 7.82 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.204 -0.665 . . . . 64.319999999999993 109.204 175.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -69.55 138.45 53.27 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.477 -0.783 . . . . 63.399999999999999 111.641 -174.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -108.02 -12.91 15.06 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.384 -0.825 . . . . 70.420000000000002 109.716 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -77.74 -55.86 4.99 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.813 -0.631 . . . . 73.140000000000001 110.714 -176.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 47.0 p -115.88 -23.15 8.73 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.387 0.613 . . . . 72.120000000000005 110.389 178.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 93.11 28.65 11.43 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.551 -0.75 . . . . 65.239999999999995 112.121 177.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -101.02 100.8 11.46 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 110.133 -0.321 . . . . 72.040000000000006 110.133 177.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 19.0 m -58.64 109.94 0.9 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.328 0.585 . . . . 61.32 110.867 -178.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 7.9 m -89.82 89.61 7.83 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.622 -0.717 . . . . 71.150000000000006 110.015 -178.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 45.4 m -83.46 109.3 17.23 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.931 -0.577 . . . . 61.340000000000003 110.317 178.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 58.9 mt -108.34 111.23 35.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.923 -0.58 . . . . 73.010000000000005 110.907 -177.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -88.96 118.54 28.76 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.981 0.42 . . . . 61.100000000000001 110.35 175.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.491 ' HB ' ' HB2' ' A' ' 94' ' ' LEU . 23.0 t -75.51 161.7 4.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.925 -0.58 . . . . 75.109999999999999 109.839 178.211 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.42 ' N ' HG12 ' A' ' 111' ' ' VAL . 37.1 m 75.48 25.41 1.24 Allowed 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.293 0.637 . . . . 73.519999999999996 110.682 -178.042 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -83.09 -44.43 7.08 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.752 -0.658 . . . . 53.210000000000001 111.769 178.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 58.4 mt -96.09 94.96 7.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.04 0.448 . . . . 71.239999999999995 110.887 179.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -101.13 148.34 25.19 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.01 -0.541 . . . . 62.340000000000003 109.854 177.17 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -145.07 115.34 7.54 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.92 -0.4 . . . . 63.439999999999998 109.92 -178.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -83.95 119.97 25.54 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.162 -0.472 . . . . 61.130000000000003 110.623 -177.059 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 50.4 m -144.16 143.2 30.98 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.951 -0.388 . . . . 75.219999999999999 109.951 177.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.7 t -161.91 152.5 17.47 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.919 0.39 . . . . 73.200000000000003 111.162 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -130.55 125.18 33.59 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.85 -0.796 . . . . 62.409999999999997 108.85 174.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.417 ' O ' ' HB2' ' A' ' 122' ' ' HIS . 33.5 t80 -92.1 -76.17 0.46 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.591 -0.277 . . . . 75.239999999999995 111.391 -169.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.417 ' HB2' ' O ' ' A' ' 121' ' ' PHE . 54.2 m170 69.2 157.36 0.15 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.497 0.665 . . . . 74.340000000000003 111.692 -176.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 43.0 m170 -117.42 -55.54 2.3 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.756 -0.656 . . . . 64.150000000000006 109.459 173.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -172.22 -60.24 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.871 -0.604 . . . . 75.209999999999994 109.66 176.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 63.93 169.52 0.16 Allowed 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.84 0.681 . . . . 71.409999999999997 112.84 177.151 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 8.4 p-80 -176.14 152.69 1.18 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.089 -0.96 . . . . 73.129999999999995 109.552 172.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.359 -0.829 . . . . 54.43 109.171 173.612 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 N--CA 1.479 1.018 0 CA-C-O 120.897 0.379 . . . . 75.5 110.203 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.69 130.37 9.11 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.175 -0.466 . . . . 74.230000000000004 110.35 179.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -101.94 113.11 4.53 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.934 -0.65 . . . . 65.140000000000001 111.572 178.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.544 ' HA ' ' HE1' ' A' ' 7' ' ' PHE . 5.6 p -98.12 88.74 4.29 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.034 0.445 . . . . 72.25 110.418 177.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 56.7 ttp -61.73 -43.13 99.45 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.544 -0.753 . . . . 75.430000000000007 110.139 178.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.55 HG23 ' H ' ' A' ' 7' ' ' PHE . 2.7 t -167.21 -64.61 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.974 -0.557 . . . . 74.209999999999994 110.935 173.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.55 ' H ' HG23 ' A' ' 6' ' ' THR . 97.9 m-85 60.16 113.75 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.387 0.613 . . . . 75.040000000000006 111.97 -178.131 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -127.13 88.12 2.76 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.187 0.518 . . . . 73.409999999999997 109.887 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.52 ' CE2' ' HB3' ' A' ' 11' ' ' ASN . 86.5 t80 -151.01 126.2 9.93 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.676 -0.693 . . . . 73.239999999999995 110.061 -178.644 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.41 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -102.1 92.91 4.97 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.804 -0.443 . . . . 72.030000000000001 109.804 -178.698 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.52 ' HB3' ' CE2' ' A' ' 9' ' ' PHE . 27.3 p30 -89.25 146.11 35.5 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-O 120.826 0.346 . . . . 63.140000000000001 110.666 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -73.91 -19.77 20.36 Favored 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 122.704 2.269 . . . . 71.329999999999998 112.166 177.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 64.76 102.76 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.678 -0.692 . . . . 75.430000000000007 111.13 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -120.49 140.69 51.07 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.154 -0.475 . . . . 75.230000000000004 110.837 178.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -89.97 -143.18 10.11 Favored Glycine 0 N--CA 1.444 -0.787 0 N-CA-C 111.332 -0.707 . . . . 71.230000000000004 111.332 174.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -148.32 -105.41 0.38 Allowed Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.499 -0.857 . . . . 73.329999999999998 112.545 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.41 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 50.8 m-80 -121.24 146.85 45.57 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 110.173 -0.306 . . . . 72.140000000000001 110.173 -178.083 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 17' ' ' ASN . 16.9 Cg_exo -68.35 -31.21 28.76 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.642 2.228 . . . . 61.409999999999997 111.33 176.189 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 11.7 t30 68.71 126.62 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.327 -0.851 . . . . 74.519999999999996 111.266 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -82.32 152.14 26.41 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.974 -0.557 . . . . 74.239999999999995 110.914 -177.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -88.67 -177.43 46.78 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.731 -0.747 . . . . 62.439999999999998 111.656 177.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -89.83 157.08 18.07 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.09 0.472 . . . . 64.099999999999994 111.077 -178.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -132.65 131.99 41.95 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.679 -0.692 . . . . 71.25 109.42 176.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.8 mp -115.68 115.78 26.96 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.949 0.404 . . . . 62.32 111.043 -176.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.9 mt -131.88 108.53 9.47 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.723 -0.671 . . . . 52.439999999999998 109.99 177.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -95.79 163.86 12.99 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.297 -0.41 . . . . 73.200000000000003 110.813 -177.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 26.2 m -122.21 23.5 9.81 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.062 -0.517 . . . . 71.349999999999994 110.899 -176.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 67.5 -163.14 0.22 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.701 -0.682 . . . . 74.120000000000005 111.125 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.5 tp60 -116.86 169.6 9.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.291 -0.413 . . . . 65.310000000000002 110.187 -175.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -75.16 128.76 36.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.787 0.327 . . . . 75.25 110.565 178.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.3 pm0 -100.74 149.83 23.4 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.55 -0.295 . . . . 75.530000000000001 111.335 -177.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -174.77 122.73 0.25 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.943 -0.572 . . . . 64.010000000000005 110.445 176.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.3 m 51.31 48.57 22.75 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.138 -0.483 . . . . 74.209999999999994 111.563 177.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -73.63 -15.49 61.26 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.87 -0.604 . . . . 74.430000000000007 112.219 -174.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.3 ttmt 70.37 -162.85 0.16 Allowed 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.871 -0.418 . . . . 71.430000000000007 109.871 -177.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.494 ' HB2' ' HD2' ' A' ' 37' ' ' PRO . 6.1 p-10 -78.74 160.59 71.64 Favored Pre-proline 0 C--O 1.235 0.318 0 CA-C-O 120.295 0.093 . . . . 74.530000000000001 110.988 -177.023 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.683 ' HA ' ' OD2' ' A' ' 42' ' ' ASP . 73.9 Cg_exo -43.22 143.52 2.11 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.945 3.097 . . . . 70.219999999999999 115.271 -175.101 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.0 m -117.78 21.25 13.03 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.82 -1.082 . . . . 62.109999999999999 110.263 178.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 52.7 t80 75.1 164.93 0.28 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.524 -0.762 . . . . 74.420000000000002 111.244 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 66.9 t30 71.84 -175.99 0.18 Allowed 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.873 -0.788 . . . . 75.200000000000003 108.873 -172.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -60.87 110.25 1.28 Allowed 'General case' 0 C--O 1.234 0.258 0 N-CA-C 108.33 -0.989 . . . . 75.340000000000003 108.33 171.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.683 ' OD2' ' HA ' ' A' ' 37' ' ' PRO . 14.9 t70 -128.18 -53.24 1.29 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.526 -0.761 . . . . 70.120000000000005 112.335 -160.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.587 ' O ' ' HG2' ' A' ' 46' ' ' GLU . 40.5 m-85 57.63 24.56 10.64 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.161 0.8 . . . . 75.219999999999999 113.161 -178.365 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -75.46 19.34 2.47 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 121.154 -0.545 . . . . 74.519999999999996 112.692 176.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.484 ' HA ' HD21 ' A' ' 51' ' ' LEU . 54.3 mt -91.24 -19.84 6.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.378 0.609 . . . . 75.239999999999995 109.631 178.276 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.587 ' HG2' ' O ' ' A' ' 43' ' ' PHE . 11.7 pt-20 -86.9 0.67 54.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.656 -0.702 . . . . 65.319999999999993 110.189 178.54 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.7 87.7 3.77 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 115.612 -0.722 . . . . 60.32 110.767 175.248 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.521 ' CB ' ' HB2' ' A' ' 52' ' ' ASP . 50.7 Cg_endo -70.01 82.9 0.77 Allowed 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.037 1.825 . . . . 72.099999999999994 111.653 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.1 m -117.03 -8.96 11.17 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.82 -0.627 . . . . 71.450000000000003 110.792 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -165.42 -32.71 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.493 -0.321 . . . . 71.230000000000004 111.749 -176.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.484 HD21 ' HA ' ' A' ' 45' ' ' ILE . 3.9 pp -88.44 -10.07 50.4 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.846 0.313 . . . . 73.420000000000002 111.846 -177.723 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.521 ' HB2' ' CB ' ' A' ' 48' ' ' PRO . 17.4 t70 -56.52 -61.38 2.45 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.237 0.458 . . . . 63.020000000000003 112.237 -173.268 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -64.14 -33.3 75.47 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.039 -0.528 . . . . 73.010000000000005 110.763 -174.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.578 ' O ' HG13 ' A' ' 58' ' ' ILE . 72.3 t80 -70.76 -59.4 2.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.027 -0.533 . . . . 74.25 111.642 -176.615 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.402 HG22 ' O ' ' A' ' 51' ' ' LEU . 14.2 t -66.26 -23.78 66.46 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.773 0.32 . . . . 75.409999999999997 111.327 -173.162 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -82.72 -34.11 27.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.594 -0.275 . . . . 51.200000000000003 110.682 177.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.89 -28.35 69.48 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.824 -0.435 . . . . 74.219999999999999 109.824 175.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.586 ' HA ' ' HG2' ' A' ' 61' ' ' GLN . 25.5 mt -62.07 -35.48 68.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.063 -0.517 . . . . 75.030000000000001 110.35 176.076 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -68.57 -32.42 72.32 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.149 -0.478 . . . . 51.229999999999997 110.847 178.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.681 ' O ' HD22 ' A' ' 63' ' ' LEU . 23.0 m -79.99 -35.43 37.49 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.198 -0.456 . . . . 73.340000000000003 110.645 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.586 ' HG2' ' HA ' ' A' ' 58' ' ' ILE . 12.2 pt20 -78.39 -1.31 32.83 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.739 0.304 . . . . 64.209999999999994 111.545 -176.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.597 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 69.4 mt -60.69 -29.44 44.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.864 0.364 . . . . 75.120000000000005 110.421 177.183 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.685 HD23 ' N ' ' A' ' 64' ' ' GLY . 0.2 OUTLIER -61.05 -19.47 61.42 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.024 -0.535 . . . . 74.530000000000001 111.876 -177.385 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.685 ' N ' HD23 ' A' ' 63' ' ' LEU . . . -112.03 -32.3 2.45 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.404 -0.678 . . . . 54.140000000000001 111.404 175.292 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -63.55 -28.29 72.24 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 121.547 -0.358 . . . . 33.530000000000001 112.431 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.613 ' O ' HG12 ' A' ' 70' ' ' ILE . 73.6 mt -52.49 -47.69 66.41 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 120.59 0.233 . . . . 72.230000000000004 110.761 176.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.433 ' HB2' ' HD2' ' A' ' 90' ' ' ARG . 71.0 mt -61.31 -30.89 70.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.188 -0.46 . . . . 70.319999999999993 111.047 -176.321 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.9 m -76.9 -36.2 56.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.18 -0.464 . . . . 75.109999999999999 110.647 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -77.79 -26.11 49.46 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.368 -0.378 . . . . 53.439999999999998 110.647 -179.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.613 HG12 ' O ' ' A' ' 66' ' ' LEU . 30.6 mm -64.64 -36.81 78.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.121 -0.49 . . . . 71.409999999999997 110.331 177.051 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.54 ' C ' HD22 ' A' ' 71' ' ' ASN . 0.2 OUTLIER -56.61 -50.89 70.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.331 -0.395 . . . . 61.43 109.967 178.605 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.1 m 67.62 111.54 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 O-C-N 123.645 0.59 . . . . 53.310000000000002 111.039 -178.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 172.18 -45.59 0.18 Allowed Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.755 -0.736 . . . . 71.019999999999996 112.094 -178.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -56.57 144.67 63.5 Favored Pre-proline 0 C--O 1.234 0.252 0 CA-C-O 120.618 0.247 . . . . 51.439999999999998 110.932 178.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.549 ' HD2' HD12 ' A' ' 87' ' ' ILE . 20.2 Cg_exo -67.98 -5.69 15.24 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.901 2.401 . . . . 65.030000000000001 112.389 177.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 106.81 166.75 22.46 Favored Glycine 0 N--CA 1.442 -0.921 0 N-CA-C 111.194 -0.762 . . . . 72.120000000000005 111.194 -178.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.479 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 6.7 ptp180 -65.15 128.74 37.05 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.562 -0.533 . . . . 45.020000000000003 109.562 175.671 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 56.3 ttp -78.9 103.71 9.03 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.603 -0.517 . . . . 73.310000000000002 109.603 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 48.8 t -71.01 102.11 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.599 -0.728 . . . . 63.219999999999999 109.721 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.413 ' HB ' ' O ' ' A' ' 83' ' ' TYR . 3.7 m -94.24 165.3 12.66 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.019 -0.734 . . . . 43.310000000000002 109.019 178.174 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -53.31 -31.45 44.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.872 0.368 . . . . 72.310000000000002 111.702 -178.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -139.73 -42.75 0.44 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.905 0.384 . . . . 75.510000000000005 110.647 -179.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.413 ' O ' ' HB ' ' A' ' 80' ' ' THR . 75.4 m-85 -76.84 144.31 39.15 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.839 -0.618 . . . . 63.340000000000003 111.54 -176.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.505 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 4.3 mp -110.66 100.15 10.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.331 -0.618 . . . . 71.040000000000006 109.331 175.741 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.605 HG22 HG23 ' A' ' 98' ' ' VAL . 12.6 t -106.49 98.4 6.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.279 -0.419 . . . . 64.329999999999998 110.806 -175.445 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.479 ' HA ' ' HA ' ' A' ' 77' ' ' ARG . 33.2 t70 -96.19 127.71 42.44 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.137 0.494 . . . . 74.510000000000005 110.24 179.256 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.549 HD12 ' HD2' ' A' ' 75' ' ' PRO . 60.9 mt -80.73 85.53 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.687 -0.688 . . . . 73.150000000000006 109.64 178.448 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.6 82.9 2.62 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.18 0.514 . . . . 54.140000000000001 111.665 -175.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -96.26 101.84 13.54 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.838 -0.619 . . . . 62.210000000000001 109.42 175.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.433 ' HD2' ' HB2' ' A' ' 67' ' ' LEU . 37.7 ttp180 -121.1 97.7 5.64 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.91 0.386 . . . . 75.439999999999998 111.083 -177.454 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 37.1 t70 60.1 82.47 0.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.8 -1.091 . . . . 71.019999999999996 111.427 175.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.93 -67.34 3.76 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.445 -0.798 . . . . 75.319999999999993 113.386 178.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 19.6 mm-40 -83.95 159.62 21.23 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.232 0.539 . . . . 62.409999999999997 111.126 -173.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.542 HD21 HG23 ' A' ' 87' ' ' ILE . 4.8 tt -135.47 134.3 39.43 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.805 -0.634 . . . . 52.240000000000002 109.609 -174.027 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.636 ' HG2' ' HG2' ' A' ' 110' ' ' GLN . 74.2 mt-30 -120.6 105.44 10.8 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.881 0.372 . . . . 55.530000000000001 110.096 175.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 43.6 tp -83.96 109.91 18.0 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.178 -0.465 . . . . 75.109999999999999 110.049 -178.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.534 ' HB3' HG23 ' A' ' 108' ' ' THR . 8.0 p30 -111.62 119.95 40.42 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.465 0.65 . . . . 43.409999999999997 111.22 -178.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.605 HG23 HG22 ' A' ' 85' ' ' VAL . 3.2 p -98.25 102.95 14.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.539 0.685 . . . . 72.019999999999996 109.478 173.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.86 ' HA ' HG22 ' A' ' 106' ' ' THR . 44.3 m -81.73 105.27 12.73 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.647 -0.706 . . . . 64.319999999999993 111.037 -177.329 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.533 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 11.4 t70 -72.42 143.82 48.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.517 -0.765 . . . . 63.399999999999999 109.769 173.369 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -109.17 -11.57 14.9 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.549 -0.296 . . . . 70.420000000000002 111.456 -178.538 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -81.05 -57.02 3.71 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.589 -0.444 . . . . 73.140000000000001 110.449 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 51.8 p -107.03 -27.45 10.63 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.094 0.473 . . . . 72.120000000000005 110.199 178.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.533 ' HA2' ' O ' ' A' ' 100' ' ' ASP . . . 91.48 20.37 38.17 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.662 -0.699 . . . . 65.239999999999995 112.661 175.657 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -76.49 95.93 3.97 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.681 -0.489 . . . . 72.040000000000006 109.681 177.03 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.86 HG22 ' HA ' ' A' ' 99' ' ' THR . 29.2 p -84.1 91.44 7.67 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.832 -0.622 . . . . 61.32 111.309 -177.003 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.444 ' HB3' ' CG1' ' A' ' 98' ' ' VAL . 33.1 t -67.14 101.55 0.9 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.129 -0.693 . . . . 71.150000000000006 109.129 176.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.534 HG23 ' HB3' ' A' ' 97' ' ' ASN . 10.1 m -104.24 107.04 17.77 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 116.033 -0.53 . . . . 61.340000000000003 110.056 -178.457 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 60.3 mt -106.69 114.36 45.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.864 -0.607 . . . . 73.010000000000005 110.353 -176.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.636 ' HG2' ' HG2' ' A' ' 95' ' ' GLN . 49.9 mt-30 -66.71 116.98 8.21 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.692 -0.484 . . . . 61.100000000000001 109.692 174.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.507 ' HB ' ' HB3' ' A' ' 94' ' ' LEU . 58.8 t -74.3 98.52 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.465 0.65 . . . . 75.109999999999999 110.828 -173.526 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.8 t -151.24 -55.3 0.15 Allowed 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.163 -1.051 . . . . 73.519999999999996 108.163 175.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 64.59 47.93 78.51 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.655 -0.702 . . . . 53.210000000000001 112.746 174.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 91.1 mt -96.81 -57.28 2.33 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 110.225 -0.287 . . . . 71.239999999999995 110.225 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 75.0 mm-40 54.61 95.62 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.855 0.722 . . . . 62.340000000000003 110.605 -173.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -58.53 98.09 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.476 -0.783 . . . . 63.439999999999998 112.124 -171.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -175.71 93.1 0.06 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.329 -1.36 . . . . 61.130000000000003 107.329 178.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 10.8 t -82.64 146.08 29.3 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.36 0.6 . . . . 75.219999999999999 111.387 -169.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 19.5 p -120.46 161.77 20.67 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.261 -0.882 . . . . 73.200000000000003 110.073 179.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -106.85 111.88 24.6 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.717 -0.475 . . . . 62.409999999999997 109.717 176.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -59.09 -49.65 77.08 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.146 -0.687 . . . . 75.239999999999995 109.146 178.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 70.72 116.81 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 114.928 -1.033 . . . . 74.340000000000003 112.551 168.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 60.1 m170 -92.35 148.38 22.17 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.054 -0.721 . . . . 64.150000000000006 109.054 171.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 52.3 p-80 -117.64 125.3 50.49 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.85 -0.34 . . . . 75.209999999999994 110.394 -176.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 42.8 m80 -127.19 -67.04 0.86 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.499 -0.318 . . . . 71.409999999999997 111.049 -179.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 68.4 m80 52.98 72.2 0.44 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.064 -0.516 . . . . 73.129999999999995 110.101 -174.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 73.8 t60 . . . . . 0 C--O 1.248 0.989 0 CA-C-O 117.941 -1.028 . . . . 54.43 110.311 -172.834 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 . . . . . 0 N--CA 1.451 -0.412 0 CA-C-O 120.516 0.198 . . . . 65.319999999999993 111.338 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 9.8 m -115.97 86.57 16.85 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 120.725 0.298 . . . . 60.32 110.304 175.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -77.37 84.57 1.93 Allowed 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.122 1.881 . . . . 72.099999999999994 111.896 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.7 m -86.07 -80.15 0.24 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.896 -0.593 . . . . 71.450000000000003 111.159 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -93.84 -37.85 11.54 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.807 0.337 . . . . 71.230000000000004 111.355 -177.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.582 HD23 ' H ' ' A' ' 51' ' ' LEU . 1.7 pt? -66.64 -13.83 61.68 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.01 -0.541 . . . . 73.420000000000002 111.273 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -49.01 -53.46 19.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.674 -0.694 . . . . 63.020000000000003 112.509 -175.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.45 -30.96 67.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.826 0.346 . . . . 73.010000000000005 111.349 -178.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.496 ' O ' HG13 ' A' ' 58' ' ' ILE . 67.2 t80 -67.23 -44.64 78.96 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.192 -0.458 . . . . 74.25 110.407 -178.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 87.0 m -55.34 -37.2 67.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.425 0.631 . . . . 75.409999999999997 111.557 178.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -80.19 -31.7 38.73 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.796 -0.638 . . . . 51.200000000000003 110.771 -174.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.81 -25.19 68.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.031 -0.532 . . . . 74.219999999999999 110.263 175.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.531 ' O ' HG13 ' A' ' 62' ' ' ILE . 2.5 mt -86.28 -45.37 16.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.974 -0.557 . . . . 75.030000000000001 110.968 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.454 ' HA ' HD12 ' A' ' 62' ' ' ILE . 76.1 mt-30 -59.14 -30.45 68.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.769 0.319 . . . . 51.229999999999997 111.283 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.5 m -66.58 -37.96 86.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.352 -0.386 . . . . 73.340000000000003 111.152 178.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.527 ' HG2' ' O ' ' A' ' 58' ' ' ILE . 11.1 pt20 -83.19 -20.9 33.8 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.794 0.33 . . . . 64.209999999999994 110.943 -178.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.531 HG13 ' O ' ' A' ' 58' ' ' ILE . 83.9 mt -66.5 -31.1 52.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.996 0.427 . . . . 75.120000000000005 109.894 177.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 91.9 mt -57.65 -32.85 67.69 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.734 -0.666 . . . . 74.530000000000001 110.933 178.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -74.51 -40.47 39.05 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.993 -0.623 . . . . 54.140000000000001 111.602 176.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -63.71 -25.99 69.49 Favored Glycine 0 C--N 1.33 0.2 0 C-N-CA 120.992 -0.623 . . . . 33.530000000000001 112.286 178.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 62' ' ' ILE . 91.8 mt -66.22 -18.34 65.29 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.706 0.289 . . . . 72.230000000000004 110.916 178.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 93.7 mt -85.59 5.97 29.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.076 0.465 . . . . 70.319999999999993 110.563 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.9 t -126.11 -42.21 1.88 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.947 -0.57 . . . . 75.109999999999999 110.587 179.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.414 ' ND2' HD21 ' A' ' 97' ' ' ASN . 86.7 m-20 -75.73 5.36 6.34 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.699 0.629 . . . . 53.439999999999998 112.699 -173.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.402 HG12 ' O ' ' A' ' 66' ' ' LEU . 50.4 mm . . . . . 0 C--N 1.322 -0.595 0 CA-C-O 121.653 0.739 . . . . 71.409999999999997 109.664 176.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.464 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 27.6 ttt . . . . . 0 N--CA 1.455 -0.207 0 CA-C-O 120.729 0.3 . . . . 73.310000000000002 110.472 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 53.1 t -85.5 97.65 5.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.373 0.606 . . . . 63.219999999999999 110.696 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.697 ' HB ' ' O ' ' A' ' 83' ' ' TYR . 6.7 m -113.65 148.86 35.53 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.307 -0.86 . . . . 43.310000000000002 108.854 177.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -73.52 -59.64 2.62 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.007 0.373 . . . . 72.310000000000002 112.007 -170.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -82.82 -14.16 54.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.795 0.331 . . . . 75.510000000000005 111.448 -174.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.697 ' O ' ' HB ' ' A' ' 80' ' ' THR . 59.4 m-85 -133.99 121.3 21.41 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.334 -0.394 . . . . 63.340000000000003 110.482 -177.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.569 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 2.9 mp -81.91 102.56 7.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.089 -0.708 . . . . 71.040000000000006 109.089 175.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.464 ' HB ' ' HB3' ' A' ' 78' ' ' MET . 47.3 t -96.69 94.31 4.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.715 -0.675 . . . . 64.329999999999998 110.769 -176.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -98.45 115.62 28.91 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.343 -0.614 . . . . 74.510000000000005 109.343 178.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 71.6 mt -82.02 94.66 2.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.939 -0.573 . . . . 73.150000000000006 110.673 -176.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.05 74.54 8.08 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.687 -0.688 . . . . 54.140000000000001 111.102 -177.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -88.59 92.73 9.31 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.147 -0.686 . . . . 62.210000000000001 109.147 173.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.441 ' HA ' ' HD2' ' A' ' 90' ' ' ARG . 13.6 tpt180 -133.68 154.16 51.14 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.818 -0.628 . . . . 75.439999999999998 109.726 -178.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.9 t70 69.93 -68.18 0.21 Allowed 'General case' 0 N--CA 1.465 0.317 0 O-C-N 124.082 0.864 . . . . 71.019999999999996 111.151 178.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 177.74 23.62 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.736 -0.745 . . . . 75.319999999999993 113.433 178.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.477 ' HA ' HE21 ' A' ' 93' ' ' GLN . 0.0 OUTLIER -138.1 152.5 48.83 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 122.265 -0.55 . . . . 62.409999999999997 110.264 178.351 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -89.61 94.58 9.91 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.761 -0.459 . . . . 52.240000000000002 109.761 176.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.474 ' HG2' ' OD1' ' A' ' 97' ' ' ASN . 7.3 tt0 -97.31 109.29 22.08 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.137 0.494 . . . . 55.530000000000001 109.692 -179.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.543 ' HB3' ' HB ' ' A' ' 109' ' ' ILE . 29.0 tp -90.11 98.64 11.89 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.868 -0.605 . . . . 75.109999999999999 110.389 -177.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.483 ' OD1' HG23 ' A' ' 108' ' ' THR . 6.5 m-20 -90.61 93.44 9.27 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.283 0.564 . . . . 43.409999999999997 110.532 -179.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.439 ' CG1' ' HD1' ' A' ' 83' ' ' TYR . 56.1 t -92.8 114.18 29.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.658 -0.701 . . . . 72.019999999999996 110.677 178.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.569 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 30.7 m -103.32 109.23 20.77 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.845 -0.616 . . . . 64.319999999999993 110.077 178.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.587 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 25.2 t70 -62.32 141.23 58.4 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.489 -0.323 . . . . 63.399999999999999 110.777 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.07 -26.69 19.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.259 -0.428 . . . . 70.420000000000002 110.251 -177.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 32.7 mtmm -70.04 -69.58 0.34 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.374 -0.375 . . . . 73.140000000000001 111.149 -174.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 12.0 t -99.05 -26.8 14.11 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.243 0.544 . . . . 72.120000000000005 109.716 -179.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.587 ' HA2' ' O ' ' A' ' 100' ' ' ASP . . . 83.65 79.45 1.06 Allowed Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.544 -0.753 . . . . 65.239999999999995 112.909 176.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.491 ' H ' ' HB3' ' A' ' 100' ' ' ASP . 68.6 mm-40 -124.69 144.16 50.36 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.587 -0.523 . . . . 72.040000000000006 109.587 174.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.9 m -89.05 96.11 10.59 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.123 0.487 . . . . 61.32 110.724 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.435 ' HB3' ' HB ' ' A' ' 98' ' ' VAL . 47.4 t -88.17 80.83 7.51 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.454 -0.573 . . . . 71.150000000000006 109.454 177.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.483 HG23 ' OD1' ' A' ' 97' ' ' ASN . 28.2 m -82.35 101.49 10.62 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.901 -0.591 . . . . 61.340000000000003 110.709 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.543 ' HB ' ' HB3' ' A' ' 96' ' ' LEU . 54.5 mt -99.88 92.34 2.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.052 -0.522 . . . . 73.010000000000005 110.514 -178.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -72.56 106.91 4.81 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.723 -0.473 . . . . 61.100000000000001 109.723 175.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.2 t . . . . . 0 C--N 1.323 -0.584 0 N-CA-C 109.688 -0.486 . . . . 75.109999999999999 109.688 177.435 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 . . . . . 0 N--CA 1.456 -0.157 0 CA-C-O 120.804 0.335 . . . . 65.319999999999993 110.923 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 47.0 p -124.75 86.7 55.69 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.492 -0.322 . . . . 60.32 110.943 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.405 ' HA ' ' HG ' ' A' ' 51' ' ' LEU . 32.0 Cg_exo -57.66 98.94 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.81 2.34 . . . . 72.099999999999994 112.702 -177.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 14.3 m -104.4 -46.83 4.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.613 -0.721 . . . . 71.450000000000003 110.375 176.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.68 -2.65 3.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.466 0.65 . . . . 71.230000000000004 110.303 174.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.484 HD23 ' H ' ' A' ' 51' ' ' LEU . 0.7 OUTLIER -95.46 0.55 53.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.672 -0.695 . . . . 73.420000000000002 110.394 -178.728 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -68.28 -40.83 81.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.142 -0.481 . . . . 63.020000000000003 109.977 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -63.69 -30.73 71.79 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.711 -0.677 . . . . 73.010000000000005 110.368 176.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -83.14 -51.57 7.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.819 -0.628 . . . . 74.25 111.322 -177.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.0 t -69.05 -26.43 64.96 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.046 0.387 . . . . 75.409999999999997 112.046 -173.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -77.3 -19.87 55.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.86 0.362 . . . . 51.200000000000003 110.433 178.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.51 -18.41 48.6 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.477 0.656 . . . . 74.219999999999999 109.683 175.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.469 ' O ' HG13 ' A' ' 62' ' ' ILE . 13.3 mt -77.04 -32.22 19.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.636 -0.711 . . . . 75.030000000000001 110.182 177.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -61.64 -27.88 68.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 51.229999999999997 110.795 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.635 ' O ' HD22 ' A' ' 63' ' ' LEU . 5.9 m -75.87 -43.15 46.95 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.21 -0.45 . . . . 73.340000000000003 110.691 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.41 ' HG2' ' O ' ' A' ' 58' ' ' ILE . 11.2 pt20 -74.53 -3.81 33.12 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.484 -0.326 . . . . 64.209999999999994 111.641 -173.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 58' ' ' ILE . 64.7 mt -66.9 -17.8 23.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.287 0.565 . . . . 75.120000000000005 110.0 174.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.635 HD22 ' O ' ' A' ' 60' ' ' SER . 0.5 OUTLIER -63.75 -19.21 64.79 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.857 -0.611 . . . . 74.530000000000001 111.199 -179.024 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.613 ' N ' HD23 ' A' ' 63' ' ' LEU . . . -81.68 -30.37 36.25 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 111.101 -0.8 . . . . 54.140000000000001 111.101 176.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -69.77 -26.02 74.89 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.081 -0.808 . . . . 33.530000000000001 111.081 175.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.493 ' HA ' HD11 ' A' ' 70' ' ' ILE . 86.8 mt -70.49 -5.45 28.86 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.089 0.471 . . . . 72.230000000000004 110.647 176.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 87.4 mt -109.41 -66.69 1.04 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.925 -0.579 . . . . 70.319999999999993 110.952 178.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 17.8 m -98.51 15.41 25.03 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.865 0.691 . . . . 75.109999999999999 112.865 -171.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -129.45 20.73 5.66 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.539 0.685 . . . . 53.439999999999998 110.197 178.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.493 HD11 ' HA ' ' A' ' 66' ' ' LEU . 45.2 mm . . . . . 0 C--O 1.235 0.323 0 CA-C-O 121.629 0.728 . . . . 71.409999999999997 109.319 178.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 59.6 ttp . . . . . 0 N--CA 1.453 -0.284 0 N-CA-C 109.299 -0.63 . . . . 73.310000000000002 109.299 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 58.5 t -67.4 103.52 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.096 0.474 . . . . 63.219999999999999 111.202 -178.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -108.19 167.6 9.9 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.686 -0.688 . . . . 43.310000000000002 110.987 176.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -64.28 -73.88 0.11 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.499 -0.318 . . . . 72.310000000000002 111.809 -174.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -120.6 32.96 5.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.809 0.814 . . . . 75.510000000000005 109.873 -178.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -125.85 144.17 50.77 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.174 -0.921 . . . . 63.340000000000003 110.243 177.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.562 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 4.4 mp -108.55 100.48 10.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.172 -0.677 . . . . 71.040000000000006 109.172 175.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.9 p -125.28 110.72 25.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.579 0.704 . . . . 64.329999999999998 110.973 -177.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -110.38 143.95 39.87 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.477 -0.783 . . . . 74.510000000000005 109.858 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 59.5 mt -87.13 98.68 7.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 109.641 -0.503 . . . . 73.150000000000006 109.641 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -88.26 89.44 7.99 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.888 -0.596 . . . . 54.140000000000001 111.146 -176.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.481 ' HA ' ' O ' ' A' ' 93' ' ' GLN . 29.0 t-20 -84.97 77.43 10.11 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.901 -0.778 . . . . 62.210000000000001 108.901 172.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.411 ' O ' ' HB3' ' A' ' 91' ' ' ASP . 47.3 ttp180 -102.6 144.45 30.99 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.737 -1.12 . . . . 75.439999999999998 109.107 -178.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.411 ' HB3' ' O ' ' A' ' 90' ' ' ARG . 11.4 t70 69.05 -67.78 0.2 Allowed 'General case' 0 N--CA 1.467 0.384 0 O-C-N 123.726 0.641 . . . . 71.019999999999996 110.664 -177.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 172.34 31.54 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.297 -0.721 . . . . 75.319999999999993 111.297 178.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.481 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 26.2 mm-40 -136.82 150.06 48.1 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.048 -0.353 . . . . 62.409999999999997 110.048 -178.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.448 ' HB2' ' HB ' ' A' ' 111' ' ' VAL . 3.6 mm? -88.24 101.92 14.32 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.102 -0.333 . . . . 52.240000000000002 110.102 178.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -104.74 121.53 43.81 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.012 0.434 . . . . 55.530000000000001 110.245 178.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 15.7 tp -103.94 102.68 12.47 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.16 -0.473 . . . . 75.109999999999999 110.169 -177.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -96.46 115.25 27.13 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.42 -0.355 . . . . 43.409999999999997 110.723 -177.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 39.7 t -99.61 111.26 28.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.171 -0.468 . . . . 72.019999999999996 110.821 178.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.562 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 43.6 m -97.75 110.59 23.13 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.813 -0.63 . . . . 64.319999999999993 110.391 177.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.489 ' HB3' ' H ' ' A' ' 105' ' ' GLN . 7.1 t70 -71.34 124.97 25.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.941 -0.572 . . . . 63.399999999999999 109.923 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.489 ' HD3' ' O ' ' A' ' 101' ' ' ARG . 3.1 tmt_? -82.84 -28.69 29.96 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.599 0.238 . . . . 70.420000000000002 110.639 -176.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -84.77 -58.4 2.73 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.491 0.663 . . . . 73.140000000000001 110.804 -175.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.7 m -88.68 -25.34 22.42 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.989 -1.005 . . . . 72.120000000000005 110.83 -172.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.97 69.32 1.41 Allowed Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.704 -0.68 . . . . 65.239999999999995 113.214 177.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.489 ' H ' ' HB3' ' A' ' 100' ' ' ASP . 44.7 mt-30 -136.82 144.75 43.82 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.993 -0.743 . . . . 72.040000000000006 108.993 176.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.2 t -110.77 94.41 4.98 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.982 0.896 . . . . 61.32 110.446 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 27.0 t -87.26 113.23 22.8 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.457 -0.792 . . . . 71.150000000000006 109.371 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 41.9 m -103.62 111.39 23.85 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.925 -0.58 . . . . 61.340000000000003 111.219 -176.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.401 HD12 ' N ' ' A' ' 109' ' ' ILE . 4.5 mp -108.34 109.47 28.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.097 -0.501 . . . . 73.010000000000005 109.649 178.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -91.61 153.83 19.46 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.017 0.436 . . . . 61.100000000000001 111.491 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.448 ' HB ' ' HB2' ' A' ' 94' ' ' LEU . 4.4 p . . . . . 0 C--N 1.325 -0.479 0 CA-C-N 115.177 -0.92 . . . . 75.109999999999999 111.683 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 N--CA 1.469 0.504 0 N-CA-C 112.757 0.651 . . . . 65.319999999999993 112.757 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 4.7 t -136.6 88.23 19.95 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-O 121.483 0.659 . . . . 60.32 110.989 -177.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -71.82 84.39 1.04 Allowed 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.398 2.066 . . . . 72.099999999999994 111.167 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 12.4 p -127.29 -72.6 0.63 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.659 -0.7 . . . . 71.450000000000003 110.786 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.95 -14.78 63.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.132 -0.485 . . . . 71.230000000000004 111.92 -177.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.421 ' O ' HG22 ' A' ' 55' ' ' THR . 2.9 pp -115.62 1.69 13.6 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.472 -0.331 . . . . 73.420000000000002 111.351 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.627 ' O ' ' HB2' ' A' ' 56' ' ' GLN . 28.3 t70 -68.05 -36.81 80.5 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.451 -0.34 . . . . 63.020000000000003 111.397 -174.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -84.66 -38.24 20.05 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.781 0.324 . . . . 73.010000000000005 110.922 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.469 ' O ' HG13 ' A' ' 58' ' ' ILE . 60.9 t80 -61.23 -57.99 10.13 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.884 -0.598 . . . . 74.25 111.42 -177.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.421 HG22 ' O ' ' A' ' 51' ' ' LEU . 7.2 t -70.01 -16.72 63.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.186 0.517 . . . . 75.409999999999997 110.958 -176.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.627 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 1.5 tp-100 -75.16 -29.96 60.59 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.385 0.612 . . . . 51.200000000000003 109.752 -178.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.72 -35.76 44.39 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.563 -0.744 . . . . 74.219999999999999 109.926 176.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.575 ' O ' HG13 ' A' ' 62' ' ' ILE . 17.3 mt -62.38 -40.07 86.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.648 -0.705 . . . . 75.030000000000001 111.055 -178.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -54.48 -32.85 58.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.429 -0.35 . . . . 51.229999999999997 111.413 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.3 t -81.51 -18.4 45.21 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.508 -0.314 . . . . 73.340000000000003 111.59 -176.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.547 ' HG2' ' O ' ' A' ' 58' ' ' ILE . 3.4 pt20 -96.63 -17.21 20.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.863 0.363 . . . . 64.209999999999994 110.687 -178.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.592 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 84.2 mt -65.15 -41.81 92.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.211 -0.45 . . . . 75.120000000000005 110.295 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.2 mp -61.59 -31.1 71.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.709 -0.678 . . . . 74.530000000000001 110.967 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -73.14 -41.8 45.9 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.658 -0.782 . . . . 54.140000000000001 111.833 178.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -71.33 -19.46 77.55 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 121.295 -0.478 . . . . 33.530000000000001 112.814 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' A' ' 62' ' ' ILE . 86.2 mt -57.35 -34.43 68.79 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.884 0.373 . . . . 72.230000000000004 110.966 178.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.432 HD12 HH11 ' A' ' 90' ' ' ARG . 97.1 mt -65.87 -36.5 83.6 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.199 -0.455 . . . . 70.319999999999993 110.851 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.9 m -71.51 -27.6 63.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.025 0.441 . . . . 75.109999999999999 110.255 177.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -72.83 -27.3 61.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.118 0.485 . . . . 53.439999999999998 109.927 176.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.531 HG12 ' O ' ' A' ' 66' ' ' LEU . 48.8 mm . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 115.888 -0.596 . . . . 71.409999999999997 109.634 175.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 45.1 ttm . . . . . 0 N--CA 1.453 -0.283 0 N-CA-C 110.299 -0.26 . . . . 73.310000000000002 110.299 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 54.2 t -72.38 124.98 30.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.507 -0.553 . . . . 63.219999999999999 109.507 176.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.625 ' HB ' ' O ' ' A' ' 83' ' ' TYR . 2.7 m -127.27 162.35 26.44 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.663 -0.244 . . . . 43.310000000000002 110.532 -176.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -72.59 -75.89 0.13 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.954 0.407 . . . . 72.310000000000002 111.264 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -88.96 5.98 41.61 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.225 -0.443 . . . . 75.510000000000005 111.781 -174.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.625 ' O ' ' HB ' ' A' ' 80' ' ' THR . 60.7 m-85 -143.81 167.65 21.81 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.882 0.372 . . . . 63.340000000000003 110.748 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.571 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 40.8 mm -121.88 99.55 7.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 108.762 -0.829 . . . . 71.040000000000006 108.762 168.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.439 HG13 HD11 ' A' ' 96' ' ' LEU . 37.1 t -85.0 82.38 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.194 0.521 . . . . 64.329999999999998 109.977 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -94.81 98.77 10.98 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.754 -0.657 . . . . 74.510000000000005 111.226 -177.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.467 HG12 HD13 ' A' ' 96' ' ' LEU . 58.2 mt -86.82 95.4 4.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.574 -0.528 . . . . 73.150000000000006 109.574 175.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -88.14 114.33 24.66 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.954 -0.566 . . . . 54.140000000000001 110.457 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.508 ' HA ' ' O ' ' A' ' 93' ' ' GLN . 2.8 t-20 -109.89 111.17 22.42 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.906 -0.588 . . . . 62.210000000000001 110.211 178.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.432 HH11 HD12 ' A' ' 67' ' ' LEU . 59.0 ttp85 -127.44 133.74 49.91 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.476 -0.564 . . . . 75.439999999999998 109.476 175.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 64.43 -86.05 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 O-C-N 123.861 0.725 . . . . 71.019999999999996 110.558 -176.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -148.64 15.1 1.22 Allowed Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 110.996 -0.842 . . . . 75.319999999999993 110.996 177.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.508 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -98.11 124.31 42.57 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.814 0.34 . . . . 62.409999999999997 110.799 -177.588 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -95.7 101.17 12.83 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.65 -0.87 . . . . 52.240000000000002 108.65 171.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.4 HE21 ' HB2' ' A' ' 95' ' ' GLN . 7.6 tt0 -117.45 110.7 18.32 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.184 -0.462 . . . . 55.530000000000001 110.754 -174.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.502 ' HG ' HG23 ' A' ' 98' ' ' VAL . 61.1 tp -89.21 109.58 20.44 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.896 -0.593 . . . . 75.109999999999999 110.971 -176.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -97.44 88.31 4.36 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.848 -0.427 . . . . 43.409999999999997 109.848 178.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.539 ' HB ' ' HB3' ' A' ' 107' ' ' SER . 43.1 t -78.95 102.55 5.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.205 0.526 . . . . 72.019999999999996 110.516 178.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.571 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 25.1 m -90.64 106.39 18.47 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.456 -0.793 . . . . 64.319999999999993 109.371 176.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -63.02 140.23 58.85 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.061 0.458 . . . . 63.399999999999999 110.73 -177.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 24.4 tpp180 -76.6 -35.47 58.09 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.672 -0.694 . . . . 70.420000000000002 111.785 -174.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -102.35 -47.44 4.49 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 111.876 0.324 . . . . 73.140000000000001 111.876 -169.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 42.7 p -89.9 -26.84 20.25 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.156 0.503 . . . . 72.120000000000005 110.486 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.03 19.02 68.21 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.855 -0.688 . . . . 65.239999999999995 112.861 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -64.8 124.49 22.11 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.242 -0.281 . . . . 72.040000000000006 110.242 174.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 36.9 m -92.92 91.64 7.5 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.234 0.54 . . . . 61.32 109.571 175.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.539 ' HB3' ' HB ' ' A' ' 98' ' ' VAL . 17.1 t -88.45 89.39 7.97 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.869 -0.605 . . . . 71.150000000000006 109.589 -179.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 32.1 m -86.84 102.86 14.7 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.78 -0.645 . . . . 61.340000000000003 110.257 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 61.4 mt -111.39 109.11 27.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.77 -0.65 . . . . 73.010000000000005 110.816 -177.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -76.14 147.48 38.5 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.431 -0.35 . . . . 61.100000000000001 110.474 174.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 5.7 p . . . . . 0 C--N 1.322 -0.587 0 CA-C-N 115.563 -0.744 . . . . 75.109999999999999 110.179 174.374 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 . . . . . 0 CA--C 1.529 0.16 0 N-CA-C 111.864 0.32 . . . . 65.319999999999993 111.864 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.7 t -137.63 74.79 45.39 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-O 121.885 0.85 . . . . 60.32 109.673 172.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -89.9 99.54 0.3 Allowed 'Trans proline' 0 N--CA 1.448 -1.2 0 C-N-CA 122.941 2.428 . . . . 72.099999999999994 112.775 -175.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 38.3 m -129.39 -62.69 0.97 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.849 -0.614 . . . . 71.450000000000003 109.759 174.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.83 -43.78 13.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.12 0.486 . . . . 71.230000000000004 110.124 178.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.9 pp -75.58 -11.12 59.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.865 -0.607 . . . . 73.420000000000002 110.613 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.562 ' O ' ' HB2' ' A' ' 56' ' ' GLN . 26.9 t70 -62.42 -50.48 71.33 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.991 -0.55 . . . . 63.020000000000003 110.439 178.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -63.41 -32.47 73.92 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.049 -0.523 . . . . 73.010000000000005 110.908 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.535 ' O ' HG13 ' A' ' 58' ' ' ILE . 57.4 t80 -68.11 -55.33 12.83 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.035 -0.53 . . . . 74.25 110.227 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.3 t -67.85 -19.22 65.02 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.25 0.548 . . . . 75.409999999999997 110.524 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.562 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 2.8 tp-100 -67.38 -41.3 85.25 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.795 -0.638 . . . . 51.200000000000003 109.4 178.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.94 -29.28 61.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.505 -0.771 . . . . 74.219999999999999 110.798 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.535 HG13 ' O ' ' A' ' 54' ' ' PHE . 20.7 mt -63.84 -35.61 73.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.123 0.487 . . . . 75.030000000000001 110.552 178.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -66.92 -22.14 65.96 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.132 -0.486 . . . . 51.229999999999997 111.263 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.3 m -85.93 -30.07 23.11 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.018 -0.537 . . . . 73.340000000000003 111.073 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 58' ' ' ILE . 3.9 pt20 -83.14 -3.33 57.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.795 0.331 . . . . 64.209999999999994 111.093 -176.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.513 HG12 ' O ' ' A' ' 58' ' ' ILE . 47.5 mm -74.95 -37.61 41.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.891 0.377 . . . . 75.120000000000005 110.343 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.567 ' H ' HD22 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -65.5 -41.89 92.72 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.008 -0.542 . . . . 74.530000000000001 110.792 -175.778 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -77.79 -22.51 69.12 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.631 -0.795 . . . . 54.140000000000001 112.346 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -77.22 -6.83 86.63 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.982 -0.627 . . . . 33.530000000000001 112.435 -178.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.616 ' O ' HG12 ' A' ' 70' ' ' ILE . 97.9 mt -70.11 -29.66 66.66 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 122.819 -0.224 . . . . 72.230000000000004 111.018 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 91.2 mt -54.28 -46.89 72.81 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.308 -0.405 . . . . 70.319999999999993 111.995 -175.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -70.8 -21.95 62.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.222 -0.445 . . . . 75.109999999999999 111.255 -178.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -94.1 -7.93 41.07 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.311 -0.404 . . . . 53.439999999999998 111.032 -178.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.616 HG12 ' O ' ' A' ' 66' ' ' LEU . 31.9 mm . . . . . 0 C--N 1.325 -0.468 0 CA-C-N 116.413 -0.358 . . . . 71.409999999999997 110.368 177.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.409 ' HB3' HG13 ' A' ' 85' ' ' VAL . 27.5 ttt . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.986 0.422 . . . . 73.310000000000002 111.043 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 46.1 t -81.87 107.39 13.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.088 -0.505 . . . . 63.219999999999999 110.154 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.779 ' HB ' ' O ' ' A' ' 83' ' ' TYR . 1.8 m -107.95 168.39 9.31 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.192 -0.458 . . . . 43.310000000000002 110.139 -178.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.44 ' H ' HG22 ' A' ' 80' ' ' THR . 22.3 p-10 -89.03 -65.33 1.03 Allowed 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.172 0.434 . . . . 72.310000000000002 112.172 -175.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -94.66 -2.72 50.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.205 0.526 . . . . 75.510000000000005 111.192 -176.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.779 ' O ' ' HB ' ' A' ' 80' ' ' THR . 31.8 m-85 -130.73 149.95 52.14 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.97 -0.752 . . . . 63.340000000000003 108.97 177.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.581 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 4.7 mp -117.5 93.92 2.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 108.914 -0.773 . . . . 71.040000000000006 108.914 172.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.409 HG13 ' HB3' ' A' ' 78' ' ' MET . 4.9 p -91.57 101.29 12.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.955 0.883 . . . . 64.329999999999998 110.216 178.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -93.81 127.26 39.45 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.339 -0.846 . . . . 74.510000000000005 109.967 -177.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 63.5 mt -93.37 109.47 21.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.162 -0.472 . . . . 73.150000000000006 110.465 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -120.77 176.24 5.63 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.915 -0.584 . . . . 54.140000000000001 110.474 179.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -139.11 123.81 18.54 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.691 -0.485 . . . . 62.210000000000001 109.691 176.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.44 ' O ' ' HB3' ' A' ' 91' ' ' ASP . 14.8 ptm180 -106.23 99.62 9.19 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.712 -0.676 . . . . 75.439999999999998 110.057 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.44 ' HB3' ' O ' ' A' ' 90' ' ' ARG . 4.8 t70 73.38 -57.97 0.61 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.878 -0.601 . . . . 71.019999999999996 111.696 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -172.2 32.07 0.12 Allowed Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 111.076 -0.809 . . . . 75.319999999999993 111.076 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.468 ' HA ' HE21 ' A' ' 93' ' ' GLN . 0.0 OUTLIER -135.8 124.52 23.85 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.613 -0.514 . . . . 62.409999999999997 109.613 -179.175 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -64.37 120.09 11.58 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.14 0.495 . . . . 52.240000000000002 110.405 176.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.423 HE22 ' HG3' ' A' ' 110' ' ' GLN . 24.2 tp60 -102.17 115.77 31.26 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.502 -0.772 . . . . 55.530000000000001 109.932 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 12.9 tp -92.62 91.05 7.37 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.303 -0.629 . . . . 75.109999999999999 109.303 178.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -83.59 96.24 8.58 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.365 -0.38 . . . . 43.409999999999997 110.77 -177.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.412 ' HB ' ' HB3' ' A' ' 107' ' ' SER . 47.1 t -88.93 104.87 15.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.332 0.587 . . . . 72.019999999999996 110.623 176.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.581 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 31.0 m -96.69 112.48 24.21 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.109 -0.95 . . . . 64.319999999999993 109.867 176.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.477 ' HB3' ' N ' ' A' ' 105' ' ' GLN . 12.6 t70 -71.26 130.93 42.66 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.185 -0.462 . . . . 63.399999999999999 111.125 178.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 -94.48 -11.47 29.63 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.188 0.518 . . . . 70.420000000000002 110.469 -176.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -86.3 -62.48 1.5 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.113 -0.494 . . . . 73.140000000000001 111.509 -176.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 63.6 p -111.35 -27.88 8.46 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.018 0.437 . . . . 72.120000000000005 111.393 -176.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 103.04 34.41 4.0 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.786 -0.643 . . . . 65.239999999999995 112.54 178.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.477 ' N ' ' HB3' ' A' ' 100' ' ' ASP . 51.3 mt-30 -71.84 115.9 11.59 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.984 -0.376 . . . . 72.040000000000006 109.984 174.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 21.1 m -86.55 92.16 8.79 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.059 0.457 . . . . 61.32 110.4 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.412 ' HB3' ' HB ' ' A' ' 98' ' ' VAL . 22.6 t -97.43 86.78 3.95 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.221 0.534 . . . . 71.150000000000006 110.126 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.4 m -91.42 95.54 10.03 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.054 -0.521 . . . . 61.340000000000003 110.289 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 57.0 mt -102.89 136.29 36.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.827 -0.624 . . . . 73.010000000000005 110.577 -175.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.423 ' HG3' HE22 ' A' ' 95' ' ' GLN . 32.4 mt-30 -95.59 163.32 13.26 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.859 0.361 . . . . 61.100000000000001 110.553 173.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.6 p . . . . . 0 C--N 1.324 -0.529 0 CA-C-N 116.002 -0.544 . . . . 75.109999999999999 110.518 176.167 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 . . . . . 0 N--CA 1.451 -0.412 0 CA-C-O 120.516 0.198 . . . . 65.319999999999993 111.338 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 9.8 m -115.97 86.57 16.85 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 120.725 0.298 . . . . 60.32 110.304 175.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -77.37 84.57 1.93 Allowed 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.122 1.881 . . . . 72.099999999999994 111.896 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.7 m -86.07 -80.15 0.24 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.896 -0.593 . . . . 71.450000000000003 111.159 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -93.84 -37.85 11.54 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.807 0.337 . . . . 71.230000000000004 111.355 -177.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.582 HD23 ' H ' ' A' ' 51' ' ' LEU . 1.7 pt? -66.64 -13.83 61.68 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.01 -0.541 . . . . 73.420000000000002 111.273 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -49.01 -53.46 19.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.674 -0.694 . . . . 63.020000000000003 112.509 -175.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.45 -30.96 67.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.826 0.346 . . . . 73.010000000000005 111.349 -178.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.496 ' O ' HG13 ' A' ' 58' ' ' ILE . 67.2 t80 -67.23 -44.64 78.96 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.192 -0.458 . . . . 74.25 110.407 -178.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 87.0 m -55.34 -37.2 67.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.425 0.631 . . . . 75.409999999999997 111.557 178.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -80.19 -31.7 38.73 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.796 -0.638 . . . . 51.200000000000003 110.771 -174.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.81 -25.19 68.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.031 -0.532 . . . . 74.219999999999999 110.263 175.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.531 ' O ' HG13 ' A' ' 62' ' ' ILE . 2.5 mt -86.28 -45.37 16.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.974 -0.557 . . . . 75.030000000000001 110.968 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.454 ' HA ' HD12 ' A' ' 62' ' ' ILE . 76.1 mt-30 -59.14 -30.45 68.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.769 0.319 . . . . 51.229999999999997 111.283 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.5 m -66.58 -37.96 86.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.352 -0.386 . . . . 73.340000000000003 111.152 178.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.527 ' HG2' ' O ' ' A' ' 58' ' ' ILE . 11.1 pt20 -83.19 -20.9 33.8 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.794 0.33 . . . . 64.209999999999994 110.943 -178.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.531 HG13 ' O ' ' A' ' 58' ' ' ILE . 83.9 mt -66.5 -31.1 52.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.996 0.427 . . . . 75.120000000000005 109.894 177.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 91.9 mt -57.65 -32.85 67.69 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.734 -0.666 . . . . 74.530000000000001 110.933 178.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -74.51 -40.47 39.05 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.993 -0.623 . . . . 54.140000000000001 111.602 176.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -63.71 -25.99 69.49 Favored Glycine 0 C--N 1.33 0.2 0 C-N-CA 120.992 -0.623 . . . . 33.530000000000001 112.286 178.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 62' ' ' ILE . 91.8 mt -66.22 -18.34 65.29 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.706 0.289 . . . . 72.230000000000004 110.916 178.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 93.7 mt -85.59 5.97 29.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.076 0.465 . . . . 70.319999999999993 110.563 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.9 t -126.11 -42.21 1.88 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.947 -0.57 . . . . 75.109999999999999 110.587 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.414 ' ND2' HD21 ' A' ' 97' ' ' ASN . 86.7 m-20 -75.73 5.36 6.34 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.699 0.629 . . . . 53.439999999999998 112.699 -173.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.402 HG12 ' O ' ' A' ' 66' ' ' LEU . 50.4 mm . . . . . 0 C--N 1.322 -0.595 0 CA-C-O 121.653 0.739 . . . . 71.409999999999997 109.664 176.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.464 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 27.6 ttt . . . . . 0 N--CA 1.455 -0.207 0 CA-C-O 120.729 0.3 . . . . 73.310000000000002 110.472 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 53.1 t -85.5 97.65 5.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.373 0.606 . . . . 63.219999999999999 110.696 -178.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.697 ' HB ' ' O ' ' A' ' 83' ' ' TYR . 6.7 m -113.65 148.86 35.53 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.307 -0.86 . . . . 43.310000000000002 108.854 177.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -73.52 -59.64 2.62 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.007 0.373 . . . . 72.310000000000002 112.007 -170.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -82.82 -14.16 54.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.795 0.331 . . . . 75.510000000000005 111.448 -174.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.697 ' O ' ' HB ' ' A' ' 80' ' ' THR . 59.4 m-85 -133.99 121.3 21.41 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.334 -0.394 . . . . 63.340000000000003 110.482 -177.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.569 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 2.9 mp -81.91 102.56 7.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.089 -0.708 . . . . 71.040000000000006 109.089 175.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.464 ' HB ' ' HB3' ' A' ' 78' ' ' MET . 47.3 t -96.69 94.31 4.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.715 -0.675 . . . . 64.329999999999998 110.769 -176.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -98.45 115.62 28.91 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.343 -0.614 . . . . 74.510000000000005 109.343 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 71.6 mt -82.02 94.66 2.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.939 -0.573 . . . . 73.150000000000006 110.673 -176.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.05 74.54 8.08 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.687 -0.688 . . . . 54.140000000000001 111.102 -177.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -88.59 92.73 9.31 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.147 -0.686 . . . . 62.210000000000001 109.147 173.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.441 ' HA ' ' HD2' ' A' ' 90' ' ' ARG . 13.6 tpt180 -133.68 154.16 51.14 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.818 -0.628 . . . . 75.439999999999998 109.726 -178.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.9 t70 69.93 -68.18 0.21 Allowed 'General case' 0 N--CA 1.465 0.317 0 O-C-N 124.082 0.864 . . . . 71.019999999999996 111.151 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 177.74 23.62 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.736 -0.745 . . . . 75.319999999999993 113.433 178.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.477 ' HA ' HE21 ' A' ' 93' ' ' GLN . 0.0 OUTLIER -138.1 152.5 48.83 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 122.265 -0.55 . . . . 62.409999999999997 110.264 178.351 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -89.61 94.58 9.91 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.761 -0.459 . . . . 52.240000000000002 109.761 176.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.474 ' HG2' ' OD1' ' A' ' 97' ' ' ASN . 7.3 tt0 -97.31 109.29 22.08 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.137 0.494 . . . . 55.530000000000001 109.692 -179.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.543 ' HB3' ' HB ' ' A' ' 109' ' ' ILE . 29.0 tp -90.11 98.64 11.89 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.868 -0.605 . . . . 75.109999999999999 110.389 -177.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.483 ' OD1' HG23 ' A' ' 108' ' ' THR . 6.5 m-20 -90.61 93.44 9.27 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.283 0.564 . . . . 43.409999999999997 110.532 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.439 ' CG1' ' HD1' ' A' ' 83' ' ' TYR . 56.1 t -92.8 114.18 29.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.658 -0.701 . . . . 72.019999999999996 110.677 178.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.569 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 30.7 m -103.32 109.23 20.77 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.845 -0.616 . . . . 64.319999999999993 110.077 178.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.587 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 25.2 t70 -62.32 141.23 58.4 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.489 -0.323 . . . . 63.399999999999999 110.777 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.07 -26.69 19.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.259 -0.428 . . . . 70.420000000000002 110.251 -177.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 32.7 mtmm -70.04 -69.58 0.34 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.374 -0.375 . . . . 73.140000000000001 111.149 -174.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 12.0 t -99.05 -26.8 14.11 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.243 0.544 . . . . 72.120000000000005 109.716 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.587 ' HA2' ' O ' ' A' ' 100' ' ' ASP . . . 83.65 79.45 1.06 Allowed Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.544 -0.753 . . . . 65.239999999999995 112.909 176.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.491 ' H ' ' HB3' ' A' ' 100' ' ' ASP . 68.6 mm-40 -124.69 144.16 50.36 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.587 -0.523 . . . . 72.040000000000006 109.587 174.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.9 m -89.05 96.11 10.59 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.123 0.487 . . . . 61.32 110.724 -178.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.435 ' HB3' ' HB ' ' A' ' 98' ' ' VAL . 47.4 t -88.17 80.83 7.51 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.454 -0.573 . . . . 71.150000000000006 109.454 177.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.483 HG23 ' OD1' ' A' ' 97' ' ' ASN . 28.2 m -82.35 101.49 10.62 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.901 -0.591 . . . . 61.340000000000003 110.709 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.543 ' HB ' ' HB3' ' A' ' 96' ' ' LEU . 54.5 mt -99.88 92.34 2.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.052 -0.522 . . . . 73.010000000000005 110.514 -178.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -72.56 106.91 4.81 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.723 -0.473 . . . . 61.100000000000001 109.723 175.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.2 t . . . . . 0 C--N 1.323 -0.584 0 N-CA-C 109.688 -0.486 . . . . 75.109999999999999 109.688 177.435 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 . . . . . 0 N--CA 1.454 -0.256 0 N-CA-C 109.755 -0.461 . . . . 65.319999999999993 109.755 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.3 m -124.24 89.12 52.27 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.106 -0.497 . . . . 60.32 110.742 -175.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.404 ' C ' ' HB2' ' A' ' 52' ' ' ASP . 24.3 Cg_exo -61.67 107.21 0.49 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.881 2.387 . . . . 72.099999999999994 112.385 -177.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.7 m -140.43 -36.9 0.47 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.965 -0.562 . . . . 71.450000000000003 110.371 175.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -92.45 -33.72 14.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.296 0.569 . . . . 71.230000000000004 110.604 176.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.431 ' H ' HD23 ' A' ' 51' ' ' LEU . 0.7 OUTLIER -101.47 0.0 35.95 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.839 -0.619 . . . . 73.420000000000002 110.665 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' A' ' 56' ' ' GLN . 14.9 t70 -62.38 -62.9 1.44 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.738 -0.664 . . . . 63.020000000000003 111.671 -173.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -69.26 -18.24 63.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.235 0.54 . . . . 73.010000000000005 110.085 -177.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -73.37 -58.15 3.51 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.553 -0.749 . . . . 74.25 110.658 178.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.5 t -70.3 -18.97 63.11 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.229 0.538 . . . . 75.409999999999997 110.461 -178.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.405 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 3.1 tp-100 -61.82 -35.51 78.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.479 -0.782 . . . . 51.200000000000003 109.978 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.98 -19.96 31.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.893 -0.594 . . . . 74.219999999999999 110.983 -179.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.426 ' O ' HG13 ' A' ' 62' ' ' ILE . 24.7 mt -71.74 -27.7 28.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.052 -0.522 . . . . 75.030000000000001 110.891 -177.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -54.88 -35.72 64.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.442 -0.344 . . . . 51.229999999999997 111.239 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.9 m -62.43 -50.41 71.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.989 0.424 . . . . 73.340000000000003 110.975 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -74.45 -17.23 60.81 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.32 -0.4 . . . . 64.209999999999994 110.846 -177.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.554 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 74.5 mt -72.8 -50.17 35.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.522 -0.547 . . . . 75.120000000000005 109.522 173.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 95.5 mt -60.45 -42.04 95.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.881 -0.599 . . . . 74.530000000000001 110.356 177.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.401 ' HA2' ' HD2' ' A' ' 90' ' ' ARG . . . -59.72 -43.85 97.46 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.852 -0.613 . . . . 54.140000000000001 112.215 176.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -65.22 -35.49 91.68 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 121.24 -0.505 . . . . 33.530000000000001 112.432 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' A' ' 62' ' ' ILE . 98.0 mt -61.66 -52.12 65.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.674 0.273 . . . . 72.230000000000004 110.595 178.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.6 mt -68.7 -31.67 70.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.001 -0.545 . . . . 70.319999999999993 111.048 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 38.3 t -56.5 -49.63 74.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.785 -0.643 . . . . 75.109999999999999 110.908 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -72.49 -19.67 61.5 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.234 -0.439 . . . . 53.439999999999998 111.768 -177.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.488 HG12 ' O ' ' A' ' 66' ' ' LEU . 46.4 mm . . . . . 0 C--N 1.328 -0.366 0 CA-C-O 121.13 0.49 . . . . 71.409999999999997 110.154 177.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 27.1 ttt . . . . . 0 N--CA 1.454 -0.255 0 CA-C-O 120.975 0.416 . . . . 73.310000000000002 110.42 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 45.4 t -76.71 105.92 6.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.875 -0.602 . . . . 63.219999999999999 109.728 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.52 ' HB ' ' O ' ' A' ' 83' ' ' TYR . 5.3 m -82.25 160.06 23.05 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.622 -0.717 . . . . 43.310000000000002 110.262 -178.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -54.48 -60.49 3.28 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.136 0.493 . . . . 72.310000000000002 111.33 -177.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.848 ' HB3' ' HD3' ' A' ' 101' ' ' ARG . 1.6 m-20 -110.43 -38.56 5.19 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.811 -0.631 . . . . 75.510000000000005 111.243 -175.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.52 ' O ' ' HB ' ' A' ' 80' ' ' THR . 17.6 m-85 -78.95 142.25 36.84 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.911 -0.586 . . . . 63.340000000000003 111.662 -177.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.57 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 49.9 mm -93.58 89.92 2.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.909 -0.587 . . . . 71.040000000000006 110.087 175.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.541 HG22 HG22 ' A' ' 98' ' ' VAL . 93.9 t -95.49 117.79 40.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.762 -0.653 . . . . 64.329999999999998 110.127 178.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -118.61 119.25 33.94 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.063 0.459 . . . . 74.510000000000005 110.447 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 52.4 mt -96.55 94.66 4.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.79 -0.641 . . . . 73.150000000000006 109.401 178.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.543 ' HB3' ' HB2' ' A' ' 95' ' ' GLN . . . -92.11 100.38 13.02 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.179 -0.464 . . . . 54.140000000000001 110.996 -177.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -96.24 108.16 20.6 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.956 -0.565 . . . . 62.210000000000001 110.334 176.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.401 ' HD2' ' HA2' ' A' ' 64' ' ' GLY . 1.6 mtp180 -136.99 131.7 33.28 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.133 -0.485 . . . . 75.439999999999998 110.252 176.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 61.45 19.99 10.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.974 -0.557 . . . . 71.019999999999996 111.35 175.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.26 -6.95 78.53 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.971 -0.633 . . . . 75.319999999999993 112.427 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.493 ' HA ' HE21 ' A' ' 93' ' ' GLN . 0.1 OUTLIER -90.75 126.82 36.12 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.194 -0.299 . . . . 62.409999999999997 110.194 -179.889 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -93.8 107.29 19.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.205 -0.452 . . . . 52.240000000000002 110.122 177.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.543 ' HB2' ' HB3' ' A' ' 88' ' ' ALA . 45.1 mt-30 -99.73 95.66 7.08 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.893 0.378 . . . . 55.530000000000001 110.269 175.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 50.3 tp -84.38 94.0 8.4 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.835 -0.62 . . . . 75.109999999999999 109.429 177.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -107.56 127.28 53.49 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.316 0.579 . . . . 43.409999999999997 110.43 -176.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.541 HG22 HG22 ' A' ' 85' ' ' VAL . 85.2 t -118.39 131.65 70.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.637 -0.71 . . . . 72.019999999999996 110.483 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.57 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 15.5 m -104.72 112.64 25.81 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.385 -0.825 . . . . 64.319999999999993 108.974 172.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -66.27 153.72 41.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.315 0.578 . . . . 63.399999999999999 111.966 -175.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.848 ' HD3' ' HB3' ' A' ' 82' ' ' ASP . 35.8 ptt180 -82.81 -30.39 28.82 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.122 -0.945 . . . . 70.420000000000002 111.821 -175.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.638 ' HG3' ' HG3' ' A' ' 101' ' ' ARG . 47.1 mttm -105.26 -62.83 1.3 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.218 0.532 . . . . 73.140000000000001 111.473 -172.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.514 ' OG1' ' HG2' ' A' ' 105' ' ' GLN . 42.9 p -78.58 -19.69 52.21 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.734 -0.666 . . . . 72.120000000000005 109.921 -177.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 70.08 26.01 74.86 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.354 -0.839 . . . . 65.239999999999995 112.413 177.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.514 ' HG2' ' OG1' ' A' ' 103' ' ' THR . 27.3 mm-40 -66.91 125.55 26.29 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.991 -0.374 . . . . 72.040000000000006 109.991 177.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.9 m -102.12 92.23 4.67 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.055 -0.72 . . . . 61.32 109.055 175.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.8 t -100.25 121.87 42.16 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.196 -0.456 . . . . 71.150000000000006 110.124 -176.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 26.8 m -102.95 102.17 12.22 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.159 -0.473 . . . . 61.340000000000003 110.442 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 54.5 mt -93.09 92.25 3.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.458 -0.571 . . . . 73.010000000000005 109.458 177.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -89.4 131.2 35.58 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.202 -0.454 . . . . 61.100000000000001 110.293 -178.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 46.5 t . . . . . 0 C--N 1.327 -0.387 0 CA-C-O 121.34 0.591 . . . . 75.109999999999999 109.743 175.481 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 . . . . . 0 N--CA 1.46 0.061 0 N-CA-C 111.807 0.299 . . . . 65.319999999999993 111.807 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 33.4 m -116.17 86.06 16.56 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 109.489 -0.56 . . . . 60.32 109.489 174.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -61.48 104.76 0.32 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.107 2.538 . . . . 72.099999999999994 112.292 -175.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.1 p -134.29 -75.61 0.47 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.538 -0.755 . . . . 71.450000000000003 110.356 178.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.54 -37.26 71.16 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.936 0.398 . . . . 71.230000000000004 110.63 177.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.409 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 3.7 pp -97.56 9.92 41.21 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.826 -0.625 . . . . 73.420000000000002 110.797 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.439 ' O ' ' HB2' ' A' ' 56' ' ' GLN . 32.7 t70 -59.09 -52.92 63.67 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.813 -0.631 . . . . 63.020000000000003 111.165 -176.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -62.37 -40.48 96.58 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.942 -0.572 . . . . 73.010000000000005 110.374 -176.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.583 ' O ' HG13 ' A' ' 58' ' ' ILE . 76.7 t80 -60.11 -63.81 1.17 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.728 -0.669 . . . . 74.25 111.826 -178.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.8 t -69.08 -19.54 64.07 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.876 0.325 . . . . 75.409999999999997 111.876 -172.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.439 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 2.7 mp0 -82.38 -36.26 26.95 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.741 0.305 . . . . 51.200000000000003 110.498 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.96 -30.69 71.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 74.219999999999999 110.474 176.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.721 ' O ' ' HG2' ' A' ' 61' ' ' GLN . 10.6 mt -70.09 -46.16 73.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.028 -0.533 . . . . 75.030000000000001 110.38 177.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -66.06 -18.88 65.63 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.167 0.508 . . . . 51.229999999999997 110.456 178.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 66.1 m -84.19 -3.26 58.04 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.074 -0.512 . . . . 73.340000000000003 111.61 177.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.721 ' HG2' ' O ' ' A' ' 58' ' ' ILE . 2.4 pt20 -105.96 -2.13 23.22 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.149 0.499 . . . . 64.209999999999994 110.089 177.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 51.6 mm -76.48 -30.53 19.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.818 -0.628 . . . . 75.120000000000005 110.886 -176.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.724 ' H ' HD22 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -61.13 -43.85 98.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.082 -0.508 . . . . 74.530000000000001 110.198 -177.245 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -83.98 -31.86 25.09 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.954 -0.641 . . . . 54.140000000000001 111.604 176.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.82 -24.26 66.37 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 121.405 -0.426 . . . . 33.530000000000001 112.833 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.444 ' O ' HG12 ' A' ' 70' ' ' ILE . 9.7 tt -55.58 -40.9 72.6 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.826 -0.435 . . . . 72.230000000000004 109.826 176.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.7 mp -80.53 13.2 2.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.042 -0.526 . . . . 70.319999999999993 111.223 -178.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 26.2 t -115.97 -21.01 9.7 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.189 0.518 . . . . 75.109999999999999 109.664 174.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -83.77 -26.78 29.37 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.954 -0.566 . . . . 53.439999999999998 110.489 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.444 HG12 ' O ' ' A' ' 66' ' ' LEU . 35.8 mm . . . . . 0 C--N 1.327 -0.379 0 CA-C-N 115.805 -0.634 . . . . 71.409999999999997 110.634 -177.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 51.8 ttm . . . . . 0 N--CA 1.454 -0.256 0 CA-C-O 121.1 0.476 . . . . 73.310000000000002 110.227 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 23.6 t -95.27 83.95 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.823 -0.626 . . . . 63.219999999999999 109.873 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.81 -179.15 5.81 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.721 -0.672 . . . . 43.310000000000002 110.036 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -74.18 -51.88 14.16 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.727 0.299 . . . . 72.310000000000002 110.632 -177.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -122.76 19.02 10.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.802 0.334 . . . . 75.510000000000005 111.721 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -135.14 111.56 9.81 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.951 0.405 . . . . 63.340000000000003 111.0 177.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.42 HD12 ' N ' ' A' ' 84' ' ' ILE . 4.2 mp -99.97 105.56 17.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.834 -0.621 . . . . 71.040000000000006 109.477 177.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.441 ' HB ' HG23 ' A' ' 98' ' ' VAL . 6.3 p -117.78 121.63 67.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.24 0.543 . . . . 64.329999999999998 110.547 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -138.38 134.7 34.49 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.591 -0.731 . . . . 74.510000000000005 110.27 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.488 ' HA ' ' O ' ' A' ' 95' ' ' GLN . 54.0 mt -89.92 101.41 12.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.112 -0.495 . . . . 73.150000000000006 110.102 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -90.85 156.43 18.03 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.972 -0.558 . . . . 54.140000000000001 110.038 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.552 ' HA ' ' O ' ' A' ' 93' ' ' GLN . 47.7 t-20 -127.53 127.28 43.69 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.016 0.436 . . . . 62.210000000000001 110.249 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -133.69 115.51 14.69 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.872 -0.604 . . . . 75.439999999999998 110.069 175.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 62.47 29.69 17.14 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.142 -0.481 . . . . 71.019999999999996 111.451 175.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.39 28.27 33.67 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.713 -0.756 . . . . 75.319999999999993 112.531 178.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.552 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 26.4 mm-40 -119.53 123.36 43.79 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.798 -0.445 . . . . 62.409999999999997 109.798 175.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -93.34 122.93 36.25 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.052 -0.522 . . . . 52.240000000000002 109.621 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.919 ' HG2' ' HG2' ' A' ' 110' ' ' GLN . 24.0 mt-30 -118.18 106.73 13.14 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.165 -0.471 . . . . 55.530000000000001 111.714 -177.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 54.1 tp -78.09 86.95 4.23 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.252 -1.018 . . . . 75.109999999999999 108.252 172.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -113.1 111.55 22.31 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.987 -0.551 . . . . 43.409999999999997 110.83 -172.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.441 HG23 ' HB ' ' A' ' 85' ' ' VAL . 7.2 p -107.39 135.23 46.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.51 -0.768 . . . . 72.019999999999996 110.718 -177.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 29.1 m -116.72 124.41 49.6 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.145 -0.48 . . . . 64.319999999999993 110.815 178.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.474 ' HB3' ' H ' ' A' ' 105' ' ' GLN . 11.2 t0 -71.64 137.21 47.72 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.224 -0.658 . . . . 63.399999999999999 109.224 175.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.585 ' O ' ' HD2' ' A' ' 101' ' ' ARG . 3.5 tmm_? -82.16 -28.37 32.16 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.897 0.379 . . . . 70.420000000000002 110.554 -176.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt -103.57 -49.46 3.68 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.164 -0.471 . . . . 73.140000000000001 111.114 -174.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.608 ' HB ' ' HG2' ' A' ' 105' ' ' GLN . 0.2 OUTLIER -88.23 -14.64 37.98 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.748 -0.66 . . . . 72.120000000000005 110.899 -175.292 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 67.34 17.09 68.0 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.87 -0.605 . . . . 65.239999999999995 113.362 178.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.608 ' HG2' ' HB ' ' A' ' 103' ' ' THR . 30.7 mm-40 -62.57 123.84 19.41 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.135 -0.32 . . . . 72.040000000000006 110.135 176.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 20.8 m -110.22 97.34 6.84 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.031 -0.531 . . . . 61.32 109.889 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.0 t -103.37 104.28 14.37 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.161 -0.472 . . . . 71.150000000000006 109.935 -177.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 28.7 m -101.1 103.15 14.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.894 -0.594 . . . . 61.340000000000003 111.182 -178.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 4.4 mp -98.5 97.8 6.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.071 0.462 . . . . 73.010000000000005 109.882 176.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.919 ' HG2' ' HG2' ' A' ' 95' ' ' GLN . 69.4 mt-30 -75.62 166.64 23.25 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.144 -0.48 . . . . 61.100000000000001 110.334 177.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.9 p . . . . . 0 C--N 1.325 -0.498 0 CA-C-O 121.569 0.699 . . . . 75.109999999999999 110.331 173.939 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.462 ' HA ' ' OE1' ' A' ' 46' ' ' GLU . 6.9 mm-40 . . . . . 0 N--CA 1.47 0.562 0 N-CA-C 113.349 0.87 . . . . 65.319999999999993 113.349 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.406 ' O ' HG23 ' A' ' 47' ' ' THR . 8.5 t -125.1 85.97 57.37 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-O 121.849 0.833 . . . . 60.32 111.055 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.448 ' HB2' ' HB2' ' A' ' 52' ' ' ASP . 11.5 Cg_exo -71.34 116.76 4.83 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.939 2.426 . . . . 72.099999999999994 111.951 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 14.6 m -98.6 -69.77 0.75 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.633 -0.258 . . . . 71.450000000000003 110.985 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.77 -40.51 18.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.885 0.374 . . . . 71.230000000000004 111.248 -176.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.582 HD23 ' H ' ' A' ' 51' ' ' LEU . 1.9 pt? -69.8 -16.94 63.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 73.420000000000002 110.908 -178.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.518 ' O ' ' HB2' ' A' ' 56' ' ' GLN . 23.1 t70 -57.37 -50.04 74.23 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.112 -0.495 . . . . 63.020000000000003 110.779 -178.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -60.31 -43.19 96.59 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.099 -0.5 . . . . 73.010000000000005 110.826 178.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.474 ' O ' HG12 ' A' ' 58' ' ' ILE . 80.9 t80 -60.6 -53.35 58.52 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.066 -0.515 . . . . 74.25 111.169 -179.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.2 t -68.99 -30.2 68.56 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.783 0.325 . . . . 75.409999999999997 110.784 -177.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.518 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 1.3 tp-100 -64.77 -44.71 89.17 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.145 0.498 . . . . 51.200000000000003 110.047 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.47 -32.99 74.84 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.554 -0.748 . . . . 74.219999999999999 111.109 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.607 ' O ' ' HG2' ' A' ' 61' ' ' GLN . 47.0 mm -66.13 -37.75 80.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.982 0.42 . . . . 75.030000000000001 110.509 177.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -69.48 -38.9 77.89 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.297 -0.41 . . . . 51.229999999999997 110.816 178.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 44.8 m -67.96 -32.14 72.35 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.349 -0.387 . . . . 73.340000000000003 111.404 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.607 ' HG2' ' O ' ' A' ' 58' ' ' ILE . 2.5 pt20 -78.42 -9.44 59.29 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.642 0.258 . . . . 64.209999999999994 111.222 -176.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.53 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 74.3 mt -62.74 -33.07 58.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.934 0.397 . . . . 75.120000000000005 110.088 -178.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 92.5 mt -53.49 -36.38 61.62 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.423 -0.808 . . . . 74.530000000000001 111.635 -178.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.65 -30.42 5.86 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.708 -0.758 . . . . 54.140000000000001 111.967 178.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -58.38 -34.99 77.04 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 121.542 -0.361 . . . . 33.530000000000001 112.952 -178.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' A' ' 62' ' ' ILE . 88.6 mt -56.55 -38.44 71.9 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.873 0.368 . . . . 72.230000000000004 111.063 178.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.1 mt -76.54 -39.18 53.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.045 0.45 . . . . 70.319999999999993 110.468 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 16.5 m -66.18 -37.95 86.85 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.836 -0.62 . . . . 75.109999999999999 111.513 -177.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -76.45 -8.55 57.39 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.966 0.358 . . . . 53.439999999999998 111.966 -175.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 66' ' ' LEU . 43.3 mm . . . . . 0 C--O 1.234 0.249 0 CA-C-O 121.419 0.628 . . . . 71.409999999999997 110.195 176.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 57.6 ttp . . . . . 0 C--O 1.236 0.346 0 CA-C-O 120.989 0.423 . . . . 73.310000000000002 110.955 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 48.2 t -70.34 102.94 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.446 -0.576 . . . . 63.219999999999999 109.446 176.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.2 m -109.6 159.68 16.9 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.015 -0.538 . . . . 43.310000000000002 109.597 -177.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -67.82 -47.07 70.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.06 0.457 . . . . 72.310000000000002 110.125 -179.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -72.66 -35.8 67.82 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.843 0.683 . . . . 75.510000000000005 112.843 -176.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.646 ' HB3' HG13 ' A' ' 98' ' ' VAL . 55.1 m-85 -157.24 169.08 25.58 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.897 0.379 . . . . 63.340000000000003 110.828 -175.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.57 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 40.3 mm -97.98 98.93 7.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.364 -0.606 . . . . 71.040000000000006 109.364 169.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 41.3 t -85.31 94.42 3.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.002 -0.544 . . . . 64.329999999999998 110.178 -178.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -98.2 102.7 14.52 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.271 0.558 . . . . 74.510000000000005 110.385 177.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 63.0 mt -88.7 106.46 16.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.657 -0.701 . . . . 73.150000000000006 109.52 175.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -106.32 162.27 13.83 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.269 -0.423 . . . . 54.140000000000001 110.214 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -138.33 123.54 19.26 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.843 0.354 . . . . 62.210000000000001 110.321 178.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 65.0 mtp180 -138.81 132.61 30.87 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.073 -0.512 . . . . 75.439999999999998 109.855 176.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 64.56 17.37 10.83 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 123.629 0.581 . . . . 71.019999999999996 111.051 178.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.06 -26.3 25.18 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 121.113 -0.565 . . . . 75.319999999999993 112.412 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.58 ' HA ' HE21 ' A' ' 93' ' ' GLN . 0.1 OUTLIER -90.25 140.78 29.35 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.062 0.458 . . . . 62.409999999999997 110.886 -175.742 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -81.12 144.75 31.47 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.707 -0.678 . . . . 52.240000000000002 110.616 179.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -122.76 107.59 12.09 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.511 -0.551 . . . . 55.530000000000001 109.511 175.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 55.7 tp -82.26 98.8 8.96 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.867 -0.606 . . . . 75.109999999999999 109.425 179.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -107.69 91.84 3.82 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.317 0.58 . . . . 43.409999999999997 110.657 -177.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.646 HG13 ' HB3' ' A' ' 83' ' ' TYR . 21.7 t -82.99 108.1 15.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.679 -0.691 . . . . 72.019999999999996 109.996 176.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.57 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 25.6 m -90.77 111.66 23.13 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.398 -0.819 . . . . 64.319999999999993 108.894 175.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.462 ' HA ' ' HD2' ' A' ' 83' ' ' TYR . 13.6 t0 -61.27 133.54 56.0 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.841 -0.618 . . . . 63.399999999999999 111.155 -177.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.463 ' C ' ' HD2' ' A' ' 101' ' ' ARG . 1.1 ppt_? -94.93 -7.92 38.56 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.551 -0.75 . . . . 70.420000000000002 110.461 -178.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -87.17 -71.92 0.54 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.976 -0.556 . . . . 73.140000000000001 110.579 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 57.5 p -97.53 -28.92 13.75 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.278 -0.419 . . . . 72.120000000000005 110.566 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 100' ' ' ASP . . . 102.29 22.73 9.56 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 121.071 -0.585 . . . . 65.239999999999995 112.867 177.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.458 ' N ' ' HB3' ' A' ' 100' ' ' ASP . 49.4 mt-30 -73.98 131.87 41.84 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.732 0.301 . . . . 72.040000000000006 110.545 177.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.5 p -91.41 108.83 20.16 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.234 0.54 . . . . 61.32 111.615 -177.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 10.0 t -96.85 86.07 3.94 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.285 -0.635 . . . . 71.150000000000006 109.285 177.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 87.2 m -91.6 104.81 17.25 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.633 -0.712 . . . . 61.340000000000003 110.671 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 54.8 mt -115.89 105.13 17.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.972 -0.558 . . . . 73.010000000000005 110.487 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -69.97 134.15 48.03 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.9 -0.407 . . . . 61.100000000000001 109.9 175.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 52.1 t . . . . . 0 C--N 1.322 -0.612 0 CA-C-O 121.135 0.493 . . . . 75.109999999999999 110.009 -179.957 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 121.334 0.588 . . . . 65.319999999999993 110.718 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.2 t -139.44 87.91 13.08 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.467 -0.788 . . . . 60.32 110.214 -179.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.464 ' HA ' HD21 ' A' ' 51' ' ' LEU . 15.0 Cg_exo -65.15 100.55 0.38 Allowed 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.647 2.232 . . . . 72.099999999999994 112.757 -176.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.3 p -146.51 -76.18 0.19 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.889 -0.596 . . . . 71.450000000000003 110.111 174.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.68 -45.73 85.4 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.001 -0.545 . . . . 71.230000000000004 110.895 178.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.497 HD23 ' H ' ' A' ' 51' ' ' LEU . 2.6 pt? -79.24 -20.2 48.79 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.984 -0.553 . . . . 73.420000000000002 110.849 179.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -57.33 -65.24 0.66 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.893 -0.594 . . . . 63.020000000000003 111.562 -174.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -67.58 -22.85 65.36 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.896 -0.593 . . . . 73.010000000000005 110.701 -176.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.563 ' O ' HG13 ' A' ' 58' ' ' ILE . 23.3 t80 -75.43 -55.91 5.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.812 -0.631 . . . . 74.25 111.287 -178.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.3 t -63.41 -26.92 68.96 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.827 0.346 . . . . 75.409999999999997 111.757 -174.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -68.6 -35.5 77.43 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.796 0.332 . . . . 51.200000000000003 110.672 -178.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.53 -29.66 59.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.043 -0.526 . . . . 74.219999999999999 109.944 177.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.563 HG13 ' O ' ' A' ' 54' ' ' PHE . 17.5 mt -65.31 -43.8 94.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.75 -0.659 . . . . 75.030000000000001 110.747 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -64.15 -22.84 67.09 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.283 -0.417 . . . . 51.229999999999997 111.143 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 58.5 m -86.94 -35.18 19.04 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.437 -0.347 . . . . 73.340000000000003 111.385 178.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.541 ' HG2' ' HA ' ' A' ' 58' ' ' ILE . 3.6 pt20 -77.58 -4.57 46.47 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.702 0.26 . . . . 64.209999999999994 111.702 -175.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.549 HG13 ' O ' ' A' ' 58' ' ' ILE . 75.4 mt -61.9 -36.26 72.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.906 0.384 . . . . 75.120000000000005 110.173 -178.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 8.5 mp -56.79 -47.16 80.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.573 -0.74 . . . . 74.530000000000001 110.302 178.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -69.01 -39.14 85.01 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.839 -0.696 . . . . 54.140000000000001 112.025 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.45 -43.36 98.83 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 121.234 -0.508 . . . . 33.530000000000001 112.216 178.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 62' ' ' ILE . 94.8 mt -58.08 -50.02 74.93 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.651 0.262 . . . . 72.230000000000004 110.757 178.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.72 HD13 ' HA ' ' A' ' 91' ' ' ASP . 96.4 mt -62.65 -30.52 71.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.125 -0.489 . . . . 70.319999999999993 111.561 -177.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 30.6 t -82.59 -35.09 27.4 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.021 0.438 . . . . 75.109999999999999 110.499 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -85.71 13.57 6.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.297 -0.41 . . . . 53.439999999999998 111.834 -177.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.429 HG12 ' O ' ' A' ' 66' ' ' LEU . 47.8 mm . . . . . 0 C--N 1.327 -0.407 0 N-CA-C 108.691 -0.855 . . . . 71.409999999999997 108.691 169.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 49.4 ttm . . . . . 0 N--CA 1.449 -0.476 0 CA-C-O 120.951 0.405 . . . . 73.310000000000002 110.1 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 60.0 t -85.6 95.79 4.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.337 0.589 . . . . 63.219999999999999 109.913 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.546 ' OG1' ' HB2' ' A' ' 83' ' ' TYR . 1.5 p -103.09 -179.09 3.85 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.506 -0.77 . . . . 43.310000000000002 109.925 176.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 13.3 t30 -85.52 -43.66 13.35 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 111.64 0.237 . . . . 72.310000000000002 111.64 -175.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.596 ' OD1' ' HD3' ' A' ' 101' ' ' ARG . 15.3 t70 -108.54 0.95 21.14 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.981 0.42 . . . . 75.510000000000005 111.91 -174.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.546 ' HB2' ' OG1' ' A' ' 80' ' ' THR . 96.3 m-85 -121.95 124.77 44.83 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 122.07 -0.394 . . . . 63.340000000000003 110.949 177.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.553 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 4.1 mp -101.1 88.53 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.4 -0.963 . . . . 71.040000000000006 108.4 171.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.5 p -126.88 137.29 58.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.041 -0.527 . . . . 64.329999999999998 111.344 -172.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -141.76 152.22 43.58 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.765 -0.652 . . . . 74.510000000000005 110.037 175.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 71.2 mt -92.58 115.4 31.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.675 -0.693 . . . . 73.150000000000006 110.452 -176.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -110.93 114.15 27.25 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.207 -0.451 . . . . 54.140000000000001 110.663 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -90.98 87.35 6.58 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.337 0.589 . . . . 62.210000000000001 109.718 174.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.412 ' HG2' ' HB2' ' A' ' 91' ' ' ASP . 43.7 ttt180 -109.27 139.57 44.04 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.674 -0.694 . . . . 75.439999999999998 110.001 177.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.72 ' HA ' HD13 ' A' ' 67' ' ' LEU . 4.7 t70 68.12 20.89 8.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.564 0.697 . . . . 71.019999999999996 110.218 172.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.73 20.77 79.84 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.456 -0.793 . . . . 75.319999999999993 112.376 -178.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.499 HE21 ' HA ' ' A' ' 93' ' ' GLN . 0.0 OUTLIER -124.43 140.92 52.49 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.763 -0.458 . . . . 62.409999999999997 109.763 179.554 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -79.39 117.5 20.42 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.699 -0.482 . . . . 52.240000000000002 109.699 176.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -123.57 122.07 37.23 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.227 -0.442 . . . . 55.530000000000001 110.733 -176.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 20.1 tp -99.8 106.47 18.35 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.73 -0.668 . . . . 75.109999999999999 109.849 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.436 ' ND2' HG23 ' A' ' 108' ' ' THR . 13.6 m120 -95.01 95.6 8.71 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.46 -0.337 . . . . 43.409999999999997 110.401 -178.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.46 ' HB ' ' HB2' ' A' ' 107' ' ' SER . 93.5 t -87.83 102.38 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.495 0 CA-C-O 121.321 0.581 . . . . 72.019999999999996 110.578 179.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.553 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 68.9 m -86.09 107.98 18.07 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.537 -0.756 . . . . 64.319999999999993 109.835 177.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.5 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 24.2 t70 -63.66 145.04 56.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.805 -0.634 . . . . 63.399999999999999 111.286 -178.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.596 ' HD3' ' OD1' ' A' ' 82' ' ' ASP . 33.2 ttt180 -92.94 -22.24 19.33 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.545 -0.752 . . . . 70.420000000000002 110.685 -178.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 35.0 mttp -80.25 -68.62 0.66 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.371 0.605 . . . . 73.140000000000001 110.545 -176.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 45.8 p -90.47 -43.0 10.54 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.476 -0.784 . . . . 72.120000000000005 110.031 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.5 ' HA2' ' O ' ' A' ' 100' ' ' ASP . . . 111.25 4.37 27.25 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 115.472 -0.786 . . . . 65.239999999999995 112.904 176.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -61.67 133.61 55.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.914 0.388 . . . . 72.040000000000006 110.631 175.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 62.6 m -92.17 100.31 12.95 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.614 -0.513 . . . . 61.32 109.614 174.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.46 ' HB2' ' HB ' ' A' ' 98' ' ' VAL . 14.1 m -73.85 101.25 3.7 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.724 -0.671 . . . . 71.150000000000006 109.294 177.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.436 HG23 ' ND2' ' A' ' 97' ' ' ASN . 0.8 OUTLIER -89.53 94.84 10.02 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.015 -0.539 . . . . 61.340000000000003 110.808 -174.446 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 35.0 mm -99.87 101.22 11.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.826 -0.624 . . . . 73.010000000000005 110.371 -177.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -78.24 154.68 30.81 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.425 -0.352 . . . . 61.100000000000001 110.658 175.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--N 1.323 -0.559 0 CA-C-N 115.565 -0.743 . . . . 75.109999999999999 111.232 178.401 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 . . . . . 0 N--CA 1.453 -0.278 0 CA-C-O 120.941 0.4 . . . . 65.319999999999993 110.094 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 25.2 m -119.71 87.73 38.01 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 115.977 -0.556 . . . . 60.32 111.002 -177.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.423 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 21.0 Cg_endo -61.44 127.91 23.27 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.469 2.112 . . . . 72.099999999999994 111.556 178.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.8 m -121.93 -42.32 2.4 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.108 0.48 . . . . 71.450000000000003 110.526 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -87.55 -36.09 17.76 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.032 -0.531 . . . . 71.230000000000004 110.707 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.429 ' O ' HG22 ' A' ' 55' ' ' THR . 0.6 OUTLIER -98.06 5.07 49.1 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.51 -0.314 . . . . 73.420000000000002 110.725 180.0 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.423 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 39.4 t0 -57.3 -64.28 0.94 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.011 -0.54 . . . . 63.020000000000003 111.54 -175.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -66.01 -26.11 67.38 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.326 -0.397 . . . . 73.010000000000005 110.864 -177.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.538 ' O ' HG13 ' A' ' 58' ' ' ILE . 89.0 t80 -69.62 -60.41 2.34 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.96 -0.564 . . . . 74.25 111.266 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.429 HG22 ' O ' ' A' ' 51' ' ' LEU . 12.9 t -74.04 -20.39 60.32 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.565 0.221 . . . . 75.409999999999997 111.48 -172.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -76.14 -33.42 59.4 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.83 0.348 . . . . 51.200000000000003 110.543 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.94 -24.02 60.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.147 0.498 . . . . 74.219999999999999 110.585 178.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.557 ' O ' HG13 ' A' ' 62' ' ' ILE . 16.1 mt -72.67 -26.69 24.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.74 -0.664 . . . . 75.030000000000001 110.718 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -56.76 -37.72 71.46 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.734 0.302 . . . . 51.229999999999997 110.958 -178.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.9 m -63.94 -43.19 96.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.089 -0.505 . . . . 73.340000000000003 111.436 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -79.81 -21.96 43.62 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 121.026 -0.269 . . . . 64.209999999999994 111.232 -175.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.557 HG13 ' O ' ' A' ' 58' ' ' ILE . 79.9 mt -66.05 -35.95 76.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.064 0.459 . . . . 75.120000000000005 109.84 177.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 92.3 mt -57.23 -46.47 82.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.579 -0.737 . . . . 74.530000000000001 111.121 178.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -65.89 -37.48 93.34 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.86 -0.686 . . . . 54.140000000000001 111.914 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.14 -40.67 99.26 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.983 -0.627 . . . . 33.530000000000001 112.055 178.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.8 mt -61.98 -41.08 97.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.0 0.428 . . . . 72.230000000000004 110.904 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.3 mt -67.37 -32.17 72.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.096 -0.502 . . . . 70.319999999999993 110.726 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.3 t -70.55 -24.8 62.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.906 -0.588 . . . . 75.109999999999999 110.551 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -69.89 -11.59 60.98 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.295 -0.411 . . . . 53.439999999999998 111.663 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 47.1 mm . . . . . 0 C--N 1.324 -0.507 0 CA-C-O 121.424 0.63 . . . . 71.409999999999997 109.965 178.28 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.498 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 26.1 ttt . . . . . 0 N--CA 1.451 -0.399 0 CA-C-O 120.862 0.363 . . . . 73.310000000000002 110.393 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.6 p -82.68 90.43 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-O 121.905 0.86 . . . . 63.219999999999999 110.43 178.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.7 ' HB ' ' O ' ' A' ' 83' ' ' TYR . 7.2 m -97.87 134.29 41.2 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.477 -0.783 . . . . 43.310000000000002 109.213 176.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -63.53 -31.9 73.19 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.262 -0.426 . . . . 72.310000000000002 111.379 -175.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.661 ' HA ' ' HG2' ' A' ' 101' ' ' ARG . 37.9 t70 -105.48 -8.18 18.23 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.428 -0.351 . . . . 75.510000000000005 111.871 -175.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.7 ' O ' ' HB ' ' A' ' 80' ' ' THR . 42.2 m-85 -147.98 134.49 19.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.379 0.609 . . . . 63.340000000000003 112.206 -175.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.572 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 49.1 mm -87.17 108.45 18.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.254 -0.647 . . . . 71.040000000000006 109.254 172.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.498 ' HB ' ' HB3' ' A' ' 78' ' ' MET . 60.2 t -116.77 113.57 43.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.752 0.31 . . . . 64.329999999999998 111.374 -174.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -124.0 144.43 49.83 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.219 0.533 . . . . 74.510000000000005 110.135 175.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 62.0 mt -102.19 113.53 38.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.83 -0.623 . . . . 73.150000000000006 110.916 -175.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -107.27 110.18 22.15 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.283 -0.417 . . . . 54.140000000000001 110.207 176.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -115.61 110.49 19.27 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.951 0.405 . . . . 62.210000000000001 110.539 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 -142.94 144.02 32.21 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.536 -0.542 . . . . 75.439999999999998 109.536 177.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.59 20.15 11.79 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 123.565 0.541 . . . . 71.019999999999996 111.122 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.93 -2.7 88.1 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.045 -0.598 . . . . 75.319999999999993 112.439 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.472 ' HA ' HE21 ' A' ' 93' ' ' GLN . 0.1 OUTLIER -93.55 126.65 38.82 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.821 0.343 . . . . 62.409999999999997 110.827 -178.059 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -83.88 105.26 14.63 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.01 -0.541 . . . . 52.240000000000002 110.23 174.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -106.62 104.89 14.68 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.994 -0.548 . . . . 55.530000000000001 109.795 178.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 33.6 tp -89.1 111.93 22.79 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.729 -0.669 . . . . 75.109999999999999 110.193 -177.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -95.5 121.1 36.83 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.814 -0.439 . . . . 43.409999999999997 109.814 179.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.572 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 7.9 p -128.11 127.06 67.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 121.44 0.638 . . . . 72.019999999999996 110.742 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.561 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 6.2 m -113.33 123.97 51.37 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.806 -0.633 . . . . 64.319999999999993 110.141 178.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.495 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 32.3 t70 -70.91 149.54 46.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.102 -0.499 . . . . 63.399999999999999 110.724 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.661 ' HG2' ' HA ' ' A' ' 82' ' ' ASP . 0.0 OUTLIER -96.73 -11.18 25.4 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.97 -0.292 . . . . 70.420000000000002 110.918 -179.08 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 26.7 mttp -89.91 -64.35 1.15 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.623 0.725 . . . . 73.140000000000001 109.791 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 46.1 p -86.61 -45.17 11.28 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.862 -1.063 . . . . 72.120000000000005 110.066 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.495 ' HA2' ' O ' ' A' ' 100' ' ' ASP . . . 99.02 18.44 24.65 Favored Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 114.902 -1.044 . . . . 65.239999999999995 112.311 -178.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.442 ' HA ' ' OE1' ' A' ' 105' ' ' GLN . 12.3 mm-40 -59.43 134.96 57.49 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 120.809 0.338 . . . . 72.040000000000006 110.284 175.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.8 m -108.82 102.47 11.49 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.013 -0.539 . . . . 61.32 109.98 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.404 ' HB3' ' CG1' ' A' ' 98' ' ' VAL . 21.1 t -101.2 125.91 47.87 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.164 -0.471 . . . . 71.150000000000006 110.374 -177.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 29.7 m -108.7 97.79 7.39 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.223 0.535 . . . . 61.340000000000003 109.604 174.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 60.3 mt -84.83 105.03 13.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.76 -0.654 . . . . 73.010000000000005 110.574 -177.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' A' ' 110' ' ' GLN . 9.5 pt20 -101.32 104.47 15.48 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.185 0.517 . . . . 61.100000000000001 110.446 179.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 10.5 p . . . . . 0 C--N 1.323 -0.557 0 CA-C-N 115.972 -0.558 . . . . 75.109999999999999 109.867 178.787 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.594 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 42.0 mt-10 . . . . . 0 CA--C 1.521 -0.165 0 CA-C-O 120.887 0.375 . . . . 65.319999999999993 110.96 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 20.3 m -107.15 86.64 2.61 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.963 -0.562 . . . . 60.32 109.687 175.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.594 ' HD3' ' O ' ' A' ' 46' ' ' GLU . 23.4 Cg_exo -63.24 98.23 0.21 Allowed 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.53 2.153 . . . . 72.099999999999994 112.225 -175.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.0 m -117.15 -77.79 0.57 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.896 -0.593 . . . . 71.450000000000003 109.91 174.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.86 -41.16 68.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.136 0.493 . . . . 71.230000000000004 110.336 178.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.639 HD23 ' H ' ' A' ' 51' ' ' LEU . 2.1 pt? -73.86 -17.97 60.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.778 -0.646 . . . . 73.420000000000002 111.214 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.467 ' HB2' ' C ' ' A' ' 48' ' ' PRO . 31.8 t70 -61.25 -53.65 54.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.823 0.344 . . . . 63.020000000000003 111.079 -176.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -77.43 22.34 0.24 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.902 -0.59 . . . . 73.010000000000005 110.991 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.442 ' O ' HG13 ' A' ' 58' ' ' ILE . 63.5 t80 -132.66 -65.91 0.7 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.321 -0.399 . . . . 74.25 110.731 -178.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.412 HG22 ' O ' ' A' ' 51' ' ' LEU . 10.5 t -69.85 -23.79 63.34 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.487 -0.324 . . . . 75.409999999999997 111.633 -173.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.43 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 2.2 mp0 -67.6 -30.43 70.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.984 0.421 . . . . 51.200000000000003 110.356 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.6 -26.49 37.79 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.067 -0.515 . . . . 74.219999999999999 110.192 177.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.546 ' O ' HG13 ' A' ' 62' ' ' ILE . 11.3 mt -69.91 -36.39 69.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.897 -0.592 . . . . 75.030000000000001 110.322 179.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -67.49 -32.09 72.67 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.068 -0.515 . . . . 51.229999999999997 110.319 178.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 7.1 m -68.45 -39.7 81.38 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.937 -0.574 . . . . 73.340000000000003 110.497 176.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.614 ' O ' ' HA3' ' A' ' 65' ' ' GLY . 2.8 pt20 -82.98 13.24 4.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.98 -0.555 . . . . 64.209999999999994 111.202 -176.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.546 HG13 ' O ' ' A' ' 58' ' ' ILE . 74.7 mt -88.79 -58.52 3.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.703 -0.48 . . . . 75.120000000000005 109.703 172.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 89.4 mt -57.97 -62.22 1.98 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.785 -0.643 . . . . 74.530000000000001 111.379 -175.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.59 3.84 78.98 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.406 -0.902 . . . . 54.140000000000001 112.255 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.614 ' HA3' ' O ' ' A' ' 61' ' ' GLN . . . -94.21 -41.59 4.24 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.759 -0.734 . . . . 33.530000000000001 112.395 -178.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.409 ' O ' HG12 ' A' ' 70' ' ' ILE . 84.1 mt -60.71 -25.06 66.14 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.066 0.46 . . . . 72.230000000000004 110.463 178.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 81.7 mt -63.37 -42.32 98.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.665 -0.698 . . . . 70.319999999999993 110.686 178.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.6 m -68.64 -29.75 68.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.076 0.465 . . . . 75.109999999999999 110.395 179.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -66.43 -25.45 66.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.865 -0.607 . . . . 53.439999999999998 110.607 178.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.409 HG12 ' O ' ' A' ' 66' ' ' LEU . 51.6 mm . . . . . 0 C--N 1.326 -0.418 0 CA-C-N 116.173 -0.467 . . . . 71.409999999999997 110.32 178.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.579 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 28.4 ttt . . . . . 0 C--O 1.233 0.212 0 N-CA-C 108.027 -1.101 . . . . 73.310000000000002 108.027 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 20.1 t -80.57 102.49 6.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.019 0.438 . . . . 63.219999999999999 112.109 -168.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.609 ' HB ' ' O ' ' A' ' 83' ' ' TYR . 5.9 m -108.11 163.34 13.25 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.114 -0.699 . . . . 43.310000000000002 109.114 174.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -65.08 -46.54 80.72 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.79 0.329 . . . . 72.310000000000002 111.043 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.542 ' HA ' ' HD2' ' A' ' 101' ' ' ARG . 28.2 m-20 -105.51 -79.53 0.56 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.912 0.387 . . . . 75.510000000000005 111.129 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.609 ' O ' ' HB ' ' A' ' 80' ' ' THR . 35.1 m-85 -67.46 122.68 18.49 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.816 -0.629 . . . . 63.340000000000003 111.524 -175.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.58 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 4.5 mp -84.73 107.08 15.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.627 -0.879 . . . . 71.040000000000006 108.627 176.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.579 ' HB ' ' HB3' ' A' ' 78' ' ' MET . 21.2 t -89.56 115.31 28.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.996 -0.547 . . . . 64.329999999999998 110.655 -175.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.812 ' HB3' ' HB2' ' A' ' 97' ' ' ASN . 13.3 t70 -106.98 106.08 16.44 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.663 -0.495 . . . . 74.510000000000005 109.663 177.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 60.0 mt -84.79 124.53 39.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.007 -0.542 . . . . 73.150000000000006 110.32 -178.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.433 ' O ' ' HB3' ' A' ' 95' ' ' GLN . . . -135.95 106.96 6.68 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.967 0.358 . . . . 54.140000000000001 111.967 -179.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -84.7 85.67 7.41 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.427 -0.953 . . . . 62.210000000000001 108.427 169.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.1 ttt180 -100.52 134.8 42.94 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.795 -0.639 . . . . 75.439999999999998 109.383 -176.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 68.59 -71.02 0.12 Allowed 'General case' 0 N--CA 1.467 0.41 0 O-C-N 123.87 0.731 . . . . 71.019999999999996 110.39 -172.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 178.52 29.62 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 111.753 -0.539 . . . . 75.319999999999993 111.753 178.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.481 HE21 ' HA ' ' A' ' 93' ' ' GLN . 0.1 OUTLIER -129.69 150.72 50.88 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 110.044 -0.354 . . . . 62.409999999999997 110.044 -177.833 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -79.91 92.6 5.55 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.4 0.619 . . . . 52.240000000000002 110.715 178.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.433 ' HB3' ' O ' ' A' ' 88' ' ' ALA . 5.2 tt0 -96.31 114.66 26.37 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.364 -0.834 . . . . 55.530000000000001 110.01 179.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 20.0 tp -101.68 112.77 25.46 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.01 -0.541 . . . . 75.109999999999999 110.413 -178.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.812 ' HB2' ' HB3' ' A' ' 86' ' ' ASP . 44.2 m-80 -93.54 103.3 15.5 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.109 -0.33 . . . . 43.409999999999997 110.109 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.434 ' CG1' ' HD2' ' A' ' 83' ' ' TYR . 68.9 t -93.35 109.22 21.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.534 0.683 . . . . 72.019999999999996 110.864 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.58 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 35.7 m -97.58 107.15 19.58 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.318 -0.855 . . . . 64.319999999999993 109.741 176.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.438 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 45.1 t0 -72.64 147.37 45.84 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.348 0.594 . . . . 63.399999999999999 111.48 -175.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.542 ' HD2' ' HA ' ' A' ' 82' ' ' ASP . 51.1 ttt180 -95.48 -26.42 15.83 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.994 -1.003 . . . . 70.420000000000002 109.66 177.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 35.9 mtpt -84.29 -65.99 0.95 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.724 -0.671 . . . . 73.140000000000001 110.984 -173.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 72.2 p -86.87 -19.0 29.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.213 0.53 . . . . 72.120000000000005 110.296 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.438 ' HA2' ' O ' ' A' ' 100' ' ' ASP . . . 71.82 21.2 79.0 Favored Glycine 0 N--CA 1.452 -0.284 0 CA-C-N 115.233 -0.894 . . . . 65.239999999999995 112.903 176.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 83.2 mm-40 -88.63 136.13 33.15 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.619 -0.512 . . . . 72.040000000000006 109.619 175.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 19.3 p -97.27 96.37 8.35 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.06 0.457 . . . . 61.32 110.711 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 29.8 m -97.72 106.85 19.23 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.723 -0.671 . . . . 71.150000000000006 110.356 -178.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 95.2 m -91.67 126.23 36.68 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.05 -0.523 . . . . 61.340000000000003 110.511 177.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 4.3 mp -115.37 111.04 34.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.188 -0.46 . . . . 73.010000000000005 109.961 177.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 95' ' ' GLN . 48.0 mt-30 -89.92 104.3 16.88 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.234 -0.439 . . . . 61.100000000000001 110.242 177.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 24.9 t . . . . . 0 C--N 1.325 -0.487 0 N-CA-C 109.176 -0.676 . . . . 75.109999999999999 109.176 177.853 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 . . . . . 0 N--CA 1.453 -0.283 0 CA-C-O 120.775 0.321 . . . . 65.319999999999993 111.467 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 2.5 t -128.56 77.92 76.63 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 121.297 0.57 . . . . 60.32 111.374 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -76.75 96.57 1.1 Allowed 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.047 2.498 . . . . 72.099999999999994 111.302 176.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.1 m -125.2 -51.06 1.66 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.007 0.432 . . . . 71.450000000000003 110.357 -178.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.82 -49.46 8.4 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.139 0.495 . . . . 71.230000000000004 110.472 -179.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.409 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 3.2 pp -75.83 -10.16 59.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.934 -0.575 . . . . 73.420000000000002 111.337 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.535 ' HA ' HG22 ' A' ' 55' ' ' THR . 17.8 t70 -57.95 -45.57 86.43 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.905 -0.588 . . . . 63.020000000000003 111.068 -179.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -61.34 -17.41 53.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.489 -0.778 . . . . 73.010000000000005 111.359 -176.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -98.84 -47.18 5.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.353 -0.385 . . . . 74.25 110.59 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.535 HG22 ' HA ' ' A' ' 52' ' ' ASP . 10.0 t -68.85 -31.49 70.49 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.56 -0.291 . . . . 75.409999999999997 111.285 -176.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -68.16 -30.89 70.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.77 0.319 . . . . 51.200000000000003 110.499 -178.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.1 -12.9 60.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.007 0.432 . . . . 74.219999999999999 111.435 -178.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.6 mm -87.79 -24.55 6.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.381 0.61 . . . . 75.030000000000001 110.073 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -64.83 -22.58 67.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.699 -0.682 . . . . 51.229999999999997 112.138 -174.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 17.3 p -73.82 -41.65 62.03 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.035 0.383 . . . . 73.340000000000003 112.035 -175.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -73.41 -18.08 61.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.803 0.335 . . . . 64.209999999999994 111.075 -176.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.591 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 57.2 mt -67.74 -28.36 41.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.179 -0.464 . . . . 75.120000000000005 110.515 -178.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.2 mp -58.41 -40.2 81.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.351 -0.386 . . . . 74.530000000000001 111.056 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -76.29 -31.46 54.77 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.577 -0.821 . . . . 54.140000000000001 112.047 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -73.66 -25.31 72.52 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.058 -0.592 . . . . 33.530000000000001 112.623 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.591 ' HG ' ' O ' ' A' ' 62' ' ' ILE . 73.0 mt -55.43 -35.9 65.91 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 122.275 0.23 . . . . 72.230000000000004 111.501 -179.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.9 mp -56.45 -30.95 63.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.863 0.363 . . . . 70.319999999999993 111.42 -178.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 25.2 t -105.0 -16.0 14.94 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.295 -0.412 . . . . 75.109999999999999 111.052 -178.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -89.59 -26.67 20.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.816 0.341 . . . . 53.439999999999998 110.954 -176.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.432 HG12 ' O ' ' A' ' 66' ' ' LEU . 48.9 mm . . . . . 0 C--N 1.328 -0.363 0 CA-C-O 121.4 0.619 . . . . 71.409999999999997 109.929 177.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 57.6 ttp . . . . . 0 N--CA 1.45 -0.441 0 CA-C-O 120.837 0.351 . . . . 73.310000000000002 110.497 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 24.8 t -67.85 126.98 28.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.867 -0.606 . . . . 63.219999999999999 109.921 177.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.595 HG21 ' HB2' ' A' ' 83' ' ' TYR . 32.0 m -148.99 140.14 23.07 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.432 -0.581 . . . . 43.310000000000002 109.432 178.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 65.6 m-20 -55.16 -62.68 1.5 Allowed 'General case' 0 C--N 1.329 -0.312 0 O-C-N 123.449 0.468 . . . . 72.310000000000002 112.093 -174.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -114.92 14.09 17.18 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.005 0.372 . . . . 75.510000000000005 112.005 -171.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.595 ' HB2' HG21 ' A' ' 80' ' ' THR . 68.5 m-85 -130.49 126.75 37.65 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.734 -0.386 . . . . 63.340000000000003 110.999 -177.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.495 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 4.1 mp -95.49 106.73 18.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.045 -0.724 . . . . 71.040000000000006 109.045 176.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.9 p -133.47 121.79 42.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.425 0.631 . . . . 64.329999999999998 111.815 -174.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -110.35 134.47 52.26 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.36 -0.836 . . . . 74.510000000000005 108.952 176.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.0 mt -83.53 80.26 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.025 -0.732 . . . . 73.150000000000006 109.025 178.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -86.61 109.42 19.14 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.429 -0.805 . . . . 54.140000000000001 111.323 -174.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -82.78 80.27 8.92 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.981 -0.748 . . . . 62.210000000000001 108.981 172.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -100.46 131.46 46.37 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.336 -0.847 . . . . 75.439999999999998 109.71 -177.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.5 t70 70.4 5.67 5.46 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 123.941 0.776 . . . . 71.019999999999996 111.034 177.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 112.04 -24.48 14.47 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.048 -0.596 . . . . 75.319999999999993 112.764 177.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.423 ' HA ' HE21 ' A' ' 93' ' ' GLN . 0.0 OUTLIER -92.59 141.34 28.6 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 122.734 -0.274 . . . . 62.409999999999997 110.94 -176.889 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.562 ' HB2' ' HB ' ' A' ' 111' ' ' VAL . 3.5 mm? -71.67 105.63 3.77 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.208 -0.664 . . . . 52.240000000000002 109.208 170.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -109.01 111.32 22.92 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.238 0.542 . . . . 55.530000000000001 110.649 -178.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 15.1 tp -81.69 99.94 9.2 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.614 -0.721 . . . . 75.109999999999999 109.263 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -94.02 106.87 18.83 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.118 -0.492 . . . . 43.409999999999997 110.341 -177.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 69.5 t -101.14 114.67 41.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.227 0.537 . . . . 72.019999999999996 111.46 -176.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.495 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 86.8 m -101.67 106.25 17.27 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.585 -0.734 . . . . 64.319999999999993 109.52 172.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.452 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 15.3 t0 -76.68 145.63 38.63 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.985 -0.552 . . . . 63.399999999999999 111.157 -178.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.54 ' O ' ' HD2' ' A' ' 101' ' ' ARG . 5.2 tmm_? -103.43 -25.76 13.14 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.789 -0.641 . . . . 70.420000000000002 109.635 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -73.73 -56.55 4.85 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.887 -0.597 . . . . 73.140000000000001 111.176 -173.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 71.7 p -109.24 -25.42 10.61 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.268 0.556 . . . . 72.120000000000005 110.265 176.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' A' ' 100' ' ' ASP . . . 98.68 13.88 39.3 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.723 -0.672 . . . . 65.239999999999995 112.644 177.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.45 ' N ' ' HB3' ' A' ' 100' ' ' ASP . 50.5 mm-40 -65.01 109.57 2.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.319 0.581 . . . . 72.040000000000006 111.165 178.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.5 m -87.97 100.13 12.68 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.409 -0.814 . . . . 61.32 109.097 176.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 7.6 t -103.08 141.18 36.27 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.937 0.399 . . . . 71.150000000000006 110.224 -175.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 46.6 m -116.69 106.08 13.13 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.075 -0.512 . . . . 61.340000000000003 110.664 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.425 HD12 ' N ' ' A' ' 109' ' ' ILE . 4.4 mp -111.52 105.15 18.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.3 -0.409 . . . . 73.010000000000005 110.721 -177.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -70.68 157.97 37.07 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.011 0.434 . . . . 61.100000000000001 110.843 175.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.562 ' HB ' ' HB2' ' A' ' 94' ' ' LEU . 3.4 p . . . . . 0 C--N 1.322 -0.627 0 CA-C-N 115.381 -0.827 . . . . 75.109999999999999 111.685 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 . . . . . 0 N--CA 1.466 0.367 0 CA-C-O 120.728 0.299 . . . . 65.319999999999993 111.005 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 28.8 m -134.8 83.4 41.34 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-O 121.05 0.452 . . . . 60.32 110.669 178.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.635 ' HB2' ' HB2' ' A' ' 52' ' ' ASP . 18.4 Cg_endo -93.97 108.49 0.16 Allowed 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 123.491 2.794 . . . . 72.099999999999994 112.124 177.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.4 m -110.18 -78.65 0.59 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.386 -0.37 . . . . 71.450000000000003 111.049 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.46 -40.64 57.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.758 0.313 . . . . 71.230000000000004 111.405 -177.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.7 pp -68.37 -22.6 64.65 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.801 0.334 . . . . 73.420000000000002 110.358 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.635 ' HB2' ' HB2' ' A' ' 48' ' ' PRO . 7.7 t70 -61.68 -41.85 98.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.975 -0.557 . . . . 63.020000000000003 110.431 177.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 -68.18 -42.42 80.01 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.799 -0.637 . . . . 73.010000000000005 109.925 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -68.34 -50.12 55.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.62 -0.718 . . . . 74.25 111.567 -175.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.5 t -67.85 -17.86 64.63 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.787 0.327 . . . . 75.409999999999997 111.575 -175.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -75.94 -21.89 56.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.835 0.35 . . . . 51.200000000000003 110.935 -177.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -82.93 -19.26 37.57 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.52 0.676 . . . . 74.219999999999999 109.867 174.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.504 ' O ' HG13 ' A' ' 62' ' ' ILE . 19.5 mt -79.39 -25.86 12.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.165 -0.925 . . . . 75.030000000000001 110.489 -179.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -57.8 -28.62 64.19 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.705 -0.68 . . . . 51.229999999999997 111.701 -176.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.7 m -79.13 -35.38 42.23 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.39 -0.368 . . . . 73.340000000000003 111.49 -177.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.443 ' HG2' ' O ' ' A' ' 58' ' ' ILE . 11.3 pt20 -82.05 -6.31 59.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.897 0.379 . . . . 64.209999999999994 111.627 -174.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.504 HG13 ' O ' ' A' ' 58' ' ' ILE . 67.7 mt -70.82 -31.93 47.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.832 0.348 . . . . 75.120000000000005 110.641 -178.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.736 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 8.8 mp -59.4 -46.97 87.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 74.530000000000001 111.512 -177.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -57.48 -27.26 58.13 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 121.177 -0.535 . . . . 54.140000000000001 112.906 -178.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -92.7 -42.63 4.41 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.558 -0.83 . . . . 33.530000000000001 112.294 178.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.559 ' HA ' ' HB2' ' A' ' 69' ' ' ASN . 1.3 pp -64.44 -23.75 67.39 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 111.415 0.154 . . . . 72.230000000000004 111.415 -176.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.736 ' HG ' ' O ' ' A' ' 63' ' ' LEU . 80.7 mt -52.17 -46.27 65.44 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.058 0.456 . . . . 70.319999999999993 110.594 177.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.6 t -90.7 -4.91 56.39 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.101 -0.499 . . . . 75.109999999999999 110.485 -177.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.559 ' HB2' ' HA ' ' A' ' 66' ' ' LEU . 9.2 m120 -86.22 -21.43 27.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.061 0.457 . . . . 53.439999999999998 109.96 174.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.466 HG12 ' O ' ' A' ' 66' ' ' LEU . 51.4 mm . . . . . 0 C--N 1.325 -0.487 0 N-CA-C 108.593 -0.891 . . . . 71.409999999999997 108.593 168.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 54.4 ttp . . . . . 0 C--O 1.234 0.248 0 CA-C-O 121.176 0.513 . . . . 73.310000000000002 111.044 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 42.5 t -97.11 98.84 7.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.607 -0.724 . . . . 63.219999999999999 109.601 177.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.2 140.91 52.44 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.064 -0.516 . . . . 43.310000000000002 111.168 -178.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -75.94 60.0 1.33 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.213 0.53 . . . . 72.310000000000002 111.736 -177.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -170.75 -41.41 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.402 -0.817 . . . . 75.510000000000005 109.165 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -144.66 123.84 12.92 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.483 -0.78 . . . . 63.340000000000003 110.183 174.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.581 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 50.6 mm -92.32 109.11 21.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 109.1 -0.704 . . . . 71.040000000000006 109.1 173.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 43.9 t -108.42 96.39 4.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.983 0.42 . . . . 64.329999999999998 110.406 -178.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -107.68 114.34 28.24 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.962 -0.563 . . . . 74.510000000000005 110.049 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 56.3 mt -80.92 86.91 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.233 -0.654 . . . . 73.150000000000006 109.233 176.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -98.38 171.36 8.23 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.856 -0.611 . . . . 54.140000000000001 110.848 -176.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.527 ' HB2' HD13 ' A' ' 94' ' ' LEU . 51.9 t-20 -146.04 138.38 25.38 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.071 -1.085 . . . . 62.210000000000001 108.071 178.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.443 ' O ' ' HB3' ' A' ' 91' ' ' ASP . 14.9 ttp180 -123.15 110.36 15.18 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.032 -0.358 . . . . 75.439999999999998 110.032 177.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.443 ' HB3' ' O ' ' A' ' 90' ' ' ARG . 15.6 t70 75.15 -45.57 0.56 Allowed 'General case' 0 N--CA 1.471 0.582 0 O-C-N 123.773 0.67 . . . . 71.019999999999996 111.837 177.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -178.46 -27.97 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.882 -0.675 . . . . 75.319999999999993 112.35 -178.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.553 HE21 ' HA ' ' A' ' 93' ' ' GLN . 0.1 OUTLIER -93.1 125.08 37.52 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.055 0.455 . . . . 62.409999999999997 110.389 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.585 ' HB2' ' HB ' ' A' ' 111' ' ' VAL . 4.2 mm? -61.44 141.69 57.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.536 -0.756 . . . . 52.240000000000002 111.114 -178.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.511 HE21 ' HA ' ' A' ' 95' ' ' GLN . 0.0 OUTLIER -131.94 97.92 4.3 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.674 -0.693 . . . . 55.530000000000001 109.566 -178.523 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.472 ' HB3' ' HB ' ' A' ' 109' ' ' ILE . 69.4 tp -80.32 113.15 18.3 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.027 -0.533 . . . . 75.109999999999999 110.289 -177.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -106.11 113.1 26.44 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.227 -0.442 . . . . 43.409999999999997 110.777 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.581 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 46.4 t -110.82 117.35 54.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.531 -0.758 . . . . 72.019999999999996 110.33 175.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.546 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 25.7 m -94.28 101.1 13.06 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.519 -0.764 . . . . 64.319999999999993 110.25 176.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.532 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 29.4 t70 -67.79 130.36 42.74 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.686 -0.688 . . . . 63.399999999999999 109.949 177.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 42.1 ttt180 -98.7 -22.93 15.65 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.915 0.388 . . . . 70.420000000000002 110.891 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -68.23 -45.44 73.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.082 -0.508 . . . . 73.140000000000001 111.157 -173.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.415 ' OG1' ' HG3' ' A' ' 105' ' ' GLN . 77.6 p -123.4 -32.86 3.34 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.303 0.573 . . . . 72.120000000000005 110.369 177.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.532 ' HA2' ' O ' ' A' ' 100' ' ' ASP . . . 103.19 30.04 5.52 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.493 -0.776 . . . . 65.239999999999995 112.435 178.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.416 ' N ' ' HB3' ' A' ' 100' ' ' ASP . 47.8 mt-30 -72.95 105.36 4.4 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.179 -0.304 . . . . 72.040000000000006 110.179 176.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 33.5 m -67.77 101.35 1.04 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.083 0.468 . . . . 61.32 110.058 176.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.519 ' HB2' ' HB ' ' A' ' 98' ' ' VAL . 23.5 m -99.77 96.38 7.56 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.012 -0.54 . . . . 71.150000000000006 110.619 -177.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 24.6 m -104.46 99.72 9.42 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.256 0.55 . . . . 61.340000000000003 110.007 176.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.472 ' HB ' ' HB3' ' A' ' 96' ' ' LEU . 4.0 mp -90.67 121.51 41.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.767 -0.651 . . . . 73.010000000000005 110.531 -176.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -82.67 110.25 17.56 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.556 -0.535 . . . . 61.100000000000001 109.556 176.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.585 ' HB ' ' HB2' ' A' ' 94' ' ' LEU . 51.0 t . . . . . 0 C--N 1.324 -0.53 0 CA-C-N 116.514 -0.312 . . . . 75.109999999999999 110.281 -177.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 . . . . . 0 N--CA 1.456 -0.172 0 CA-C-O 121.721 0.772 . . . . 65.319999999999993 109.375 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 21.6 m -114.97 86.52 13.62 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.162 -0.926 . . . . 60.32 109.909 178.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.682 ' HB2' ' HB2' ' A' ' 52' ' ' ASP . 48.5 Cg_endo -70.68 83.65 0.85 Allowed 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.24 1.96 . . . . 72.099999999999994 112.69 -177.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.6 m -96.57 -54.99 3.06 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.754 -0.657 . . . . 71.450000000000003 109.913 173.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -100.78 -27.92 13.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.99 0.424 . . . . 71.230000000000004 111.109 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.511 HD23 ' H ' ' A' ' 51' ' ' LEU . 0.8 OUTLIER -87.15 -3.03 59.04 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.997 -0.547 . . . . 73.420000000000002 111.591 -176.609 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.682 ' HB2' ' HB2' ' A' ' 48' ' ' PRO . 17.2 t70 -62.59 -69.23 0.27 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.51 -0.314 . . . . 63.020000000000003 111.589 -176.098 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -66.09 -23.91 66.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.269 0.557 . . . . 73.010000000000005 110.155 177.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.559 ' O ' HG13 ' A' ' 58' ' ' ILE . 85.3 t80 -61.56 -53.42 56.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.583 -0.735 . . . . 74.25 110.817 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.428 ' O ' ' HG3' ' A' ' 59' ' ' GLN . 9.8 t -69.12 -21.42 64.03 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.133 0.492 . . . . 75.409999999999997 110.873 -177.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -73.42 -39.65 64.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.242 0.544 . . . . 51.200000000000003 109.915 178.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.64 -29.36 69.37 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.646 -0.706 . . . . 74.219999999999999 109.998 175.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.58 ' HA ' ' HG2' ' A' ' 61' ' ' GLN . 15.8 mt -64.07 -39.29 84.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.879 -0.6 . . . . 75.030000000000001 110.44 176.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.428 ' HG3' ' O ' ' A' ' 55' ' ' THR . 73.0 mt-30 -58.1 -42.29 85.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.279 -0.419 . . . . 51.229999999999997 110.438 178.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.5 m -61.16 -45.31 95.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.078 -0.51 . . . . 73.340000000000003 110.584 177.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.671 ' O ' ' HA3' ' A' ' 65' ' ' GLY . 3.1 pt20 -80.81 7.74 9.75 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.824 -0.625 . . . . 64.209999999999994 110.85 -176.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.517 HG13 ' O ' ' A' ' 58' ' ' ILE . 83.2 mt -100.8 -55.84 5.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.954 -0.758 . . . . 75.120000000000005 108.954 168.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 89.6 mt -59.04 -41.42 87.81 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.613 -0.721 . . . . 74.530000000000001 111.049 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -108.85 -0.66 32.05 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.713 -0.756 . . . . 54.140000000000001 112.199 178.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.671 ' HA3' ' O ' ' A' ' 61' ' ' GLN . . . -85.44 -22.12 52.08 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.847 -0.692 . . . . 33.530000000000001 112.492 -176.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 62' ' ' ILE . 90.8 mt -60.08 -30.54 69.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.014 0.435 . . . . 72.230000000000004 109.985 176.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 70.3 mt -67.36 -33.07 74.46 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.483 -0.78 . . . . 70.319999999999993 110.682 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 9.2 m -73.27 -32.22 64.54 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.047 -0.524 . . . . 75.109999999999999 110.388 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -91.34 10.99 25.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.027 -0.533 . . . . 53.439999999999998 111.622 -177.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 36.1 mm . . . . . 0 C--N 1.331 -0.23 0 CA-C-O 121.158 0.504 . . . . 71.409999999999997 109.964 174.581 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.825 ' HB3' HG13 ' A' ' 85' ' ' VAL . 48.9 ttm . . . . . 0 N--CA 1.452 -0.364 0 N-CA-C 109.865 -0.42 . . . . 73.310000000000002 109.865 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 59.9 t -87.79 111.31 21.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.041 -0.527 . . . . 63.219999999999999 110.552 -177.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.663 HG22 ' H ' ' A' ' 82' ' ' ASP . 24.5 m -130.67 138.95 50.29 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.902 -0.59 . . . . 43.310000000000002 109.819 178.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -67.69 -23.32 65.28 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.946 0.403 . . . . 72.310000000000002 111.132 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.663 ' H ' HG22 ' A' ' 80' ' ' THR . 25.0 m-20 -97.66 -19.14 18.46 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.177 -0.465 . . . . 75.510000000000005 111.462 -177.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -144.38 136.8 26.58 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.5 0.556 . . . . 63.340000000000003 112.5 -171.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.593 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 4.1 mp -98.23 105.68 17.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 108.172 -1.048 . . . . 71.040000000000006 108.172 169.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.825 HG13 ' HB3' ' A' ' 78' ' ' MET . 5.6 p -135.98 135.66 50.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.258 0.551 . . . . 64.329999999999998 111.75 -174.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -128.43 143.49 51.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.473 -0.785 . . . . 74.510000000000005 109.18 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.41 HD12 ' N ' ' A' ' 87' ' ' ILE . 4.3 mp -95.85 86.63 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.355 -0.609 . . . . 73.150000000000006 109.355 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -105.26 128.12 53.28 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.784 -0.644 . . . . 54.140000000000001 111.223 -175.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -84.36 115.81 22.71 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.037 -0.727 . . . . 62.210000000000001 109.037 174.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -130.99 132.51 45.06 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.949 -0.389 . . . . 75.439999999999998 109.949 177.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.9 t70 68.11 11.15 8.24 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 124.036 0.835 . . . . 71.019999999999996 110.574 179.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 97.59 -0.08 59.49 Favored Glycine 0 N--CA 1.452 -0.248 0 CA-C-N 115.675 -0.693 . . . . 75.319999999999993 112.402 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.546 HE21 ' HA ' ' A' ' 93' ' ' GLN . 0.0 OUTLIER -114.29 134.41 54.97 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.752 0.31 . . . . 62.409999999999997 110.423 179.171 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.4 HD13 ' HA ' ' A' ' 94' ' ' LEU . 4.0 mm? -67.0 108.9 2.77 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.117 -0.697 . . . . 52.240000000000002 109.117 173.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.409 HE21 ' HB2' ' A' ' 95' ' ' GLN . 6.1 tt0 -105.57 110.41 22.73 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.74 -0.664 . . . . 55.530000000000001 110.538 -173.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 17.3 tp -88.24 94.08 9.71 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.865 -0.607 . . . . 75.109999999999999 109.75 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -85.83 102.55 13.78 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.195 -0.457 . . . . 43.409999999999997 110.499 -179.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 24.6 t -94.39 123.56 46.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.057 0.456 . . . . 72.019999999999996 111.119 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.593 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 32.1 m -111.61 107.99 17.32 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.155 -0.475 . . . . 64.319999999999993 110.12 174.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.502 ' HB3' ' H ' ' A' ' 105' ' ' GLN . 15.3 t70 -65.99 131.1 45.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.776 -0.647 . . . . 63.399999999999999 110.3 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.557 ' HA ' ' NE ' ' A' ' 101' ' ' ARG . 2.8 tpm_? -107.88 17.72 22.14 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.609 0.718 . . . . 70.420000000000002 110.796 -177.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.5 mtpm? -107.11 -66.78 0.99 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.855 0.836 . . . . 73.140000000000001 109.039 175.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.2 m -91.3 -40.59 11.41 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 114.175 -1.375 . . . . 72.120000000000005 109.211 -178.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 98.11 82.98 1.69 Allowed Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.514 -0.767 . . . . 65.239999999999995 113.02 177.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.502 ' H ' ' HB3' ' A' ' 100' ' ' ASP . 54.5 mt-30 -143.15 142.31 31.43 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.099 -0.704 . . . . 72.040000000000006 109.099 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.9 m -105.06 85.6 2.3 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.48 0.657 . . . . 61.32 110.221 178.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.32 119.74 26.03 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.483 -0.78 . . . . 71.150000000000006 109.957 178.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 37.5 m -105.71 107.44 18.44 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.015 0.436 . . . . 61.340000000000003 111.291 -176.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.401 ' N ' HD12 ' A' ' 109' ' ' ILE . 4.5 mp -102.57 97.83 6.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.144 -0.48 . . . . 73.010000000000005 109.843 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -79.86 123.74 28.02 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.016 -0.735 . . . . 61.100000000000001 109.016 177.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.7 t . . . . . 0 C--N 1.325 -0.461 0 CA-C-O 121.181 0.515 . . . . 75.109999999999999 111.072 -175.718 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 . . . . . 0 CA--C 1.526 0.044 0 CA-C-O 121.864 0.84 . . . . 65.319999999999993 109.732 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 4.8 t -138.25 87.22 16.13 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 114.923 -1.035 . . . . 60.32 109.443 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.633 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 59.2 Cg_endo -70.93 83.78 0.88 Allowed 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.626 2.217 . . . . 72.099999999999994 113.244 -173.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 21.0 m -93.75 -68.0 0.82 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.037 -0.529 . . . . 71.450000000000003 110.297 174.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -107.69 -3.97 18.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.195 0.521 . . . . 71.230000000000004 111.061 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.474 HD23 ' H ' ' A' ' 51' ' ' LEU . 1.1 pt? -108.09 7.89 27.89 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.947 -0.57 . . . . 73.420000000000002 110.139 -178.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.633 ' HB3' ' HB2' ' A' ' 48' ' ' PRO . 19.4 p-10 -68.65 -52.8 27.26 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.7 -0.682 . . . . 63.020000000000003 111.246 -174.145 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -65.98 -29.21 69.56 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.985 0.422 . . . . 73.010000000000005 110.43 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.519 ' O ' HG13 ' A' ' 58' ' ' ILE . 70.7 t80 -66.36 -62.93 1.21 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.726 -0.67 . . . . 74.25 110.899 -178.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.1 t -66.89 -21.48 66.0 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.01 0.433 . . . . 75.409999999999997 110.933 -176.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.51 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 3.9 tp-100 -68.98 -43.36 75.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.253 0.549 . . . . 51.200000000000003 109.809 -179.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.52 -32.57 74.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.464 -0.789 . . . . 74.219999999999999 110.266 178.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.579 ' O ' HG13 ' A' ' 62' ' ' ILE . 19.6 mt -63.34 -39.88 86.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.901 -0.59 . . . . 75.030000000000001 110.644 178.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -64.48 -25.0 67.81 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.254 -0.43 . . . . 51.229999999999997 111.057 178.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.2 t -89.7 -38.88 13.54 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.308 -0.406 . . . . 73.340000000000003 110.748 -178.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.503 ' HG2' ' HA ' ' A' ' 58' ' ' ILE . 3.6 pt20 -66.91 -13.2 61.48 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.91 0.386 . . . . 64.209999999999994 110.878 -177.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.579 HG13 ' O ' ' A' ' 58' ' ' ILE . 76.8 mt -62.53 -33.68 60.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.565 -0.531 . . . . 75.120000000000005 109.565 175.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.0 mp -68.09 -28.93 67.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.224 -0.898 . . . . 74.530000000000001 110.586 -179.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -62.88 -47.51 88.3 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 111.414 -0.674 . . . . 54.140000000000001 111.414 178.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -72.76 -35.07 58.94 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.854 -0.689 . . . . 33.530000000000001 111.711 177.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.416 ' C ' ' H ' ' A' ' 68' ' ' SER . 47.1 tp -60.85 -49.41 77.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.018 0.437 . . . . 72.230000000000004 110.178 177.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 98.8 mt -79.74 32.28 0.25 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.184 0.516 . . . . 70.319999999999993 110.64 178.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.416 ' H ' ' C ' ' A' ' 66' ' ' LEU . 61.5 m -135.75 -50.94 0.73 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.436 -0.802 . . . . 75.109999999999999 109.592 174.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -69.67 -26.6 64.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.016 -0.538 . . . . 53.439999999999998 111.632 -178.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 50.8 mm . . . . . 0 C--N 1.327 -0.412 0 CA-C-O 121.093 0.473 . . . . 71.409999999999997 110.573 -178.246 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 50.5 ttm . . . . . 0 C--O 1.233 0.222 0 N-CA-C 110.212 -0.292 . . . . 73.310000000000002 110.212 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.0 p -73.98 125.27 32.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.204 0.526 . . . . 63.219999999999999 110.779 -179.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.786 ' HB ' ' O ' ' A' ' 83' ' ' TYR . 17.0 m -138.85 152.59 47.95 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.518 -0.919 . . . . 43.310000000000002 108.518 177.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -65.46 -60.04 3.37 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.656 0.613 . . . . 72.310000000000002 112.656 -170.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -101.39 2.57 39.62 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.446 0.641 . . . . 75.510000000000005 111.419 -171.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.786 ' O ' ' HB ' ' A' ' 80' ' ' THR . 60.6 m-85 -146.03 116.31 7.48 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.927 -0.579 . . . . 63.340000000000003 110.105 178.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.645 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 3.8 mp -84.68 104.06 12.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.946 -0.761 . . . . 71.040000000000006 108.946 175.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 73.5 t -94.73 111.97 26.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.729 -0.669 . . . . 64.329999999999998 111.201 -174.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -111.05 100.58 9.23 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.005 0.431 . . . . 74.510000000000005 110.448 175.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 58.1 mt -89.49 97.22 6.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.431 -0.581 . . . . 73.150000000000006 109.431 176.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -104.58 130.05 52.61 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.062 -0.517 . . . . 54.140000000000001 111.599 -174.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.422 ' HA ' ' O ' ' A' ' 93' ' ' GLN . 26.4 t-20 -108.53 87.36 2.48 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.342 -0.614 . . . . 62.210000000000001 109.342 171.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.408 ' O ' ' HB3' ' A' ' 91' ' ' ASP . 10.3 ttp180 -106.68 146.14 31.13 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.511 -0.922 . . . . 75.439999999999998 108.511 177.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.408 ' HB3' ' O ' ' A' ' 90' ' ' ARG . 24.9 t70 69.13 -70.49 0.14 Allowed 'General case' 0 N--CA 1.469 0.488 0 O-C-N 123.732 0.645 . . . . 71.019999999999996 110.53 -176.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 179.18 22.04 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 121.005 -0.617 . . . . 75.319999999999993 112.341 176.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.522 ' HA ' HE21 ' A' ' 93' ' ' GLN . 0.1 OUTLIER -126.27 141.59 51.86 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 122.676 -0.308 . . . . 62.409999999999997 110.574 -175.864 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -81.41 109.96 16.39 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.192 -0.67 . . . . 52.240000000000002 109.192 173.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.443 HE21 ' HB2' ' A' ' 95' ' ' GLN . 6.0 tt0 -113.73 110.71 20.61 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.119 0.485 . . . . 55.530000000000001 110.666 -177.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.46 ' HB3' ' O ' ' A' ' 109' ' ' ILE . 59.6 tp -85.71 97.02 9.9 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.557 -0.747 . . . . 75.109999999999999 110.206 179.062 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.6 m-20 -95.53 100.36 12.12 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.074 -0.512 . . . . 43.409999999999997 110.113 177.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 50.7 t -94.96 111.59 25.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.817 -0.629 . . . . 72.019999999999996 110.364 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.645 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 22.8 m -89.94 103.35 16.02 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.873 -0.603 . . . . 64.319999999999993 109.665 175.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.595 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 9.8 t70 -58.72 147.64 32.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.096 -0.502 . . . . 63.399999999999999 110.842 178.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.401 ' HD2' ' HA ' ' A' ' 101' ' ' ARG . 23.5 tpt180 -113.6 -9.02 13.28 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.856 0.36 . . . . 70.420000000000002 111.314 -177.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm -78.87 -49.81 12.27 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.005 0.431 . . . . 73.140000000000001 110.806 177.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 36.5 p -113.23 -35.62 5.28 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.747 -0.661 . . . . 72.120000000000005 109.952 176.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.595 ' HA2' ' O ' ' A' ' 100' ' ' ASP . . . 91.57 81.11 1.42 Allowed Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.461 -0.79 . . . . 65.239999999999995 112.242 178.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.537 ' H ' ' HB3' ' A' ' 100' ' ' ASP . 49.6 mt-30 -137.47 139.98 40.93 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.253 -0.647 . . . . 72.040000000000006 109.253 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.9 t -84.38 95.45 8.75 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.585 0.707 . . . . 61.32 111.089 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 59.4 m -84.22 102.98 13.03 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.854 -0.612 . . . . 71.150000000000006 109.933 176.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 23.8 m -92.15 109.85 21.22 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.289 -0.414 . . . . 61.340000000000003 110.857 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.46 ' O ' ' HB3' ' A' ' 96' ' ' LEU . 4.9 mp -117.2 97.91 6.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.947 0.404 . . . . 73.010000000000005 109.94 175.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -74.74 153.25 38.91 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.453 -0.339 . . . . 61.100000000000001 110.92 178.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 8.4 p . . . . . 0 C--N 1.323 -0.579 0 CA-C-N 115.608 -0.724 . . . . 75.109999999999999 110.461 177.305 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 . . . . . 0 N--CA 1.467 0.407 0 CA-C-O 120.691 0.281 . . . . 65.319999999999993 111.546 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.0 m -124.53 87.9 53.89 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.386 -0.37 . . . . 60.32 110.726 -175.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -69.97 120.83 7.51 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 123.134 2.556 . . . . 72.099999999999994 112.658 -176.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 52.0 m -97.51 -86.15 0.35 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.352 -0.385 . . . . 71.450000000000003 111.409 177.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.91 12.83 28.9 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.046 0.451 . . . . 71.230000000000004 111.623 -176.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.4 pp -119.01 1.9 11.46 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.276 -0.42 . . . . 73.420000000000002 110.572 179.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -63.45 -60.3 3.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.63 -0.714 . . . . 63.020000000000003 111.538 -174.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.436 ' HA ' ' HB2' ' A' ' 56' ' ' GLN . 7.7 p30 -78.15 -13.75 59.74 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.921 -0.582 . . . . 73.010000000000005 110.906 -175.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.551 ' O ' HG13 ' A' ' 58' ' ' ILE . 83.9 t80 -66.55 -58.39 5.3 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.234 -0.439 . . . . 74.25 110.095 176.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.7 t -74.3 -12.29 60.5 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.186 0.517 . . . . 75.409999999999997 110.419 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.436 ' HB2' ' HA ' ' A' ' 53' ' ' ASN . 2.1 tp-100 -70.63 -47.75 58.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.759 -0.655 . . . . 51.200000000000003 109.643 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.23 -28.24 67.07 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.728 -0.669 . . . . 74.219999999999999 110.894 179.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.56 ' O ' HG13 ' A' ' 62' ' ' ILE . 26.6 mt -63.09 -39.52 85.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.163 -0.471 . . . . 75.030000000000001 110.649 179.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -64.31 -31.04 72.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.151 -0.477 . . . . 51.229999999999997 110.658 179.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.1 m -81.04 -41.52 22.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.146 -0.479 . . . . 73.340000000000003 111.339 -178.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.521 ' HG2' ' HA ' ' A' ' 58' ' ' ILE . 4.1 pt20 -66.78 -19.0 65.66 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.518 -0.31 . . . . 64.209999999999994 111.49 -176.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.56 HG13 ' O ' ' A' ' 58' ' ' ILE . 86.5 mt -62.23 -47.42 93.18 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 N-CA-C 109.31 -0.626 . . . . 75.120000000000005 109.31 175.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.0 mp -64.39 -43.21 95.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.451 -0.795 . . . . 74.530000000000001 110.498 178.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -57.5 -44.68 93.65 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 121.226 -0.512 . . . . 54.140000000000001 112.578 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -75.21 -44.15 23.68 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.682 -0.77 . . . . 33.530000000000001 112.453 178.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.604 ' O ' HG12 ' A' ' 70' ' ' ILE . 57.0 tp -58.72 -50.35 74.21 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 122.313 0.245 . . . . 72.230000000000004 111.297 -177.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 85.5 mt -63.34 -17.65 62.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.445 -0.343 . . . . 70.319999999999993 111.912 -176.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.1 t -78.27 -45.77 21.96 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.76 -0.459 . . . . 75.109999999999999 109.76 178.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -78.5 -11.49 59.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.046 -0.525 . . . . 53.439999999999998 111.149 -176.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.604 HG12 ' O ' ' A' ' 66' ' ' LEU . 27.4 mm . . . . . 0 C--N 1.328 -0.35 0 CA-C-O 120.725 0.298 . . . . 71.409999999999997 110.478 176.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.588 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 28.0 ttt . . . . . 0 N--CA 1.45 -0.439 0 N-CA-C 109.78 -0.452 . . . . 73.310000000000002 109.78 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 19.1 t -86.53 76.12 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.397 0.618 . . . . 63.219999999999999 110.267 -176.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.0 -175.44 5.4 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.728 -0.669 . . . . 43.310000000000002 110.089 179.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -79.67 -43.81 22.06 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.663 0.268 . . . . 72.310000000000002 110.772 -177.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.559 ' O ' ' HB2' ' A' ' 101' ' ' ARG . 8.2 t0 -101.6 -76.52 0.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.657 -0.497 . . . . 75.510000000000005 109.657 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.507 ' HB3' HG13 ' A' ' 98' ' ' VAL . 17.0 m-85 -79.38 115.4 19.0 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.407 -0.361 . . . . 63.340000000000003 111.048 -174.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.464 HD12 ' HB ' ' A' ' 99' ' ' THR . 0.9 OUTLIER -83.83 103.38 11.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.595 0.712 . . . . 71.040000000000006 109.197 170.843 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.588 ' HB ' ' HB3' ' A' ' 78' ' ' MET . 37.6 t -94.3 139.65 18.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.639 -0.709 . . . . 64.329999999999998 111.195 -169.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -108.73 105.07 14.49 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.573 -0.528 . . . . 74.510000000000005 109.573 174.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 74.4 mt -78.72 113.69 18.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.287 -0.415 . . . . 73.150000000000006 109.968 178.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -107.8 109.57 21.16 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.184 -0.462 . . . . 54.140000000000001 111.128 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.564 ' HA ' ' O ' ' A' ' 93' ' ' GLN . 3.5 t-20 -111.44 83.01 1.7 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.202 0.525 . . . . 62.210000000000001 109.726 174.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 90' ' ' ARG . 30.2 ttp180 -105.27 121.07 43.1 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.959 -0.564 . . . . 75.439999999999998 109.744 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.4 t70 69.04 -83.11 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.369 -0.832 . . . . 71.019999999999996 111.207 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -144.14 12.13 2.08 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.63 -0.795 . . . . 75.319999999999993 112.583 -178.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.564 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -103.24 126.73 50.55 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.769 0.319 . . . . 62.409999999999997 111.461 -179.094 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 94' ' ' LEU . 4.3 mm? -96.36 98.22 10.09 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.909 -0.774 . . . . 52.240000000000002 108.909 168.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.44 HE21 ' HB2' ' A' ' 95' ' ' GLN . 4.6 tt0 -112.36 126.62 55.47 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.213 -0.449 . . . . 55.530000000000001 110.396 -175.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 13.6 tp -103.69 100.8 10.63 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.135 -0.484 . . . . 75.109999999999999 110.196 -176.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -88.96 97.83 11.41 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.175 -0.466 . . . . 43.409999999999997 111.045 -177.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.507 HG13 ' HB3' ' A' ' 83' ' ' TYR . 39.0 t -90.32 115.2 29.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.869 -0.605 . . . . 72.019999999999996 110.841 -179.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.464 ' HB ' HD12 ' A' ' 84' ' ' ILE . 47.6 m -104.6 114.79 29.23 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.673 -0.694 . . . . 64.319999999999993 109.964 175.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.506 ' HA ' ' HD1' ' A' ' 83' ' ' TYR . 26.0 t70 -60.79 141.97 56.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.97 -0.559 . . . . 63.399999999999999 111.105 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.559 ' HB2' ' O ' ' A' ' 82' ' ' ASP . 10.0 tpt180 -88.55 -10.94 47.13 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.151 -0.477 . . . . 70.420000000000002 111.367 -174.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm -107.62 -67.71 0.94 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.74 0.305 . . . . 73.140000000000001 111.622 -171.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 45.8 p -85.62 -33.09 21.73 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.271 0.558 . . . . 72.120000000000005 109.997 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 99.6 23.55 10.89 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.279 -0.873 . . . . 65.239999999999995 112.644 177.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.445 ' N ' ' HB3' ' A' ' 100' ' ' ASP . 98.2 mt-30 -59.58 130.68 48.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.725 0.298 . . . . 72.040000000000006 110.737 175.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.2 p -102.89 88.4 3.17 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.172 0.51 . . . . 61.32 110.398 176.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 9.7 t -91.21 105.65 17.95 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.766 -0.652 . . . . 71.150000000000006 109.489 -178.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.5 m -91.24 107.8 19.45 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.986 -0.552 . . . . 61.340000000000003 110.388 -178.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 59.5 mt -110.01 116.0 51.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.416 -0.356 . . . . 73.010000000000005 110.882 -175.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -71.71 168.2 18.26 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.003 0.43 . . . . 61.100000000000001 111.207 175.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.7 p . . . . . 0 C--N 1.325 -0.5 0 CA-C-N 115.748 -0.66 . . . . 75.109999999999999 111.306 -179.338 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 . . . . . 0 N--CA 1.455 -0.186 0 CA-C-O 121.011 0.434 . . . . 65.319999999999993 110.28 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 25.8 m -151.11 86.02 4.93 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 116.006 -0.543 . . . . 60.32 109.688 174.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.643 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 28.2 Cg_endo -62.16 110.58 1.05 Allowed 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 122.826 2.351 . . . . 72.099999999999994 112.29 -178.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 26.7 m -123.69 -25.54 4.3 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.005 -0.543 . . . . 71.450000000000003 110.415 177.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.3 -37.33 0.31 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 71.230000000000004 111.374 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.2 pp -73.09 -12.6 60.97 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.536 -0.302 . . . . 73.420000000000002 111.409 -176.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.643 ' HB3' ' HB2' ' A' ' 48' ' ' PRO . 4.3 p-10 -63.63 -56.59 14.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.289 -0.414 . . . . 63.020000000000003 110.864 -178.317 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -64.61 -28.76 69.84 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.229 0.538 . . . . 73.010000000000005 110.108 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.444 ' O ' HG13 ' A' ' 58' ' ' ILE . 77.6 t80 -66.26 -49.86 65.71 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.414 -0.812 . . . . 74.25 111.028 179.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.445 ' O ' ' HG3' ' A' ' 59' ' ' GLN . 8.9 t -72.46 -19.48 61.55 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.708 0.262 . . . . 75.409999999999997 111.708 -176.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.438 ' HG3' ' O ' ' A' ' 52' ' ' ASP . 60.9 mt-30 -64.39 -43.69 93.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.895 0.378 . . . . 51.200000000000003 111.096 -178.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.72 -24.89 61.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.337 -0.392 . . . . 74.219999999999999 111.422 -178.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.444 HG13 ' O ' ' A' ' 54' ' ' PHE . 8.6 mt -76.35 -18.67 15.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.107 0.479 . . . . 75.030000000000001 110.974 -176.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.445 ' HG3' ' O ' ' A' ' 55' ' ' THR . 77.4 mt-30 -67.21 -19.16 65.51 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.374 -0.375 . . . . 51.229999999999997 110.98 -178.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 61.0 m -74.87 -34.8 62.29 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.53 -0.304 . . . . 73.340000000000003 111.484 178.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.436 ' HG2' ' O ' ' A' ' 58' ' ' ILE . 11.1 pt20 -82.2 -5.58 58.6 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.862 0.363 . . . . 64.209999999999994 110.966 -177.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.554 HG23 ' HA3' ' A' ' 92' ' ' GLY . 67.7 mt -65.34 -36.02 76.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.284 0.564 . . . . 75.120000000000005 109.799 175.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 9.2 mp -63.47 -35.7 81.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.414 -0.812 . . . . 74.530000000000001 110.622 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -65.7 -40.68 95.92 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.285 -0.726 . . . . 54.140000000000001 111.285 175.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -66.33 -19.56 68.62 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 121.147 -0.549 . . . . 33.530000000000001 112.385 177.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 62' ' ' ILE . 85.5 mt -74.44 -31.9 62.43 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.046 0.45 . . . . 72.230000000000004 110.168 176.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 49.0 mt -74.83 -42.58 57.73 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.996 -0.742 . . . . 70.319999999999993 108.996 175.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.8 m -75.52 5.83 5.45 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.107 -0.951 . . . . 75.109999999999999 111.246 178.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.956 ' HA ' ' HG3' ' A' ' 90' ' ' ARG . 50.6 t30 -82.43 -25.86 33.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.195 -0.457 . . . . 53.439999999999998 110.997 -178.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.0 mp . . . . . 0 C--N 1.324 -0.531 0 CA-C-N 116.204 -0.453 . . . . 71.409999999999997 110.997 -175.812 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.761 ' HB3' HG13 ' A' ' 85' ' ' VAL . 47.9 ttm . . . . . 0 N--CA 1.451 -0.424 0 N-CA-C 108.897 -0.779 . . . . 73.310000000000002 108.897 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.4 p -88.53 98.31 7.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.867 0.842 . . . . 63.219999999999999 111.827 -173.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.7 p -122.77 156.93 33.47 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.209 -0.905 . . . . 43.310000000000002 109.451 171.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -78.28 -41.18 34.72 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.811 0.338 . . . . 72.310000000000002 111.368 -175.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.713 ' HB3' ' HD3' ' A' ' 102' ' ' LYS . 7.5 m-20 -81.45 -21.68 38.64 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.174 -0.466 . . . . 75.510000000000005 111.282 -174.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -137.49 135.89 37.2 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.978 0.418 . . . . 63.340000000000003 111.363 -177.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.669 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 4.1 mp -105.93 84.94 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 108.407 -0.96 . . . . 71.040000000000006 108.407 172.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.761 HG13 ' HB3' ' A' ' 78' ' ' MET . 2.3 p -91.18 106.8 17.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.642 0.734 . . . . 64.329999999999998 110.455 -177.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -111.51 128.0 55.88 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.316 -0.856 . . . . 74.510000000000005 110.32 -175.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.51 HG12 HD13 ' A' ' 96' ' ' LEU . 19.4 mt -95.86 103.73 15.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.278 -0.419 . . . . 73.150000000000006 110.375 -177.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -88.56 146.76 24.96 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.899 0.381 . . . . 54.140000000000001 111.009 -178.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -139.53 110.3 6.76 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.107 -0.497 . . . . 62.210000000000001 109.764 178.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.956 ' HG3' ' HA ' ' A' ' 69' ' ' ASN . 66.8 ttt180 -147.12 141.44 26.31 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.024 -0.535 . . . . 75.439999999999998 109.565 179.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.2 t70 71.71 2.94 4.48 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.449 0.642 . . . . 71.019999999999996 110.452 177.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.554 ' HA3' HG23 ' A' ' 62' ' ' ILE . . . 97.13 -8.62 65.07 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 111.183 -0.767 . . . . 75.319999999999993 111.183 -176.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.403 HE21 ' HA ' ' A' ' 93' ' ' GLN . 0.0 OUTLIER -90.07 135.33 33.72 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.875 0.369 . . . . 62.409999999999997 110.346 179.324 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 94' ' ' LEU . 4.4 mm? -91.97 131.51 37.22 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.408 -0.59 . . . . 52.240000000000002 109.408 173.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.414 ' HG2' ' ND2' ' A' ' 97' ' ' ASN . 6.2 tt0 -133.48 108.1 8.44 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.0 -0.545 . . . . 55.530000000000001 110.468 -178.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.588 ' HB3' ' HB ' ' A' ' 109' ' ' ILE . 44.2 tp -88.83 111.16 21.71 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.757 -0.656 . . . . 75.109999999999999 110.295 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.414 ' ND2' ' HG2' ' A' ' 95' ' ' GLN . 48.7 m-80 -104.56 107.41 18.34 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.881 0.372 . . . . 43.409999999999997 110.63 178.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.6 t -87.02 107.18 16.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.983 -0.553 . . . . 72.019999999999996 110.137 176.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.669 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 28.0 m -89.84 104.1 16.7 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 115.667 -0.697 . . . . 64.319999999999993 109.524 177.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.609 ' HB3' ' N ' ' A' ' 105' ' ' GLN . 32.3 t70 -71.11 127.39 32.43 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.335 -0.848 . . . . 63.399999999999999 110.865 -177.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.413 ' HA ' ' NE ' ' A' ' 101' ' ' ARG . 5.1 tpm_? -99.28 1.94 45.08 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.462 0.648 . . . . 70.420000000000002 110.166 -178.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.713 ' HD3' ' HB3' ' A' ' 82' ' ' ASP . 25.3 mmmt -89.45 -57.08 3.01 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.054 -0.521 . . . . 73.140000000000001 110.421 -178.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 64.2 p -115.08 -31.35 6.07 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.453 0.644 . . . . 72.120000000000005 110.258 178.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.43 ' HA2' ' O ' ' A' ' 100' ' ' ASP . . . 110.01 29.88 3.63 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 115.414 -0.812 . . . . 65.239999999999995 112.378 178.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.609 ' N ' ' HB3' ' A' ' 100' ' ' ASP . 84.1 mm-40 -64.04 160.71 17.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.108 0.48 . . . . 72.040000000000006 110.17 171.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 27.1 m -140.81 87.46 2.11 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.244 -0.65 . . . . 61.32 109.244 174.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.4 t -85.2 114.73 22.53 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.406 -0.815 . . . . 71.150000000000006 109.567 -178.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 19.5 m -102.18 114.79 29.25 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.065 -0.516 . . . . 61.340000000000003 110.72 -178.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.588 ' HB ' ' HB3' ' A' ' 96' ' ' LEU . 4.4 mp -105.97 96.6 4.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.048 -0.523 . . . . 73.010000000000005 109.767 177.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -93.54 142.72 27.02 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.193 -0.458 . . . . 61.100000000000001 109.88 178.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 92.6 t . . . . . 0 C--N 1.325 -0.483 0 N-CA-C 110.189 -0.3 . . . . 75.109999999999999 110.189 176.575 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 . . . . . 0 C--O 1.234 0.258 0 CA-C-O 121.386 0.612 . . . . 65.319999999999993 109.869 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.425 HG23 ' O ' ' A' ' 47' ' ' THR . 9.9 t -120.59 88.04 42.51 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.19 -0.914 . . . . 60.32 109.877 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -67.6 93.52 0.37 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.306 2.671 . . . . 72.099999999999994 113.725 -172.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 72.8 m -105.61 -69.75 0.81 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.089 -0.505 . . . . 71.450000000000003 110.607 172.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.39 -38.35 90.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.873 0.368 . . . . 71.230000000000004 111.922 -178.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.426 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 3.2 pp -95.4 12.06 30.6 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.166 -0.47 . . . . 73.420000000000002 111.67 -175.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' ' 56' ' ' GLN . 15.9 t70 -57.41 -42.87 83.14 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.939 0.399 . . . . 63.020000000000003 111.121 -178.165 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -89.09 15.88 8.03 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.172 -0.467 . . . . 73.010000000000005 111.2 -177.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.765 ' HE1' ' HG2' ' A' ' 105' ' ' GLN . 67.6 t80 -122.97 -64.8 1.15 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.231 -0.44 . . . . 74.25 110.527 -179.333 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.1 m -66.64 -28.08 68.19 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.323 -0.399 . . . . 75.409999999999997 111.586 -175.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.471 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 2.0 mp0 -69.45 -29.62 67.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.829 0.347 . . . . 51.200000000000003 110.835 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.61 -26.1 60.63 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.286 0.565 . . . . 74.219999999999999 110.116 176.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.401 ' O ' HG13 ' A' ' 62' ' ' ILE . 12.1 mt -71.32 -25.47 25.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.458 -0.792 . . . . 75.030000000000001 110.591 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -55.11 -34.14 63.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.605 -0.27 . . . . 51.229999999999997 110.861 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 36.0 t -62.56 -48.92 77.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.184 -0.462 . . . . 73.340000000000003 111.141 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -73.28 -24.95 60.5 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.818 -0.353 . . . . 64.209999999999994 111.05 -176.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.659 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 75.4 mt -76.81 -56.92 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.946 0.403 . . . . 75.120000000000005 110.037 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 84.8 mt -62.1 -33.05 73.72 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.998 -0.546 . . . . 74.530000000000001 111.678 -175.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -77.33 -24.25 66.26 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.493 -0.86 . . . . 54.140000000000001 112.449 179.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -94.2 -20.78 29.32 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.041 -0.6 . . . . 33.530000000000001 112.865 -176.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.659 ' HG ' ' O ' ' A' ' 62' ' ' ILE . 69.7 mt -59.25 -15.58 16.3 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.459 0.54 . . . . 72.230000000000004 112.459 -176.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 84.1 mt -58.69 -41.69 86.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.018 0.437 . . . . 70.319999999999993 110.183 177.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.502 ' HB2' ' HB1' ' A' ' 88' ' ' ALA . 19.7 m -71.97 -24.66 61.63 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.875 -0.602 . . . . 75.109999999999999 110.751 -179.145 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.446 ' ND2' ' HB2' ' A' ' 88' ' ' ALA . 13.4 m120 -80.85 -22.72 39.65 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.865 -0.607 . . . . 53.439999999999998 111.106 -177.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.413 HG12 ' O ' ' A' ' 66' ' ' LEU . 49.5 mm . . . . . 0 C--N 1.327 -0.396 0 N-CA-C 112.171 0.434 . . . . 71.409999999999997 112.171 -174.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.752 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 50.0 ttm . . . . . 0 CA--C 1.521 -0.136 0 CA-C-O 121.278 0.561 . . . . 73.310000000000002 110.776 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 53.4 t -105.22 106.33 20.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.029 -0.532 . . . . 63.219999999999999 110.397 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 14.7 p -127.31 159.4 34.5 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.973 -0.558 . . . . 43.310000000000002 110.177 175.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -62.97 -46.17 88.96 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.368 -0.378 . . . . 72.310000000000002 110.933 -176.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -77.7 -25.91 49.76 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.106 0.409 . . . . 75.510000000000005 112.106 -172.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.421 ' CE1' ' HA ' ' A' ' 100' ' ' ASP . 14.6 m-85 -149.15 136.35 19.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.233 0.54 . . . . 63.340000000000003 111.811 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.614 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 51.7 mm -98.42 99.44 8.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.315 -0.624 . . . . 71.040000000000006 109.315 175.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.752 ' HB ' ' HB3' ' A' ' 78' ' ' MET . 29.1 t -103.38 86.74 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.288 0.566 . . . . 64.329999999999998 110.257 -177.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -91.11 124.01 35.01 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.955 -0.566 . . . . 74.510000000000005 109.711 -177.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 70.5 mt -98.16 117.48 43.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.074 -0.512 . . . . 73.150000000000006 110.386 -175.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.584 ' HB3' ' HB2' ' A' ' 95' ' ' GLN . . . -110.89 87.83 2.63 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.262 0.553 . . . . 54.140000000000001 111.142 -178.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -97.58 107.64 20.19 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.431 -0.951 . . . . 62.210000000000001 108.431 171.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.483 ' HB3' ' HB3' ' A' ' 68' ' ' SER . 11.5 tpt180 -160.03 147.56 16.55 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.041 -0.527 . . . . 75.439999999999998 109.989 -176.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.3 t70 71.21 0.63 3.5 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 123.748 0.655 . . . . 71.019999999999996 111.111 173.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 114.37 -23.74 12.1 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 115.808 -0.633 . . . . 75.319999999999993 112.443 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.428 HE21 ' HA ' ' A' ' 93' ' ' GLN . 0.0 OUTLIER -95.67 159.07 15.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.351 0.595 . . . . 62.409999999999997 111.697 -175.094 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -106.32 116.59 32.19 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.382 -0.826 . . . . 52.240000000000002 109.451 175.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.584 ' HB2' ' HB3' ' A' ' 88' ' ' ALA . 19.5 mt-30 -121.05 127.94 52.18 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.242 -0.435 . . . . 55.530000000000001 110.15 -179.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.419 ' C ' HD22 ' A' ' 97' ' ' ASN . 41.3 tp -109.94 121.69 45.83 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 110.041 -0.355 . . . . 75.109999999999999 110.041 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.485 ' ND2' HG23 ' A' ' 108' ' ' THR . 0.9 OUTLIER -112.91 102.2 10.22 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.903 -0.406 . . . . 43.409999999999997 109.903 177.625 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.614 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 6.4 p -113.9 115.61 50.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.412 0.625 . . . . 72.019999999999996 111.281 -178.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.581 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 41.2 m -92.44 123.13 35.53 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.805 -0.634 . . . . 64.319999999999993 111.045 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.476 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 26.9 t70 -75.08 158.43 33.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.57 -0.741 . . . . 63.399999999999999 110.649 177.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 11.6 mmt180 -115.61 2.54 13.78 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.486 0.55 . . . . 70.420000000000002 112.486 -176.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -108.13 -35.58 6.54 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.58 0.705 . . . . 73.140000000000001 110.264 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 14.4 p -121.81 -23.2 5.55 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.066 -0.97 . . . . 72.120000000000005 110.325 176.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.476 ' HA2' ' O ' ' A' ' 100' ' ' ASP . . . 83.65 14.56 72.94 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.659 -0.7 . . . . 65.239999999999995 111.986 -179.059 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.765 ' HG2' ' HE1' ' A' ' 54' ' ' PHE . 49.7 mt-30 -63.94 101.81 0.42 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.748 0.308 . . . . 72.040000000000006 110.404 177.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 98' ' ' VAL . 58.5 m -85.88 109.33 18.64 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.829 -0.434 . . . . 61.32 109.829 177.211 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 17.7 t -86.71 105.34 16.87 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.991 -0.55 . . . . 71.150000000000006 109.735 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.485 HG23 ' ND2' ' A' ' 97' ' ' ASN . 8.5 m -92.96 96.1 9.9 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.77 -0.65 . . . . 61.340000000000003 109.813 177.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 65.0 mt -102.86 114.33 42.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.179 -0.464 . . . . 73.010000000000005 111.539 -174.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.505 ' HG2' ' HG2' ' A' ' 95' ' ' GLN . 43.6 mt-30 -95.09 121.19 36.47 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.456 -0.572 . . . . 61.100000000000001 109.456 172.058 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 93.4 t . . . . . 0 C--N 1.327 -0.4 0 CA-C-O 121.174 0.511 . . . . 75.109999999999999 111.949 -175.696 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.433 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 30.9 tt0 . . . . . 0 CA--C 1.53 0.192 0 CA-C-O 121.782 0.801 . . . . 65.319999999999993 109.621 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 8.2 m -113.02 86.15 8.81 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.116 -0.947 . . . . 60.32 109.236 175.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' A' ' 46' ' ' GLU . 17.1 Cg_exo -66.21 99.22 0.41 Allowed 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.692 2.262 . . . . 72.099999999999994 113.157 -173.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.8 m -127.85 -59.46 1.2 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.824 -0.625 . . . . 71.450000000000003 109.603 174.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.54 -46.37 15.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.027 -0.533 . . . . 71.230000000000004 110.263 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.54 HD23 ' H ' ' A' ' 51' ' ' LEU . 1.4 pt? -74.6 -13.35 60.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 73.420000000000002 110.778 179.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.621 ' O ' ' HB2' ' A' ' 56' ' ' GLN . 27.0 t70 -62.69 -47.23 84.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.151 -0.477 . . . . 63.020000000000003 110.457 -179.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -79.2 9.91 4.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.426 -0.352 . . . . 73.010000000000005 110.865 178.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.456 ' O ' HG13 ' A' ' 58' ' ' ILE . 82.4 t80 -109.65 -64.82 1.21 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.759 0.314 . . . . 74.25 110.432 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.47 ' O ' ' HG2' ' A' ' 59' ' ' GLN . 12.9 t -73.5 -18.5 61.1 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.937 0.347 . . . . 75.409999999999997 111.937 -174.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.621 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 2.3 mp0 -75.09 -28.11 60.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.802 0.334 . . . . 51.200000000000003 110.614 -178.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -79.57 -18.83 50.86 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.536 0.684 . . . . 74.219999999999999 109.771 175.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.516 ' O ' HG13 ' A' ' 62' ' ' ILE . 21.7 mt -79.3 -29.06 13.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.37 -0.832 . . . . 75.030000000000001 110.604 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.47 ' HG2' ' O ' ' A' ' 55' ' ' THR . 15.1 mm-40 -53.29 -37.61 62.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.132 -0.485 . . . . 51.229999999999997 111.136 -178.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.8 m -62.71 -46.55 87.6 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.046 -0.525 . . . . 73.340000000000003 111.022 179.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -77.78 -16.14 58.58 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.844 -0.342 . . . . 64.209999999999994 111.082 -178.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.516 HG13 ' O ' ' A' ' 58' ' ' ILE . 64.7 mt -71.27 -43.09 74.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.302 -0.629 . . . . 75.120000000000005 109.302 172.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 97.1 mt -61.45 -41.56 97.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.926 -0.579 . . . . 74.530000000000001 110.096 175.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -65.15 -37.33 93.98 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.771 -0.728 . . . . 54.140000000000001 111.714 175.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.21 -37.34 94.37 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 111.784 -0.526 . . . . 33.530000000000001 111.784 176.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 62' ' ' ILE . 95.9 mt -56.9 -59.51 4.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.593 0.235 . . . . 72.230000000000004 110.998 178.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 pp -65.6 -10.4 35.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.864 0.364 . . . . 70.319999999999993 111.741 -176.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.405 ' HA ' ' HG3' ' A' ' 90' ' ' ARG . 31.4 m -95.86 -46.43 6.56 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.662 0.267 . . . . 75.109999999999999 111.246 178.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -92.08 -26.85 18.11 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.399 0.518 . . . . 53.439999999999998 112.399 -172.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 36.1 mm . . . . . 0 N--CA 1.465 0.305 0 CA-C-O 121.268 0.556 . . . . 71.409999999999997 110.452 -178.981 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 58.9 ttp . . . . . 0 N--CA 1.45 -0.425 0 N-CA-C 109.642 -0.503 . . . . 73.310000000000002 109.642 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 60.9 t -74.35 102.81 2.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.243 0.544 . . . . 63.219999999999999 111.043 -176.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.666 ' HB ' ' O ' ' A' ' 83' ' ' TYR . 17.5 m -120.95 142.15 50.01 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.376 -0.829 . . . . 43.310000000000002 109.28 178.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -70.15 -36.31 74.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.903 0.382 . . . . 72.310000000000002 111.08 -174.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -82.4 -40.1 21.74 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.94 -0.573 . . . . 75.510000000000005 111.491 -176.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.666 ' O ' ' HB ' ' A' ' 80' ' ' THR . 49.6 m-85 -139.96 120.8 14.46 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.205 -0.294 . . . . 63.340000000000003 110.205 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.66 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 4.2 mp -83.68 99.89 6.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.069 -0.715 . . . . 71.040000000000006 109.069 178.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.3 t -91.01 106.7 17.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.609 -0.723 . . . . 64.329999999999998 111.097 -175.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -105.23 122.91 46.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.058 -0.519 . . . . 74.510000000000005 109.693 176.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 56.8 mt -101.55 118.12 47.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.286 -0.416 . . . . 73.150000000000006 110.524 -175.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -112.51 88.48 2.83 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.109 0.48 . . . . 54.140000000000001 110.492 178.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -95.33 88.54 5.16 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.195 -0.669 . . . . 62.210000000000001 109.195 175.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.405 ' HG3' ' HA ' ' A' ' 68' ' ' SER . 56.7 ttp180 -130.75 143.06 50.48 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.567 -0.742 . . . . 75.439999999999998 109.717 -177.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 37.7 t70 65.7 24.16 11.56 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.64 0.733 . . . . 71.019999999999996 110.664 174.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.24 5.15 90.26 Favored Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 115.577 -0.738 . . . . 75.319999999999993 112.623 178.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.455 ' HA ' HE21 ' A' ' 93' ' ' GLN . 0.0 OUTLIER -104.4 134.4 47.68 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.873 0.368 . . . . 62.409999999999997 110.759 -179.622 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.491 ' HB2' ' HB ' ' A' ' 111' ' ' VAL . 4.5 mm? -91.97 96.34 10.31 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.867 -0.606 . . . . 52.240000000000002 109.39 174.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -106.33 110.0 22.1 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.327 0.584 . . . . 55.530000000000001 110.695 -179.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 35.8 tp -94.06 109.38 21.14 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.453 -0.794 . . . . 75.109999999999999 110.034 -178.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -97.82 93.06 6.15 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.949 0.404 . . . . 43.409999999999997 110.52 -179.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 56.0 t -85.01 103.63 12.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.143 0.497 . . . . 72.019999999999996 110.369 177.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.66 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 57.9 m -77.31 104.43 7.82 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.204 -0.665 . . . . 64.319999999999993 109.204 175.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -69.55 138.45 53.27 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.477 -0.783 . . . . 63.399999999999999 111.641 -174.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -108.02 -12.91 15.06 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.384 -0.825 . . . . 70.420000000000002 109.716 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -77.74 -55.86 4.99 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.813 -0.631 . . . . 73.140000000000001 110.714 -176.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 47.0 p -115.88 -23.15 8.73 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.387 0.613 . . . . 72.120000000000005 110.389 178.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 93.11 28.65 11.43 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.551 -0.75 . . . . 65.239999999999995 112.121 177.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -101.02 100.8 11.46 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 110.133 -0.321 . . . . 72.040000000000006 110.133 177.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 19.0 m -58.64 109.94 0.9 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.328 0.585 . . . . 61.32 110.867 -178.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 7.9 m -89.82 89.61 7.83 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.622 -0.717 . . . . 71.150000000000006 110.015 -178.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 45.4 m -83.46 109.3 17.23 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.931 -0.577 . . . . 61.340000000000003 110.317 178.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 58.9 mt -108.34 111.23 35.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.923 -0.58 . . . . 73.010000000000005 110.907 -177.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -88.96 118.54 28.76 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.981 0.42 . . . . 61.100000000000001 110.35 175.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.491 ' HB ' ' HB2' ' A' ' 94' ' ' LEU . 23.0 t . . . . . 0 C--N 1.322 -0.598 0 CA-C-N 115.925 -0.58 . . . . 75.109999999999999 109.839 178.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 . . . . . 0 C--O 1.232 0.153 0 CA-C-O 121.128 0.489 . . . . 65.319999999999993 110.189 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.7 87.7 3.77 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 115.612 -0.722 . . . . 60.32 110.767 175.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.521 ' CB ' ' HB2' ' A' ' 52' ' ' ASP . 50.7 Cg_endo -70.01 82.9 0.77 Allowed 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.037 1.825 . . . . 72.099999999999994 111.653 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.1 m -117.03 -8.96 11.17 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.82 -0.627 . . . . 71.450000000000003 110.792 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -165.42 -32.71 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.493 -0.321 . . . . 71.230000000000004 111.749 -176.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.402 ' O ' HG22 ' A' ' 55' ' ' THR . 3.9 pp -88.44 -10.07 50.4 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.846 0.313 . . . . 73.420000000000002 111.846 -177.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.521 ' HB2' ' CB ' ' A' ' 48' ' ' PRO . 17.4 t70 -56.52 -61.38 2.45 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.237 0.458 . . . . 63.020000000000003 112.237 -173.268 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -64.14 -33.3 75.47 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.039 -0.528 . . . . 73.010000000000005 110.763 -174.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.578 ' O ' HG13 ' A' ' 58' ' ' ILE . 72.3 t80 -70.76 -59.4 2.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.027 -0.533 . . . . 74.25 111.642 -176.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.402 HG22 ' O ' ' A' ' 51' ' ' LEU . 14.2 t -66.26 -23.78 66.46 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.773 0.32 . . . . 75.409999999999997 111.327 -173.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -82.72 -34.11 27.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.594 -0.275 . . . . 51.200000000000003 110.682 177.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.89 -28.35 69.48 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.824 -0.435 . . . . 74.219999999999999 109.824 175.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.586 ' HA ' ' HG2' ' A' ' 61' ' ' GLN . 25.5 mt -62.07 -35.48 68.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.063 -0.517 . . . . 75.030000000000001 110.35 176.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -68.57 -32.42 72.32 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.149 -0.478 . . . . 51.229999999999997 110.847 178.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.681 ' O ' HD22 ' A' ' 63' ' ' LEU . 23.0 m -79.99 -35.43 37.49 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.198 -0.456 . . . . 73.340000000000003 110.645 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.586 ' HG2' ' HA ' ' A' ' 58' ' ' ILE . 3.2 pt20 -78.39 -1.31 32.83 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.739 0.304 . . . . 64.209999999999994 111.545 -176.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.597 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 69.4 mt -60.69 -29.44 44.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.864 0.364 . . . . 75.120000000000005 110.421 177.183 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.685 HD23 ' N ' ' A' ' 64' ' ' GLY . 0.2 OUTLIER -61.05 -19.47 61.42 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.024 -0.535 . . . . 74.530000000000001 111.876 -177.385 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.685 ' N ' HD23 ' A' ' 63' ' ' LEU . . . -112.03 -32.3 2.45 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.404 -0.678 . . . . 54.140000000000001 111.404 175.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -63.55 -28.29 72.24 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 121.547 -0.358 . . . . 33.530000000000001 112.431 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.613 ' O ' HG12 ' A' ' 70' ' ' ILE . 73.6 mt -52.49 -47.69 66.41 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 120.59 0.233 . . . . 72.230000000000004 110.761 176.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.433 ' HB2' ' HD2' ' A' ' 90' ' ' ARG . 71.0 mt -61.31 -30.89 70.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.188 -0.46 . . . . 70.319999999999993 111.047 -176.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.9 m -76.9 -36.2 56.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.18 -0.464 . . . . 75.109999999999999 110.647 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -77.79 -26.11 49.46 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.368 -0.378 . . . . 53.439999999999998 110.647 -179.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.613 HG12 ' O ' ' A' ' 66' ' ' LEU . 30.6 mm . . . . . 0 C--N 1.331 -0.22 0 CA-C-N 116.121 -0.49 . . . . 71.409999999999997 110.331 177.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 56.3 ttp . . . . . 0 N--CA 1.447 -0.617 0 N-CA-C 109.603 -0.517 . . . . 73.310000000000002 109.603 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 48.8 t -71.01 102.11 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.599 -0.728 . . . . 63.219999999999999 109.721 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.413 ' HB ' ' O ' ' A' ' 83' ' ' TYR . 3.7 m -94.24 165.3 12.66 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.019 -0.734 . . . . 43.310000000000002 109.019 178.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -53.31 -31.45 44.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.872 0.368 . . . . 72.310000000000002 111.702 -178.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -139.73 -42.75 0.44 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.905 0.384 . . . . 75.510000000000005 110.647 -179.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.413 ' O ' ' HB ' ' A' ' 80' ' ' THR . 75.4 m-85 -76.84 144.31 39.15 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.839 -0.618 . . . . 63.340000000000003 111.54 -176.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.505 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 4.3 mp -110.66 100.15 10.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.331 -0.618 . . . . 71.040000000000006 109.331 175.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.605 HG22 HG23 ' A' ' 98' ' ' VAL . 12.6 t -106.49 98.4 6.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.279 -0.419 . . . . 64.329999999999998 110.806 -175.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -96.19 127.71 42.44 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.137 0.494 . . . . 74.510000000000005 110.24 179.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.542 HG23 HD21 ' A' ' 94' ' ' LEU . 60.9 mt -80.73 85.53 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.687 -0.688 . . . . 73.150000000000006 109.64 178.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.6 82.9 2.62 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.18 0.514 . . . . 54.140000000000001 111.665 -175.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -96.26 101.84 13.54 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.838 -0.619 . . . . 62.210000000000001 109.42 175.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.433 ' HD2' ' HB2' ' A' ' 67' ' ' LEU . 37.7 ttp180 -121.1 97.7 5.64 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.91 0.386 . . . . 75.439999999999998 111.083 -177.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 37.1 t70 60.1 82.47 0.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.8 -1.091 . . . . 71.019999999999996 111.427 175.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.93 -67.34 3.76 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.445 -0.798 . . . . 75.319999999999993 113.386 178.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.551 HE21 ' HA ' ' A' ' 93' ' ' GLN . 0.1 OUTLIER -83.95 159.62 21.23 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.232 0.539 . . . . 62.409999999999997 111.126 -173.167 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.542 HD21 HG23 ' A' ' 87' ' ' ILE . 4.8 tt -135.47 134.3 39.43 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.805 -0.634 . . . . 52.240000000000002 109.609 -174.027 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.636 ' HG2' ' HG2' ' A' ' 110' ' ' GLN . 22.8 mt-30 -120.6 105.44 10.8 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.881 0.372 . . . . 55.530000000000001 110.096 175.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 43.6 tp -83.96 109.91 18.0 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.178 -0.465 . . . . 75.109999999999999 110.049 -178.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.534 ' HB3' HG23 ' A' ' 108' ' ' THR . 8.0 p30 -111.62 119.95 40.42 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.465 0.65 . . . . 43.409999999999997 111.22 -178.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.605 HG23 HG22 ' A' ' 85' ' ' VAL . 3.2 p -98.25 102.95 14.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.539 0.685 . . . . 72.019999999999996 109.478 173.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.86 ' HA ' HG22 ' A' ' 106' ' ' THR . 44.3 m -81.73 105.27 12.73 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.647 -0.706 . . . . 64.319999999999993 111.037 -177.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.533 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 11.4 t70 -72.42 143.82 48.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.517 -0.765 . . . . 63.399999999999999 109.769 173.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -109.17 -11.57 14.9 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.549 -0.296 . . . . 70.420000000000002 111.456 -178.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -81.05 -57.02 3.71 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.589 -0.444 . . . . 73.140000000000001 110.449 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 51.8 p -107.03 -27.45 10.63 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.094 0.473 . . . . 72.120000000000005 110.199 178.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.533 ' HA2' ' O ' ' A' ' 100' ' ' ASP . . . 91.48 20.37 38.17 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.662 -0.699 . . . . 65.239999999999995 112.661 175.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -76.49 95.93 3.97 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.681 -0.489 . . . . 72.040000000000006 109.681 177.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.86 HG22 ' HA ' ' A' ' 99' ' ' THR . 29.2 p -84.1 91.44 7.67 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.832 -0.622 . . . . 61.32 111.309 -177.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.444 ' HB3' ' CG1' ' A' ' 98' ' ' VAL . 33.1 t -67.14 101.55 0.9 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.129 -0.693 . . . . 71.150000000000006 109.129 176.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.534 HG23 ' HB3' ' A' ' 97' ' ' ASN . 10.1 m -104.24 107.04 17.77 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 116.033 -0.53 . . . . 61.340000000000003 110.056 -178.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 60.3 mt -106.69 114.36 45.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.864 -0.607 . . . . 73.010000000000005 110.353 -176.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.636 ' HG2' ' HG2' ' A' ' 95' ' ' GLN . 49.9 mt-30 -66.71 116.98 8.21 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.692 -0.484 . . . . 61.100000000000001 109.692 174.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.507 ' HB ' ' HB3' ' A' ' 94' ' ' LEU . 58.8 t . . . . . 0 C--N 1.322 -0.592 0 CA-C-O 121.465 0.65 . . . . 75.109999999999999 110.828 -173.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.2 mtt . . . . . 0 N--CA 1.48 1.063 0 CA-C-O 120.823 0.344 . . . . 75.5 110.429 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.87 162.43 29.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 74.230000000000004 111.058 -178.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -92.32 73.64 1.46 Allowed Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.85 -0.691 . . . . 65.140000000000001 112.138 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.3 p -74.01 119.41 18.18 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.512 0.196 . . . . 72.25 110.999 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.418 ' O ' ' N ' ' A' ' 7' ' ' PHE . 4.2 mpp? 67.61 -71.93 0.1 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.689 0.796 . . . . 75.430000000000007 111.305 -178.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.427 HG23 ' H ' ' A' ' 7' ' ' PHE . 15.2 t 51.56 -65.57 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.652 1.581 . . . . 74.209999999999994 113.435 -177.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.427 ' H ' HG23 ' A' ' 6' ' ' THR . 83.4 m-85 -89.81 -61.06 1.77 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.369 -0.604 . . . . 75.040000000000006 109.369 175.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 59.33 28.03 17.26 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.614 0.721 . . . . 73.409999999999997 111.181 176.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -108.71 98.41 7.92 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 121.981 -0.45 . . . . 73.239999999999995 110.124 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -125.68 -175.7 3.41 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.63 -0.713 . . . . 72.030000000000001 109.601 177.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.2 t30 63.67 84.92 0.18 Allowed Pre-proline 0 N--CA 1.467 0.39 0 O-C-N 123.737 0.648 . . . . 63.140000000000001 110.521 -177.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -81.43 131.56 7.56 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.942 2.428 . . . . 71.329999999999998 112.25 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.5 m120 70.58 103.35 0.06 Allowed 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.41 0.892 . . . . 75.430000000000007 113.41 176.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -90.72 146.06 24.3 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.461 -0.791 . . . . 75.230000000000004 109.14 166.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.86 -64.27 1.75 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.49 -0.862 . . . . 71.230000000000004 112.227 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 140.06 -178.66 19.66 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.956 -0.64 . . . . 73.329999999999998 111.8 -179.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -121.59 142.68 36.26 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.705 0.253 . . . . 72.140000000000001 110.62 -178.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -90.89 152.01 3.99 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.931 2.421 . . . . 61.409999999999997 112.874 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -99.11 153.6 18.77 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.188 -0.671 . . . . 74.519999999999996 109.188 176.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -128.63 157.7 40.58 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.946 0.403 . . . . 74.239999999999995 110.944 -178.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -105.41 5.12 40.87 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.736 -0.745 . . . . 62.439999999999998 111.973 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 72.15 -55.5 0.67 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.773 0.829 . . . . 64.099999999999994 111.57 -178.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 56.39 45.95 21.8 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.102 0.477 . . . . 71.25 111.35 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.4 pp -77.23 -6.38 52.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.043 -0.526 . . . . 62.32 111.191 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 89.5 mt 63.9 174.26 0.18 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.503 -0.771 . . . . 52.439999999999998 112.618 174.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 -127.25 -82.51 0.61 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.662 -0.699 . . . . 73.200000000000003 109.384 175.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.9 p -172.12 134.93 0.75 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.259 -0.882 . . . . 71.349999999999994 109.092 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -138.36 116.9 12.09 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.842 0.353 . . . . 74.120000000000005 111.279 -177.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 13.9 tm0? -108.01 -36.34 6.37 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.478 -0.564 . . . . 65.310000000000002 109.478 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.409 ' HB2' ' HB2' ' A' ' 54' ' ' PHE . . . 75.51 -37.49 0.33 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.749 0.82 . . . . 75.25 112.759 173.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.683 ' HG2' ' H ' ' A' ' 32' ' ' ASN . 0.0 OUTLIER 44.78 -84.76 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.794 1.238 . . . . 75.530000000000001 114.066 179.528 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.683 ' H ' ' HG2' ' A' ' 31' ' ' GLN . 39.6 t-20 -111.97 134.41 53.55 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.665 0.269 . . . . 64.010000000000005 110.677 -171.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.421 ' C ' ' H ' ' A' ' 35' ' ' LYS . 5.6 p -64.55 -51.53 62.35 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.746 -0.464 . . . . 74.209999999999994 109.746 174.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 57.9 t80 71.9 -25.4 0.18 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.793 0.837 . . . . 74.430000000000007 112.282 173.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.552 ' HG2' HG21 ' A' ' 47' ' ' THR . 22.8 tptm -140.35 31.19 1.92 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.256 0.551 . . . . 71.430000000000007 109.719 -178.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.454 ' HB2' ' HD2' ' A' ' 37' ' ' PRO . 2.9 p30 -61.18 156.9 46.97 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.088 -0.505 . . . . 74.530000000000001 111.288 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.454 ' HD2' ' HB2' ' A' ' 36' ' ' ASP . 9.5 Cg_endo -50.95 142.98 32.16 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.497 2.798 . . . . 70.219999999999999 113.851 -178.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 29.8 t -139.31 135.64 34.01 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.2 -0.909 . . . . 62.109999999999999 109.325 178.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 59.4 t80 56.86 68.72 0.82 Allowed 'General case' 0 C--O 1.234 0.252 0 O-C-N 123.778 0.674 . . . . 74.420000000000002 110.485 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 17.2 m120 63.06 24.29 14.41 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.422 -0.808 . . . . 75.200000000000003 110.784 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.42 ' HB2' ' HB3' ' A' ' 37' ' ' PRO . 26.8 t70 63.52 105.98 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.538 -0.755 . . . . 75.340000000000003 111.625 -175.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -88.2 -42.24 12.43 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.851 -0.613 . . . . 70.120000000000005 109.863 175.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -169.38 19.36 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.854 -0.612 . . . . 75.219999999999999 110.133 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -73.17 -38.38 54.54 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.506 -0.854 . . . . 74.519999999999996 112.182 -172.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.3 mt -76.82 -18.45 14.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.665 0.745 . . . . 75.239999999999995 109.834 -178.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -95.6 8.91 42.02 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.484 -0.78 . . . . 65.319999999999993 111.338 -177.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.552 HG21 ' HG2' ' A' ' 35' ' ' LYS . 9.8 m -115.97 86.57 16.85 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 120.725 0.298 . . . . 60.32 110.304 175.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -77.37 84.57 1.93 Allowed 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.122 1.881 . . . . 72.099999999999994 111.896 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.7 m -86.07 -80.15 0.24 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.896 -0.593 . . . . 71.450000000000003 111.159 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -93.84 -37.85 11.54 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.807 0.337 . . . . 71.230000000000004 111.355 -177.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.582 HD23 ' H ' ' A' ' 51' ' ' LEU . 1.7 pt? -66.64 -13.83 61.68 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.01 -0.541 . . . . 73.420000000000002 111.273 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -49.01 -53.46 19.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.674 -0.694 . . . . 63.020000000000003 112.509 -175.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.45 -30.96 67.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.826 0.346 . . . . 73.010000000000005 111.349 -178.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.496 ' O ' HG13 ' A' ' 58' ' ' ILE . 67.2 t80 -67.23 -44.64 78.96 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.192 -0.458 . . . . 74.25 110.407 -178.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 87.0 m -55.34 -37.2 67.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.425 0.631 . . . . 75.409999999999997 111.557 178.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -80.19 -31.7 38.73 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.796 -0.638 . . . . 51.200000000000003 110.771 -174.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.81 -25.19 68.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.031 -0.532 . . . . 74.219999999999999 110.263 175.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.531 ' O ' HG13 ' A' ' 62' ' ' ILE . 2.5 mt -86.28 -45.37 16.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.974 -0.557 . . . . 75.030000000000001 110.968 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.454 ' HA ' HD12 ' A' ' 62' ' ' ILE . 76.1 mt-30 -59.14 -30.45 68.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.769 0.319 . . . . 51.229999999999997 111.283 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.5 m -66.58 -37.96 86.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.352 -0.386 . . . . 73.340000000000003 111.152 178.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.527 ' HG2' ' O ' ' A' ' 58' ' ' ILE . 11.1 pt20 -83.19 -20.9 33.8 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.794 0.33 . . . . 64.209999999999994 110.943 -178.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.531 HG13 ' O ' ' A' ' 58' ' ' ILE . 83.9 mt -66.5 -31.1 52.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.996 0.427 . . . . 75.120000000000005 109.894 177.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 91.9 mt -57.65 -32.85 67.69 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.734 -0.666 . . . . 74.530000000000001 110.933 178.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -74.51 -40.47 39.05 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.993 -0.623 . . . . 54.140000000000001 111.602 176.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -63.71 -25.99 69.49 Favored Glycine 0 C--N 1.33 0.2 0 C-N-CA 120.992 -0.623 . . . . 33.530000000000001 112.286 178.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 62' ' ' ILE . 91.8 mt -66.22 -18.34 65.29 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.706 0.289 . . . . 72.230000000000004 110.916 178.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 93.7 mt -85.59 5.97 29.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.076 0.465 . . . . 70.319999999999993 110.563 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.9 t -126.11 -42.21 1.88 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.947 -0.57 . . . . 75.109999999999999 110.587 179.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.414 ' ND2' HD21 ' A' ' 97' ' ' ASN . 86.7 m-20 -75.73 5.36 6.34 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.699 0.629 . . . . 53.439999999999998 112.699 -173.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.402 HG12 ' O ' ' A' ' 66' ' ' LEU . 50.4 mm -99.73 -13.57 8.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.653 0.739 . . . . 71.409999999999997 109.664 176.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -98.59 8.92 44.32 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.589 -0.732 . . . . 61.43 110.678 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.2 p -86.77 -164.18 1.03 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.851 -0.613 . . . . 53.310000000000002 110.45 178.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 122.07 7.74 7.65 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.7 -0.762 . . . . 71.019999999999996 112.311 -177.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -57.44 148.12 56.06 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 120.665 0.269 . . . . 51.439999999999998 111.262 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.68 -10.34 23.38 Favored 'Trans proline' 0 CA--C 1.532 0.407 0 C-N-CA 122.587 2.191 . . . . 65.030000000000001 112.666 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -83.74 56.12 5.04 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 121.131 -0.557 . . . . 72.120000000000005 112.435 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -106.68 -176.01 2.96 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.003 -0.369 . . . . 45.020000000000003 110.003 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.464 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 27.6 ttt -122.42 115.63 22.58 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.729 0.3 . . . . 73.310000000000002 110.472 178.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 53.1 t -85.5 97.65 5.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.373 0.606 . . . . 63.219999999999999 110.696 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.697 ' HB ' ' O ' ' A' ' 83' ' ' TYR . 6.7 m -113.65 148.86 35.53 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.307 -0.86 . . . . 43.310000000000002 108.854 177.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -73.52 -59.64 2.62 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.007 0.373 . . . . 72.310000000000002 112.007 -170.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -82.82 -14.16 54.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.795 0.331 . . . . 75.510000000000005 111.448 -174.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.697 ' O ' ' HB ' ' A' ' 80' ' ' THR . 59.4 m-85 -133.99 121.3 21.41 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.334 -0.394 . . . . 63.340000000000003 110.482 -177.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.569 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 2.9 mp -81.91 102.56 7.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.089 -0.708 . . . . 71.040000000000006 109.089 175.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.464 ' HB ' ' HB3' ' A' ' 78' ' ' MET . 47.3 t -96.69 94.31 4.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.715 -0.675 . . . . 64.329999999999998 110.769 -176.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -98.45 115.62 28.91 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.343 -0.614 . . . . 74.510000000000005 109.343 178.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 71.6 mt -82.02 94.66 2.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.939 -0.573 . . . . 73.150000000000006 110.673 -176.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.05 74.54 8.08 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.687 -0.688 . . . . 54.140000000000001 111.102 -177.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -88.59 92.73 9.31 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.147 -0.686 . . . . 62.210000000000001 109.147 173.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.441 ' HA ' ' HD2' ' A' ' 90' ' ' ARG . 13.6 tpt180 -133.68 154.16 51.14 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.818 -0.628 . . . . 75.439999999999998 109.726 -178.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.9 t70 69.93 -68.18 0.21 Allowed 'General case' 0 N--CA 1.465 0.317 0 O-C-N 124.082 0.864 . . . . 71.019999999999996 111.151 178.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 177.74 23.62 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.736 -0.745 . . . . 75.319999999999993 113.433 178.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.477 HE21 ' HA ' ' A' ' 93' ' ' GLN . 0.0 OUTLIER -138.1 152.5 48.83 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 122.265 -0.55 . . . . 62.409999999999997 110.264 178.351 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -89.61 94.58 9.91 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.761 -0.459 . . . . 52.240000000000002 109.761 176.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.474 ' HG2' ' OD1' ' A' ' 97' ' ' ASN . 7.3 tt0 -97.31 109.29 22.08 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.137 0.494 . . . . 55.530000000000001 109.692 -179.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.543 ' HB3' ' HB ' ' A' ' 109' ' ' ILE . 29.0 tp -90.11 98.64 11.89 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.868 -0.605 . . . . 75.109999999999999 110.389 -177.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.483 ' OD1' HG23 ' A' ' 108' ' ' THR . 6.5 m-20 -90.61 93.44 9.27 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.283 0.564 . . . . 43.409999999999997 110.532 -179.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.439 ' CG1' ' HD1' ' A' ' 83' ' ' TYR . 56.1 t -92.8 114.18 29.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.658 -0.701 . . . . 72.019999999999996 110.677 178.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.569 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 30.7 m -103.32 109.23 20.77 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.845 -0.616 . . . . 64.319999999999993 110.077 178.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.587 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 25.2 t70 -62.32 141.23 58.4 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.489 -0.323 . . . . 63.399999999999999 110.777 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.07 -26.69 19.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.259 -0.428 . . . . 70.420000000000002 110.251 -177.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 32.7 mtmm -70.04 -69.58 0.34 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.374 -0.375 . . . . 73.140000000000001 111.149 -174.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 12.0 t -99.05 -26.8 14.11 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.243 0.544 . . . . 72.120000000000005 109.716 -179.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.587 ' HA2' ' O ' ' A' ' 100' ' ' ASP . . . 83.65 79.45 1.06 Allowed Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.544 -0.753 . . . . 65.239999999999995 112.909 176.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.491 ' H ' ' HB3' ' A' ' 100' ' ' ASP . 68.6 mm-40 -124.69 144.16 50.36 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.587 -0.523 . . . . 72.040000000000006 109.587 174.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.9 m -89.05 96.11 10.59 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.123 0.487 . . . . 61.32 110.724 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.435 ' HB3' ' HB ' ' A' ' 98' ' ' VAL . 47.4 t -88.17 80.83 7.51 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.454 -0.573 . . . . 71.150000000000006 109.454 177.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.483 HG23 ' OD1' ' A' ' 97' ' ' ASN . 28.2 m -82.35 101.49 10.62 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.901 -0.591 . . . . 61.340000000000003 110.709 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.543 ' HB ' ' HB3' ' A' ' 96' ' ' LEU . 54.5 mt -99.88 92.34 2.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.052 -0.522 . . . . 73.010000000000005 110.514 -178.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -72.56 106.91 4.81 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.723 -0.473 . . . . 61.100000000000001 109.723 175.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.2 t -76.23 104.75 4.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.688 -0.486 . . . . 75.109999999999999 109.688 177.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.3 t -147.86 125.46 11.77 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.749 -0.659 . . . . 73.519999999999996 110.31 -178.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 92.77 52.7 2.07 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.915 -0.66 . . . . 53.210000000000001 113.035 175.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 77.4 mt -106.16 -75.81 0.62 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.011 -0.366 . . . . 71.239999999999995 110.011 174.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 66.38 15.33 10.06 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.605 -0.725 . . . . 62.340000000000003 111.202 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -100.78 93.49 5.58 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.632 0.729 . . . . 63.439999999999998 109.705 173.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -105.26 101.74 11.27 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.496 -0.775 . . . . 61.130000000000003 110.547 -176.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 38.3 m -83.3 101.8 11.53 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.306 -0.628 . . . . 75.219999999999999 109.306 174.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -57.8 120.27 8.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.983 -0.553 . . . . 73.200000000000003 110.587 -177.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -120.92 116.21 24.69 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.84 -0.618 . . . . 62.409999999999997 110.352 -177.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -141.08 95.32 2.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.21 -0.45 . . . . 75.239999999999995 110.494 178.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 26.0 m80 63.95 -168.96 0.2 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.884 -0.598 . . . . 74.340000000000003 111.325 175.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 37.8 m80 58.42 46.71 14.8 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.811 -0.632 . . . . 64.150000000000006 110.991 176.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -84.09 11.36 8.14 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.681 -0.69 . . . . 75.209999999999994 111.035 -177.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 23.7 t-80 -139.57 109.64 6.44 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.221 -0.445 . . . . 71.409999999999997 109.879 175.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -147.14 139.2 24.45 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.692 -0.685 . . . . 73.129999999999995 109.998 176.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.619 -0.705 . . . . 54.43 109.56 -176.022 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.046 0 CA-C-O 120.864 0.364 . . . . 75.5 110.273 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -99.96 141.34 32.91 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.942 0.401 . . . . 74.230000000000004 111.374 -176.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -137.09 81.69 0.28 Allowed Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 111.193 -0.763 . . . . 65.140000000000001 111.193 177.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.8 t -100.21 -10.4 21.41 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.528 0.204 . . . . 72.25 111.046 -175.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 4.8 mpp? 58.5 -167.17 0.15 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.083 -0.508 . . . . 75.430000000000007 110.558 -177.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 16.2 m -141.53 -78.26 0.27 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.608 -0.269 . . . . 74.209999999999994 110.452 175.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.426 ' HB3' ' HE2' ' A' ' 9' ' ' PHE . 69.6 m-85 65.63 114.44 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 O-C-N 123.918 0.761 . . . . 75.040000000000006 111.327 -178.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -111.26 112.63 24.55 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.518 0.675 . . . . 73.409999999999997 111.208 -177.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.426 ' HE2' ' HB3' ' A' ' 7' ' ' PHE . 96.1 m-85 -118.69 99.77 6.99 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.01 -0.541 . . . . 73.239999999999995 110.837 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.461 ' O ' ' HB2' ' A' ' 11' ' ' ASN . 73.0 mtp180 -111.47 -17.19 13.15 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.228 -0.442 . . . . 72.030000000000001 109.809 174.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 10' ' ' ARG . 40.6 m-80 73.37 155.96 0.16 Allowed Pre-proline 0 N--CA 1.466 0.356 0 O-C-N 123.943 0.777 . . . . 63.140000000000001 111.067 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.94 -45.17 43.0 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.091 2.528 . . . . 71.329999999999998 113.424 -177.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 72.4 154.94 0.15 Allowed 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.78 0.675 . . . . 75.430000000000007 110.459 -178.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 65.11 -175.0 0.18 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.279 0.562 . . . . 75.230000000000004 111.414 -178.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -166.57 38.82 0.25 Allowed Glycine 0 N--CA 1.448 -0.501 0 N-CA-C 111.213 -0.755 . . . . 71.230000000000004 111.213 176.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 110.58 150.76 12.49 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.959 -0.639 . . . . 73.329999999999998 111.66 -176.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.406 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 91.1 m-20 -94.81 151.52 39.08 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 110.151 -0.314 . . . . 72.140000000000001 110.151 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 17' ' ' ASN . 5.0 Cg_exo -75.95 74.67 4.39 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.726 2.284 . . . . 61.409999999999997 111.792 178.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -96.85 -162.06 0.92 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.017 -0.538 . . . . 74.519999999999996 110.729 -177.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 44.9 88.57 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.686 0.995 . . . . 74.239999999999995 113.686 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.51 -27.9 73.58 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.544 -0.753 . . . . 62.439999999999998 111.232 173.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 75.09 -59.77 0.53 Allowed 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.917 0.887 . . . . 64.099999999999994 112.271 173.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 27.2 t80 67.65 97.17 0.06 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.553 0.692 . . . . 71.25 110.734 -177.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.0 mp -106.12 -175.28 2.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.448 -0.796 . . . . 62.32 110.954 -177.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 75.6 mt 58.63 72.47 0.52 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.324 -0.853 . . . . 52.439999999999998 111.638 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.503 ' O ' ' HA ' ' A' ' 49' ' ' SER . 13.6 m120 -124.43 89.54 3.09 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.08 -0.711 . . . . 73.200000000000003 109.08 175.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.2 m -71.43 93.5 1.17 Allowed 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.266 0.555 . . . . 71.349999999999994 110.902 -176.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -88.94 149.18 23.42 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.646 -0.706 . . . . 74.120000000000005 109.796 177.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -84.36 51.93 2.22 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.067 0.461 . . . . 65.310000000000002 111.482 -173.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.64 -35.92 22.33 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.963 -0.562 . . . . 75.25 110.06 177.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.444 ' HG2' ' H ' ' A' ' 32' ' ' ASN . 6.4 tt0 63.11 -167.39 0.21 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.388 -0.824 . . . . 75.530000000000001 111.357 177.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.444 ' H ' ' HG2' ' A' ' 31' ' ' GLN . 15.5 m120 73.21 168.58 0.31 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.301 0.64 . . . . 64.010000000000005 111.067 -176.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.5 m -86.36 -21.92 26.94 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.438 0.533 . . . . 74.209999999999994 112.438 -172.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -133.07 105.14 6.88 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.581 -0.448 . . . . 74.430000000000007 111.236 -174.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.444 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 25.1 tptp -132.66 108.46 9.06 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.955 -0.757 . . . . 71.430000000000007 108.955 174.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.527 ' HB2' ' HD2' ' A' ' 37' ' ' PRO . 4.0 p-10 -140.65 166.08 25.47 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 115.998 -0.546 . . . . 74.530000000000001 110.173 -173.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.527 ' HD2' ' HB2' ' A' ' 36' ' ' ASP . 21.2 Cg_endo -61.6 -26.52 80.54 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.192 1.928 . . . . 70.219999999999999 111.629 176.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.2 m 68.07 -74.6 0.07 Allowed 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.414 -0.812 . . . . 62.109999999999999 110.807 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -143.71 167.0 23.31 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.735 -0.468 . . . . 74.420000000000002 109.735 177.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 70.09 90.35 0.1 Allowed 'General case' 0 C--O 1.234 0.245 0 O-C-N 123.707 0.629 . . . . 75.200000000000003 110.379 178.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.7 t0 62.69 93.41 0.05 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.159 -0.928 . . . . 75.340000000000003 110.669 -176.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -85.09 30.09 0.61 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.242 -0.89 . . . . 70.120000000000005 110.996 -172.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -66.1 -25.31 66.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.82 0.343 . . . . 75.219999999999999 110.859 -177.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.568 ' HA2' ' OG1' ' A' ' 47' ' ' THR . . . -64.43 -16.67 60.96 Favored Glycine 0 C--N 1.332 0.339 0 CA-C-N 115.826 -0.625 . . . . 74.519999999999996 113.406 -174.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 62.4 mt -64.99 -25.19 37.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.313 0.578 . . . . 75.239999999999995 110.63 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -112.28 11.82 20.19 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.937 -0.574 . . . . 65.319999999999993 110.923 -176.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.568 ' OG1' ' HA2' ' A' ' 44' ' ' GLY . 47.0 p -124.75 86.7 55.69 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.492 -0.322 . . . . 60.32 110.943 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.405 ' HA ' ' HG ' ' A' ' 51' ' ' LEU . 32.0 Cg_exo -57.66 98.94 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.81 2.34 . . . . 72.099999999999994 112.702 -177.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.503 ' HA ' ' O ' ' A' ' 26' ' ' ASN . 14.3 m -104.4 -46.83 4.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.613 -0.721 . . . . 71.450000000000003 110.375 176.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.444 ' HB3' ' HB3' ' A' ' 35' ' ' LYS . . . -131.68 -2.65 3.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.466 0.65 . . . . 71.230000000000004 110.303 174.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.484 HD23 ' H ' ' A' ' 51' ' ' LEU . 0.7 OUTLIER -95.46 0.55 53.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.672 -0.695 . . . . 73.420000000000002 110.394 -178.728 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -68.28 -40.83 81.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.142 -0.481 . . . . 63.020000000000003 109.977 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -63.69 -30.73 71.79 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.711 -0.677 . . . . 73.010000000000005 110.368 176.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -83.14 -51.57 7.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.819 -0.628 . . . . 74.25 111.322 -177.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.0 t -69.05 -26.43 64.96 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.046 0.387 . . . . 75.409999999999997 112.046 -173.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -77.3 -19.87 55.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.86 0.362 . . . . 51.200000000000003 110.433 178.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.51 -18.41 48.6 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.477 0.656 . . . . 74.219999999999999 109.683 175.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.469 ' O ' HG13 ' A' ' 62' ' ' ILE . 13.3 mt -77.04 -32.22 19.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.636 -0.711 . . . . 75.030000000000001 110.182 177.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -61.64 -27.88 68.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 51.229999999999997 110.795 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.635 ' O ' HD22 ' A' ' 63' ' ' LEU . 5.9 m -75.87 -43.15 46.95 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.21 -0.45 . . . . 73.340000000000003 110.691 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.41 ' HG2' ' O ' ' A' ' 58' ' ' ILE . 11.2 pt20 -74.53 -3.81 33.12 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.484 -0.326 . . . . 64.209999999999994 111.641 -173.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 58' ' ' ILE . 64.7 mt -66.9 -17.8 23.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.287 0.565 . . . . 75.120000000000005 110.0 174.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.635 HD22 ' O ' ' A' ' 60' ' ' SER . 0.5 OUTLIER -63.75 -19.21 64.79 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.857 -0.611 . . . . 74.530000000000001 111.199 -179.024 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.613 ' N ' HD23 ' A' ' 63' ' ' LEU . . . -81.68 -30.37 36.25 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 111.101 -0.8 . . . . 54.140000000000001 111.101 176.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -69.77 -26.02 74.89 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.081 -0.808 . . . . 33.530000000000001 111.081 175.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.493 ' HA ' HD11 ' A' ' 70' ' ' ILE . 86.8 mt -70.49 -5.45 28.86 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.089 0.471 . . . . 72.230000000000004 110.647 176.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 87.4 mt -109.41 -66.69 1.04 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.925 -0.579 . . . . 70.319999999999993 110.952 178.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 17.8 m -98.51 15.41 25.03 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.865 0.691 . . . . 75.109999999999999 112.865 -171.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -129.45 20.73 5.66 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.539 0.685 . . . . 53.439999999999998 110.197 178.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.493 HD11 ' HA ' ' A' ' 66' ' ' LEU . 45.2 mm -93.18 -7.12 10.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-O 121.629 0.728 . . . . 71.409999999999997 109.319 178.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 -52.13 -61.35 2.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.946 -1.025 . . . . 61.43 110.233 177.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 75.4 p 51.98 24.17 2.5 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.619 0.768 . . . . 53.310000000000002 112.996 175.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -76.08 -19.46 78.57 Favored Glycine 0 N--CA 1.454 -0.157 0 C-N-CA 120.768 -0.729 . . . . 71.019999999999996 112.883 -178.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.9 150.24 39.46 Favored Pre-proline 0 CA--C 1.532 0.278 0 N-CA-C 111.951 0.352 . . . . 51.439999999999998 111.951 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -72.77 -4.91 16.22 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.87 2.38 . . . . 65.030000000000001 113.333 -177.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 120.74 -114.95 2.77 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.77 -0.729 . . . . 72.120000000000005 112.163 178.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.403 ' HB2' ' O ' ' A' ' 85' ' ' VAL . 6.5 ptp180 -132.5 -176.13 3.99 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.113 -0.329 . . . . 45.020000000000003 110.113 -178.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 59.6 ttp -116.68 116.2 27.09 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.299 -0.63 . . . . 73.310000000000002 109.299 172.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 58.5 t -67.4 103.52 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.096 0.474 . . . . 63.219999999999999 111.202 -178.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -108.19 167.6 9.9 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.686 -0.688 . . . . 43.310000000000002 110.987 176.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -64.28 -73.88 0.11 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.499 -0.318 . . . . 72.310000000000002 111.809 -174.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -120.6 32.96 5.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.809 0.814 . . . . 75.510000000000005 109.873 -178.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -125.85 144.17 50.77 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.174 -0.921 . . . . 63.340000000000003 110.243 177.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.562 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 4.4 mp -108.55 100.48 10.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.172 -0.677 . . . . 71.040000000000006 109.172 175.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.403 ' O ' ' HB2' ' A' ' 77' ' ' ARG . 3.9 p -125.28 110.72 25.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.579 0.704 . . . . 64.329999999999998 110.973 -177.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -110.38 143.95 39.87 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.477 -0.783 . . . . 74.510000000000005 109.858 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 59.5 mt -87.13 98.68 7.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 109.641 -0.503 . . . . 73.150000000000006 109.641 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -88.26 89.44 7.99 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.888 -0.596 . . . . 54.140000000000001 111.146 -176.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.481 ' HA ' ' O ' ' A' ' 93' ' ' GLN . 29.0 t-20 -84.97 77.43 10.11 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.901 -0.778 . . . . 62.210000000000001 108.901 172.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.411 ' O ' ' HB3' ' A' ' 91' ' ' ASP . 47.3 ttp180 -102.6 144.45 30.99 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.737 -1.12 . . . . 75.439999999999998 109.107 -178.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.411 ' HB3' ' O ' ' A' ' 90' ' ' ARG . 11.4 t70 69.05 -67.78 0.2 Allowed 'General case' 0 N--CA 1.467 0.384 0 O-C-N 123.726 0.641 . . . . 71.019999999999996 110.664 -177.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 172.34 31.54 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.297 -0.721 . . . . 75.319999999999993 111.297 178.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.481 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 26.2 mm-40 -136.82 150.06 48.1 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.048 -0.353 . . . . 62.409999999999997 110.048 -178.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.448 ' HB2' ' HB ' ' A' ' 111' ' ' VAL . 3.6 mm? -88.24 101.92 14.32 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.102 -0.333 . . . . 52.240000000000002 110.102 178.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -104.74 121.53 43.81 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.012 0.434 . . . . 55.530000000000001 110.245 178.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 15.7 tp -103.94 102.68 12.47 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.16 -0.473 . . . . 75.109999999999999 110.169 -177.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -96.46 115.25 27.13 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.42 -0.355 . . . . 43.409999999999997 110.723 -177.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 39.7 t -99.61 111.26 28.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.171 -0.468 . . . . 72.019999999999996 110.821 178.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.562 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 43.6 m -97.75 110.59 23.13 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.813 -0.63 . . . . 64.319999999999993 110.391 177.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.489 ' HB3' ' H ' ' A' ' 105' ' ' GLN . 7.1 t70 -71.34 124.97 25.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.941 -0.572 . . . . 63.399999999999999 109.923 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.489 ' HD3' ' O ' ' A' ' 101' ' ' ARG . 3.1 tmt_? -82.84 -28.69 29.96 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.599 0.238 . . . . 70.420000000000002 110.639 -176.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -84.77 -58.4 2.73 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.491 0.663 . . . . 73.140000000000001 110.804 -175.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.7 m -88.68 -25.34 22.42 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.989 -1.005 . . . . 72.120000000000005 110.83 -172.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.97 69.32 1.41 Allowed Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.704 -0.68 . . . . 65.239999999999995 113.214 177.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.489 ' H ' ' HB3' ' A' ' 100' ' ' ASP . 44.7 mt-30 -136.82 144.75 43.82 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.993 -0.743 . . . . 72.040000000000006 108.993 176.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.2 t -110.77 94.41 4.98 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.982 0.896 . . . . 61.32 110.446 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 27.0 t -87.26 113.23 22.8 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.457 -0.792 . . . . 71.150000000000006 109.371 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 41.9 m -103.62 111.39 23.85 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.925 -0.58 . . . . 61.340000000000003 111.219 -176.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.401 HD12 ' N ' ' A' ' 109' ' ' ILE . 4.5 mp -108.34 109.47 28.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.097 -0.501 . . . . 73.010000000000005 109.649 178.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -91.61 153.83 19.46 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.017 0.436 . . . . 61.100000000000001 111.491 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.448 ' HB ' ' HB2' ' A' ' 94' ' ' LEU . 4.4 p -54.71 111.12 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.177 -0.92 . . . . 75.109999999999999 111.683 -179.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.8 m -135.81 137.03 41.14 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.154 -0.93 . . . . 73.519999999999996 108.839 177.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 173.2 -108.96 0.29 Allowed Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.103 -1.046 . . . . 53.210000000000001 112.854 -177.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 87.4 mt -97.73 78.87 2.64 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.947 0.403 . . . . 71.239999999999995 111.154 -174.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -115.66 -10.81 11.77 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.126 0.489 . . . . 62.340000000000003 110.294 177.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -112.01 173.22 6.46 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.081 -0.509 . . . . 63.439999999999998 110.514 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -108.86 133.74 52.48 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.171 -0.468 . . . . 61.130000000000003 111.405 -178.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 24.3 m -86.81 112.77 22.04 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.078 -0.51 . . . . 75.219999999999999 110.343 174.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 17.6 m -100.23 112.54 24.87 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.506 -0.316 . . . . 73.200000000000003 110.413 177.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -90.72 74.43 6.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.952 0.406 . . . . 62.409999999999997 110.735 -177.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -149.04 124.69 10.44 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.189 -0.46 . . . . 75.239999999999995 110.459 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.431 ' HD2' ' O ' ' A' ' 123' ' ' HIS . 3.4 t-160 -144.72 113.96 7.0 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.491 -0.559 . . . . 74.340000000000003 109.491 177.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.449 ' O ' ' HD2' ' A' ' 125' ' ' HIS . 30.3 t60 -66.46 139.4 57.97 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.692 -0.484 . . . . 64.150000000000006 109.692 176.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 26.3 m80 -67.97 118.07 10.67 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.114 0.483 . . . . 75.209999999999994 111.655 -176.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.449 ' HD2' ' O ' ' A' ' 123' ' ' HIS . 34.8 m-70 -120.97 129.67 53.52 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.546 -0.752 . . . . 71.409999999999997 109.259 175.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.541 ' O ' ' HB2' ' A' ' 127' ' ' HIS . 45.9 p-80 -74.47 156.73 36.62 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.945 -0.391 . . . . 73.129999999999995 109.945 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.541 ' HB2' ' O ' ' A' ' 126' ' ' HIS . 15.8 m80 . . . . . 0 C--O 1.247 0.951 0 O-C-N 124.039 0.837 . . . . 54.43 110.56 -171.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.203 0 CA-C-O 120.318 0.104 . . . . 75.5 111.132 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 65.43 -168.97 0.2 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.032 0.444 . . . . 74.230000000000004 111.711 176.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 120.88 -15.62 9.55 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 121.003 -0.618 . . . . 65.140000000000001 111.82 -177.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 35.2 m -73.33 85.13 1.44 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.349 0.595 . . . . 72.25 111.148 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 85.3 mtp -128.88 93.2 3.55 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.531 -0.759 . . . . 75.430000000000007 109.132 173.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 48.2 p -94.69 -17.26 22.4 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.013 -0.54 . . . . 74.209999999999994 111.37 -175.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 68.07 -58.25 0.46 Allowed 'General case' 0 N--CA 1.466 0.326 0 O-C-N 123.932 0.77 . . . . 75.040000000000006 110.747 -176.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 72.51 -64.18 0.4 Allowed 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.804 0.842 . . . . 73.409999999999997 112.129 173.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 62.35 -172.14 0.16 Allowed 'General case' 0 C--O 1.234 0.274 0 O-C-N 123.629 0.581 . . . . 73.239999999999995 110.286 -175.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -147.93 -43.79 0.16 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.367 -0.379 . . . . 72.030000000000001 110.684 175.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 68.94 146.9 0.11 Allowed Pre-proline 0 N--CA 1.468 0.471 0 O-C-N 123.734 0.646 . . . . 63.140000000000001 111.882 177.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -68.98 -46.79 1.39 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.43 2.087 . . . . 71.329999999999998 111.462 176.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 68.03 120.31 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 O-C-N 124.257 0.973 . . . . 75.430000000000007 112.208 178.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 90.0 t80 72.11 121.14 0.04 OUTLIER 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.847 0.832 . . . . 75.230000000000004 112.03 177.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -140.19 -165.41 10.28 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 114.857 -1.065 . . . . 71.230000000000004 110.584 174.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 132.12 174.7 13.71 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.466 -0.873 . . . . 73.329999999999998 112.471 176.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -106.64 143.67 27.5 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 110.36 -0.237 . . . . 72.140000000000001 110.36 -178.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.75 126.83 10.39 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.457 2.105 . . . . 61.409999999999997 112.126 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -90.55 101.78 14.52 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.708 -0.478 . . . . 74.519999999999996 109.708 176.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -115.39 117.39 30.28 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.883 -0.599 . . . . 74.239999999999995 110.83 -176.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.81 157.34 23.52 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.749 -0.739 . . . . 62.439999999999998 111.992 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.93 142.72 38.21 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.932 0.396 . . . . 64.099999999999994 110.783 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -123.54 114.68 20.39 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.866 -0.607 . . . . 71.25 109.684 178.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.618 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 99.0 mt -130.58 133.42 46.18 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.451 -0.341 . . . . 62.32 111.484 -176.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.618 ' HG ' ' O ' ' A' ' 24' ' ' LEU . 4.6 pp 53.5 -179.87 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.671 1.189 . . . . 52.439999999999998 114.145 174.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -173.54 121.29 0.34 Allowed 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.133 -0.94 . . . . 73.200000000000003 108.855 178.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.3 t -68.65 116.68 9.44 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.001 -0.37 . . . . 71.349999999999994 110.001 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -144.08 114.95 7.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.873 0.368 . . . . 74.120000000000005 111.419 -176.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 24.9 tp60 -102.14 77.55 1.69 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.874 -0.603 . . . . 65.310000000000002 109.505 175.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -147.25 117.24 7.23 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.216 -0.447 . . . . 75.25 110.942 -177.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.405 ' HB3' HE21 ' A' ' 31' ' ' GLN . 0.0 OUTLIER 43.62 38.88 2.1 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.176 0.99 . . . . 75.530000000000001 112.213 -179.699 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 21.9 p-10 -121.46 179.54 4.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.25 -0.886 . . . . 64.010000000000005 109.668 178.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 30.0 m 71.56 -47.86 0.67 Allowed 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.318 0.647 . . . . 74.209999999999994 111.619 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -128.25 106.28 8.92 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.505 0.669 . . . . 74.430000000000007 111.695 178.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.7 ttmm -122.29 176.44 5.86 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.096 -1.075 . . . . 71.430000000000007 108.096 174.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.41 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 6.6 p-10 -66.3 144.39 98.69 Favored Pre-proline 0 C--N 1.325 -0.499 0 C-N-CA 121.132 -0.227 . . . . 74.530000000000001 111.1 -177.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.504 ' HA ' ' HB2' ' A' ' 42' ' ' ASP . 81.1 Cg_exo -48.97 148.34 9.36 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 124.041 3.161 . . . . 70.219999999999999 114.338 -177.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 39.3 m -134.4 -23.25 1.67 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.659 -0.7 . . . . 62.109999999999999 111.676 -179.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -112.65 55.19 0.7 Allowed 'General case' 0 N--CA 1.464 0.248 0 O-C-N 122.136 -0.353 . . . . 74.420000000000002 111.415 -175.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 54.36 79.99 0.13 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.733 -0.667 . . . . 75.200000000000003 111.314 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.4 t70 70.75 102.6 0.06 Allowed 'General case' 0 N--CA 1.468 0.444 0 O-C-N 123.882 0.739 . . . . 75.340000000000003 110.572 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.504 ' HB2' ' HA ' ' A' ' 37' ' ' PRO . 0.4 OUTLIER -106.43 13.61 28.3 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.991 -0.55 . . . . 70.120000000000005 112.254 -172.577 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 83.0 t80 59.61 0.55 0.23 Allowed 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 112.066 0.395 . . . . 75.219999999999999 112.066 -175.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -91.84 34.44 4.38 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 121.09 -0.576 . . . . 74.519999999999996 112.931 -177.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 41.1 mm -96.33 -60.15 2.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 110.304 -0.258 . . . . 75.239999999999995 110.304 176.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 68.63 -52.05 0.56 Allowed 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.871 0.868 . . . . 65.319999999999993 112.757 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 4.7 t -136.6 88.23 19.95 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-O 121.483 0.659 . . . . 60.32 110.989 -177.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -71.82 84.39 1.04 Allowed 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.398 2.066 . . . . 72.099999999999994 111.167 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 12.4 p -127.29 -72.6 0.63 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.659 -0.7 . . . . 71.450000000000003 110.786 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.95 -14.78 63.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.132 -0.485 . . . . 71.230000000000004 111.92 -177.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.421 ' O ' HG22 ' A' ' 55' ' ' THR . 2.9 pp -115.62 1.69 13.6 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.472 -0.331 . . . . 73.420000000000002 111.351 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.627 ' O ' ' HB2' ' A' ' 56' ' ' GLN . 28.3 t70 -68.05 -36.81 80.5 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.451 -0.34 . . . . 63.020000000000003 111.397 -174.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -84.66 -38.24 20.05 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.781 0.324 . . . . 73.010000000000005 110.922 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.469 ' O ' HG13 ' A' ' 58' ' ' ILE . 60.9 t80 -61.23 -57.99 10.13 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.884 -0.598 . . . . 74.25 111.42 -177.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.421 HG22 ' O ' ' A' ' 51' ' ' LEU . 7.2 t -70.01 -16.72 63.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.186 0.517 . . . . 75.409999999999997 110.958 -176.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.627 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 1.5 tp-100 -75.16 -29.96 60.59 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.385 0.612 . . . . 51.200000000000003 109.752 -178.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.72 -35.76 44.39 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.563 -0.744 . . . . 74.219999999999999 109.926 176.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.575 ' O ' HG13 ' A' ' 62' ' ' ILE . 17.3 mt -62.38 -40.07 86.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.648 -0.705 . . . . 75.030000000000001 111.055 -178.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -54.48 -32.85 58.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.429 -0.35 . . . . 51.229999999999997 111.413 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.3 t -81.51 -18.4 45.21 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.508 -0.314 . . . . 73.340000000000003 111.59 -176.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.547 ' HG2' ' O ' ' A' ' 58' ' ' ILE . 3.4 pt20 -96.63 -17.21 20.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.863 0.363 . . . . 64.209999999999994 110.687 -178.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.592 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 84.2 mt -65.15 -41.81 92.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.211 -0.45 . . . . 75.120000000000005 110.295 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.2 mp -61.59 -31.1 71.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.709 -0.678 . . . . 74.530000000000001 110.967 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -73.14 -41.8 45.9 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.658 -0.782 . . . . 54.140000000000001 111.833 178.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -71.33 -19.46 77.55 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 121.295 -0.478 . . . . 33.530000000000001 112.814 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' A' ' 62' ' ' ILE . 86.2 mt -57.35 -34.43 68.79 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.884 0.373 . . . . 72.230000000000004 110.966 178.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.432 HD12 HH11 ' A' ' 90' ' ' ARG . 97.1 mt -65.87 -36.5 83.6 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.199 -0.455 . . . . 70.319999999999993 110.851 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.9 m -71.51 -27.6 63.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.025 0.441 . . . . 75.109999999999999 110.255 177.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -72.83 -27.3 61.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.118 0.485 . . . . 53.439999999999998 109.927 176.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.531 HG12 ' O ' ' A' ' 66' ' ' LEU . 48.8 mm -71.2 -23.31 23.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.888 -0.596 . . . . 71.409999999999997 109.634 175.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -78.46 6.92 7.46 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.728 -0.669 . . . . 61.43 110.574 178.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 46.3 p 52.22 31.0 8.53 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.304 1.041 . . . . 53.310000000000002 113.112 172.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.59 31.74 67.84 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 121.076 -0.583 . . . . 71.019999999999996 113.388 174.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 22.0 ptmt -56.78 144.23 67.0 Favored Pre-proline 0 C--O 1.235 0.322 0 O-C-N 122.803 -0.233 . . . . 51.439999999999998 110.565 174.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 74' ' ' LYS . 34.6 Cg_exo -59.49 132.12 44.3 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 122.788 2.326 . . . . 65.030000000000001 111.75 177.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -133.04 -85.67 0.27 Allowed Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.6 -0.809 . . . . 72.120000000000005 113.176 -177.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.432 ' CB ' ' HA ' ' A' ' 86' ' ' ASP . 23.8 ptt180 -79.4 147.45 32.35 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.193 0.521 . . . . 45.020000000000003 111.844 -174.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 45.1 ttm -119.68 131.54 55.45 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.52 -0.764 . . . . 73.310000000000002 110.299 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 54.2 t -72.38 124.98 30.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.507 -0.553 . . . . 63.219999999999999 109.507 176.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.625 ' HB ' ' O ' ' A' ' 83' ' ' TYR . 2.7 m -127.27 162.35 26.44 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.663 -0.244 . . . . 43.310000000000002 110.532 -176.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -72.59 -75.89 0.13 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.954 0.407 . . . . 72.310000000000002 111.264 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -88.96 5.98 41.61 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.225 -0.443 . . . . 75.510000000000005 111.781 -174.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.625 ' O ' ' HB ' ' A' ' 80' ' ' THR . 60.7 m-85 -143.81 167.65 21.81 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.882 0.372 . . . . 63.340000000000003 110.748 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.571 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 40.8 mm -121.88 99.55 7.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 108.762 -0.829 . . . . 71.040000000000006 108.762 168.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.439 HG13 HD11 ' A' ' 96' ' ' LEU . 37.1 t -85.0 82.38 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.194 0.521 . . . . 64.329999999999998 109.977 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.432 ' HA ' ' CB ' ' A' ' 77' ' ' ARG . 26.1 t70 -94.81 98.77 10.98 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.754 -0.657 . . . . 74.510000000000005 111.226 -177.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.467 HG12 HD13 ' A' ' 96' ' ' LEU . 58.2 mt -86.82 95.4 4.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.574 -0.528 . . . . 73.150000000000006 109.574 175.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -88.14 114.33 24.66 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.954 -0.566 . . . . 54.140000000000001 110.457 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.508 ' HA ' ' O ' ' A' ' 93' ' ' GLN . 2.8 t-20 -109.89 111.17 22.42 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.906 -0.588 . . . . 62.210000000000001 110.211 178.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.432 HH11 HD12 ' A' ' 67' ' ' LEU . 59.0 ttp85 -127.44 133.74 49.91 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.476 -0.564 . . . . 75.439999999999998 109.476 175.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 64.43 -86.05 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 O-C-N 123.861 0.725 . . . . 71.019999999999996 110.558 -176.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -148.64 15.1 1.22 Allowed Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 110.996 -0.842 . . . . 75.319999999999993 110.996 177.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.508 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -98.11 124.31 42.57 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.814 0.34 . . . . 62.409999999999997 110.799 -177.588 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -95.7 101.17 12.83 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.65 -0.87 . . . . 52.240000000000002 108.65 171.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.4 HE21 ' HB2' ' A' ' 95' ' ' GLN . 7.6 tt0 -117.45 110.7 18.32 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.184 -0.462 . . . . 55.530000000000001 110.754 -174.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.502 ' HG ' HG23 ' A' ' 98' ' ' VAL . 61.1 tp -89.21 109.58 20.44 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.896 -0.593 . . . . 75.109999999999999 110.971 -176.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -97.44 88.31 4.36 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.848 -0.427 . . . . 43.409999999999997 109.848 178.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.539 ' HB ' ' HB3' ' A' ' 107' ' ' SER . 43.1 t -78.95 102.55 5.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.205 0.526 . . . . 72.019999999999996 110.516 178.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.571 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 25.1 m -90.64 106.39 18.47 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.456 -0.793 . . . . 64.319999999999993 109.371 176.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -63.02 140.23 58.85 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.061 0.458 . . . . 63.399999999999999 110.73 -177.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 24.4 tpp180 -76.6 -35.47 58.09 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.672 -0.694 . . . . 70.420000000000002 111.785 -174.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -102.35 -47.44 4.49 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 111.876 0.324 . . . . 73.140000000000001 111.876 -169.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 42.7 p -89.9 -26.84 20.25 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.156 0.503 . . . . 72.120000000000005 110.486 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.03 19.02 68.21 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.855 -0.688 . . . . 65.239999999999995 112.861 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -64.8 124.49 22.11 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.242 -0.281 . . . . 72.040000000000006 110.242 174.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 36.9 m -92.92 91.64 7.5 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.234 0.54 . . . . 61.32 109.571 175.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.539 ' HB3' ' HB ' ' A' ' 98' ' ' VAL . 17.1 t -88.45 89.39 7.97 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.869 -0.605 . . . . 71.150000000000006 109.589 -179.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 32.1 m -86.84 102.86 14.7 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.78 -0.645 . . . . 61.340000000000003 110.257 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 61.4 mt -111.39 109.11 27.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.77 -0.65 . . . . 73.010000000000005 110.816 -177.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -76.14 147.48 38.5 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.431 -0.35 . . . . 61.100000000000001 110.474 174.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 5.7 p -55.68 128.22 15.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.563 -0.744 . . . . 75.109999999999999 110.179 174.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.3 m -98.74 -32.36 11.42 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.208 -0.451 . . . . 73.519999999999996 110.493 -177.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 129.98 -139.11 10.7 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.993 -0.622 . . . . 53.210000000000001 111.696 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 86.3 mt -99.8 -77.12 0.53 Allowed 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 121.099 -0.24 . . . . 71.239999999999995 110.425 178.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 60.64 78.74 0.27 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.883 -0.599 . . . . 62.340000000000003 110.944 -177.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -112.09 131.94 55.14 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.694 -0.685 . . . . 63.439999999999998 110.055 178.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -94.39 -50.57 5.17 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.115 -0.493 . . . . 61.130000000000003 109.851 -179.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 52.7 m 66.81 165.83 0.21 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.204 -0.907 . . . . 75.219999999999999 112.282 176.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 21.0 p -74.48 132.71 42.12 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.662 -0.699 . . . . 73.200000000000003 110.761 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -91.92 -29.62 16.57 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.173 -0.467 . . . . 62.409999999999997 109.968 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 72.19 145.85 0.07 Allowed 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.158 -0.928 . . . . 75.239999999999995 111.711 178.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 24.9 p-80 -145.32 140.14 27.55 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.025 -0.732 . . . . 74.340000000000003 109.025 171.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -80.94 127.42 32.55 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.684 -0.487 . . . . 64.150000000000006 109.684 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 20.0 p-80 -69.26 139.44 54.42 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.734 -0.666 . . . . 75.209999999999994 111.303 -174.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 27.6 m170 -87.15 154.08 21.01 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.976 -0.75 . . . . 71.409999999999997 108.976 172.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.481 ' O ' ' HB2' ' A' ' 127' ' ' HIS . 5.6 t-160 -89.93 128.02 36.14 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.422 -0.955 . . . . 73.129999999999995 108.422 175.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.481 ' HB2' ' O ' ' A' ' 126' ' ' HIS . 36.6 m80 . . . . . 0 C--O 1.252 1.188 0 CA-C-O 117.992 -1.004 . . . . 54.43 109.805 -172.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.5 ptm . . . . . 0 N--CA 1.484 1.243 0 CA-C-O 120.624 0.25 . . . . 75.5 110.565 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.03 -40.78 0.05 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.905 0.383 . . . . 74.230000000000004 111.07 -178.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 115.91 60.32 0.34 Allowed Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 111.336 -0.705 . . . . 65.140000000000001 111.336 -176.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.408 ' O ' ' HB2' ' A' ' 5' ' ' MET . 14.6 t -69.33 144.24 53.56 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.632 0.253 . . . . 72.25 110.663 -176.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.408 ' HB2' ' O ' ' A' ' 4' ' ' THR . 0.8 OUTLIER 72.04 -55.7 0.66 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.701 0.8 . . . . 75.430000000000007 112.037 -178.174 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.0 t 43.72 88.14 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.038 0.935 . . . . 74.209999999999994 112.469 -177.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.527 ' HB2' ' CE2' ' A' ' 9' ' ' PHE . 14.4 p90 -82.4 114.53 20.92 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.514 -0.766 . . . . 75.040000000000006 110.543 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -110.86 -51.28 2.88 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.535 -0.757 . . . . 73.409999999999997 110.774 -176.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.527 ' CE2' ' HB2' ' A' ' 7' ' ' PHE . 77.4 m-85 61.09 39.64 15.92 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.57 0.7 . . . . 73.239999999999995 109.267 -177.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.446 HH11 ' HD3' ' A' ' 10' ' ' ARG . 0.8 OUTLIER -82.84 70.93 9.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.914 -1.039 . . . . 72.030000000000001 111.787 -174.234 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -144.41 85.18 8.83 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.611 -0.722 . . . . 63.140000000000001 110.863 175.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -66.57 -31.82 40.38 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.96 2.44 . . . . 71.329999999999998 111.97 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 52.72 59.25 4.61 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.611 -0.722 . . . . 75.430000000000007 111.399 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -148.83 128.79 13.48 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.032 -0.531 . . . . 75.230000000000004 109.926 -178.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -162.72 -115.38 0.34 Allowed Glycine 0 N--CA 1.45 -0.368 0 N-CA-C 111.1 -0.8 . . . . 71.230000000000004 111.1 177.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 120.5 165.33 12.77 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.751 -0.738 . . . . 73.329999999999998 112.672 176.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -117.91 144.56 34.83 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 109.353 -0.61 . . . . 72.140000000000001 109.353 178.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.98 -56.76 0.22 Allowed 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 122.176 1.917 . . . . 61.409999999999997 112.916 -176.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -176.92 -170.58 0.32 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.184 -0.673 . . . . 74.519999999999996 109.184 -178.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -125.13 154.84 40.84 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.766 -0.457 . . . . 74.239999999999995 109.766 178.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -138.35 132.22 5.72 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.727 -0.749 . . . . 62.439999999999998 111.891 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -164.15 117.47 1.41 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.911 -0.403 . . . . 64.099999999999994 109.911 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -155.84 122.33 5.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.362 0.601 . . . . 71.25 111.139 -177.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.533 HD12 ' O ' ' A' ' 24' ' ' LEU . 3.0 pp -157.32 131.29 8.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.703 -0.68 . . . . 62.32 110.728 176.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 80.3 mt -135.68 -27.63 1.15 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.525 -0.761 . . . . 52.439999999999998 110.975 177.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -63.69 138.45 58.5 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.334 -0.394 . . . . 73.200000000000003 110.407 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 10.4 m -68.91 118.65 12.11 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.958 -0.565 . . . . 71.349999999999994 111.418 -177.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -120.31 165.87 14.28 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.98 -0.554 . . . . 74.120000000000005 110.13 178.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -100.0 128.99 46.01 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 110.071 -0.344 . . . . 65.310000000000002 110.071 -178.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.59 178.34 8.02 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.062 -0.517 . . . . 75.25 110.622 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 65.74 177.17 0.21 Allowed 'General case' 0 N--CA 1.466 0.327 0 O-C-N 123.623 0.577 . . . . 75.530000000000001 111.445 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 16.6 m120 62.56 3.76 1.2 Allowed 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.335 -0.848 . . . . 64.010000000000005 112.992 173.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.0 p -129.3 11.54 5.91 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.084 0.401 . . . . 74.209999999999994 112.084 -173.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 82.3 t80 58.93 81.31 0.17 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.687 0.756 . . . . 74.430000000000007 110.135 -176.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.535 ' HD2' ' H ' ' A' ' 36' ' ' ASP . 0.0 OUTLIER -174.04 174.93 2.87 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.621 -1.251 . . . . 71.430000000000007 107.621 -175.315 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.535 ' H ' ' HD2' ' A' ' 35' ' ' LYS . 4.0 p30 -65.27 143.54 98.8 Favored Pre-proline 0 C--N 1.328 -0.366 0 C-N-CA 120.266 -0.573 . . . . 74.530000000000001 109.837 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.658 ' HB2' ' OD1' ' A' ' 42' ' ' ASP . 88.7 Cg_endo -91.0 172.64 3.01 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.227 2.618 . . . . 70.219999999999999 112.554 -176.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.452 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 5.8 m 174.4 23.63 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.51 0.724 . . . . 62.109999999999999 110.912 -170.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.429 ' O ' ' HB3' ' A' ' 42' ' ' ASP . 61.2 t80 -150.7 157.67 43.23 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 120.143 -0.623 . . . . 74.420000000000002 111.862 -170.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 65.2 t30 56.89 58.76 3.84 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.769 -0.65 . . . . 75.200000000000003 110.987 177.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.1 t70 50.27 74.29 0.22 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.071 -0.968 . . . . 75.340000000000003 111.082 -178.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.658 ' OD1' ' HB2' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -158.38 -51.52 0.06 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.032 -0.986 . . . . 70.120000000000005 110.067 -176.306 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.452 ' HA ' ' HA ' ' A' ' 38' ' ' SER . 8.7 t80 58.19 -0.35 0.11 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.582 0.956 . . . . 75.219999999999999 113.582 174.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.438 ' HA2' ' HG2' ' A' ' 37' ' ' PRO . . . 122.38 55.27 0.21 Allowed Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.474 -0.87 . . . . 74.519999999999996 112.752 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 49.7 mm -58.98 -25.39 29.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.112 0.482 . . . . 75.239999999999995 110.943 175.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.433 ' HB2' ' HD3' ' A' ' 37' ' ' PRO . 24.0 mm-40 -82.63 4.31 25.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.395 -0.366 . . . . 65.319999999999993 111.864 179.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.7 t -137.63 74.79 45.39 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-O 121.885 0.85 . . . . 60.32 109.673 172.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -89.9 99.54 0.3 Allowed 'Trans proline' 0 N--CA 1.448 -1.2 0 C-N-CA 122.941 2.428 . . . . 72.099999999999994 112.775 -175.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 38.3 m -129.39 -62.69 0.97 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.849 -0.614 . . . . 71.450000000000003 109.759 174.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.83 -43.78 13.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.12 0.486 . . . . 71.230000000000004 110.124 178.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.9 pp -75.58 -11.12 59.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.865 -0.607 . . . . 73.420000000000002 110.613 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.562 ' O ' ' HB2' ' A' ' 56' ' ' GLN . 26.9 t70 -62.42 -50.48 71.33 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.991 -0.55 . . . . 63.020000000000003 110.439 178.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -63.41 -32.47 73.92 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.049 -0.523 . . . . 73.010000000000005 110.908 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.535 ' O ' HG13 ' A' ' 58' ' ' ILE . 57.4 t80 -68.11 -55.33 12.83 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.035 -0.53 . . . . 74.25 110.227 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.3 t -67.85 -19.22 65.02 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.25 0.548 . . . . 75.409999999999997 110.524 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.562 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 2.8 tp-100 -67.38 -41.3 85.25 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.795 -0.638 . . . . 51.200000000000003 109.4 178.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.94 -29.28 61.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.505 -0.771 . . . . 74.219999999999999 110.798 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.535 HG13 ' O ' ' A' ' 54' ' ' PHE . 20.7 mt -63.84 -35.61 73.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.123 0.487 . . . . 75.030000000000001 110.552 178.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -66.92 -22.14 65.96 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.132 -0.486 . . . . 51.229999999999997 111.263 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.3 m -85.93 -30.07 23.11 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.018 -0.537 . . . . 73.340000000000003 111.073 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 58' ' ' ILE . 3.9 pt20 -83.14 -3.33 57.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.795 0.331 . . . . 64.209999999999994 111.093 -176.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.513 HG12 ' O ' ' A' ' 58' ' ' ILE . 47.5 mm -74.95 -37.61 41.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.891 0.377 . . . . 75.120000000000005 110.343 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.567 ' H ' HD22 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -65.5 -41.89 92.72 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.008 -0.542 . . . . 74.530000000000001 110.792 -175.778 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -77.79 -22.51 69.12 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.631 -0.795 . . . . 54.140000000000001 112.346 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -77.22 -6.83 86.63 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.982 -0.627 . . . . 33.530000000000001 112.435 -178.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.616 ' O ' HG12 ' A' ' 70' ' ' ILE . 97.9 mt -70.11 -29.66 66.66 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 122.819 -0.224 . . . . 72.230000000000004 111.018 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 91.2 mt -54.28 -46.89 72.81 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.308 -0.405 . . . . 70.319999999999993 111.995 -175.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -70.8 -21.95 62.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.222 -0.445 . . . . 75.109999999999999 111.255 -178.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -94.1 -7.93 41.07 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.311 -0.404 . . . . 53.439999999999998 111.032 -178.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.616 HG12 ' O ' ' A' ' 66' ' ' LEU . 31.9 mm -81.07 -26.39 10.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.413 -0.358 . . . . 71.409999999999997 110.368 177.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -54.33 -64.47 0.82 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.068 -0.515 . . . . 61.43 111.073 -177.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 68.9 p 52.15 -168.84 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.611 0.765 . . . . 53.310000000000002 112.643 178.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 104.55 2.16 43.64 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.58 -0.819 . . . . 71.019999999999996 113.041 175.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.467 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 2.3 pptp? -56.7 144.54 65.18 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-O 120.634 0.254 . . . . 51.439999999999998 111.343 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 74' ' ' LYS . 11.5 Cg_exo -71.49 -30.56 14.99 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 122.923 2.415 . . . . 65.030000000000001 112.3 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 168.67 -162.37 36.13 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.983 -0.627 . . . . 72.120000000000005 111.902 -179.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.489 ' HA ' HD12 ' A' ' 87' ' ' ILE . 29.3 ptt180 -151.04 171.78 16.77 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.279 -0.267 . . . . 45.020000000000003 110.279 -178.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.409 ' HB3' HG13 ' A' ' 85' ' ' VAL . 27.5 ttt -100.98 119.03 38.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.986 0.422 . . . . 73.310000000000002 111.043 -177.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 46.1 t -81.87 107.39 13.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.088 -0.505 . . . . 63.219999999999999 110.154 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.779 ' HB ' ' O ' ' A' ' 83' ' ' TYR . 1.8 m -107.95 168.39 9.31 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.192 -0.458 . . . . 43.310000000000002 110.139 -178.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.44 ' H ' HG22 ' A' ' 80' ' ' THR . 22.3 p-10 -89.03 -65.33 1.03 Allowed 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.172 0.434 . . . . 72.310000000000002 112.172 -175.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -94.66 -2.72 50.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.205 0.526 . . . . 75.510000000000005 111.192 -176.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.779 ' O ' ' HB ' ' A' ' 80' ' ' THR . 31.8 m-85 -130.73 149.95 52.14 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.97 -0.752 . . . . 63.340000000000003 108.97 177.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.581 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 4.7 mp -117.5 93.92 2.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 108.914 -0.773 . . . . 71.040000000000006 108.914 172.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.409 HG13 ' HB3' ' A' ' 78' ' ' MET . 4.9 p -91.57 101.29 12.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.955 0.883 . . . . 64.329999999999998 110.216 178.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -93.81 127.26 39.45 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.339 -0.846 . . . . 74.510000000000005 109.967 -177.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.489 HD12 ' HA ' ' A' ' 77' ' ' ARG . 63.5 mt -93.37 109.47 21.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.162 -0.472 . . . . 73.150000000000006 110.465 -178.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -120.77 176.24 5.63 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.915 -0.584 . . . . 54.140000000000001 110.474 179.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -139.11 123.81 18.54 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.691 -0.485 . . . . 62.210000000000001 109.691 176.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.44 ' O ' ' HB3' ' A' ' 91' ' ' ASP . 14.8 ptm180 -106.23 99.62 9.19 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.712 -0.676 . . . . 75.439999999999998 110.057 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.44 ' HB3' ' O ' ' A' ' 90' ' ' ARG . 4.8 t70 73.38 -57.97 0.61 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.878 -0.601 . . . . 71.019999999999996 111.696 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -172.2 32.07 0.12 Allowed Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 111.076 -0.809 . . . . 75.319999999999993 111.076 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.468 HE21 ' HA ' ' A' ' 93' ' ' GLN . 0.0 OUTLIER -135.8 124.52 23.85 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.613 -0.514 . . . . 62.409999999999997 109.613 -179.175 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -64.37 120.09 11.58 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.14 0.495 . . . . 52.240000000000002 110.405 176.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.423 HE22 ' HG3' ' A' ' 110' ' ' GLN . 24.2 tp60 -102.17 115.77 31.26 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.502 -0.772 . . . . 55.530000000000001 109.932 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 12.9 tp -92.62 91.05 7.37 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.303 -0.629 . . . . 75.109999999999999 109.303 178.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -83.59 96.24 8.58 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.365 -0.38 . . . . 43.409999999999997 110.77 -177.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.412 ' HB ' ' HB3' ' A' ' 107' ' ' SER . 47.1 t -88.93 104.87 15.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.332 0.587 . . . . 72.019999999999996 110.623 176.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.581 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 31.0 m -96.69 112.48 24.21 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.109 -0.95 . . . . 64.319999999999993 109.867 176.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.477 ' HB3' ' N ' ' A' ' 105' ' ' GLN . 12.6 t70 -71.26 130.93 42.66 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.185 -0.462 . . . . 63.399999999999999 111.125 178.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 -94.48 -11.47 29.63 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.188 0.518 . . . . 70.420000000000002 110.469 -176.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -86.3 -62.48 1.5 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.113 -0.494 . . . . 73.140000000000001 111.509 -176.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 63.6 p -111.35 -27.88 8.46 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.018 0.437 . . . . 72.120000000000005 111.393 -176.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 103.04 34.41 4.0 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.786 -0.643 . . . . 65.239999999999995 112.54 178.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.477 ' N ' ' HB3' ' A' ' 100' ' ' ASP . 51.3 mt-30 -71.84 115.9 11.59 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.984 -0.376 . . . . 72.040000000000006 109.984 174.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 21.1 m -86.55 92.16 8.79 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.059 0.457 . . . . 61.32 110.4 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.412 ' HB3' ' HB ' ' A' ' 98' ' ' VAL . 22.6 t -97.43 86.78 3.95 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.221 0.534 . . . . 71.150000000000006 110.126 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.4 m -91.42 95.54 10.03 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.054 -0.521 . . . . 61.340000000000003 110.289 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 57.0 mt -102.89 136.29 36.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.827 -0.624 . . . . 73.010000000000005 110.577 -175.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.423 ' HG3' HE22 ' A' ' 95' ' ' GLN . 32.4 mt-30 -95.59 163.32 13.26 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.859 0.361 . . . . 61.100000000000001 110.553 173.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.6 p -66.43 118.69 10.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.002 -0.544 . . . . 75.109999999999999 110.518 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 17.6 t -93.64 90.4 6.6 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.16 -0.473 . . . . 73.519999999999996 110.462 -178.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 59.8 -130.54 49.82 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.567 -0.742 . . . . 53.210000000000001 112.816 178.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 96.0 mt -127.93 17.1 6.78 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.858 0.361 . . . . 71.239999999999995 110.595 -177.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -77.71 -38.36 47.46 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.312 -0.403 . . . . 62.340000000000003 110.302 178.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 10.0 t30 67.86 134.39 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.449 0 O-C-N 123.921 0.763 . . . . 63.439999999999998 112.108 178.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -62.15 105.43 0.59 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.031 -0.532 . . . . 61.130000000000003 109.735 175.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.4 m -125.18 175.38 7.44 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.889 0.376 . . . . 75.219999999999999 111.242 -173.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.449 HG22 ' H ' ' A' ' 120' ' ' ASP . 3.3 m -122.17 170.55 9.77 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.991 -0.744 . . . . 73.200000000000003 108.991 178.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.449 ' H ' HG22 ' A' ' 119' ' ' THR . 2.6 p-10 -72.11 -39.55 68.81 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 117.81 0.277 . . . . 62.409999999999997 111.287 -178.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 64.15 104.72 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.265 0.555 . . . . 75.239999999999995 111.474 -178.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -85.28 123.5 30.83 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.864 -0.607 . . . . 74.340000000000003 110.327 -177.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 23.2 t60 -86.29 -47.33 9.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.883 0.373 . . . . 64.150000000000006 110.616 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 70.3 t60 -108.78 105.94 15.74 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.994 -0.548 . . . . 75.209999999999994 110.735 -176.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 23.3 t60 -89.15 -47.75 7.87 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.582 -0.525 . . . . 71.409999999999997 109.582 175.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 66.9 t-80 -165.1 141.03 5.49 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.934 -0.765 . . . . 73.129999999999995 108.934 178.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 41.3 p-80 . . . . . 0 C--O 1.243 0.743 0 CA-C-O 118.283 -0.865 . . . . 54.43 109.826 179.392 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.2 mtt . . . . . 0 N--CA 1.48 1.063 0 CA-C-O 120.823 0.344 . . . . 75.5 110.429 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.87 162.43 29.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 74.230000000000004 111.058 -178.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -92.32 73.64 1.46 Allowed Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.85 -0.691 . . . . 65.140000000000001 112.138 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.3 p -74.01 119.41 18.18 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.512 0.196 . . . . 72.25 110.999 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.418 ' O ' ' N ' ' A' ' 7' ' ' PHE . 4.2 mpp? 67.61 -71.93 0.1 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.689 0.796 . . . . 75.430000000000007 111.305 -178.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.427 HG23 ' H ' ' A' ' 7' ' ' PHE . 15.2 t 51.56 -65.57 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.652 1.581 . . . . 74.209999999999994 113.435 -177.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.427 ' H ' HG23 ' A' ' 6' ' ' THR . 83.4 m-85 -89.81 -61.06 1.77 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.369 -0.604 . . . . 75.040000000000006 109.369 175.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 59.33 28.03 17.26 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.614 0.721 . . . . 73.409999999999997 111.181 176.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -108.71 98.41 7.92 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 121.981 -0.45 . . . . 73.239999999999995 110.124 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -125.68 -175.7 3.41 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.63 -0.713 . . . . 72.030000000000001 109.601 177.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.2 t30 63.67 84.92 0.18 Allowed Pre-proline 0 N--CA 1.467 0.39 0 O-C-N 123.737 0.648 . . . . 63.140000000000001 110.521 -177.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -81.43 131.56 7.56 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.942 2.428 . . . . 71.329999999999998 112.25 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.5 m120 70.58 103.35 0.06 Allowed 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.41 0.892 . . . . 75.430000000000007 113.41 176.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -90.72 146.06 24.3 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.461 -0.791 . . . . 75.230000000000004 109.14 166.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.86 -64.27 1.75 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.49 -0.862 . . . . 71.230000000000004 112.227 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 140.06 -178.66 19.66 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.956 -0.64 . . . . 73.329999999999998 111.8 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -121.59 142.68 36.26 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.705 0.253 . . . . 72.140000000000001 110.62 -178.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -90.89 152.01 3.99 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.931 2.421 . . . . 61.409999999999997 112.874 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -99.11 153.6 18.77 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.188 -0.671 . . . . 74.519999999999996 109.188 176.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -128.63 157.7 40.58 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.946 0.403 . . . . 74.239999999999995 110.944 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -105.41 5.12 40.87 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.736 -0.745 . . . . 62.439999999999998 111.973 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 72.15 -55.5 0.67 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.773 0.829 . . . . 64.099999999999994 111.57 -178.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 56.39 45.95 21.8 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.102 0.477 . . . . 71.25 111.35 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.4 pp -77.23 -6.38 52.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.043 -0.526 . . . . 62.32 111.191 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 89.5 mt 63.9 174.26 0.18 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.503 -0.771 . . . . 52.439999999999998 112.618 174.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 -127.25 -82.51 0.61 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.662 -0.699 . . . . 73.200000000000003 109.384 175.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.9 p -172.12 134.93 0.75 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.259 -0.882 . . . . 71.349999999999994 109.092 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -138.36 116.9 12.09 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.842 0.353 . . . . 74.120000000000005 111.279 -177.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 13.9 tm0? -108.01 -36.34 6.37 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.478 -0.564 . . . . 65.310000000000002 109.478 178.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.409 ' HB2' ' HB2' ' A' ' 54' ' ' PHE . . . 75.51 -37.49 0.33 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.749 0.82 . . . . 75.25 112.759 173.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.683 ' HG2' ' H ' ' A' ' 32' ' ' ASN . 0.0 OUTLIER 44.78 -84.76 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.794 1.238 . . . . 75.530000000000001 114.066 179.528 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.683 ' H ' ' HG2' ' A' ' 31' ' ' GLN . 39.6 t-20 -111.97 134.41 53.55 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.665 0.269 . . . . 64.010000000000005 110.677 -171.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.421 ' C ' ' H ' ' A' ' 35' ' ' LYS . 5.6 p -64.55 -51.53 62.35 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.746 -0.464 . . . . 74.209999999999994 109.746 174.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 57.9 t80 71.9 -25.4 0.18 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.793 0.837 . . . . 74.430000000000007 112.282 173.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.552 ' HG2' HG21 ' A' ' 47' ' ' THR . 22.8 tptm -140.35 31.19 1.92 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.256 0.551 . . . . 71.430000000000007 109.719 -178.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.454 ' HB2' ' HD2' ' A' ' 37' ' ' PRO . 2.9 p30 -61.18 156.9 46.97 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.088 -0.505 . . . . 74.530000000000001 111.288 -179.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.454 ' HD2' ' HB2' ' A' ' 36' ' ' ASP . 9.5 Cg_endo -50.95 142.98 32.16 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.497 2.798 . . . . 70.219999999999999 113.851 -178.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 29.8 t -139.31 135.64 34.01 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.2 -0.909 . . . . 62.109999999999999 109.325 178.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 59.4 t80 56.86 68.72 0.82 Allowed 'General case' 0 C--O 1.234 0.252 0 O-C-N 123.778 0.674 . . . . 74.420000000000002 110.485 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 17.2 m120 63.06 24.29 14.41 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.422 -0.808 . . . . 75.200000000000003 110.784 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.42 ' HB2' ' HB3' ' A' ' 37' ' ' PRO . 26.8 t70 63.52 105.98 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.538 -0.755 . . . . 75.340000000000003 111.625 -175.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -88.2 -42.24 12.43 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.851 -0.613 . . . . 70.120000000000005 109.863 175.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -169.38 19.36 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.854 -0.612 . . . . 75.219999999999999 110.133 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -73.17 -38.38 54.54 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.506 -0.854 . . . . 74.519999999999996 112.182 -172.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.3 mt -76.82 -18.45 14.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.665 0.745 . . . . 75.239999999999995 109.834 -178.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -95.6 8.91 42.02 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.484 -0.78 . . . . 65.319999999999993 111.338 -177.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.552 HG21 ' HG2' ' A' ' 35' ' ' LYS . 9.8 m -115.97 86.57 16.85 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 120.725 0.298 . . . . 60.32 110.304 175.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -77.37 84.57 1.93 Allowed 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.122 1.881 . . . . 72.099999999999994 111.896 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.7 m -86.07 -80.15 0.24 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.896 -0.593 . . . . 71.450000000000003 111.159 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -93.84 -37.85 11.54 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.807 0.337 . . . . 71.230000000000004 111.355 -177.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.582 HD23 ' H ' ' A' ' 51' ' ' LEU . 1.7 pt? -66.64 -13.83 61.68 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.01 -0.541 . . . . 73.420000000000002 111.273 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -49.01 -53.46 19.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.674 -0.694 . . . . 63.020000000000003 112.509 -175.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.45 -30.96 67.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.826 0.346 . . . . 73.010000000000005 111.349 -178.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.496 ' O ' HG13 ' A' ' 58' ' ' ILE . 67.2 t80 -67.23 -44.64 78.96 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.192 -0.458 . . . . 74.25 110.407 -178.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 87.0 m -55.34 -37.2 67.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.425 0.631 . . . . 75.409999999999997 111.557 178.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -80.19 -31.7 38.73 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.796 -0.638 . . . . 51.200000000000003 110.771 -174.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.81 -25.19 68.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.031 -0.532 . . . . 74.219999999999999 110.263 175.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.531 ' O ' HG13 ' A' ' 62' ' ' ILE . 2.5 mt -86.28 -45.37 16.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.974 -0.557 . . . . 75.030000000000001 110.968 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.454 ' HA ' HD12 ' A' ' 62' ' ' ILE . 76.1 mt-30 -59.14 -30.45 68.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.769 0.319 . . . . 51.229999999999997 111.283 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.5 m -66.58 -37.96 86.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.352 -0.386 . . . . 73.340000000000003 111.152 178.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.527 ' HG2' ' O ' ' A' ' 58' ' ' ILE . 11.1 pt20 -83.19 -20.9 33.8 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.794 0.33 . . . . 64.209999999999994 110.943 -178.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.531 HG13 ' O ' ' A' ' 58' ' ' ILE . 83.9 mt -66.5 -31.1 52.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.996 0.427 . . . . 75.120000000000005 109.894 177.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 91.9 mt -57.65 -32.85 67.69 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.734 -0.666 . . . . 74.530000000000001 110.933 178.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -74.51 -40.47 39.05 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.993 -0.623 . . . . 54.140000000000001 111.602 176.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -63.71 -25.99 69.49 Favored Glycine 0 C--N 1.33 0.2 0 C-N-CA 120.992 -0.623 . . . . 33.530000000000001 112.286 178.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 62' ' ' ILE . 91.8 mt -66.22 -18.34 65.29 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.706 0.289 . . . . 72.230000000000004 110.916 178.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 93.7 mt -85.59 5.97 29.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.076 0.465 . . . . 70.319999999999993 110.563 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.9 t -126.11 -42.21 1.88 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.947 -0.57 . . . . 75.109999999999999 110.587 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.414 ' ND2' HD21 ' A' ' 97' ' ' ASN . 86.7 m-20 -75.73 5.36 6.34 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.699 0.629 . . . . 53.439999999999998 112.699 -173.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.402 HG12 ' O ' ' A' ' 66' ' ' LEU . 50.4 mm -99.73 -13.57 8.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.653 0.739 . . . . 71.409999999999997 109.664 176.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -98.59 8.92 44.32 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.589 -0.732 . . . . 61.43 110.678 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.2 p -86.77 -164.18 1.03 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.851 -0.613 . . . . 53.310000000000002 110.45 178.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 122.07 7.74 7.65 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.7 -0.762 . . . . 71.019999999999996 112.311 -177.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -57.44 148.12 56.06 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 120.665 0.269 . . . . 51.439999999999998 111.262 178.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.68 -10.34 23.38 Favored 'Trans proline' 0 CA--C 1.532 0.407 0 C-N-CA 122.587 2.191 . . . . 65.030000000000001 112.666 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -83.74 56.12 5.04 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 121.131 -0.557 . . . . 72.120000000000005 112.435 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -106.68 -176.01 2.96 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.003 -0.369 . . . . 45.020000000000003 110.003 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.464 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 27.6 ttt -122.42 115.63 22.58 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.729 0.3 . . . . 73.310000000000002 110.472 178.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 53.1 t -85.5 97.65 5.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.373 0.606 . . . . 63.219999999999999 110.696 -178.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.697 ' HB ' ' O ' ' A' ' 83' ' ' TYR . 6.7 m -113.65 148.86 35.53 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.307 -0.86 . . . . 43.310000000000002 108.854 177.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -73.52 -59.64 2.62 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.007 0.373 . . . . 72.310000000000002 112.007 -170.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -82.82 -14.16 54.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.795 0.331 . . . . 75.510000000000005 111.448 -174.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.697 ' O ' ' HB ' ' A' ' 80' ' ' THR . 59.4 m-85 -133.99 121.3 21.41 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.334 -0.394 . . . . 63.340000000000003 110.482 -177.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.569 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 2.9 mp -81.91 102.56 7.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.089 -0.708 . . . . 71.040000000000006 109.089 175.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.464 ' HB ' ' HB3' ' A' ' 78' ' ' MET . 47.3 t -96.69 94.31 4.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.715 -0.675 . . . . 64.329999999999998 110.769 -176.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -98.45 115.62 28.91 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.343 -0.614 . . . . 74.510000000000005 109.343 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 71.6 mt -82.02 94.66 2.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.939 -0.573 . . . . 73.150000000000006 110.673 -176.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.05 74.54 8.08 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.687 -0.688 . . . . 54.140000000000001 111.102 -177.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -88.59 92.73 9.31 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.147 -0.686 . . . . 62.210000000000001 109.147 173.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.441 ' HA ' ' HD2' ' A' ' 90' ' ' ARG . 13.6 tpt180 -133.68 154.16 51.14 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.818 -0.628 . . . . 75.439999999999998 109.726 -178.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.9 t70 69.93 -68.18 0.21 Allowed 'General case' 0 N--CA 1.465 0.317 0 O-C-N 124.082 0.864 . . . . 71.019999999999996 111.151 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 177.74 23.62 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.736 -0.745 . . . . 75.319999999999993 113.433 178.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.477 HE21 ' HA ' ' A' ' 93' ' ' GLN . 0.0 OUTLIER -138.1 152.5 48.83 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 122.265 -0.55 . . . . 62.409999999999997 110.264 178.351 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -89.61 94.58 9.91 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.761 -0.459 . . . . 52.240000000000002 109.761 176.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.474 ' HG2' ' OD1' ' A' ' 97' ' ' ASN . 7.3 tt0 -97.31 109.29 22.08 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.137 0.494 . . . . 55.530000000000001 109.692 -179.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.543 ' HB3' ' HB ' ' A' ' 109' ' ' ILE . 29.0 tp -90.11 98.64 11.89 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.868 -0.605 . . . . 75.109999999999999 110.389 -177.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.483 ' OD1' HG23 ' A' ' 108' ' ' THR . 6.5 m-20 -90.61 93.44 9.27 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.283 0.564 . . . . 43.409999999999997 110.532 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.439 ' CG1' ' HD1' ' A' ' 83' ' ' TYR . 56.1 t -92.8 114.18 29.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.658 -0.701 . . . . 72.019999999999996 110.677 178.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.569 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 30.7 m -103.32 109.23 20.77 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.845 -0.616 . . . . 64.319999999999993 110.077 178.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.587 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 25.2 t70 -62.32 141.23 58.4 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.489 -0.323 . . . . 63.399999999999999 110.777 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.07 -26.69 19.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.259 -0.428 . . . . 70.420000000000002 110.251 -177.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 32.7 mtmm -70.04 -69.58 0.34 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.374 -0.375 . . . . 73.140000000000001 111.149 -174.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 12.0 t -99.05 -26.8 14.11 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.243 0.544 . . . . 72.120000000000005 109.716 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.587 ' HA2' ' O ' ' A' ' 100' ' ' ASP . . . 83.65 79.45 1.06 Allowed Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.544 -0.753 . . . . 65.239999999999995 112.909 176.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.491 ' H ' ' HB3' ' A' ' 100' ' ' ASP . 68.6 mm-40 -124.69 144.16 50.36 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.587 -0.523 . . . . 72.040000000000006 109.587 174.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.9 m -89.05 96.11 10.59 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.123 0.487 . . . . 61.32 110.724 -178.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.435 ' HB3' ' HB ' ' A' ' 98' ' ' VAL . 47.4 t -88.17 80.83 7.51 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.454 -0.573 . . . . 71.150000000000006 109.454 177.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.483 HG23 ' OD1' ' A' ' 97' ' ' ASN . 28.2 m -82.35 101.49 10.62 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.901 -0.591 . . . . 61.340000000000003 110.709 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.543 ' HB ' ' HB3' ' A' ' 96' ' ' LEU . 54.5 mt -99.88 92.34 2.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.052 -0.522 . . . . 73.010000000000005 110.514 -178.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -72.56 106.91 4.81 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.723 -0.473 . . . . 61.100000000000001 109.723 175.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.2 t -76.23 104.75 4.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.688 -0.486 . . . . 75.109999999999999 109.688 177.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.3 t -147.86 125.46 11.77 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.749 -0.659 . . . . 73.519999999999996 110.31 -178.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 92.77 52.7 2.07 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.915 -0.66 . . . . 53.210000000000001 113.035 175.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 77.4 mt -106.16 -75.81 0.62 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.011 -0.366 . . . . 71.239999999999995 110.011 174.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 66.38 15.33 10.06 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.605 -0.725 . . . . 62.340000000000003 111.202 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -100.78 93.49 5.58 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.632 0.729 . . . . 63.439999999999998 109.705 173.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -105.26 101.74 11.27 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.496 -0.775 . . . . 61.130000000000003 110.547 -176.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 38.3 m -83.3 101.8 11.53 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.306 -0.628 . . . . 75.219999999999999 109.306 174.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -57.8 120.27 8.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.983 -0.553 . . . . 73.200000000000003 110.587 -177.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -120.92 116.21 24.69 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.84 -0.618 . . . . 62.409999999999997 110.352 -177.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -141.08 95.32 2.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.21 -0.45 . . . . 75.239999999999995 110.494 178.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 26.0 m80 63.95 -168.96 0.2 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.884 -0.598 . . . . 74.340000000000003 111.325 175.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 37.8 m80 58.42 46.71 14.8 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.811 -0.632 . . . . 64.150000000000006 110.991 176.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -84.09 11.36 8.14 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.681 -0.69 . . . . 75.209999999999994 111.035 -177.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 23.7 t-80 -139.57 109.64 6.44 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.221 -0.445 . . . . 71.409999999999997 109.879 175.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -147.14 139.2 24.45 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.692 -0.685 . . . . 73.129999999999995 109.998 176.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.619 -0.705 . . . . 54.43 109.56 -176.022 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 N--CA 1.482 1.126 0 N-CA-C 109.957 -0.386 . . . . 75.5 109.957 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -143.17 129.1 19.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.067 0.461 . . . . 74.230000000000004 111.171 -178.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -146.39 94.44 0.16 Allowed Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 110.812 -0.915 . . . . 65.140000000000001 110.812 178.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 14.4 p -73.0 -70.5 0.35 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 111.721 0.267 . . . . 72.25 111.721 -173.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 82.3 mtp 59.53 -169.65 0.14 Allowed 'General case' 0 N--CA 1.465 0.312 0 O-C-N 123.559 0.537 . . . . 75.430000000000007 110.829 -177.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 76.9 p 52.98 92.76 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.666 0.786 . . . . 74.209999999999994 112.574 176.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -76.08 145.82 39.81 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.148 -0.478 . . . . 75.040000000000006 109.718 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -148.71 94.77 2.32 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.422 0.629 . . . . 73.409999999999997 111.165 178.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -167.14 151.56 6.98 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.174 -0.921 . . . . 73.239999999999995 109.476 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 -108.57 -76.45 0.61 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.476 -0.329 . . . . 72.030000000000001 110.682 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 53.83 65.17 5.75 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-N 115.407 -0.815 . . . . 63.140000000000001 110.94 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -76.18 -32.89 3.82 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.903 2.402 . . . . 71.329999999999998 112.469 -175.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.7 m120 67.7 113.79 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 O-C-N 123.799 0.687 . . . . 75.430000000000007 111.328 -174.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -145.35 175.53 10.23 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.566 -0.743 . . . . 75.230000000000004 109.598 -178.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 107.44 -154.27 16.64 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.606 -0.807 . . . . 71.230000000000004 112.036 -178.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.63 94.96 1.32 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.885 -0.674 . . . . 73.329999999999998 111.707 -178.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -91.76 144.27 29.15 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-O 120.57 0.224 . . . . 72.140000000000001 110.675 -176.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.55 149.99 27.6 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.501 2.134 . . . . 61.409999999999997 112.253 176.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -141.23 98.55 3.39 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.469 -0.567 . . . . 74.519999999999996 109.469 175.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -134.1 145.45 49.36 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.981 -0.554 . . . . 74.239999999999995 110.338 -178.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -163.51 -171.31 29.59 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 111.059 -0.817 . . . . 62.439999999999998 111.059 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -152.14 104.53 2.97 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 117.029 0.414 . . . . 64.099999999999994 111.332 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -112.42 119.51 38.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.099 -0.5 . . . . 71.25 109.657 175.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.492 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 5.4 mp -127.66 171.89 11.26 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 110.043 -0.354 . . . . 62.32 110.043 -179.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 24' ' ' LEU . 0.5 OUTLIER 47.49 -167.89 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.44 1.096 . . . . 52.439999999999998 112.814 -179.758 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 29.1 p-10 -166.37 166.79 16.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.904 -0.589 . . . . 73.200000000000003 109.686 177.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 10.4 p -119.19 159.14 24.58 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.41 -0.359 . . . . 71.349999999999994 110.336 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -155.05 135.16 13.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.403 -0.362 . . . . 74.120000000000005 110.841 -178.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -112.43 -83.79 0.59 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.16 -0.473 . . . . 65.310000000000002 110.88 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -176.64 175.31 1.72 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.909 -0.587 . . . . 75.25 109.49 -177.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -111.96 134.27 53.63 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.73 0.3 . . . . 75.530000000000001 110.388 176.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -70.91 101.09 2.08 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.405 -0.591 . . . . 64.010000000000005 109.405 175.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.8 p -145.71 -177.92 5.83 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.319 -0.401 . . . . 74.209999999999994 111.103 -173.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.494 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 57.3 m-85 -112.44 27.84 9.29 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.65 -0.5 . . . . 74.430000000000007 109.65 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 34' ' ' TYR . 0.3 OUTLIER 70.97 16.35 6.5 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.663 -0.698 . . . . 71.430000000000007 109.426 -174.533 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.459 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 5.6 p-10 -74.7 149.57 86.0 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 114.782 -1.099 . . . . 74.530000000000001 111.537 -177.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.748 ' HD2' ' HA2' ' A' ' 44' ' ' GLY . 4.1 Cg_exo -77.17 173.84 13.74 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.886 2.391 . . . . 70.219999999999999 111.368 173.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.6 t -168.21 146.78 4.43 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.639 -0.504 . . . . 62.109999999999999 109.639 -174.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 16.8 t80 69.3 162.52 0.22 Allowed 'General case' 0 CA--C 1.532 0.266 0 O-C-N 123.879 0.737 . . . . 74.420000000000002 110.446 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 59.94 57.49 3.06 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.428 -0.351 . . . . 75.200000000000003 110.489 -178.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 46.95 24.62 0.38 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.553 1.141 . . . . 75.340000000000003 113.466 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -121.55 123.16 41.33 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.588 -0.523 . . . . 70.120000000000005 109.588 173.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -130.57 32.05 4.46 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.381 -0.599 . . . . 75.219999999999999 109.381 -179.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.748 ' HA2' ' HD2' ' A' ' 37' ' ' PRO . . . 117.75 35.75 1.04 Allowed Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 115.462 -0.79 . . . . 74.519999999999996 111.892 -179.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 59.7 mt -84.45 -48.47 16.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.453 -0.573 . . . . 75.239999999999995 109.453 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.583 ' HB2' ' HG3' ' A' ' 37' ' ' PRO . 62.9 mm-40 -67.5 123.87 21.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.906 -0.588 . . . . 65.319999999999993 109.755 173.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.3 m -124.24 89.12 52.27 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.106 -0.497 . . . . 60.32 110.742 -175.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.404 ' C ' ' HB2' ' A' ' 52' ' ' ASP . 24.3 Cg_exo -61.67 107.21 0.49 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.881 2.387 . . . . 72.099999999999994 112.385 -177.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.7 m -140.43 -36.9 0.47 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.965 -0.562 . . . . 71.450000000000003 110.371 175.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -92.45 -33.72 14.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.296 0.569 . . . . 71.230000000000004 110.604 176.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.431 ' H ' HD23 ' A' ' 51' ' ' LEU . 0.7 OUTLIER -101.47 0.0 35.95 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.839 -0.619 . . . . 73.420000000000002 110.665 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' A' ' 56' ' ' GLN . 14.9 t70 -62.38 -62.9 1.44 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.738 -0.664 . . . . 63.020000000000003 111.671 -173.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -69.26 -18.24 63.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.235 0.54 . . . . 73.010000000000005 110.085 -177.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -73.37 -58.15 3.51 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.553 -0.749 . . . . 74.25 110.658 178.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.5 t -70.3 -18.97 63.11 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.229 0.538 . . . . 75.409999999999997 110.461 -178.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.405 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 3.1 tp-100 -61.82 -35.51 78.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.479 -0.782 . . . . 51.200000000000003 109.978 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.98 -19.96 31.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.893 -0.594 . . . . 74.219999999999999 110.983 -179.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.426 ' O ' HG13 ' A' ' 62' ' ' ILE . 24.7 mt -71.74 -27.7 28.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.052 -0.522 . . . . 75.030000000000001 110.891 -177.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -54.88 -35.72 64.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.442 -0.344 . . . . 51.229999999999997 111.239 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.9 m -62.43 -50.41 71.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.989 0.424 . . . . 73.340000000000003 110.975 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -74.45 -17.23 60.81 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.32 -0.4 . . . . 64.209999999999994 110.846 -177.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.554 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 74.5 mt -72.8 -50.17 35.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.522 -0.547 . . . . 75.120000000000005 109.522 173.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 95.5 mt -60.45 -42.04 95.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.881 -0.599 . . . . 74.530000000000001 110.356 177.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.401 ' HA2' ' HD2' ' A' ' 90' ' ' ARG . . . -59.72 -43.85 97.46 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.852 -0.613 . . . . 54.140000000000001 112.215 176.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -65.22 -35.49 91.68 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 121.24 -0.505 . . . . 33.530000000000001 112.432 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' A' ' 62' ' ' ILE . 98.0 mt -61.66 -52.12 65.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.674 0.273 . . . . 72.230000000000004 110.595 178.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.6 mt -68.7 -31.67 70.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.001 -0.545 . . . . 70.319999999999993 111.048 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.501 ' OG ' ' HG2' ' A' ' 74' ' ' LYS . 38.3 t -56.5 -49.63 74.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.785 -0.643 . . . . 75.109999999999999 110.908 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -72.49 -19.67 61.5 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.234 -0.439 . . . . 53.439999999999998 111.768 -177.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.488 HG12 ' O ' ' A' ' 66' ' ' LEU . 46.4 mm -75.89 -36.12 31.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.13 0.49 . . . . 71.409999999999997 110.154 177.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -71.3 -57.84 4.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.732 -0.667 . . . . 61.43 110.707 -177.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.3 m -157.09 156.72 33.27 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.454 -0.339 . . . . 53.310000000000002 110.373 -176.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -70.64 64.07 0.85 Allowed Glycine 0 C--N 1.332 0.344 0 N-CA-C 111.685 -0.566 . . . . 71.019999999999996 111.685 172.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.501 ' HG2' ' OG ' ' A' ' 68' ' ' SER . 2.1 pptp? -56.45 157.95 8.78 Favored Pre-proline 0 C--N 1.324 -0.524 0 C-N-CA 124.142 0.977 . . . . 51.439999999999998 113.283 -175.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.41 159.73 36.0 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 123.093 2.529 . . . . 65.030000000000001 111.037 171.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -85.82 -165.31 40.45 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 120.86 -0.686 . . . . 72.120000000000005 112.686 -178.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.433 HH11 ' HD2' ' A' ' 77' ' ' ARG . 5.7 ptp85 -99.64 127.04 45.75 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 122.559 -0.377 . . . . 45.020000000000003 110.245 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 27.1 ttt -82.26 107.35 14.87 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.975 0.416 . . . . 73.310000000000002 110.42 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 45.4 t -76.71 105.92 6.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.875 -0.602 . . . . 63.219999999999999 109.728 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.52 ' HB ' ' O ' ' A' ' 83' ' ' TYR . 5.3 m -82.25 160.06 23.05 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.622 -0.717 . . . . 43.310000000000002 110.262 -178.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -54.48 -60.49 3.28 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.136 0.493 . . . . 72.310000000000002 111.33 -177.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.848 ' HB3' ' HD3' ' A' ' 101' ' ' ARG . 1.6 m-20 -110.43 -38.56 5.19 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.811 -0.631 . . . . 75.510000000000005 111.243 -175.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.52 ' O ' ' HB ' ' A' ' 80' ' ' THR . 17.6 m-85 -78.95 142.25 36.84 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.911 -0.586 . . . . 63.340000000000003 111.662 -177.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.57 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 49.9 mm -93.58 89.92 2.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.909 -0.587 . . . . 71.040000000000006 110.087 175.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.541 HG22 HG22 ' A' ' 98' ' ' VAL . 93.9 t -95.49 117.79 40.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.762 -0.653 . . . . 64.329999999999998 110.127 178.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -118.61 119.25 33.94 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.063 0.459 . . . . 74.510000000000005 110.447 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 52.4 mt -96.55 94.66 4.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.79 -0.641 . . . . 73.150000000000006 109.401 178.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.543 ' HB3' ' HB2' ' A' ' 95' ' ' GLN . . . -92.11 100.38 13.02 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.179 -0.464 . . . . 54.140000000000001 110.996 -177.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -96.24 108.16 20.6 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.956 -0.565 . . . . 62.210000000000001 110.334 176.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.401 ' HD2' ' HA2' ' A' ' 64' ' ' GLY . 1.6 mtp180 -136.99 131.7 33.28 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.133 -0.485 . . . . 75.439999999999998 110.252 176.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 61.45 19.99 10.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.974 -0.557 . . . . 71.019999999999996 111.35 175.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.26 -6.95 78.53 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.971 -0.633 . . . . 75.319999999999993 112.427 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.493 HE21 ' HA ' ' A' ' 93' ' ' GLN . 0.1 OUTLIER -90.75 126.82 36.12 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.194 -0.299 . . . . 62.409999999999997 110.194 -179.889 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -93.8 107.29 19.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.205 -0.452 . . . . 52.240000000000002 110.122 177.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.543 ' HB2' ' HB3' ' A' ' 88' ' ' ALA . 45.1 mt-30 -99.73 95.66 7.08 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.893 0.378 . . . . 55.530000000000001 110.269 175.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 50.3 tp -84.38 94.0 8.4 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.835 -0.62 . . . . 75.109999999999999 109.429 177.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -107.56 127.28 53.49 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.316 0.579 . . . . 43.409999999999997 110.43 -176.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.541 HG22 HG22 ' A' ' 85' ' ' VAL . 85.2 t -118.39 131.65 70.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.637 -0.71 . . . . 72.019999999999996 110.483 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.57 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 15.5 m -104.72 112.64 25.81 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.385 -0.825 . . . . 64.319999999999993 108.974 172.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -66.27 153.72 41.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.315 0.578 . . . . 63.399999999999999 111.966 -175.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.848 ' HD3' ' HB3' ' A' ' 82' ' ' ASP . 35.8 ptt180 -82.81 -30.39 28.82 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.122 -0.945 . . . . 70.420000000000002 111.821 -175.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.638 ' HG3' ' HG3' ' A' ' 101' ' ' ARG . 47.1 mttm -105.26 -62.83 1.3 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.218 0.532 . . . . 73.140000000000001 111.473 -172.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.514 ' OG1' ' HG2' ' A' ' 105' ' ' GLN . 42.9 p -78.58 -19.69 52.21 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.734 -0.666 . . . . 72.120000000000005 109.921 -177.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 70.08 26.01 74.86 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.354 -0.839 . . . . 65.239999999999995 112.413 177.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.514 ' HG2' ' OG1' ' A' ' 103' ' ' THR . 27.3 mm-40 -66.91 125.55 26.29 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.991 -0.374 . . . . 72.040000000000006 109.991 177.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.9 m -102.12 92.23 4.67 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.055 -0.72 . . . . 61.32 109.055 175.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.8 t -100.25 121.87 42.16 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.196 -0.456 . . . . 71.150000000000006 110.124 -176.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 26.8 m -102.95 102.17 12.22 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.159 -0.473 . . . . 61.340000000000003 110.442 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 54.5 mt -93.09 92.25 3.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.458 -0.571 . . . . 73.010000000000005 109.458 177.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -89.4 131.2 35.58 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.202 -0.454 . . . . 61.100000000000001 110.293 -178.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 46.5 t -78.02 81.37 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.34 0.591 . . . . 75.109999999999999 109.743 175.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 21.9 t -161.79 140.39 9.42 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.304 -0.862 . . . . 73.519999999999996 109.157 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -89.51 0.37 80.42 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.397 -0.906 . . . . 53.210000000000001 111.933 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 96.2 mt -99.37 67.66 1.57 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.936 0.398 . . . . 71.239999999999995 111.006 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -92.22 82.21 5.0 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.514 -0.55 . . . . 62.340000000000003 109.514 175.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -116.0 -40.91 3.24 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.004 -0.544 . . . . 63.439999999999998 110.567 -176.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -67.43 127.92 34.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.05 -0.523 . . . . 61.130000000000003 109.779 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 23.1 t -63.96 100.27 0.3 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.167 0.508 . . . . 75.219999999999999 110.477 -178.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 27.1 m -96.61 105.91 18.09 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.541 -0.754 . . . . 73.200000000000003 109.883 -178.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -142.77 132.58 24.07 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.749 -0.66 . . . . 62.409999999999997 109.589 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -128.04 74.5 1.54 Allowed 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.546 -0.539 . . . . 75.239999999999995 109.546 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -66.17 110.82 3.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.813 -0.63 . . . . 74.340000000000003 110.857 178.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 42.5 p-80 -128.03 110.48 12.54 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.223 -0.899 . . . . 64.150000000000006 109.901 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -77.34 74.85 3.9 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.461 0.648 . . . . 75.209999999999994 109.996 -178.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -150.07 130.21 13.58 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.406 -0.816 . . . . 71.409999999999997 109.848 -178.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 64.1 t-80 -137.44 149.31 46.78 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.725 -0.472 . . . . 73.129999999999995 109.725 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 48.5 t60 . . . . . 0 C--O 1.246 0.872 0 CA-C-O 118.23 -0.891 . . . . 54.43 109.563 176.353 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 N--CA 1.484 1.225 0 N-CA-C 110.338 -0.245 . . . . 75.5 110.338 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.29 172.93 12.44 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.513 -0.312 . . . . 74.230000000000004 110.293 -178.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 143.06 -97.36 0.2 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.995 -0.622 . . . . 65.140000000000001 111.733 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.4 m 57.14 44.84 21.72 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.234 0.54 . . . . 72.25 110.91 178.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 47.9 ttm 56.03 62.95 2.17 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.489 0.662 . . . . 75.430000000000007 110.265 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.2 t -86.92 -12.9 46.3 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.965 -0.561 . . . . 74.209999999999994 110.392 -177.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 69.21 164.17 0.24 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.588 -0.733 . . . . 75.040000000000006 112.062 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.592 HE21 ' HB2' ' A' ' 10' ' ' ARG . 27.9 tt0 -154.74 -46.1 0.09 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.207 -0.906 . . . . 73.409999999999997 109.641 179.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 60.3 85.54 0.11 Allowed 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 115.306 -0.861 . . . . 73.239999999999995 111.238 -178.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.592 ' HB2' HE21 ' A' ' 8' ' ' GLN . 8.2 tpt180 -116.65 132.17 56.76 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.062 -0.718 . . . . 72.030000000000001 109.062 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -130.48 86.81 52.14 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-O 120.769 0.318 . . . . 63.140000000000001 110.718 -176.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -73.8 156.28 48.53 Favored 'Trans proline' 0 C--O 1.238 0.486 0 C-N-CA 122.646 2.231 . . . . 71.329999999999998 112.112 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 71.99 153.44 0.13 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.549 -0.751 . . . . 75.430000000000007 110.791 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -97.02 168.18 10.62 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.959 0.409 . . . . 75.230000000000004 111.423 -174.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -96.39 74.9 0.76 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.933 -0.651 . . . . 71.230000000000004 111.832 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -126.83 41.3 1.64 Allowed Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.717 -0.754 . . . . 73.329999999999998 112.462 -178.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 66.73 156.91 0.13 Allowed Pre-proline 0 N--CA 1.468 0.444 0 C-N-CA 123.364 0.666 . . . . 72.140000000000001 111.512 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -74.55 64.51 5.62 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.619 2.213 . . . . 61.409999999999997 112.288 177.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -162.83 101.96 1.01 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.717 -0.674 . . . . 74.519999999999996 110.237 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -151.87 -51.6 0.12 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.206 -0.452 . . . . 74.239999999999995 110.153 177.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 160.8 101.05 0.16 Allowed Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 111.186 -0.766 . . . . 62.439999999999998 111.186 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -139.09 -15.97 1.1 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 111.832 0.308 . . . . 64.099999999999994 111.832 -174.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 58.26 66.2 1.14 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.341 0.591 . . . . 71.25 109.899 -174.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.0 tp -87.45 94.63 9.75 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.843 -0.617 . . . . 62.32 110.07 -178.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 90.0 mt -118.76 -66.85 1.03 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.929 -0.578 . . . . 52.439999999999998 110.428 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 58.0 t30 57.48 76.17 0.33 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.648 -0.705 . . . . 73.200000000000003 110.072 -174.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 49.1 m -77.44 84.72 3.84 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.706 -0.679 . . . . 71.349999999999994 110.951 -176.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.62 173.59 6.27 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.431 -0.804 . . . . 74.120000000000005 109.698 174.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 21.7 tp60 -81.25 -45.82 15.71 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 121.08 -0.248 . . . . 65.310000000000002 110.889 -177.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 67.94 166.32 0.24 Allowed 'General case' 0 N--CA 1.466 0.345 0 O-C-N 123.834 0.709 . . . . 75.25 111.644 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -112.52 -85.37 0.58 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.1 -0.5 . . . . 75.530000000000001 110.809 -178.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.554 HD22 ' HA ' ' A' ' 35' ' ' LYS . 64.4 t30 59.71 -174.46 0.11 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.709 -0.678 . . . . 64.010000000000005 110.412 -177.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.6 m -123.36 101.05 7.14 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 122.069 -0.395 . . . . 74.209999999999994 110.699 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.735 ' O ' ' HD3' ' A' ' 35' ' ' LYS . 16.9 t80 67.1 27.41 8.61 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 115.821 -0.627 . . . . 74.430000000000007 109.655 175.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.735 ' HD3' ' O ' ' A' ' 34' ' ' TYR . 0.0 OUTLIER 49.85 12.57 0.08 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.488 1.515 . . . . 71.430000000000007 113.689 179.602 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -120.62 161.93 37.12 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 109.256 -0.646 . . . . 74.530000000000001 109.256 175.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.784 ' HB3' ' HB2' ' A' ' 42' ' ' ASP . 76.6 Cg_exo -52.51 144.47 41.17 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.743 2.295 . . . . 70.219999999999999 112.673 178.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.9 m -85.33 -80.49 0.21 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.248 -0.433 . . . . 62.109999999999999 112.012 -175.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -164.83 165.71 20.3 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 121.249 -0.18 . . . . 74.420000000000002 111.466 -174.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 59.52 89.07 0.07 Allowed 'General case' 0 N--CA 1.47 0.55 0 O-C-N 124.112 0.883 . . . . 75.200000000000003 112.218 175.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.7 t70 54.84 83.93 0.08 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.497 0.665 . . . . 75.340000000000003 110.693 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.784 ' HB2' ' HB3' ' A' ' 37' ' ' PRO . 1.3 p30 -105.45 -82.82 0.52 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.716 -0.674 . . . . 70.120000000000005 111.503 -176.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 55.73 30.56 15.83 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.037 0.446 . . . . 75.219999999999999 111.886 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -92.81 12.68 69.34 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.693 -0.765 . . . . 74.519999999999996 111.838 178.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.488 HG13 ' HG2' ' A' ' 37' ' ' PRO . 48.2 mt -86.32 -36.39 10.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.089 0.471 . . . . 75.239999999999995 110.369 -178.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -81.47 -0.43 41.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.782 -0.644 . . . . 65.319999999999993 111.807 -176.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 33.4 m -116.17 86.06 16.56 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 109.489 -0.56 . . . . 60.32 109.489 174.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -61.48 104.76 0.32 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.107 2.538 . . . . 72.099999999999994 112.292 -175.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.1 p -134.29 -75.61 0.47 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.538 -0.755 . . . . 71.450000000000003 110.356 178.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.54 -37.26 71.16 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.936 0.398 . . . . 71.230000000000004 110.63 177.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.409 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 3.7 pp -97.56 9.92 41.21 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.826 -0.625 . . . . 73.420000000000002 110.797 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.439 ' O ' ' HB2' ' A' ' 56' ' ' GLN . 32.7 t70 -59.09 -52.92 63.67 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.813 -0.631 . . . . 63.020000000000003 111.165 -176.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -62.37 -40.48 96.58 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.942 -0.572 . . . . 73.010000000000005 110.374 -176.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.583 ' O ' HG13 ' A' ' 58' ' ' ILE . 76.7 t80 -60.11 -63.81 1.17 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.728 -0.669 . . . . 74.25 111.826 -178.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.8 t -69.08 -19.54 64.07 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.876 0.325 . . . . 75.409999999999997 111.876 -172.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.439 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 2.7 mp0 -82.38 -36.26 26.95 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.741 0.305 . . . . 51.200000000000003 110.498 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.96 -30.69 71.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 74.219999999999999 110.474 176.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.721 ' O ' ' HG2' ' A' ' 61' ' ' GLN . 10.6 mt -70.09 -46.16 73.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.028 -0.533 . . . . 75.030000000000001 110.38 177.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -66.06 -18.88 65.63 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.167 0.508 . . . . 51.229999999999997 110.456 178.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 66.1 m -84.19 -3.26 58.04 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.074 -0.512 . . . . 73.340000000000003 111.61 177.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.721 ' HG2' ' O ' ' A' ' 58' ' ' ILE . 2.4 pt20 -105.96 -2.13 23.22 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.149 0.499 . . . . 64.209999999999994 110.089 177.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 51.6 mm -76.48 -30.53 19.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.818 -0.628 . . . . 75.120000000000005 110.886 -176.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.724 ' H ' HD22 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -61.13 -43.85 98.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.082 -0.508 . . . . 74.530000000000001 110.198 -177.245 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -83.98 -31.86 25.09 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.954 -0.641 . . . . 54.140000000000001 111.604 176.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.82 -24.26 66.37 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 121.405 -0.426 . . . . 33.530000000000001 112.833 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.444 ' O ' HG12 ' A' ' 70' ' ' ILE . 9.7 tt -55.58 -40.9 72.6 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.826 -0.435 . . . . 72.230000000000004 109.826 176.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.7 mp -80.53 13.2 2.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.042 -0.526 . . . . 70.319999999999993 111.223 -178.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.412 ' HA ' ' ND2' ' A' ' 71' ' ' ASN . 26.2 t -115.97 -21.01 9.7 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.189 0.518 . . . . 75.109999999999999 109.664 174.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -83.77 -26.78 29.37 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.954 -0.566 . . . . 53.439999999999998 110.489 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.444 HG12 ' O ' ' A' ' 66' ' ' LEU . 35.8 mm -84.34 -4.8 8.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.805 -0.634 . . . . 71.409999999999997 110.634 -177.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.412 ' ND2' ' HA ' ' A' ' 68' ' ' SER . 94.5 m-20 -80.21 7.27 9.74 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.34 -0.391 . . . . 61.43 111.696 -177.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 67.9 p 53.3 -163.61 0.09 Allowed 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.291 0.636 . . . . 53.310000000000002 111.711 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.439 ' HA3' HD11 ' A' ' 94' ' ' LEU . . . 122.19 -63.13 0.53 Allowed Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.784 -0.722 . . . . 71.019999999999996 111.333 178.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 1.103 ' HB3' ' HB ' ' A' ' 87' ' ' ILE . 14.4 pttm -57.48 143.43 74.68 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-O 120.55 0.214 . . . . 51.439999999999998 110.99 172.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -81.72 -10.82 11.71 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.4 2.066 . . . . 65.030000000000001 111.231 173.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 165.0 150.03 6.04 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 114.836 -1.075 . . . . 72.120000000000005 110.84 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 11.9 ptp85 -97.04 171.71 8.3 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.901 -0.407 . . . . 45.020000000000003 109.901 177.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 51.8 ttm -125.72 113.45 17.35 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.1 0.476 . . . . 73.310000000000002 110.227 175.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 23.6 t -95.27 83.95 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.823 -0.626 . . . . 63.219999999999999 109.873 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.81 -179.15 5.81 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.721 -0.672 . . . . 43.310000000000002 110.036 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -74.18 -51.88 14.16 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.727 0.299 . . . . 72.310000000000002 110.632 -177.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -122.76 19.02 10.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.802 0.334 . . . . 75.510000000000005 111.721 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -135.14 111.56 9.81 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.951 0.405 . . . . 63.340000000000003 111.0 177.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.42 HD12 ' N ' ' A' ' 84' ' ' ILE . 4.2 mp -99.97 105.56 17.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.834 -0.621 . . . . 71.040000000000006 109.477 177.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.441 ' HB ' HG23 ' A' ' 98' ' ' VAL . 6.3 p -117.78 121.63 67.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.24 0.543 . . . . 64.329999999999998 110.547 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -138.38 134.7 34.49 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.591 -0.731 . . . . 74.510000000000005 110.27 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 1.103 ' HB ' ' HB3' ' A' ' 74' ' ' LYS . 54.0 mt -89.92 101.41 12.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.112 -0.495 . . . . 73.150000000000006 110.102 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -90.85 156.43 18.03 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.972 -0.558 . . . . 54.140000000000001 110.038 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.552 ' HA ' ' O ' ' A' ' 93' ' ' GLN . 47.7 t-20 -127.53 127.28 43.69 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.016 0.436 . . . . 62.210000000000001 110.249 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -133.69 115.51 14.69 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.872 -0.604 . . . . 75.439999999999998 110.069 175.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 62.47 29.69 17.14 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.142 -0.481 . . . . 71.019999999999996 111.451 175.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.39 28.27 33.67 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.713 -0.756 . . . . 75.319999999999993 112.531 178.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.552 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 26.4 mm-40 -119.53 123.36 43.79 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.798 -0.445 . . . . 62.409999999999997 109.798 175.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.439 HD11 ' HA3' ' A' ' 73' ' ' GLY . 4.0 mm? -93.34 122.93 36.25 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.052 -0.522 . . . . 52.240000000000002 109.621 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.919 ' HG2' ' HG2' ' A' ' 110' ' ' GLN . 24.0 mt-30 -118.18 106.73 13.14 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.165 -0.471 . . . . 55.530000000000001 111.714 -177.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 54.1 tp -78.09 86.95 4.23 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.252 -1.018 . . . . 75.109999999999999 108.252 172.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -113.1 111.55 22.31 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.987 -0.551 . . . . 43.409999999999997 110.83 -172.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.441 HG23 ' HB ' ' A' ' 85' ' ' VAL . 7.2 p -107.39 135.23 46.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.51 -0.768 . . . . 72.019999999999996 110.718 -177.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 29.1 m -116.72 124.41 49.6 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.145 -0.48 . . . . 64.319999999999993 110.815 178.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.474 ' HB3' ' H ' ' A' ' 105' ' ' GLN . 11.2 t0 -71.64 137.21 47.72 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.224 -0.658 . . . . 63.399999999999999 109.224 175.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.585 ' HD2' ' O ' ' A' ' 101' ' ' ARG . 3.5 tmm_? -82.16 -28.37 32.16 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.897 0.379 . . . . 70.420000000000002 110.554 -176.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt -103.57 -49.46 3.68 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.164 -0.471 . . . . 73.140000000000001 111.114 -174.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.608 ' HB ' ' HG2' ' A' ' 105' ' ' GLN . 0.2 OUTLIER -88.23 -14.64 37.98 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.748 -0.66 . . . . 72.120000000000005 110.899 -175.292 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 67.34 17.09 68.0 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.87 -0.605 . . . . 65.239999999999995 113.362 178.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.608 ' HG2' ' HB ' ' A' ' 103' ' ' THR . 30.7 mm-40 -62.57 123.84 19.41 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.135 -0.32 . . . . 72.040000000000006 110.135 176.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 20.8 m -110.22 97.34 6.84 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.031 -0.531 . . . . 61.32 109.889 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.0 t -103.37 104.28 14.37 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.161 -0.472 . . . . 71.150000000000006 109.935 -177.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 28.7 m -101.1 103.15 14.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.894 -0.594 . . . . 61.340000000000003 111.182 -178.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 4.4 mp -98.5 97.8 6.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.071 0.462 . . . . 73.010000000000005 109.882 176.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.919 ' HG2' ' HG2' ' A' ' 95' ' ' GLN . 69.4 mt-30 -75.62 166.64 23.25 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.144 -0.48 . . . . 61.100000000000001 110.334 177.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.9 p -55.76 101.4 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.569 0.699 . . . . 75.109999999999999 110.331 173.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 6.5 m -129.52 -5.04 4.75 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.711 -0.677 . . . . 73.519999999999996 110.428 -176.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -81.91 -84.98 0.76 Allowed Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 120.858 -0.687 . . . . 53.210000000000001 112.579 -175.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 89.2 mt 66.94 -81.37 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 108.856 -0.794 . . . . 71.239999999999995 108.856 -173.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 42.73 53.29 4.89 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 124.327 1.017 . . . . 62.340000000000003 112.442 166.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -64.51 101.62 0.47 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.249 0.547 . . . . 63.439999999999998 109.878 -178.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -80.77 118.72 22.55 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.317 -0.856 . . . . 61.130000000000003 109.629 -176.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.1 m -132.43 174.82 9.86 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.601 0.238 . . . . 75.219999999999999 110.783 -176.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 4.6 m 70.61 20.83 5.63 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.761 0.791 . . . . 73.200000000000003 110.48 178.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -101.02 96.85 7.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.834 -0.621 . . . . 62.409999999999997 109.351 173.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -95.72 103.63 15.52 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.329 0.585 . . . . 75.239999999999995 110.146 -177.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -119.77 93.98 4.25 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.308 -0.86 . . . . 74.340000000000003 109.237 -175.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -145.14 94.51 2.54 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.532 0.682 . . . . 64.150000000000006 111.823 -177.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -125.0 -174.73 3.11 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.413 -0.812 . . . . 75.209999999999994 109.503 173.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 63.15 37.5 11.35 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 107.874 -1.158 . . . . 71.409999999999997 107.874 -170.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -103.47 132.89 49.34 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 114.562 -1.199 . . . . 73.129999999999995 110.708 -175.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 . . . . . 0 C--O 1.245 0.834 0 N-CA-C 109.032 -0.729 . . . . 54.43 109.032 178.228 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.3 mtt . . . . . 0 N--CA 1.479 0.982 0 N-CA-C 110.166 -0.309 . . . . 75.5 110.166 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 58.81 -161.0 0.26 Allowed 'General case' 0 C--O 1.235 0.311 0 O-C-N 123.636 0.585 . . . . 74.230000000000004 111.008 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 94.8 -12.0 69.11 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.821 -0.704 . . . . 65.140000000000001 112.572 177.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.8 m 58.55 83.3 0.12 Allowed 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.549 0.69 . . . . 72.25 110.935 -179.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 12.7 tpt -92.03 151.6 20.38 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.654 -0.703 . . . . 75.430000000000007 110.403 -177.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 25.3 m 68.8 97.03 0.06 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.821 -0.627 . . . . 74.209999999999994 111.091 178.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -68.19 114.38 6.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.139 -0.482 . . . . 75.040000000000006 109.931 177.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.1 tm0? -85.01 -34.86 22.26 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.98 -0.554 . . . . 73.409999999999997 109.959 -175.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 19.3 t80 55.9 30.73 16.49 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.703 -0.68 . . . . 73.239999999999995 111.658 173.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 37.3 mtt180 53.18 54.62 10.01 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.188 0.518 . . . . 72.030000000000001 112.397 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.421 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 34.5 m-80 -93.26 145.33 29.83 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 109.285 -0.635 . . . . 63.140000000000001 109.285 173.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 11' ' ' ASN . 37.3 Cg_exo -59.98 -36.89 88.43 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.61 2.207 . . . . 71.329999999999998 112.617 -175.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.27 153.96 0.06 Allowed 'General case' 0 N--CA 1.473 0.693 0 O-C-N 124.183 0.927 . . . . 75.430000000000007 110.697 -177.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -122.53 137.17 54.97 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 121.925 -0.485 . . . . 75.230000000000004 110.563 -178.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.19 131.39 7.44 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.843 -0.617 . . . . 71.230000000000004 111.701 178.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.66 157.31 34.17 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.827 -0.701 . . . . 73.329999999999998 112.174 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -113.54 151.11 44.23 Favored Pre-proline 0 C--N 1.321 -0.646 0 N-CA-C 110.243 -0.28 . . . . 72.140000000000001 110.243 -177.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -67.46 -19.5 48.97 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 122.713 2.275 . . . . 61.409999999999997 111.934 175.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.6 t30 72.06 -61.78 0.48 Allowed 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.956 0.902 . . . . 74.519999999999996 110.574 178.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -118.66 -63.0 1.46 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.947 -0.57 . . . . 74.239999999999995 109.777 175.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -164.29 40.13 0.31 Allowed Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 111.034 -0.826 . . . . 62.439999999999998 111.034 177.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 65.4 26.2 11.97 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 122.765 0.426 . . . . 64.099999999999994 110.872 -178.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 83.9 t80 66.11 102.67 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.187 -0.915 . . . . 71.25 111.262 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 92.9 mt -123.7 -172.97 2.64 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.712 -0.677 . . . . 62.32 110.083 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 45.47 88.26 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.124 0.969 . . . . 52.439999999999998 112.391 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -68.19 159.57 30.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.232 -0.894 . . . . 73.200000000000003 110.794 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 51.9 m -77.86 87.1 4.08 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.151 0.5 . . . . 71.349999999999994 112.131 -174.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.17 112.11 17.17 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.111 -1.07 . . . . 74.120000000000005 108.111 167.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -75.2 99.53 4.03 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.561 0.696 . . . . 65.310000000000002 111.771 -172.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -176.53 179.97 1.09 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 113.999 -1.455 . . . . 75.25 107.759 176.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -87.72 93.78 9.55 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.085 -0.709 . . . . 75.530000000000001 109.085 174.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -79.05 83.42 5.13 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.649 -0.705 . . . . 64.010000000000005 111.204 -172.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.9 m -86.6 104.79 16.37 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.558 -0.746 . . . . 74.209999999999994 109.839 176.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -138.71 29.73 2.34 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.375 0.607 . . . . 74.430000000000007 109.627 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -96.39 6.05 49.59 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.351 -0.84 . . . . 71.430000000000007 109.879 -177.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -88.31 151.31 48.53 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.584 -0.735 . . . . 74.530000000000001 111.742 -176.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.616 ' HD3' ' HA3' ' A' ' 44' ' ' GLY . 5.1 Cg_endo -47.46 149.3 4.55 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 124.288 3.325 . . . . 70.219999999999999 113.979 175.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.2 t -140.31 107.96 5.62 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.652 -0.704 . . . . 62.109999999999999 109.28 177.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.7 t80 60.8 96.84 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 O-C-N 123.825 0.703 . . . . 74.420000000000002 111.613 -179.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 65.5 22.69 11.85 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.18 -0.463 . . . . 75.200000000000003 111.426 177.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.572 ' HA ' ' HB3' ' A' ' 37' ' ' PRO . 24.2 t70 67.03 140.41 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.835 0.826 . . . . 75.340000000000003 111.633 -177.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -122.63 -68.47 0.88 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.668 -0.696 . . . . 70.120000000000005 110.309 -176.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -146.3 23.96 1.29 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.474 0.654 . . . . 75.219999999999999 109.326 -176.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.616 ' HA3' ' HD3' ' A' ' 37' ' ' PRO . . . -109.76 46.12 1.22 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.694 -0.765 . . . . 74.519999999999996 112.888 -172.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 62.0 mt -78.18 -66.49 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 110.058 -0.349 . . . . 75.239999999999995 110.058 177.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.462 ' OE1' ' HA ' ' A' ' 46' ' ' GLU . 6.9 mm-40 71.13 -34.36 0.3 Allowed 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.349 0.87 . . . . 65.319999999999993 113.349 175.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.406 ' O ' HG23 ' A' ' 47' ' ' THR . 8.5 t -125.1 85.97 57.37 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-O 121.849 0.833 . . . . 60.32 111.055 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.448 ' HB2' ' HB2' ' A' ' 52' ' ' ASP . 11.5 Cg_exo -71.34 116.76 4.83 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.939 2.426 . . . . 72.099999999999994 111.951 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 14.6 m -98.6 -69.77 0.75 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.633 -0.258 . . . . 71.450000000000003 110.985 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.77 -40.51 18.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.885 0.374 . . . . 71.230000000000004 111.248 -176.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.582 HD23 ' H ' ' A' ' 51' ' ' LEU . 1.9 pt? -69.8 -16.94 63.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 73.420000000000002 110.908 -178.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.518 ' O ' ' HB2' ' A' ' 56' ' ' GLN . 23.1 t70 -57.37 -50.04 74.23 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.112 -0.495 . . . . 63.020000000000003 110.779 -178.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -60.31 -43.19 96.59 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.099 -0.5 . . . . 73.010000000000005 110.826 178.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.474 ' O ' HG12 ' A' ' 58' ' ' ILE . 80.9 t80 -60.6 -53.35 58.52 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.066 -0.515 . . . . 74.25 111.169 -179.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.2 t -68.99 -30.2 68.56 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.783 0.325 . . . . 75.409999999999997 110.784 -177.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.518 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 1.3 tp-100 -64.77 -44.71 89.17 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.145 0.498 . . . . 51.200000000000003 110.047 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.47 -32.99 74.84 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.554 -0.748 . . . . 74.219999999999999 111.109 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.607 ' O ' ' HG2' ' A' ' 61' ' ' GLN . 47.0 mm -66.13 -37.75 80.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.982 0.42 . . . . 75.030000000000001 110.509 177.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -69.48 -38.9 77.89 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.297 -0.41 . . . . 51.229999999999997 110.816 178.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 44.8 m -67.96 -32.14 72.35 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.349 -0.387 . . . . 73.340000000000003 111.404 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.607 ' HG2' ' O ' ' A' ' 58' ' ' ILE . 2.5 pt20 -78.42 -9.44 59.29 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.642 0.258 . . . . 64.209999999999994 111.222 -176.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.53 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 74.3 mt -62.74 -33.07 58.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.934 0.397 . . . . 75.120000000000005 110.088 -178.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 92.5 mt -53.49 -36.38 61.62 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.423 -0.808 . . . . 74.530000000000001 111.635 -178.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.65 -30.42 5.86 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.708 -0.758 . . . . 54.140000000000001 111.967 178.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -58.38 -34.99 77.04 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 121.542 -0.361 . . . . 33.530000000000001 112.952 -178.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' A' ' 62' ' ' ILE . 88.6 mt -56.55 -38.44 71.9 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.873 0.368 . . . . 72.230000000000004 111.063 178.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.1 mt -76.54 -39.18 53.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.045 0.45 . . . . 70.319999999999993 110.468 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 16.5 m -66.18 -37.95 86.85 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.836 -0.62 . . . . 75.109999999999999 111.513 -177.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -76.45 -8.55 57.39 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.966 0.358 . . . . 53.439999999999998 111.966 -175.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 66' ' ' LEU . 43.3 mm -73.12 -35.74 48.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-O 121.419 0.628 . . . . 71.409999999999997 110.195 176.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -68.5 -31.21 70.31 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.581 -0.736 . . . . 61.43 110.797 -177.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.8 p 58.24 9.99 1.15 Allowed 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.23 1.012 . . . . 53.310000000000002 112.15 -176.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -84.36 92.51 1.72 Allowed Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.944 -0.646 . . . . 71.019999999999996 111.525 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.465 ' HD2' ' O ' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -55.8 143.2 61.33 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-O 121.071 0.462 . . . . 51.439999999999998 111.571 178.961 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -83.28 170.5 11.95 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.731 2.287 . . . . 65.030000000000001 112.318 -178.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -147.35 74.53 0.29 Allowed Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 120.597 -0.811 . . . . 72.120000000000005 112.361 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.45 ' O ' ' HG3' ' A' ' 77' ' ' ARG . 18.8 ptt85 -81.31 101.02 9.51 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.334 0.587 . . . . 45.020000000000003 109.617 174.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 57.6 ttp -106.86 109.31 21.18 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.949 -0.569 . . . . 73.310000000000002 110.955 -176.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 48.2 t -70.34 102.94 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.446 -0.576 . . . . 63.219999999999999 109.446 176.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.2 m -109.6 159.68 16.9 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.015 -0.538 . . . . 43.310000000000002 109.597 -177.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -67.82 -47.07 70.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.06 0.457 . . . . 72.310000000000002 110.125 -179.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -72.66 -35.8 67.82 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.843 0.683 . . . . 75.510000000000005 112.843 -176.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.646 ' HB3' HG13 ' A' ' 98' ' ' VAL . 55.1 m-85 -157.24 169.08 25.58 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.897 0.379 . . . . 63.340000000000003 110.828 -175.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.57 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 40.3 mm -97.98 98.93 7.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.364 -0.606 . . . . 71.040000000000006 109.364 169.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 41.3 t -85.31 94.42 3.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.002 -0.544 . . . . 64.329999999999998 110.178 -178.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -98.2 102.7 14.52 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.271 0.558 . . . . 74.510000000000005 110.385 177.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 63.0 mt -88.7 106.46 16.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.657 -0.701 . . . . 73.150000000000006 109.52 175.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -106.32 162.27 13.83 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.269 -0.423 . . . . 54.140000000000001 110.214 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -138.33 123.54 19.26 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.843 0.354 . . . . 62.210000000000001 110.321 178.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 65.0 mtp180 -138.81 132.61 30.87 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.073 -0.512 . . . . 75.439999999999998 109.855 176.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 64.56 17.37 10.83 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 123.629 0.581 . . . . 71.019999999999996 111.051 178.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.06 -26.3 25.18 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 121.113 -0.565 . . . . 75.319999999999993 112.412 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.58 HE21 ' HA ' ' A' ' 93' ' ' GLN . 0.1 OUTLIER -90.25 140.78 29.35 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.062 0.458 . . . . 62.409999999999997 110.886 -175.742 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -81.12 144.75 31.47 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.707 -0.678 . . . . 52.240000000000002 110.616 179.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -122.76 107.59 12.09 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.511 -0.551 . . . . 55.530000000000001 109.511 175.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 55.7 tp -82.26 98.8 8.96 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.867 -0.606 . . . . 75.109999999999999 109.425 179.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -107.69 91.84 3.82 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.317 0.58 . . . . 43.409999999999997 110.657 -177.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.646 HG13 ' HB3' ' A' ' 83' ' ' TYR . 21.7 t -82.99 108.1 15.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.679 -0.691 . . . . 72.019999999999996 109.996 176.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.57 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 25.6 m -90.77 111.66 23.13 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.398 -0.819 . . . . 64.319999999999993 108.894 175.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.462 ' HA ' ' HD2' ' A' ' 83' ' ' TYR . 13.6 t0 -61.27 133.54 56.0 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.841 -0.618 . . . . 63.399999999999999 111.155 -177.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.463 ' C ' ' HD2' ' A' ' 101' ' ' ARG . 1.1 ppt_? -94.93 -7.92 38.56 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.551 -0.75 . . . . 70.420000000000002 110.461 -178.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -87.17 -71.92 0.54 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.976 -0.556 . . . . 73.140000000000001 110.579 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 57.5 p -97.53 -28.92 13.75 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.278 -0.419 . . . . 72.120000000000005 110.566 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 100' ' ' ASP . . . 102.29 22.73 9.56 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 121.071 -0.585 . . . . 65.239999999999995 112.867 177.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.458 ' N ' ' HB3' ' A' ' 100' ' ' ASP . 49.4 mt-30 -73.98 131.87 41.84 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.732 0.301 . . . . 72.040000000000006 110.545 177.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.5 p -91.41 108.83 20.16 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.234 0.54 . . . . 61.32 111.615 -177.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 10.0 t -96.85 86.07 3.94 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.285 -0.635 . . . . 71.150000000000006 109.285 177.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 87.2 m -91.6 104.81 17.25 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.633 -0.712 . . . . 61.340000000000003 110.671 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 54.8 mt -115.89 105.13 17.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.972 -0.558 . . . . 73.010000000000005 110.487 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -69.97 134.15 48.03 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.9 -0.407 . . . . 61.100000000000001 109.9 175.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 52.1 t -88.64 93.79 4.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.135 0.493 . . . . 75.109999999999999 110.009 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.9 p -170.28 -41.58 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.547 -0.751 . . . . 73.519999999999996 110.644 -176.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 101.39 81.68 1.6 Allowed Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 111.352 -0.699 . . . . 53.210000000000001 111.352 -178.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 96.2 mt -82.45 -69.85 0.59 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 110.721 -0.103 . . . . 71.239999999999995 110.721 -175.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 44.56 33.87 1.0 Allowed 'General case' 0 N--CA 1.474 0.742 0 O-C-N 124.181 0.926 . . . . 62.340000000000003 111.652 -177.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -68.22 -57.53 5.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.702 -0.681 . . . . 63.439999999999998 110.983 -177.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 64.03 171.25 0.18 Allowed 'General case' 0 N--CA 1.469 0.477 0 O-C-N 123.744 0.653 . . . . 61.130000000000003 111.46 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 19.5 m 60.08 -155.94 0.35 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.804 -0.635 . . . . 75.219999999999999 110.719 177.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 49.5 p 58.42 105.61 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.129 0.972 . . . . 73.200000000000003 112.758 177.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 17.6 t70 74.52 120.5 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 114.642 -1.163 . . . . 62.409999999999997 112.094 176.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -149.98 36.76 0.69 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.413 -0.812 . . . . 75.239999999999995 109.339 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 22.8 p-80 -77.33 -29.15 53.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.291 -0.868 . . . . 74.340000000000003 112.364 -170.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 54.6 m-70 63.35 -85.79 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 122.507 0.323 . . . . 64.150000000000006 110.791 -173.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 19.0 p80 -122.76 15.82 10.19 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.132 -0.692 . . . . 75.209999999999994 109.132 175.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 13.1 p-80 57.85 111.69 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.346 1.459 . . . . 71.409999999999997 112.467 -175.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -62.99 -22.6 66.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.676 -1.147 . . . . 73.129999999999995 111.545 175.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 83.2 t60 . . . . . 0 C--O 1.246 0.92 0 CA-C-O 118.801 -0.619 . . . . 54.43 109.477 179.798 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 pmm? . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 109.974 -0.38 . . . . 75.5 109.974 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.47 -76.51 0.13 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.65 0.262 . . . . 74.230000000000004 110.879 -178.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 63.39 67.27 2.14 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 121.011 -0.614 . . . . 65.140000000000001 111.901 -177.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.9 m -130.5 148.37 52.3 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 122.658 -0.319 . . . . 72.25 110.859 -176.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 27.0 ptt? 47.05 93.29 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.655 1.182 . . . . 75.430000000000007 112.904 179.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 21.0 p -84.8 -83.53 0.16 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.356 -0.838 . . . . 74.209999999999994 110.885 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -99.45 123.64 43.9 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.257 -0.429 . . . . 75.040000000000006 110.488 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -120.18 94.5 4.4 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.816 -0.629 . . . . 73.409999999999997 110.028 178.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -94.12 119.23 32.67 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.268 -0.424 . . . . 73.239999999999995 109.945 179.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.4 ' HG3' ' HD3' ' A' ' 12' ' ' PRO . 14.3 ptt180 -91.92 176.72 6.41 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.161 -0.472 . . . . 72.030000000000001 110.435 -178.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -117.47 88.31 28.28 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-O 121.316 0.579 . . . . 63.140000000000001 110.541 176.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.4 ' HD3' ' HG3' ' A' ' 10' ' ' ARG . 47.4 Cg_endo -69.51 80.17 0.82 Allowed 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 122.256 1.971 . . . . 71.329999999999998 111.569 178.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 66.49 -176.08 0.19 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.366 -0.833 . . . . 75.430000000000007 109.769 -175.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -107.35 177.57 4.8 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 110.089 -0.337 . . . . 75.230000000000004 110.089 -178.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -101.04 175.27 26.02 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.758 -0.734 . . . . 71.230000000000004 111.795 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.97 -106.29 0.64 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.722 -0.751 . . . . 73.329999999999998 112.382 178.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -108.17 142.96 26.42 Favored Pre-proline 0 C--N 1.319 -0.752 0 C-N-CA 121.019 -0.273 . . . . 72.140000000000001 111.349 -177.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -74.05 -33.2 6.23 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 123.046 2.497 . . . . 61.409999999999997 110.396 169.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 29.3 t30 -134.89 123.91 24.17 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.77 -1.104 . . . . 74.519999999999996 108.665 173.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -83.65 140.78 31.96 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.756 0.312 . . . . 74.239999999999995 110.32 -178.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -150.76 -157.88 8.02 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.771 -0.728 . . . . 62.439999999999998 112.079 -178.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 63.63 -166.42 0.23 Allowed 'General case' 0 C--O 1.236 0.377 0 C-N-CA 122.962 0.505 . . . . 64.099999999999994 111.124 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 75.0 t80 75.17 -29.82 0.19 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.499 0.719 . . . . 71.25 111.544 177.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 89.7 mt -66.25 104.33 1.17 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.916 0.389 . . . . 62.32 110.605 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 94.2 mt -122.89 129.71 51.96 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.932 -0.576 . . . . 52.439999999999998 110.208 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -98.31 101.81 13.37 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.267 -0.424 . . . . 73.200000000000003 109.869 176.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.3 m -86.86 176.95 7.44 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.974 -0.557 . . . . 71.349999999999994 110.094 -179.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.4 170.35 16.53 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.394 -0.366 . . . . 74.120000000000005 110.044 176.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 71.69 160.54 0.22 Allowed 'General case' 0 N--CA 1.469 0.475 0 O-C-N 123.848 0.718 . . . . 65.310000000000002 110.471 -175.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 63.84 -166.84 0.22 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.809 -0.632 . . . . 75.25 110.561 -178.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 32.5 mm-40 64.63 18.62 11.49 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.098 0.475 . . . . 75.530000000000001 110.394 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -139.59 -160.2 1.04 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.613 -0.721 . . . . 64.010000000000005 109.164 -179.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.6 t 73.72 80.42 0.13 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.575 0.702 . . . . 74.209999999999994 110.746 175.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -105.2 -14.64 15.31 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.398 -0.819 . . . . 74.430000000000007 110.589 177.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.4 mptt 63.82 34.22 12.06 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 122.472 1.129 . . . . 71.430000000000007 108.269 -167.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.523 ' HB2' ' HD2' ' A' ' 37' ' ' PRO . 8.0 p-10 -79.43 165.61 47.01 Favored Pre-proline 0 N--CA 1.448 -0.536 0 CA-C-N 113.322 -1.763 . . . . 74.530000000000001 110.715 -177.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.523 ' HD2' ' HB2' ' A' ' 36' ' ' ASP . 84.4 Cg_exo -48.24 144.0 13.71 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.537 2.825 . . . . 70.219999999999999 114.564 -174.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 45.4 m -138.14 -63.39 0.56 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.942 -1.026 . . . . 62.109999999999999 108.264 173.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -175.97 106.58 0.08 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.61 -0.723 . . . . 74.420000000000002 109.985 171.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 63.4 t30 75.74 137.27 0.06 Allowed 'General case' 0 N--CA 1.47 0.568 0 O-C-N 124.103 0.877 . . . . 75.200000000000003 111.537 178.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.1 t70 68.93 29.76 4.83 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 122.049 0.928 . . . . 75.340000000000003 109.793 -176.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -83.92 60.79 6.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.004 -0.998 . . . . 70.120000000000005 110.903 -176.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.456 ' CE2' HD22 ' A' ' 51' ' ' LEU . 54.7 m-85 -82.45 5.39 20.68 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.456 -0.338 . . . . 75.219999999999999 111.491 -177.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.08 -15.01 66.84 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.932 -0.651 . . . . 74.519999999999996 112.09 176.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 45.4 mt -78.41 -20.33 13.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.868 -0.419 . . . . 75.239999999999995 109.868 176.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 64.0 86.61 0.12 Allowed 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.192 -0.913 . . . . 65.319999999999993 110.718 -174.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.2 t -139.44 87.91 13.08 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.467 -0.788 . . . . 60.32 110.214 -179.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.464 ' HA ' HD21 ' A' ' 51' ' ' LEU . 15.0 Cg_exo -65.15 100.55 0.38 Allowed 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.647 2.232 . . . . 72.099999999999994 112.757 -176.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.3 p -146.51 -76.18 0.19 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.889 -0.596 . . . . 71.450000000000003 110.111 174.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.68 -45.73 85.4 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.001 -0.545 . . . . 71.230000000000004 110.895 178.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.497 HD23 ' H ' ' A' ' 51' ' ' LEU . 2.6 pt? -79.24 -20.2 48.79 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.984 -0.553 . . . . 73.420000000000002 110.849 179.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -57.33 -65.24 0.66 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.893 -0.594 . . . . 63.020000000000003 111.562 -174.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -67.58 -22.85 65.36 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.896 -0.593 . . . . 73.010000000000005 110.701 -176.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.563 ' O ' HG13 ' A' ' 58' ' ' ILE . 23.3 t80 -75.43 -55.91 5.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.812 -0.631 . . . . 74.25 111.287 -178.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.3 t -63.41 -26.92 68.96 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.827 0.346 . . . . 75.409999999999997 111.757 -174.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -68.6 -35.5 77.43 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.796 0.332 . . . . 51.200000000000003 110.672 -178.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.53 -29.66 59.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.043 -0.526 . . . . 74.219999999999999 109.944 177.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.563 HG13 ' O ' ' A' ' 54' ' ' PHE . 17.5 mt -65.31 -43.8 94.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.75 -0.659 . . . . 75.030000000000001 110.747 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -64.15 -22.84 67.09 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.283 -0.417 . . . . 51.229999999999997 111.143 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 58.5 m -86.94 -35.18 19.04 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.437 -0.347 . . . . 73.340000000000003 111.385 178.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.541 ' HG2' ' HA ' ' A' ' 58' ' ' ILE . 3.6 pt20 -77.58 -4.57 46.47 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.702 0.26 . . . . 64.209999999999994 111.702 -175.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.549 HG13 ' O ' ' A' ' 58' ' ' ILE . 75.4 mt -61.9 -36.26 72.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.906 0.384 . . . . 75.120000000000005 110.173 -178.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 8.5 mp -56.79 -47.16 80.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.573 -0.74 . . . . 74.530000000000001 110.302 178.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -69.01 -39.14 85.01 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.839 -0.696 . . . . 54.140000000000001 112.025 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.45 -43.36 98.83 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 121.234 -0.508 . . . . 33.530000000000001 112.216 178.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 62' ' ' ILE . 94.8 mt -58.08 -50.02 74.93 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.651 0.262 . . . . 72.230000000000004 110.757 178.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.72 HD13 ' HA ' ' A' ' 91' ' ' ASP . 96.4 mt -62.65 -30.52 71.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.125 -0.489 . . . . 70.319999999999993 111.561 -177.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 30.6 t -82.59 -35.09 27.4 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.021 0.438 . . . . 75.109999999999999 110.499 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -85.71 13.57 6.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.297 -0.41 . . . . 53.439999999999998 111.834 -177.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.429 HG12 ' O ' ' A' ' 66' ' ' LEU . 47.8 mm -71.73 -29.57 34.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 108.691 -0.855 . . . . 71.409999999999997 108.691 169.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -89.99 29.68 1.17 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.466 -0.788 . . . . 61.43 110.499 -177.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.4 p -74.84 -56.97 4.22 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.455 -0.572 . . . . 53.310000000000002 109.455 173.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -104.14 82.61 0.37 Allowed Glycine 0 N--CA 1.442 -0.916 0 N-CA-C 110.586 -1.006 . . . . 71.019999999999996 110.586 171.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.505 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 0.5 OUTLIER -55.86 144.28 57.68 Favored Pre-proline 0 C--O 1.235 0.34 0 CA-C-O 120.917 0.389 . . . . 51.439999999999998 111.869 -176.386 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.505 ' HD3' ' HA ' ' A' ' 74' ' ' LYS . 7.6 Cg_exo -73.37 -164.38 0.2 Allowed 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 123.332 2.688 . . . . 65.030000000000001 112.535 -178.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -59.12 107.4 1.19 Allowed Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.778 -0.647 . . . . 72.120000000000005 112.711 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 24.6 ptt180 -103.52 149.98 24.34 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 110.397 -0.223 . . . . 45.020000000000003 110.397 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 49.4 ttm -79.07 103.97 9.38 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.951 0.405 . . . . 73.310000000000002 110.1 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 60.0 t -85.6 95.79 4.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.337 0.589 . . . . 63.219999999999999 109.913 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.546 ' OG1' ' HB2' ' A' ' 83' ' ' TYR . 1.5 p -103.09 -179.09 3.85 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.506 -0.77 . . . . 43.310000000000002 109.925 176.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 13.3 t30 -85.52 -43.66 13.35 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 111.64 0.237 . . . . 72.310000000000002 111.64 -175.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.596 ' OD1' ' HD3' ' A' ' 101' ' ' ARG . 15.3 t70 -108.54 0.95 21.14 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.981 0.42 . . . . 75.510000000000005 111.91 -174.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.546 ' HB2' ' OG1' ' A' ' 80' ' ' THR . 96.3 m-85 -121.95 124.77 44.83 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 122.07 -0.394 . . . . 63.340000000000003 110.949 177.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.553 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 4.1 mp -101.1 88.53 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.4 -0.963 . . . . 71.040000000000006 108.4 171.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.5 p -126.88 137.29 58.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.041 -0.527 . . . . 64.329999999999998 111.344 -172.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -141.76 152.22 43.58 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.765 -0.652 . . . . 74.510000000000005 110.037 175.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 71.2 mt -92.58 115.4 31.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.675 -0.693 . . . . 73.150000000000006 110.452 -176.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -110.93 114.15 27.25 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.207 -0.451 . . . . 54.140000000000001 110.663 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -90.98 87.35 6.58 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.337 0.589 . . . . 62.210000000000001 109.718 174.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.412 ' HG2' ' HB2' ' A' ' 91' ' ' ASP . 43.7 ttt180 -109.27 139.57 44.04 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.674 -0.694 . . . . 75.439999999999998 110.001 177.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.72 ' HA ' HD13 ' A' ' 67' ' ' LEU . 4.7 t70 68.12 20.89 8.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.564 0.697 . . . . 71.019999999999996 110.218 172.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.73 20.77 79.84 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.456 -0.793 . . . . 75.319999999999993 112.376 -178.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.499 HE21 ' HA ' ' A' ' 93' ' ' GLN . 0.0 OUTLIER -124.43 140.92 52.49 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.763 -0.458 . . . . 62.409999999999997 109.763 179.554 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -79.39 117.5 20.42 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.699 -0.482 . . . . 52.240000000000002 109.699 176.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -123.57 122.07 37.23 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.227 -0.442 . . . . 55.530000000000001 110.733 -176.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 20.1 tp -99.8 106.47 18.35 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.73 -0.668 . . . . 75.109999999999999 109.849 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.436 ' ND2' HG23 ' A' ' 108' ' ' THR . 13.6 m120 -95.01 95.6 8.71 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.46 -0.337 . . . . 43.409999999999997 110.401 -178.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.46 ' HB ' ' HB2' ' A' ' 107' ' ' SER . 93.5 t -87.83 102.38 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.495 0 CA-C-O 121.321 0.581 . . . . 72.019999999999996 110.578 179.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.553 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 68.9 m -86.09 107.98 18.07 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.537 -0.756 . . . . 64.319999999999993 109.835 177.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.5 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 24.2 t70 -63.66 145.04 56.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.805 -0.634 . . . . 63.399999999999999 111.286 -178.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.596 ' HD3' ' OD1' ' A' ' 82' ' ' ASP . 33.2 ttt180 -92.94 -22.24 19.33 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.545 -0.752 . . . . 70.420000000000002 110.685 -178.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 35.0 mttp -80.25 -68.62 0.66 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.371 0.605 . . . . 73.140000000000001 110.545 -176.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 45.8 p -90.47 -43.0 10.54 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.476 -0.784 . . . . 72.120000000000005 110.031 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.5 ' HA2' ' O ' ' A' ' 100' ' ' ASP . . . 111.25 4.37 27.25 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 115.472 -0.786 . . . . 65.239999999999995 112.904 176.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -61.67 133.61 55.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.914 0.388 . . . . 72.040000000000006 110.631 175.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 62.6 m -92.17 100.31 12.95 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.614 -0.513 . . . . 61.32 109.614 174.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.46 ' HB2' ' HB ' ' A' ' 98' ' ' VAL . 14.1 m -73.85 101.25 3.7 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.724 -0.671 . . . . 71.150000000000006 109.294 177.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.436 HG23 ' ND2' ' A' ' 97' ' ' ASN . 0.8 OUTLIER -89.53 94.84 10.02 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.015 -0.539 . . . . 61.340000000000003 110.808 -174.446 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 35.0 mm -99.87 101.22 11.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.826 -0.624 . . . . 73.010000000000005 110.371 -177.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -78.24 154.68 30.81 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.425 -0.352 . . . . 61.100000000000001 110.658 175.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.2 p -54.83 126.65 12.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.565 -0.743 . . . . 75.109999999999999 111.232 178.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 35.6 t -159.63 156.19 27.49 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.125 -0.489 . . . . 73.519999999999996 110.212 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -155.57 26.1 0.59 Allowed Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 110.936 -0.866 . . . . 53.210000000000001 110.936 176.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 83.9 mt -103.78 81.59 1.9 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 120.985 0.421 . . . . 71.239999999999995 111.327 -174.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -117.6 38.95 3.45 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.991 -0.55 . . . . 62.340000000000003 109.68 176.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -82.86 119.14 24.0 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.623 -0.717 . . . . 63.439999999999998 110.683 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -150.06 -69.16 0.2 Allowed 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.648 -0.871 . . . . 61.130000000000003 108.648 176.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 11.2 t 55.19 74.67 0.35 Allowed 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.344 -0.844 . . . . 75.219999999999999 110.941 176.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 85.5 m -152.79 127.72 9.63 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.853 -0.612 . . . . 73.200000000000003 110.181 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -87.44 92.7 9.18 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.162 0.506 . . . . 62.409999999999997 109.781 176.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.548 ' HB2' ' CD2' ' A' ' 123' ' ' HIS . 47.9 p90 -123.36 127.92 49.16 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.781 -0.645 . . . . 75.239999999999995 110.548 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -90.49 -73.82 0.51 Allowed 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.688 -0.856 . . . . 74.340000000000003 108.688 175.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.548 ' CD2' ' HB2' ' A' ' 121' ' ' PHE . 72.9 m-70 63.35 104.11 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.333 -0.849 . . . . 64.150000000000006 112.965 175.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -160.96 -24.04 0.06 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.392 -0.822 . . . . 75.209999999999994 109.975 173.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 67.4 -176.17 0.2 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.747 -0.661 . . . . 71.409999999999997 111.593 178.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -132.57 133.32 43.55 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.727 -0.669 . . . . 73.129999999999995 109.888 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.022 -0.989 . . . . 54.43 109.681 173.56 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.477 0.898 0 N-CA-C 110.229 -0.286 . . . . 75.5 110.229 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 66.76 -68.48 0.14 Allowed 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.971 0.795 . . . . 74.230000000000004 110.832 -176.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.533 ' O ' ' HG3' ' A' ' 5' ' ' MET . . . -170.3 85.12 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 111.024 -0.831 . . . . 65.140000000000001 111.024 177.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.8 m -68.83 108.63 3.52 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.963 0.411 . . . . 72.25 110.296 -178.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.533 ' HG3' ' O ' ' A' ' 3' ' ' GLY . 52.2 mtt -114.57 124.54 52.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.344 -0.389 . . . . 75.430000000000007 111.122 -174.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.1 t -141.7 -43.47 0.35 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.098 -0.501 . . . . 74.209999999999994 109.926 174.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 56.39 112.94 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.909 0.884 . . . . 75.040000000000006 112.107 179.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -99.08 90.62 4.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.146 -0.479 . . . . 73.409999999999997 111.013 -176.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -119.25 101.07 7.72 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.757 -0.656 . . . . 73.239999999999995 109.864 177.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.408 ' O ' ' HB2' ' A' ' 11' ' ' ASN . 25.0 mmt180 -124.63 -71.55 0.71 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.31 -0.404 . . . . 72.030000000000001 110.662 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 10' ' ' ARG . 94.3 m-20 71.02 147.84 0.12 Allowed Pre-proline 0 N--CA 1.47 0.568 0 O-C-N 123.878 0.736 . . . . 63.140000000000001 111.533 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 11' ' ' ASN . 32.3 Cg_exo -58.33 -52.77 5.01 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.963 2.442 . . . . 71.329999999999998 112.439 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 62.61 81.64 0.2 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.924 -0.58 . . . . 75.430000000000007 111.042 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -85.64 165.72 16.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.858 -0.61 . . . . 75.230000000000004 110.762 -179.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -111.47 -56.99 0.47 Allowed Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 111.323 -0.711 . . . . 71.230000000000004 111.323 176.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.16 175.1 30.3 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.848 -0.691 . . . . 73.329999999999998 112.523 178.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -123.69 150.5 61.93 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 109.896 -0.409 . . . . 72.140000000000001 109.896 -177.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -64.32 -37.05 42.18 Favored 'Trans proline' 0 C--O 1.236 0.399 0 C-N-CA 122.829 2.353 . . . . 61.409999999999997 112.793 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 71.04 139.8 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 O-C-N 123.83 0.706 . . . . 74.519999999999996 111.051 -178.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -116.46 143.69 45.26 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.075 -0.511 . . . . 74.239999999999995 109.976 -178.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -111.14 147.17 17.78 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 121.002 -0.618 . . . . 62.439999999999998 111.691 178.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -128.81 132.7 47.86 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.843 0.322 . . . . 64.099999999999994 110.524 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -132.02 105.93 7.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.274 0.559 . . . . 71.25 110.602 178.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.3 mp -128.35 95.05 4.04 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.671 -0.695 . . . . 62.32 110.421 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.9 mp -123.85 -51.7 1.8 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.436 -0.347 . . . . 52.439999999999998 110.175 178.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 54.1 t30 65.7 -85.34 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 O-C-N 123.902 0.751 . . . . 73.200000000000003 110.782 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.4 p -173.74 130.55 0.42 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.918 -0.401 . . . . 71.349999999999994 109.918 179.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -111.32 86.99 2.44 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.072 -0.513 . . . . 74.120000000000005 109.705 178.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -120.83 123.44 42.59 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.16 -0.473 . . . . 65.310000000000002 110.741 -178.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -132.95 84.63 2.15 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.924 -0.58 . . . . 75.25 110.192 177.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -106.22 141.44 37.55 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.167 -0.47 . . . . 75.530000000000001 110.206 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -109.88 96.75 6.45 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.055 -0.521 . . . . 64.010000000000005 110.863 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.5 p -91.77 107.53 19.27 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.963 -0.754 . . . . 74.209999999999994 108.963 172.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -81.1 -16.06 54.17 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.328 0.492 . . . . 74.430000000000007 112.328 -167.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.529 ' O ' ' HB2' ' A' ' 42' ' ' ASP . 59.0 tttt -87.93 79.34 8.08 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.439 0.638 . . . . 71.430000000000007 110.321 -176.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.557 ' HB2' ' HD2' ' A' ' 37' ' ' PRO . 2.0 p30 -103.22 165.06 14.26 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.256 -0.884 . . . . 74.530000000000001 110.9 -176.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.557 ' HD2' ' HB2' ' A' ' 36' ' ' ASP . 46.0 Cg_endo -69.77 -34.57 14.26 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.43 2.087 . . . . 70.219999999999999 112.404 177.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 70.8 m -159.22 -54.61 0.06 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.134 -0.485 . . . . 62.109999999999999 109.833 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -175.81 146.61 0.74 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.915 -0.584 . . . . 74.420000000000002 109.754 173.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.7 t30 71.37 103.97 0.06 Allowed 'General case' 0 N--CA 1.469 0.482 0 O-C-N 123.762 0.664 . . . . 75.200000000000003 110.916 177.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.2 t70 71.51 113.9 0.05 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.026 -0.988 . . . . 75.340000000000003 111.125 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.529 ' HB2' ' O ' ' A' ' 35' ' ' LYS . 8.5 p-10 -82.68 -11.07 58.62 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.481 -0.781 . . . . 70.120000000000005 110.956 -176.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -83.78 9.35 12.09 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.044 -0.525 . . . . 75.219999999999999 110.818 -178.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -80.08 10.92 38.62 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.071 -0.585 . . . . 74.519999999999996 112.341 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 63.1 mt -85.31 -52.5 12.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.913 0.387 . . . . 75.239999999999995 110.176 178.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -115.59 138.71 50.79 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.307 -0.406 . . . . 65.319999999999993 110.094 176.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 25.2 m -119.71 87.73 38.01 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 115.977 -0.556 . . . . 60.32 111.002 -177.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.423 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 21.0 Cg_endo -61.44 127.91 23.27 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.469 2.112 . . . . 72.099999999999994 111.556 178.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.8 m -121.93 -42.32 2.4 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.108 0.48 . . . . 71.450000000000003 110.526 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -87.55 -36.09 17.76 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.032 -0.531 . . . . 71.230000000000004 110.707 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.429 ' O ' HG22 ' A' ' 55' ' ' THR . 0.6 OUTLIER -98.06 5.07 49.1 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.51 -0.314 . . . . 73.420000000000002 110.725 180.0 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.423 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 39.4 t0 -57.3 -64.28 0.94 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.011 -0.54 . . . . 63.020000000000003 111.54 -175.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -66.01 -26.11 67.38 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.326 -0.397 . . . . 73.010000000000005 110.864 -177.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.538 ' O ' HG13 ' A' ' 58' ' ' ILE . 89.0 t80 -69.62 -60.41 2.34 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.96 -0.564 . . . . 74.25 111.266 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.429 HG22 ' O ' ' A' ' 51' ' ' LEU . 12.9 t -74.04 -20.39 60.32 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.565 0.221 . . . . 75.409999999999997 111.48 -172.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -76.14 -33.42 59.4 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.83 0.348 . . . . 51.200000000000003 110.543 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.94 -24.02 60.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.147 0.498 . . . . 74.219999999999999 110.585 178.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.557 ' O ' HG13 ' A' ' 62' ' ' ILE . 16.1 mt -72.67 -26.69 24.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.74 -0.664 . . . . 75.030000000000001 110.718 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -56.76 -37.72 71.46 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.734 0.302 . . . . 51.229999999999997 110.958 -178.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.9 m -63.94 -43.19 96.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.089 -0.505 . . . . 73.340000000000003 111.436 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -79.81 -21.96 43.62 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 121.026 -0.269 . . . . 64.209999999999994 111.232 -175.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.557 HG13 ' O ' ' A' ' 58' ' ' ILE . 79.9 mt -66.05 -35.95 76.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.064 0.459 . . . . 75.120000000000005 109.84 177.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 92.3 mt -57.23 -46.47 82.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.579 -0.737 . . . . 74.530000000000001 111.121 178.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -65.89 -37.48 93.34 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.86 -0.686 . . . . 54.140000000000001 111.914 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.14 -40.67 99.26 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.983 -0.627 . . . . 33.530000000000001 112.055 178.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.8 mt -61.98 -41.08 97.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.0 0.428 . . . . 72.230000000000004 110.904 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.3 mt -67.37 -32.17 72.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.096 -0.502 . . . . 70.319999999999993 110.726 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.3 t -70.55 -24.8 62.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.906 -0.588 . . . . 75.109999999999999 110.551 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -69.89 -11.59 60.98 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.295 -0.411 . . . . 53.439999999999998 111.663 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 47.1 mm -87.68 -17.25 8.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.424 0.63 . . . . 71.409999999999997 109.965 178.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -106.69 -52.16 2.82 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.824 -0.626 . . . . 61.43 110.786 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 21.5 p 51.39 30.18 5.89 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 114.12 1.155 . . . . 53.310000000000002 114.12 175.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -157.61 15.44 0.31 Allowed Glycine 0 CA--C 1.517 0.18 0 C-N-CA 120.141 -1.028 . . . . 71.019999999999996 112.954 177.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.46 ' HD3' ' H ' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -57.67 144.08 74.16 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.747 0.308 . . . . 51.439999999999998 111.56 -178.889 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 74' ' ' LYS . 5.4 Cg_exo -80.0 -17.64 10.6 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.768 2.312 . . . . 65.030000000000001 111.273 172.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 119.76 -125.93 6.52 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.807 -0.633 . . . . 72.120000000000005 111.76 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.437 HH11 ' HD2' ' A' ' 77' ' ' ARG . 14.5 ptt180 -139.93 164.47 29.9 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.766 -0.457 . . . . 45.020000000000003 109.766 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.498 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 26.1 ttt -110.19 117.15 32.93 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.862 0.363 . . . . 73.310000000000002 110.393 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.6 p -82.68 90.43 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-O 121.905 0.86 . . . . 63.219999999999999 110.43 178.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.7 ' HB ' ' O ' ' A' ' 83' ' ' TYR . 7.2 m -97.87 134.29 41.2 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.477 -0.783 . . . . 43.310000000000002 109.213 176.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -63.53 -31.9 73.19 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.262 -0.426 . . . . 72.310000000000002 111.379 -175.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.661 ' HA ' ' HG2' ' A' ' 101' ' ' ARG . 37.9 t70 -105.48 -8.18 18.23 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.428 -0.351 . . . . 75.510000000000005 111.871 -175.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.7 ' O ' ' HB ' ' A' ' 80' ' ' THR . 42.2 m-85 -147.98 134.49 19.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.379 0.609 . . . . 63.340000000000003 112.206 -175.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.572 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 49.1 mm -87.17 108.45 18.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.254 -0.647 . . . . 71.040000000000006 109.254 172.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.498 ' HB ' ' HB3' ' A' ' 78' ' ' MET . 60.2 t -116.77 113.57 43.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.752 0.31 . . . . 64.329999999999998 111.374 -174.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -124.0 144.43 49.83 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.219 0.533 . . . . 74.510000000000005 110.135 175.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 62.0 mt -102.19 113.53 38.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.83 -0.623 . . . . 73.150000000000006 110.916 -175.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -107.27 110.18 22.15 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.283 -0.417 . . . . 54.140000000000001 110.207 176.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -115.61 110.49 19.27 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.951 0.405 . . . . 62.210000000000001 110.539 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 -142.94 144.02 32.21 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.536 -0.542 . . . . 75.439999999999998 109.536 177.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.59 20.15 11.79 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 123.565 0.541 . . . . 71.019999999999996 111.122 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.93 -2.7 88.1 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.045 -0.598 . . . . 75.319999999999993 112.439 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.472 HE21 ' HA ' ' A' ' 93' ' ' GLN . 0.1 OUTLIER -93.55 126.65 38.82 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.821 0.343 . . . . 62.409999999999997 110.827 -178.059 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -83.88 105.26 14.63 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.01 -0.541 . . . . 52.240000000000002 110.23 174.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -106.62 104.89 14.68 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.994 -0.548 . . . . 55.530000000000001 109.795 178.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 33.6 tp -89.1 111.93 22.79 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.729 -0.669 . . . . 75.109999999999999 110.193 -177.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -95.5 121.1 36.83 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.814 -0.439 . . . . 43.409999999999997 109.814 179.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.572 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 7.9 p -128.11 127.06 67.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 121.44 0.638 . . . . 72.019999999999996 110.742 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.561 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 6.2 m -113.33 123.97 51.37 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.806 -0.633 . . . . 64.319999999999993 110.141 178.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.495 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 32.3 t70 -70.91 149.54 46.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.102 -0.499 . . . . 63.399999999999999 110.724 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.661 ' HG2' ' HA ' ' A' ' 82' ' ' ASP . 0.0 OUTLIER -96.73 -11.18 25.4 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.97 -0.292 . . . . 70.420000000000002 110.918 -179.08 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 26.7 mttp -89.91 -64.35 1.15 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.623 0.725 . . . . 73.140000000000001 109.791 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 46.1 p -86.61 -45.17 11.28 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.862 -1.063 . . . . 72.120000000000005 110.066 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.495 ' HA2' ' O ' ' A' ' 100' ' ' ASP . . . 99.02 18.44 24.65 Favored Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 114.902 -1.044 . . . . 65.239999999999995 112.311 -178.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.442 ' HA ' ' OE1' ' A' ' 105' ' ' GLN . 12.3 mm-40 -59.43 134.96 57.49 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 120.809 0.338 . . . . 72.040000000000006 110.284 175.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.8 m -108.82 102.47 11.49 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.013 -0.539 . . . . 61.32 109.98 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.404 ' HB3' ' CG1' ' A' ' 98' ' ' VAL . 21.1 t -101.2 125.91 47.87 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.164 -0.471 . . . . 71.150000000000006 110.374 -177.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 29.7 m -108.7 97.79 7.39 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.223 0.535 . . . . 61.340000000000003 109.604 174.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 60.3 mt -84.83 105.03 13.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.76 -0.654 . . . . 73.010000000000005 110.574 -177.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' A' ' 110' ' ' GLN . 9.5 pt20 -101.32 104.47 15.48 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.185 0.517 . . . . 61.100000000000001 110.446 179.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 10.5 p -67.86 126.99 28.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.972 -0.558 . . . . 75.109999999999999 109.867 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.4 m -116.04 125.3 52.27 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.928 0.394 . . . . 73.519999999999996 110.462 -178.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 168.71 50.93 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.922 -0.656 . . . . 53.210000000000001 111.912 -177.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 89.1 mt -115.18 100.14 7.93 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.246 0.545 . . . . 71.239999999999995 110.582 -178.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -129.02 -36.14 1.79 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.369 -0.832 . . . . 62.340000000000003 110.042 175.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 71.05 128.88 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 O-C-N 124.076 0.86 . . . . 63.439999999999998 111.12 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -81.17 -26.07 36.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.627 -0.715 . . . . 61.130000000000003 111.673 -176.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 49.3 m 62.3 -167.06 0.21 Allowed 'General case' 0 CA--C 1.533 0.317 0 O-C-N 123.299 0.374 . . . . 75.219999999999999 110.327 -176.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.5 p -114.42 -79.62 0.59 Allowed 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.776 -0.369 . . . . 73.200000000000003 111.711 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 19.0 t70 62.38 95.39 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 O-C-N 123.852 0.72 . . . . 62.409999999999997 110.472 -173.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -132.55 125.83 31.44 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.945 -0.571 . . . . 75.239999999999995 109.952 178.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -86.7 107.26 18.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.635 0.731 . . . . 74.340000000000003 110.639 -177.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 13.8 p80 -114.28 118.16 33.15 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.933 -0.766 . . . . 64.150000000000006 108.933 175.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -150.2 142.58 24.3 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.981 -0.554 . . . . 75.209999999999994 110.287 -175.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -114.1 125.39 53.91 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.121 -0.49 . . . . 71.409999999999997 110.758 176.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -93.01 -47.83 6.8 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.197 -1.038 . . . . 73.129999999999995 108.197 169.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 14.0 t-80 . . . . . 0 C--O 1.249 1.046 0 CA-C-N 114.938 -1.028 . . . . 54.43 108.831 174.78 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.479 1.008 0 CA-C-O 120.629 0.252 . . . . 75.5 110.502 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -139.75 118.05 12.04 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.413 -0.358 . . . . 74.230000000000004 110.527 178.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 170.7 39.79 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 111.188 -0.765 . . . . 65.140000000000001 111.188 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.3 m -84.82 88.96 7.44 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.153 0.502 . . . . 72.25 110.82 -175.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 87.1 mtp -95.91 86.42 4.33 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.017 -0.538 . . . . 75.430000000000007 109.997 177.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.4 m -70.24 -53.6 16.28 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.611 -0.722 . . . . 74.209999999999994 110.599 -179.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -84.0 117.54 23.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.146 0.498 . . . . 75.040000000000006 110.186 178.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -138.69 42.9 2.13 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.378 0.608 . . . . 73.409999999999997 110.537 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -91.61 102.93 15.57 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.495 -0.775 . . . . 73.239999999999995 109.531 176.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.02 136.75 38.71 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.256 -0.429 . . . . 72.030000000000001 110.196 -175.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 57.6 t30 66.32 86.27 0.14 Allowed Pre-proline 0 N--CA 1.469 0.516 0 O-C-N 123.665 0.603 . . . . 63.140000000000001 111.642 175.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -68.75 -25.76 33.31 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.915 2.41 . . . . 71.329999999999998 111.637 176.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.3 t30 71.34 116.74 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.604 -0.726 . . . . 75.430000000000007 111.476 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -148.34 110.67 4.65 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.772 -0.649 . . . . 75.230000000000004 110.879 178.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -106.19 115.89 4.93 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 111.378 -0.689 . . . . 71.230000000000004 111.378 175.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -90.15 169.03 34.39 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.73 -0.748 . . . . 73.329999999999998 112.008 -178.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.432 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 12.4 m120 -93.94 143.1 25.93 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 109.927 -0.397 . . . . 72.140000000000001 109.927 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 17' ' ' ASN . 5.1 Cg_exo -77.58 -28.57 5.29 Favored 'Trans proline' 0 CA--C 1.529 0.264 0 C-N-CA 122.946 2.431 . . . . 61.409999999999997 112.39 176.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 65.33 179.77 0.19 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.894 -0.594 . . . . 74.519999999999996 111.709 179.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -154.16 135.68 14.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.073 -0.512 . . . . 74.239999999999995 110.657 178.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -172.55 77.65 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.633 -0.794 . . . . 62.439999999999998 112.719 -178.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -149.84 114.36 5.26 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.849 0.357 . . . . 64.099999999999994 110.19 178.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.435 ' HB2' ' HG ' ' A' ' 25' ' ' LEU . 78.6 m-85 -109.1 -25.05 10.87 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.002 -0.545 . . . . 71.25 111.113 -175.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.4 mp 59.12 58.15 3.22 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.936 -0.574 . . . . 62.32 110.277 -176.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.435 ' HG ' ' HB2' ' A' ' 23' ' ' PHE . 98.2 mt -84.26 56.58 3.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.633 -0.712 . . . . 52.439999999999998 111.129 -176.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -87.15 81.59 7.95 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.732 -0.47 . . . . 73.200000000000003 109.732 177.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.4 m -89.36 -56.56 3.22 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.034 -0.53 . . . . 71.349999999999994 110.469 -178.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 64.61 -82.38 0.03 OUTLIER 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.668 -0.696 . . . . 74.120000000000005 112.148 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 67.18 -73.59 0.08 Allowed 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 123.377 0.671 . . . . 65.310000000000002 110.727 -174.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 66.95 135.39 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.627 0.771 . . . . 75.25 112.545 177.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.8 mp0 -88.15 8.2 28.06 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.454 -0.793 . . . . 75.530000000000001 109.76 176.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 59.1 t30 69.57 177.53 0.26 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.081 -0.963 . . . . 64.010000000000005 110.709 178.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.7 m -101.78 19.64 17.82 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.127 0.417 . . . . 74.209999999999994 112.127 -175.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 21.8 m-30 -76.91 79.44 3.48 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.292 -0.633 . . . . 74.430000000000007 109.292 174.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -96.82 83.62 3.45 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.321 0.581 . . . . 71.430000000000007 110.839 -175.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.565 ' HB2' ' HD2' ' A' ' 37' ' ' PRO . 5.1 p-10 -162.81 158.26 18.81 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 114.739 -1.119 . . . . 74.530000000000001 108.587 175.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.78 ' HG3' ' HA ' ' A' ' 45' ' ' ILE . 10.0 Cg_endo -52.18 151.26 17.42 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 123.432 2.754 . . . . 70.219999999999999 114.571 -173.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.9 m 75.6 13.92 2.88 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 114.753 -1.112 . . . . 62.109999999999999 112.147 176.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -121.52 83.77 2.14 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.494 -0.558 . . . . 74.420000000000002 109.494 171.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 66.84 4.83 3.65 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.34 -0.846 . . . . 75.200000000000003 111.338 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -165.75 134.82 3.25 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.283 -0.636 . . . . 75.340000000000003 109.283 178.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -121.47 25.25 9.49 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.78 0.324 . . . . 70.120000000000005 110.722 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -106.68 -23.52 12.41 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.426 -0.352 . . . . 75.219999999999999 111.062 -176.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.462 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . -83.02 36.91 2.69 Favored Glycine 0 CA--C 1.518 0.223 0 C-N-CA 120.608 -0.806 . . . . 74.519999999999996 112.337 178.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.78 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 61.5 mt -58.86 -56.24 18.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.876 0.369 . . . . 75.239999999999995 111.435 -175.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.594 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 42.0 mt-10 -100.01 28.31 4.93 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.28 -0.418 . . . . 65.319999999999993 110.96 -177.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 20.3 m -107.15 86.64 2.61 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.963 -0.562 . . . . 60.32 109.687 175.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.594 ' HD3' ' O ' ' A' ' 46' ' ' GLU . 23.4 Cg_exo -63.24 98.23 0.21 Allowed 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.53 2.153 . . . . 72.099999999999994 112.225 -175.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.0 m -117.15 -77.79 0.57 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.896 -0.593 . . . . 71.450000000000003 109.91 174.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.86 -41.16 68.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.136 0.493 . . . . 71.230000000000004 110.336 178.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.639 HD23 ' H ' ' A' ' 51' ' ' LEU . 2.1 pt? -73.86 -17.97 60.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.778 -0.646 . . . . 73.420000000000002 111.214 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.467 ' HB2' ' C ' ' A' ' 48' ' ' PRO . 31.8 t70 -61.25 -53.65 54.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.823 0.344 . . . . 63.020000000000003 111.079 -176.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -77.43 22.34 0.24 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.902 -0.59 . . . . 73.010000000000005 110.991 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.442 ' O ' HG13 ' A' ' 58' ' ' ILE . 63.5 t80 -132.66 -65.91 0.7 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.321 -0.399 . . . . 74.25 110.731 -178.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.412 HG22 ' O ' ' A' ' 51' ' ' LEU . 10.5 t -69.85 -23.79 63.34 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.487 -0.324 . . . . 75.409999999999997 111.633 -173.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.43 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 2.2 mp0 -67.6 -30.43 70.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.984 0.421 . . . . 51.200000000000003 110.356 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.6 -26.49 37.79 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.067 -0.515 . . . . 74.219999999999999 110.192 177.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.546 ' O ' HG13 ' A' ' 62' ' ' ILE . 11.3 mt -69.91 -36.39 69.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.897 -0.592 . . . . 75.030000000000001 110.322 179.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -67.49 -32.09 72.67 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.068 -0.515 . . . . 51.229999999999997 110.319 178.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 7.1 m -68.45 -39.7 81.38 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.937 -0.574 . . . . 73.340000000000003 110.497 176.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.614 ' O ' ' HA3' ' A' ' 65' ' ' GLY . 2.8 pt20 -82.98 13.24 4.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.98 -0.555 . . . . 64.209999999999994 111.202 -176.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.546 HG13 ' O ' ' A' ' 58' ' ' ILE . 74.7 mt -88.79 -58.52 3.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.703 -0.48 . . . . 75.120000000000005 109.703 172.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 89.4 mt -57.97 -62.22 1.98 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.785 -0.643 . . . . 74.530000000000001 111.379 -175.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.59 3.84 78.98 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.406 -0.902 . . . . 54.140000000000001 112.255 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.614 ' HA3' ' O ' ' A' ' 61' ' ' GLN . . . -94.21 -41.59 4.24 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.759 -0.734 . . . . 33.530000000000001 112.395 -178.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.409 ' O ' HG12 ' A' ' 70' ' ' ILE . 84.1 mt -60.71 -25.06 66.14 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.066 0.46 . . . . 72.230000000000004 110.463 178.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 81.7 mt -63.37 -42.32 98.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.665 -0.698 . . . . 70.319999999999993 110.686 178.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.6 m -68.64 -29.75 68.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.076 0.465 . . . . 75.109999999999999 110.395 179.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -66.43 -25.45 66.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.865 -0.607 . . . . 53.439999999999998 110.607 178.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.409 HG12 ' O ' ' A' ' 66' ' ' LEU . 51.6 mm -76.42 -31.84 21.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.173 -0.467 . . . . 71.409999999999997 110.32 178.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -79.89 -45.69 18.16 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.118 -0.492 . . . . 61.43 111.298 -178.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 66.3 p 57.37 178.41 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.919 0.888 . . . . 53.310000000000002 111.795 -175.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.01 23.12 76.11 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.938 -0.649 . . . . 71.019999999999996 111.787 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -56.73 142.66 71.27 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.315 -0.442 . . . . 51.439999999999998 112.156 -177.549 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 74' ' ' LYS . 9.8 Cg_endo -90.44 -164.81 0.16 Allowed 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 123.564 2.842 . . . . 65.030000000000001 110.951 173.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 176.48 -123.42 0.9 Allowed Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 119.373 -1.394 . . . . 72.120000000000005 113.856 176.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 14.0 ptt180 -59.63 129.59 42.68 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.619 0.97 . . . . 45.020000000000003 113.619 -171.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.579 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 28.4 ttt -122.54 116.65 24.26 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.027 -1.101 . . . . 73.310000000000002 108.027 166.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 20.1 t -80.57 102.49 6.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.019 0.438 . . . . 63.219999999999999 112.109 -168.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.609 ' HB ' ' O ' ' A' ' 83' ' ' TYR . 5.9 m -108.11 163.34 13.25 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.114 -0.699 . . . . 43.310000000000002 109.114 174.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -65.08 -46.54 80.72 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.79 0.329 . . . . 72.310000000000002 111.043 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.542 ' HA ' ' HD2' ' A' ' 101' ' ' ARG . 28.2 m-20 -105.51 -79.53 0.56 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.912 0.387 . . . . 75.510000000000005 111.129 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.609 ' O ' ' HB ' ' A' ' 80' ' ' THR . 35.1 m-85 -67.46 122.68 18.49 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.816 -0.629 . . . . 63.340000000000003 111.524 -175.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.58 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 4.5 mp -84.73 107.08 15.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.627 -0.879 . . . . 71.040000000000006 108.627 176.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.579 ' HB ' ' HB3' ' A' ' 78' ' ' MET . 21.2 t -89.56 115.31 28.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.996 -0.547 . . . . 64.329999999999998 110.655 -175.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.812 ' HB3' ' HB2' ' A' ' 97' ' ' ASN . 13.3 t70 -106.98 106.08 16.44 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.663 -0.495 . . . . 74.510000000000005 109.663 177.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 60.0 mt -84.79 124.53 39.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.007 -0.542 . . . . 73.150000000000006 110.32 -178.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.433 ' O ' ' HB3' ' A' ' 95' ' ' GLN . . . -135.95 106.96 6.68 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.967 0.358 . . . . 54.140000000000001 111.967 -179.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -84.7 85.67 7.41 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.427 -0.953 . . . . 62.210000000000001 108.427 169.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.1 ttt180 -100.52 134.8 42.94 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.795 -0.639 . . . . 75.439999999999998 109.383 -176.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 68.59 -71.02 0.12 Allowed 'General case' 0 N--CA 1.467 0.41 0 O-C-N 123.87 0.731 . . . . 71.019999999999996 110.39 -172.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 178.52 29.62 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 111.753 -0.539 . . . . 75.319999999999993 111.753 178.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.481 HE21 ' HA ' ' A' ' 93' ' ' GLN . 0.1 OUTLIER -129.69 150.72 50.88 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 110.044 -0.354 . . . . 62.409999999999997 110.044 -177.833 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -79.91 92.6 5.55 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.4 0.619 . . . . 52.240000000000002 110.715 178.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.433 ' HB3' ' O ' ' A' ' 88' ' ' ALA . 5.2 tt0 -96.31 114.66 26.37 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.364 -0.834 . . . . 55.530000000000001 110.01 179.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 20.0 tp -101.68 112.77 25.46 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.01 -0.541 . . . . 75.109999999999999 110.413 -178.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.812 ' HB2' ' HB3' ' A' ' 86' ' ' ASP . 44.2 m-80 -93.54 103.3 15.5 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.109 -0.33 . . . . 43.409999999999997 110.109 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.434 ' CG1' ' HD2' ' A' ' 83' ' ' TYR . 68.9 t -93.35 109.22 21.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.534 0.683 . . . . 72.019999999999996 110.864 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.58 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 35.7 m -97.58 107.15 19.58 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.318 -0.855 . . . . 64.319999999999993 109.741 176.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.438 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 45.1 t0 -72.64 147.37 45.84 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.348 0.594 . . . . 63.399999999999999 111.48 -175.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.542 ' HD2' ' HA ' ' A' ' 82' ' ' ASP . 51.1 ttt180 -95.48 -26.42 15.83 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.994 -1.003 . . . . 70.420000000000002 109.66 177.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 35.9 mtpt -84.29 -65.99 0.95 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.724 -0.671 . . . . 73.140000000000001 110.984 -173.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 72.2 p -86.87 -19.0 29.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.213 0.53 . . . . 72.120000000000005 110.296 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.438 ' HA2' ' O ' ' A' ' 100' ' ' ASP . . . 71.82 21.2 79.0 Favored Glycine 0 N--CA 1.452 -0.284 0 CA-C-N 115.233 -0.894 . . . . 65.239999999999995 112.903 176.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 83.2 mm-40 -88.63 136.13 33.15 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.619 -0.512 . . . . 72.040000000000006 109.619 175.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 19.3 p -97.27 96.37 8.35 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.06 0.457 . . . . 61.32 110.711 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 29.8 m -97.72 106.85 19.23 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.723 -0.671 . . . . 71.150000000000006 110.356 -178.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 95.2 m -91.67 126.23 36.68 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.05 -0.523 . . . . 61.340000000000003 110.511 177.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 4.3 mp -115.37 111.04 34.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.188 -0.46 . . . . 73.010000000000005 109.961 177.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 95' ' ' GLN . 48.0 mt-30 -89.92 104.3 16.88 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.234 -0.439 . . . . 61.100000000000001 110.242 177.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 24.9 t -85.89 91.44 3.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.176 -0.676 . . . . 75.109999999999999 109.176 177.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 9.7 m -104.3 -37.67 7.16 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 113.345 0.869 . . . . 73.519999999999996 113.345 -169.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -105.97 23.0 30.32 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 119.92 -1.134 . . . . 53.210000000000001 114.851 -167.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 93.0 mt 54.4 70.47 0.61 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.526 0.679 . . . . 71.239999999999995 110.242 178.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -99.43 22.77 10.22 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.26 -0.882 . . . . 62.340000000000003 111.672 -170.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -166.21 166.4 16.91 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.604 -0.517 . . . . 63.439999999999998 109.604 178.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 53.3 t30 72.87 96.24 0.07 Allowed 'General case' 0 N--CA 1.466 0.348 0 O-C-N 123.883 0.74 . . . . 61.130000000000003 110.626 -178.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 33.8 t -147.4 144.53 28.75 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.656 -0.702 . . . . 75.219999999999999 109.177 -178.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 9.6 m 70.56 155.57 0.14 Allowed 'General case' 0 CA--C 1.535 0.396 0 O-C-N 123.74 0.65 . . . . 73.200000000000003 110.514 -176.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -85.27 146.48 27.03 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.973 0.416 . . . . 62.409999999999997 110.398 178.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -102.52 110.55 22.52 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.849 -0.614 . . . . 75.239999999999995 110.55 -179.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -74.43 136.83 42.35 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.086 -0.507 . . . . 74.340000000000003 109.808 178.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 60.0 t60 -67.01 104.91 1.5 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.625 -0.509 . . . . 64.150000000000006 109.625 179.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.495 ' CG ' ' H ' ' A' ' 125' ' ' HIS . 2.2 p80 -53.46 -75.91 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.543 0 O-C-N 123.808 0.692 . . . . 75.209999999999994 112.241 -172.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.495 ' H ' ' CG ' ' A' ' 124' ' ' HIS . 54.3 t-80 66.32 134.32 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.461 0.648 . . . . 71.409999999999997 112.208 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -115.72 -51.41 2.67 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.08 -0.509 . . . . 73.129999999999995 109.888 172.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 . . . . . 0 C--O 1.247 0.942 0 CA-C-O 118.417 -0.801 . . . . 54.43 109.38 176.965 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.0 mtm . . . . . 0 N--CA 1.48 1.033 0 CA-C-O 120.995 0.426 . . . . 75.5 110.279 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -116.74 123.36 47.0 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.88 -0.6 . . . . 74.230000000000004 110.175 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 139.94 146.68 4.9 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.359 -0.696 . . . . 65.140000000000001 111.359 -178.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.9 t -65.56 -31.02 71.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.684 0.242 . . . . 72.25 111.077 -177.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 15.9 tpt -161.87 -38.65 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.677 -0.238 . . . . 75.430000000000007 111.179 -179.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.7 m 58.95 76.07 0.37 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.706 0.765 . . . . 74.209999999999994 110.035 -173.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -95.93 -32.85 12.42 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.441 -0.799 . . . . 75.040000000000006 110.82 -175.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -170.58 -66.67 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.264 -0.426 . . . . 73.409999999999997 110.318 -178.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 71.5 t80 61.15 85.16 0.12 Allowed 'General case' 0 C--O 1.231 0.12 0 CA-C-O 121.591 0.71 . . . . 73.239999999999995 110.556 -177.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.44 ' O ' ' HD3' ' A' ' 12' ' ' PRO . 38.7 ttt180 -105.33 146.37 29.48 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.715 -0.675 . . . . 72.030000000000001 109.967 178.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -73.44 92.55 0.04 OUTLIER Pre-proline 0 N--CA 1.466 0.355 0 C-N-CA 124.067 0.947 . . . . 63.140000000000001 111.707 178.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' A' ' 10' ' ' ARG . 1.3 Cg_endo -77.35 125.8 7.99 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.993 2.462 . . . . 71.329999999999998 113.198 -167.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 51.2 t30 71.94 121.81 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.303 -0.862 . . . . 75.430000000000007 112.316 173.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -138.22 130.64 29.09 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.242 -0.89 . . . . 75.230000000000004 109.145 175.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -159.17 122.31 1.13 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.572 -0.823 . . . . 71.230000000000004 112.148 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -138.52 133.03 6.05 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 121.001 -0.618 . . . . 73.329999999999998 111.861 178.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.412 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 19.2 m120 -96.85 144.08 27.23 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 109.98 -0.378 . . . . 72.140000000000001 109.98 178.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 17' ' ' ASN . 6.3 Cg_exo -75.78 -55.91 0.06 OUTLIER 'Trans proline' 0 CA--C 1.53 0.289 0 C-N-CA 122.831 2.354 . . . . 61.409999999999997 112.708 -178.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 39.7 t-20 -158.97 139.67 12.6 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.413 -0.588 . . . . 74.519999999999996 109.413 -177.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -88.44 -28.39 20.92 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.839 0.352 . . . . 74.239999999999995 110.812 -177.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -122.53 -106.09 1.86 Allowed Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.43 -0.89 . . . . 62.439999999999998 113.164 -174.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 71.82 155.09 0.15 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.628 0.771 . . . . 64.099999999999994 111.685 -174.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 65.8 t80 64.01 86.04 0.13 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.369 -0.832 . . . . 71.25 111.479 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.732 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 3.2 mm? -126.21 141.07 52.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.895 -0.593 . . . . 62.32 110.693 178.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.732 ' HG ' ' O ' ' A' ' 24' ' ' LEU . 1.7 pp 64.59 153.03 0.05 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.688 1.195 . . . . 52.439999999999998 113.11 173.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -139.73 94.3 2.76 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.172 -0.922 . . . . 73.200000000000003 109.85 174.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.538 ' HB3' HD22 ' A' ' 81' ' ' ASN . 39.0 m 69.34 -67.66 0.21 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.741 -0.663 . . . . 71.349999999999994 112.201 178.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 63.71 -86.35 0.02 OUTLIER 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.796 0.838 . . . . 74.120000000000005 111.772 -177.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 52.3 tp60 -145.23 117.32 8.34 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.045 0.45 . . . . 65.310000000000002 110.664 -176.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.438 ' O ' ' HB3' ' A' ' 31' ' ' GLN . . . -172.64 -157.2 0.1 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.357 -0.838 . . . . 75.25 108.758 -178.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.47 ' O ' ' HB3' ' A' ' 32' ' ' ASN . 28.0 tp60 75.32 -17.82 0.48 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.351 0.5 . . . . 75.530000000000001 112.351 170.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.47 ' HB3' ' O ' ' A' ' 31' ' ' GLN . 26.7 t-20 71.52 112.27 0.06 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.238 0.542 . . . . 64.010000000000005 109.561 -170.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.4 m -74.99 98.65 3.65 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.079 -0.509 . . . . 74.209999999999994 111.03 -174.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -61.27 131.56 50.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.794 -0.639 . . . . 74.430000000000007 109.348 175.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 48.8 tttt -99.81 16.56 23.28 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.28 0.562 . . . . 71.430000000000007 110.029 -178.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.55 ' HB2' ' HD2' ' A' ' 37' ' ' PRO . 0.6 OUTLIER -131.31 162.51 55.47 Favored Pre-proline 0 C--N 1.325 -0.488 0 N-CA-C 108.818 -0.808 . . . . 74.530000000000001 108.818 175.965 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.6 ' HG2' ' HB3' ' A' ' 42' ' ' ASP . 28.1 Cg_endo -62.21 -19.99 68.52 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.716 2.277 . . . . 70.219999999999999 114.913 -170.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.595 ' HB3' ' HB2' ' A' ' 42' ' ' ASP . 38.4 t -136.14 -71.04 0.46 Allowed 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.254 -0.578 . . . . 62.109999999999999 111.974 -174.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -179.82 140.74 0.14 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.433 -0.581 . . . . 74.420000000000002 109.433 -170.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.523 HD22 ' C ' ' A' ' 40' ' ' ASN . 0.1 OUTLIER 54.09 29.46 10.36 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.832 0.678 . . . . 75.200000000000003 112.832 173.655 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.7 t70 72.39 85.64 0.12 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.159 -0.928 . . . . 75.340000000000003 110.53 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.6 ' HB3' ' HG2' ' A' ' 37' ' ' PRO . 20.7 t70 -82.79 -22.59 34.2 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.767 -1.106 . . . . 70.120000000000005 111.032 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 40.5 p90 47.21 25.61 0.57 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.285 1.034 . . . . 75.219999999999999 112.965 -178.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -82.77 13.46 42.61 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.83 -0.7 . . . . 74.519999999999996 112.241 177.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 45.0 mt -69.75 -26.54 30.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.574 0.702 . . . . 75.239999999999995 110.013 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -75.87 -9.31 58.5 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.034 -0.984 . . . . 65.319999999999993 111.467 -177.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 2.5 t -128.56 77.92 76.63 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 121.297 0.57 . . . . 60.32 111.374 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -76.75 96.57 1.1 Allowed 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.047 2.498 . . . . 72.099999999999994 111.302 176.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.1 m -125.2 -51.06 1.66 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.007 0.432 . . . . 71.450000000000003 110.357 -178.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.82 -49.46 8.4 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.139 0.495 . . . . 71.230000000000004 110.472 -179.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.409 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 3.2 pp -75.83 -10.16 59.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.934 -0.575 . . . . 73.420000000000002 111.337 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.535 ' HA ' HG22 ' A' ' 55' ' ' THR . 17.8 t70 -57.95 -45.57 86.43 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.905 -0.588 . . . . 63.020000000000003 111.068 -179.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -61.34 -17.41 53.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.489 -0.778 . . . . 73.010000000000005 111.359 -176.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -98.84 -47.18 5.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.353 -0.385 . . . . 74.25 110.59 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.535 HG22 ' HA ' ' A' ' 52' ' ' ASP . 10.0 t -68.85 -31.49 70.49 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.56 -0.291 . . . . 75.409999999999997 111.285 -176.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -68.16 -30.89 70.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.77 0.319 . . . . 51.200000000000003 110.499 -178.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.1 -12.9 60.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.007 0.432 . . . . 74.219999999999999 111.435 -178.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.6 mm -87.79 -24.55 6.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.381 0.61 . . . . 75.030000000000001 110.073 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -64.83 -22.58 67.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.699 -0.682 . . . . 51.229999999999997 112.138 -174.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 17.3 p -73.82 -41.65 62.03 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.035 0.383 . . . . 73.340000000000003 112.035 -175.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -73.41 -18.08 61.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.803 0.335 . . . . 64.209999999999994 111.075 -176.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.591 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 57.2 mt -67.74 -28.36 41.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.179 -0.464 . . . . 75.120000000000005 110.515 -178.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.2 mp -58.41 -40.2 81.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.351 -0.386 . . . . 74.530000000000001 111.056 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -76.29 -31.46 54.77 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.577 -0.821 . . . . 54.140000000000001 112.047 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -73.66 -25.31 72.52 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.058 -0.592 . . . . 33.530000000000001 112.623 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.591 ' HG ' ' O ' ' A' ' 62' ' ' ILE . 73.0 mt -55.43 -35.9 65.91 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 122.275 0.23 . . . . 72.230000000000004 111.501 -179.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.9 mp -56.45 -30.95 63.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.863 0.363 . . . . 70.319999999999993 111.42 -178.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 25.2 t -105.0 -16.0 14.94 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.295 -0.412 . . . . 75.109999999999999 111.052 -178.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -89.59 -26.67 20.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.816 0.341 . . . . 53.439999999999998 110.954 -176.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.432 HG12 ' O ' ' A' ' 66' ' ' LEU . 48.9 mm -75.79 -21.29 15.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.4 0.619 . . . . 71.409999999999997 109.929 177.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -68.53 -20.29 64.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.883 -0.599 . . . . 61.43 110.066 176.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 73.2 p 54.28 -169.62 0.06 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.229 -0.896 . . . . 53.310000000000002 111.716 -177.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 88.93 -50.06 3.66 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.807 -0.711 . . . . 71.019999999999996 112.802 177.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.592 ' HD2' ' O ' ' A' ' 75' ' ' PRO . 0.2 OUTLIER -56.01 152.21 22.16 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 122.303 0.241 . . . . 51.439999999999998 111.44 -175.92 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.592 ' O ' ' HD2' ' A' ' 74' ' ' LYS . 38.3 Cg_exo -61.37 177.6 0.8 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.362 2.708 . . . . 65.030000000000001 113.329 -177.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -93.27 -151.83 28.48 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.712 -0.756 . . . . 72.120000000000005 112.49 -178.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.475 ' HE ' ' HB3' ' A' ' 77' ' ' ARG . 1.3 ptp180 -114.34 162.1 17.05 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.742 0.306 . . . . 45.020000000000003 110.439 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 57.6 ttp -106.25 134.5 49.28 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.837 0.351 . . . . 73.310000000000002 110.497 -176.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 24.8 t -67.85 126.98 28.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.867 -0.606 . . . . 63.219999999999999 109.921 177.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.595 HG21 ' HB2' ' A' ' 83' ' ' TYR . 32.0 m -148.99 140.14 23.07 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.432 -0.581 . . . . 43.310000000000002 109.432 178.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.538 HD22 ' HB3' ' A' ' 27' ' ' SER . 65.6 m-20 -55.16 -62.68 1.5 Allowed 'General case' 0 C--N 1.329 -0.312 0 O-C-N 123.449 0.468 . . . . 72.310000000000002 112.093 -174.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -114.92 14.09 17.18 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.005 0.372 . . . . 75.510000000000005 112.005 -171.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.595 ' HB2' HG21 ' A' ' 80' ' ' THR . 68.5 m-85 -130.49 126.75 37.65 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.734 -0.386 . . . . 63.340000000000003 110.999 -177.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.495 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 4.1 mp -95.49 106.73 18.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.045 -0.724 . . . . 71.040000000000006 109.045 176.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.9 p -133.47 121.79 42.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.425 0.631 . . . . 64.329999999999998 111.815 -174.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -110.35 134.47 52.26 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.36 -0.836 . . . . 74.510000000000005 108.952 176.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.0 mt -83.53 80.26 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.025 -0.732 . . . . 73.150000000000006 109.025 178.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.426 ' HA ' ' HD3' ' A' ' 74' ' ' LYS . . . -86.61 109.42 19.14 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.429 -0.805 . . . . 54.140000000000001 111.323 -174.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -82.78 80.27 8.92 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.981 -0.748 . . . . 62.210000000000001 108.981 172.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -100.46 131.46 46.37 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.336 -0.847 . . . . 75.439999999999998 109.71 -177.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.5 t70 70.4 5.67 5.46 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 123.941 0.776 . . . . 71.019999999999996 111.034 177.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 112.04 -24.48 14.47 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.048 -0.596 . . . . 75.319999999999993 112.764 177.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.423 HE21 ' HA ' ' A' ' 93' ' ' GLN . 0.0 OUTLIER -92.59 141.34 28.6 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 122.734 -0.274 . . . . 62.409999999999997 110.94 -176.889 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.562 ' HB2' ' HB ' ' A' ' 111' ' ' VAL . 3.5 mm? -71.67 105.63 3.77 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.208 -0.664 . . . . 52.240000000000002 109.208 170.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -109.01 111.32 22.92 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.238 0.542 . . . . 55.530000000000001 110.649 -178.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 15.1 tp -81.69 99.94 9.2 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.614 -0.721 . . . . 75.109999999999999 109.263 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -94.02 106.87 18.83 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.118 -0.492 . . . . 43.409999999999997 110.341 -177.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 69.5 t -101.14 114.67 41.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.227 0.537 . . . . 72.019999999999996 111.46 -176.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.495 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 86.8 m -101.67 106.25 17.27 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.585 -0.734 . . . . 64.319999999999993 109.52 172.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.452 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 15.3 t0 -76.68 145.63 38.63 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.985 -0.552 . . . . 63.399999999999999 111.157 -178.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.54 ' HD2' ' O ' ' A' ' 101' ' ' ARG . 5.2 tmm_? -103.43 -25.76 13.14 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.789 -0.641 . . . . 70.420000000000002 109.635 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -73.73 -56.55 4.85 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.887 -0.597 . . . . 73.140000000000001 111.176 -173.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 71.7 p -109.24 -25.42 10.61 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.268 0.556 . . . . 72.120000000000005 110.265 176.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' A' ' 100' ' ' ASP . . . 98.68 13.88 39.3 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.723 -0.672 . . . . 65.239999999999995 112.644 177.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.45 ' N ' ' HB3' ' A' ' 100' ' ' ASP . 50.5 mm-40 -65.01 109.57 2.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.319 0.581 . . . . 72.040000000000006 111.165 178.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.5 m -87.97 100.13 12.68 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.409 -0.814 . . . . 61.32 109.097 176.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 7.6 t -103.08 141.18 36.27 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.937 0.399 . . . . 71.150000000000006 110.224 -175.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 46.6 m -116.69 106.08 13.13 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.075 -0.512 . . . . 61.340000000000003 110.664 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.425 HD12 ' N ' ' A' ' 109' ' ' ILE . 4.4 mp -111.52 105.15 18.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.3 -0.409 . . . . 73.010000000000005 110.721 -177.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -70.68 157.97 37.07 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.011 0.434 . . . . 61.100000000000001 110.843 175.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.562 ' HB ' ' HB2' ' A' ' 94' ' ' LEU . 3.4 p -59.41 114.61 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.381 -0.827 . . . . 75.109999999999999 111.685 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.7 p -90.22 -35.56 15.27 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.492 -0.777 . . . . 73.519999999999996 110.294 177.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 142.72 97.27 0.26 Allowed Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 111.153 -0.779 . . . . 53.210000000000001 111.153 -179.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 74.9 mt -86.64 -60.17 2.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.321 0.105 . . . . 71.239999999999995 111.088 -173.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 63.66 107.63 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 O-C-N 123.872 0.732 . . . . 62.340000000000003 111.474 -177.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -111.07 148.88 31.66 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.106 -0.497 . . . . 63.439999999999998 110.936 -177.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -108.72 110.33 21.7 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.886 -1.153 . . . . 61.130000000000003 107.886 172.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.0 t -65.8 -71.97 0.17 Allowed 'General case' 0 C--N 1.328 -0.358 0 O-C-N 123.223 0.327 . . . . 75.219999999999999 111.263 -171.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.0 m -153.06 128.58 10.0 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.632 -0.258 . . . . 73.200000000000003 110.746 -177.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -107.51 137.64 45.17 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.757 -0.46 . . . . 62.409999999999997 109.757 174.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -82.96 136.82 34.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.265 -0.425 . . . . 75.239999999999995 111.575 -172.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 79.4 m-70 -129.77 174.95 9.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.705 -0.68 . . . . 74.340000000000003 109.234 175.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 66.5 -167.48 0.21 Allowed 'General case' 0 N--CA 1.467 0.392 0 O-C-N 123.521 0.513 . . . . 64.150000000000006 111.52 178.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 6.8 t60 59.16 78.54 0.26 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.18 -0.918 . . . . 75.209999999999994 111.691 177.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -176.9 159.3 1.71 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.455 -0.793 . . . . 71.409999999999997 109.025 174.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 28.9 m80 -107.17 168.1 9.45 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 121.013 -0.275 . . . . 73.129999999999995 110.529 178.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.384 -0.817 . . . . 54.43 110.279 -175.804 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.0 ttm . . . . . 0 N--CA 1.478 0.945 0 N-CA-C 110.46 -0.2 . . . . 75.5 110.46 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.27 175.42 0.18 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.508 0.671 . . . . 74.230000000000004 112.473 177.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -89.46 -131.9 4.44 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.766 -0.73 . . . . 65.140000000000001 112.134 175.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.5 m -111.31 -62.36 1.56 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 110.005 -0.368 . . . . 72.25 110.005 177.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 27.0 ttt -179.49 -59.91 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.847 -0.615 . . . . 75.430000000000007 110.185 177.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 28.2 m 71.38 148.12 0.08 Allowed 'General case' 0 CA--C 1.536 0.433 0 O-C-N 123.388 0.43 . . . . 74.209999999999994 110.508 -178.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -78.73 -54.58 5.95 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 122.109 -0.369 . . . . 75.040000000000006 111.815 -176.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -112.53 21.35 15.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.736 0.303 . . . . 73.409999999999997 111.459 -174.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 55.7 t80 63.99 -80.28 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.642 -0.708 . . . . 73.239999999999995 111.712 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -158.31 82.53 0.84 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.886 0.374 . . . . 72.030000000000001 110.055 -177.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -128.75 86.61 57.06 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 116.09 -0.505 . . . . 63.140000000000001 110.096 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -74.64 107.39 2.45 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 123.279 2.653 . . . . 71.329999999999998 113.354 -174.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 22.0 m120 68.97 121.59 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 O-C-N 124.227 0.955 . . . . 75.430000000000007 112.785 173.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -97.64 136.65 37.7 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.286 -0.87 . . . . 75.230000000000004 109.035 175.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 130.94 133.09 3.47 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.478 -0.867 . . . . 71.230000000000004 111.401 -176.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 138.12 -76.25 0.36 Allowed Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.262 -0.735 . . . . 73.329999999999998 111.262 -177.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.439 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 6.0 m-20 66.07 146.42 0.1 Allowed Pre-proline 0 N--CA 1.469 0.52 0 C-N-CA 123.104 0.562 . . . . 72.140000000000001 111.841 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 17' ' ' ASN . 24.1 Cg_exo -65.11 -28.41 56.76 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.431 2.087 . . . . 61.409999999999997 111.44 174.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -105.29 104.97 14.8 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.796 -0.638 . . . . 74.519999999999996 109.482 177.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -140.54 149.35 42.32 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.355 -0.384 . . . . 74.239999999999995 110.119 -178.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 159.76 -69.95 0.24 Allowed Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.841 -0.695 . . . . 62.439999999999998 112.455 177.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 64.99 98.95 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 O-C-N 124.134 0.549 . . . . 64.099999999999994 111.373 -176.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -68.69 112.66 5.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.967 -0.56 . . . . 71.25 110.5 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.642 HD12 ' HG ' ' A' ' 25' ' ' LEU . 2.6 pp -137.58 9.4 2.89 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.941 -0.572 . . . . 62.32 110.911 -177.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.642 ' HG ' HD12 ' A' ' 24' ' ' LEU . 97.7 mt -117.42 162.22 18.3 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.93 -0.577 . . . . 52.439999999999998 110.419 178.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 62.7 t30 66.62 102.13 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 O-C-N 123.856 0.722 . . . . 73.200000000000003 111.457 178.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.8 m -86.12 172.55 10.49 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.75 -0.659 . . . . 71.349999999999994 110.632 -179.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -95.24 115.71 27.79 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.668 0.27 . . . . 74.120000000000005 110.478 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -110.67 171.58 7.38 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.175 -0.466 . . . . 65.310000000000002 110.043 -179.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 71.95 -48.89 0.68 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.616 0.766 . . . . 75.25 111.439 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -81.06 151.4 28.39 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.121 -0.49 . . . . 75.530000000000001 109.872 176.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 55.5 t30 72.19 141.75 0.06 Allowed 'General case' 0 N--CA 1.469 0.522 0 O-C-N 123.976 0.797 . . . . 64.010000000000005 111.094 -176.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.3 m 63.15 58.3 1.46 Allowed 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.902 -0.59 . . . . 74.209999999999994 110.813 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 99.7 m-85 -81.48 77.01 8.39 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.872 -0.604 . . . . 74.430000000000007 111.51 -174.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm -129.0 -164.99 1.45 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.102 -0.703 . . . . 71.430000000000007 109.102 174.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -70.37 143.42 90.6 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-O 121.062 0.458 . . . . 74.530000000000001 110.863 -177.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.875 ' HB3' ' H ' ' A' ' 43' ' ' PHE . 13.6 Cg_endo -57.1 164.07 6.98 Favored 'Trans proline' 0 N--CA 1.473 0.318 0 C-N-CA 123.983 3.122 . . . . 70.219999999999999 113.864 178.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.5 t -65.65 -69.92 0.27 Allowed 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.705 -0.68 . . . . 62.109999999999999 109.977 176.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -140.26 152.7 46.13 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.554 0.216 . . . . 74.420000000000002 110.778 177.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 20.1 m120 59.07 30.56 20.39 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.853 -0.612 . . . . 75.200000000000003 112.587 172.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.538 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 11.9 t70 62.05 36.27 15.48 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.204 0.526 . . . . 75.340000000000003 110.789 176.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -45.2 -67.59 0.27 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.219 -0.9 . . . . 70.120000000000005 111.786 178.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.875 ' H ' ' HB3' ' A' ' 37' ' ' PRO . 11.3 m-85 -105.48 36.2 2.59 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.684 0.278 . . . . 75.219999999999999 110.773 175.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -79.08 3.35 65.96 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.802 -0.713 . . . . 74.519999999999996 111.978 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 58.3 mt -107.33 -42.64 6.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.291 -0.455 . . . . 75.239999999999995 110.568 -179.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 63.35 -165.45 0.24 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.889 -0.596 . . . . 65.319999999999993 111.005 -178.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 28.8 m -134.8 83.4 41.34 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-O 121.05 0.452 . . . . 60.32 110.669 178.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.635 ' HB2' ' HB2' ' A' ' 52' ' ' ASP . 18.4 Cg_endo -93.97 108.49 0.16 Allowed 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 123.491 2.794 . . . . 72.099999999999994 112.124 177.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.4 m -110.18 -78.65 0.59 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.386 -0.37 . . . . 71.450000000000003 111.049 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.46 -40.64 57.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.758 0.313 . . . . 71.230000000000004 111.405 -177.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.7 pp -68.37 -22.6 64.65 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.801 0.334 . . . . 73.420000000000002 110.358 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.635 ' HB2' ' HB2' ' A' ' 48' ' ' PRO . 7.7 t70 -61.68 -41.85 98.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.975 -0.557 . . . . 63.020000000000003 110.431 177.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 -68.18 -42.42 80.01 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.799 -0.637 . . . . 73.010000000000005 109.925 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -68.34 -50.12 55.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.62 -0.718 . . . . 74.25 111.567 -175.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.5 t -67.85 -17.86 64.63 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.787 0.327 . . . . 75.409999999999997 111.575 -175.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -75.94 -21.89 56.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.835 0.35 . . . . 51.200000000000003 110.935 -177.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -82.93 -19.26 37.57 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.52 0.676 . . . . 74.219999999999999 109.867 174.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.504 ' O ' HG13 ' A' ' 62' ' ' ILE . 19.5 mt -79.39 -25.86 12.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.165 -0.925 . . . . 75.030000000000001 110.489 -179.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -57.8 -28.62 64.19 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.705 -0.68 . . . . 51.229999999999997 111.701 -176.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.7 m -79.13 -35.38 42.23 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.39 -0.368 . . . . 73.340000000000003 111.49 -177.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.443 ' HG2' ' O ' ' A' ' 58' ' ' ILE . 11.3 pt20 -82.05 -6.31 59.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.897 0.379 . . . . 64.209999999999994 111.627 -174.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.504 HG13 ' O ' ' A' ' 58' ' ' ILE . 67.7 mt -70.82 -31.93 47.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.832 0.348 . . . . 75.120000000000005 110.641 -178.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.736 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 8.8 mp -59.4 -46.97 87.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 74.530000000000001 111.512 -177.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -57.48 -27.26 58.13 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 121.177 -0.535 . . . . 54.140000000000001 112.906 -178.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -92.7 -42.63 4.41 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.558 -0.83 . . . . 33.530000000000001 112.294 178.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.559 ' HA ' ' HB2' ' A' ' 69' ' ' ASN . 1.3 pp -64.44 -23.75 67.39 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 111.415 0.154 . . . . 72.230000000000004 111.415 -176.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.736 ' HG ' ' O ' ' A' ' 63' ' ' LEU . 80.7 mt -52.17 -46.27 65.44 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.058 0.456 . . . . 70.319999999999993 110.594 177.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.6 t -90.7 -4.91 56.39 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.101 -0.499 . . . . 75.109999999999999 110.485 -177.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.559 ' HB2' ' HA ' ' A' ' 66' ' ' LEU . 9.2 m120 -86.22 -21.43 27.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.061 0.457 . . . . 53.439999999999998 109.96 174.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.466 HG12 ' O ' ' A' ' 66' ' ' LEU . 51.4 mm -72.59 -31.7 38.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 108.593 -0.891 . . . . 71.409999999999997 108.593 168.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -68.78 -56.08 9.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.074 -0.967 . . . . 61.43 109.767 175.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 48.5 m -97.69 101.43 12.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.883 -0.598 . . . . 53.310000000000002 111.26 178.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -76.68 82.87 1.05 Allowed Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.5 -0.773 . . . . 71.019999999999996 111.344 177.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -55.03 142.17 57.49 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.484 -0.358 . . . . 51.439999999999998 110.88 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -66.46 -47.58 2.97 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 122.768 2.312 . . . . 65.030000000000001 112.076 -178.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 175.83 116.21 0.45 Allowed Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 115.68 -0.691 . . . . 72.120000000000005 111.734 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.488 ' HD2' ' O ' ' A' ' 77' ' ' ARG . 0.1 OUTLIER -90.47 143.21 26.97 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.666 0.27 . . . . 45.020000000000003 110.359 177.536 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 54.4 ttp -85.87 114.52 22.86 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.176 0.513 . . . . 73.310000000000002 111.044 -174.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 42.5 t -97.11 98.84 7.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.607 -0.724 . . . . 63.219999999999999 109.601 177.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.2 140.91 52.44 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.064 -0.516 . . . . 43.310000000000002 111.168 -178.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -75.94 60.0 1.33 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.213 0.53 . . . . 72.310000000000002 111.736 -177.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -170.75 -41.41 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.402 -0.817 . . . . 75.510000000000005 109.165 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -144.66 123.84 12.92 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.483 -0.78 . . . . 63.340000000000003 110.183 174.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.581 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 50.6 mm -92.32 109.11 21.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 109.1 -0.704 . . . . 71.040000000000006 109.1 173.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 43.9 t -108.42 96.39 4.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.983 0.42 . . . . 64.329999999999998 110.406 -178.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.464 ' OD1' ' HG2' ' A' ' 77' ' ' ARG . 10.9 t70 -107.68 114.34 28.24 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.962 -0.563 . . . . 74.510000000000005 110.049 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 56.3 mt -80.92 86.91 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.233 -0.654 . . . . 73.150000000000006 109.233 176.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -98.38 171.36 8.23 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.856 -0.611 . . . . 54.140000000000001 110.848 -176.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.527 ' HB2' HD13 ' A' ' 94' ' ' LEU . 51.9 t-20 -146.04 138.38 25.38 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.071 -1.085 . . . . 62.210000000000001 108.071 178.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.443 ' O ' ' HB3' ' A' ' 91' ' ' ASP . 14.9 ttp180 -123.15 110.36 15.18 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.032 -0.358 . . . . 75.439999999999998 110.032 177.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.443 ' HB3' ' O ' ' A' ' 90' ' ' ARG . 15.6 t70 75.15 -45.57 0.56 Allowed 'General case' 0 N--CA 1.471 0.582 0 O-C-N 123.773 0.67 . . . . 71.019999999999996 111.837 177.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -178.46 -27.97 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.882 -0.675 . . . . 75.319999999999993 112.35 -178.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.553 HE21 ' HA ' ' A' ' 93' ' ' GLN . 0.1 OUTLIER -93.1 125.08 37.52 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.055 0.455 . . . . 62.409999999999997 110.389 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.585 ' HB2' ' HB ' ' A' ' 111' ' ' VAL . 4.2 mm? -61.44 141.69 57.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.536 -0.756 . . . . 52.240000000000002 111.114 -178.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.511 HE21 ' HA ' ' A' ' 95' ' ' GLN . 0.0 OUTLIER -131.94 97.92 4.3 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.674 -0.693 . . . . 55.530000000000001 109.566 -178.523 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.472 ' HB3' ' HB ' ' A' ' 109' ' ' ILE . 69.4 tp -80.32 113.15 18.3 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.027 -0.533 . . . . 75.109999999999999 110.289 -177.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -106.11 113.1 26.44 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.227 -0.442 . . . . 43.409999999999997 110.777 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.581 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 46.4 t -110.82 117.35 54.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.531 -0.758 . . . . 72.019999999999996 110.33 175.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.546 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 25.7 m -94.28 101.1 13.06 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.519 -0.764 . . . . 64.319999999999993 110.25 176.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.532 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 29.4 t70 -67.79 130.36 42.74 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.686 -0.688 . . . . 63.399999999999999 109.949 177.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 42.1 ttt180 -98.7 -22.93 15.65 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.915 0.388 . . . . 70.420000000000002 110.891 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -68.23 -45.44 73.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.082 -0.508 . . . . 73.140000000000001 111.157 -173.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.415 ' OG1' ' HG3' ' A' ' 105' ' ' GLN . 77.6 p -123.4 -32.86 3.34 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.303 0.573 . . . . 72.120000000000005 110.369 177.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.532 ' HA2' ' O ' ' A' ' 100' ' ' ASP . . . 103.19 30.04 5.52 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.493 -0.776 . . . . 65.239999999999995 112.435 178.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.416 ' N ' ' HB3' ' A' ' 100' ' ' ASP . 47.8 mt-30 -72.95 105.36 4.4 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.179 -0.304 . . . . 72.040000000000006 110.179 176.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 33.5 m -67.77 101.35 1.04 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.083 0.468 . . . . 61.32 110.058 176.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.519 ' HB2' ' HB ' ' A' ' 98' ' ' VAL . 23.5 m -99.77 96.38 7.56 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.012 -0.54 . . . . 71.150000000000006 110.619 -177.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 24.6 m -104.46 99.72 9.42 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.256 0.55 . . . . 61.340000000000003 110.007 176.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.472 ' HB ' ' HB3' ' A' ' 96' ' ' LEU . 4.0 mp -90.67 121.51 41.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.767 -0.651 . . . . 73.010000000000005 110.531 -176.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -82.67 110.25 17.56 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.556 -0.535 . . . . 61.100000000000001 109.556 176.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.585 ' HB ' ' HB2' ' A' ' 94' ' ' LEU . 51.0 t -87.87 129.19 39.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.514 -0.312 . . . . 75.109999999999999 110.281 -177.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.6 t 69.24 -155.48 0.16 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.745 -0.661 . . . . 73.519999999999996 109.724 -176.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 94.16 -71.33 1.22 Allowed Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 111.199 -0.76 . . . . 53.210000000000001 111.199 -177.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 94.6 mt -96.93 75.13 2.66 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.044 0.449 . . . . 71.239999999999995 110.043 177.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -139.83 132.78 29.36 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.58 -0.736 . . . . 62.340000000000003 109.936 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 34.4 p30 -162.33 167.74 23.33 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.623 -0.262 . . . . 63.439999999999998 110.937 179.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -150.02 151.55 33.46 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.862 0.363 . . . . 61.130000000000003 110.887 175.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 12.1 t -116.75 152.7 33.79 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.673 -0.862 . . . . 75.219999999999999 108.673 174.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 8.9 t -59.8 126.42 27.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.3 0.571 . . . . 73.200000000000003 110.674 -178.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -80.33 91.54 5.67 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.594 0.711 . . . . 62.409999999999997 111.262 -176.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -67.28 138.37 56.8 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.176 -0.675 . . . . 75.239999999999995 109.176 175.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 60.2 m-70 -68.08 123.54 20.94 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.258 0.551 . . . . 74.340000000000003 110.866 -175.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 52.9 m-70 -88.45 139.61 30.31 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.183 -0.917 . . . . 64.150000000000006 111.209 -171.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.514 ' CD2' ' H ' ' A' ' 125' ' ' HIS . 1.3 t-160 -135.76 -164.26 1.52 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.272 -1.01 . . . . 75.209999999999994 108.272 173.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.514 ' H ' ' CD2' ' A' ' 124' ' ' HIS . 48.3 t60 -111.92 94.05 4.76 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.062 0.458 . . . . 71.409999999999997 111.121 -173.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.521 ' O ' ' HB2' ' A' ' 127' ' ' HIS . 10.1 t60 -94.58 174.68 6.99 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.976 -1.12 . . . . 73.129999999999995 107.976 173.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.521 ' HB2' ' O ' ' A' ' 126' ' ' HIS . 8.9 m-70 . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.106 -0.95 . . . . 54.43 110.564 -178.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.0 ttm . . . . . 0 N--CA 1.478 0.954 0 CA-C-O 121.134 0.493 . . . . 75.5 109.976 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.77 155.46 41.72 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.96 -0.564 . . . . 74.230000000000004 110.696 -177.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -89.95 -77.93 1.33 Allowed Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 111.597 -0.601 . . . . 65.140000000000001 111.597 177.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.428 HG22 ' HG3' ' A' ' 5' ' ' MET . 26.9 m 72.91 150.09 0.1 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 122.81 0.444 . . . . 72.25 111.758 178.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.428 ' HG3' HG22 ' A' ' 4' ' ' THR . 72.8 mtm 74.47 81.69 0.11 Allowed 'General case' 0 C--O 1.236 0.342 0 C-N-CA 123.477 0.711 . . . . 75.430000000000007 112.586 176.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 89.4 m -106.87 99.76 9.3 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.907 -0.775 . . . . 74.209999999999994 108.907 168.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -128.14 126.4 41.02 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.338 0.59 . . . . 75.040000000000006 112.454 -170.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -139.13 90.61 2.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.435 -0.802 . . . . 73.409999999999997 109.933 172.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.618 ' HD2' ' HG3' ' A' ' 10' ' ' ARG . 31.2 p90 -102.59 173.11 6.48 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.834 -0.621 . . . . 73.239999999999995 110.015 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.618 ' HG3' ' HD2' ' A' ' 9' ' ' PHE . 72.7 mtp180 68.74 -169.02 0.18 Allowed 'General case' 0 C--O 1.236 0.365 0 O-C-N 124.022 0.826 . . . . 72.030000000000001 110.307 -174.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 62.18 81.13 0.24 Allowed Pre-proline 0 CA--C 1.532 0.255 0 O-C-N 123.483 0.489 . . . . 63.140000000000001 110.602 -178.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -78.12 -39.49 0.46 Allowed 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.702 2.268 . . . . 71.329999999999998 113.539 -176.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 66.6 t30 63.73 -175.04 0.16 Allowed 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 109.573 -0.528 . . . . 75.430000000000007 109.573 -174.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 72.7 t80 74.32 134.93 0.05 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.294 0.569 . . . . 75.230000000000004 111.208 176.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -96.45 149.78 19.41 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.814 -0.707 . . . . 71.230000000000004 112.714 -178.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -72.68 121.95 8.18 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.861 -0.685 . . . . 73.329999999999998 111.521 177.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.2 143.37 26.02 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-O 120.642 0.258 . . . . 72.140000000000001 110.677 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -66.98 -29.35 40.87 Favored 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 122.556 2.171 . . . . 61.409999999999997 111.364 175.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 65.06 23.36 12.46 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.523 -0.762 . . . . 74.519999999999996 111.18 179.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -75.4 146.44 40.79 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.977 -0.556 . . . . 74.239999999999995 109.831 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -133.87 173.56 21.21 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.439 -0.886 . . . . 62.439999999999998 112.641 -176.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -91.96 4.24 53.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.528 0.164 . . . . 64.099999999999994 111.207 -178.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 13.9 p90 44.37 79.91 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.071 0.949 . . . . 71.25 112.819 178.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.403 ' N ' HD23 ' A' ' 24' ' ' LEU . 2.5 pt? -146.37 134.1 21.14 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.753 -0.658 . . . . 62.32 110.453 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 81.6 mt -85.52 -69.04 0.69 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.467 -0.333 . . . . 52.439999999999998 110.608 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.8 m120 60.4 38.84 19.19 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.045 -0.525 . . . . 73.200000000000003 111.469 178.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.1 m -72.62 156.06 39.38 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.085 -0.507 . . . . 71.349999999999994 110.081 177.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -109.37 8.14 25.35 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.444 -0.343 . . . . 74.120000000000005 110.905 -176.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 62.7 -164.54 0.25 Allowed 'General case' 0 N--CA 1.465 0.307 0 O-C-N 123.563 0.54 . . . . 65.310000000000002 110.652 -177.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.98 168.84 12.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.219 0.533 . . . . 75.25 111.366 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -130.32 166.95 19.31 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.802 -0.636 . . . . 75.530000000000001 110.125 -177.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -88.63 174.0 8.3 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.335 -0.393 . . . . 64.010000000000005 110.154 177.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.8 m -87.22 -44.48 11.43 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.53 -0.305 . . . . 74.209999999999994 111.355 -176.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 67.92 8.97 6.83 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.549 0.69 . . . . 74.430000000000007 110.542 -174.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -161.21 79.18 0.59 Allowed 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 107.692 -1.225 . . . . 71.430000000000007 107.692 175.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -105.04 151.85 39.55 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.269 -0.878 . . . . 74.530000000000001 111.089 -172.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.472 ' HD3' HG13 ' A' ' 45' ' ' ILE . 48.0 Cg_endo -69.9 -12.81 33.36 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.608 2.205 . . . . 70.219999999999999 111.505 176.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.0 m 69.2 6.42 5.65 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.257 -0.883 . . . . 62.109999999999999 112.167 176.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.493 ' HD1' ' ND2' ' A' ' 40' ' ' ASN . 2.8 t80 -162.96 139.49 7.36 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.966 -0.383 . . . . 74.420000000000002 109.966 175.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.493 ' ND2' ' HD1' ' A' ' 39' ' ' TYR . 38.0 m-80 65.21 68.8 0.49 Allowed 'General case' 0 C--O 1.235 0.301 0 O-C-N 123.992 0.807 . . . . 75.200000000000003 110.137 -177.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.3 t70 71.84 140.42 0.05 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.165 -0.925 . . . . 75.340000000000003 110.801 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -82.79 -2.7 55.25 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 122.111 -0.368 . . . . 70.120000000000005 111.398 -176.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -112.56 20.68 16.39 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 109.484 -0.561 . . . . 75.219999999999999 109.484 170.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -76.2 39.88 1.45 Allowed Glycine 0 C--N 1.335 0.527 0 CA-C-N 115.791 -0.64 . . . . 74.519999999999996 113.766 -173.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.472 HG13 ' HD3' ' A' ' 37' ' ' PRO . 17.8 mt -118.17 25.07 4.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 107.869 -1.16 . . . . 75.239999999999995 107.869 174.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 56.63 46.04 21.03 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 114.459 -1.246 . . . . 65.319999999999993 109.375 -174.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 21.6 m -114.97 86.52 13.62 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.162 -0.926 . . . . 60.32 109.909 178.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.682 ' HB2' ' HB2' ' A' ' 52' ' ' ASP . 48.5 Cg_endo -70.68 83.65 0.85 Allowed 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.24 1.96 . . . . 72.099999999999994 112.69 -177.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.6 m -96.57 -54.99 3.06 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.754 -0.657 . . . . 71.450000000000003 109.913 173.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -100.78 -27.92 13.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.99 0.424 . . . . 71.230000000000004 111.109 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.511 HD23 ' H ' ' A' ' 51' ' ' LEU . 0.8 OUTLIER -87.15 -3.03 59.04 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.997 -0.547 . . . . 73.420000000000002 111.591 -176.609 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.682 ' HB2' ' HB2' ' A' ' 48' ' ' PRO . 17.2 t70 -62.59 -69.23 0.27 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.51 -0.314 . . . . 63.020000000000003 111.589 -176.098 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -66.09 -23.91 66.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.269 0.557 . . . . 73.010000000000005 110.155 177.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.559 ' O ' HG13 ' A' ' 58' ' ' ILE . 85.3 t80 -61.56 -53.42 56.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.583 -0.735 . . . . 74.25 110.817 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.428 ' O ' ' HG3' ' A' ' 59' ' ' GLN . 9.8 t -69.12 -21.42 64.03 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.133 0.492 . . . . 75.409999999999997 110.873 -177.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -73.42 -39.65 64.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.242 0.544 . . . . 51.200000000000003 109.915 178.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.64 -29.36 69.37 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.646 -0.706 . . . . 74.219999999999999 109.998 175.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.58 ' HA ' ' HG2' ' A' ' 61' ' ' GLN . 15.8 mt -64.07 -39.29 84.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.879 -0.6 . . . . 75.030000000000001 110.44 176.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.428 ' HG3' ' O ' ' A' ' 55' ' ' THR . 73.0 mt-30 -58.1 -42.29 85.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.279 -0.419 . . . . 51.229999999999997 110.438 178.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.5 m -61.16 -45.31 95.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.078 -0.51 . . . . 73.340000000000003 110.584 177.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.671 ' O ' ' HA3' ' A' ' 65' ' ' GLY . 3.1 pt20 -80.81 7.74 9.75 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.824 -0.625 . . . . 64.209999999999994 110.85 -176.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.517 HG13 ' O ' ' A' ' 58' ' ' ILE . 83.2 mt -100.8 -55.84 5.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.954 -0.758 . . . . 75.120000000000005 108.954 168.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 89.6 mt -59.04 -41.42 87.81 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.613 -0.721 . . . . 74.530000000000001 111.049 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -108.85 -0.66 32.05 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.713 -0.756 . . . . 54.140000000000001 112.199 178.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.671 ' HA3' ' O ' ' A' ' 61' ' ' GLN . . . -85.44 -22.12 52.08 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.847 -0.692 . . . . 33.530000000000001 112.492 -176.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 62' ' ' ILE . 90.8 mt -60.08 -30.54 69.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.014 0.435 . . . . 72.230000000000004 109.985 176.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 70.3 mt -67.36 -33.07 74.46 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.483 -0.78 . . . . 70.319999999999993 110.682 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 9.2 m -73.27 -32.22 64.54 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.047 -0.524 . . . . 75.109999999999999 110.388 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -91.34 10.99 25.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.027 -0.533 . . . . 53.439999999999998 111.622 -177.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 36.1 mm -66.11 -34.7 71.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.158 0.504 . . . . 71.409999999999997 109.964 174.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -62.85 -60.58 3.28 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.711 -0.677 . . . . 61.43 110.728 176.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.5 m 73.66 -44.49 0.58 Allowed 'General case' 0 CA--C 1.535 0.401 0 O-C-N 123.631 0.582 . . . . 53.310000000000002 112.489 175.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.39 12.59 13.48 Favored Glycine 0 CA--C 1.519 0.314 0 N-CA-C 114.005 0.362 . . . . 71.019999999999996 114.005 -173.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.33 146.34 53.32 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.953 0.376 . . . . 51.439999999999998 110.211 175.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -58.27 -55.67 2.06 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.938 2.425 . . . . 65.030000000000001 112.979 -174.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 174.2 -154.97 20.58 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 119.838 -1.173 . . . . 72.120000000000005 113.089 -178.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 -127.94 176.02 7.92 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.564 -0.318 . . . . 45.020000000000003 110.367 -174.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.825 ' HB3' HG13 ' A' ' 85' ' ' VAL . 48.9 ttm -130.77 115.23 16.35 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.865 -0.42 . . . . 73.310000000000002 109.865 176.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 59.9 t -87.79 111.31 21.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.041 -0.527 . . . . 63.219999999999999 110.552 -177.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.663 HG22 ' H ' ' A' ' 82' ' ' ASP . 24.5 m -130.67 138.95 50.29 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.902 -0.59 . . . . 43.310000000000002 109.819 178.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -67.69 -23.32 65.28 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.946 0.403 . . . . 72.310000000000002 111.132 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.663 ' H ' HG22 ' A' ' 80' ' ' THR . 25.0 m-20 -97.66 -19.14 18.46 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.177 -0.465 . . . . 75.510000000000005 111.462 -177.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -144.38 136.8 26.58 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.5 0.556 . . . . 63.340000000000003 112.5 -171.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.593 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 4.1 mp -98.23 105.68 17.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 108.172 -1.048 . . . . 71.040000000000006 108.172 169.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.825 HG13 ' HB3' ' A' ' 78' ' ' MET . 5.6 p -135.98 135.66 50.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.258 0.551 . . . . 64.329999999999998 111.75 -174.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -128.43 143.49 51.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.473 -0.785 . . . . 74.510000000000005 109.18 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.41 HD12 ' N ' ' A' ' 87' ' ' ILE . 4.3 mp -95.85 86.63 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.355 -0.609 . . . . 73.150000000000006 109.355 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -105.26 128.12 53.28 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.784 -0.644 . . . . 54.140000000000001 111.223 -175.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -84.36 115.81 22.71 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.037 -0.727 . . . . 62.210000000000001 109.037 174.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -130.99 132.51 45.06 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.949 -0.389 . . . . 75.439999999999998 109.949 177.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.9 t70 68.11 11.15 8.24 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 124.036 0.835 . . . . 71.019999999999996 110.574 179.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 97.59 -0.08 59.49 Favored Glycine 0 N--CA 1.452 -0.248 0 CA-C-N 115.675 -0.693 . . . . 75.319999999999993 112.402 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.546 HE21 ' HA ' ' A' ' 93' ' ' GLN . 0.0 OUTLIER -114.29 134.41 54.97 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.752 0.31 . . . . 62.409999999999997 110.423 179.171 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.4 HD13 ' HA ' ' A' ' 94' ' ' LEU . 4.0 mm? -67.0 108.9 2.77 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.117 -0.697 . . . . 52.240000000000002 109.117 173.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.409 HE21 ' HB2' ' A' ' 95' ' ' GLN . 6.1 tt0 -105.57 110.41 22.73 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.74 -0.664 . . . . 55.530000000000001 110.538 -173.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 17.3 tp -88.24 94.08 9.71 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.865 -0.607 . . . . 75.109999999999999 109.75 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -85.83 102.55 13.78 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.195 -0.457 . . . . 43.409999999999997 110.499 -179.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 24.6 t -94.39 123.56 46.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.057 0.456 . . . . 72.019999999999996 111.119 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.593 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 32.1 m -111.61 107.99 17.32 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.155 -0.475 . . . . 64.319999999999993 110.12 174.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.502 ' HB3' ' H ' ' A' ' 105' ' ' GLN . 15.3 t70 -65.99 131.1 45.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.776 -0.647 . . . . 63.399999999999999 110.3 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.557 ' HA ' ' NE ' ' A' ' 101' ' ' ARG . 2.8 tpm_? -107.88 17.72 22.14 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.609 0.718 . . . . 70.420000000000002 110.796 -177.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.5 mtpm? -107.11 -66.78 0.99 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.855 0.836 . . . . 73.140000000000001 109.039 175.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.2 m -91.3 -40.59 11.41 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 114.175 -1.375 . . . . 72.120000000000005 109.211 -178.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 98.11 82.98 1.69 Allowed Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.514 -0.767 . . . . 65.239999999999995 113.02 177.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.502 ' H ' ' HB3' ' A' ' 100' ' ' ASP . 54.5 mt-30 -143.15 142.31 31.43 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.099 -0.704 . . . . 72.040000000000006 109.099 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.9 m -105.06 85.6 2.3 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.48 0.657 . . . . 61.32 110.221 178.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.32 119.74 26.03 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.483 -0.78 . . . . 71.150000000000006 109.957 178.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 37.5 m -105.71 107.44 18.44 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.015 0.436 . . . . 61.340000000000003 111.291 -176.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.401 ' N ' HD12 ' A' ' 109' ' ' ILE . 4.5 mp -102.57 97.83 6.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.144 -0.48 . . . . 73.010000000000005 109.843 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -79.86 123.74 28.02 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.016 -0.735 . . . . 61.100000000000001 109.016 177.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.7 t -64.56 101.96 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.181 0.515 . . . . 75.109999999999999 111.072 -175.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.9 p -81.65 -26.88 34.41 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.478 -0.783 . . . . 73.519999999999996 110.576 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 131.78 92.37 0.56 Allowed Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.914 -0.66 . . . . 53.210000000000001 111.512 -177.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 96.0 mt -126.92 94.85 4.14 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.694 0.283 . . . . 71.239999999999995 110.599 -177.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -105.97 95.18 5.6 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.442 0.639 . . . . 62.340000000000003 110.088 176.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -143.12 150.57 39.66 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.253 -0.885 . . . . 63.439999999999998 109.991 178.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -171.36 163.36 6.95 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.188 -0.46 . . . . 61.130000000000003 109.916 -178.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 24.6 m 58.54 78.35 0.26 Allowed 'General case' 0 C--N 1.33 -0.282 0 O-C-N 123.616 0.573 . . . . 75.219999999999999 111.697 178.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -76.72 117.11 18.01 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.08 -0.509 . . . . 73.200000000000003 110.418 176.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -75.17 -45.33 41.39 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.057 -0.52 . . . . 62.409999999999997 110.952 -177.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -72.44 99.31 2.44 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.87 0.843 . . . . 75.239999999999995 110.375 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -117.14 17.6 14.77 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.524 -0.762 . . . . 74.340000000000003 110.571 -177.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 46.8 m80 72.23 100.55 0.07 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.171 -0.922 . . . . 64.150000000000006 112.469 174.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -132.86 8.85 4.15 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.712 0.768 . . . . 75.209999999999994 108.93 173.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.4 ' CE1' ' HA ' ' A' ' 127' ' ' HIS . 13.3 t-80 -120.28 118.34 30.17 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.763 -1.108 . . . . 71.409999999999997 109.795 -175.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -79.44 4.59 15.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.445 -0.343 . . . . 73.129999999999995 111.563 -176.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.4 ' HA ' ' CE1' ' A' ' 125' ' ' HIS . 23.2 t-160 . . . . . 0 C--O 1.247 0.938 0 CA-C-O 117.99 -1.005 . . . . 54.43 109.917 -174.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ptt? . . . . . 0 N--CA 1.481 1.095 0 N-CA-C 110.138 -0.319 . . . . 75.5 110.138 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.99 -167.02 0.22 Allowed 'General case' 0 C--O 1.234 0.284 0 O-C-N 123.832 0.708 . . . . 74.230000000000004 111.228 178.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 106.37 100.18 2.64 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.936 -0.65 . . . . 65.140000000000001 111.853 179.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.3 p -69.43 101.09 1.49 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.178 0.513 . . . . 72.25 111.066 -179.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.418 ' O ' ' HB ' ' A' ' 6' ' ' THR . 26.9 ptt? -137.08 167.89 20.66 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.673 -0.694 . . . . 75.430000000000007 109.696 -176.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.418 ' HB ' ' O ' ' A' ' 5' ' ' MET . 90.9 m 74.45 131.92 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.575 0.702 . . . . 74.209999999999994 112.092 175.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -109.36 -78.45 0.59 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.914 -0.585 . . . . 75.040000000000006 110.905 178.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 48.86 19.64 0.28 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.352 1.061 . . . . 73.409999999999997 112.961 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -96.02 178.65 5.34 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 110.444 -0.206 . . . . 73.239999999999995 110.444 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 76.2 mtp85 62.27 80.92 0.21 Allowed 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.532 0.682 . . . . 72.030000000000001 110.877 -177.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 36.7 t-20 -77.9 140.72 62.86 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.038 -0.983 . . . . 63.140000000000001 109.268 -178.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -48.42 151.36 4.77 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.622 2.881 . . . . 71.329999999999998 113.463 176.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 57.9 t30 62.21 88.86 0.09 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.262 -0.881 . . . . 75.430000000000007 110.972 -177.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -136.44 122.57 20.34 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.433 -0.803 . . . . 75.230000000000004 110.137 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.62 -32.88 2.11 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.661 -0.699 . . . . 71.230000000000004 111.601 -178.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 112.88 161.59 15.06 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.93 -0.653 . . . . 73.329999999999998 112.859 177.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -106.0 145.08 30.2 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 109.719 -0.475 . . . . 72.140000000000001 109.719 175.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -63.86 115.84 3.33 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 122.801 2.334 . . . . 61.409999999999997 112.403 178.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -114.78 166.43 11.76 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.007 -0.542 . . . . 74.519999999999996 110.3 -178.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -69.36 136.01 51.13 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.119 -0.326 . . . . 74.239999999999995 110.119 178.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -101.99 160.18 17.87 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.802 -0.713 . . . . 62.439999999999998 112.71 -177.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.59 141.46 39.5 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.933 0.396 . . . . 64.099999999999994 110.935 178.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -119.0 104.18 10.25 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.888 -0.596 . . . . 71.25 110.553 -178.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -169.31 134.21 1.48 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.008 -0.542 . . . . 62.32 110.733 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 93.0 mt -121.14 69.7 0.9 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.84 -0.618 . . . . 52.439999999999998 109.34 175.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -124.57 -27.23 3.74 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.687 -0.688 . . . . 73.200000000000003 110.904 -174.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 19.9 m -102.48 110.29 22.19 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.354 -0.385 . . . . 71.349999999999994 110.785 -178.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -101.46 159.28 15.41 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.094 -0.503 . . . . 74.120000000000005 110.146 176.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -86.11 111.16 20.09 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.027 0.441 . . . . 65.310000000000002 110.592 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -75.4 151.37 38.16 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.85 -0.613 . . . . 75.25 110.446 179.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 70.8 mm-40 -85.0 86.26 7.4 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.274 0.559 . . . . 75.530000000000001 110.055 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -135.93 29.28 3.15 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.779 -0.646 . . . . 64.010000000000005 110.72 -177.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.0 p -55.59 105.56 0.19 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 121.517 0.675 . . . . 74.209999999999994 111.132 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -139.14 12.78 2.62 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.275 -0.875 . . . . 74.430000000000007 109.726 -172.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 49.7 tptt 68.36 37.24 2.78 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.141 -0.936 . . . . 71.430000000000007 108.722 -173.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.433 ' HB2' ' HD2' ' A' ' 37' ' ' PRO . 5.9 p-10 -80.48 158.13 71.75 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 114.696 -1.138 . . . . 74.530000000000001 110.919 -178.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.579 ' HD3' HG12 ' A' ' 45' ' ' ILE . 31.3 Cg_endo -65.47 -29.9 52.98 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.736 2.29 . . . . 70.219999999999999 112.398 178.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 42.0 m 66.53 -70.09 0.11 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.458 0.703 . . . . 62.109999999999999 111.457 -177.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -95.06 150.96 19.61 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.532 -0.304 . . . . 74.420000000000002 110.591 179.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 20.0 m120 63.92 74.32 0.42 Allowed 'General case' 0 C--N 1.329 -0.323 0 O-C-N 123.966 0.791 . . . . 75.200000000000003 111.205 176.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.3 t70 65.99 117.9 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.198 -0.91 . . . . 75.340000000000003 111.708 179.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.505 ' HA ' ' HG2' ' A' ' 37' ' ' PRO . 10.9 p-10 -83.96 3.93 31.99 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.878 -0.601 . . . . 70.120000000000005 111.551 -175.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -99.51 6.17 45.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.533 -0.303 . . . . 75.219999999999999 110.427 176.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -77.54 47.38 2.71 Favored Glycine 0 CA--C 1.521 0.422 0 C-N-CA 121.207 -0.52 . . . . 74.519999999999996 113.027 -177.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.579 HG12 ' HD3' ' A' ' 37' ' ' PRO . 11.6 mt -112.19 8.24 8.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 108.808 -0.812 . . . . 75.239999999999995 108.808 177.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 53.79 64.74 1.73 Allowed 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 114.755 -1.111 . . . . 65.319999999999993 109.732 -171.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 4.8 t -138.25 87.22 16.13 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 114.923 -1.035 . . . . 60.32 109.443 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.633 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 59.2 Cg_endo -70.93 83.78 0.88 Allowed 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.626 2.217 . . . . 72.099999999999994 113.244 -173.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 21.0 m -93.75 -68.0 0.82 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.037 -0.529 . . . . 71.450000000000003 110.297 174.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -107.69 -3.97 18.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.195 0.521 . . . . 71.230000000000004 111.061 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.474 HD23 ' H ' ' A' ' 51' ' ' LEU . 1.1 pt? -108.09 7.89 27.89 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.947 -0.57 . . . . 73.420000000000002 110.139 -178.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.633 ' HB3' ' HB2' ' A' ' 48' ' ' PRO . 19.4 p-10 -68.65 -52.8 27.26 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.7 -0.682 . . . . 63.020000000000003 111.246 -174.145 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -65.98 -29.21 69.56 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.985 0.422 . . . . 73.010000000000005 110.43 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.519 ' O ' HG13 ' A' ' 58' ' ' ILE . 70.7 t80 -66.36 -62.93 1.21 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.726 -0.67 . . . . 74.25 110.899 -178.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.1 t -66.89 -21.48 66.0 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.01 0.433 . . . . 75.409999999999997 110.933 -176.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.51 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 3.9 tp-100 -68.98 -43.36 75.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.253 0.549 . . . . 51.200000000000003 109.809 -179.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.52 -32.57 74.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.464 -0.789 . . . . 74.219999999999999 110.266 178.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.579 ' O ' HG13 ' A' ' 62' ' ' ILE . 19.6 mt -63.34 -39.88 86.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.901 -0.59 . . . . 75.030000000000001 110.644 178.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -64.48 -25.0 67.81 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.254 -0.43 . . . . 51.229999999999997 111.057 178.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.2 t -89.7 -38.88 13.54 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.308 -0.406 . . . . 73.340000000000003 110.748 -178.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.503 ' HG2' ' HA ' ' A' ' 58' ' ' ILE . 3.6 pt20 -66.91 -13.2 61.48 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.91 0.386 . . . . 64.209999999999994 110.878 -177.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.579 HG13 ' O ' ' A' ' 58' ' ' ILE . 76.8 mt -62.53 -33.68 60.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.565 -0.531 . . . . 75.120000000000005 109.565 175.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.0 mp -68.09 -28.93 67.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.224 -0.898 . . . . 74.530000000000001 110.586 -179.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -62.88 -47.51 88.3 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 111.414 -0.674 . . . . 54.140000000000001 111.414 178.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -72.76 -35.07 58.94 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.854 -0.689 . . . . 33.530000000000001 111.711 177.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.416 ' C ' ' H ' ' A' ' 68' ' ' SER . 47.1 tp -60.85 -49.41 77.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.018 0.437 . . . . 72.230000000000004 110.178 177.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 98.8 mt -79.74 32.28 0.25 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.184 0.516 . . . . 70.319999999999993 110.64 178.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.441 ' HA ' ' ND2' ' A' ' 71' ' ' ASN . 61.5 m -135.75 -50.94 0.73 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.436 -0.802 . . . . 75.109999999999999 109.592 174.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -69.67 -26.6 64.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.016 -0.538 . . . . 53.439999999999998 111.632 -178.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 50.8 mm -82.73 -19.59 10.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.093 0.473 . . . . 71.409999999999997 110.573 -178.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.476 ' HB3' ' OD1' ' A' ' 89' ' ' ASN . 51.8 m-20 -66.62 -61.11 2.15 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.214 -0.448 . . . . 61.43 110.852 -176.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.493 HG22 ' HG2' ' A' ' 74' ' ' LYS . 16.0 m -154.58 150.98 28.31 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.546 -0.539 . . . . 53.310000000000002 109.546 -178.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -82.97 -44.76 6.97 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.997 -0.621 . . . . 71.019999999999996 112.49 -178.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.493 ' HG2' HG22 ' A' ' 72' ' ' THR . 63.0 pttt -57.97 144.13 75.99 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-O 120.689 0.28 . . . . 51.439999999999998 110.393 175.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 74' ' ' LYS . 11.6 Cg_exo -70.71 -33.65 12.64 Favored 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.544 2.163 . . . . 65.030000000000001 112.121 -178.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.503 ' HA3' ' O ' ' A' ' 87' ' ' ILE . . . 88.68 -27.67 7.01 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 121.006 -0.616 . . . . 72.120000000000005 111.828 -177.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.433 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 4.4 tmt_? -66.59 121.11 14.63 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.93 -0.396 . . . . 45.020000000000003 109.93 178.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 50.5 ttm -115.5 122.3 45.3 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.981 -0.554 . . . . 73.310000000000002 110.212 -178.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.419 ' HB ' ' NH1' ' A' ' 77' ' ' ARG . 8.0 p -73.98 125.27 32.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.204 0.526 . . . . 63.219999999999999 110.779 -179.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.786 ' HB ' ' O ' ' A' ' 83' ' ' TYR . 17.0 m -138.85 152.59 47.95 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.518 -0.919 . . . . 43.310000000000002 108.518 177.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -65.46 -60.04 3.37 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.656 0.613 . . . . 72.310000000000002 112.656 -170.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -101.39 2.57 39.62 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.446 0.641 . . . . 75.510000000000005 111.419 -171.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.786 ' O ' ' HB ' ' A' ' 80' ' ' THR . 60.6 m-85 -146.03 116.31 7.48 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.927 -0.579 . . . . 63.340000000000003 110.105 178.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.645 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 3.8 mp -84.68 104.06 12.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.946 -0.761 . . . . 71.040000000000006 108.946 175.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 73.5 t -94.73 111.97 26.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.729 -0.669 . . . . 64.329999999999998 111.201 -174.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 77' ' ' ARG . 26.8 t70 -111.05 100.58 9.23 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.005 0.431 . . . . 74.510000000000005 110.448 175.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.503 ' O ' ' HA3' ' A' ' 76' ' ' GLY . 58.1 mt -89.49 97.22 6.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.431 -0.581 . . . . 73.150000000000006 109.431 176.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -104.58 130.05 52.61 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.062 -0.517 . . . . 54.140000000000001 111.599 -174.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.476 ' OD1' ' HB3' ' A' ' 71' ' ' ASN . 26.4 t-20 -108.53 87.36 2.48 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.342 -0.614 . . . . 62.210000000000001 109.342 171.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.408 ' O ' ' HB3' ' A' ' 91' ' ' ASP . 10.3 ttp180 -106.68 146.14 31.13 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.511 -0.922 . . . . 75.439999999999998 108.511 177.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.408 ' HB3' ' O ' ' A' ' 90' ' ' ARG . 24.9 t70 69.13 -70.49 0.14 Allowed 'General case' 0 N--CA 1.469 0.488 0 O-C-N 123.732 0.645 . . . . 71.019999999999996 110.53 -176.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 179.18 22.04 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 121.005 -0.617 . . . . 75.319999999999993 112.341 176.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.522 HE21 ' HA ' ' A' ' 93' ' ' GLN . 0.1 OUTLIER -126.27 141.59 51.86 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 122.676 -0.308 . . . . 62.409999999999997 110.574 -175.864 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -81.41 109.96 16.39 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.192 -0.67 . . . . 52.240000000000002 109.192 173.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.443 HE21 ' HB2' ' A' ' 95' ' ' GLN . 6.0 tt0 -113.73 110.71 20.61 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.119 0.485 . . . . 55.530000000000001 110.666 -177.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.46 ' HB3' ' O ' ' A' ' 109' ' ' ILE . 59.6 tp -85.71 97.02 9.9 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.557 -0.747 . . . . 75.109999999999999 110.206 179.062 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.6 m-20 -95.53 100.36 12.12 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.074 -0.512 . . . . 43.409999999999997 110.113 177.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 50.7 t -94.96 111.59 25.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.817 -0.629 . . . . 72.019999999999996 110.364 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.645 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 22.8 m -89.94 103.35 16.02 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.873 -0.603 . . . . 64.319999999999993 109.665 175.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.595 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 9.8 t70 -58.72 147.64 32.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.096 -0.502 . . . . 63.399999999999999 110.842 178.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.401 ' HD2' ' HA ' ' A' ' 101' ' ' ARG . 23.5 tpt180 -113.6 -9.02 13.28 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.856 0.36 . . . . 70.420000000000002 111.314 -177.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm -78.87 -49.81 12.27 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.005 0.431 . . . . 73.140000000000001 110.806 177.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 36.5 p -113.23 -35.62 5.28 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.747 -0.661 . . . . 72.120000000000005 109.952 176.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.595 ' HA2' ' O ' ' A' ' 100' ' ' ASP . . . 91.57 81.11 1.42 Allowed Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.461 -0.79 . . . . 65.239999999999995 112.242 178.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.537 ' H ' ' HB3' ' A' ' 100' ' ' ASP . 49.6 mt-30 -137.47 139.98 40.93 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.253 -0.647 . . . . 72.040000000000006 109.253 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.9 t -84.38 95.45 8.75 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.585 0.707 . . . . 61.32 111.089 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 59.4 m -84.22 102.98 13.03 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.854 -0.612 . . . . 71.150000000000006 109.933 176.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 23.8 m -92.15 109.85 21.22 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.289 -0.414 . . . . 61.340000000000003 110.857 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.46 ' O ' ' HB3' ' A' ' 96' ' ' LEU . 4.9 mp -117.2 97.91 6.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.947 0.404 . . . . 73.010000000000005 109.94 175.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -74.74 153.25 38.91 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.453 -0.339 . . . . 61.100000000000001 110.92 178.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 8.4 p -58.88 132.36 23.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.608 -0.724 . . . . 75.109999999999999 110.461 177.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.49 91.23 6.85 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.421 -0.585 . . . . 73.519999999999996 109.421 179.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -78.56 47.89 3.09 Favored Glycine 0 N--CA 1.453 -0.167 0 CA-C-N 115.966 -0.561 . . . . 53.210000000000001 112.509 -178.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 96.2 mt -124.08 83.35 2.13 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.005 0.431 . . . . 71.239999999999995 110.29 -178.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -130.78 -27.21 2.13 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.874 -0.603 . . . . 62.340000000000003 110.134 176.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 50.34 178.88 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.622 1.169 . . . . 63.439999999999998 113.31 177.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -165.17 121.4 1.42 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.33 0.586 . . . . 61.130000000000003 110.946 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 48.9 m -143.54 91.56 2.27 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.7 -0.852 . . . . 75.219999999999999 108.7 172.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 17.4 m -120.67 97.69 5.67 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.861 -0.609 . . . . 73.200000000000003 111.023 -174.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -150.56 104.49 3.21 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.195 -0.457 . . . . 62.409999999999997 111.143 177.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -141.99 97.87 3.22 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.975 -0.75 . . . . 75.239999999999995 108.975 171.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -76.28 105.68 7.47 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.715 -0.675 . . . . 74.340000000000003 111.733 -171.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -79.88 111.96 16.71 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.638 -0.875 . . . . 64.150000000000006 108.638 171.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -129.31 -23.38 2.97 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.74 -0.384 . . . . 75.209999999999994 111.525 -176.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 29.7 m170 66.71 168.65 0.23 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.426 0.631 . . . . 71.409999999999997 111.111 -178.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 12.8 p80 -123.47 140.01 53.43 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.964 -0.754 . . . . 73.129999999999995 108.964 172.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 . . . . . 0 C--O 1.247 0.947 0 O-C-N 123.825 0.703 . . . . 54.43 110.473 -178.256 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.2 mtt . . . . . 0 N--CA 1.481 1.08 0 N-CA-C 110.445 -0.206 . . . . 75.5 110.445 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 68.9 -65.97 0.26 Allowed 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.451 0.7 . . . . 74.230000000000004 112.436 178.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.46 77.36 1.06 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 121.378 -0.439 . . . . 65.140000000000001 112.796 -177.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.9 t -151.11 33.13 0.59 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.872 0.844 . . . . 72.25 109.566 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 20.6 ptp -94.32 126.78 39.79 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.947 -0.57 . . . . 75.430000000000007 111.754 -176.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 25.2 m -121.94 121.85 38.04 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.682 -0.69 . . . . 74.209999999999994 109.818 177.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -117.64 -70.63 0.78 Allowed 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.781 -0.367 . . . . 75.040000000000006 111.969 -175.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 59.01 39.52 23.37 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 122.195 0.997 . . . . 73.409999999999997 108.636 -174.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -78.73 -27.18 44.83 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.385 -1.28 . . . . 73.239999999999995 111.543 -170.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 10' ' ' ARG . 44.3 ttp180 -80.17 125.68 30.14 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.993 0.425 . . . . 72.030000000000001 110.717 -176.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.408 ' HB2' ' HD2' ' A' ' 12' ' ' PRO . 8.3 p30 -84.25 156.63 62.99 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.876 -0.602 . . . . 63.140000000000001 110.126 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.408 ' HD2' ' HB2' ' A' ' 11' ' ' ASN . 11.5 Cg_endo -56.11 -40.53 84.3 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.851 2.367 . . . . 71.329999999999998 112.857 -179.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 67.84 123.27 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 O-C-N 123.825 0.703 . . . . 75.430000000000007 111.928 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -124.09 154.27 40.22 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.993 -0.549 . . . . 75.230000000000004 109.77 176.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 128.12 112.84 1.7 Allowed Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.613 -0.803 . . . . 71.230000000000004 112.024 -178.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -169.76 -170.51 34.3 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 110.982 -0.847 . . . . 73.329999999999998 110.982 178.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.514 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 84.8 m-20 65.17 166.29 0.12 Allowed Pre-proline 0 N--CA 1.468 0.427 0 O-C-N 123.62 0.247 . . . . 72.140000000000001 110.968 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.514 ' HD2' ' HB3' ' A' ' 17' ' ' ASN . 46.1 Cg_endo -71.61 63.51 3.0 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 121.802 1.668 . . . . 61.409999999999997 111.031 172.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -119.79 91.74 3.62 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.224 -0.898 . . . . 74.519999999999996 108.643 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -105.6 117.3 33.67 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.79 -0.641 . . . . 74.239999999999995 110.047 -173.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -72.14 96.92 0.72 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 121.064 -0.589 . . . . 62.439999999999998 111.679 177.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -92.49 72.51 5.15 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.194 0.521 . . . . 64.099999999999994 110.725 -177.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -129.53 137.24 50.67 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.675 -0.693 . . . . 71.25 110.206 177.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.754 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 94.9 mt -137.23 168.82 18.87 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.538 -0.542 . . . . 62.32 109.538 177.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.754 ' HG ' ' O ' ' A' ' 24' ' ' LEU . 4.0 pp 53.58 -173.19 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 O-C-N 124.09 0.869 . . . . 52.439999999999998 111.897 178.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -162.44 174.47 12.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.445 -0.343 . . . . 73.200000000000003 110.491 177.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 45.2 p -156.19 151.94 27.23 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.084 -0.507 . . . . 71.349999999999994 110.748 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.18 129.88 34.78 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.074 -0.713 . . . . 74.120000000000005 109.074 172.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -99.87 170.9 8.21 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.9 -0.32 . . . . 65.310000000000002 111.013 -172.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 67.28 -168.39 0.2 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.549 -0.75 . . . . 75.25 111.375 -179.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 57.6 53.6 7.15 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.351 0.596 . . . . 75.530000000000001 110.068 -176.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.781 ' HB2' ' HB3' ' A' ' 36' ' ' ASP . 4.3 p-10 -64.27 -50.44 67.89 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.43 -0.804 . . . . 64.010000000000005 110.579 178.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 50.4 m 61.44 -76.5 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 O-C-N 123.866 0.729 . . . . 74.209999999999994 112.348 178.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -140.36 1.71 1.8 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.496 -0.32 . . . . 74.430000000000007 111.83 -175.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -98.8 4.61 47.66 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.428 -0.509 . . . . 71.430000000000007 110.484 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.781 ' HB3' ' HB2' ' A' ' 32' ' ' ASN . 5.9 p-10 -80.93 144.72 55.72 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.863 -0.608 . . . . 74.530000000000001 110.707 -178.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.448 ' HG2' HG13 ' A' ' 45' ' ' ILE . 13.5 Cg_exo -71.48 156.17 58.58 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 123.238 2.625 . . . . 70.219999999999999 112.538 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.4 m -149.81 -39.04 0.14 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.876 -0.602 . . . . 62.109999999999999 110.023 177.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -156.36 135.86 12.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.133 -0.485 . . . . 74.420000000000002 110.366 174.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.6 t30 72.13 10.59 6.02 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.65 -0.705 . . . . 75.200000000000003 110.99 177.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -150.54 147.92 28.05 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.09 -0.505 . . . . 75.340000000000003 110.043 177.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -151.67 19.61 0.71 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.479 0.657 . . . . 70.120000000000005 109.363 173.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -105.08 -16.21 14.86 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.437 -0.801 . . . . 75.219999999999999 110.594 -174.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -82.56 39.11 2.66 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.941 -0.647 . . . . 74.519999999999996 112.786 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.448 HG13 ' HG2' ' A' ' 37' ' ' PRO . 57.9 mt -122.66 -65.05 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 110.019 -0.363 . . . . 75.239999999999995 110.019 177.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 67.43 -70.51 0.12 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.444 -0.798 . . . . 65.319999999999993 111.546 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.0 m -124.53 87.9 53.89 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.386 -0.37 . . . . 60.32 110.726 -175.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -69.97 120.83 7.51 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 123.134 2.556 . . . . 72.099999999999994 112.658 -176.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 52.0 m -97.51 -86.15 0.35 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.352 -0.385 . . . . 71.450000000000003 111.409 177.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.91 12.83 28.9 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.046 0.451 . . . . 71.230000000000004 111.623 -176.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.4 pp -119.01 1.9 11.46 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.276 -0.42 . . . . 73.420000000000002 110.572 179.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -63.45 -60.3 3.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.63 -0.714 . . . . 63.020000000000003 111.538 -174.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.436 ' HA ' ' HB2' ' A' ' 56' ' ' GLN . 7.7 p30 -78.15 -13.75 59.74 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.921 -0.582 . . . . 73.010000000000005 110.906 -175.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.551 ' O ' HG13 ' A' ' 58' ' ' ILE . 83.9 t80 -66.55 -58.39 5.3 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.234 -0.439 . . . . 74.25 110.095 176.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.7 t -74.3 -12.29 60.5 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.186 0.517 . . . . 75.409999999999997 110.419 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.436 ' HB2' ' HA ' ' A' ' 53' ' ' ASN . 2.1 tp-100 -70.63 -47.75 58.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.759 -0.655 . . . . 51.200000000000003 109.643 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.23 -28.24 67.07 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.728 -0.669 . . . . 74.219999999999999 110.894 179.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.56 ' O ' HG13 ' A' ' 62' ' ' ILE . 26.6 mt -63.09 -39.52 85.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.163 -0.471 . . . . 75.030000000000001 110.649 179.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -64.31 -31.04 72.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.151 -0.477 . . . . 51.229999999999997 110.658 179.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.1 m -81.04 -41.52 22.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.146 -0.479 . . . . 73.340000000000003 111.339 -178.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.521 ' HG2' ' HA ' ' A' ' 58' ' ' ILE . 4.1 pt20 -66.78 -19.0 65.66 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.518 -0.31 . . . . 64.209999999999994 111.49 -176.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.56 HG13 ' O ' ' A' ' 58' ' ' ILE . 86.5 mt -62.23 -47.42 93.18 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 N-CA-C 109.31 -0.626 . . . . 75.120000000000005 109.31 175.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.0 mp -64.39 -43.21 95.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.451 -0.795 . . . . 74.530000000000001 110.498 178.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -57.5 -44.68 93.65 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 121.226 -0.512 . . . . 54.140000000000001 112.578 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -75.21 -44.15 23.68 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.682 -0.77 . . . . 33.530000000000001 112.453 178.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.604 ' O ' HG12 ' A' ' 70' ' ' ILE . 57.0 tp -58.72 -50.35 74.21 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 122.313 0.245 . . . . 72.230000000000004 111.297 -177.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 85.5 mt -63.34 -17.65 62.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.445 -0.343 . . . . 70.319999999999993 111.912 -176.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.1 t -78.27 -45.77 21.96 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.76 -0.459 . . . . 75.109999999999999 109.76 178.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -78.5 -11.49 59.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.046 -0.525 . . . . 53.439999999999998 111.149 -176.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.604 HG12 ' O ' ' A' ' 66' ' ' LEU . 27.4 mm -61.34 -38.86 80.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.725 0.298 . . . . 71.409999999999997 110.478 176.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.411 ' ND2' ' H ' ' A' ' 91' ' ' ASP . 27.4 m-80 -62.74 -72.05 0.14 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.988 -0.551 . . . . 61.43 110.235 -178.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.503 HG22 ' HG3' ' A' ' 74' ' ' LYS . 16.7 m -135.5 97.7 3.75 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.319 -0.623 . . . . 53.310000000000002 109.319 174.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -90.84 16.54 58.1 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.862 -0.685 . . . . 71.019999999999996 113.762 -170.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.562 ' HB2' ' HD2' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -56.96 156.31 13.47 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 117.257 0.528 . . . . 51.439999999999998 109.975 174.746 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.562 ' HD2' ' HB2' ' A' ' 74' ' ' LYS . 44.1 Cg_exo -23.11 -55.63 0.05 OUTLIER 'Trans proline' 0 C--N 1.358 1.075 1 C-N-CA 125.306 4.004 . . . . 65.030000000000001 115.519 -172.018 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.42 ' HA2' ' HB ' ' A' ' 87' ' ' ILE . . . 80.48 -55.22 4.65 Favored Glycine 0 C--O 1.228 -0.236 0 C-N-CA 120.877 -0.678 . . . . 72.120000000000005 112.436 177.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 42.2 ptt85 -69.82 108.15 3.83 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.158 0.504 . . . . 45.020000000000003 110.592 176.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.588 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 28.0 ttt -91.01 105.03 17.54 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.757 -0.656 . . . . 73.310000000000002 109.78 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 19.1 t -86.53 76.12 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.397 0.618 . . . . 63.219999999999999 110.267 -176.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.0 -175.44 5.4 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.728 -0.669 . . . . 43.310000000000002 110.089 179.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -79.67 -43.81 22.06 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.663 0.268 . . . . 72.310000000000002 110.772 -177.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.559 ' O ' ' HB2' ' A' ' 101' ' ' ARG . 8.2 t0 -101.6 -76.52 0.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.657 -0.497 . . . . 75.510000000000005 109.657 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.507 ' HB3' HG13 ' A' ' 98' ' ' VAL . 17.0 m-85 -79.38 115.4 19.0 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.407 -0.361 . . . . 63.340000000000003 111.048 -174.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.464 HD12 ' HB ' ' A' ' 99' ' ' THR . 0.9 OUTLIER -83.83 103.38 11.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.595 0.712 . . . . 71.040000000000006 109.197 170.843 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.588 ' HB ' ' HB3' ' A' ' 78' ' ' MET . 37.6 t -94.3 139.65 18.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.639 -0.709 . . . . 64.329999999999998 111.195 -169.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -108.73 105.07 14.49 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.573 -0.528 . . . . 74.510000000000005 109.573 174.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.42 ' HB ' ' HA2' ' A' ' 76' ' ' GLY . 74.4 mt -78.72 113.69 18.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.287 -0.415 . . . . 73.150000000000006 109.968 178.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -107.8 109.57 21.16 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.184 -0.462 . . . . 54.140000000000001 111.128 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.564 ' HA ' ' O ' ' A' ' 93' ' ' GLN . 3.5 t-20 -111.44 83.01 1.7 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.202 0.525 . . . . 62.210000000000001 109.726 174.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 90' ' ' ARG . 30.2 ttp180 -105.27 121.07 43.1 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.959 -0.564 . . . . 75.439999999999998 109.744 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.411 ' H ' ' ND2' ' A' ' 71' ' ' ASN . 26.4 t70 69.04 -83.11 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.369 -0.832 . . . . 71.019999999999996 111.207 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -144.14 12.13 2.08 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.63 -0.795 . . . . 75.319999999999993 112.583 -178.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.564 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -103.24 126.73 50.55 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.769 0.319 . . . . 62.409999999999997 111.461 -179.094 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 94' ' ' LEU . 4.3 mm? -96.36 98.22 10.09 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.909 -0.774 . . . . 52.240000000000002 108.909 168.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.44 HE21 ' HB2' ' A' ' 95' ' ' GLN . 4.6 tt0 -112.36 126.62 55.47 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.213 -0.449 . . . . 55.530000000000001 110.396 -175.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 13.6 tp -103.69 100.8 10.63 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.135 -0.484 . . . . 75.109999999999999 110.196 -176.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -88.96 97.83 11.41 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.175 -0.466 . . . . 43.409999999999997 111.045 -177.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.507 HG13 ' HB3' ' A' ' 83' ' ' TYR . 39.0 t -90.32 115.2 29.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.869 -0.605 . . . . 72.019999999999996 110.841 -179.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.464 ' HB ' HD12 ' A' ' 84' ' ' ILE . 47.6 m -104.6 114.79 29.23 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.673 -0.694 . . . . 64.319999999999993 109.964 175.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.506 ' HA ' ' HD1' ' A' ' 83' ' ' TYR . 26.0 t70 -60.79 141.97 56.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.97 -0.559 . . . . 63.399999999999999 111.105 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.559 ' HB2' ' O ' ' A' ' 82' ' ' ASP . 10.0 tpt180 -88.55 -10.94 47.13 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.151 -0.477 . . . . 70.420000000000002 111.367 -174.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm -107.62 -67.71 0.94 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.74 0.305 . . . . 73.140000000000001 111.622 -171.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 45.8 p -85.62 -33.09 21.73 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.271 0.558 . . . . 72.120000000000005 109.997 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 99.6 23.55 10.89 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.279 -0.873 . . . . 65.239999999999995 112.644 177.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.445 ' N ' ' HB3' ' A' ' 100' ' ' ASP . 98.2 mt-30 -59.58 130.68 48.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.725 0.298 . . . . 72.040000000000006 110.737 175.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.2 p -102.89 88.4 3.17 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.172 0.51 . . . . 61.32 110.398 176.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 9.7 t -91.21 105.65 17.95 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.766 -0.652 . . . . 71.150000000000006 109.489 -178.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.5 m -91.24 107.8 19.45 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.986 -0.552 . . . . 61.340000000000003 110.388 -178.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 59.5 mt -110.01 116.0 51.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.416 -0.356 . . . . 73.010000000000005 110.882 -175.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -71.71 168.2 18.26 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.003 0.43 . . . . 61.100000000000001 111.207 175.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.7 p -69.57 110.66 3.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.748 -0.66 . . . . 75.109999999999999 111.306 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 9.2 t -108.67 95.21 5.5 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.92 -0.582 . . . . 73.519999999999996 109.976 177.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -106.04 50.62 0.8 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.686 -0.769 . . . . 53.210000000000001 112.116 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 93.4 mt -120.26 116.55 25.79 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.129 -0.323 . . . . 71.239999999999995 110.129 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -123.66 93.32 3.9 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.071 -0.513 . . . . 62.340000000000003 110.959 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -88.47 88.58 7.67 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.914 0.388 . . . . 63.439999999999998 110.015 176.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -78.37 134.13 37.47 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.985 -0.552 . . . . 61.130000000000003 110.526 -178.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 56.1 m -144.09 150.67 38.51 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.932 -0.395 . . . . 75.219999999999999 109.932 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.0 t -103.6 148.53 25.89 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.836 0.351 . . . . 73.200000000000003 110.198 -178.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -96.68 112.72 24.35 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.348 -0.387 . . . . 62.409999999999997 110.214 -178.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -112.46 177.29 4.69 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.233 -0.44 . . . . 75.239999999999995 110.937 -174.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 28.9 t60 60.39 83.07 0.15 Allowed 'General case' 0 C--N 1.33 -0.254 0 O-C-N 123.695 0.622 . . . . 74.340000000000003 110.818 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -112.18 146.28 38.37 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.056 -0.52 . . . . 64.150000000000006 110.785 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -102.05 128.7 48.39 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.295 -0.632 . . . . 75.209999999999994 109.295 177.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 65.6 m170 -100.35 -49.48 4.23 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 121.024 -0.27 . . . . 71.409999999999997 111.52 -174.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 25.6 p80 -152.38 -178.79 7.04 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.957 0.408 . . . . 73.129999999999995 111.304 -173.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 . . . . . 0 C--O 1.245 0.818 0 CA-C-N 115.711 -0.677 . . . . 54.43 109.224 172.483 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 ttt . . . . . 0 N--CA 1.48 1.042 0 N-CA-C 109.914 -0.402 . . . . 75.5 109.914 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 66.11 107.58 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 O-C-N 123.822 0.702 . . . . 74.230000000000004 111.126 -176.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.26 -3.92 71.84 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 115.841 -0.618 . . . . 65.140000000000001 113.257 -176.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 27.8 m -69.37 103.41 1.99 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.846 0.355 . . . . 72.25 110.696 178.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 22.9 ttt -146.65 104.5 3.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.08 -0.509 . . . . 75.430000000000007 109.964 -178.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.4 p -126.1 129.41 49.03 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.946 0.403 . . . . 74.209999999999994 111.449 -176.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -102.42 -47.14 4.57 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.053 -0.522 . . . . 75.040000000000006 110.896 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 80.5 mm-40 59.42 47.38 11.21 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.517 0.675 . . . . 73.409999999999997 109.254 -171.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -87.79 150.91 23.27 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.138 -0.937 . . . . 73.239999999999995 110.333 -174.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.8 ptt85 -111.53 163.88 13.58 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.189 -0.46 . . . . 72.030000000000001 111.466 -176.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -139.38 86.25 14.54 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 109.579 -0.526 . . . . 63.140000000000001 109.579 175.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -68.85 -45.15 2.3 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.986 2.457 . . . . 71.329999999999998 112.685 -176.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.4 t30 69.37 114.92 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 O-C-N 123.867 0.729 . . . . 75.430000000000007 110.473 -177.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -76.68 169.26 18.61 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.126 -0.488 . . . . 75.230000000000004 111.272 -175.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -95.16 161.32 23.32 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.813 -0.708 . . . . 71.230000000000004 112.713 -175.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.34 -77.59 0.7 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.044 -0.598 . . . . 73.329999999999998 112.535 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.451 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 4.8 m-20 -101.37 144.42 28.53 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-O 120.684 0.278 . . . . 72.140000000000001 110.797 -178.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 17' ' ' ASN . 3.6 Cg_exo -75.43 -55.13 0.07 OUTLIER 'Trans proline' 0 CA--C 1.53 0.306 0 C-N-CA 122.894 2.396 . . . . 61.409999999999997 111.86 176.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -170.75 169.69 6.88 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.496 -0.927 . . . . 74.519999999999996 108.496 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 74.01 113.55 0.06 Allowed 'General case' 0 N--CA 1.467 0.416 0 O-C-N 123.751 0.657 . . . . 74.239999999999995 110.97 178.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -128.61 -71.38 0.14 Allowed Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.625 -0.797 . . . . 62.439999999999998 112.82 -176.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -143.22 146.94 34.1 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.884 0.373 . . . . 64.099999999999994 111.416 -175.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -130.24 110.46 11.56 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.911 -0.586 . . . . 71.25 109.706 175.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.751 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 6.6 mp -102.82 -167.43 1.39 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.132 -0.486 . . . . 62.32 110.201 -178.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.751 ' HG ' ' O ' ' A' ' 24' ' ' LEU . 4.3 pp 58.99 -178.05 0.08 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.456 1.102 . . . . 52.439999999999998 112.051 -177.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.407 HD21 ' HA2' ' A' ' 44' ' ' GLY . 15.3 t-20 -143.94 154.94 43.83 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.743 -0.465 . . . . 73.200000000000003 109.743 -175.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.9 p -69.25 -84.07 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 121.269 -0.172 . . . . 71.349999999999994 110.786 176.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -170.43 89.71 0.15 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.772 0.32 . . . . 74.120000000000005 111.322 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -90.41 24.04 2.74 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.472 0.653 . . . . 65.310000000000002 110.25 177.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.82 0.66 56.37 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.538 -0.755 . . . . 75.25 110.666 178.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -109.97 138.62 46.09 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.041 -0.527 . . . . 75.530000000000001 110.929 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -65.98 111.07 3.15 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.9 -0.591 . . . . 64.010000000000005 110.129 177.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.5 t 60.07 82.91 0.15 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.374 -0.83 . . . . 74.209999999999994 110.147 -175.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -82.56 -15.66 51.45 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.617 -0.719 . . . . 74.430000000000007 110.724 -177.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.7 ttmt 72.48 -163.64 0.11 Allowed 'General case' 0 C--O 1.233 0.209 0 N-CA-C 108.761 -0.829 . . . . 71.430000000000007 108.761 -177.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.492 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 9.1 p-10 -72.89 143.23 84.03 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-O 120.688 0.28 . . . . 74.530000000000001 110.287 179.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.541 ' HB2' ' O ' ' A' ' 41' ' ' ASP . 5.7 Cg_exo -79.55 144.7 17.95 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.845 2.363 . . . . 70.219999999999999 111.63 177.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.2 m -136.84 5.37 2.85 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 111.786 0.291 . . . . 62.109999999999999 111.786 -173.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -125.49 91.97 3.52 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.918 -0.313 . . . . 74.420000000000002 111.059 -177.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 61.62 6.76 1.63 Allowed 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.96 0.726 . . . . 75.200000000000003 112.96 174.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.541 ' O ' ' HB2' ' A' ' 37' ' ' PRO . 8.9 t70 -144.2 152.34 40.72 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.299 -0.41 . . . . 75.340000000000003 110.115 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -145.61 12.72 1.33 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.951 -0.568 . . . . 70.120000000000005 109.559 174.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.42 ' C ' ' H ' ' A' ' 45' ' ' ILE . 94.5 m-85 -100.55 -11.45 20.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.678 -0.692 . . . . 75.219999999999999 110.713 -179.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.407 ' HA2' HD21 ' A' ' 26' ' ' ASN . . . -73.08 24.08 0.86 Allowed Glycine 0 CA--C 1.52 0.402 0 CA-C-N 116.2 -0.455 . . . . 74.519999999999996 113.35 -179.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.42 ' H ' ' C ' ' A' ' 43' ' ' PHE . 57.4 mt -79.29 -30.43 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 109.477 -0.564 . . . . 75.239999999999995 109.477 176.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -77.03 140.02 40.22 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.564 -0.743 . . . . 65.319999999999993 110.28 -178.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 25.8 m -151.11 86.02 4.93 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 116.006 -0.543 . . . . 60.32 109.688 174.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.643 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 28.2 Cg_endo -62.16 110.58 1.05 Allowed 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 122.826 2.351 . . . . 72.099999999999994 112.29 -178.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 26.7 m -123.69 -25.54 4.3 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.005 -0.543 . . . . 71.450000000000003 110.415 177.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.3 -37.33 0.31 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 71.230000000000004 111.374 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.2 pp -73.09 -12.6 60.97 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.536 -0.302 . . . . 73.420000000000002 111.409 -176.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.643 ' HB3' ' HB2' ' A' ' 48' ' ' PRO . 4.3 p-10 -63.63 -56.59 14.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.289 -0.414 . . . . 63.020000000000003 110.864 -178.317 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -64.61 -28.76 69.84 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.229 0.538 . . . . 73.010000000000005 110.108 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.444 ' O ' HG13 ' A' ' 58' ' ' ILE . 77.6 t80 -66.26 -49.86 65.71 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.414 -0.812 . . . . 74.25 111.028 179.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.445 ' O ' ' HG3' ' A' ' 59' ' ' GLN . 8.9 t -72.46 -19.48 61.55 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.708 0.262 . . . . 75.409999999999997 111.708 -176.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.438 ' HG3' ' O ' ' A' ' 52' ' ' ASP . 60.9 mt-30 -64.39 -43.69 93.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.895 0.378 . . . . 51.200000000000003 111.096 -178.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.72 -24.89 61.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.337 -0.392 . . . . 74.219999999999999 111.422 -178.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.444 HG13 ' O ' ' A' ' 54' ' ' PHE . 8.6 mt -76.35 -18.67 15.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.107 0.479 . . . . 75.030000000000001 110.974 -176.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.445 ' HG3' ' O ' ' A' ' 55' ' ' THR . 77.4 mt-30 -67.21 -19.16 65.51 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.374 -0.375 . . . . 51.229999999999997 110.98 -178.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 61.0 m -74.87 -34.8 62.29 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.53 -0.304 . . . . 73.340000000000003 111.484 178.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.436 ' HG2' ' O ' ' A' ' 58' ' ' ILE . 11.1 pt20 -82.2 -5.58 58.6 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.862 0.363 . . . . 64.209999999999994 110.966 -177.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.554 HG23 ' HA3' ' A' ' 92' ' ' GLY . 67.7 mt -65.34 -36.02 76.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.284 0.564 . . . . 75.120000000000005 109.799 175.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 9.2 mp -63.47 -35.7 81.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.414 -0.812 . . . . 74.530000000000001 110.622 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -65.7 -40.68 95.92 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.285 -0.726 . . . . 54.140000000000001 111.285 175.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -66.33 -19.56 68.62 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 121.147 -0.549 . . . . 33.530000000000001 112.385 177.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 62' ' ' ILE . 85.5 mt -74.44 -31.9 62.43 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.046 0.45 . . . . 72.230000000000004 110.168 176.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 49.0 mt -74.83 -42.58 57.73 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.996 -0.742 . . . . 70.319999999999993 108.996 175.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.8 m -75.52 5.83 5.45 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.107 -0.951 . . . . 75.109999999999999 111.246 178.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.956 ' HA ' ' HG3' ' A' ' 90' ' ' ARG . 50.6 t30 -82.43 -25.86 33.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.195 -0.457 . . . . 53.439999999999998 110.997 -178.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.0 mp -84.59 -50.67 14.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.204 -0.453 . . . . 71.409999999999997 110.997 -175.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -111.08 -88.48 0.51 Allowed 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.192 -0.603 . . . . 61.43 111.004 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 92.0 m -168.38 126.46 1.12 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.098 -0.704 . . . . 53.310000000000002 109.098 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -152.32 42.56 0.68 Allowed Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.119 -1.039 . . . . 71.019999999999996 111.937 178.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.636 ' HB2' ' O ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -56.96 144.97 66.54 Favored Pre-proline 0 C--N 1.327 -0.376 0 O-C-N 123.517 0.187 . . . . 51.439999999999998 110.978 179.937 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.484 ' HD3' ' HB2' ' A' ' 89' ' ' ASN . 16.1 Cg_endo -58.05 -44.06 42.88 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.951 2.434 . . . . 65.030000000000001 112.929 -175.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 168.26 -156.89 28.76 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.474 -0.869 . . . . 72.120000000000005 112.133 -179.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -150.76 175.46 11.96 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 110.146 -0.316 . . . . 45.020000000000003 110.146 -177.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.761 ' HB3' HG13 ' A' ' 85' ' ' VAL . 47.9 ttm -121.95 121.07 36.24 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.897 -0.779 . . . . 73.310000000000002 108.897 173.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.4 p -88.53 98.31 7.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.867 0.842 . . . . 63.219999999999999 111.827 -173.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.7 p -122.77 156.93 33.47 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.209 -0.905 . . . . 43.310000000000002 109.451 171.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -78.28 -41.18 34.72 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.811 0.338 . . . . 72.310000000000002 111.368 -175.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.713 ' HB3' ' HD3' ' A' ' 102' ' ' LYS . 7.5 m-20 -81.45 -21.68 38.64 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.174 -0.466 . . . . 75.510000000000005 111.282 -174.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -137.49 135.89 37.2 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.978 0.418 . . . . 63.340000000000003 111.363 -177.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.669 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 4.1 mp -105.93 84.94 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 108.407 -0.96 . . . . 71.040000000000006 108.407 172.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.761 HG13 ' HB3' ' A' ' 78' ' ' MET . 2.3 p -91.18 106.8 17.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.642 0.734 . . . . 64.329999999999998 110.455 -177.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -111.51 128.0 55.88 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.316 -0.856 . . . . 74.510000000000005 110.32 -175.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.636 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 19.4 mt -95.86 103.73 15.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.278 -0.419 . . . . 73.150000000000006 110.375 -177.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -88.56 146.76 24.96 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.899 0.381 . . . . 54.140000000000001 111.009 -178.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.484 ' HB2' ' HD3' ' A' ' 75' ' ' PRO . 3.3 t-20 -139.53 110.3 6.76 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.107 -0.497 . . . . 62.210000000000001 109.764 178.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.956 ' HG3' ' HA ' ' A' ' 69' ' ' ASN . 66.8 ttt180 -147.12 141.44 26.31 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.024 -0.535 . . . . 75.439999999999998 109.565 179.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.2 t70 71.71 2.94 4.48 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.449 0.642 . . . . 71.019999999999996 110.452 177.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.554 ' HA3' HG23 ' A' ' 62' ' ' ILE . . . 97.13 -8.62 65.07 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 111.183 -0.767 . . . . 75.319999999999993 111.183 -176.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.403 HE21 ' HA ' ' A' ' 93' ' ' GLN . 0.0 OUTLIER -90.07 135.33 33.72 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.875 0.369 . . . . 62.409999999999997 110.346 179.324 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 94' ' ' LEU . 4.4 mm? -91.97 131.51 37.22 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.408 -0.59 . . . . 52.240000000000002 109.408 173.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.414 ' HG2' ' ND2' ' A' ' 97' ' ' ASN . 6.2 tt0 -133.48 108.1 8.44 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.0 -0.545 . . . . 55.530000000000001 110.468 -178.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.588 ' HB3' ' HB ' ' A' ' 109' ' ' ILE . 44.2 tp -88.83 111.16 21.71 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.757 -0.656 . . . . 75.109999999999999 110.295 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.414 ' ND2' ' HG2' ' A' ' 95' ' ' GLN . 48.7 m-80 -104.56 107.41 18.34 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.881 0.372 . . . . 43.409999999999997 110.63 178.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.6 t -87.02 107.18 16.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.983 -0.553 . . . . 72.019999999999996 110.137 176.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.669 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 28.0 m -89.84 104.1 16.7 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 115.667 -0.697 . . . . 64.319999999999993 109.524 177.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.609 ' HB3' ' N ' ' A' ' 105' ' ' GLN . 32.3 t70 -71.11 127.39 32.43 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.335 -0.848 . . . . 63.399999999999999 110.865 -177.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.413 ' HA ' ' NE ' ' A' ' 101' ' ' ARG . 5.1 tpm_? -99.28 1.94 45.08 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.462 0.648 . . . . 70.420000000000002 110.166 -178.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.713 ' HD3' ' HB3' ' A' ' 82' ' ' ASP . 25.3 mmmt -89.45 -57.08 3.01 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.054 -0.521 . . . . 73.140000000000001 110.421 -178.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 64.2 p -115.08 -31.35 6.07 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.453 0.644 . . . . 72.120000000000005 110.258 178.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.43 ' HA2' ' O ' ' A' ' 100' ' ' ASP . . . 110.01 29.88 3.63 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 115.414 -0.812 . . . . 65.239999999999995 112.378 178.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.609 ' N ' ' HB3' ' A' ' 100' ' ' ASP . 84.1 mm-40 -64.04 160.71 17.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.108 0.48 . . . . 72.040000000000006 110.17 171.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 27.1 m -140.81 87.46 2.11 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.244 -0.65 . . . . 61.32 109.244 174.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.4 t -85.2 114.73 22.53 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.406 -0.815 . . . . 71.150000000000006 109.567 -178.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 19.5 m -102.18 114.79 29.25 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.065 -0.516 . . . . 61.340000000000003 110.72 -178.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.588 ' HB ' ' HB3' ' A' ' 96' ' ' LEU . 4.4 mp -105.97 96.6 4.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.048 -0.523 . . . . 73.010000000000005 109.767 177.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -93.54 142.72 27.02 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.193 -0.458 . . . . 61.100000000000001 109.88 178.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 92.6 t -68.38 124.13 23.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 110.189 -0.3 . . . . 75.109999999999999 110.189 176.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.3 m -58.88 -52.39 65.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.833 -0.621 . . . . 73.519999999999996 111.268 -177.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 175.19 153.29 10.04 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.518 -0.848 . . . . 53.210000000000001 112.411 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.531 HD12 HD11 ' A' ' 62' ' ' ILE . 56.9 mt -119.92 93.09 3.94 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.387 -0.597 . . . . 71.239999999999995 109.387 179.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -133.47 100.16 4.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.408 -0.36 . . . . 62.340000000000003 111.784 -173.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 175.2 131.73 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.878 -0.601 . . . . 63.439999999999998 109.885 177.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -106.34 -71.46 0.75 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 121.012 -0.275 . . . . 61.130000000000003 110.465 177.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 39.4 t 70.71 145.28 0.06 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.636 0.731 . . . . 75.219999999999999 112.294 176.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 17.2 m -145.59 145.22 30.89 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.703 -0.68 . . . . 73.200000000000003 110.107 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -136.98 137.72 39.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.181 0.515 . . . . 62.409999999999997 110.702 174.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -115.04 144.93 42.85 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.777 -0.823 . . . . 75.239999999999995 108.777 170.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 9.6 p-80 -144.95 119.56 9.76 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.149 0.5 . . . . 74.340000000000003 111.462 -174.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 44.1 m-70 -101.65 -163.3 1.0 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.444 -0.798 . . . . 64.150000000000006 110.268 177.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 6.4 p-80 56.08 -174.23 0.06 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.611 1.165 . . . . 75.209999999999994 112.401 179.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 32.9 m170 62.28 49.9 4.07 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.168 0.509 . . . . 71.409999999999997 110.999 -174.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 16.6 t-80 -94.42 -1.5 53.53 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.64 0.734 . . . . 73.129999999999995 109.172 177.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 . . . . . 0 C--O 1.245 0.818 0 CA-C-N 115.314 -0.857 . . . . 54.43 109.251 176.649 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.4 mtm . . . . . 0 N--CA 1.481 1.12 0 N-CA-C 110.341 -0.244 . . . . 75.5 110.341 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -121.05 152.93 38.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.666 0.27 . . . . 74.230000000000004 110.958 -179.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 107.84 -42.69 1.87 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.115 -0.564 . . . . 65.140000000000001 112.105 178.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.1 m -110.61 36.89 2.93 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.481 0.658 . . . . 72.25 109.913 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 50.9 ttm -91.81 131.19 37.34 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.773 -0.649 . . . . 75.430000000000007 109.517 178.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 35.6 p -75.69 89.39 2.8 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.659 0.614 . . . . 74.209999999999994 112.659 -172.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -141.44 -71.39 0.35 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.926 -0.579 . . . . 75.040000000000006 111.008 175.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -88.04 -46.0 9.7 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.296 -0.411 . . . . 73.409999999999997 111.863 -176.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 67.88 157.21 0.13 Allowed 'General case' 0 N--CA 1.468 0.458 0 O-C-N 123.72 0.637 . . . . 73.239999999999995 110.934 -176.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.496 ' HE ' ' HA ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -75.59 -37.93 59.48 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.429 -0.35 . . . . 72.030000000000001 110.576 175.942 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 65.12 86.31 0.14 Allowed Pre-proline 0 N--CA 1.467 0.376 0 O-C-N 123.988 0.805 . . . . 63.140000000000001 110.884 178.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -64.74 140.41 67.52 Favored 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 123.039 2.493 . . . . 71.329999999999998 112.93 -177.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.8 m120 71.52 172.6 0.31 Allowed 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.6 -0.727 . . . . 75.430000000000007 111.953 176.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -134.07 147.75 50.94 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.553 -0.749 . . . . 75.230000000000004 110.028 -177.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.53 64.6 4.01 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 121.19 -0.528 . . . . 71.230000000000004 112.354 178.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -156.6 79.16 0.18 Allowed Glycine 0 N--CA 1.451 -0.314 0 N-CA-C 111.401 -0.68 . . . . 73.329999999999998 111.401 179.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -92.67 155.52 41.84 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-O 120.399 0.143 . . . . 72.140000000000001 111.076 -174.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -58.39 137.54 80.96 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.865 2.377 . . . . 61.409999999999997 111.769 176.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -140.68 144.73 35.81 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.25 -0.432 . . . . 74.519999999999996 110.831 -175.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 43.5 t30 68.1 105.53 0.05 Allowed 'General case' 0 N--CA 1.468 0.45 0 O-C-N 124.105 0.878 . . . . 74.239999999999995 111.954 178.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -134.12 57.2 0.7 Allowed Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 111.424 -0.67 . . . . 62.439999999999998 111.424 177.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.53 68.25 4.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.327 0.584 . . . . 64.099999999999994 111.244 -178.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.609 ' HE1' ' HA ' ' A' ' 26' ' ' ASN . 3.5 t80 -167.71 100.98 0.48 Allowed 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.387 -0.968 . . . . 71.25 108.387 177.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.4 mt -109.55 -2.62 17.47 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.135 0.42 . . . . 62.32 112.135 -169.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 87.5 mt -101.57 -68.27 0.83 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.911 -0.316 . . . . 52.439999999999998 111.437 -178.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.609 ' HA ' ' HE1' ' A' ' 23' ' ' PHE . 28.2 t-20 66.27 98.83 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.624 0.726 . . . . 73.200000000000003 110.467 -175.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.5 m -83.96 95.84 8.66 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.54 -0.755 . . . . 71.349999999999994 110.771 -174.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.18 -52.65 21.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.981 -0.554 . . . . 74.120000000000005 110.844 179.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 61.55 23.64 13.89 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.843 -0.617 . . . . 65.310000000000002 110.579 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -139.08 152.18 47.32 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.155 -0.475 . . . . 75.25 110.303 -178.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -99.49 -82.31 0.44 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.913 -0.585 . . . . 75.530000000000001 109.84 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 179.02 122.08 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.958 -1.127 . . . . 64.010000000000005 107.958 177.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.3 t -86.38 -4.22 59.13 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 121.192 -0.203 . . . . 74.209999999999994 111.291 -173.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -142.16 97.79 3.2 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 121.174 0.512 . . . . 74.430000000000007 110.672 -176.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 21.5 pttm -93.29 1.95 56.79 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.786 0.803 . . . . 71.430000000000007 109.097 178.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -104.99 145.32 30.5 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 114.938 -1.028 . . . . 74.530000000000001 110.134 -174.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.549 ' HA ' ' HB2' ' A' ' 42' ' ' ASP . 37.1 Cg_endo -66.27 143.84 72.23 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.192 1.928 . . . . 70.219999999999999 111.989 178.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.9 m -119.62 -37.94 3.07 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.205 -0.665 . . . . 62.109999999999999 109.205 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -102.43 13.04 35.61 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.198 -0.91 . . . . 74.420000000000002 109.474 175.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.4 t30 69.73 4.39 4.71 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.056 -0.974 . . . . 75.200000000000003 110.874 179.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -144.49 69.09 1.26 Allowed 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.808 -0.812 . . . . 75.340000000000003 108.808 178.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.549 ' HB2' ' HA ' ' A' ' 37' ' ' PRO . 7.8 m-20 -132.43 -85.2 0.47 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.702 -0.681 . . . . 70.120000000000005 110.937 -175.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -141.85 31.3 1.62 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.451 0.643 . . . . 75.219999999999999 109.974 -177.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.422 ' HA2' ' HD3' ' A' ' 37' ' ' PRO . . . -76.54 48.38 2.56 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 121.032 -0.604 . . . . 74.519999999999996 112.559 -178.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 21.0 mt -106.35 -39.88 5.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.484 0.659 . . . . 75.239999999999995 109.797 -177.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -76.64 -20.43 56.7 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.323 -0.853 . . . . 65.319999999999993 109.869 178.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.425 HG23 ' O ' ' A' ' 47' ' ' THR . 9.9 t -120.59 88.04 42.51 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.19 -0.914 . . . . 60.32 109.877 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -67.6 93.52 0.37 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.306 2.671 . . . . 72.099999999999994 113.725 -172.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 72.8 m -105.61 -69.75 0.81 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.089 -0.505 . . . . 71.450000000000003 110.607 172.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.39 -38.35 90.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.873 0.368 . . . . 71.230000000000004 111.922 -178.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.426 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 3.2 pp -95.4 12.06 30.6 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.166 -0.47 . . . . 73.420000000000002 111.67 -175.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' ' 56' ' ' GLN . 15.9 t70 -57.41 -42.87 83.14 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.939 0.399 . . . . 63.020000000000003 111.121 -178.165 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -89.09 15.88 8.03 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.172 -0.467 . . . . 73.010000000000005 111.2 -177.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.765 ' HE1' ' HG2' ' A' ' 105' ' ' GLN . 67.6 t80 -122.97 -64.8 1.15 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.231 -0.44 . . . . 74.25 110.527 -179.333 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.1 m -66.64 -28.08 68.19 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.323 -0.399 . . . . 75.409999999999997 111.586 -175.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.471 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 2.0 mp0 -69.45 -29.62 67.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.829 0.347 . . . . 51.200000000000003 110.835 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.61 -26.1 60.63 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.286 0.565 . . . . 74.219999999999999 110.116 176.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.401 ' O ' HG13 ' A' ' 62' ' ' ILE . 12.1 mt -71.32 -25.47 25.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.458 -0.792 . . . . 75.030000000000001 110.591 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -55.11 -34.14 63.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.605 -0.27 . . . . 51.229999999999997 110.861 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 36.0 t -62.56 -48.92 77.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.184 -0.462 . . . . 73.340000000000003 111.141 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -73.28 -24.95 60.5 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.818 -0.353 . . . . 64.209999999999994 111.05 -176.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.659 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 75.4 mt -76.81 -56.92 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.946 0.403 . . . . 75.120000000000005 110.037 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 84.8 mt -62.1 -33.05 73.72 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.998 -0.546 . . . . 74.530000000000001 111.678 -175.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -77.33 -24.25 66.26 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.493 -0.86 . . . . 54.140000000000001 112.449 179.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -94.2 -20.78 29.32 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.041 -0.6 . . . . 33.530000000000001 112.865 -176.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.659 ' HG ' ' O ' ' A' ' 62' ' ' ILE . 69.7 mt -59.25 -15.58 16.3 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.459 0.54 . . . . 72.230000000000004 112.459 -176.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 84.1 mt -58.69 -41.69 86.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.018 0.437 . . . . 70.319999999999993 110.183 177.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.502 ' HB2' ' HB1' ' A' ' 88' ' ' ALA . 19.7 m -71.97 -24.66 61.63 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.875 -0.602 . . . . 75.109999999999999 110.751 -179.145 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.446 ' ND2' ' HB2' ' A' ' 88' ' ' ALA . 13.4 m120 -80.85 -22.72 39.65 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.865 -0.607 . . . . 53.439999999999998 111.106 -177.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.413 HG12 ' O ' ' A' ' 66' ' ' LEU . 49.5 mm -100.65 -37.38 5.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 112.171 0.434 . . . . 71.409999999999997 112.171 -174.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -61.6 -88.19 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.497 0.925 . . . . 61.43 113.497 -170.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 53.2 m -170.44 144.0 2.39 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.535 -0.543 . . . . 53.310000000000002 109.535 -173.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.571 ' HA3' ' O ' ' A' ' 89' ' ' ASN . . . 143.96 -67.26 0.44 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 121.12 -0.562 . . . . 71.019999999999996 111.985 175.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.527 ' HD3' ' H ' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -54.3 143.09 46.97 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-O 120.807 0.337 . . . . 51.439999999999998 110.978 179.24 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 74' ' ' LYS . 2.8 Cg_exo -78.29 -24.84 7.56 Favored 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 122.882 2.388 . . . . 65.030000000000001 112.087 174.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -176.85 165.93 36.38 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.686 -0.768 . . . . 72.120000000000005 112.652 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 77' ' ' ARG . 1.9 ptm180 -121.54 142.78 49.74 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.401 -0.592 . . . . 45.020000000000003 109.401 178.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.752 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 50.0 ttm -94.88 104.7 16.6 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.278 0.561 . . . . 73.310000000000002 110.776 -176.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 53.4 t -105.22 106.33 20.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.029 -0.532 . . . . 63.219999999999999 110.397 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 14.7 p -127.31 159.4 34.5 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.973 -0.558 . . . . 43.310000000000002 110.177 175.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -62.97 -46.17 88.96 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.368 -0.378 . . . . 72.310000000000002 110.933 -176.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -77.7 -25.91 49.76 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.106 0.409 . . . . 75.510000000000005 112.106 -172.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.421 ' CE1' ' HA ' ' A' ' 100' ' ' ASP . 14.6 m-85 -149.15 136.35 19.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.233 0.54 . . . . 63.340000000000003 111.811 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.614 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 51.7 mm -98.42 99.44 8.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.315 -0.624 . . . . 71.040000000000006 109.315 175.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.752 ' HB ' ' HB3' ' A' ' 78' ' ' MET . 29.1 t -103.38 86.74 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.288 0.566 . . . . 64.329999999999998 110.257 -177.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -91.11 124.01 35.01 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.955 -0.566 . . . . 74.510000000000005 109.711 -177.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 70.5 mt -98.16 117.48 43.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.074 -0.512 . . . . 73.150000000000006 110.386 -175.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.584 ' HB3' ' HB2' ' A' ' 95' ' ' GLN . . . -110.89 87.83 2.63 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.262 0.553 . . . . 54.140000000000001 111.142 -178.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.571 ' O ' ' HA3' ' A' ' 73' ' ' GLY . 2.9 t-20 -97.58 107.64 20.19 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.431 -0.951 . . . . 62.210000000000001 108.431 171.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.483 ' HB3' ' HB3' ' A' ' 68' ' ' SER . 11.5 tpt180 -160.03 147.56 16.55 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.041 -0.527 . . . . 75.439999999999998 109.989 -176.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.3 t70 71.21 0.63 3.5 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 123.748 0.655 . . . . 71.019999999999996 111.111 173.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 114.37 -23.74 12.1 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 115.808 -0.633 . . . . 75.319999999999993 112.443 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.428 HE21 ' HA ' ' A' ' 93' ' ' GLN . 0.0 OUTLIER -95.67 159.07 15.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.351 0.595 . . . . 62.409999999999997 111.697 -175.094 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -106.32 116.59 32.19 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.382 -0.826 . . . . 52.240000000000002 109.451 175.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.584 ' HB2' ' HB3' ' A' ' 88' ' ' ALA . 19.5 mt-30 -121.05 127.94 52.18 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.242 -0.435 . . . . 55.530000000000001 110.15 -179.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.419 ' C ' HD22 ' A' ' 97' ' ' ASN . 41.3 tp -109.94 121.69 45.83 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 110.041 -0.355 . . . . 75.109999999999999 110.041 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.485 ' ND2' HG23 ' A' ' 108' ' ' THR . 0.9 OUTLIER -112.91 102.2 10.22 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.903 -0.406 . . . . 43.409999999999997 109.903 177.625 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.614 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 6.4 p -113.9 115.61 50.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.412 0.625 . . . . 72.019999999999996 111.281 -178.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.581 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 41.2 m -92.44 123.13 35.53 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.805 -0.634 . . . . 64.319999999999993 111.045 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.476 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 26.9 t70 -75.08 158.43 33.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.57 -0.741 . . . . 63.399999999999999 110.649 177.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 11.6 mmt180 -115.61 2.54 13.78 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.486 0.55 . . . . 70.420000000000002 112.486 -176.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -108.13 -35.58 6.54 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.58 0.705 . . . . 73.140000000000001 110.264 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 14.4 p -121.81 -23.2 5.55 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.066 -0.97 . . . . 72.120000000000005 110.325 176.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.476 ' HA2' ' O ' ' A' ' 100' ' ' ASP . . . 83.65 14.56 72.94 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.659 -0.7 . . . . 65.239999999999995 111.986 -179.059 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.765 ' HG2' ' HE1' ' A' ' 54' ' ' PHE . 49.7 mt-30 -63.94 101.81 0.42 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.748 0.308 . . . . 72.040000000000006 110.404 177.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 98' ' ' VAL . 58.5 m -85.88 109.33 18.64 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.829 -0.434 . . . . 61.32 109.829 177.211 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 17.7 t -86.71 105.34 16.87 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.991 -0.55 . . . . 71.150000000000006 109.735 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.485 HG23 ' ND2' ' A' ' 97' ' ' ASN . 8.5 m -92.96 96.1 9.9 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.77 -0.65 . . . . 61.340000000000003 109.813 177.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 65.0 mt -102.86 114.33 42.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.179 -0.464 . . . . 73.010000000000005 111.539 -174.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.505 ' HG2' ' HG2' ' A' ' 95' ' ' GLN . 43.6 mt-30 -95.09 121.19 36.47 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.456 -0.572 . . . . 61.100000000000001 109.456 172.058 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 93.4 t -65.66 124.54 20.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.174 0.511 . . . . 75.109999999999999 111.949 -175.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.6 m -93.42 -174.29 3.46 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.492 -0.776 . . . . 73.519999999999996 110.306 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -120.28 -158.22 10.45 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.195 -1.002 . . . . 53.210000000000001 111.929 176.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 77.1 mt -144.88 -62.19 0.36 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.609 0.204 . . . . 71.239999999999995 111.086 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 62.45 86.46 0.11 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.813 -0.631 . . . . 62.340000000000003 109.656 -174.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -170.52 98.7 0.25 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.772 -0.649 . . . . 63.439999999999998 109.96 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -104.56 -37.82 7.0 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.053 -0.521 . . . . 61.130000000000003 111.171 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 50.0 m 62.14 91.77 0.06 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.219 0.533 . . . . 75.219999999999999 110.565 -178.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.8 p -76.11 86.64 2.98 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.358 0.599 . . . . 73.200000000000003 111.318 -178.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.419 ' OD2' ' HD2' ' A' ' 122' ' ' HIS . 33.5 t70 -101.31 -73.1 0.66 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.689 -0.687 . . . . 62.409999999999997 110.221 -178.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 64.72 -82.84 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.652 -0.703 . . . . 75.239999999999995 112.541 175.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.419 ' HD2' ' OD2' ' A' ' 120' ' ' ASP . 91.3 m-70 66.27 102.58 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.35 0.66 . . . . 74.340000000000003 111.401 -173.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -82.72 91.43 7.01 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.417 -0.586 . . . . 64.150000000000006 109.417 174.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 17.7 p80 -100.11 121.74 41.88 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.702 -0.681 . . . . 75.209999999999994 110.594 -176.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 51.3 t60 -119.03 161.82 19.61 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.241 -1.022 . . . . 71.409999999999997 108.241 178.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 6.7 p80 59.17 170.12 0.07 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.06 0.944 . . . . 73.129999999999995 111.592 -177.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 44.0 t-80 . . . . . 0 C--O 1.244 0.816 0 CA-C-O 118.13 -0.938 . . . . 54.43 110.123 178.293 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 110.094 -0.336 . . . . 75.5 110.094 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 65.27 59.76 0.8 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.299 0.571 . . . . 74.230000000000004 111.386 178.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -129.31 124.24 4.44 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 115.65 -0.705 . . . . 65.140000000000001 111.627 177.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.2 t -81.74 143.77 31.59 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.133 0.492 . . . . 72.25 110.836 -177.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.14 124.47 47.8 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.097 -0.501 . . . . 75.430000000000007 109.746 176.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 26.7 m -153.65 -48.53 0.09 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.391 -0.368 . . . . 74.209999999999994 111.129 -178.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -64.57 -80.9 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.372 -0.376 . . . . 75.040000000000006 111.636 -178.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 49.33 61.23 3.25 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.051 0.54 . . . . 73.409999999999997 111.55 176.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -113.67 172.32 7.05 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.197 -0.456 . . . . 73.239999999999995 111.315 -174.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -164.11 108.87 1.0 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.653 -0.703 . . . . 72.030000000000001 109.536 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.3 t30 65.07 87.87 0.12 Allowed Pre-proline 0 N--CA 1.466 0.371 0 O-C-N 123.22 0.325 . . . . 63.140000000000001 111.036 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.78 -33.25 80.2 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 123.072 2.515 . . . . 71.329999999999998 112.572 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 25.2 t30 73.24 106.48 0.07 Allowed 'General case' 0 N--CA 1.467 0.388 0 O-C-N 123.798 0.686 . . . . 75.430000000000007 112.098 174.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -123.21 104.74 9.35 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.596 -0.729 . . . . 75.230000000000004 109.24 173.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 174.25 51.69 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.621 -0.8 . . . . 71.230000000000004 112.251 -179.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -100.5 103.39 2.61 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.997 -0.621 . . . . 73.329999999999998 111.663 178.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.438 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 50.3 m-80 -117.54 148.88 43.83 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 110.381 -0.229 . . . . 72.140000000000001 110.381 -177.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 17' ' ' ASN . 5.5 Cg_exo -77.5 94.11 1.07 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.282 2.655 . . . . 61.409999999999997 113.62 -175.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 47.02 -87.92 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 114.329 1.233 . . . . 74.519999999999996 114.329 172.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -177.59 -179.76 0.85 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.756 0.312 . . . . 74.239999999999995 110.236 -170.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -120.44 -46.27 0.37 Allowed Glycine 0 N--CA 1.452 -0.294 0 N-CA-C 111.299 -0.72 . . . . 62.439999999999998 111.299 175.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 63.75 -168.51 0.2 Allowed 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 123.414 0.685 . . . . 64.099999999999994 111.809 176.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -131.43 145.5 51.83 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.113 -0.494 . . . . 71.25 110.027 -177.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.554 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 5.4 mp -112.57 114.43 27.07 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.111 -0.329 . . . . 62.32 110.111 179.13 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' A' ' 24' ' ' LEU . 4.4 pp 48.81 -166.14 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 O-C-N 124.074 0.859 . . . . 52.439999999999998 112.095 178.272 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -172.42 -85.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.789 -0.448 . . . . 73.200000000000003 109.789 173.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.5 p 176.09 136.75 0.05 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.695 -0.684 . . . . 71.349999999999994 109.174 177.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -142.55 125.53 16.22 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.667 0.27 . . . . 74.120000000000005 110.759 -178.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -128.06 126.43 41.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.114 -0.494 . . . . 65.310000000000002 110.087 178.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -98.73 7.17 46.39 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.087 -0.506 . . . . 75.25 111.767 -173.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -90.3 83.44 5.96 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.413 0.625 . . . . 75.530000000000001 111.084 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -161.29 -176.28 5.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.403 -0.817 . . . . 64.010000000000005 109.422 178.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.9 m 62.18 37.11 14.58 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 121.318 0.58 . . . . 74.209999999999994 111.053 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -93.96 11.67 28.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.773 -0.649 . . . . 74.430000000000007 110.655 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.456 ' HD2' ' HA ' ' A' ' 35' ' ' LYS . 17.3 tptm -107.82 176.32 5.18 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.853 -0.795 . . . . 71.430000000000007 108.853 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.431 ' H ' ' HG3' ' A' ' 35' ' ' LYS . 10.1 m-20 -44.24 142.98 2.06 Favored Pre-proline 0 N--CA 1.467 0.411 0 O-C-N 123.758 0.662 . . . . 74.530000000000001 112.246 -175.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.523 ' HG3' HG12 ' A' ' 45' ' ' ILE . 18.0 Cg_endo -59.16 152.74 57.35 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 123.419 2.746 . . . . 70.219999999999999 113.545 -175.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 28.2 t -146.58 38.34 1.02 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.77 -1.105 . . . . 62.109999999999999 108.447 -178.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.405 ' O ' ' HB2' ' A' ' 40' ' ' ASN . 24.4 t80 73.02 160.54 0.23 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-N 114.705 -1.134 . . . . 74.420000000000002 109.958 -174.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.405 ' HB2' ' O ' ' A' ' 39' ' ' TYR . 91.1 m-20 71.74 3.83 4.82 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.218 0.607 . . . . 75.200000000000003 111.073 -177.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -174.69 130.29 0.33 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.334 -0.987 . . . . 75.340000000000003 108.334 175.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -127.02 21.3 6.84 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.153 0.502 . . . . 70.120000000000005 110.773 -177.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -111.12 -21.32 12.0 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.781 -0.645 . . . . 75.219999999999999 110.772 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -75.6 46.82 2.03 Favored Glycine 0 C--O 1.223 -0.588 0 C-N-CA 121.152 -0.547 . . . . 74.519999999999996 112.858 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.523 HG12 ' HG3' ' A' ' 37' ' ' PRO . 10.4 mt -99.45 -6.69 9.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.143 -0.688 . . . . 75.239999999999995 109.143 178.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.433 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 30.9 tt0 64.58 24.47 13.03 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.027 -0.988 . . . . 65.319999999999993 109.621 -174.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 8.2 m -113.02 86.15 8.81 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.116 -0.947 . . . . 60.32 109.236 175.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' A' ' 46' ' ' GLU . 17.1 Cg_exo -66.21 99.22 0.41 Allowed 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.692 2.262 . . . . 72.099999999999994 113.157 -173.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.8 m -127.85 -59.46 1.2 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.824 -0.625 . . . . 71.450000000000003 109.603 174.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.54 -46.37 15.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.027 -0.533 . . . . 71.230000000000004 110.263 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.54 HD23 ' H ' ' A' ' 51' ' ' LEU . 1.4 pt? -74.6 -13.35 60.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 73.420000000000002 110.778 179.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.621 ' O ' ' HB2' ' A' ' 56' ' ' GLN . 27.0 t70 -62.69 -47.23 84.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.151 -0.477 . . . . 63.020000000000003 110.457 -179.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -79.2 9.91 4.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.426 -0.352 . . . . 73.010000000000005 110.865 178.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.456 ' O ' HG13 ' A' ' 58' ' ' ILE . 82.4 t80 -109.65 -64.82 1.21 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.759 0.314 . . . . 74.25 110.432 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.47 ' O ' ' HG2' ' A' ' 59' ' ' GLN . 12.9 t -73.5 -18.5 61.1 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.937 0.347 . . . . 75.409999999999997 111.937 -174.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.621 ' HB2' ' O ' ' A' ' 52' ' ' ASP . 2.3 mp0 -75.09 -28.11 60.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.802 0.334 . . . . 51.200000000000003 110.614 -178.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -79.57 -18.83 50.86 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.536 0.684 . . . . 74.219999999999999 109.771 175.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.516 ' O ' HG13 ' A' ' 62' ' ' ILE . 21.7 mt -79.3 -29.06 13.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.37 -0.832 . . . . 75.030000000000001 110.604 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.47 ' HG2' ' O ' ' A' ' 55' ' ' THR . 15.1 mm-40 -53.29 -37.61 62.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.132 -0.485 . . . . 51.229999999999997 111.136 -178.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.8 m -62.71 -46.55 87.6 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.046 -0.525 . . . . 73.340000000000003 111.022 179.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -77.78 -16.14 58.58 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.844 -0.342 . . . . 64.209999999999994 111.082 -178.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.516 HG13 ' O ' ' A' ' 58' ' ' ILE . 64.7 mt -71.27 -43.09 74.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.302 -0.629 . . . . 75.120000000000005 109.302 172.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 97.1 mt -61.45 -41.56 97.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.926 -0.579 . . . . 74.530000000000001 110.096 175.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -65.15 -37.33 93.98 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.771 -0.728 . . . . 54.140000000000001 111.714 175.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.21 -37.34 94.37 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 111.784 -0.526 . . . . 33.530000000000001 111.784 176.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 62' ' ' ILE . 95.9 mt -56.9 -59.51 4.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.593 0.235 . . . . 72.230000000000004 110.998 178.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 pp -65.6 -10.4 35.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.864 0.364 . . . . 70.319999999999993 111.741 -176.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.405 ' HA ' ' HG3' ' A' ' 90' ' ' ARG . 31.4 m -95.86 -46.43 6.56 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.662 0.267 . . . . 75.109999999999999 111.246 178.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -92.08 -26.85 18.11 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.399 0.518 . . . . 53.439999999999998 112.399 -172.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 36.1 mm -66.58 -20.97 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 121.268 0.556 . . . . 71.409999999999997 110.452 -178.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.434 HD22 ' N ' ' A' ' 71' ' ' ASN . 0.9 OUTLIER -68.36 -28.81 67.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.106 0.479 . . . . 61.43 110.28 175.925 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.8 m -96.9 -49.35 5.07 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.106 -0.497 . . . . 53.310000000000002 110.638 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 85.11 -89.72 1.62 Allowed Glycine 0 N--CA 1.449 -0.433 0 N-CA-C 111.682 -0.567 . . . . 71.019999999999996 111.682 -178.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -57.82 153.77 30.61 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.595 -0.302 . . . . 51.439999999999998 110.203 174.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.43 123.79 14.67 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.17 1.914 . . . . 65.030000000000001 111.809 177.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -96.55 64.67 1.07 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.627 -0.797 . . . . 72.120000000000005 112.494 -176.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -165.33 125.12 1.81 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.084 0.468 . . . . 45.020000000000003 110.923 178.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 58.9 ttp -112.58 108.19 17.18 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.907 -0.588 . . . . 73.310000000000002 109.642 178.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 60.9 t -74.35 102.81 2.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.243 0.544 . . . . 63.219999999999999 111.043 -176.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.666 ' HB ' ' O ' ' A' ' 83' ' ' TYR . 17.5 m -120.95 142.15 50.01 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.376 -0.829 . . . . 43.310000000000002 109.28 178.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -70.15 -36.31 74.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.903 0.382 . . . . 72.310000000000002 111.08 -174.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -82.4 -40.1 21.74 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.94 -0.573 . . . . 75.510000000000005 111.491 -176.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.666 ' O ' ' HB ' ' A' ' 80' ' ' THR . 49.6 m-85 -139.96 120.8 14.46 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.205 -0.294 . . . . 63.340000000000003 110.205 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.66 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 4.2 mp -83.68 99.89 6.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.069 -0.715 . . . . 71.040000000000006 109.069 178.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.3 t -91.01 106.7 17.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.609 -0.723 . . . . 64.329999999999998 111.097 -175.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -105.23 122.91 46.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.058 -0.519 . . . . 74.510000000000005 109.693 176.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 56.8 mt -101.55 118.12 47.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.286 -0.416 . . . . 73.150000000000006 110.524 -175.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -112.51 88.48 2.83 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.109 0.48 . . . . 54.140000000000001 110.492 178.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -95.33 88.54 5.16 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.195 -0.669 . . . . 62.210000000000001 109.195 175.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.405 ' HG3' ' HA ' ' A' ' 68' ' ' SER . 56.7 ttp180 -130.75 143.06 50.48 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.567 -0.742 . . . . 75.439999999999998 109.717 -177.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 37.7 t70 65.7 24.16 11.56 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.64 0.733 . . . . 71.019999999999996 110.664 174.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.24 5.15 90.26 Favored Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 115.577 -0.738 . . . . 75.319999999999993 112.623 178.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.455 HE21 ' HA ' ' A' ' 93' ' ' GLN . 0.0 OUTLIER -104.4 134.4 47.68 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.873 0.368 . . . . 62.409999999999997 110.759 -179.622 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.491 ' HB2' ' HB ' ' A' ' 111' ' ' VAL . 4.5 mm? -91.97 96.34 10.31 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.867 -0.606 . . . . 52.240000000000002 109.39 174.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -106.33 110.0 22.1 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.327 0.584 . . . . 55.530000000000001 110.695 -179.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 35.8 tp -94.06 109.38 21.14 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.453 -0.794 . . . . 75.109999999999999 110.034 -178.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -97.82 93.06 6.15 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.949 0.404 . . . . 43.409999999999997 110.52 -179.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 56.0 t -85.01 103.63 12.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.143 0.497 . . . . 72.019999999999996 110.369 177.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.66 ' HB ' ' HB ' ' A' ' 84' ' ' ILE . 57.9 m -77.31 104.43 7.82 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.204 -0.665 . . . . 64.319999999999993 109.204 175.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -69.55 138.45 53.27 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.477 -0.783 . . . . 63.399999999999999 111.641 -174.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -108.02 -12.91 15.06 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.384 -0.825 . . . . 70.420000000000002 109.716 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -77.74 -55.86 4.99 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.813 -0.631 . . . . 73.140000000000001 110.714 -176.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 47.0 p -115.88 -23.15 8.73 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.387 0.613 . . . . 72.120000000000005 110.389 178.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 93.11 28.65 11.43 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.551 -0.75 . . . . 65.239999999999995 112.121 177.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -101.02 100.8 11.46 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 110.133 -0.321 . . . . 72.040000000000006 110.133 177.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 19.0 m -58.64 109.94 0.9 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.328 0.585 . . . . 61.32 110.867 -178.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 7.9 m -89.82 89.61 7.83 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.622 -0.717 . . . . 71.150000000000006 110.015 -178.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 45.4 m -83.46 109.3 17.23 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.931 -0.577 . . . . 61.340000000000003 110.317 178.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 58.9 mt -108.34 111.23 35.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.923 -0.58 . . . . 73.010000000000005 110.907 -177.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -88.96 118.54 28.76 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.981 0.42 . . . . 61.100000000000001 110.35 175.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.491 ' HB ' ' HB2' ' A' ' 94' ' ' LEU . 23.0 t -75.51 161.7 4.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.925 -0.58 . . . . 75.109999999999999 109.839 178.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.42 ' N ' HG12 ' A' ' 111' ' ' VAL . 37.1 m 75.48 25.41 1.24 Allowed 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.293 0.637 . . . . 73.519999999999996 110.682 -178.042 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -83.09 -44.43 7.08 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.752 -0.658 . . . . 53.210000000000001 111.769 178.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 58.4 mt -96.09 94.96 7.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.04 0.448 . . . . 71.239999999999995 110.887 179.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -101.13 148.34 25.19 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.01 -0.541 . . . . 62.340000000000003 109.854 177.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -145.07 115.34 7.54 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.92 -0.4 . . . . 63.439999999999998 109.92 -178.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -83.95 119.97 25.54 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.162 -0.472 . . . . 61.130000000000003 110.623 -177.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 50.4 m -144.16 143.2 30.98 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.951 -0.388 . . . . 75.219999999999999 109.951 177.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.7 t -161.91 152.5 17.47 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.919 0.39 . . . . 73.200000000000003 111.162 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -130.55 125.18 33.59 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.85 -0.796 . . . . 62.409999999999997 108.85 174.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.417 ' O ' ' HB2' ' A' ' 122' ' ' HIS . 33.5 t80 -92.1 -76.17 0.46 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.591 -0.277 . . . . 75.239999999999995 111.391 -169.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.417 ' HB2' ' O ' ' A' ' 121' ' ' PHE . 54.2 m170 69.2 157.36 0.15 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.497 0.665 . . . . 74.340000000000003 111.692 -176.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 43.0 m170 -117.42 -55.54 2.3 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.756 -0.656 . . . . 64.150000000000006 109.459 173.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -172.22 -60.24 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.871 -0.604 . . . . 75.209999999999994 109.66 176.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 63.93 169.52 0.16 Allowed 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.84 0.681 . . . . 71.409999999999997 112.84 177.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 8.4 p-80 -176.14 152.69 1.18 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.089 -0.96 . . . . 73.129999999999995 109.552 172.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.359 -0.829 . . . . 54.43 109.171 173.612 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 N--CA 1.479 1.018 0 CA-C-O 120.897 0.379 . . . . 75.5 110.203 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.69 130.37 9.11 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.175 -0.466 . . . . 74.230000000000004 110.35 179.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -101.94 113.11 4.53 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.934 -0.65 . . . . 65.140000000000001 111.572 178.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.544 ' HA ' ' HE1' ' A' ' 7' ' ' PHE . 5.6 p -98.12 88.74 4.29 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.034 0.445 . . . . 72.25 110.418 177.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 56.7 ttp -61.73 -43.13 99.45 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.544 -0.753 . . . . 75.430000000000007 110.139 178.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.55 HG23 ' H ' ' A' ' 7' ' ' PHE . 2.7 t -167.21 -64.61 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.974 -0.557 . . . . 74.209999999999994 110.935 173.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.55 ' H ' HG23 ' A' ' 6' ' ' THR . 97.9 m-85 60.16 113.75 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.387 0.613 . . . . 75.040000000000006 111.97 -178.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -127.13 88.12 2.76 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.187 0.518 . . . . 73.409999999999997 109.887 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.52 ' CE2' ' HB3' ' A' ' 11' ' ' ASN . 86.5 t80 -151.01 126.2 9.93 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.676 -0.693 . . . . 73.239999999999995 110.061 -178.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.41 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -102.1 92.91 4.97 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.804 -0.443 . . . . 72.030000000000001 109.804 -178.698 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.52 ' HB3' ' CE2' ' A' ' 9' ' ' PHE . 27.3 p30 -89.25 146.11 35.5 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-O 120.826 0.346 . . . . 63.140000000000001 110.666 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -73.91 -19.77 20.36 Favored 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 122.704 2.269 . . . . 71.329999999999998 112.166 177.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 64.76 102.76 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.678 -0.692 . . . . 75.430000000000007 111.13 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -120.49 140.69 51.07 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.154 -0.475 . . . . 75.230000000000004 110.837 178.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -89.97 -143.18 10.11 Favored Glycine 0 N--CA 1.444 -0.787 0 N-CA-C 111.332 -0.707 . . . . 71.230000000000004 111.332 174.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -148.32 -105.41 0.38 Allowed Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.499 -0.857 . . . . 73.329999999999998 112.545 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.41 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 50.8 m-80 -121.24 146.85 45.57 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 110.173 -0.306 . . . . 72.140000000000001 110.173 -178.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 17' ' ' ASN . 16.9 Cg_exo -68.35 -31.21 28.76 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.642 2.228 . . . . 61.409999999999997 111.33 176.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 11.7 t30 68.71 126.62 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.327 -0.851 . . . . 74.519999999999996 111.266 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -82.32 152.14 26.41 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.974 -0.557 . . . . 74.239999999999995 110.914 -177.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -88.67 -177.43 46.78 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.731 -0.747 . . . . 62.439999999999998 111.656 177.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -89.83 157.08 18.07 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.09 0.472 . . . . 64.099999999999994 111.077 -178.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -132.65 131.99 41.95 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.679 -0.692 . . . . 71.25 109.42 176.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.8 mp -115.68 115.78 26.96 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.949 0.404 . . . . 62.32 111.043 -176.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.9 mt -131.88 108.53 9.47 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.723 -0.671 . . . . 52.439999999999998 109.99 177.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -95.79 163.86 12.99 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.297 -0.41 . . . . 73.200000000000003 110.813 -177.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 26.2 m -122.21 23.5 9.81 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.062 -0.517 . . . . 71.349999999999994 110.899 -176.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 67.5 -163.14 0.22 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.701 -0.682 . . . . 74.120000000000005 111.125 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.5 tp60 -116.86 169.6 9.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.291 -0.413 . . . . 65.310000000000002 110.187 -175.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -75.16 128.76 36.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.787 0.327 . . . . 75.25 110.565 178.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.3 pm0 -100.74 149.83 23.4 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.55 -0.295 . . . . 75.530000000000001 111.335 -177.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -174.77 122.73 0.25 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.943 -0.572 . . . . 64.010000000000005 110.445 176.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.3 m 51.31 48.57 22.75 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.138 -0.483 . . . . 74.209999999999994 111.563 177.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -73.63 -15.49 61.26 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.87 -0.604 . . . . 74.430000000000007 112.219 -174.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.3 ttmt 70.37 -162.85 0.16 Allowed 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.871 -0.418 . . . . 71.430000000000007 109.871 -177.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.494 ' HB2' ' HD2' ' A' ' 37' ' ' PRO . 6.1 p-10 -78.74 160.59 71.64 Favored Pre-proline 0 C--O 1.235 0.318 0 CA-C-O 120.295 0.093 . . . . 74.530000000000001 110.988 -177.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.683 ' HA ' ' OD2' ' A' ' 42' ' ' ASP . 73.9 Cg_exo -43.22 143.52 2.11 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.945 3.097 . . . . 70.219999999999999 115.271 -175.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.0 m -117.78 21.25 13.03 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.82 -1.082 . . . . 62.109999999999999 110.263 178.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 52.7 t80 75.1 164.93 0.28 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.524 -0.762 . . . . 74.420000000000002 111.244 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 66.9 t30 71.84 -175.99 0.18 Allowed 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.873 -0.788 . . . . 75.200000000000003 108.873 -172.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -60.87 110.25 1.28 Allowed 'General case' 0 C--O 1.234 0.258 0 N-CA-C 108.33 -0.989 . . . . 75.340000000000003 108.33 171.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.683 ' OD2' ' HA ' ' A' ' 37' ' ' PRO . 14.9 t70 -128.18 -53.24 1.29 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.526 -0.761 . . . . 70.120000000000005 112.335 -160.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.587 ' O ' ' HG2' ' A' ' 46' ' ' GLU . 40.5 m-85 57.63 24.56 10.64 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.161 0.8 . . . . 75.219999999999999 113.161 -178.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -75.46 19.34 2.47 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 121.154 -0.545 . . . . 74.519999999999996 112.692 176.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.484 ' HA ' HD21 ' A' ' 51' ' ' LEU . 54.3 mt -91.24 -19.84 6.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.378 0.609 . . . . 75.239999999999995 109.631 178.276 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.587 ' HG2' ' O ' ' A' ' 43' ' ' PHE . 11.7 pt-20 -86.9 0.67 54.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.656 -0.702 . . . . 65.319999999999993 110.189 178.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.7 87.7 3.77 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 115.612 -0.722 . . . . 60.32 110.767 175.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.521 ' CB ' ' HB2' ' A' ' 52' ' ' ASP . 50.7 Cg_endo -70.01 82.9 0.77 Allowed 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.037 1.825 . . . . 72.099999999999994 111.653 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.1 m -117.03 -8.96 11.17 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.82 -0.627 . . . . 71.450000000000003 110.792 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -165.42 -32.71 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.493 -0.321 . . . . 71.230000000000004 111.749 -176.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.484 HD21 ' HA ' ' A' ' 45' ' ' ILE . 3.9 pp -88.44 -10.07 50.4 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.846 0.313 . . . . 73.420000000000002 111.846 -177.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.521 ' HB2' ' CB ' ' A' ' 48' ' ' PRO . 17.4 t70 -56.52 -61.38 2.45 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.237 0.458 . . . . 63.020000000000003 112.237 -173.268 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -64.14 -33.3 75.47 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.039 -0.528 . . . . 73.010000000000005 110.763 -174.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.578 ' O ' HG13 ' A' ' 58' ' ' ILE . 72.3 t80 -70.76 -59.4 2.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.027 -0.533 . . . . 74.25 111.642 -176.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.402 HG22 ' O ' ' A' ' 51' ' ' LEU . 14.2 t -66.26 -23.78 66.46 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.773 0.32 . . . . 75.409999999999997 111.327 -173.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -82.72 -34.11 27.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.594 -0.275 . . . . 51.200000000000003 110.682 177.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.89 -28.35 69.48 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.824 -0.435 . . . . 74.219999999999999 109.824 175.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.586 ' HA ' ' HG2' ' A' ' 61' ' ' GLN . 25.5 mt -62.07 -35.48 68.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.063 -0.517 . . . . 75.030000000000001 110.35 176.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -68.57 -32.42 72.32 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.149 -0.478 . . . . 51.229999999999997 110.847 178.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.681 ' O ' HD22 ' A' ' 63' ' ' LEU . 23.0 m -79.99 -35.43 37.49 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.198 -0.456 . . . . 73.340000000000003 110.645 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.586 ' HG2' ' HA ' ' A' ' 58' ' ' ILE . 3.2 pt20 -78.39 -1.31 32.83 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.739 0.304 . . . . 64.209999999999994 111.545 -176.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.597 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 69.4 mt -60.69 -29.44 44.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.864 0.364 . . . . 75.120000000000005 110.421 177.183 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.685 HD23 ' N ' ' A' ' 64' ' ' GLY . 0.2 OUTLIER -61.05 -19.47 61.42 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.024 -0.535 . . . . 74.530000000000001 111.876 -177.385 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.685 ' N ' HD23 ' A' ' 63' ' ' LEU . . . -112.03 -32.3 2.45 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.404 -0.678 . . . . 54.140000000000001 111.404 175.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -63.55 -28.29 72.24 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 121.547 -0.358 . . . . 33.530000000000001 112.431 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.613 ' O ' HG12 ' A' ' 70' ' ' ILE . 73.6 mt -52.49 -47.69 66.41 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 120.59 0.233 . . . . 72.230000000000004 110.761 176.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.433 ' HB2' ' HD2' ' A' ' 90' ' ' ARG . 71.0 mt -61.31 -30.89 70.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.188 -0.46 . . . . 70.319999999999993 111.047 -176.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.9 m -76.9 -36.2 56.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.18 -0.464 . . . . 75.109999999999999 110.647 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -77.79 -26.11 49.46 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.368 -0.378 . . . . 53.439999999999998 110.647 -179.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.613 HG12 ' O ' ' A' ' 66' ' ' LEU . 30.6 mm -64.64 -36.81 78.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.121 -0.49 . . . . 71.409999999999997 110.331 177.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.54 ' C ' HD22 ' A' ' 71' ' ' ASN . 0.2 OUTLIER -56.61 -50.89 70.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.331 -0.395 . . . . 61.43 109.967 178.605 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.1 m 67.62 111.54 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 O-C-N 123.645 0.59 . . . . 53.310000000000002 111.039 -178.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 172.18 -45.59 0.18 Allowed Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.755 -0.736 . . . . 71.019999999999996 112.094 -178.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -56.57 144.67 63.5 Favored Pre-proline 0 C--O 1.234 0.252 0 CA-C-O 120.618 0.247 . . . . 51.439999999999998 110.932 178.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.549 ' HD2' HD12 ' A' ' 87' ' ' ILE . 20.2 Cg_exo -67.98 -5.69 15.24 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.901 2.401 . . . . 65.030000000000001 112.389 177.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 106.81 166.75 22.46 Favored Glycine 0 N--CA 1.442 -0.921 0 N-CA-C 111.194 -0.762 . . . . 72.120000000000005 111.194 -178.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.479 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 6.7 ptp180 -65.15 128.74 37.05 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.562 -0.533 . . . . 45.020000000000003 109.562 175.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 56.3 ttp -78.9 103.71 9.03 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.603 -0.517 . . . . 73.310000000000002 109.603 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 48.8 t -71.01 102.11 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.599 -0.728 . . . . 63.219999999999999 109.721 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.413 ' HB ' ' O ' ' A' ' 83' ' ' TYR . 3.7 m -94.24 165.3 12.66 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.019 -0.734 . . . . 43.310000000000002 109.019 178.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -53.31 -31.45 44.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.872 0.368 . . . . 72.310000000000002 111.702 -178.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -139.73 -42.75 0.44 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.905 0.384 . . . . 75.510000000000005 110.647 -179.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.413 ' O ' ' HB ' ' A' ' 80' ' ' THR . 75.4 m-85 -76.84 144.31 39.15 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.839 -0.618 . . . . 63.340000000000003 111.54 -176.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.505 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 4.3 mp -110.66 100.15 10.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.331 -0.618 . . . . 71.040000000000006 109.331 175.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.605 HG22 HG23 ' A' ' 98' ' ' VAL . 12.6 t -106.49 98.4 6.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.279 -0.419 . . . . 64.329999999999998 110.806 -175.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.479 ' HA ' ' HA ' ' A' ' 77' ' ' ARG . 33.2 t70 -96.19 127.71 42.44 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.137 0.494 . . . . 74.510000000000005 110.24 179.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.549 HD12 ' HD2' ' A' ' 75' ' ' PRO . 60.9 mt -80.73 85.53 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.687 -0.688 . . . . 73.150000000000006 109.64 178.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.6 82.9 2.62 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.18 0.514 . . . . 54.140000000000001 111.665 -175.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -96.26 101.84 13.54 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.838 -0.619 . . . . 62.210000000000001 109.42 175.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.433 ' HD2' ' HB2' ' A' ' 67' ' ' LEU . 37.7 ttp180 -121.1 97.7 5.64 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.91 0.386 . . . . 75.439999999999998 111.083 -177.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 37.1 t70 60.1 82.47 0.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.8 -1.091 . . . . 71.019999999999996 111.427 175.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.93 -67.34 3.76 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.445 -0.798 . . . . 75.319999999999993 113.386 178.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.551 HE21 ' HA ' ' A' ' 93' ' ' GLN . 0.1 OUTLIER -83.95 159.62 21.23 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.232 0.539 . . . . 62.409999999999997 111.126 -173.167 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.542 HD21 HG23 ' A' ' 87' ' ' ILE . 4.8 tt -135.47 134.3 39.43 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.805 -0.634 . . . . 52.240000000000002 109.609 -174.027 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.636 ' HG2' ' HG2' ' A' ' 110' ' ' GLN . 22.8 mt-30 -120.6 105.44 10.8 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.881 0.372 . . . . 55.530000000000001 110.096 175.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 43.6 tp -83.96 109.91 18.0 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.178 -0.465 . . . . 75.109999999999999 110.049 -178.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.534 ' HB3' HG23 ' A' ' 108' ' ' THR . 8.0 p30 -111.62 119.95 40.42 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.465 0.65 . . . . 43.409999999999997 111.22 -178.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.605 HG23 HG22 ' A' ' 85' ' ' VAL . 3.2 p -98.25 102.95 14.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.539 0.685 . . . . 72.019999999999996 109.478 173.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.86 ' HA ' HG22 ' A' ' 106' ' ' THR . 44.3 m -81.73 105.27 12.73 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.647 -0.706 . . . . 64.319999999999993 111.037 -177.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.533 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 11.4 t70 -72.42 143.82 48.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.517 -0.765 . . . . 63.399999999999999 109.769 173.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -109.17 -11.57 14.9 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.549 -0.296 . . . . 70.420000000000002 111.456 -178.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -81.05 -57.02 3.71 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.589 -0.444 . . . . 73.140000000000001 110.449 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 51.8 p -107.03 -27.45 10.63 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.094 0.473 . . . . 72.120000000000005 110.199 178.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.533 ' HA2' ' O ' ' A' ' 100' ' ' ASP . . . 91.48 20.37 38.17 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.662 -0.699 . . . . 65.239999999999995 112.661 175.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -76.49 95.93 3.97 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.681 -0.489 . . . . 72.040000000000006 109.681 177.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.86 HG22 ' HA ' ' A' ' 99' ' ' THR . 29.2 p -84.1 91.44 7.67 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.832 -0.622 . . . . 61.32 111.309 -177.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.444 ' HB3' ' CG1' ' A' ' 98' ' ' VAL . 33.1 t -67.14 101.55 0.9 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.129 -0.693 . . . . 71.150000000000006 109.129 176.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.534 HG23 ' HB3' ' A' ' 97' ' ' ASN . 10.1 m -104.24 107.04 17.77 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 116.033 -0.53 . . . . 61.340000000000003 110.056 -178.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 60.3 mt -106.69 114.36 45.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.864 -0.607 . . . . 73.010000000000005 110.353 -176.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.636 ' HG2' ' HG2' ' A' ' 95' ' ' GLN . 49.9 mt-30 -66.71 116.98 8.21 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.692 -0.484 . . . . 61.100000000000001 109.692 174.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.507 ' HB ' ' HB3' ' A' ' 94' ' ' LEU . 58.8 t -74.3 98.52 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.465 0.65 . . . . 75.109999999999999 110.828 -173.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.8 t -151.24 -55.3 0.15 Allowed 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.163 -1.051 . . . . 73.519999999999996 108.163 175.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 64.59 47.93 78.51 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.655 -0.702 . . . . 53.210000000000001 112.746 174.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 91.1 mt -96.81 -57.28 2.33 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 110.225 -0.287 . . . . 71.239999999999995 110.225 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 75.0 mm-40 54.61 95.62 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.855 0.722 . . . . 62.340000000000003 110.605 -173.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -58.53 98.09 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.476 -0.783 . . . . 63.439999999999998 112.124 -171.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -175.71 93.1 0.06 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.329 -1.36 . . . . 61.130000000000003 107.329 178.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 10.8 t -82.64 146.08 29.3 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.36 0.6 . . . . 75.219999999999999 111.387 -169.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 19.5 p -120.46 161.77 20.67 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.261 -0.882 . . . . 73.200000000000003 110.073 179.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -106.85 111.88 24.6 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.717 -0.475 . . . . 62.409999999999997 109.717 176.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -59.09 -49.65 77.08 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.146 -0.687 . . . . 75.239999999999995 109.146 178.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 70.72 116.81 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 114.928 -1.033 . . . . 74.340000000000003 112.551 168.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 60.1 m170 -92.35 148.38 22.17 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.054 -0.721 . . . . 64.150000000000006 109.054 171.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 52.3 p-80 -117.64 125.3 50.49 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.85 -0.34 . . . . 75.209999999999994 110.394 -176.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 42.8 m80 -127.19 -67.04 0.86 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.499 -0.318 . . . . 71.409999999999997 111.049 -179.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 68.4 m80 52.98 72.2 0.44 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.064 -0.516 . . . . 73.129999999999995 110.101 -174.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 73.8 t60 . . . . . 0 C--O 1.248 0.989 0 CA-C-O 117.941 -1.028 . . . . 54.43 110.311 -172.834 . . . . . . . . 0 0 . 1 stop_ save_